0001493152-24-014436.txt : 20240412 0001493152-24-014436.hdr.sgml : 20240412 20240412145756 ACCESSION NUMBER: 0001493152-24-014436 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 93 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240412 DATE AS OF CHANGE: 20240412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Better Choice Co Inc. CENTRAL INDEX KEY: 0001471727 STANDARD INDUSTRIAL CLASSIFICATION: BEVERAGES [2080] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 834284557 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40477 FILM NUMBER: 24841115 BUSINESS ADDRESS: STREET 1: 12400 RACE TRACK ROAD CITY: TAMPA STATE: FL ZIP: 33626 BUSINESS PHONE: 813-792-4352 MAIL ADDRESS: STREET 1: 12400 RACE TRACK ROAD CITY: TAMPA STATE: FL ZIP: 33626 FORMER COMPANY: FORMER CONFORMED NAME: Sport Endurance, Inc. DATE OF NAME CHANGE: 20090904 10-K 1 form10-k.htm
false FY 0001471727 Better Choice Co Inc. P2Y P10Y 0001471727 2023-01-01 2023-12-31 0001471727 2023-09-30 0001471727 2024-04-11 0001471727 2022-01-01 2022-12-31 0001471727 2023-12-31 0001471727 2022-12-31 0001471727 us-gaap:CommonStockMember 2021-12-31 0001471727 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001471727 us-gaap:RetainedEarningsMember 2021-12-31 0001471727 2021-12-31 0001471727 us-gaap:CommonStockMember 2022-12-31 0001471727 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001471727 us-gaap:RetainedEarningsMember 2022-12-31 0001471727 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001471727 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001471727 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001471727 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001471727 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001471727 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001471727 us-gaap:CommonStockMember 2023-12-31 0001471727 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001471727 us-gaap:RetainedEarningsMember 2023-12-31 0001471727 us-gaap:IPOMember 2021-07-01 2021-07-01 0001471727 us-gaap:IPOMember 2021-07-01 0001471727 us-gaap:SubsequentEventMember 2024-03-08 2024-03-08 0001471727 us-gaap:MeasurementInputEbitdaMultipleMember 2023-01-01 2023-12-31 0001471727 us-gaap:MoneyMarketFundsMember 2022-12-31 0001471727 2022-05-10 0001471727 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-12-31 0001471727 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-12-31 0001471727 BTTR:ECommerceMember 2023-01-01 2023-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember BTTR:ECommerceMember 2023-01-01 2023-12-31 0001471727 BTTR:ECommerceMember 2022-01-01 2022-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember BTTR:ECommerceMember 2022-01-01 2022-12-31 0001471727 BTTR:BrickAndMortarMember 2023-01-01 2023-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember BTTR:BrickAndMortarMember 2023-01-01 2023-12-31 0001471727 BTTR:BrickAndMortarMember 2022-01-01 2022-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember BTTR:BrickAndMortarMember 2022-01-01 2022-12-31 0001471727 BTTR:DirectToConsumerMember 2023-01-01 2023-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember BTTR:DirectToConsumerMember 2023-01-01 2023-12-31 0001471727 BTTR:DirectToConsumerMember 2022-01-01 2022-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember BTTR:DirectToConsumerMember 2022-01-01 2022-12-31 0001471727 BTTR:InternationalMember 2023-01-01 2023-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember BTTR:InternationalMember 2023-01-01 2023-12-31 0001471727 BTTR:InternationalMember 2022-01-01 2022-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember BTTR:InternationalMember 2022-01-01 2022-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember 2023-01-01 2023-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember 2022-01-01 2022-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember BTTR:TwoCustomersMember BTTR:ECommerceMember 2023-01-01 2023-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember BTTR:TwoCustomersMember BTTR:ECommerceMember 2022-01-01 2022-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember BTTR:CustomerOneMember BTTR:ECommerceMember 2023-01-01 2023-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember BTTR:CustomerTwoMember BTTR:ECommerceMember 2023-01-01 2023-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember BTTR:CustomerOneMember BTTR:ECommerceMember 2022-01-01 2022-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember BTTR:CustomerTwoMember BTTR:ECommerceMember 2022-01-01 2022-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember BTTR:OneCustomerMember BTTR:InternationalMember 2023-01-01 2023-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember BTTR:OneCustomerMember BTTR:InternationalMember 2022-01-01 2022-12-31 0001471727 us-gaap:CommonStockMember BTTR:IHeartMediaMember 2019-08-28 2019-08-28 0001471727 us-gaap:CommonStockMember BTTR:IHeartMediaMember 2020-03-05 2020-03-05 0001471727 us-gaap:EquipmentMember 2023-12-31 0001471727 us-gaap:EquipmentMember 2022-12-31 0001471727 us-gaap:EquipmentMember srt:MinimumMember 2023-12-31 0001471727 us-gaap:EquipmentMember srt:MaximumMember 2023-12-31 0001471727 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001471727 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001471727 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2023-12-31 0001471727 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2023-12-31 0001471727 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-12-31 0001471727 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-12-31 0001471727 us-gaap:ComputerSoftwareIntangibleAssetMember srt:MinimumMember 2023-12-31 0001471727 us-gaap:ComputerSoftwareIntangibleAssetMember srt:MaximumMember 2023-12-31 0001471727 us-gaap:ComputerEquipmentMember 2023-12-31 0001471727 us-gaap:ComputerEquipmentMember 2022-12-31 0001471727 us-gaap:ComputerEquipmentMember srt:MinimumMember 2023-12-31 0001471727 us-gaap:ComputerEquipmentMember srt:MaximumMember 2023-12-31 0001471727 2022-07-31 0001471727 2022-10-01 0001471727 us-gaap:CustomerRelationshipsMember 2023-12-31 0001471727 us-gaap:CustomerRelationshipsMember 2023-01-01 2023-12-31 0001471727 us-gaap:TradeNamesMember 2023-12-31 0001471727 us-gaap:TradeNamesMember 2023-01-01 2023-12-31 0001471727 us-gaap:CustomerRelationshipsMember 2022-12-31 0001471727 us-gaap:TradeNamesMember 2022-12-31 0001471727 BTTR:TermLoanMember 2023-12-31 0001471727 BTTR:TermLoanMember 2023-01-01 2023-12-31 0001471727 BTTR:TermLoanMember 2022-12-31 0001471727 us-gaap:LineOfCreditMember 2023-12-31 0001471727 us-gaap:LineOfCreditMember 2023-01-01 2023-12-31 0001471727 us-gaap:LineOfCreditMember 2022-12-31 0001471727 us-gaap:LineOfCreditMember 2022-01-01 2022-12-31 0001471727 us-gaap:LineOfCreditMember us-gaap:FederalFundsEffectiveSwapRateMember 2022-01-01 2022-12-31 0001471727 us-gaap:LineOfCreditMember us-gaap:FederalFundsEffectiveSwapRateMember 2023-01-01 2023-12-31 0001471727 BTTR:TermLoanMember BTTR:OldPlankTrailCommunityBankNAMember 2021-01-06 0001471727 us-gaap:LineOfCreditMember BTTR:OldPlankTrailCommunityBankNAMember 2021-01-06 0001471727 BTTR:TermLoanMember BTTR:OldPlankTrailCommunityBankNAMember 2021-01-06 2021-01-06 0001471727 us-gaap:LineOfCreditMember BTTR:OldPlankTrailCommunityBankNAMember 2021-01-06 2021-01-06 0001471727 BTTR:TermLoanMember BTTR:LondonInterbankOfferedRateMember BTTR:OldPlankTrailCommunityBankNAMember 2021-01-06 2021-01-06 0001471727 us-gaap:LineOfCreditMember BTTR:LondonInterbankOfferedRateMember BTTR:OldPlankTrailCommunityBankNAMember 2021-01-06 2021-01-06 0001471727 us-gaap:FederalFundsEffectiveSwapRateMember BTTR:OldPlankTrailCommunityBankNAMember BTTR:SecondAmendmentMember 2021-01-06 2021-01-06 0001471727 us-gaap:FederalFundsEffectiveSwapRateMember BTTR:OldPlankTrailCommunityBankNAMember BTTR:ThirdAmendmentMember 2021-01-06 2021-01-06 0001471727 us-gaap:LineOfCreditMember BTTR:WintrustCreditFacilityMember 2021-01-06 2021-01-06 0001471727 BTTR:WintrustCreditFacilityMember us-gaap:LineOfCreditMember 2022-03-31 0001471727 BTTR:WintrustCreditFacilityMember us-gaap:LineOfCreditMember 2023-03-31 0001471727 BTTR:WintrustCreditFacilityMember us-gaap:LineOfCreditMember 2022-09-30 0001471727 BTTR:WintrustCreditFacilityMember us-gaap:LineOfCreditMember 2021-08-12 0001471727 BTTR:WintrustCreditFacilityMember us-gaap:LineOfCreditMember 2021-08-13 0001471727 BTTR:WintrustCreditFacilityMember us-gaap:LineOfCreditMember 2022-01-01 0001471727 BTTR:WintrustCreditFacilityMember us-gaap:LineOfCreditMember 2023-01-01 0001471727 BTTR:WintrustCreditFacilityMember us-gaap:LineOfCreditMember 2022-10-24 0001471727 BTTR:WintrustCreditFacilityMember us-gaap:LineOfCreditMember 2023-06-21 2023-06-21 0001471727 BTTR:WintrustCreditFacilityMember us-gaap:LineOfCreditMember 2023-12-31 0001471727 BTTR:WintrustCreditFacilityMember us-gaap:LineOfCreditMember 2022-12-31 0001471727 BTTR:WintrustReceivablesCreditFacilityMember 2023-06-21 2023-06-21 0001471727 BTTR:WintrustReceivablesCreditFacilityMember srt:MaximumMember 2023-06-21 0001471727 BTTR:WintrustReceivablesCreditFacilityMember us-gaap:PrimeRateMember 2023-06-21 2023-06-21 0001471727 BTTR:WintrustReceivablesCreditFacilityMember 2023-12-31 0001471727 BTTR:WintrustReceivablesCreditFacilityMember 2023-01-01 2023-12-31 0001471727 us-gaap:LineOfCreditMember BTTR:AlphiaTermLoanFacilityMember 2023-06-21 0001471727 us-gaap:LineOfCreditMember BTTR:AlphiaTermLoanFacilityMember 2023-12-31 0001471727 us-gaap:LineOfCreditMember BTTR:AlphiaTermLoanFacilityMember 2023-01-01 2023-12-31 0001471727 BTTR:TermLoanMember us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-12-31 0001471727 BTTR:TermLoanMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-12-31 0001471727 BTTR:TermLoanMember us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-12-31 0001471727 BTTR:TermLoanMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0001471727 us-gaap:LineOfCreditMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-12-31 0001471727 us-gaap:LineOfCreditMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-12-31 0001471727 us-gaap:LineOfCreditMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-12-31 0001471727 us-gaap:LineOfCreditMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0001471727 BTTR:FirstTrancheWarrantMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember BTTR:AlphiaTermLoanFacilityMember 2023-06-21 0001471727 BTTR:SecondTrancheWarrantMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember BTTR:AlphiaTermLoanFacilityMember 2023-06-21 0001471727 us-gaap:SecuredDebtMember BTTR:AlphiaTermLoanFacilityMember us-gaap:LineOfCreditMember 2023-06-21 2023-06-21 0001471727 us-gaap:LineOfCreditMember us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-12-31 0001471727 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001471727 BTTR:FirstTrancheWarrantMember us-gaap:MeasurementInputExercisePriceMember 2023-12-21 0001471727 BTTR:SecondTrancheWarrantMember us-gaap:MeasurementInputExercisePriceMember 2023-12-21 0001471727 BTTR:FirstTrancheWarrantMember us-gaap:MeasurementInputSharePriceMember 2023-12-21 0001471727 BTTR:SecondTrancheWarrantMember us-gaap:MeasurementInputSharePriceMember 2023-12-21 0001471727 BTTR:FirstTrancheWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-21 0001471727 BTTR:SecondTrancheWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-21 0001471727 BTTR:FirstTrancheWarrantMember us-gaap:MeasurementInputExpectedTermMember 2023-12-21 0001471727 BTTR:SecondTrancheWarrantMember us-gaap:MeasurementInputExpectedTermMember 2023-12-21 0001471727 BTTR:FirstTrancheWarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-21 0001471727 BTTR:SecondTrancheWarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-21 0001471727 BTTR:FirstTrancheWarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-12-21 0001471727 BTTR:SecondTrancheWarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-12-21 0001471727 us-gaap:WarrantMember 2022-12-31 0001471727 us-gaap:WarrantMember 2023-12-31 0001471727 BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2019-11-10 0001471727 BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2019-11-11 0001471727 BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2019-11-11 2019-11-11 0001471727 BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2021-01-01 0001471727 BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2022-01-01 0001471727 BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2023-01-01 0001471727 us-gaap:EmployeeStockOptionMember srt:MinimumMember 2023-01-01 2023-12-31 0001471727 us-gaap:EmployeeStockOptionMember srt:MaximumMember 2023-01-01 2023-12-31 0001471727 BTTR:TwoThousandNineteenIncentiveAwardPlanMember srt:MaximumMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001471727 BTTR:TwoThousandNineteenIncentiveAwardPlanMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001471727 BTTR:TwoThousandNineteenIncentiveAwardPlanMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001471727 BTTR:TwoThousandNineteenIncentiveAwardPlanMember us-gaap:EmployeeStockOptionMember 2023-12-31 0001471727 us-gaap:RestrictedStockMember BTTR:BoardOfDirectorsMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2022-02-01 2022-02-28 0001471727 us-gaap:RestrictedStockMember BTTR:BoardOfDirectorsMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2022-10-01 2022-12-31 0001471727 us-gaap:RestrictedStockMember BTTR:BoardOfDirectorsMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2023-01-01 2023-01-31 0001471727 us-gaap:RestrictedStockMember BTTR:ExecutivesAndEmployeesMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2023-01-01 2023-01-31 0001471727 us-gaap:RestrictedStockMember BTTR:BoardOfDirectorsMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2023-01-01 2023-03-31 0001471727 us-gaap:RestrictedStockMember BTTR:ExecutivesAndEmployeesMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2023-04-01 2023-06-30 0001471727 us-gaap:RestrictedStockMember BTTR:TwoMemberOfBoardOfDirectorsMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2023-07-01 2023-09-30 0001471727 2021-01-01 2021-12-31 0001471727 srt:MinimumMember 2023-01-01 2023-12-31 0001471727 srt:MaximumMember 2023-01-01 2023-12-31 0001471727 srt:MinimumMember 2022-01-01 2022-12-31 0001471727 srt:MaximumMember 2022-01-01 2022-12-31 0001471727 BTTR:BoardOfDirectorsMember 2023-01-01 2023-12-31 0001471727 BTTR:BoardOfDirectorsMember 2022-01-01 2022-12-31 0001471727 srt:DirectorMember 2023-12-31 0001471727 srt:DirectorMember 2022-12-31 0001471727 BTTR:BelievecoMember srt:DirectorMember 2023-01-01 2023-12-31 0001471727 BTTR:BelievecoMember srt:DirectorMember 2023-12-31 0001471727 us-gaap:DomesticCountryMember 2023-12-31 0001471727 us-gaap:DomesticCountryMember 2022-12-31 0001471727 us-gaap:InventoriesMember us-gaap:SupplierConcentrationRiskMember BTTR:TwoVendorsMember 2023-01-01 2023-12-31 0001471727 us-gaap:InventoriesMember us-gaap:SupplierConcentrationRiskMember BTTR:TwoVendorsMember 2022-01-01 2022-12-31 0001471727 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember BTTR:TwoCustomersMember 2023-01-01 2023-12-31 0001471727 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember BTTR:ThreeCustomersMember 2022-01-01 2022-12-31 0001471727 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember BTTR:ThreeCustomersMember 2023-01-01 2023-12-31 0001471727 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember BTTR:ThreeCustomersMember 2022-01-01 2022-12-31 0001471727 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001471727 us-gaap:EmployeeStockMember 2022-01-01 2022-12-31 0001471727 BTTR:OtherOptionMember 2022-01-01 2022-12-31 0001471727 BTTR:WarrantLiabilitiesMember 2023-01-01 2023-12-31 0001471727 BTTR:FirstTrancheWarrantMember 2023-01-01 2023-12-31 0001471727 BTTR:SecondTrancheWarrantMember 2023-01-01 2023-12-31 0001471727 us-gaap:EmployeeStockMember 2023-01-01 2023-12-31 0001471727 BTTR:AimiaPetHealthcoIncMember us-gaap:SubsequentEventMember 2024-02-09 2024-02-09 0001471727 us-gaap:SubsequentEventMember BTTR:BoardOfDirectorsMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2024-02-01 2024-02-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares BTTR:Integer xbrli:pure BTTR:Segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-K

 

(Mark One)

 

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Fiscal Year Ended December 31, 2023

 

Or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from            to           

 

Commission File Number: 001-40477

 

Better Choice Company Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   83-4284557
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)

 

12400 Race Track Road

Tampa, Florida 33626

   (212) 896-1254
(Address of Principal Executive Offices) (Zip Code)   (Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange on which Registered
Common Stock, $0.001 par value share   BTTR   NYSE American

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.) Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☐

 

If an emerging growth company, indicate by a check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by a check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant, as of the last business day of the registrant’s most recently completed third fiscal quarter, based on the closing sale price of $4.96 as reported on the NYSE American was: $3,615,969.

 

The number of shares outstanding of each of the registrant’s classes of common stock as of the latest practicable date was: 893,601 shares of $0.001 par value common stock outstanding as of April 11, 2024.

 

DOCUMENTS INCORPORATED BY REFERENCE:

 

The information required by Items 10, 11, 12, 13, and 14 will be furnished (and are hereby incorporated) by an amendment hereto or pursuant to a definitive proxy statement pursuant to Regulation 14A that will contain such information.

 

 

 

 

 

 

Better Choice Company Inc.

Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2023

TABLE OF CONTENTS

 

  Part I  
1. Business 4
1A. Risk Factors 8
1B. Unresolved Staff Comments 23
1C. Cybersecurity 23
2. Properties 23
3. Legal Proceedings 23
4. Mine Safety Disclosures 23
  Part II  
5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 24
6. [Reserved] 25
7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 26
7A. Quantitative and Qualitative Disclosures About Market Risk 34
8. Financial Statements and Supplementary Data 35
9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 59
9A. Controls and Procedures 59
9B. Other Information 59
  Part III
10. Directors, Executive Officers and Corporate Governance 60
11. Executive Compensation 64
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 69
13. Certain Relationships and Related Transactions, and Director Independence 69
14. Principal Accountant Fees and Services 70
  Part IV  
15. Exhibits and Financial Statement Schedules 71
16. Form 10-K Summary 73
  Signatures 74

 

2

 

 

FORWARD-LOOKING STATEMENTS

 

This report contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical fact included in this report are forward-looking statements. Forward-looking statements discuss our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “aim,” “anticipate,” “believe,” “can,” “could,” “estimate,” “expect,” “forecast,” “intend,” “likely,” “may,” “outlook,” “plan,” “potential,” “project,” “projection,” “seek,” “should,” “will,” “would,” the negatives thereof and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. They appear in a number of places throughout this report and include statements regarding our intentions, beliefs or current expectations concerning, among other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the industry in which we operate. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected, including, but not limited to, those summarized below:

 

●our ability to continue as a going concern;
●the impact of damage to or interruption of our information technology systems due to cyber-attacks or other circumstances beyond our control;
●business interruptions resulting from geopolitical actions, including war and terrorism;
●our ability to successfully implement our growth strategy;
●failure to achieve growth or manage anticipated growth;
●our ability to achieve or maintain profitability;
●the loss of key members of our senior management team;
●our ability to generate sufficient cash flow or raise capital on acceptable terms to run our operations, service our debt and make necessary capital expenditures;
●our dependence on our subsidiaries for payments, advances and transfers of funds due to our holding company status;
●our ability to successfully develop additional products and services or successfully market and commercialize such products and services;
●competition in our market;
●our ability to attract new and retain existing customers, suppliers, distributors or retail partners;
●allegations that our products cause injury or illness or fail to comply with government regulations;
●our ability to manage our supply chain effectively;
●our or our co-manufacturers’ and suppliers’ ability to comply with legal and regulatory requirements;
●the effect of potential price increases and shortages on the inputs, commodities and ingredients that we require, whether as a result of the continued actual or perceived effects of broader geopolitical and macroeconomic conditions, including the military conflict between Russia and Ukraine;
●our ability to develop and maintain our brand and brand reputation;
●compliance with data privacy rules;
●our compliance with applicable regulations issued by the U.S. Food and Drug Administration (“FDA”), the U.S. Federal Trade Commission (“FTC”), the U.S. Department of Agriculture (“USDA”), and other federal, state and local regulatory authorities, including those regarding marketing pet food, products and supplements;
●risk of our products being recalled for a variety of reasons, including product defects, packaging safety and inadequate or inaccurate labeling disclosure;
●risk of shifting customer demand in relation to raw pet foods, premium kibble and canned pet food products, and failure to respond to such changes in customer taste quickly and effectively; and
●other factors discussed under the headings “Risk Factors,” “Business,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Annual Report on Form 10-K.

 

While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results. Important factors that could cause actual results to differ materially from our expectations, or cautionary statements, are disclosed under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this report. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. You should evaluate all forward-looking statements made in this report in the context of these risks and uncertainties.

 

NOTE REGARDING TRADEMARKS

 

We own or have rights to use the trademarks and trade names that we use in conjunction with the operation of our business. Each trademark or trade name of any other company appearing in this Annual Report on Form 10-K is, to our knowledge, owned by such other company. Solely for convenience, our trademarks and trade names referred to in this Annual Report on Form 10-K may appear without the ® or ™ symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the right of the applicable licensor to these trademarks and trade names.

 

3

 

 

PART I

 

ITEM 1. BUSINESS

 

Our History

 

On December 17, 2018, Better Choice Company, Inc. (the “Company”, or “Better Choice”) made a $2.2 million investment in TruPet LLC (“TruPet”), an online seller of pet foods, pet nutritional products and related pet supplies. On February 2, 2019, the Company entered into a definitive agreement to acquire the remainder of TruPet and closed the acquisition on May 6, 2019.

 

On February 28, 2019, Better Choice entered into a definitive agreement to acquire all of the outstanding shares of Bona Vida, Inc. (“Bona Vida”) and closed the acquisition on May 6, 2019.

 

On October 15, 2019, Better Choice entered into a Stock Purchase Agreement (as amended, the “Halo Agreement”) with Halo, Thriving Paws, LLC, a Delaware limited liability company (“Thriving Paws”), HH-Halo LP, a Delaware limited partnership (“HH-Halo” and, together with Thriving Paws, the “Sellers”) and HH-Halo, in the capacity of the representative of the Sellers. Pursuant to the terms and subject to the conditions of the Halo Agreement, among other things, the Company agreed to purchase from the Sellers 100% of the issued and outstanding capital stock of Halo, Purely for Pets, Inc. (“Halo”) (the “Halo Acquisition”). The Company closed the Halo Acquisition on December 19, 2019.

 

Overview of Our Business

 

Better Choice is a pet health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier and longer lives. Our mission is to become the most innovative premium pet food company in the world, and we are motivated by our commitment to making products with integrity and treating pets and their parents with respect. We believe that our broad portfolio of pet health and wellness products are well positioned to benefit from the trends of growing pet humanization and an increased consumer focus on health and wellness, and have adopted a laser focused, channel specific approach to growth that is driven by new product innovation.

 

We sell our premium and super-premium products (which we believe generally includes products with a retail price greater than $0.20 per ounce) under the Halo brand umbrella, including Halo Holistic™, Halo Elevate® and the former TruDog brand, which has been rebranded and successfully integrated under the Halo brand umbrella during the third quarter of 2022. Our core products sold under the Halo brand are made with high-quality, thoughtfully sourced ingredients for natural, science based nutrition. Each innovative recipe is formulated with leading veterinary and nutrition experts to deliver optimal health. Our diverse and established customer base has enabled us to penetrate multiple channels of trade, which we believe enables us to deliver on core consumer needs and serve pet parents wherever they shop. We group these channels of trade into four distinct categories: E-commerce, which includes the sale of product to online retailers such as Amazon and Chewy; Brick & Mortar, which primarily includes the sale of product to Pet Specialty retailers such as Petco, Pet Supplies Plus and neighborhood pet stores, as well as to select grocery chains; Direct to Consumer (“DTC”) which includes the sale of product through our website halopets.com; and International, which includes the sale of product to foreign distribution partners and to select international retailers. In December 2023, the Company made a strategic exit out of Petco stores (while remaining on Petco.com), and Pet Supplies Plus. As of Q1 2024, the Company has made plans to exit its DTC channel in Q2 2024, in an effort to improve profitability.

 

New product innovation represents the cornerstone of our growth plan, supported by our own research and development, and acquisitions. Our established supply and distribution infrastructure allows us to bring new products to market in nine months, generally. Our outsourced manufacturing model is flexible, scalable and encourages innovation allowing us to offer a breadth of assortment in dog and cat food products under the Halo brand, serving a wide variety of customer needs.

 

Halo is the brand for a new generation of pet parents. For millennial pet parents who view their pets as children, we believe Halo provides the world’s best nutrition for the world’s best kids. Halo offers two premium sub-lines of natural dog and cat food for this audience - Halo Holistic, which includes the former TruDog brand, and Halo Elevate.

 

Halo Holistic is designed for the pet parent seeking high-quality ingredients for digestive health. Halo Holistic is the only super-premium pet food certified by the Global Animal Partnership and the Marine Stewardship Council, both of which are animal welfare organizations recognized worldwide. Halo Holistic also supports complete digestive health with prebiotics, probiotics and postbiotics. Additionally, it’s made with whole animal proteins only and no meat meals.

 

Halo Elevate®, our second sub-line which launched during 2022, provides best-in-class nutrition. We believe it’s the only natural pet food with leading nutrient levels to support the top five pet parent health concerns which include digestive health, heart and immunity support, healthy skin and coat, hip and joint support and strength and energy. Each recipe delivers natural, science-based nutrition for optimal health. Both Halo Holistic and Halo Elevate® provide confidence and validation to empower millennial pet parents.

 

Our Products and Brands

 

We have a broad portfolio of over 100 active premium and super premium animal health and wellness products for dogs and cats, which includes products sold under the Halo brand across multiple forms, including foods, treats, toppers, dental products, chews, and supplements. Our products consist of naturally formulated premium kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products and supplements. Our products are sustainably sourced, derived from real whole meat and no rendered meat meal and include non-GMO fruits and vegetables.

 

Our products are manufactured by an established network of co-manufacturers in partnership with Better Choice. We have maintained each of our key co-manufacturing relationships for more than four years, with certain relationships in place for more than ten years and with the launch of Halo Elevate®, we expanded and engaged two new co-manufacturing partners in 2022.

 

4

 

 

Our Customers and Channels

 

In 2023, we generated $48.6 million of gross sales and $38.6 million of net sales. By channel in 2023, E-Commerce generated approximately $19.1 million of gross sales and $13.4 million of net sales, Direct-to-Consumer generated approximately $6.4 million of gross sales and $5.6 million of net sales, Brick & Mortar generated approximately $9.4 million of gross sales and $5.9 million of net sales and International generated approximately $13.7 million of gross sales and $13.7 million of net sales. The following chart provides a breakdown of our net sales by channel for the year ended December 31, 2023:

 

 

In 2023, approximately 50% of our net sales were made online, through a combination of E-commerce partner websites, such as Amazon, Chewy, Petflow, Thrive Market and Vitacost, and our DTC website, hosted on Shopify. A majority of our online sales are driven by repeat purchases from existing customers. In Packaged Facts’ Surveys of Pet Owners, pet products and services are at the bottom of the list of household spending cutbacks, second only to human medicine and healthcare. Reflecting both the higher prices and Americans’ deep commitments to their pets, pet parents remain tenacious when it comes to pet care, with 68% spending more in February 2023 vs. January 2022 even as they looked for ways to economize. We anticipate our ability to reach a growing base of diverse customers online will continue to improve as E-commerce penetration increases.

 

In addition to our domestic sales channels, the Halo brand’s international sales declined (37)% in 2023, resulting primarily in an effort to normalize inventory levels in our key Asian markets as well as macroeconomic factors impacting consumer behavior. With increasing levels of economic financial status in the Asian markets and demand for premium and super-premium, western manufactured products, with China representing the largest market opportunity for growth and 80% of Better Choice’s $13.7 million of international sales in 2023.

 

Supply Chain, Manufacturing and Logistics

 

Halo partners with a number of co-manufacturing partners to produce its products. Products sold today under the Halo brand are made strictly from naturally raised animals on sustainable farms and are manufactured in the U.S and use healthy, natural ingredients, with all purchases transacted in U.S. dollars. By sourcing cage-free poultry, pasture-raised beef, and wild-caught fish from certified sustainable fisheries and not including meat meals or other animal byproducts in its formulations, our Halo brand is able to provide pets and pet parents with a nutritious and highly digestible suite of food and treats. Some products are preserved using either freeze drying or gentle air dehydration to eliminate the need for artificial preservatives and added chemicals. Our treats and chews are oven-baked, using natural ingredients for maximum nutrition and protein content. Halo’s dog and cat foods meet The Association of American Feed Control Officials (“AAFCO”) guidelines and are small-batch tested for common contaminants prior to leaving the manufacturer.

 

We utilize logistics service providers as a part of our supply chain, primarily for shipping and logistics support. Fulfillment of orders is managed by a third-party warehousing and logistics partner, Fidelitone. Our warehouse was located in Lebanon, Tennessee throughout 2021 and relocated to Wauconda, Illinois in 2022. Our DTC ecosystem allows us to efficiently manage and customize the online shopping experience for customers, including a customer dashboard where shoppers can manage and track orders and order history. Our products are shipped by trusted carriers for expeditious and reliable delivery.

 

Raw Materials and Principal Suppliers

 

We rely upon the supply of raw materials that meet our high-quality specifications and sourcing requirements. We source Global Animal Partnership (“GAP”) certified cage-free chicken, GAP certified cage-free turkey, Marine Stewardship Council (“MSC”) certified wild-caught salmon and whitefish and select non-GMO fruits and vegetables, such as peas, sweet potatoes and lentils. If any raw material is adulterated and does not meet our specifications, it could significantly impact our ability to source manufactured products and could materially and adversely impact our business, financial condition and results of operations.

 

For the supply and co-manufacturing of our products, we have relied on: Alphia, Inc. (“Alphia” f/k/a “C.J. Foods”) for dry kibble which transitioned to Barrett Petfood Innovations during 2022, then back to Alphia during 2023; Simmons Pet Food, Inc. (“Simmons”) and Thai Union Manufacturing Co., LTD. for canned wet food; BrightPet Nutrition Group, LLC (“BrightPet”) for vegan kibble and freeze dried treats; Carnivore Meat Company, LLC (“Carnivore”) for the supply and co-manufacturing of freeze-dried food and treats. We sourced approximately 64% of inventory purchases from two vendors for the year ended December 31, 2023 and approximately 69% from three vendors for the year ended December 31, 2022.

 

5

 

 

Sales and Marketing

 

Our marketing strategies are designed to clearly communicate to consumers about the benefits of our products and to build awareness of our brands. We deploy a broad set of marketing tools across various forms of media to reach consumers through multiple touch points and engage with a number of marketing agencies to develop content and product packaging. Our marketing initiatives include the use of social and digital marketing, Search Engine Optimization, email and SMS marketing, and paid media (Facebook, Instagram & YouTube), among other proven strategies to generate and convert sales prospects into loyal, satisfied customers. In addition to directly targeting and educating consumers of our products, we partner with a number of retailers such as Amazon, Chewy and Petco to develop joint sales and marketing initiatives to increase sales and acquire new customers.

 

In recent years, consumer purchasing behaviors have shifted dramatically and E-Commerce penetration has significantly increased. In the fourth quarter of 2023, management shifted from a Brick & Mortar channel focus to a digital first strategy as a result of its annual operating plan process and has strategically reallocated marketing investments to work more effectively and efficiently in its larger e-commerce platforms to drive growth and brand awareness.

 

Competition

 

The pet health and wellness industry is highly competitive. Competitive factors include product quality, ingredients, brand awareness and loyalty, product variety, product packaging and design, reputation, price, advertising, promotion, and nutritional claims. We believe that we compete effectively with respect to each of these factors. We compete with manufacturers of conventional pet food such as Mars, Nestlé and Big Heart Pet Brands (part of the J.M. Smucker Company), and manufacturers of specialty and natural pet food such as Blue Buffalo (part of General Mills), Wellness, Fromm, Orijen, Merrick (part of Nestlé), Stella and Chewy, Open Farm and Freshpet. In addition, we compete with many regional niche brands in individual geographic markets.

 

Employees and Human Capital Resources

 

As of December 31, 2023, we had 31 full time employees and one part time employee. Our human capital resource objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and additional employees. The principal purposes of our equity incentive plans are to attract, retain and motivate selected employees, consultants and directors through the granting of stock-based compensation awards. Our employees are not represented by any labor union or any collective bargaining arrangement with respect to their employment with us. We have never experienced any work stoppages or strikes as a result of labor disputes and we believe our overall relationships with our employees are positive and the strength of our team is a critical success factor in becoming the most innovative premium pet food company in the world. Our employees share an entrepreneurial spirit, a passion for excellence and the inspiration to drive the future of the pet health and wellness industry.

 

Our core values are Integrity, Respect, Working Smarter and Faster and Building Lasting Relationships in all that we do. We continually focus on employee engagement and a diverse, inclusive culture in order to ensure the continued strength and well-being of our workforce. We strive to create a workplace where employees feel engaged, believe in our mission, understand their role in our strategy and are passionate about the work they do. We conduct employee engagement surveys to provide us with valuable insights into employee perspectives and experiences. We also hold frequent virtual town-hall meetings and team building events to provide updates, celebrate milestones in the business, communicate initiatives, recognize significant individual accomplishments and provide a forum for employees to communicate and engage with our entire employee base. We value and embrace diversity by fostering a culture that encompasses the unique attributes, ideas, perspectives, and experiences of our employees, customers, suppliers and communities. We believe a more inclusive and diverse work environment allows us to achieve better results and makes us a stronger business.

 

We operate under a “Win From Anywhere” culture, which is our approach to creating a flexible and entrepreneurial working environment built for long term success. Winning from anywhere means our employees can work from anywhere in the country. We believe this culture provides the ability for us to attract the best talent and we now have employees all over the U.S. that are winning from anywhere.

 

Government Regulation

 

The regulation of animal food products is complex, multi-faceted, and continually changing. The U.S. Food and Drug Administration (“FDA”), the U.S. Federal Trade Commission (“FTC”), the U.S. Department of Agriculture (“USDA”) and other regulatory authorities at the federal, state and local levels, as well as authorities in foreign countries, extensively regulate, among other things, the research, development, testing, composition, manufacture, import, export, labeling, storage, distribution, promotion, marketing, and post-market reporting of animal foods. We are required to navigate a complex regulatory framework in the locations in which we wish to manufacture, test, import, export, or sell our products.

 

6

 

 

FDA Regulation of Animal Foods

 

The FDA regulates foods, including foods intended for animals, under the Federal Food, Drug and Cosmetic Act (“FDCA”) and its implementing regulations. The FDCA defines “food” as articles used for food or drink for man or other animals, which includes products that are intended primarily for nutritional use, taste, or aroma and the components of such products. For animal foods in particular, this definition applies based on their intended use regardless of labelling as animal food, treats, or supplements. The FDA also imposes certain requirements on animal foods relating to their composition, manufacturing, labeling, and marketing. Among other things, the facilities in which our products and ingredients are manufactured must register with the FDA, comply with current good manufacturing practices (“cGMPs”) and comply with a range of food safety requirements.

 

Although pet foods are not required to obtain premarket approval from the FDA, any substance that is added to or is expected to become a component of a pet food must be used in accordance with a food additive regulation, unless it is generally recognized as safe (“GRAS”) under the conditions of its intended use or if it appears on an FDA-recognized list of acceptable animal food ingredients in the Official Publication of AAFCO. A food may be adulterated if it uses an ingredient that is neither GRAS nor an approved food additive, and that food may not be legally marketed in the U.S.

 

The labeling of pet foods is regulated by both the FDA and state regulatory authorities. FDA regulations require proper identification of the product, a net quantity statement, a statement of the name and place of business of the manufacturer or distributor and proper listing of all the ingredients in order of predominance by weight. The FDA also considers certain specific claims on pet food labels to be medical claims and therefore subject to prior review and approval by the FDA. The FDA has a list of specific factors it will consider in determining whether to initiate enforcement action against such products if they do not comply with the regulatory requirements applicable to drugs, including, among other things, whether the product is only made available through or under the direction of a veterinarian and does not present a known safety risk when used as labeled. The FDA may classify some of our products differently than we do and may impose more stringent regulations which could lead to possible enforcement action.

 

Under the FDCA, the FDA may require the recall of an animal food product if there is a reasonable probability that the product is adulterated or misbranded, and the use of or exposure to the product will cause serious adverse health consequences or death. In addition, pet food manufacturers may voluntarily recall or withdraw their products from the market. If the FDA believes that our products are adulterated, misbranded or otherwise marketed in violation of the FDCA, the agency make take further enforcement action, including: restrictions on the marketing or manufacturing of a product; required modification of promotional materials or issuance of corrective marketing information; issuance of safety alerts, press releases, or other communications containing warnings or other safety information about a product; warning or untitled letters; product seizure or detention; refusal to permit the import or export of products; fines, injunctions, or consent decrees; and/or imposition of civil or criminal penalties.

 

Chinese Regulations

 

General Administration of Quality Supervision, Inspection and Quarantine of the People’s Republic of China (“AQSIQ”) is responsible for the unified inspection and quarantine of imported pet food (also referred to in the regulations as “Feed”). Only registered pet food manufacturers from AQSIQ approved countries (which includes the U.S.) can import pet food to China, and may do so only if they have first received an import registration certificate from the Ministry of Agriculture (“MOA”). In order to obtain an import registration certificate, a manufacturer must submit standardized application materials (in both English and Chinese) along with product samples to the MOA for approval, and if approved, such import registration certificate shall be valid for five years. Overseas companies are also prohibited from engaging in the direct sale of imported pet food within the territory of China and should establish a sales organization or appoint a sales agent within the territory of China and file a record with the MOA within six months from the date the manufacturer obtains its import registration certificate. All imported pet food must be packaged, and the packaging must comply with China’s safety and hygiene regulation and must have Chinese labels that are in conformity with the relevant regulations.

 

We are also subject to labor and employment laws, laws governing advertising, privacy laws, safety regulations and other laws, including consumer protection regulations that regulate retailers or govern the promotion and sale of merchandise. Our operations, and those of our distributors and suppliers, are subject to various laws and regulations relating to environmental protection and worker health and safety matters. We monitor changes in these laws and believe that we are in material compliance with applicable laws. See additional information under the heading “Risks Related to the Regulation of our Business and Products” in this Annual Report on Form 10-K for a discussion of risks relating to federal, state, local and international regulation of our business.

 

7

 

 

Our Trademarks and Other Intellectual Property

 

We believe that our intellectual property has substantial value and has contributed significantly to the success of our business. Our trademarks are valuable assets that reinforce our brand, our sub-brands and our consumers’ perception of our products. The current registrations of these trademarks in the U.S. and foreign countries are effective for varying periods of time and may be renewed periodically, provided that we, as the registered owner, or our licensees where applicable, comply with all applicable renewal requirements including, where necessary, the continued use of the trademarks in connection with the goods or services identified in the applicable registrations. In addition to trademark protection, we have registered more than 100 domain names, including www.betterchoicecompany.com, www.halopets.com, www.trupet.com, www.trudog.com and www.rawgo.com, that are important to the successful implementation of our marketing and advertising strategy. We rely on and carefully protect unpatented proprietary expertise, recipes and formulations, continuing innovation and other trade secrets to develop and maintain our competitive position.

 

Corporate Information

 

We were incorporated in the State of Nevada in 2001 under the name Cayenne Construction, Inc., and in 2009, changed our name to Sports Endurance, Inc. Effective March 11, 2019, we changed our name to Better Choice Company Inc. after reincorporating in Delaware. We have three subsidiaries - Halo, Purely for Pets, Inc., Bona Vida, Inc. and Wamore Corporation S.A. Our principal executive offices are located at 12400 Race Track Road, Tampa, FL 33626. Our website is available at https://www.betterchoicecompany.com. Our website and the information contained on or connected to that site are not, and should not be deemed to be part of or incorporated into this Annual Report on Form 10-K.

 

Available Information

 

We file annual, quarterly and current reports and other information with the SEC that are publicly available at www.sec.gov. Our SEC filings are also available under the Investor Relations section of our website at www.betterchoicecompany.com as soon as reasonably practicable after they are filed with or furnished to the SEC. Information contained on or connected to our website are not incorporated into this Annual Report on Form 10-K.

 

ITEM 1A. RISK FACTORS

 

As a smaller reporting company, we are not required to provide a statement of risk factors. Nonetheless, we are voluntarily providing risk factors herein. You should consider carefully the following risk factors, together with all the other information in this Annual Report on Form 10-K, and in our other public filings with the SEC. The occurrence of any of the following risks could harm our business, financial condition, results of operations and/or growth prospects or cause our actual results to differ materially from those contained in forward-looking statements we have made in this report and those we may make from time to time. You should consider all of the risk factors described when evaluating our business.

 

Risks Related to Our Business and Industry

 

Increases in sourcing, manufacturing, freight and/or warehousing costs, supply shortages, interruption in our sourcing operations and/or supply changes could have an adverse effect on our business, financial condition, and operating results.

 

Our products are sourced from a limited number of independent third-party suppliers, which we depend upon for the manufacture of all our products. Some of the ingredients, packaging materials, and other products we purchase may only be available from a single supplier or a limited group of suppliers. While alternate sources of supply are generally available, the supply and price are subject to market conditions and are influenced by other factors beyond our control. We do not have long-term contracts with many of our suppliers, and therefore they could increase prices or cease doing business with us. As a result, we may be subject to price fluctuations or demand disruptions.

 

The prices of raw materials, packaging materials and freight are subject to fluctuations in price attributable to, among other things, global competition for resources, weather conditions, changes in supply and demand of raw materials, or other commodities, fuel prices and government-sponsored agricultural programs. Volatility in the prices of raw materials and other supplies we purchase could increase our cost of sales and reduce our profitability, and we have no guarantees that prices will not rise. Our ability to pass along higher costs through price increases to our customers is dependent upon competitive conditions and pricing methodologies employed in the various sales channels in which we compete, and we may not be successful in implementing price increases. In addition, any price increases we do implement may result in lower sales volumes. Customers and consumers may choose to shift purchases to lower-priced private label or other value offerings which may adversely affect our results of operations.

 

We cannot control all of the various factors that might affect our ability to ship orders of our products to customers in a timely manner or to meet our quality standards. Such factors include, among other things, natural disasters or adverse weather and climate conditions; political and financial instability; strikes; unforeseen public health crises, including pandemics and epidemics such as the COVID-19 pandemic; acts of war or terrorism and other catastrophic events, whether occurring in the U.S. or internationally (including, without limitation, the conflict in Ukraine). From time to time, a co-manufacturer may experience financial difficulties, bankruptcy or other business disruptions, which could disrupt our supply of products or require that we incur additional expense by providing financial accommodations to the co-manufacturer or taking other steps to seek to minimize or avoid supply disruption, such as establishing a new co-manufacturing arrangement with another provider. Further, we may be unable to locate an additional or alternate co-manufacturing arrangement in a timely manner or on commercially reasonable terms, if at all. Any delay, interruption or increased cost in the proprietary value-branded products that might occur for any reason could affect our ability to meet customer demand, adversely affect our net sales, increase our cost of sales and hurt our results of operations, which in turn may injure our reputation and customer relationships, thereby harming our business.

 

8

 

 

Our ability to meet increases in demand may be impacted by our reliance on our suppliers and we are subject to the risk of shortages and long lead times. We may not be able to develop alternate sources in a timely manner. Therefore, we may not be able to source sufficient product on terms that are acceptable to us, or at all, which may undermine our ability to fill our orders in a timely manner. The occurrence of any of the foregoing could increase our costs, disrupt our operations, or could have a materially adverse impact on our business, financial condition, results of operations or prospects.

 

If we fail to maintain and expand our brand, or the quality of our products that customers have come to expect, our business could suffer.

 

The continued development and maintenance of our brand and the quality of our products is critical to our success. We seek to maintain, extend, and expand our brand image through marketing investments, including advertising and consumer promotions, and product innovation. Maintaining, promoting and positioning our brand and reputation will depend on, among other factors, the success of preserving the quality of our products, the availability of our products, marketing and merchandising efforts, the nutritional benefits provided to pets and our ability to provide a consistent, high-quality customer experience.

 

The success of our brand may suffer if our marketing plans or product initiatives do not have the desired impact on our brand’s image or its ability to attract customers. Brand value is based on perceptions of subjective qualities, and any incident that erodes the loyalty of our customers, suppliers or co-manufacturers, including adverse publicity or a governmental investigation or litigation, could significantly reduce the value of our brand and significantly damage our business. Further, our brand value could diminish significantly due to a number of factors, including consumer perception that we have acted in an irresponsible manner, adverse publicity about our products (whether or not valid), our failure to maintain the quality of our products, product contamination, the failure of our products to deliver consistently positive consumer experiences, inadequate labor conditions, health or safety issues at our co-manufacturers, or the products becoming unavailable to consumers.

 

If we are unable to build and sustain brand equity by offering recognizably superior products, we may be unable to maintain premium pricing over private label products. The growing use of social and digital media by consumers increases the speed and extent that information and opinions can be shared. Negative posts or comments about us or our brands or products on social or digital media could damage our brands and reputation. If we fail to maintain the favorable perception of our brands, our business, financial condition and results of operations could be negatively impacted.

 

We may not be able to successfully implement and/or manage our growth strategy on a timely basis or we may not grow at all.

 

Our future success depends on our ability to implement our growth strategy of introducing new products and expanding into new markets and attracting new consumers to our brand and sub-brands. Our ability to implement this growth strategy depends, among other things, on our ability to: establish our brands and reputation as a well-managed enterprise committed to delivering premium quality products to the pet health and wellness industry; partner with retailers and other potential distributors of our products; continue to effectively compete in specialty channels and respond to competitive developments; continue to market and sell our products through a multi-channel distribution strategy and achieve joint growth targets with our distribution partners; expand and maintain brand loyalty; develop new proprietary value-branded products and product line extensions that appeal to consumers; maintain and, to the extent necessary, improve our high standards for product quality, safety and integrity; maintain sources from suppliers that comply with all federal, state and local laws for the required supply of quality ingredients to meet our growing demand; identify and successfully enter and market our products in new geographic markets and market segments; execute value-focused pricing strategies; and attract, integrate, retain and motivate qualified personnel. We may not be able to successfully implement our growth strategy and may need to change our strategy in order to maintain our growth. If we fail to implement our growth strategy or if we invest resources in a growth strategy that ultimately proves unsuccessful, our business, financial condition and results of operations may be materially adversely affected.

 

If we succeed in growing our business, such growth could strain our management team and capital resources. Our ability to manage operations and control growth will be dependent on our ability to raise and spend capital to successfully attract, train, motivate, retain and manage new members of senior management and other key personnel and continue to update and improve our management and operational systems, infrastructure and other resources, financial and management controls, and reporting systems and procedures. Failure to manage our growth effectively could cause us to misallocate management or financial resources, and result in additional expenditures and inefficient use of existing human and capital resources. Such slower than expected growth may require us to restrict or cease our operations and go out of business. Additionally, our anticipated growth will increase the demands placed on our suppliers, resulting in an increased need for us to manage our suppliers and monitor for quality assurance and comply with all applicable laws. Any failure by us to manage our growth effectively could impair our ability to achieve our business objectives.

 

9

 

 

Our recurring losses and significant accumulated deficit have raised substantial doubt regarding our ability to continue as a going concern.

 

We have experienced recurring operating losses, have a significant accumulated deficit and are required to maintain certain thresholds to comply with the financial covenants associated with the Alphia Term Loan, including minimum liquidity, minimum EBITDA, and maximum marketing spend ratio. We expect to continue to generate operating losses and consume cash resources in the near term. Without generating sufficient cash flow from operations or additional debt or equity financing, these conditions raise substantial doubt about our ability to continue as a going concern, meaning that we may be unable to continue operations for the foreseeable future or realize assets and discharge liabilities in the ordinary course of operations. If we need to seek additional financing to fund our business activities in the future and there remains doubt about our ability to continue as a going concern, investors or other financing sources may be unwilling to provide additional funding on commercially reasonable terms or at all. If we are unable to obtain sufficient funding, our business, prospects, financial condition and results of operations will be materially and adversely affected and we may be unable to continue as a going concern. If we are unable to continue as a going concern, we may have to liquidate our assets and may receive less than the value at which those assets are carried on our consolidated financial statements, and it is likely that investors will lose all or a part of their investment.

 

If our amortizable intangible assets become impaired, then we could be required to record a significant charge to earnings.

 

We evaluate intangible assets for impairment at least annually. We monitor the existence of potential impairment indicators throughout the year and will evaluate for impairment whenever events or circumstances indicate that the fair value of a reporting unit is below its carrying value. Factors that may be considered a change in circumstances indicating that the carrying value of our amortizable intangible assets may not be recoverable include declines in stock price, market capitalization or cash flows, and slower growth rates in our industry. Depending on the results of these evaluations, we could be required to record a significant charge to earnings in our consolidated financial statements during the period in which any impairment of amortizable intangible assets were determined, negatively impacting our results of operations.

 

If we do not successfully develop additional products and services, or if such products and services are developed but not successfully commercialized, our business will be adversely affected.

 

Our success will depend, in part, on our ability to develop and market new products and improvements to our existing products. The process of identifying and commercializing new products is complex, uncertain and may involve considerable costs, and if we fail to accurately predict customers’ changing needs and preferences, our business could be harmed. The success of our innovation and product development efforts is affected by, among other things, the technical capability of our team; our ability to establish new supplier relationships and third-party consultants in developing and testing new products, and complying with governmental regulations; our attractiveness as a partner for outside research and development scientists and entrepreneurs; and the success of our management and sales team in introducing and marketing new products.

 

We have already and may have to continue to commit significant resources to commercializing new products before knowing whether our investments will result in products the market will accept. Substantial promotional expenditures may be required to introduce new products to the market, or improve our market position. To remain competitive and expand and keep shelf placement for our products, we may need to increase our advertising spending to maintain and increase consumer awareness, protect and grow our existing market share or promote new products, which could affect our operating results. We may not always be able to respond quickly and effectively to changes in customer taste and demand due to the amount of time and financial resources that may be required to bring new products to market, which could result in our competitors taking advantage of changes in customer trends before we are able to and harm our brand and reputation.

 

10

 

 

Furthermore, developing and commercializing new products may divert management’s attention from other aspects of our business and place a strain on management, operational and financial resources, as well as our information systems. We may not execute successfully on commercializing those products because of errors in product planning or timing, technical hurdles that we fail to overcome in a timely fashion, or a lack of appropriate resources. Launching new products or updating existing products may also leave us with obsolete inventory that we may not be able to sell or we may sell at significantly discounted prices. If we are unable to successfully develop or otherwise acquire new products, our business, financial condition and results of operations may be materially adversely affected.

 

Because we are engaged in a highly competitive business, if we are unable to compete effectively, our results of operations could be adversely affected.

 

The pet health and wellness industry is highly competitive. We compete on the basis of product and ingredient quality, product availability, palatability, brand awareness, loyalty and trust, product variety and innovation, product packaging and design, reputation, price and convenience and promotional efforts. The pet products and services retail industry has become increasingly competitive due to the expansion of pet-related product offerings by certain supermarkets, warehouse clubs, and other mass and general retail and online merchandisers and the entrance of other specialty retailers into the pet food and pet supply market, which makes it more difficult for us to compete for brand recognition and differentiation of our products and services. We face direct competition from companies that sell various pet health and wellness products at a lower price point and distribute such products to traditional retailers, which are larger than we are and have greater financial resources. Price gaps between products may result in market share erosion and harm our business. Our current and potential competitors may also establish cooperative or strategic relationships amongst themselves or with third parties that may further enhance their resources and offerings. Further, it is possible that domestic or foreign companies, some with greater experience in the pet health and wellness industry or greater financial resources than we possess, will seek to provide products or services that compete directly or indirectly with ours in the future.

 

Many of our competitors may have longer operating histories, greater brand recognition, larger fulfillment infrastructures, greater technical capabilities, significantly greater financial, marketing and other resources and larger customer bases than we do. These factors may allow our competitors to derive greater net sales and profits from their existing customer base, acquire customers at lower costs or respond more quickly than we can to new or emerging technologies and changes in consumer preferences or habits. These competitors may engage in more extensive research and development efforts, undertake more far-reaching marketing campaigns and adopt more aggressive pricing policies, which may allow them to build larger customer bases or generate net sales from their customer bases more effectively than we do.

 

Our competitors may be able to identify and adapt to changes in consumer preferences more quickly than us due to their resources and scale. They may also be more successful in marketing and selling their products, better able to increase prices to reflect cost pressures and better able to increase their promotional activity, which may impact us and the entire pet health and wellness industry. Increased competition as to any of our products could result in price reduction, increased costs, reduced margins and loss of market share, which could negatively affect our profitability. While we believe we are better equipped to customize products for the pet health and wellness market generally as compared to other companies in the industry, there can be no assurance that we will be able to successfully compete against these other companies. Expansion into markets served by our competitors and entry of new competitors or expansion of existing competitors into our markets could materially adversely affect our business, financial condition and results of operations.

 

If we fail to attract new customers, or retain existing customers, or fail to do either in a cost-effective manner, we may not be able to increase sales.

 

We are highly dependent on the effectiveness of our marketing messages and the efficiency of our advertising expenditures in generating consumer awareness and sales of our products. We may not always be successful in developing effective messages and new marketing channels, as consumer preferences and competition change, and in achieving efficiency in our advertising expenditures. We depend heavily on internet-based advertising to market our products through internet-based media and e-commerce platforms. If we are unable to continue utilizing such platforms, if those media and platforms diminish in importance or size, or if we are unable to direct our advertising to our target consumer groups, our advertising efforts may be ineffective, and our business could be adversely affected. The costs of advertising through these platforms have increased significantly, which could decrease efficiency in the use of our advertising expenditures, and we expect these costs may continue to increase in the future.

 

11

 

 

Consumers are increasingly using digital tools as a part of their shopping experience. As a result, our future growth and profitability will depend in part on:

 

●the effectiveness and efficiency of our online experience for disparate worldwide audiences, including advertising and search optimization programs in generating consumer awareness and sales of our products;

 

●our ability to prevent confusion among consumers that can result from search engines that allow competitors to use or bid on our trademarks to direct consumers to competitors’ websites;

 

●our ability to prevent Internet publication or television broadcast of false or misleading information regarding our products or our competitors’ products;

 

●the nature and tone of consumer sentiment published on various social media sites; and

 

●the stability of our website and other e-commerce platforms we sell our products on. In recent years, a number of DTC, Internet-based retailers have emerged and have driven up the cost of basic search terms, which has and may continue to increase the cost of our Internet-based marketing programs.

 

If our marketing messages are ineffective or our advertising expenditures, geographic price-points, and other marketing programs, including digital programs, are inefficient in creating awareness and consideration of our products and brand name and in driving consumer traffic to our website or to our other sales channels, our sales, profitability, cash flows and financial condition may be adversely impacted. In addition, if we are not effective in preventing the publication of confusing, false or misleading information regarding our brand or our products, or if there arises significant negative consumer sentiment on social media regarding our brand or our products, our sales, profitability, cash flows and financial condition may be adversely impacted.

 

Food safety and food-borne illness incidents may materially adversely affect our business by exposing us to lawsuits, product recalls or regulatory enforcement actions, increasing our operating costs and reducing demand for our product offerings.

 

Selling food for consumption involves inherent legal and other risks, and there is increasing governmental scrutiny of and public awareness regarding food safety. Unexpected side effects, illness, injury or death related to allergens, food-borne illnesses or other food safety incidents caused by products we sell, or involving our suppliers or co-manufacturers, could result in the discontinuance of sales of these products or our relationships with such suppliers or co-manufacturers, or otherwise result in increased operating costs, regulatory enforcement actions or harm to our reputation. Shipment of adulterated or misbranded products, even if inadvertent, can result in criminal or civil liability. Such incidents could also expose us to product liability, negligence or other lawsuits, including consumer class action lawsuits. Any claims brought against us may exceed or be outside the scope of our existing or future insurance policy coverage or limits. Any judgment against us that is more than our policy limits or not covered by our policies or not subject to insurance would have to be paid from our cash reserves, which would reduce our capital resources.

 

The occurrence of food-borne illnesses or other food safety incidents could also adversely affect the price and availability of affected ingredients, resulting in higher costs, disruptions in supply and a reduction in our sales. Furthermore, any instances of food contamination or regulatory noncompliance, whether or not caused by our actions, could compel us, our suppliers, our distributors or our customers, depending on the circumstances, to conduct a recall in accordance with FDA regulations, comparable state laws or foreign laws in jurisdictions in which we operate. Food recalls could result in significant losses due to their costs, the destruction of product inventory, lost sales due to the unavailability of the product for a period of time and potential loss of existing distributors or customers and a potential negative impact on our ability to attract new customers due to negative consumer experiences or because of an adverse impact on our brand and reputation. The costs of a recall could exceed or be outside the scope of our existing or future insurance policy coverage or limits.

 

In addition, food companies have been subject to targeted, large-scale tampering as well as to opportunistic, individual product tampering, and we, like any food company, could be a target for product tampering. Forms of tampering could include the introduction of foreign material, chemical contaminants and pathological organisms into consumer products as well as product substitution. FDA regulations require companies like us to analyze, prepare and implement mitigation strategies specifically to address tampering (i.e., intentional adulteration) designed to inflict widespread public health harm. If we do not adequately address the possibility, or any actual instance, of intentional adulteration, we could face possible seizure or recall of our products and the imposition of civil or criminal sanctions, which could materially adversely affect our business, financial condition and operating results.

 

We may not be able to manage our manufacturing and supply chain effectively, which may adversely affect our results of operations.

 

We must accurately forecast demand for all of our products in order to ensure that we have enough products available to meet the needs of our customers. Our forecasts are based on multiple assumptions that may cause our estimates to be inaccurate and affect our ability to obtain adequate co-manufacturing capacity in order to meet the demand for our products. If we do not accurately align our manufacturing capabilities with demand, our business, financial condition and results of operations may be materially adversely affected.

 

In addition, we must continuously monitor our inventory and product mix against forecasted demand. If we underestimate demand, we risk having inadequate supplies. We also face the risk of having too much inventory on hand that may reach its expiration date and become unsalable, and we may be forced to rely on markdowns or promotional sales to dispose of excess or slow-moving inventory. If we are unable to manage our supply chain effectively, our operating costs could increase and our profit margins could decrease.

 

12

 

 

If any of our independent shipping providers experience delays or disruptions, our business could be adversely affected.

 

We rely on independent shipping service providers to ship raw materials and products from our third-party suppliers and to ship products from our manufacturing and distribution warehouses to our customers. Our utilization of any shipping companies that we may elect to use, is subject to risks, including increases in fuel prices, employee strikes, organized labor activities and inclement weather, which may impact the shipping company’s ability to provide delivery services sufficient to meet our shipping needs. If we are not able to negotiate acceptable terms with these companies or they experience performance problems or other difficulties, it could negatively impact our operating results and customer experience.

 

Our intellectual property rights may be inadequate to protect our business.

 

We attempt to protect our intellectual property rights, both in the U.S. and in foreign countries, through a combination of patent, trademark, copyright and trade secret laws, as well as licensing agreements and third-party nondisclosure and assignment agreements. Because of the differences in foreign trademark, patent and other laws concerning proprietary rights, our intellectual property rights may not receive the same degree of protection in foreign countries as they would in the U.S. Our failure to obtain or maintain adequate protection of our intellectual property rights for any reason could have a material adverse effect on our business, results of operations and financial condition.

 

We also rely on unpatented proprietary technology. It is possible that others will independently develop the same or similar technology or otherwise obtain access to our unpatented technology. To protect our trade secrets and other proprietary information, we require employees, consultants, advisors and collaborators to enter into confidentiality agreements. We cannot assure you that these agreements will provide meaningful protection for our trade secrets, know-how or other proprietary information in the event of any unauthorized use, misappropriation or disclosure of such trade secrets, know-how or other proprietary information. If we are unable to maintain the proprietary nature of our technologies, we could be materially adversely affected.

 

We rely on our trademarks, trade names, and brand names to distinguish our products from the products of our competitors, and have registered or applied to register many of these trademarks. We cannot assure you that our trademark applications will be approved. Third parties may also oppose our trademark applications, or otherwise challenge our use of the trademarks. In the event that our trademarks are successfully challenged, we could be forced to rebrand our products, which could result in loss of brand recognition, and could require us to devote significant additional resources to advertising and marketing new brands. Further, we cannot assure you that competitors will not infringe our trademarks, or that we will have adequate resources to enforce our trademarks.

 

We depend on the knowledge and skills of our senior management and other key employees, and if we are unable to retain and motivate them or recruit additional qualified personnel, our business may suffer.

 

We have benefited substantially from the leadership and performance of our senior management, as well as other key employees. Our success will depend on our ability to retain our current management and key employees, and to attract and retain qualified personnel in the future, and we cannot guarantee that we will be able to retain our personnel or attract new, qualified personnel. In addition, we do not maintain any “key person” life insurance policies. The loss of the services of members of our senior management or key employees could prevent or delay the implementation and completion of our strategic objectives, or divert management’s attention to seeking qualified replacements.

 

A failure of one or more key information technology systems, networks or processes may materially adversely affect our ability to conduct our business.

 

The efficient operation of our business depends on our information technology systems. We rely on our information technology systems to effectively manage our sales and marketing, accounting and financial and legal and compliance functions, engineering and product development tasks, research and development data, communications, supply chain, order entry and fulfillment and other business processes. We also rely on third parties and virtualized infrastructure to operate and support our information technology systems. The failure of our information technology systems, or those of our third-party service providers, to perform as we anticipate could disrupt our business and could result in transaction errors, processing inefficiencies and the loss of sales and customers, causing our business and results of operations to suffer.

 

In addition, our information technology systems may be vulnerable to damage or interruption from circumstances beyond our control, including fire, natural disasters, power outages, systems failures, security breaches, cyber-attacks and computer viruses. The failure of our information technology systems to perform as a result of any of these factors or our failure to effectively restore our systems or implement new systems could disrupt our entire operation and could result in decreased sales, increased overhead costs, excess inventory and product shortages and a loss of important information.

 

13

 

 

Further, it is critically important for us to maintain the confidentiality and integrity of our information technology systems. To the extent that we have information in our databases that our customers consider confidential or sensitive, any unauthorized disclosure of, or access to, such information could result in a violation of applicable data privacy and security, data protection, and consumer protection laws and regulations, legal and financial exposure, damage to our reputation, a loss of confidence of our customers, suppliers and manufacturers and lost sales. Despite the implementation of certain security measures, our systems may still be vulnerable to physical break-ins, computer viruses, programming errors, attacks by third parties or similar disruptive problems. If any of these risks materialize, our reputation and our ability to conduct our business may be materially adversely affected.

 

We rely heavily on third-party commerce platforms to conduct our businesses. If one of those platforms is compromised, our business, financial condition and results of operations could be harmed.

 

We currently rely upon third-party commerce platforms, including Shopify. We also rely on e-mail service providers, bandwidth providers, Internet service providers and mobile networks to deliver e-mail and “push” communications to customers and to allow customers to access our website. Any damage to, or failure of, our systems or the systems of our third-party commerce platform providers could result in interruptions to the availability or functionality of our website and mobile applications. As a result, we could lose customer data and miss order fulfillment deadlines, which could result in decreased sales, increased overhead costs, excess inventory and product shortages.

 

In the future, the loss of access to these third-party platforms, or any significant cost increases from operating on the marketplaces, could significantly reduce our revenues, and the success of our business depends partly on continued access to these third-party platforms. Our relationships with our third-party commerce platform providers could deteriorate as a result of a variety of factors, such as if they become concerned about our ability to deliver quality products on a timely basis or to protect a third-party’s intellectual property. In addition, third-party marketplace providers could prohibit our access to these marketplaces if we are not able to meet the applicable required terms of use. If for any reason our arrangements with our third-party commerce platform providers are terminated or interrupted, such termination or interruption could adversely affect our business, financial condition, and results of operations.

 

In addition, we exercise little control over these providers, which increases our vulnerability to problems with the services they provide. We could experience additional expense in arranging for new facilities, technology, services and support. The failure of our third-party commerce platform providers to meet our capacity requirements could result in interruption in the availability or functionality of our website and mobile applications, which could adversely affect our business and results of operations.

 

We may face difficulties as we expand our business and operations into jurisdictions in which we have no prior operating experience.

 

We plan in the future to expand our operations and business into jurisdictions outside of the jurisdictions where we currently carry on business, including internationally. There can be no assurance that any market for our products will develop in any such foreign jurisdiction. We may face new or unexpected risks or significantly increase our exposure to one or more existing risk factors, including economic instability, new competition, changes in laws and regulations, including the possibility that we could be in violation of these laws and regulations as a result of such changes, and the effects of competition.

 

In addition, it may be difficult for us to understand and accurately predict taste preferences and purchasing habits of consumers in new markets. It is costly to establish, develop and maintain operations and develop and promote our brands in new jurisdictions. As we expand our business into other jurisdictions, we may encounter regulatory, legal, personnel, technological and other difficulties that increase our expenses and/or delay our ability to become profitable in such countries, which may have a material adverse effect on our business and brand. These factors may limit our capability to successfully expand our operations in, or export our products to, those other jurisdictions.

 

There may be decreased spending on pets in a challenging economic climate.

 

A challenging economic climate, including adverse changes in interest rates, volatile commodity markets and inflation, contraction in the availability of credit in the market and reductions in consumer spending, or a slow-down in the general economy or a shift in consumer preferences to less expensive products may result in reduced demand for our products which may affect our profitability. Pet ownership and the purchase of pet-related products may constitute discretionary spending for some consumers and any material decline in consumer discretionary spending may reduce overall levels of spending on pets. As a result, a challenging economic climate may cause a decline in demand for our products which could be disproportionate as compared to competing pet food brands since our products command a price premium.

 

Since a significant portion of our revenue has been and is expected to be derived from China, a slowdown in economic growth in China could adversely impact the sales of our products in China, which could have a material adverse effect on our results of operations and financial condition. In addition, a deterioration in trade relations between the U.S. and China or other countries, or the negative perception of U.S. brands by Chinese or other international consumers, could have a material adverse effect on our results of operations and financial condition.

 

14

 

 

If economic conditions result in decreased spending on pets and have a negative impact on our suppliers or distributors, our business, financial condition and results of operations may be materially adversely affected.

 

Significant merchandise returns or refunds could harm our business.

 

We allow our customers to return products or obtain refunds, subject to our return and refunds policy. If merchandise returns or refunds are significant or higher than anticipated and forecasted, our business, financial condition, and results of operations could be adversely affected. Further, we modify our policies relating to returns or refunds from time to time, and may do so in the future, which may result in customer dissatisfaction and harm to our reputation or brand, or an increase in the number of product returns or the amount of refunds we make.

 

We may seek to grow our company and business through acquisitions, investments or through strategic alliances and our failure to identify and successfully integrate and manage these assets could have a material adverse effect on the anticipated benefits of the acquisition and our business, financial condition or results of operations.

 

We expect to consider opportunities to acquire or make investments in new or complementary businesses, facilities, technologies or products, or enter into strategic alliances, which may enhance our capabilities, expand our network, complement our current products or expand the breadth of our markets. In 2019, we completed three significant acquisitions that involved the combination of three businesses that historically have operated as independent companies. The success of these completed acquisitions and any future acquisitions will depend in large part on the success of our management team in integrating the operations, strategies, technologies and personnel. Potential and completed acquisitions, investments and other strategic alliances involve numerous risks, including: problems integrating the purchased business, facilities, technologies or products; issues maintaining uniform standards, procedures, controls and policies; assumed liabilities; unanticipated costs associated with acquisitions, investments or strategic alliances; diversion of management’s attention from our existing business; adverse effects on existing business relationships with suppliers, manufacturers, and retail customers; risks associated with entering new markets in which we have limited or no experience; potential write-offs of acquired assets and/or an impairment of any goodwill recorded as a result of an acquisition; potential loss of key employees of acquired businesses; and increased legal and accounting compliance costs.

 

We may fail to realize some or all of the anticipated benefits of the acquisitions if the integration process takes longer than expected or is more costly than expected. Our failure to meet the challenges involved in successfully integrating acquisitions, including the operations of Halo, or to otherwise realize any of the anticipated benefits of the acquisitions could impair our financial condition and results of operations. Furthermore, we do not know if we will be able to identify additional acquisitions or strategic relationships we deem suitable or whether we will be able to successfully complete any such transactions on favorable terms or at all. Our ability to successfully grow through strategic transactions depends upon our ability to identify, negotiate, complete and integrate suitable target businesses, facilities, technologies and products and to obtain any necessary financing. These efforts could be expensive and time-consuming and may disrupt our ongoing business.

 

Premiums for our insurance coverage may not continue to be commercially justifiable, and our insurance coverage may have limitations and other exclusions and may not be sufficient to cover our potential liabilities.

 

We have insurance to protect our assets, operations and employees. While we believe our insurance coverage addresses all material risks to which we are exposed and is adequate and customary in our current state of operations, such insurance is subject to coverage limits and exclusions and may not be available for the risks and hazards to which we are exposed. No assurance can be given that such insurance will be adequate to cover our liabilities or will be generally available in the future or, if available, that premiums will be commercially justifiable. If we are unable to obtain such insurances or if we were to incur substantial liability and such damages were not covered by insurance or were in excess of policy limits, we may be prevented from entering into certain business sectors, our growth may be inhibited, and we may be exposed to additional risk and financial liabilities, which could have a material adverse effect on our business, results of operations and financial condition could be materially adversely affected.

 

Adverse litigation judgments or settlements resulting from legal proceedings relating to our business operations could materially adversely affect our business, financial condition and results of operations.

 

From time to time, we are subject to allegations, and may be party to legal claims and regulatory proceedings, relating to our business operations. Such allegations, claims and proceedings may be brought by third parties, including our customers, employees, governmental or regulatory bodies or competitors. Defending against such claims and proceedings, regardless of their merits or outcomes, is costly and time consuming and may divert management’s attention and personnel resources from our normal business operations, and the outcome of many of these claims and proceedings cannot be predicted. If any of these claims or proceedings were to be determined adversely to us, a judgment, a fine or a settlement involving a payment of a material sum of money were to occur, or injunctive relief were issued against us, our reputation could be affected and our business, financial condition and results of operations could be materially adversely affected.

 

15

 

 

If third parties claim that we infringe upon their intellectual property rights, our business and results of operations could be adversely affected.

 

Any claims of intellectual property infringement, even those without merit, could be expensive and time consuming to defend; could require us to cease selling the products that incorporate the challenged intellectual property; could require us to redesign, reengineer, or rebrand the product, if feasible; could divert management’s attention and resources; or could require us to enter into royalty or licensing agreements in order to obtain the right to use a third party’s intellectual property. Any royalty or licensing agreements, if required, may not be available to us on acceptable terms or at all.

 

A successful claim of infringement against us could result in our being required to pay significant damages, enter into costly license or royalty agreements, or stop the sale of certain products, any of which could have a negative impact on our business, financial condition, results of operations and our future prospects.

 

Failure to comply with the U.S. Foreign Corrupt Practices Act, other applicable anti-corruption and anti-bribery laws, and applicable trade control laws could subject us to penalties and other adverse consequences.

 

We operate our business in part outside of the U.S. and our operations are subject to the U.S. Foreign Corrupt Practices Act (the “FCPA”), as well as the anti-corruption and anti-bribery laws in the countries where we do business. In addition, we are subject to U.S. and other applicable trade control regulations that restrict with whom we may transact business, including the trade sanctions enforced by the U.S. Treasury, Office of Foreign Assets Control (“OFAC”). We also plan to expand our operations outside of the U.S. in the future and our risks related to the FCPA will increase as we grow our international presence. Any violations of these anti-corruption or trade controls laws, or even allegations of such violations, can lead to an investigation and/or enforcement action, which could disrupt our operations, involve significant management distraction, and lead to significant costs and expenses, including legal fees. In addition, our brand and reputation, our sales activities or our stock price could be adversely affected if we become the subject of any negative publicity related to actual or potential violations of anti-corruption, anti-bribery or trade control laws and regulations.

 

Our ability to utilize our net operating loss carryforwards may be limited.

 

Our ability to utilize our federal net operating loss carryforwards and federal tax credit may be limited under Section 382 of the Code as amended by the Tax Cut and Jobs Act (the “TCJA”). The limitations apply if we experience an “ownership change”. Similar provisions of state tax law may also apply. If we have experienced an ownership change at any time since our formation, we may already be subject to limitations on our ability to utilize our existing net operating losses to offset taxable income. In addition, future changes in our stock ownership, which may be outside of our control, may trigger an ownership change and, consequently, the limitations under Section 382. As a result, if or when we earn net taxable income, our ability to use our pre-change net operating loss carryforwards to offset such taxable income may be subject to limitations, which could adversely affect our future cash flows.

 

We may have material liabilities that have not been discovered since the closing of the acquisitions.

 

As a result of our acquisitions in 2019, the prior business plan and management relating to Better Choice Company was abandoned. We may have material liabilities based on activities of our subsidiaries before the acquisitions that have not been discovered or asserted. We could experience losses as a result of any such undisclosed liabilities that are discovered in the future, which could materially harm our business and financial condition. Although the agreements entered into in connection with the acquisitions contains customary representations and warranties from Bona Vida, Halo and TruPet concerning their assets, liabilities, financial condition and affairs, there may be limited or no recourse against the pre-acquisition stockholders or principals in the event those representations prove to be untrue. As a result, our current and future stockholders will bear some, or all, of the risks relating to any such unknown or undisclosed liabilities.

 

Risks Related to the Regulation of our Business and Products

 

We and our co-manufacturers and suppliers are subject to extensive governmental regulation and may be subject to enforcement if we are not in compliance with applicable requirements.

 

We and our third-party suppliers are subject to a broad range of foreign, federal, state and local laws and regulations governing, among other things, the testing, development, manufacture, distribution, marketing and post-market reporting of animal foods. These include laws administered by the FDA, the FTC, the USDA, and other federal, state and local regulatory authorities. Because we market food, supplements and other products that are regulated as food and cosmetic care products for animals, we and the companies that manufacture our products are subject to the requirements of the FDCA and regulations promulgated thereunder by the FDA. The FDCA and related regulations govern, among other things, the manufacturing, composition, ingredients, packaging, labeling and safety of food for animals. The FDA requires that facilities that manufacture animal food products comply with a range of requirements. If our third-party suppliers cannot successfully manufacture products that conform to our specifications and the strict regulatory requirements, they may be subject to adverse inspectional findings or enforcement actions, which could materially impact our ability to market our products, could result in their inability to continue manufacturing for us or could result in a recall of our products that have already been distributed.

 

16

 

 

If the FDA or other regulatory authority determines that we or they have not complied with the applicable regulatory requirements, our business, financial condition and results of operations may be materially adversely impacted. If we do not comply with labeling requirements, including making unlawful claims about our products, we could be subject to public warning letters and possible further enforcement. Failure by us or our co-manufacturers and suppliers to comply with applicable laws and regulations or to obtain and maintain necessary permits, licenses and registrations relating to our or our partners’ operations could subject us to administrative and civil penalties, including fines, injunctions, recalls or seizures, warning letters, restrictions on the marketing or manufacturing of our products, or refusals to permit the import or export of products, as well as potential criminal sanctions, which could result in increased operating costs resulting in a material effect on our operating results and business. For further detail, refer to the information under “Item 1. Business—Government Regulation” in this Annual Report on Form 10-K.

 

International expansion of our business could expose us to substantial business, regulatory, political, financial and economic risks.

 

We currently conduct business and market products in the U.S., Canada and select Asian markets, including China. The expansion of our business outside of the U.S. could expose us to substantial risks, which may include, but are not limited to, the following:

 

●political, social and economic instability;

 

●higher levels of credit risk, corruption and payment fraud;

 

●regulations that might add difficulties in repatriating cash earned outside the U.S. and otherwise prevent us from freely moving cash;

 

●import and export controls and restrictions and changes in trade regulations

 

●compliance with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act and similar laws in other jurisdictions;

 

●multiple, conflicting and changing laws and regulations such as privacy, security and data use regulations, tax laws, trade regulations, economic sanctions and embargoes, employment laws, anti-corruption laws, regulatory requirements, reimbursement or payor regimes and other governmental approvals, permits and licenses;

 

●failure by us, our collaborators or our distributors to obtain regulatory clearance, authorization or approval for the use of our products in various countries;

 

●additional potentially relevant third-party patent rights;

 

●complexities and difficulties in obtaining intellectual property protection and enforcing our intellectual property;

 

●logistics and regulations associated with shipping samples and customer orders, including infrastructure conditions and transportation delays;

 

●the impact of local and regional financial crises;

 

●natural disasters, political and economic instability, including wars, terrorism and political unrest, and outbreak of disease;

 

●breakdowns in infrastructure, utilities and other services;

 

●boycotts, curtailment of trade and other business restrictions; and

 

●the other risks and uncertainties described in this Form 10K

 

Any of these factors could significantly harm our future international expansion and operations and, consequently, our revenue and results of operations.

 

Changes in government regulations and trade policies may materially and adversely affect our sales and results of operations.

 

The U.S. or foreign governments may take administrative, legislative, or regulatory action that could materially interfere with our ability to sell products in certain countries and/or to certain customers, particularly in China. As part of our attempt to broaden its customer base, we have begun offering our products to Chinese consumers. Our decision to export products to China requires us to comply with Chinese rules, laws, and regulations, as well as certain domestic and international laws relating to the import and export of goods to foreign countries. These laws are often changing, and the costs associated with complying with these laws and regulations may adversely affect us. Additionally, changes in the current laws may make importing products to China more difficult, which may also negatively affect our business. Furthermore, changes in U.S. trade policy more generally could trigger retaliatory actions by affected countries, which could impose restrictions on our ability to do business in or with affected countries or prohibit, reduce or discourage purchases of our products by foreign customers. Changes in, and responses to, U.S. trade policy could reduce the competitiveness of our products, cause our sales to decline and adversely impact our ability to compete, which could materially and adversely impact our business, financial condition and results of operations.

 

17

 

 

There is significant uncertainty about the future relationship between the U.S. and China with respect to trade policies, treaties, government regulations and tariffs. An escalation of recent trade tensions between the U.S. and China has resulted in trade restrictions that could harm our ability to participate in Chinese markets and numerous additional such restrictions have been threatened by both countries. The U.S. and China have imposed a number of tariffs and other restrictions on items imported or exported between the U.S. and China. We cannot predict what actions may ultimately be taken with respect to tariffs or trade relations between the U.S. and China or other countries, what products may be subject to such actions, or what actions may be taken by the other countries in retaliation. The institution of trade tariffs both globally and between the U.S. and China specifically carries the risk of negatively impacting China’s overall economic condition, which could have negative repercussions for our business. Our products are and may continue to be subject to export license requirements or restrictions, particularly in respect of China.

 

Our products may be subject to recalls for a variety of reasons, which could require us to expend significant management and capital resources.

 

Manufacturers and distributors of products are sometimes subject to the recall or return of their products for a variety of reasons, including product defects, such as contamination, adulteration, unintended harmful side effects or interactions with other substances, packaging safety and inadequate or inaccurate labeling disclosure. Although we have detailed procedures in place for testing finished products, there can be no assurance that any quality, potency or contamination problems will be detected in time to avoid unforeseen product recalls, regulatory action or lawsuits, whether frivolous or otherwise. If any of the animal food or care products produced by us are recalled due to an alleged product defect or for any other reason, we could be required to incur the unexpected expense of the recall and any legal proceedings that might arise in connection with the recall. We had to issue a recall in 2018 for one of our products after a single retail sample collected by the Michigan Department of Agriculture tested positive for Salmonella. Although customers reported no incidents of injury or illness in association with this product, the recall negatively affected our results. As a result of any such recall, customers may be hesitant to purchase our products in the future and we may lose a significant amount of sales and may not be able to replace those sales at an acceptable margin or at all. In addition, a product recall may require significant management attention or damage our reputation and goodwill or that of our products or brands. Additionally, product recalls may lead to increased scrutiny of our operations by the FDA or other state or federal regulatory agencies, requiring further management attention, increased compliance costs and potential legal fees, fines, penalties and other expenses.

 

Changes in existing laws or regulations, including how such existing laws or regulations are enforced by federal, state, and local authorities, or the adoption of new laws or regulations may increase our costs and otherwise adversely affect our business, financial condition and results of operations.

 

The manufacture and marketing of animal food products is highly regulated, and we and our co-manufacturers and suppliers are subject to a variety of federal and state laws and regulations applicable to pet food and treats. These laws and regulations apply to many aspects of our business, including the manufacture, packaging, labeling, distribution, advertising, sale, quality and safety of our products. We could incur costs, including fines, penalties, and third-party claims, in the event of any violations of, or liabilities under, such requirements, including any competitor or consumer challenges relating to compliance with such requirements. For example, in connection with the marketing and advertisement of our products, we could be the target of claims relating to false or deceptive advertising, including under the auspices of the FTC and state consumer protection statutes. The regulatory environment in which we operate could change significantly and adversely in the future. The laws and regulations that apply to our products and business may change in the future and we may incur (directly or indirectly) material costs to comply with current or future laws and regulations or any required product recalls. New or revised government laws and regulations could significantly limit our ability to run our business as it is currently conducted, result in additional compliance costs and, in the event of noncompliance, lead to administrative or civil remedies, including fines, injunctions, withdrawals, recalls or seizures and confiscations, as well as potential criminal sanctions. Any such changes or actions by the FDA or other regulatory agencies could have a material adverse effect on our co-manufacturers, our suppliers or our business, financial condition and results of operations.

 

Risks Related to Our Capital Structure

 

We are a holding company and rely on payments, advances and transfers of funds from our subsidiaries to meet our obligations and pay any dividends.

 

We have limited direct operations and significant assets other than ownership of 100% of the capital stock of our subsidiaries. Because we primarily conduct our operations through our subsidiaries, we depend on those entities for payments to generate the funds necessary to meet our financial obligations, and to pay any dividends with respect to our common stock. Legal and contractual restrictions in our term loan and revolving line of credit agreement and other agreements that may govern future indebtedness of our subsidiaries, as well as the financial condition and operating requirements of our subsidiaries, may limit our ability to obtain cash from our subsidiaries. The earnings from, or other available assets of, our subsidiaries might not be sufficient to make distributions or obtain loans to enable us to meet certain of our obligations. Any of the foregoing could materially and adversely affect our business, financial condition, results of operations and cash flows.

 

18

 

 

Our level of indebtedness and related covenants could limit our operational and financial flexibility and could significantly adversely affect our business if we breach such covenants and default on such indebtedness.

 

Our ability to meet our debt service obligations depends upon our operating and financial performance, which is subject to general economic and competitive conditions and to financial, business and other factors affecting our operations, many of which are beyond our control. If we are unable to service our debt, we may need to sell inventory and other material assets, restructure or refinance our debt, or seek additional equity capital. If our inability to meet our debt service obligations results in an event of default as defined under our Alphia term loan and Wintrust receivables credit facility, the lenders thereunder may be able to take possession of substantially all of our assets. Prevailing economic conditions and global credit markets could adversely impact our ability to do so.

 

In addition, our debt agreements contain limits on our ability to, among other things, incur additional debt, grant liens, undergo certain fundamental changes, make investments, and dispose of inventory. These restrictions may prevent us from taking actions that we believe would be in the best interests of the business and may make it difficult for us to successfully execute our business strategy or effectively compete with companies that are not similarly restricted. If we determine that we need to take any action that is restricted under our debt agreements, we will need to first obtain a waiver from the related lenders. Obtaining such waivers, if needed, may impose additional costs or we may be unable to obtain such waivers. Our ability to comply with these restrictive covenants in future periods will largely depend on our ability to successfully implement our overall business strategy. The breach of any of these covenants or restrictions could result in a default, which could result in the acceleration of our outstanding debt. In the event of an acceleration of such debt, we could be forced to apply all available cash flows to repay such debt, which could also force us into bankruptcy or liquidation.

 

For information regarding our outstanding debt, refer to “Note 8 - Debt” in the Notes to Consolidated Financial Statements included in Item 8. Financial Statements and Supplementary Data of this report, which is incorporated into this Item 1A by reference.

 

Our common stock may be deemed to be a “penny stock” and the “penny stock” rules could adversely affect the market price of our common stock.

 

The SEC has adopted Rule 3a51-1, which establishes the definition of a “penny stock” as any equity security that has a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share, subject to certain exceptions. Our common stock may be deemed to be a penny stock. For any transaction involving a penny stock, unless exempt, Rule 15g-9 requires that a broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive (i) the purchaser’s written acknowledgment of the receipt of a risk disclosure statement; (ii) a written agreement to transactions involving penny stocks; and (iii) a signed and dated copy of a written suitability statement. Generally, brokers may be less willing to execute transactions in securities subject to the “penny stock” rules. This may make it more difficult for investors to dispose of our common stock and cause a decline in the market value of our stock.

 

Our failure to meet the continued listing requirements of NYSE American could result in a delisting of our common stock and could make it more difficult to raise capital in the future.

 

NYSE has listing requirements for inclusion of securities for trading on the NYSE American, including minimum levels of stockholders’ equity, market value of publicly held shares, number of public stockholders and stock price. There can be no assurance that we will be successful in maintaining the listing of NYSE American as it is possible we may fail to satisfy the continued listing requirements, such as the corporate governance requirements or the minimum stock price requirement. During the third quarter, the Company received a notice of noncompliance from the NYSE American. If we fail to satisfy the continued listing requirements before the end of the cure period, the NYSE American may take steps to delist our common stock. Such a delisting or the announcement of such delisting will have a negative effect on the price of our common stock and would impair your ability to sell or purchase our common stock when you wish to do so. In the event of a delisting, we may attempt to take actions to restore our compliance with the NYSE American listing requirements, but we can provide no assurance that any such action taken by us would allow our common stock to become listed again, stabilize the market price or improve the liquidity of our common stock, prevent our common stock from dropping below the NYSE American minimum listing requirements or prevent future non-compliance with the NYSE American listing requirements. If we do not maintain the listing of our common stock on NYSE American, it could make it harder for us to raise additional capital in the long-term. If we are unable to raise capital when needed in the future, we may have to cease or reduce operations.

 

Our common stock prices may be volatile.

 

The market price of our common stock has been and may continue to be highly volatile and subject to wide fluctuations. Our financial performance, government regulatory action, tax laws, interest rates and market conditions in general could have a significant impact on the future market price of our common stock.

 

19

 

 

The public price of our common stock could also be subject to wide fluctuations in response to the risk factors described in this report and others beyond our control, including: the number of shares of our common stock publicly owned and available for trading; actual or anticipated quarterly variations in our results of operations or those of our competitors; our actual or anticipated operating performance and the operating performance of similar companies in our industry; our announcements or our competitors’ announcements regarding significant contracts, acquisitions, or strategic investments; general economic conditions and their impact on the pet food markets; the overall performance of the equity markets; threatened or actual litigation; changes in laws or regulations relating to our industry; any major change in our board of directors or management; publication of research reports about us or our industry or changes in recommendations or withdrawal of research coverage by securities analysts; and sales or expected sales of shares of our common stock by us, and our officers, directors, and significant stockholders. From time to time, our affiliates may sell stock for reasons due to their personal financial circumstances. These sales may be interpreted by other stockholders as an indication of our performance and result in subsequent sales of our stock that have the effect of creating downward pressure on the market price of our common stock.

 

The volatility of the market price of our common stock may adversely affect the ability of investors to purchase or sell shares of our common stock. Investors may also experience losses on their investments in our stock due to price fluctuations. In addition, the stock market in general has experienced extreme price and volume fluctuations that often have been unrelated or disproportionate to the operating performance of those companies. Securities class action litigation has often been instituted against companies following periods of volatility in the overall market and in the market price of a company’s securities. Such litigation, if instituted against us, could result in very substantial costs, divert our management’s attention and resources and harm our business, operating results, and financial condition.

 

We do not expect to pay any cash dividends to the holders of the common stock in the foreseeable future and the availability and timing of future cash dividends, if any, is uncertain.

 

We expect to use cash flow from future operations to repay debt and support the growth of our business and do not expect to declare or pay any cash dividends on our common stock in the foreseeable future. Our Wintrust receivables credit facility and Alphia term loan place certain restrictions on the ability of us and our subsidiaries to pay cash dividends. We may amend our current credit facilities or enter into new debt arrangements that also prohibit or restrict our ability to pay cash dividends on our common stock.

 

Subject to such restrictions, our board of directors will determine the amount and timing of stockholder dividends, if any, that we may pay in future periods. In making this determination, our directors will consider all relevant factors, including the amount of cash available for dividends, capital expenditures, covenants, prohibitions or limitations with respect to dividends, applicable law, general operational requirements and other variables. We cannot predict the amount or timing of any future dividends you may receive, and if we do commence the payment of dividends, we may be unable to pay, maintain or increase dividends over time. Therefore, you may not be able to realize any return on your investment in our common stock for an extended period of time, if at all.

 

Future sales of our common stock, or the perception that such sales may occur, may depress our share price, and any additional capital through the sale of equity or convertible securities may dilute your ownership in us.

 

In the future, we may issue our previously authorized and unissued securities. We are authorized to issue 200,000,000 shares of common stock and 4,000,000 shares of preferred stock with such designations, preferences and rights as determined by our board of directors. The potential issuance of such additional shares of common stock will result in the dilution of the ownership interests of the holders of our common stock and may create downward pressure on the trading price, if any, of our common stock. The sales of substantial amounts of our common stock pursuant to our effective registration statements, or the perception that these sales may occur, could cause the market price of our common stock to decline and impair our ability to raise capital. These shares also may be sold pursuant to Rule 144 under the Securities Act, depending on their holding period and subject to restrictions in the case of shares held by persons deemed to be our affiliates. We also may grant additional registration rights in connection with any future issuance of our capital stock.

 

For information regarding our outstanding stockholders’ equity and potentially dilutive securities, refer to “Note 8 - Debt”, “Note 10 - Commitments and contingencies”, “Note 11 - Warrants” and “Note 12 - Share-based compensation” in the Notes to Consolidated Financial Statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K, which is incorporated into this Item 1A by reference.

 

The market price of our common stock may not attract new investors, including institutional investors, and may not satisfy the investing requirements of those investors. Consequently, the trading liquidity of our common stock may not improve.

 

There can be no assurance that the share price of our stock will attract new investors, including institutional investors. In addition, there can be no assurance that the market price of our common stock will satisfy the investing requirements of those investors. As a result, the trading liquidity of our common stock may not necessarily improve.

 

20

 

 

We may issue preferred stock whose terms could adversely affect the voting power or value of our common stock.

 

Our certificate of incorporation authorizes us to issue, without the approval of our stockholders, one or more classes or series of preferred stock having such designations, preferences, limitations and relative rights, including preferences over our common stock with respect to dividends and distributions, as our board of directors may determine. The terms of one or more classes or series of preferred stock could adversely impact the voting power or value of our common stock. For example, we might grant holders of preferred stock the right to elect some number of our directors in all events or on the happening of specified events, or the right to veto specified transactions. Similarly, the repurchase or redemption rights or liquidation preferences we might grant to holders of preferred stock could affect the value of the common stock. The issuance of such preferred stock could also be used as a method of discouraging, delaying or preventing a change of control.

 

The administrative and regulatory costs of public company compliance could consume a significant amount of our resources.

 

The rules and regulations related to being a public company require us to incur significant legal, accounting and other expenses. The legal and financial compliance make some activities more time-consuming and costly, particularly after we are no longer a smaller reporting company. Moreover, if we are not able to comply with the requirements or regulations as a public reporting company in any regard, we could be subject to sanctions or investigations by the SEC or other regulatory authorities, which would require additional financial and management resources.

 

In addition, the Sarbanes-Oxley Act of 2002 and rules subsequently implemented by the SEC impose various requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and corporate governance practices. Our management and other personnel devote a substantial amount of time to these compliance initiatives. To achieve compliance with Section 404 within the prescribed period, we will be engaged in a costly and challenging process to document and evaluate our internal control over financial reporting. In this regard, we will need to continue to dedicate internal resources and potentially engage outside consultants or hire an internal audit resource to assess and document the adequacy of internal control over financial reporting, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that neither we nor our independent registered public accounting firm will be able to conclude within the prescribed timeframe that our internal control over financial reporting is effective as required by Section 404. This could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements.

 

We are a smaller reporting company which could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.

 

We are a smaller reporting company, as defined in Item 10(f)(1) of Regulation S-K, and we may take advantage of certain reduced disclosure obligations. To the extent we take advantage of such reduced disclosure obligations while we continue to qualify as a smaller reporting company, it may make comparison of our financial statements with other public companies difficult or impossible. Some investors may find our common stock less attractive because we may rely on these exemptions, which could result in a less active trading market for our common stock, and our stock price may be more volatile.

 

Our bylaws designate the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, employees or agents.

 

Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will, to the fullest extent permitted by applicable law, be the sole and exclusive forum for (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director or officer (or affiliate of any of the foregoing) of us to us or the our shareholders, (iii) any action asserting a claim arising pursuant to any provision of the DGCL or our certificate of incorporation or bylaws, or (iv) any other action asserting a claim arising under, in connection with, and governed by the internal affairs doctrine; provided that these exclusive forum provisions will not apply to suits brought to enforce any liability or duty created by the Securities Act or the Exchange Act, or to any claim for which the federal courts have exclusive jurisdiction. Any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock will be deemed to have notice of, and consented to, the provisions of our bylaws described in the preceding sentence. This choice of forum provision may limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, employees or agents, which may discourage such lawsuits against us and such persons. Alternatively, if a court were to find these provisions of our bylaws inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect our business, financial condition or results of operations.

 

21

 

 

Provisions in our certificate of incorporation and bylaws and Delaware law may discourage a takeover attempt even if a takeover might be beneficial to our stockholders.

 

Provisions contained in our certificate of incorporation and bylaws could make it more difficult for a third party to acquire us after we have become a publicly traded company. Provisions in our certificate of incorporation and bylaws impose various procedural and other requirements, which could make it more difficult for stockholders to effect certain corporate actions. For example, our certificate of incorporation authorizes our board of directors to determine the rights, preferences, privileges and restrictions of unissued series of preferred stock without any vote or action by our stockholders. Thus, our board of directors can authorize and issue shares of preferred stock with voting or conversion rights that could dilute the voting power of holders of our other series of capital stock. These rights may have the effect of delaying or deterring a change of control of our company. Additionally, our certificate of incorporation and/or bylaws establish limitations on the removal of directors and on the ability of our stockholders to call special meetings and include advance notice requirements for nominations for election to our board of directors and for proposing matters that can be acted upon at stockholder meetings.

 

Moreover, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the General Corporation Law of the State of Delaware (the “DGCL”), which prohibits an “interested stockholder” owning in excess of 15% of our outstanding voting stock from merging or combining with us for a period of three years after the date of the transaction in which such stockholder acquired in excess of 15% of our outstanding voting stock, unless the merger or combination is approved in a prescribed manner. These provisions could limit the price that certain investors might be willing to pay in the future for shares of our common stock.

 

Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available to us.

 

Our certificate of incorporation provides that we will indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law. In addition, as permitted by Section 145 of the Delaware General Corporation Law, our certificate of incorporation and our indemnification agreements that we have entered into with our directors and officers provide that:

 

●We will indemnify our directors and officers for serving us in those capacities or for serving other business enterprises at our request, to the fullest extent permitted by Delaware law. Delaware law provides that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe such person’s conduct was unlawful.

 

●We may, in our discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law.

 

●We are required to advance expenses, as incurred, to our directors and officers in connection with defending a proceeding, except that such directors or officers shall undertake to repay such advances if it is ultimately determined that such person is not entitled to indemnification.

 

●We will not be obligated pursuant to the indemnification agreements entered into with our directors and executive officers to indemnify a person with respect to proceedings initiated by that person, except with respect to proceedings to enforce an indemnitees right to indemnification or advancement of expenses, proceedings authorized by our board of directors and if offered by us in our sole discretion.

 

●The rights conferred in our certificate of incorporation are not exclusive, and we are authorized to enter into indemnification agreements with our directors, officers, employees and agents and to obtain insurance to indemnify such persons.

 

●We may not retroactively amend our certificate of incorporation or indemnification agreement provisions to reduce our indemnification obligations to directors, officers, employees and agents.

 

As a result of these provisions, if an investor were able to enforce an action against our directors or officers, in all likelihood, we would be required to pay any expenses they incurred in defending the lawsuit and any judgment or settlement they otherwise would be required to pay. Accordingly, our indemnification obligations could divert needed financial resources and may adversely affect our business, financial condition, results of operations and cash flows, and adversely affect the value of our business.

 

22

 

 

ITEM 1B.UNRESOLVED STAFF COMMENTS

 

None.

 

ITEM 1C.CYBERSECURITY

 

Cybersecurity risk management is an important part of the Company’s overall risk management efforts. We maintain a comprehensive enterprise-wide information security program that comprises policies and controls designed to identify, safeguard against, detect, respond to, mitigate and manage reasonably foreseeable cybersecurity risks and threats. Our approach utilizes diverse security tools to prevent, identify, investigate, resolve and recover from vulnerabilities and security incidents. These include, but are not limited to, internal reporting, monitoring and detection tools. We use a collaborative, enterprise-wide strategy to address cybersecurity risks and allocate significant resources to our cybersecurity and risk management processes, which efforts are intended to adapt to the evolving cybersecurity landscape and promptly address emerging threats. Our cybersecurity risk management program aligns with the National Institute of Standards and Technology (NIST) framework and is organized into five key functions: identification, protection, detection, response and recovery. We regularly assess the threat landscape and employ a layered cybersecurity strategy to prevent, detect and mitigate threats.

 

All employees undergo security awareness training, with regular testing through simulated phishing emails. Certain employee positions require additional role-based, specialized security awareness or other cybersecurity training, as applicable. Simulations, drills and assessments are conducted to test our defenses from both a technical and an operational perspective.

 

We assess risks associated with third-party providers as part of our overall cybersecurity risk management framework by reviewing system and organization controls reports, when available, and other independent reports. We also generally require third parties to, among other things, maintain security controls to protect our confidential information and to promptly notify us of material breaches that may impact our data.

 

Our Board of Directors has oversight of our enterprise risk assessment and risk management processes, as well as the steps taken to mitigate these risks, including for cybersecurity matters. The Audit Committee of our Board of Directors has oversight of cybersecurity risk assessment and risk management policies as part of its risk management oversight responsibilities, and is responsible for ensuring that the Company has processes in place to identify, evaluate and manage cybersecurity risks, as well as appropriate processes and programs to mitigate cybersecurity incidents if they occur. Significant cybersecurity matters, including those related to incidents, are escalated to the Board of Directors.

 

We face cybersecurity threats in the ordinary course of our business and have faced cybersecurity threats and breach attempts in the past. Such threats and breach attempts have not materially affected our business, strategy, results of operations or financial condition. At any given time, however, we may face known or unknown cybersecurity risks and threats that cannot be fully prevented or mitigated, and we may discover vulnerabilities in our cybersecurity programs. Therefore, we may not be successful in preventing or mitigating a cybersecurity incident that could have a material adverse effect on us. For more information on the cybersecurity risks we face, please refer to “A failure of one or more key information technology systems, networks or processes may materially adversely affect our ability to conduct our business.” in Item 1A. “Risk Factors.”

 

ITEM 2.PROPERTIES

 

Our principal place of business is located at 12400 Race Track Road, Tampa, FL 33626, which consists of approximately 5,000 square feet of office space which we lease. Our lease for this location is scheduled to expire on January 31, 2026.

 

We do not own any properties or land.

 

We believe our facilities are adequate and suitable for our current needs and that suitable additional or alternative space will be available if the need arises in the future.

 

ITEM 3.LEGAL PROCEEDINGS

 

From time to time, we are subject to litigation and other proceedings that arise in the ordinary course of our business. Subject to the inherent uncertainties of litigation and although no assurances are possible, we believe that there are no pending lawsuits or claims that, individually or in the aggregate, will have a material adverse effect on our business, financial condition or our yearly results of operations.

 

ITEM 4.MINE SAFETY DISCLOSURES

 

Not applicable.

 

23

 

 

PART II

 

ITEM 5.MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Market Information

 

Our common stock is currently listed on the NYSE American marketplace under the symbol “BTTR” after the consummation of our IPO on July 1, 2021 and was previously listed on the OTC Market Group Inc.’s OTCQX market after being upgraded from the OTCQB on December 28, 2020 where it had been trading since June 2010. The following table sets forth, for the periods indicated and as reported on the NYSE American and OTC Markets, the high and low bid prices for our common stock. Such over-the-counter market quotations reflect inter-dealer prices, without retail mark-up, mark-downs or commissions, and may not necessarily represent actual transactions:

 

   High   Low 
2022          
First Quarter (1)  $158.00   $84.40 
Second Quarter (1)  $121.60   $74.40 
Third Quarter (1)  $106.00   $31.20 
Fourth Quarter (1)  $49.60   $17.60 
2023          
First Quarter (1)  $33.20   $13.00 
Second Quarter (1)  $22.60   $7.76 
Third Quarter (1)  $11.20   $4.44 
Fourth Quarter (1)  $23.20   $4.88 

 

(1)The high and low bid prices for this quarter were reported by the NYSE American marketplace.

 

Holders of Common Stock

 

As of April 11, 2024, we had 893,601 shares of our common stock issued and outstanding. As of April 11, 2024, there were 154 record holders of our common stock. Certain shares are held in “street” name and accordingly, the number of beneficial owners of such shares is not known or included in the foregoing number. This number of holders of record also does not include stockholders whose shares may be held in trust by other entities.

 

Dividend Policy

 

We do not currently anticipate declaring or paying cash dividends on our common stock in the foreseeable future. We currently intend to retain our future earnings, if any, to finance the development and expansion of our business. Any future determination to pay dividends will be at the discretion of our board of directors and will depend upon then-existing conditions, including our results of operations and financial condition, capital requirements, business prospects, statutory and contractual restrictions on our ability to pay cash dividends, including restrictions contained in our credit agreements, and other factors our board of directors may deem relevant. Accordingly, you may need to sell your shares of our common stock to realize a return on your investment, and you may not be able to sell your shares at or above the price you paid for them.

 

Securities Authorized for Issuance under Equity Compensation Plans

 

Information about our equity compensation plans is included in Item 12 of Part III of this Annual Report on Form 10-K.

 

Recent Sales of Unregistered Securities

 

Since January 1, 2022, the registrant made the following issuances and purchases of its unregistered securities as described below. All share amounts have been retroactively adjusted to give effect to a reverse stock split of 1-for-44 effective March 20, 2024.

 

(1) On February 1, 2022, the registrant issued 4,962 shares of common stock to five non-employee directors in return for services provided in their capacity as directors.

 

(2) On November 2, 2022, the registrant issued 927 shares of common stock to a member of its board of directors for service as interim CEO.

 

(3) On December 30, 2022, the registrant issued 562 shares of common stock to a member of its board of directors for service as interim CEO.

 

24

 

 

(4) On January 4, 2023, the registrant issued 20,292 shares of common stock to its board of directors in return for services provided in their capacity as directors.

 

(5) On January 11, 2023, the registrant issued 4,545 shares of common stock to its key executives as part of their compensation packages.

 

(6) On January 31, 2023, the registrant issued 409 shares of common stock to a member of its board of directors for service as interim CEO.

 

(7) On April 30, 2023, the registrant issued 909 shares of common stock to a member of its executive management as part of their compensation package.

 

(8) On September 5, 2023, the registrant issued 34,090 shares of common stock to two members of its board of directors in return for services provided in their capacity as directors.

 

Unless otherwise stated above, the issuances of the above securities were deemed to be exempt from registration under the Securities Act in reliance upon Section 4(a)(2) of the Securities Act, or Regulation D promulgated thereunder, or Rule 701 promulgated under Section 3(b) of the Securities Act as transactions by an issuer not involving any public offering or pursuant to benefit plans and contracts relating to compensation as provided under Rule 701. The recipients of the securities in each of these transactions represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof and appropriate legends were placed upon the stock certificates issued in these transactions.

 

Purchases of Equity Securities by the Issuer

 

There were no repurchases of Better Choice Company common stock during the year ended December 31, 2023:

 

ITEM 6.[RESERVED]

 

25

 

 

ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

The following discussion includes forward-looking statements about our business, financial condition and results of operations, including discussions about management’s expectations for our business. The financial condition, results of operations and cash flows discussed in this Management’s Discussion and Analysis of Financial Condition and Results of Operations are those of Better Choice Company Inc. and its consolidated subsidiaries, collectively, the “Company,” “Better Choice Company,” “we,” “our,” or “us”. These statements represent projections, beliefs and expectations based on current circumstances and conditions and in light of recent events and trends, and you should not construe these statements either as assurances of performance or as promises of a given course of action. Instead, various known and unknown factors are likely to cause our actual performance and management’s actions to vary, and the results of these variances may be both material and adverse. A description of material factors known to us that may cause our results to vary or may cause management to deviate from its current plans and expectations, is set forth under “Risk Factors.” See “Cautionary Note Regarding Forward-Looking Statements.” The following discussion should also be read in conjunction with our audited consolidated financial statements including the notes thereto appearing elsewhere in this filing. Accordingly, readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. We undertake no obligation to publicly release the results of any revision to these forward-looking statements which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

 

Overview and Outlook

 

Better Choice is a pet health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier and longer lives. Our mission is to become the most innovative premium pet food company in the world, and we are motivated by our commitment to making products with integrity and treating pets and their parents with respect. We believe that our broad portfolio of pet health and wellness products are well positioned to benefit from the trends of growing pet humanization and an increased consumer focus on health and wellness, and have adopted a laser focused, channel specific approach to growth that is driven by new product innovation.

 

We sell our premium and super-premium products (which we believe generally includes products with a retail price greater than $0.20 per ounce) under the Halo brand umbrella, including Halo Holistic™, Halo Elevate® and the former TruDog brand, which has been rebranded and successfully integrated under the Halo brand umbrella during the third quarter of 2022. Our core products sold under the Halo brand are made with high-quality, thoughtfully sourced ingredients for natural, science based nutrition. Each innovative recipe is formulated with leading veterinary and nutrition experts to deliver optimal health. Our diverse and established customer base has enabled us to penetrate multiple channels of trade, which we believe enables us to deliver on core consumer needs and serve pet parents wherever they shop. We group these channels of trade into four distinct categories: E-commerce, which includes the sale of product to online retailers such as Amazon and Chewy; Brick & Mortar, which primarily includes the sale of product to Pet Specialty retailers such as Petco, Pet Supplies Plus and neighborhood pet stores, as well as to select grocery chains; Direct to Consumer (“DTC”) which includes the sale of product through our website halopets.com; and International, which includes the sale of product to foreign distribution partners and to select international retailers. In December 2023, the Company made a strategic exit out of Petco stores (while remaining on Petco.com), and Pet Supplies Plus. As of Q1 2024, the Company has made plans to exit its DTC channel in Q2 2024, in an effort to improve profitability.

 

The Global Pet Food and Treat Market

 

The U.S. represents the largest and most developed market for pet food globally, with food and treats accounting for approximately $58 billion, or 42% of the total U.S. pet care market in 2022. According to the American Pet Product Association, between 66% of all households in the U.S. own a pet, equating to a total pet population of more than 130 million companion animals and an average of 1.7 pets per household. Pet spending represents a significant portion of household spend on consumer products, as this translates to an average annual spend on pet care of more than $1,500 per pet owning household, with $460 of this spend attributed to pet food and treats.

 

26

 

 

Historically, consumer spending on pets grew at an approximately 3% CAGR in the decade leading up to the COVID-19 pandemic, driven by steady annual increases in household pet ownership of approximately 1%, the continued premiumization of the category and the humanization of pets. This surge in pet acquisition has led to an increase in the forecasted growth of the pet care industry over the next ten years. The U.S. pet food industry is expected to grow at a 4.96% CAGR between 2021 and 2028 (Statistica).

 

From a demographic perspective, younger pet owners are more likely to spend a higher percentage of their income on pets, treat their pet as an important member of the family and to purchase products from pet specialty and online retailers rather than from grocery stores. Along these lines, women are 3.2 times more interested in purchasing pet food than men, and are 2.4 times more likely to engage with search ads than men. Taken holistically, these traits suggest a preference to purchase more premium and super-premium pet food and treats from brands like Halo, with a tendency to purchase products in the channels where we compete.

 

Globally, Asia is the second largest market for pet products, with China representing the largest market opportunity for growth. Like the U.S., growth in the Asian pet care industry has been driven by dramatic increases in household pet ownership. We believe that growth in Asia is fueled by increasing levels of economic financial status and demand for premium, western manufactured products as a result of product quality concerns. This demand has been supported by a rapidly growing middle class in China, where a McKinsey report estimated that in 2018 roughly 730 million people in urban areas fell into the income categories of “aspirants” and “affluents,” with the Brookings group estimating that approximately 60 million people are added to these income categories each year. We believe that this growth drove the increase in the number of dog-owning Chinese households as measured by Euromonitor, which increased from 12% in 2015 to 20% in 2020, according to Euromonitor. According to Euromonitor, the Chinese market for premium dry dog and cat food is anticipated to grow at a 20% CAGR and 28% CAGR, respectively, from 2015 through 2025, suggesting that the Chinese pet market has significant room for growth in the foreseeable future. We are focused on targeting Chinese pet owners with the highest willingness to pay, which tend to be urban dwelling millennial and Gen-Z women. In 2021, 80% of our products were purchased online, and approximately 50% of our end-consumers were born after 1990.

 

Our Growth Strategy

 

●Strong Innovation Pipeline. We have a robust and growing pipeline of new products, and believe our size is an advantage as we are nimble enough to quickly bring new products to market, but large enough to benefit from strong existing customer relationships and established economies of scale with our co-manufacturers.

 

●Ability to Leverage Differentiated Omni-Channel Strategy for Growth. We believe that we can leverage our differentiated omni-channel strategy to design and sell products purpose-built for success in specific channels while maintaining our ability to leverage marketing and sales resources cross-channel. We believe that this strategy will allow us to deliver on core consumer needs, maximize gross margin and respond to changing channel dynamics that have accelerated in recent years.

 

●Capitalize on Continuing Trends of Humanization of Pets. We believe our combination of innovative products designed specifically for certain channels can assist our growth to become a leader in the premium and super-premium categories across dog and cat food.

 

●Well Positioned to Capitalize on a Once-in-a-Generation Demographic Shift in Asia. We believe that Asia represents the largest macro-growth opportunity in the global pet food industry. In China, the number of households that own a pet has doubled in the last five years, with younger pet owners leading growth.

 

Recent Corporate Developments

 

On September 13, 2022, we announced that Scott Lerner was stepping down from his role as Chief Executive Officer (“CEO”), effective September 14, 2022. Also on September 13, 2022, we announced that Lionel F. Conacher was appointed as Interim CEO, effective September 14, 2022.

 

On March 2, 2023, we announced that Robert Sauermann was resigning from his role as Chief Operating Officer (“COO”), effective March 17, 2023. On March 21, 2023, we announced that Sharla Cook was resigning from her role as Chief Financial Officer (“CFO”), effective April 3, 2023. Also on March 21, 2023, we announced that Carolina Martinez was appointed as Interim CFO, effective April 3, 2023.

 

On May 11, 2023, we announced that Lionel F. Conacher was resigning from his role as Interim CEO of the Company, effective May 22, 2023. Mr. Conacher will still continue to serve on the Board as a Director. On May 11, 2023, we announced that Kent Cunningham was appointed as Chief Executive Officer of the Company, effective May 22, 2023.

 

On August 2, 2023, we announced that Carolina Martinez was appointed as Chief Financial Officer, Treasurer and Secretary of the Company, effective August 7, 2023. On August 28, 2023, we announced that Donald Young, was resigning from his role as Chief Sales Officer of the Company, effective September 8, 2023.

 

In December 2023, the Company made a strategic exit out of Petco stores (while remaining on Petco.com), and Pet Supplies Plus. As of Q1 2024, the Company has made plans to exit its DTC channel in Q2 2024, in an effort to improve profitability.

 

27

 

 

Results of Operations for the Years Ended December 31, 2023 and 2022

 

The following table sets forth our consolidated results for the periods presented (in thousands):

 

   Years Ended December 31,   Change 
   2023   2022   $   % 
Net sales  $38,592   $54,660   $(16,068)   (29)%
Cost of goods sold   26,795    39,399    (12,604)   (32)%
Gross profit   11,797    15,261    (3,464)   (23)%
Operating expenses:                    
Selling, general and administrative   24,444    35,430    (10,986)   (31)%
Impairment of goodwill   —    18,614    (18,614)   (100)%
Impairment of intangible assets   8,532    —    —    100%
Total operating expenses   32,976    54,044    (21,068)   (39)%
Loss from operations   (21,179)   (38,783)   17,604    45%
Other expense:                    
Interest expense   (1,353)   (551)   (802)   (146)%
Change in fair value of warrant liabilities   (236)   —    (236)   (100)%
Total other expense   (1,589)   (551)   (1,038)   (188)%
Net loss before income taxes   (22,768)   (39,334)   16,566    (42)%
Income tax expense (benefit)   2    (18)   20    111%
Net loss available to common stockholders  $(22,770)  $(39,316)  $16,546    (42)%

 

Net sales

 

We sell our products through online retailers, pet specialty retailers, our online portal directly to our consumers and internationally to foreign distribution partners (transacted in U.S. dollars). Generally, our sales transactions are single performance obligations that are recorded at the time the product is shipped from our distribution centers and when control transfers. We offer a variety of trade promotions, discounts and incentives to our customers, which impacts the transaction price of our products and our net sales accordingly. DTC net sales include revenue derived from shipping fees and are net of loyalty points earned (a portion of revenue is deferred at the time of the sale as points are earned and not recognized until the redemption of the points, estimated based on historical experience). We record a revenue reserve based on historical return rates to account for customer returns.

 

Information about our revenue channels is as follows (in thousands):

 

   Twelve Months Ended December 31, 
   2023   2022 
E-commerce (1)  $13,405    35%  $14,565    27%
Brick & Mortar   5,870    15%   11,624    21%
DTC   5,597    15%   6,620    12%
International (2)   13,720    35%   21,851    40%
Net Sales  $38,592    100%  $54,660    100%

 

(1)Our E-commerce channel includes two customers that amounted to greater than 10% of total net sales. These customers had $5.9 million and $7.1 million of net sales for the year ended December 31, 2023, respectively and $7.5 million and $6.6 million of net sales for the year ended December 31, 2022, respectively.

 

(2)One of our International customers that distributes products in China amounted to greater than 10% of total net sales during the years ended December 31, 2023 and December 31, 2022 and represented $11.0 million and $17.7 million of net sales, respectively.

 

28

 

 

Net sales decreased $(16.1) million, or (29)%, to $38.6 million for the year ended December 31, 2023 compared to $54.7 million for the year ended December 31, 2022. The decrease in net sales for the year ended December 31, 2023 is primarily attributable to supply chain constraints and the downstream impact it has on our business. We experienced significant production delays from our dry kibble co-manufacturing partner stemming from short-term shortages in raw materials, labor constraints, and capacity constraints. The inconsistency in supply created material out-of-stocks which resulted in less-than-optimal fill rates of our Halo Elevate® product line, sold primarily in our Brick & Mortar channel. Since closing the Alphia Term Loan, we have fully transitioned our dry kibble manufacturing to Alphia which, albeit a very positive change needed for stabilizing supply and for long-term sustainability, has had a short-term impact to our International channel as it created registration delays in certain foreign markets, in turn delaying ordering and product launches.

 

Key factors that we expect to affect our future sales growth include new product innovation and launches, our expansion strategy in each of the sales channels and our key supplier relationships.

 

Gross profit

 

Cost of goods sold consists primarily of the cost of product obtained from co-manufacturers, packaging materials, freight costs for shipping inventory to the warehouse, as well as third-party warehouse and order fulfillment costs. We review inventory on hand periodically to identify damages, slow moving inventory, and/or aged inventory. Based on this analysis, we record inventories at the lower of cost or net realizable value, with any reduction in value expensed as cost of goods sold.

 

Our products are manufactured to our specifications by our co-manufacturers using raw materials. We work with our co-manufacturers to secure a supply of raw materials that meet our specifications. In addition to procuring raw materials that meet our formulation requirements, our co-manufacturers manufacture, test and package our products. We design our packaging for our co-manufacturers and the packaging is shipped directly to them.

 

Our gross profit has been and will continue to be affected by a variety of factors, primarily product sales mix, volumes sold, discounts offered to newly acquired and recurring customers, the cost of our manufactured products, and the cost of freight from the manufacturer to the warehouse.

 

During the year ended December 31, 2023, gross profit decreased $(3.5) million, or (23)%, to $11.8 million compared to $15.3 million during the year ended December 31, 2022. Gross profit margin increased 3% to 31% for the year ended December 31, 2023 compared to 28% for the year ended December 31, 2022. The decrease in gross profit is primarily attributable to selling excess inventory at a discount. As a result, revenue increased at a rate lower than the rate at which cost of goods sold (“COGS”) increased. The increase in gross profit margin for the year ended December 31, 2023 is primarily attributable to a decrease in revenue at a rate lower than the rate at which cost of goods sold decreased. For the year ended December 31, 2023, the average price per pound cost $1.82, versus $1.88 for the year ended December 31, 2022. We also implemented a 7% price increase across our Halo Holistic™ and Halo masterbrand wet product lines in August 2022, and a 12.5% sales price increase on our Halo Elevate® products in 2023.

 

We continue to actively work with our co-manufacturing and freight partners to generate future cost savings and realize improved gross margins in future periods. We could see continued margin variability due to the current economic environment and pricing pressures due to inflationary costs for both transportation and raw materials. We will continue to refine and optimize our overall pricing strategy as we evaluate the future impact of inflation and align ourselves with the market.

 

Operating expenses

 

Our Selling, general and administrative (“SG&A”) expenses consist of the following:

 

●Sales and marketing costs, for specific customer promotional programs, paid media, content creation expenses and our DTC selling platform. Marketing costs are geared towards customer acquisition and retention and building brand awareness. During the year ended December 31, 2023, sales and marketing costs decreased approximately $(7.0) million or (48)%, to $7.6 million from $14.6 million during the year ended December 31, 2022. The decrease was driven primarily by lower marketing and advertising agency fees related to the Halo brand renovation and migration from the former TruDog brand, as well as increased marketing spend in our International sales channel during 2022.

 

●Employee compensation and benefits decreased approximately $(1.1) million or (15)% during the year ended December 31, 2023 to $6.4 million from $7.5 million during the year ended December 31, 2022. The decrease was primarily related to a reduction in employee headcount, partially offset by higher severance costs during the first half of 2022.

 

●Share-based compensation includes expenses related to equity awards issued to employees and non-employee directors. During the year ended December 31, 2023, Share-based compensation decreased $(1.2) million or (40)% to $1.8 million compared to $3.0 million for the year ended December 31, 2022. The decrease is driven by reduction of senior management headcount resulting in cancellations of options during 2023, partially offset by common stock issued for board service and accelerated vesting of a certain stock option grant during 2022, interim CEO service compensation and additional option grants.

 

29

 

 

●Freight, which is primarily related to the shipping of DTC orders to customers, decreased $(0.3) million or (16)% during the year ended December 31, 2023 to $1.3 million from $1.6 million during the year ended December 31, 2022. Freight costs are generally decreasing due to lower DTC sales as described above.

 

●Non-cash charges including depreciation, amortization, disposal or sale of assets and bad debt expense decreased $(0.2) million or (8)% to $1.7 million during the year ended December 31, 2023 from $1.8 million during the year ended December 31, 2022. The decrease was driven by disposals of certain assets during 2023, offset by additional capital expenditures throughout 2022.

 

●Other general and administrative costs for various general corporate expenses, including professional services, information technology, insurance, travel, costs related to merchant credit card fees, product development costs, rent, and certain tax costs. During the year ended December 31, 2023, other general and administrative costs decreased $(1.3) million, or (19)% to $5.6 million compared to $6.9 million in the year ended December 31, 2022. The decrease was driven by commission fees related to sales in our International channel, and lower professional fees related to investor relations.

 

Impairment of goodwill included an impairment charge of $18.6 million during the year ended December 31, 2022, while there was no corresponding activity for the year ended December 31, 2023. Impairment of long-lived intangible assets resulted in an impairment charge of $8.5 million for the year ended December 31, 2023, with no corresponding activity for the year ended December 31, 2022. See “Note 6 - Goodwill and intangible assets” for additional information.

 

Interest expense, net

 

During the year ended December 31, 2023, interest expense increased $0.8 million, or 146% to $1.4 million from $0.6 million for the fiscal year ended December 31, 2022. Interest expense for the year ended December 31, 2023 is comprised of interest on our Wintrust Receivables Credit Facility, Alphia Term Loan, the amortization of debt issuance costs, and interest accretion on the Alphia Term Loan. Interest expense for the year ended December 31, 2022 is comprised of interest on our Wintrust Credit Facility, Wintrust term loan, and the amortization of debt issuance costs.

 

Change in fair value of warrant liabilities

 

Common stock warrants classified as liabilities are revalued at each balance sheet date subsequent to the initial issuance and changes in the fair value are reflected in the Consolidated Statements of Operations as change in fair value of warrant liabilities. See “Note 11 - Warrants” for additional information.

 

Income taxes

 

Our income tax expense (benefit) provision consists of an estimate of federal and state income taxes based on enacted federal and state tax rates, as adjusted for any allowable credits, deductions and uncertain tax positions as they arise. During the year ended December 31, 2023, we recorded income tax expense of less than $0.1 million, which relates to the change in valuation allowance. During the year ended December 31, 2022, we recorded income tax benefit of less than $0.1 million, which relates to indefinite-lived assets. The effective tax rate for the years ended December 31, 2023 and 2022 was 0%, which differs from the U.S. Federal statutory rate of 21% due to permanent differences attributable to the impairment of goodwill in 2022 and because our losses have been fully offset by a valuation allowance due to uncertainty of realizing the tax benefit of NOLs for the years ended December 31, 2023 and 2022.

 

30

 

 

Liquidity and capital resources

 

Historically, we have financed our operations primarily through the sales of shares of our common stock, warrants, preferred stock, and loans. In connection with our IPO, we issued and sold 181,818 shares of common stock at a price of $5.00 per share. On July 1, 2021 we received total net proceeds of approximately $36.1 million from the IPO, after deducting underwriting discounts and commissions of $2.8 million, and offering costs of approximately $1.1 million. On December 31, 2023 and December 31, 2022, we had cash and cash equivalents and restricted cash of $4.5 million and $9.5 million, respectively.

 

We are subject to risks common in the pet wellness consumer market including, but not limited to, dependence on key personnel, competitive forces, successful marketing and sale of our products, the successful protection of our proprietary technologies, ability to grow into new markets, and compliance with government regulations. As of December 31, 2023, we have not experienced a significant adverse impact to our business, financial condition or cash flows resulting from geopolitical actions or threat of cyber-attacks. However, we have seen adverse impacts to our gross profit margin due to inflationary pressures in the current economic environment. Uncertainties regarding the continued economic impact of inflationary pressures, geopolitical actions and threat of cyber-attacks are likely to result in sustained market turmoil, which could negatively impact our business, financial condition, and cash flows in the future.

 

We have historically incurred losses and expect to continue to generate operating losses and consume cash resources in the near term. These conditions raise substantial doubt about our ability to continue as a going concern for a period of twelve months from the date these interim condensed consolidated financial statements are issued, meaning that we may be unable to generate sufficient operating cash flows to pay our short-term obligations. We have implemented and continue to implement plans to achieve operating profitability, including various margin improvement initiatives, the consolidation of and introduction of new co-manufacturers, the optimization of our pricing strategy and ingredient profiles, and new product innovation.

 

Our ability to raise additional capital may be adversely impacted by the potential worsening of global economic conditions, including inflationary pressures, and the recent disruptions to, and volatility in, the credit and financial markets in the United States and worldwide resulting from geopolitical tensions. If we seek additional financing to fund our business activities in the future and there remains doubt about our ability to continue as a going concern, investors or other financing sources may be unwilling to provide additional funding on commercially reasonable terms or at all. If we are unable to raise the necessary funds when needed or achieve planned cost savings, or other strategic objectives are not achieved, we may not be able to continue our operations, or we could be required to modify our operations that could slow future growth.

 

A summary of our cash flows is as follows (in thousands):

 

   Year Ended December 31, 
   2023   2022 
Cash flows (used in) provided by:          
Operating activities  $97   $(20,553)
Investing activities   (18)   (198)
Financing activities   (5,097)   1,282 
Net (decrease) increase in cash and cash equivalents  $(5,018)  $(19,469)

 

Cash flows from operating activities

 

Cash provided by operating activities increased $20.7 million, or 100%, during the year ended December 31, 2023 compared to the year ended December 31, 2022. The increase in cash used in operating activities was primarily driven by significant fluctuations in our working capital, including a comparative decrease in our inventory balance of $3.6 million as we built inventory during 2022 to support the Halo Elevate® launch and the rebranding of TruDog and Halo Holistic™, and focused on improving working capital and cash conversion cycle in 2023 by bringing inventory levels down to a healthier level. Additionally, we realized a comparative increase in accounts receivables of $2.4 million due to timing of sales and collections, and a comparative increase in accounts payable of $4.0 million due to dry kibble inventory rebuild in 2023 after transition to a new dry kibble manufacturer.

 

Cash flows from investing activities

 

Cash used in investing activities was less than $0.0 million during the year ended December 31, 2023 and $0.2 million during the year ended December 31, 2022. The cash used in investing activities is related to capital expenditures.

 

31

 

 

Cash flows from financing activities

 

Cash used in financing activities was $5.1 million, during the year ended December 31, 2023 and cash provided by financing activities was $1.3 million during the year ended December 31, 2022. The cash used in financing activities for the year ended December 31, 2023 was related to the pay down of the revolving line of credit of $(13.5) million and payments on the Wintrust Receivables Credit Facility of $(6.1) million, offset by proceeds from the Wintrust revolving line of credit of $1.9 million and $5.0 million from the Alphia facility and proceeds of $7.8 million from the Wintrust Receivables Credit Facility. The cash provided by financing activities for the year ended December 31, 2022 was related to net proceeds from the revolving line of credit of $6.7 million and net proceeds from a short term financing arrangement of $0.2 million, partially offset by payments on the term loan of $5.5 million and debt issuance costs of $0.1 million.

 

Wintrust Credit Facility

 

On January 6, 2021, Halo entered into a credit facility with Old Plank Trail Community Bank, N.A., an affiliate of Wintrust, consisting of a $6.0 million term loan and a $6.0 million revolving line of credit, each scheduled to mature on January 6, 2024. The Wintrust Credit Facility is secured by a general guaranty and security interest on the assets, including the intellectual property of us and our subsidiaries. We have also pledged all of the capital stock of Halo held by us as additional collateral.

 

The Wintrust Credit Facility subjects us to certain financial covenants, including the maintenance of a fixed charge coverage ratio of no less than 1.25 to 1.00, tested as of the last day of each fiscal quarter. For the test as of December 31, 2021, we failed to satisfy the fixed charge coverage ratio and entered into a default waiver agreement with Wintrust in which Wintrust waived the existing default through the next testing date, March 31, 2022. Additionally, on March 25, 2022, we entered into the second amendment to the Wintrust Credit Facility, which removed the financial covenant to maintain a fixed charge coverage ratio and included a new financial covenant to maintain a minimum liquidity, as well updated the rate at which the Wintrust Credit Facility bore interest.

 

Furthermore, on October 24, 2022, we entered into the third amendment to the Wintrust Credit Facility which provided for an increase to the revolving line of credit, set the amount of Halo’s obligation to pledge a deposit account with Wintrust to a fixed amount throughout the remainder of the term and provided updates to the interest rate, maturity date and minimum liquidity amount associated with the financial covenant.

 

On June 21, 2023, the Company paid off the entire balance in the sum of $13.5 million of the Wintrust Credit Facility removing any covenant requirements to be met at December 31, 2023. As of December 31, 2023, there was no outstanding balance related to the Wintrust Credit Facility

 

See “Note 8 - Debt” to our audited consolidated financial statements included in this Annual Report on Form 10-K for more information.

 

Wintrust Receivables Credit Facility

 

On June 21, 2023, the Company entered into an account purchase agreement with Wintrust Receivables Finance, a division of Wintrust Bank N.A. (“Wintrust”) pursuant to which Wintrust will purchase, at its discretion, eligible customer invoices and advance up to 75% of the face amount of all purchased amounts up to $4,750,000. Each advance under the AP Agreement will bear interest at the U.S. prime rate, plus 2.5%. The AP Agreement has an initial term of two years and will automatically renew annually unless terminated by the Company on at least 60 days’ notice. The Wintrust Receivables Credit Facility is secured by a general security interest in the assets of the Company. The Wintrust Receivables Credit Facility is guaranteed secured by the Company pursuant to that certain Unlimited Continuing Guaranty Agreement dated as of June 21, 2023.

 

As of December 31, 2023, the balance outstanding on the Wintrust Receivables Credit Facility amounted to $1.7 million.

 

Alphia Term Loan

 

On June 21, 2023, the Company entered into a term loan credit agreement with Alphia Inc., a leading custom manufacturer of super-premium pet food in the U.S. Pursuant to the Term Loan Agreement, Alphia made a term loan to the Company in the original principal amount of $5,000,000 (the “Term Loan”). The Term Loan is also evidenced by that certain Term Note dated as of June 21, 2023 issued by the Company to Alphia (the “Term Note”). The proceeds of the Term Loan, together with a portion of the Company’s cash on hand, were used to retire all of the outstanding obligations of Halo, Purely for Pets, Inc. (“Halo”), a wholly-owned subsidiary of the Company, under Halo’s long-term credit facility with Old Plank Trail Community Bank, N.A., an affiliate of Wintrust Bank, N.A. The Term Loan will bear interest at a rate of 10% per annum, compounded quarterly, and will mature on June 21, 2026. Accrued interest on the Term Loan is payable quarterly in cash or, at the election of the Company, in-kind by capitalizing such interest and adding it to the then-outstanding principal amount of the Term Loan. The Term Loan Agreement and Term Note provide for customary financial covenants and customary events of default, including, among others, those relating to failure to make payment, bankruptcy, breaches of representations and material adverse effects. The Company may prepay the principal of the Term Loan at any time upon written notice to Alphia and subject to a prepayment penalty if such prepayment occurs prior to June 21, 2025.

 

32

 

 

The Term Loan is secured by a general security interest on the assets, including the intellectual property, of the Company and Halo pursuant to (i) that certain Term Loan Security Agreement, dated June 21, 2023, made by the Company and Halo in favor of Alphia (the “Security Agreement”) and (ii) that certain Intellectual Property Security Agreement, dated as of June 21, 2023 of the Company and Halo in favor of Alphia (the “Intellectual Property Security Agreement”). The Company has also pledged all of the capital stock of Halo held by the Company as additional collateral for the Term Loan.

 

The term Loan is guaranteed by Halo pursuant to that certain Term Loan Guaranty, dated as of June 21, 2023, by and between Halo and Alphia (the “Term Loan Guaranty”).

 

In conjunction with the Term Loan, the Company issued to Alphia (i) a warrant (the “First Tranche Warrant”) to purchase 148,758 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”) at a price of $11.44 per share, and (ii) a warrant (the “Second Tranche Warrant” and together with the First Tranche Warrant, the “Warrants”) to purchase 186,882 shares of Common Stock at a price of $11.44 per share. Unless exercised, the Warrants expire on June 21, 2028. Alphia’s exercise of the Second Tranche Warrant is subject to the approval of the Company’s stockholders. The Warrants contained certain anti-dilution provisions in favor of Alphia in connection with any equity offering consummated by the Company prior to December 21, 2023 and equity issuances below the exercise price of the Warrants. The anti-dilution protection in the agreement that would have made Alphia whole in the event of a capital raise or a change in control that other shareholders would not get, expired on December 31, 2023. The Warrants also contain a cashless exercise option at the election of Alphia.

 

Additionally, in conjunction with the Term Loan, the Company entered into a Side Letter Agreement with Alphia (the “Side Letter”) pursuant to which Alphia was granted a right of first refusal on any of the following relating to the Company or any of its subsidiaries and to the extent such transactions constitute a change of control: (i) any transfer, sale, lease or encumbrance of all or any portion of the capital stock or assets (other than the sale of inventory in the ordinary course of business), (ii) any merger, consolidation or other business combination, (iii) any recapitalization, reorganization or any other extraordinary business transaction, (iv) or any equity issuance or debt incurrence. Alphia’s right of first refusal is effective so long as the Term Loan remains outstanding and for a period of 12 months thereafter. The Side Letter also provides Alphia with certain Board observer rights.

 

As of December 31, 2023, our indebtedness on the Alphia Term Loan Facility amounted to $2.9 million net of debt issuance costs of $0.2 million. For details about the terms, covenants and restrictions contained in the Alphia Term Loan Facility, see “Note 8 - Debt” to our audited consolidated financial statements included in this Annual Report on Form 10-K for more information.

 

Contractual Commitments and Obligations

 

We are contractually obligated to make future cash payments for various items, including debt arrangements, certain purchase obligations, as well as the lease arrangement for our office. See “Note 8 - Debt” to our audited consolidated financial statements included in this Annual Report on Form 10-K for more information about our debt obligations. Our purchase obligations include certain ongoing marketing projects, software subscriptions as well as in-transit or in-production purchase orders with our suppliers, for which amounts vary depending on the purchasing cycle. The majority of our software subscriptions are not under long-term contracts, and we do not have long-term contracts or commitments with any of our suppliers beyond active purchase orders. These purchase obligations were not material as of the date of this Annual Report on Form 10-K.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements, as defined by applicable regulations of the SEC, that are reasonably likely to have a current or future material effect on our financial condition, results of operations, liquidity, capital expenditures or capital resources.

 

Critical Accounting Estimates

 

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of our consolidated financial statements and related disclosures requires us to make estimates, assumptions and judgements that affect the reported amounts of assets, liabilities, net sales, costs and expenses and related disclosures. We believe that the estimates, assumptions and judgments involved in the accounting policies described below have the greatest potential impact on our financial statements and, therefore, we consider these to be our critical accounting estimates. Accordingly, we evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions and conditions. See “Note 1 - Nature of business and summary of significant accounting policies” to our audited consolidated financial statements included in this Annual Report on Form 10-K for a description of our significant accounting policies.

 

33

 

 

Goodwill Impairment

 

We evaluate goodwill for impairment at least annually at the reporting unit level. We monitor the existence of potential impairment indicators throughout the year and will evaluate for impairment whenever events or circumstances indicate that the fair value of a reporting unit is below its carrying value. Impairment testing is based on our current business strategy in light of present industry and economic conditions, as well as future expectations. Fair value measurements used in the impairment review of goodwill are Level 3 measurements.

 

When evaluating goodwill for impairment, we have the option to first assess qualitative factors to determine whether it is more likely than not the fair value of a reporting unit is less than its carrying amount. Qualitative factors include macroeconomic conditions, industry and market conditions, and overall company financial performance. If, after assessing the totality of events and circumstances, we determine that it is more likely than not the fair value of the reporting unit is greater than its carrying amount, a quantitative impairment test is unnecessary. If the fair value exceeds the carrying value, we conclude that no goodwill impairment has occurred. If the carrying value of the reporting unit exceeds its fair value, we recognize an impairment loss in an amount equal to the excess, not to exceed the carrying value of the goodwill. We consider fair value to be substantially in excess of carrying value at a 20% premium or greater.

 

When performing a quantitative impairment test, determining the fair value of a reporting unit involves the use of significant estimates and assumptions to evaluate the impact of operational and macroeconomic changes. If a quantitative assessment is deemed necessary, we determine fair value using a weighted average of widely accepted valuation techniques, including the income approach and market approach. The income approach applies a fair value methodology based on discounted cash flows which contains uncertainties because it requires management to make significant assumptions and judgments including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term rate of growth for our business, estimation of the useful life over which cash flows will occur, and determination of our weighted average cost of capital or discount rate, which is risk-adjusted to reflect the specific risk profile of our business. The market approach includes determining appropriate comparable companies and applying an estimated multiple to apply to our operating results. The primary market multiples to which we compare are revenue and earnings before interest, taxes, depreciation and amortization. See “Note 1 - Nature of business and summary of significant accounting policies” for further information about our policy for fair value measurements.

 

Share-Based Compensation

 

Share-based compensation expense is measured based on the estimated fair value of awards granted to employees, directors, officers and consultants on the grant date. Forfeitures are accounted for as they occur, therefore there are no forfeiture related estimates required.

 

The fair value of an option award is estimated on the date of grant using the Black–Scholes option valuation model, which requires the development of input assumptions, as described in “Note 12 - Share-based compensation”. Determining the appropriate fair value model and calculating the fair value of share-based payment awards requires the input of the subjective assumptions described in “Note 12 - Share-based compensation”. The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates, which involve inherent uncertainties and the application of management’s judgment. See “Note 12 - Share-based compensation” to our audited consolidated financial statements included in this Annual Report on Form 10-K for more information.

 

Accounting for Warrants

 

The fair value of warrants is estimated using a Monte Carlo and/or Black-Scholes valuation model. The assumptions used in these models included the simulation of future stock prices based on future financing events, likelihood of mandatory exercise of the warrants, and timing and likelihood of fundamental transactions, such as a change in control. Both valuation methodologies use key inputs, including expected stock volatility, the risk–free interest rate, the expected life of the option and the expected dividend yield. Expected volatility is calculated based on the analysis of other public companies within the pet wellness and internet commerce (e-commerce) sectors. Risk–free interest rates are calculated based on risk–free rates for the appropriate term. The expected life is estimated based on contractual terms as well as expected exercise dates. The dividend yield is based on the historical dividends issued by us. The valuation of the warrants is subject to uncertainty as a result of the unobservable inputs. If the volatility rate or risk-free interest rate were to change, the value of the warrants would be impacted.

 

Warrants that are classified as liabilities due to the terms of the warrant obligation are measured at fair value on a recurring basis at the end of each reporting period and as a result, we recorded an adjustment to the warrant liabilities to reflect the fair value as of December 21, 2023. The warrant liabilities were subsequently reclassified to equity (See “Note 11 - Warrants” for more information). Warrants that are classified as equity or considered compensation are measured at fair value on a non-recurring basis on the date of issuance. See “Note 11 - Warrants” to our audited consolidated financial statements included in this Annual Report on Form 10-K for more information.

 

ITEM 7A.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and is not required to provide the information under this Item.

 

34

 

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

Better Choice Company Inc.

Index to Consolidated Financial Statements

 

  Page
Report of Independent Registered Public Accounting Firm (BDO USA, P.C.; Tampa, Florida; PCAOB ID #243) 36
Consolidated Statements of Operations for the years ended December 31, 2023 and 2022 38
Consolidated Balance Sheets as of December 31, 2023 and 2022 39
Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2023 and 2022 40
Consolidated Statements of Cash Flows for the years ended December 31, 2023 and 2022 41
Notes to the Consolidated Financial Statements 42

 

All financial statement schedules have been omitted, since the required information is not applicable or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the consolidated financial statements and accompanying notes.

 

35

 

 

Report of Independent Registered Public Accounting Firm

 

To the Shareholders and the Board of Directors

Better Choice Company Inc.

Tampa, Florida

 

Opinion on the Consolidated Financial Statements

 

We have audited the accompanying consolidated balance sheets of Better Choice Company Inc. (the “Company”) as of December 31, 2023 and 2022, the related consolidated statements of operations, stockholders’ equity, and cash flows for the years then ended, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2023 and 2022, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Going Concern Uncertainty

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has continually incurred operating losses, has an accumulated deficit and failed to meet certain financial covenants as of December 31, 2023. These matters create substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the date these consolidated financial statements are issued. Management’s plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matter

 

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which it relates.

 

Accounting Treatment of Alphia Warrants

 

As described in Note 11 to the consolidated financial statements, on June 21, 2023, the Company issued warrants to Alphia to purchase 148,758 (First Tranche) and 186,882 (Second Tranche) shares of the Company’s common stock (collectively the “Alphia warrants”). The Company evaluated the Alphia warrants under ASC 815-40, Derivatives and Hedging-Contracts in an Entity’s Own Equity and concluded they did not meet the criteria to be classified in shareholders’ equity. Specifically, there were contingent exercise provisions and settlement provisions that existed, including provisions where the number of shares available under the warrants may be adjusted based on a percentage of equity. Because the number of outstanding common shares was not a fair value input to a fixed-for-fixed model, this provision violated indexation guidance. Therefore, the Alphia warrants were not indexed to the Company’s stock.

 

As a result, the Alphia warrants were initially recorded as liabilities and remeasured at fair value each reporting period until provisions precluding equity classification lapsed. The anti-dilution provisions, which previously precluded equity treatment of the Alphia warrants, expired on December 21, 2023, and thus were reclassified and presented in equity as of December 31, 2023.

 

36

 

 

We identified the Company’s accounting treatment related to and classification of the Alphia warrants as a critical audit matter, specifically the Company’s classification of the Alphia warrants as a liability upon issuance. The principal considerations for our determination involves management’s application of the complex technical accounting matters related to the accounting treatment and classification of the Alphia warrants as a result of certain provisions included within the Alphia warrant agreements. Auditing these elements involved especially challenging, subjective or complex auditor judgment due to the nature and extent of audit effort required to address this matter, including the extent of specialized skill or knowledge needed.

 

The primary procedures we performed to address this critical audit matter included:

 

  ● Inspecting the Alphia warrant agreements along with management’s technical accounting memo to understand the facts and circumstances within the Alphia warrant agreements and other assumptions impacting the appropriate accounting and classification of the Alphia warrants.
     
  ● Utilizing personnel with specialized knowledge and skill in accounting for complex financial instruments to assist in evaluating the appropriateness of management’s interpretation on how to apply the relevant accounting guidance for the classification of the Alphia warrants.

 

/s/ BDO USA, P.C.

 

We have served as the Company’s auditor since 2021.

 

Tampa, Florida

 

April 12, 2024

 

37

 

 

Better Choice Company Inc.

Consolidated Statements of Operations

(Dollars in thousands, except share and per share amounts)

 

   2023   2022 
   Year ended December 31, 
   2023   2022 
Net sales  $38,592   $54,660 
Cost of goods sold   26,795    39,399 
Gross profit   11,797    15,261 
Operating expenses:          
Selling, general and administrative   24,444    35,430 
Impairment of goodwill   —    18,614 
Impairment of intangible assets   8,532    — 
Total operating expenses   32,976    54,044 
Loss from operations   (21,179)   (38,783)
Other expense:          
Interest expense   (1,353)   (551)
Change in fair value of warrant liabilities   (236)   — 
Total other expense   (1,589)   (551)
Net loss before income taxes   (22,768)   (39,334)
Income tax expense (benefit)   2    (18)
Net loss available to common stockholders  $(22,770)  $(39,316)
Weighted average number of shares outstanding, basic   705,185    667,114 
Weighted average number of shares outstanding, diluted   705,185    667,114 
Net loss per share available to common stockholders, basic  $(32.29)  $(58.93)
Net loss per share available to common stockholders, diluted  $(32.29)  $(58.93)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

38

 

 

Better Choice Company Inc.

Consolidated Balance Sheets

(Dollars in thousands, except share and per share amounts)

 

   December 31,   December 31, 
   2023   2022 
Assets          
Cash and cash equivalents  $4,455   $3,173 
Restricted cash   —    6,300 
Accounts receivable, net   4,354    6,744 
Inventories, net   6,611    10,257 
Prepaid expenses and other current assets   812    1,051 
Total Current Assets   16,232    27,525 
Fixed assets, net   230    375 
Right-of-use assets, operating leases   120    173 
Intangible assets, net   —    10,059 
Other assets   155    544 
Total Assets  $16,737   $38,676 
Liabilities & Stockholders’ Equity          
Current Liabilities          
Accounts payable  $6,928   $2,932 
Accrued and other liabilities   2,085    2,596 
Line of credit   1,741    — 
Term loan, net   2,881    — 
Operating lease liability   57    52 
Total Current Liabilities   13,692    5,580 
Non-current Liabilities          
Line of credit, net   —    11,444 
Operating lease liability   67    124 
Total Non-current Liabilities   67    11,568 
Total Liabilities   13,759    17,148 
Stockholders’ Equity          
Common Stock, $0.001 par value, 200,000,000 shares authorized, 729,026 & 668,869 shares issued and outstanding as of December 31, 2023 and 2022, respectively   32    29 
Additional paid-in capital   324,288    320,071 
Accumulated deficit   (321,342)   (298,572)
Total Stockholders’ Equity   2,978    21,528 
Total Liabilities and Stockholders’ Equity  $16,737   $38,676 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

39

 

 

Better Choice Company Inc.

Consolidated Statements of Stockholders’ Equity

(Dollars in thousands, except shares)

 

   Shares   Amount   Capital   Deficit   Equity 
   Common Stock  

Additional

Paid-In

   Accumulated  

Total

Stockholders’

 
   Shares   Amount   Capital   Deficit   Equity 
Balance as of December 31, 2021   662,417   $29   $317,102   $(259,256)  $           57,875 
Share-based compensation   6,452    —    2,969    —    2,969 
Net loss available to common stockholders   —    —    —    (39,316)   (39,316)
Balance as of December 31, 2022   668,869   $29   $320,071   $(298,572)  $21,528 
Share-based compensation   60,157    3    1,773    —    1,776 
Reclassification of Alphia Warrants   —    —    2,444    —    2,444 
Net loss available to common stockholders   —    —    —    (22,770)   (22,770)
Balance as of December 31, 2023   729,026   $32   $324,288   $(321,342)  $2,978 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

40

 

 

Better Choice Company Inc.

Consolidated Statements of Cash Flows

(Dollars in thousands)

 

   2023   2022 
   Year Ended December 31, 
   2023   2022 
Cash Flow from Operating Activities:          
Net loss available to common stockholders  $(22,770)  $(39,316)
Adjustments to reconcile net loss to net cash used in operating activities:          
Loss of disposal of assets   11    — 
Depreciation and amortization   1,678    1,690 
Amortization of debt issuance costs and discounts   193    56 
Goodwill impairment   —    18,614 
Intangible asset impairment   8,532    — 
Share-based compensation   1,773    2,969 
Change in fair value of warrant liabilities   236    — 
Amortization of prepaid assets   —    2,095 
Inventory reserve   (474)   1,809 
PIK interest expense on term loan   254    — 
Accreted interest expense on term loan   291    — 
Income tax provision   (2)   — 
Other   4    126 
Changes in operating assets and liabilities:          
Accounts receivable   2,387    (66)
Inventories   4,120    (6,821)
Prepaid expenses and other assets   628    (1,047)
Accounts payable   3,996    (761)
Accrued and other liabilities   (760)   99 
Cash Provided by (Used in) Operating Activities  $97   $(20,553)
           
Cash Flow from Investing Activities:          
Capital expenditures  $(18)  $(198)
Cash Used in Investing Activities  $(18)  $(198)
           
Cash Flow from Financing Activities:          
Proceeds from short-term financing arrangement  $—   $413 
Payments on short-term financing arrangement   —    (248)
Proceeds from revolving lines of credit   1,906    12,317 
Payments on revolving lines of credit   (13,500)   (5,640)
Proceeds from line of credit   7,841    — 
Payments on line of credit   (6,100)   — 
Proceeds from term loan   5,000    — 
Payments on term loans   —    (5,450)
Payment of loan issuance costs   (244)   (110)
Cash (Used in) Provided by Financing Activities  $(5,097)  $1,282 
           
Net decrease in cash and cash equivalents and restricted cash  $(5,018)  $(19,469)
Total cash and cash equivalents and restricted cash, beginning of period   9,473    28,942 
Total cash and cash equivalents and restricted cash, end of period  $4,455   $9,473 
           
Supplemental cash flow information          
           
Cash paid during the year for:          
Income taxes  $—   $12 
Interest  $543   $444 
Noncash items:          
Reclassification of warrants to equity  $2,444   $— 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

41

 

 

Notes to the Consolidated Financial Statements

 

Note 1 – Nature of business and summary of significant accounting policies

 

Nature of the business

 

Better Choice Company Inc. (the “Company”) is a pet health and wellness company focused on providing pet products and services that help dogs and cats live healthier, happier and longer lives. The Company has a broad portfolio of pet health and wellness products for dogs and cats sold under its Halo brand across multiple forms, including foods, treats, toppers, dental products, chews and supplements. The products consist of kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products and supplements.

 

Initial public offering

 

The Company completed its initial public offering (the “IPO”) on July 1, 2021, in which it issued and sold 181,818 shares of its common stock at a price of $5.00 per share. The total net proceeds from the IPO were approximately $36.1 million, after deducting underwriting discounts and commissions of $2.8 million, and offering costs of approximately $1.1 million. These IPO costs were recorded as a reduction of stockholders’ equity, and presented net of cash proceeds received in the Consolidated Statement of Cash Flows.

 

Upon the commencement of the IPO, all of the Company’s outstanding convertible notes payable automatically converted into 107,555 shares of common stock and upon the consummation of the IPO, all outstanding shares of the Series F convertible preferred stock were converted into 131,012 shares of common stock. Additionally, since the anti-dilution provision of the Series F Warrants were no longer effective upon consummation of the Company’s IPO, these warrants met the requirements to be considered equity and the outstanding Series F Warrants were reclassified as such.

 

Reverse stock split

 

On March 8, 2024, the Company’s Board of Directors approved a reverse stock split of the Company’s issued and outstanding shares of common stock at a ratio of 1-for-44, effective March 20, 2024 (the “Reverse Split”). In addition, the conversion rates of the Company’s outstanding preferred stock and convertible notes and the exercise prices of the Company’s underlying common stock purchase warrants and stock options were proportionately adjusted at the applicable reverse stock split ratio in accordance with the terms of such instruments. Proportionate voting rights and other rights of common stockholders were not affected by the Reverse Stock Split, other than as a result of the rounding up of fractional shares. No fractional shares of common stock were issued in connection with the Reverse Stock Split.

 

Accordingly, all share and per share amounts related to the Company’s common stock for all periods presented in the accompanying consolidated financial statements and notes thereto have been retroactively adjusted, where applicable, to reflect the Reverse Stock Split. The number of authorized shares and the par values of the common stock and convertible preferred stock were not adjusted as a result of the Reverse Stock Split.

 

Basis of presentation

 

The Company’s consolidated financial statements are prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for annual financial reports and accounting principles generally accepted in the U.S. (“GAAP”).

 

Consolidation

 

The financial statements are presented on a consolidated basis and include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

 

Use of estimates

 

The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On an ongoing basis, the Company evaluates these assumptions, judgments and estimates. Actual results may differ from these estimates.

 

In the opinion of management, the consolidated financial statements contain all adjustments necessary for a fair statement of the results of operations for the years ended December 31, 2023 and 2022, the financial position as of December 31, 2023 and 2022 and the cash flows for the years ended December 31, 2023 and 2022.

 

42

 

 

Going concern considerations

 

The Company is subject to risks common in the pet wellness consumer market including, but not limited to, dependence on key personnel, competitive forces, successful marketing and sale of its products, the successful protection of its proprietary technologies, ability to grow into new markets, and compliance with government regulations. The Company has continually incurred losses and has an accumulated deficit. The Company’s term loan agreement with Alphia imposes certain financial covenants, including minimum liquidity of $3.0 million, minimum EBITDA of $(4.5) million, and maximum marketing spend ratio of 30%. The Company was not in compliance with certain covenants related to the Alphia Term Loan Facility as of December 31, 2023 and the debt is callable by the lender. Our continued operating losses along with our failure to meet the financial covenants create substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the date these consolidated financial statements are issued. The Company does not currently expect it will be able to generate sufficient cash flow from operations to maintain sufficient liquidity to meet the required financial covenants in certain periods prior to maturity giving the lender the right to call the debt. The Company will need to either raise additional capital or obtain additional financing, and/or secure future waivers or amendments from its lenders or accomplish some combination of these items to maintain sufficient liquidity. There can be no assurance that the Company will be successful in raising additional capital, securing future waivers and/or amendments from its lenders, renewing or refinancing its existing debt or securing new financing. If the Company is unsuccessful in doing so, it may need to reduce the scope of its operations, repay amounts owed to its lenders or sell certain assets.

 

During the third quarter, the Company received a notice of noncompliance from the NYSE American. If the Company fails to satisfy the continued listing requirements before the end of the cure period, the NYSE American may take steps to delist its common stock. Such a delisting or the announcement of such delisting will have a negative effect on the price of the Company’s common stock and would impair the ability for investors to sell or purchase the Company’s common stock. In the event of a delisting, the Company may attempt to take actions to restore its compliance with the NYSE American listing requirements, but can provide no assurance that any such action taken by the Company would allow its common stock to become listed again, stabilize the market price or improve the liquidity of its common stock, prevent its common stock from dropping below the NYSE American minimum listing requirements or prevent future non-compliance with the NYSE American listing requirements. If the Company does not maintain the listing of its common stock on NYSE American, it could make it harder for the Company to raise additional capital in the long-term. If the Company is unable to raise capital when needed in the future, it may have to cease or reduce operations. There can be no assurance that the Company will be able to satisfy the continued listing requirements in the future.

 

The Company is continuing to implement plans to achieve operating profitability, as well as implementing other strategic objectives to address liquidity. The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and payments of liabilities in the ordinary course of business. Accordingly, the consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount of and classification of liabilities that may result should the Company be unable to continue as a going concern.

 

Summary of significant accounting policies

 

Cash and cash equivalents

 

Cash and cash equivalents include demand deposits held with banks and highly liquid investments with original maturities of ninety days or less at acquisition date. Cash and cash equivalents are stated at cost, which approximates fair value because of the short-term nature of these instruments. The Company’s cash equivalents are held in government money market funds and at times may exceed federally insured limits. For purposes of reporting cash flows, the Company considers all cash accounts that are not subject to withdrawal restrictions or penalties to be cash and cash equivalents. At December 31, 2022, the Company had $8.0 million in money market funds all of which were held in cash. As of December 31, 2023, the Company had closed its money market funds.

 

Restricted cash

 

The Company was required to maintain a restricted cash balance of $6.3 million as of December 31, 2022, in connection with the Wintrust Credit Facility. As a result of the full repayment of the Wintrust Credit Facility, there are no restrictions on cash as of December 31, 2023. See “Note 8 - Debt” for additional information.

 

Accounts receivable and allowance for credit losses

 

Accounts receivable consist of unpaid buyer invoices from the Company’s customers and credit card payments receivable from third-party credit card processing companies. Accounts receivable is stated at the amount billed to customers, net of point of sale and cash discounts. The Company assesses the collectability of all receivables on an ongoing basis by considering its historical credit loss experience, current economic conditions, and other relevant factors. Based on this analysis, an allowance for credit losses is recorded, and the provision is included within SG&A expense. The Company recorded approximately $0.1 million allowance for credit losses for the years ended December 31, 2023 and 2022.

 

43

 

 

Inventories

 

Inventories, consisting of finished goods available for sale as well as packaging materials, are valued using the first-in first-out (“FIFO”) method and are recorded at the lower of cost or net realizable value. Cost is determined on a standard cost basis and includes the purchase price, as well as inbound freight costs and packaging costs.

 

The Company regularly reviews inventory quantities on hand. Excess or obsolete reserves are established when inventory is estimated to not be sellable before expiration dates based on forecasted usage, product demand and product life cycle. Additionally, inventory valuation reflects adjustments for anticipated physical inventory losses that have occurred since the last physical inventory.

 

Fixed Assets

 

Fixed assets are recorded at cost and depreciated using the straight-line method over the estimated useful lives of the assets, and depreciation expense is included within SG&A expense. Expenditures for normal repairs and maintenance are charged to operations as incurred. The cost of fixed assets that are retired or otherwise disposed of and the related accumulated depreciation are removed from the fixed asset accounts in the year of disposal and the resulting gain or loss is included in SG&A expense.

 

The Company assesses potential impairments of its fixed assets whenever events or changes in circumstances indicate that the asset’s carrying value may not be recoverable. An impairment charge would be recognized when the carrying amount of the identified asset grouping exceeds its fair value and is not recoverable, which would occur if the carrying amount exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the identified asset grouping.

 

Goodwill

 

Goodwill is evaluated for impairment either through a qualitative or quantitative approach at least annually, or more frequently if an event occurs or circumstances change that indicate the carrying value of a reporting unit may not be recoverable. If a quantitative assessment is performed that indicates the carrying amount of a reporting unit exceeds its fair market value, an impairment loss is recognized to reduce the carrying amount to its fair market value. The fair market value is determined based on a weighting of the present value of projected future cash flows (the “income approach”) and the use of comparative market approaches (“market approach”). Factors requiring significant judgment include, among others, the assumptions related to discount rates, forecasted operating results, long-term growth rates, the determination of comparable companies and market multiples. Fair value measurements used in the impairment review of goodwill are Level 3 measurements. See further information about the Company’s policy for fair value measurements within this section below. See “Note 6 - Goodwill and intangible assets” for additional information regarding the goodwill impairment test.

 

Intangible assets

 

Finite-lived Intangible assets acquired are carried at cost, less accumulated amortization. Amortization expense is included in selling, general and administrative expenses on the consolidated statements of operations. The Company assesses long lived assets, including finite-lived intangible assets, for impairment whenever events or changes in circumstances indicate the carrying amount of the asset group may not be recoverable. The Company operates as a single reporting unit and as such, is the asset group when assessing finite-lived intangible assets for impairment. If impairment indicators are present, the Company performs a recoverability test by comparing the sum of the estimated undiscounted future cash flows attributable to its long-lived asset group to its carrying value. If the carrying amount of an asset group is not recoverable, an impairment loss is recognized based on the excess of the carrying value of the impaired asset group over its fair value. An impairment loss for an asset group is allocated to the long-lived assets of the group on a pro rata basis using the relative carrying amounts of those assets, except that the loss allocated to an individual long-lived asset of the group shall not reduce the carrying amount of that asset below its fair value whenever that fair value is determinable without undue cost and effort.

 

Share repurchases

 

On May 10, 2022, the Company’s board of directors approved a share repurchase program that authorized the repurchase of up to $3.0 million of the Company’s outstanding common stock in the open market through December 31, 2022. Repurchased shares are immediately retired and returned to unissued status. During the years ended December 31, 2023 and 2022, no shares were repurchased.

 

Common stock warrants

 

Common stock warrants are recorded as either liabilities or as equity instruments, depending on the specific terms of the warrant agreement. Warrants classified as liabilities are revalued at each balance sheet date subsequent to the initial issuance and changes in the fair value are reflected in the Consolidated Statements of Operations as change in fair value of warrant liabilities. Upon exercise, the warrant is marked to fair value on the exercise date and the related fair value is reclassified to equity.

 

Income taxes

 

Income taxes are recorded in accordance with FASB ASC Topic 740, “Income Taxes (ASC 740)”, which provides for deferred taxes using an asset and liability approach. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the consolidated financial statements and tax bases of assets and liabilities and for loss and credit carryforwards using enacted tax rates anticipated to be in effect for the year in which the differences are expected to reverse. Valuation allowances are provided, if, based upon the weight of available evidence, it is more likely than not that some or all the deferred tax assets will not be realized.

 

44

 

 

The Company accounts for uncertain tax positions in accordance with the provisions of ASC 740. When uncertain tax positions exist, the Company recognizes the tax benefit of tax positions to the extent that some or all the benefit will more likely than not be realized. The determination as to whether the tax benefit will more likely than not be realized is based upon the technical merits of the tax position, as well as consideration of the available facts and circumstances. As of December 31, 2023 and 2022, the Company does not have any significant uncertain income tax positions. If incurred, the Company would classify interest and penalties on uncertain tax positions as income tax expense.

 

The Company was incorporated on May 6, 2019. Prior to this date, the Company operated as a flow through entity for state and U.S. federal tax purposes. The Company files a U.S. federal and state income tax return, including for its wholly owned subsidiaries.

 

Revenue

 

Generally, the Company’s customer contracts have a single performance obligation, and revenue is recognized when the product is shipped as this is when it has been determined that control has been transferred. Amounts billed and due from customers are classified as receivables and require payment on a short-term basis and therefore do not have any significant financing components.

 

Revenue is measured as the amount of consideration the Company expects in exchange for transferring goods, which varies with changes in trade incentives the Company offers to its customers. Trade incentives consist primarily of customer pricing allowances and merchandising funds, and point of sale discounts. Estimates of trade promotion expense and coupon redemption costs are based upon programs offered, timing of those offers, estimated redemption/usage rates from historical performance, management’s experience and current economic trends.

 

Cost of goods sold

 

Cost of goods sold consists primarily of the cost of product obtained from co-manufacturers, packaging materials, freight costs for shipping inventory to the warehouse, as well as third-party warehouse and order fulfillment costs.

 

Advertising

 

The Company charges advertising costs to expense as incurred and such charges are included in SG&A expense. The Company’s advertising expenses consist primarily of online advertising, search costs, email advertising and radio advertising. In addition, the Company reimburses its customers and third parties for in store activities and record these costs as advertising expenses. Advertising costs were $6.8 million and $12.2 million for the years ended December 31, 2023 and 2022, respectively, of which $2.1 million is related to the amortization of the prepaid advertising contract with iHeart for the year ended December 31, 2022. See “Note 4 - Prepaid expenses and other current assets” for additional information on the prepaid advertising contract with iHeart.

 

Freight Out

 

Costs incurred for shipping and handling, including moving finished product to customers are included in SG&A expense. Shipping costs associated with moving finished products to customers were $1.3 million and $1.6 million for the years ended December 31, 2023 and 2022, respectively.

 

Research and development

 

Research and development costs related to developing and testing new products are expensed as incurred and included in SG&A expense. Research and development costs were $0.1 million and $0.5 million for the years ended December 31, 2023 and 2022, respectively.

 

Share-based compensation

 

Share-based compensation awards are measured at their estimated fair value on each respective grant date. The Company recognizes share-based payment expenses over the requisite service period. The Company’s share-based compensation awards are subject only to service based vesting conditions. Pursuant to ASC 718-10-35-8, the Company recognizes compensation cost for stock awards with only service conditions that have a graded vesting schedule on a straight-line basis over the service period for each separately vesting portion of the award as if the award was, in-substance, multiple awards. Forfeitures are recognized as they occur.

 

Operating leases

 

The Company determines if a contract or arrangement meets the definition of a lease at inception. The Company has elected to make the accounting policy election for short-term leases. For leases with terms greater than 12 months, the Company records the related asset and obligation at the present value of lease payments over the term. Lease renewal options are only included in the measurement if the Company is reasonably certain to exercise the optional renewals. Any variable lease costs, other than those dependent upon an index or rate, are expensed as incurred. If a lease does not provide a readily available implicit rate, the Company estimates the incremental borrowing discount rate based on information available at lease commencement.

 

The Company’s only remaining operating lease as of December 31, 2023 relates to office space. There are no material residual value guarantees or material restrictive covenants.

 

45

 

 

Fair value of financial instruments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy uses a framework which requires categorizing assets and liabilities into one of three levels based on the inputs used in valuing the asset or liability.

 

Level 1 inputs are unadjusted, quoted market prices in active markets for identical assets or liabilities.

 

Level 2 inputs are observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.

 

Level 3 inputs include unobservable inputs that are supported by little, infrequent or no market activity and reflect management’s own assumptions about inputs used in pricing the asset or liability.

 

Level 1 provides the most reliable measure of fair value, while Level 3 generally requires significant management judgment. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s financial instruments recognized on the Consolidated Balance Sheets consist of cash and cash equivalents, restricted cash, accounts receivable, prepaid assets, accounts payable, term loan, line of credit, accrued liabilities and other liabilities.

 

The fair value of the Company’s money market funds is based on quoted market prices using Level 1 inputs. The fair value for the Company’s term loan and line of credit approximates carrying value as the instrument has a variable interest rate that approximates market rates. The inputs related to the Company’s term loan and line of credit are reflected as Level 3 inputs.

 

The Company values it’s warrant liabilities using Level 3 inputs.

 

Fair value measurements of non-financial assets and non-financial liabilities reflect Level 3 inputs and are primarily used to measure the estimated fair values of goodwill, other intangible assets and long-lived assets impairment analyses.

 

Basic and diluted (loss) income per share

 

Basic and diluted (loss) income per share has been determined by dividing the net (loss) income available to common stockholders for the applicable period by the basic and diluted weighted average number of shares outstanding, respectively. Common stock equivalents are excluded from the computation of diluted weighted average shares outstanding when their effect is anti-dilutive.

 

Segment information

 

Operating segments are defined as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision-maker (“CODM”) in making decisions regarding resource allocation and assessing performance. The Company has viewed its operations and manages its business as one segment. The Company’s CODM reviews operating results on an aggregated basis. All the assets and operations of the Company are in the U.S.

 

New Accounting Standards

 

Recently adopted

 

ASU 2016-13 “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”

 

In June 2016, the FASB issued ASU 2016-13, a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The standard was effective for the Company on January 1, 2023. The new standard did not have a material impact on the consolidated financial statements for the year ended December 31, 2023.

 

Note 2 – Revenue

 

The Company records revenue net of discounts, which primarily consist of trade promotions, certain customer allowances and early pay discounts.

 

The Company excludes sales taxes collected from revenues. Retail-partner based customers are not subject to sales tax.

 

46

 

 

The Company’s direct-to-consumer (“DTC”) loyalty program enables customers to accumulate points based on their spending. A portion of revenue is deferred at the time of sale when points are earned and recognized when the loyalty points are redeemed.

 

Revenue channels

 

The Company groups its revenue channels into four categories: E-commerce, which includes the sale of product to online retailers such as Amazon and Chewy; Brick & Mortar, which primarily includes the sale of product to Pet Specialty retailers such as Petco, Pet Supplies Plus and neighborhood pet stores, as well as to select grocery chains; DTC, which includes the sale of product through the Company’s website; and International, which includes the sale of product to foreign distribution partners and to select international retailers (transacted in U.S. dollars).

 

Information about the Company’s net sales by revenue channel is as follows (in thousands):

 

   Twelve Months Ended December 31, 
   2023   2022 
E-commerce (1)  $13,405    35%  $14,565    27%
Brick & Mortar  $5,870    15%  $11,624    21%
DTC  $5,597    15%  $6,620    12%
International (2)  $13,720    35%  $21,851    40%
Net Sales  $38,592    100%  $54,660    100%

 

(1) The Company’s E-commerce channel includes two customers that amounted to greater than 10% of the Company’s total net sales. These customers had $5.9 million and $7.1 million of net sales for the year ended December 31, 2023, respectively and $7.5 million and $6.6 million of net sales for the year ended December 31, 2022, respectively.
   
(2) One of the Company’s International customers that distributes products in China amounted to greater than 10% of the Company’s total net sales during the years ended December 31, 2023 and December 31, 2022 and represented $11.0 million and $17.7 million of net sales, respectively.

 

Note 3 - Inventories

 

Inventories are summarized as follows (in thousands):

 

   December 31, 2023   December 31, 2022 
Food, treats and supplements  $6,296   $10,212 
Inventory packaging and supplies   1,166    1,699 
Total Inventories   7,462    11,911 
Inventory reserve   (851)   (1,654)
Inventories, net  $6,611   $10,257 

 

Note 4 – Prepaid expenses and other current assets

 

Prepaid expenses and other current assets are summarized as follows (in thousands):

 

   December 31, 2023   December 31, 2022 
Prepaid advertising contract with iHeart (1)  $—   $— 
Prepaid marketing expenses   451    — 
Other prepaid expenses and other current assets   361    1,051 
Total Prepaid expenses and other current assets  $812   $1,051 

 

(1) On August 28, 2019, the Company entered into a radio advertising agreement with iHeart Media + Entertainment, Inc. (“iHeart”) and issued 166,667 shares of common stock valued at $3.4 million for future advertising services. The Company issued an additional 20,834 shares valued at $0.1 million on March 5, 2020 pursuant to the agreement. The current portion of the remaining value, reflected above, is the remaining value of services that the Company expects to utilize within the twelve months following the reporting period date, unless the term is extended. The Company utilized the remaining advertising services during the year ended December 31, 2022.

 

47

 

 

Note 5 - Fixed assets

 

Fixed assets consist of the following (in thousands):

 

   Estimated Useful Life  December 31, 2023   December 31, 2022 
Equipment  2 - 5 years  $18   $7 
Furniture and fixtures  2 - 5 years   221    221 
Computer software, including website development  2 - 3 years   187    187 
Computer equipment  1 - 2 years   108    129 
Total fixed assets      534    544 
Accumulated depreciation      (304)   (169)
Fixed assets, net     $230   $375 

 

Depreciation expense was $0.2 million for the years ended December 31, 2023 and 2022, respectively.

 

Note 6 – Goodwill and intangible assets

 

Goodwill

 

The change in the carrying amount of goodwill for the years ended December 31, 2023 and 2022 is summarized as follows (in thousands):

 

   December 31, 2023   December 31, 2022 
Beginning balance  $—   $18,614 
Impairment expense   —    (18,614)
Ending balance  $—   $— 

 

Goodwill is evaluated for impairment if an event occurs or circumstances change that indicate the carrying value of a reporting unit may not be recoverable. During July 2022, the Company completed a legal merger of TruPet and Halo, Purely for Pets, Inc., a wholly owned subsidiary of Better Choice Company Inc. (“Halo”), with Halo as the surviving entity in connection with the execution of rebranding its former TruDog brand under the Halo brand umbrella. In conjunction with the legal merger and rebranding, the Company performed an analysis of its reporting units and concluded it has one reporting unit after the legal merger and rebrand, and as such, the Company performed a quantitative goodwill assessment as of July 1, 2022 in addition to its annual impairment test as of October 1, 2022.

 

Under the quantitative approach, the Company makes various estimates and assumptions to determine the estimated fair value of the reporting unit using a combination of a discounted cash flow model and a guideline comparable analysis. The fair value measurements used in the impairment review of goodwill are Level 3 measurements which include unobservable inputs that are supported by little, infrequent or no market activity and reflect management’s own assumptions. The key assumptions used in estimating the fair value of its reporting units as of July 1, 2022 and October 1, 2022 utilizing the income approach include the discount rate and revenue growth rates. The discount rate utilized in estimating the fair value of its reporting units as of July 1, 2022 and October 1 2022 was 20.0%, reflecting the assessment of a market participant’s view of the risks associated with the projected cash flows. Revenue growth rates varied for each year included in the valuation model based on management’s best estimate of forecasted operating results. The assumptions used in estimating the fair values are based on currently available data and management’s best estimates of revenues, EBITDA margins, and cash flows and, accordingly, a change in market conditions or other factors could have a material effect on the estimated values. There are inherent uncertainties related to the assumptions used and to management’s application of these assumptions. As a result of the annual impairment test, the Company recorded an intangible asset impairment charge of $18.6 million during the year ended December 31, 2022, resulting in full impairment to the goodwill carrying value.

 

Intangible assets

 

The Company’s intangible assets include the trade name and customer relationships. As of December 31, 2023, impairment indicators were present which required a recoverability test to be performed. As a result of the recoverability test, the carrying value of the asset group exceeded its fair value and the Company recorded an impairment charge of $8.5 million for the year ended December 31, 2023, which resulted in a full impairment to the carrying value of the trade name and customer relationships. This non-cash charge was recorded to intangible asset impairment expenses on the consolidated statements of operations. The Company did not record any impairment loss on long-lived assets for the year ended December 31, 2022.

 

The assumptions used in estimating the undiscounted future cash flows are based on currently available data and management’s best estimates of future income statement and working capital elements. A change in market conditions or other factors could have a material effect on the estimated values. Fair value was determined based on discounted cash flows requiring judgement. These factors include, among others, the assumptions related to discount rates, forecasted operating results, long-term growth rates, the determination of comparable companies and market multiples. The measurements used in the impairment review of finite-lived intangible assets are Level 3 measurements. There are inherent uncertainties related to the assumptions used and to management’s application of these assumptions.

 

The Company’s intangible assets (in thousands) and related useful lives (in years) are as follows:

 

       December 31, 2023 
  

Estimated

Useful

Life (in years)

  

Gross Carrying

Amount

  

Accumulated

Amortization

   Impairment Loss  

Net Carrying

Amount

 
Customer relationships  —   $7,190   $(4,142)  $(3,048)  $— 
Trade name  —    7,500    (2,016)   (5,484)   — 
Total intangible assets      $14,690   $(6,158)  $(8,532)  $— 

 

       December 31, 2022 
  

Estimated Useful

Life (in years)

  

Gross Carrying

Amount

  

Accumulated

Amortization

  

Net Carrying

Amount

 
Customer relationships  7   $7,190   $(3,115)  $4,075 
Trade name  15    7,500    (1,516)   5,984 
Total intangible assets      $14,690   $(4,631)  $10,059 

 

Amortization expense was $1.5 million for the years ended December 31, 2023 and 2022, respectively.

 

48

 

 

The Company assesses intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be fully recoverable. If impairment indicators are present, the Company performs a recoverability test by comparing the sum of the estimated undiscounted future cash flows attributable to these long-lived assets to their carrying value. The assumptions used in estimating the undiscounted future cash flows are based on currently available data and management’s best estimates of revenues, EBITDA margins, and working capital and, accordingly, a change in market conditions or other factors could have a material effect on the estimated values. There are inherent uncertainties related to the assumptions used and to management’s application of these assumptions. As a result of the recoverability test performed, the carrying value of the asset group exceeded its fair value, therefore a quantitative impairment test was performed to compare the fair value of the trade name and customer relationships assets with their carrying value. As a result, the Company recorded an impairment charge of $8.5 million during the year ended December 31, 2023, resulting in full impairment to the carrying value of the trade name and customer relationships intangible assets.

 

Note 7 – Accrued and other liabilities

 

Accrued and other liabilities consist of the following (in thousands):

 

   December 31, 2023   December 31, 2022 
Accrued taxes   105    110 
Accrued payroll and benefits   487    688 
Accrued trade promotions and advertising   90    567 
Accrued interest   254    84 
Accrued commissions   686    385 
Deferred revenue   7    336 
Short-term financing   162    165 
Other   294    261 
Total accrued and other liabilities  $2,085   $2,596 

 

Note 8 – Debt

 

The components of the Company’s debt consist of the following (in thousands):

 

   December 31, 2023  December 31, 2022
   Amount   Rate  

Maturity
date

  Amount   Rate  

Maturity
date

Term loan, net  $2,881    (2)   6/21/2026  $—         
Line of credit, net   1,741    (3)   6/21/2025   11,444    (1)   10/31/2024
Total debt   4,622            11,444         
Less current portion   4,622            —         
Total long-term debt  $—           $11,444         

 

(1) Interest at a variable rate of the daily U.S. Federal Funds Rate plus 375 basis points with an interest rate floor of 3.75% per annum.
   
(2) Interest at a fixed rate of 10.00% per annum.
   
(3) Interest at a variable rate of the daily U.S. Federal Funds Rate plus 250 basis points with an interest rate floor of 5.50% per annum.

 

Wintrust term loan and lines of credit

 

On January 6, 2021, Halo entered into a credit facility with Old Plank Trail Community Bank, N.A., an affiliate of Wintrust Bank, N.A. (“Wintrust”) consisting of a $6.0 million term loan and a $6.0 million revolving line of credit, each scheduled to mature on January 6, 2024 and each bore interest at a variable rate of LIBOR plus 250 basis points, with an interest rate floor of 2.50% per annum (the “Wintrust Credit Facility”). The Second Wintrust Amendment described below updated the rate at which the Wintrust Credit Facility bore interest to the greater of the daily U.S. Federal Funds Rate plus 285 basis points, or the interest rate floor, which remained unchanged. The Third Wintrust Amendment described below updated the interest rate on the Wintrust Credit Facility to the U.S. Federal Funds Rate plus 375 basis points, with an interest rate floor of 3.75% and extends the maturity date of the Wintrust Credit Facility from January 6, 2024 to October 31, 2024. Accrued interest on the Wintrust Credit Facility is payable monthly which commenced on February 1, 2021. Principal payments were required to be made monthly on the term loan commencing February 2021 with a balloon payment upon the original maturity date. The proceeds from the Wintrust Credit Facility were used (i) to repay outstanding principal, interest and fees under the previous revolving line of credit with Citizens Business Bank (the “ABL Facility”) and (ii) for general corporate purposes.

 

49

 

 

The Wintrust Credit Facility subjected the Company to certain financial covenants, including the maintenance of a fixed charge coverage ratio of no less than 1.25 to 1.00, tested as of the last day of each fiscal quarter. The numerator in the fixed charge coverage ratio was the operating cash flow of Halo, defined as Halo EBITDA less cash paid for unfinanced Halo capital expenditures, income taxes and dividends. The denominator was fixed charges such as interest expense and principal payments paid or payable on other indebtedness attributable to Halo. As of December 31, 2021, the Company failed to satisfy the fixed charge coverage ratio and entered into a default waiver agreement with Wintrust in which Wintrust waived the existing default through the next testing date, March 31, 2022. As part of the Second Wintrust Amendment described below, the financial covenants were amended to subject the Company to a minimum liquidity covenant test in lieu of a fixed charge coverage ratio which required the Company to maintain liquidity, tested on the last day of each fiscal quarter beginning March 31, 2022, of no less than (i) $13.0 million as of the last day of each fiscal quarter ending March 31, 2022, through and including the last day of the fiscal quarter ending December 31, 2022 and (ii) $12.0 million as of the last day of the fiscal quarter ending March 31, 2023, and as of the last day of each fiscal quarter thereafter. Furthermore, as part of the Third Wintrust Amendment described below, the financial covenants were further amended to require the Company to maintain a minimum liquidity of $8.5 million tested on the last day of each fiscal quarter beginning September 30, 2022 and thereafter.

 

The Wintrust Credit Facility is secured by a general guaranty and security interest on the assets, including the intellectual property, of the Company and its subsidiaries. The Company has also pledged all of the capital stock of Halo held by the Company as additional collateral. Furthermore, the Wintrust Credit Facility was supported by a collateral pledge by a member of the Company’s board of directors; as a result of the First Wintrust Amendment described below, this collateral pledge was terminated and released.

 

On August 13, 2021, Halo entered into the first amendment to the Wintrust Credit Facility (the “First Wintrust Amendment”) to increase the revolving line of credit from $6.0 million to $7.5 million. The First Wintrust Amendment also required Halo to secure the credit facility with a pledge of a deposit account in the amount of $7.2 million, which was decreased to $6.9 million on January 1, 2022 and was to further decrease to $6.0 million on January 1, 2023. Additionally, on March 25, 2022, the Company entered into the second amendment to the Wintrust Credit Facility (the “Second Wintrust Amendment”) which provided for the release of the Company’s Bona Vida subsidiary as a guarantor, an update to the financial covenants as described above and an update to the rate at which the Wintrust Credit Facility bore interest, which is also described above. Furthermore, on October 24, 2022, the Company entered into the third amendment to the Wintrust Credit Facility (the “third Wintrust Amendment”) which provided for an increase to the revolving line of credit from $7.5 million to $13.5 million, set the amount of Halo’s obligation to pledge a deposit account with Wintrust to a fixed amount of $6.3 million throughout the remainder of the term and provided updates to the interest rate, maturity date and financial covenants as described above.

 

As part of the Third Wintrust Amendment described above, Halo used a portion of the increased revolving credit facility to repay and retire the outstanding term loan portion of the Wintrust Credit Facility.

 

On June 21, 2023, the Company paid off the entire balance in the sum of $13.5 million of the Wintrust Credit Facility removing any covenant requirements to be met at December 31, 2023.

 

As of December 31, 2023, there was no outstanding balance related to the Wintrust Credit Facility. As of December 31, 2022, the line of credit outstanding was $11.4 million, net of debt issuance costs of less than $0.2 million. Debt issuance costs are amortized using the effective interest method.

 

Wintrust Receivables Credit Facility

 

On June 21, 2023, the Company entered into an account purchase agreement with Wintrust Receivables Finance (AP Agreement), a division of Wintrust Bank N.A. (“Wintrust”) pursuant to which Wintrust will purchase, at its discretion, eligible customer invoices and advance up to 75% of the face amount of all purchased invoices. The maximum outstanding balance can be $4.8 million. Each advance under the Advance Purchase Agreement will bear a variable interest rate at the prime rate plus 2.5% percentage per annum. The interest rate at December 31, 2023 was 11.0% per annum. The AP Agreement has an initial term of two years and will automatically renew annually unless terminated by the Company on at least 60 days’ notice. The Wintrust Receivables Credit Facility is guaranteed and secured by a general security interest in the assets of the Company. The Company continues to service the receivables, the transfers are at full recourse and the eligible customer invoices are not legally isolated from the Company. As such, the Wintrust Receivables Credit Facility was accounted for as a secured borrowing under ASC 860.

 

The Wintrust Receivables Credit Facility limits or restrict the ability of the Company to incur additional indebtedness; incur additional liens; make dividends and other restricted payments; make investments; sell, assign, transfer or dispose of certain assets; make optional prepayments of other indebtedness; engage in transactions with affiliates; and enter into restrictive agreements. The Wintrust Receivables Credit Facility does not include any financial covenants and if an event of default occurs, Wintrust is entitled to accelerate the advances made thereunder and exercise rights against the collateral.

 

50

 

 

Borrowing under the Wintrust Receivables Credit Facility are classified as current debt as a result of a required lockbox arrangement and a subjective acceleration clause. During the year ended December 31, 2023, the Company sold receivables having an aggregate face value of $10.5 million, in exchange for cash proceeds of $7.8 million. As of December 31, 2023, the balance outstanding on the Wintrust Receivables Credit Facility amounted to $1.7 million.

 

Alphia Term Loan Facility

 

On June 21, 2023, the Company entered into a term loan credit agreement (the “Term Loan Agreement”) with Alphia Inc. (“Alphia”), a custom manufacturer of super-premium pet food in the U.S. Pursuant to the Term Loan Agreement, Alphia made a term loan to the Company in the original principal amount of $5.0 million (the “Term Loan”). In conjunction with the Term Loan Agreement, the Company issued warrants to Alphia (see Note 11 – Warrants for further discussion). The proceeds of the Term Loan, together with a portion of the Company’s cash on hand, were used to retire all of the outstanding obligations of Halo, Purely for Pets, Inc. (“Halo”), a wholly-owned subsidiary of the Company, under Halo’s long-term credit facility with Old Plank Trail Community Bank, N.A., an affiliate of Wintrust Bank, N.A described above.

 

The Term Loan bears an interest rate of 10% per annum, compounded quarterly, and will mature on June 21, 2026. Accrued interest on the Term Loan is payable quarterly in cash or, at the election of the Company, in-kind by capitalizing such interest and adding it to the then-outstanding principal amount of the Term Loan. The Term Loan Agreement provides for customary financial covenants and customary events of default, including, among others, those relating to failure to make payment, bankruptcy, breaches of representations and material adverse effects. The Company was not in compliance with these covenants as of December 31, 2023. The Company may prepay the principal of the Term Loan at any time upon written notice to Alphia and subject to a prepayment penalty if such prepayment occurs prior to June 21, 2025.

 

The Term Loan is secured by a general security interest on the assets, including the intellectual property of the Company and Halo pursuant to (i) that certain Term Loan Security Agreement, dated June 21, 2023, made by the Company and Halo in favor of Alphia (the “Security Agreement”) and (ii) that certain Intellectual Property Security Agreement, dated as of June 21, 2023, of the Company and Halo in favor of Alphia (the “Intellectual Property Security Agreement”). The Company has also pledged all of the capital stock of Halo held by the Company as additional collateral for the Term Loan.

 

The term Loan is guaranteed by Halo pursuant to that certain Term Loan Guaranty, dated as of June 21, 2023, by and between Halo and Alphia (the “Term Loan Guaranty”).

 

As of December 31, 2023, the Company’s indebtedness on the Alphia Term Loan Facility is $5.0 million and $0.3 million of payable-in-kind (“PIK”) interest. As discussed below, the total value of the consideration received in connection with the Term Loan Agreement was first allocated to the Warrants (as defined in Note 11) at fair value, with the remainder allocated to debt. Accordingly, the Company recorded a debt discount of $2.2 million on the Alphia Term Loan Agreement (see Note 11 for further discussion). Furthermore, the Company incurred debt issuance costs of $0.2 million. The discount and debt issuance costs associated with the Term Loan Agreement are amortized using the effective interest method.

 

Future Debt Maturities

 

Future debt maturities as of December 31, 2023 and for succeeding years are as follows (in thousands):

 

Year ending December 31:    
2024  $5,291 
2025  $— 
2026  $— 
Total  $5,291 

 

Note 9 - Fair Value Measurements

 

The carrying amounts of cash and cash equivalents, trade accounts receivable, prepaid expenses and other current assets, accounts payable and accrued expenses approximate fair value because of the short-term nature of these financial instruments. The carrying amounts of borrowings under credit facilities approximates fair value as variable interest rates on these instruments approximates current market rates.

 

51

 

 

The Company estimates the fair value of the term loan based on a discounted cash flow method. The carrying value of the term loan was based on an accounting entry where proceeds from the loan were first allocated to the warrants liabilities. The following table presents the carrying amount and fair value of the Company’s term note and line of credit by hierarchy level:

 

        December 31, 2023   December 31, 2022 
   Fair Value
Hierarchy		    Carrying
Amount		   Fair
Value		   Carrying
Amount		   Fair
Value		 
Term loan, net   Level 3(2)   $2,881   $3,314   $—   $— 
Line of credit   Level 2(1)   $1,741   $1,741   $11,444   $11,444 

 

(1) the fair value estimates are based upon observable market data
   
(2) the fair value estimates are based on unobservable inputs reflecting management’s assumptions about inputs used in pricing the asset or liability

 

 

Note 10 – Commitments and contingencies

 

The Company has manufacturing agreements with its vendors that provides for the company to make its commercial best efforts to purchase minimum quantities in the ordinary course of business. The Company had no material purchase obligations as of December 31, 2023 or 2022.

 

The Company may be involved in legal proceedings, claims, and regulatory, tax, or government inquiries and investigations that arise in the ordinary course of business resulting in loss contingencies. The Company accrues for loss contingencies when losses become probable and are reasonably estimable. If the reasonable estimate of the loss is a range and no amount within the range is a better estimate, the minimum amount of the range is recorded as a liability. Legal costs such as outside counsel fees and expenses are charged to expense in the period incurred and are recorded in SG&A expenses. The Company does not accrue for contingent losses that are considered to be reasonably possible, but not probable; however, the Company discloses the range of such reasonably possible losses. Loss contingencies considered remote are generally not disclosed.

 

Litigation is subject to numerous uncertainties and the outcome of individual claims and contingencies is not predictable. It is possible that some legal matters for which reserves have or have not been established could result in an unfavorable outcome for the Company and any such unfavorable outcome could be of a material nature or have a material adverse effect on the Company’s consolidated financial condition, results of operations and cash flows. Management is not aware of any claims or lawsuits that may have a material adverse effect on the consolidated financial position or results of operations of the Company.

 

Note 11 – Warrants

 

The following summarizes the Company’s outstanding warrants to purchase shares of the Company’s common stock as of and for the years ended December 31, 2023 and 2022: 

 

   Warrants   Weighted Average
Exercise Price		 
Warrants outstanding as of December 31, 2021   214,400   $5.92 
Issued   —   $— 
Exercised   —   $— 
Terminated/Expired   —   $— 
Warrants outstanding as of December 31, 2022   214,400   $5.92 
Issued   335,639   $11.44 
Exercised   —   $— 
Terminated/Expired   —   $— 
Warrants outstanding as of December 31, 2023   550,039   $2.47 

 

The intrinsic value of outstanding warrants was $0.0 million as of December 31, 2023 and 2022, respectively. The following discussion provides details on the various types of outstanding warrants and the related relevant disclosures around each type.

 

The warrants shown in the table above outstanding as of December 31, 2022, are equity classified warrants issued between May 2019 and January 2021. There was no intrinsic value associated with these equity warrants as of December 31, 2022.

 

In conjunction with the Alphia Term Loan Facility mentioned in Note 8 - Debt, the Company issued to Alphia (i) a warrant (the “First Tranche Warrant”) to purchase 148,758 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”) at a price of $11.44 per share, and (ii) a warrant (the “Second Tranche Warrant” and together with the First Tranche Warrant, the “Warrants” or the “Alphia Warrants”) to purchase 186,882 shares of Common Stock at a price of $11.44 per share. Unless exercised, the Warrants expire on June 21, 2028. Alphia’s exercise of the Second Tranche Warrant was subject to the approval of the Company’s stockholders and was approved on November 15, 2023. The Warrants contained certain anti-dilution provisions in favor of Alphia in connection with any equity offering consummated by the Company prior to December 21, 2023 and equity issuances below the exercise price of the Warrants. The Warrants also contain a cashless exercise option at the election of Alphia.

 

52

 

 

Additionally, in conjunction with the Term Loan, the Company entered into a Side Letter Agreement with Alphia (the “Side Letter”) pursuant to which Alphia was granted a right of first refusal on any of the following relating to the Company or any of its subsidiaries and to the extent such transactions constitute a change of control: (i) any transfer, sale, lease or encumbrance of all or any portion of the capital stock or assets (other than the sale of inventory in the ordinary course of business), (ii) any merger, consolidation or other business combination, (iii) any recapitalization, reorganization or any other extraordinary business transaction, (iv) or any equity issuance or debt incurrence. Alphia’s right of first refusal is effective so long as the Term Loan remains outstanding and for a period of 12 months thereafter. The Side Letter also provides Alphia with certain Board observer rights.

 

The Company evaluated the Alphia Warrants under ASC 815-40, Derivatives and Hedging-Contracts in Entity’s Own Equity (“ASC 815-40”) and concluded they did not initially meet the criteria to be classified in shareholders’ equity. Specifically, there were contingent exercise provisions and settlement provisions that existed, including provisions where the number of shares available under the warrants may be adjusted based on a percentage of equity. Because the number of outstanding common shares was not a fair value input to a fixed-for-fixed model, this provision violated indexation guidance. Therefore, the warrants were not indexed to the Company’s stock. The Alphia warrant liabilities were remeasured at fair value each reporting period until provisions precluding equity classification lapsed and the Company reassessed the warrants classification on December 21, 2023. The total value of the consideration received in connection with the Alphia Term Loan Agreement was first allocated to warrants liabilities at fair value, with the remainder allocated to the Alphia Term Loan Agreement. Accordingly, the Company recorded a discount of $2.2 million on the Alphia Term Loan Agreement (see Note 8 – Debt for further discussion).

 

The Alphia warrant liabilities were determined using a risk-neutral Monte Carlo simulation based approach, a Level 3 valuation. The significant inputs to the warrant liabilities were as follows: 

 

   December 21, 2023 
   First Tranche
Warrant		   Second Tranche
Warrant		 
Exercise price  $11.44   $11.44 
Stock price  $12.00   $12.00 
Volatility   62.0%   62.0%
Time to maturity   5 years    5 years 
Risk-free rate   3.92%   3.92%
Dividend yield   —%   —%

 

The following table summarizes the Alphia warrant liability activity for twelve months ended December 31, 2023:

 

Balance as of December 31, 2022  $— 
Warrant liabilities issued   2,208 
Change in fair value of warrant liabilities   236 
Reclassification of warrants liabilities to equity   (2,444)
Balance as of December 31, 2023  $— 

 

The change in fair value related to the Alphia warrant liabilities was $0.2 million for the twelve months ended December 31, 2023. There were no transfers to/from levels 1, 2 and 3 during the twelve months ended December 31, 2023. The anti-dilution provisions which previously precluded equity treatment of the warrants, expired on December 21, 2023, and thus the warrants were reclassified and presented in equity as of December 31, 2023.

 

Note 12 – Share-based compensation

 

During the year ended December 31, 2023 and December 31, 2022, the Company recognized $1.8 million and $3.0 million, respectively, of share-based compensation expense.

 

On November 11, 2019, the Company received shareholder approval for the Amended and Restated 2019 Incentive Award Plan (the “Amended 2019 Plan”). The Amended 2019 Plan provides for the grant of stock options, stock appreciation rights, restricted stock awards, restricted stock units, other stock or cash-based awards or a dividend equivalent award. The Amended 2019 Plan authorized the issuance of 24,621 shares of common stock which was increased to 34,091 after the Halo acquisition; the Amended 2019 Plan also provides for an annual increase on the first day of each calendar year beginning on January 1, 2020 and ending on and including January 1, 2029, equal to the lesser of (A) 10% of the shares of common stock outstanding (on an as-converted basis) on the last day of the immediately preceding fiscal year and (B) such smaller number of shares of common stock as determined by the Board; provided, however, not more than 204,546 shares of common stock shall be authorized for issuance. The authorized shares for issuance was increased to 61,364 on January 1, 2021, increased to 127,606 on January 1, 2022 and again increased to 194,493 on January 1, 2023.

 

53

 

 

Stock options

 

The following table provides detail of the options granted and outstanding (dollars in thousands): 

 

   Options  

Weighted

Average

Exercise Price

   Weighted
Average
Remaining
Contractual
Life (Years)		   Aggregate
Intrinsic Value		 
Options outstanding as of December 31, 2021   61   $6.10    8.5   $— 
Granted   14   $2.24           
Forfeited/Expired   (5)  $5.26           
Options outstanding as of December 31, 2022   70   $5.39    7.2   $— 
                     
Options exercisable as of December 31, 2022   49   $5.84    6.5   $— 
Fully vested options as of December 31, 2022   49   $5.84    6.5   $— 
Options expected to vest as of December 31, 2022   21   $4.32    8.8   $— 

 

   Options  

Weighted
Average

Exercise Price

   Weighted
Average
Remaining
Contractual
Life (Years)		   Aggregate
Intrinsic Value		 
Options outstanding as of December 31, 2022   70   $5.39    7.2   $— 
Granted   5    0.35           
Forfeited/Expired   (21)   5.19           
Options outstanding as of December 31, 2023   54   $5.03    5.7   $— 
                     
Options exercisable as of December 31, 2023   46   $5.54    5.2   $— 
Fully vested options as of December 31, 2023   46   $5.54    5.2   $— 
Options expected to vest as of December 31, 2023   8   $1.74    8.9   $— 

 

Options granted under the Amended 2019 Plan vest over a period of two to three years. All vested options are exercisable and may be exercised through the ten-year anniversary of the grant date (or such earlier date described in the applicable award agreement).

 

During the years ended December 31, 2023 and 2022, $1.0 million and $2.4 million, respectively, of share-based compensation expense was recognized related to options issued. As of December 31, 2023, unrecognized share-based compensation related to options was $0.2 million, which is expected to be recognized over a weighted average period of 0.4 years.

 

The fair value of an option award is estimated on the date of grant using the Black–Scholes option valuation model, using the following assumptions primarily based on historical data:

 

    Years Ended December 31, 
    2023    2022 
Risk-free interest rate   0.33 - 4.02%   1.70 - 4.02%
Expected volatility (1)   0.0% - 72.5%   65.0% - 72.5%
Expected dividend yield   —%   —%
Expected life (years) (2)   0 - 7.6    6.0 - 6.5 

 

(1) Expected volatility was determined using a combination of historical volatility and implied volatility.
(2) For certain options, the simplified method is utilized to determine the expected life due to the lack of historical data.

 

54

 

 

Restricted Stock Awards

 

In February 2022, the Company granted 4,962 shares of restricted common stock to members of its board of directors under the Amended 2019 Plan as compensation for annual board service. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of $0.5 million upon issuance.

 

During the fourth quarter of 2022, the Company granted 1,489 shares of restricted common stock to a member of its board of directors for service as interim CEO. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of less than $0.1 million upon issuance.

 

In January 2023, the Company granted 20,292 shares of restricted common stock to members of its board of directors under the Amended 2019 Plan as compensation for annual board service. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of $0.5 million upon issuance.

 

In January 2023, the Company granted 4,545 shares of restricted common stock to certain executives and employees under the Amended 2019 Plan as performance bonus compensation totaling $0.1 million. These restricted stock awards were issued on the grant date with a one year cliff vesting condition and the Company will recognize the expense over the vesting period.

 

During the first quarter of 2023, the Company granted 409 shares of restricted common stock to a member of its board of directors for service as interim CEO. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of less than $0.1 million upon issuance.

 

During the second quarter of 2023, the Company granted 909 shares of restricted common stock to certain executives and employees under the Amended 2019 Plan as performance bonus compensation totaling less than $0.1 million. These restricted stock awards were issued on the grant date with a one year cliff vesting condition and the Company will recognize the expense over the vesting period.

 

During the third quarter of 2023, the Company granted 34,090 shares of restricted common stock to two members of its board of directors. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of less than $0.3 million upon issuance.

 

Note 13 – Employee benefit plans

 

The Company has a qualified defined contribution 401(k) plan, which covers substantially all of its employees. Participants are entitled to make pre-tax and/or Roth post-tax contributions up to the annual maximums established by the IRS. The Company matches participant contributions pursuant to the terms of the plan, which contributions are limited to a percentage of the participant’s eligible compensation. The Company made contributions related to the plan and recognized expense of $0.1 million and $0.2 million during the years ended December 31, 2023 and 2022, respectively.

 

Note 14 – Related party transactions

 

Director Fees

 

The Company pays quarterly board of director fees. Board of director fees totaled $0.3 million during the years ended December 31, 2023 and 2022. As of December 31, 2023 and 2021, $0.1 million of these director fees were in accounts payable on the Consolidated Balance Sheets, respectively.

 

Marketing Support Services

 

On March 7, 2023, the Company entered into an agreement with Believeco to provide marketing support services for an interim period. A member of the Company’s board of directors is a partner at Believeco. As of December 31, 2023 marketing expense related to Believeco totaled $0.4 million of which $0.1 million is included within Accounts Payable.

 

Note 15 – Income taxes

 

For the year ended December 31, 2023, the Company recorded income tax expense of less than $0.1 million. For the year ended December 31, 2022, the Company recorded income tax benefit of less than $0.1 million. For the years ended December 31, 2023 and 2022, the Company’s effective tax rate was 0%. The Company’s effective tax rate differs from the U.S. federal statutory rate of 21% primarily because the Company’s losses have been fully offset by a valuation allowance due to uncertainty of realizing the tax benefit of net operating losses (“NOLs”) for the years ended December 31, 2023 and 2022.

 

55

 

 

The following table is a reconciliation of the components that caused the Company’s provision for income taxes to differ from amounts computed by applying the U.S. federal statutory rate of 21% (in thousands):

 

   Years Ended December 31, 
   2023   2022 
Statutory U.S. Federal income tax  $(4,782)   21.0%  $(8,260)   21.0%
State income taxes, net   (309)   1.3%   (167)   0.4%
Meals and entertainment   5    —%   —    —%
Change in valuation allowance   5,031    (22.1)%   5,384    (13.7)%
Goodwill impairment   —    —%   3,802    (9.7)%
Warrant valuation   50    (0.2)%   —    —%
Tax effect of non-deductible equity instruments   —    —%   —    0.1%
Return to provision adjustment   5    —%   (5)   —%
Other   2    —%   (772)   2.0%
Total provision  $2    0.0%  $(18)   0.1%

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

 

Significant components of the Company’s deferred tax assets and liabilities are as follows (in thousands): 

 

   2023   2022 
   December 31, 
   2023   2022 
Deferred income tax assets:          
Net operating loss carryforwards  $21,662   $19,182 
ROU assets   28    42 
Share-based compensation   5,320    5,251 
Inventory   68    157 
Other assets   2,508    2,306 
Gross deferred tax assets   29,586    26,938 
Valuation allowance   (29,509)   (24,479)
Net deferred tax assets  $77   $2,459 
Deferred income tax liabilities:          
Fixed assets   (50)   (86)
Operating lease liabilities   (27)   (41)
Intangibles   —    (2,332)
Deferred tax liabilities, net of valuation allowance  $—   $— 

 

As of December 31, 2023, the Company had a deferred tax asset (before valuation allowance) recorded on gross federal and state net operating loss carryforwards of approximately $89.7 million and $59.3 million, respectively. The net operating losses will begin to expire in 2026.

 

The Internal Revenue Code, as amended (“IRC”), imposes restrictions on the utilization of NOLs and other tax attributes in the event of an “ownership change” of a corporation. Accordingly, a company’s ability to use pre-change NOLs may be limited as prescribed under IRC Section 382. Events which may cause limitation in the amount of the NOLs and credits that can be utilized annually include, but are not limited to, a cumulative ownership change of more than 50% over a three-year period.

 

Management assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to use the existing deferred tax assets in the future. A significant piece of objective negative evidence evaluated was the cumulative loss incurred through the years ended December 31, 2023 and 2022. Such objective evidence limits the ability to consider other subjective positive evidence such as current year taxable income and future income projections. On the basis of this evaluation, as of December 31, 2023, a valuation allowance of $(29.5) million was recorded since it is more likely than not that the deferred tax assets will not be realized.

 

56

 

 

Changes in valuation allowance are as follows (in thousands): 

 

   2023   2022 
   Years Ended December 31, 
   2023   2022 
Valuation allowance, at beginning of year  $24,479   $19,095 
Increase in valuation allowance   5,030    5,384 
Valuation allowance, at end of year  $29,509   $24,479 

 

As of December 31, 2023 and 2022, the Company does not have any significant uncertain tax positions and as of December 31, 2023 and 2022, the Company had no accrued interest and penalties related to uncertain income tax positions. The Company does not anticipate that the amount of unrecognized tax benefits will significantly increase or decrease within the next twelve months. If incurred, the Company would classify interest and penalties on uncertain tax positions as income tax expense.

 

The Company is subject to taxation in the U.S. federal and various state jurisdictions. The Company is not currently under audit by any taxing authorities. The Company remains open to examination by tax jurisdictions for tax years beginning with the 2020 tax year for federal and 2018 for states. Federal and state net operating losses are subject to review by taxing authorities in the year utilized and future years.

 

Note 16 – Concentrations

 

Major suppliers

 

The Company sourced approximately 64% of its inventory purchases from two vendors for the year ended December 31, 2023. The Company sourced approximately 69% of its inventory purchases from three vendors for the year ended December 31, 2022.

 

Major customers

 

Accounts receivable from two customers represented 79% of accounts receivable as of December 31, 2023. Accounts receivable from three customers represented 88% of accounts receivable as of December 31, 2022. Three customers represented 62% of gross sales for the year ended December 31, 2023. Three customers represented 58% of gross sales for the year ended December 31, 2022.

 

Credit risk

 

As of December 31, 2023 and 2022, the Company’s cash and cash equivalents were deposited in accounts at several financial institutions and may maintain some balances in excess of federally insured limits. The Company maintains its cash and cash equivalents with high-quality, accredited financial institutions and, accordingly, such funds are subject to minimal credit risk. The Company has not experienced any losses historically in these accounts and believes it is not exposed to significant credit risk in its cash and cash equivalents.

 

Note 17 – Loss per share

 

The Company presents loss per share on a basic and diluted basis. Basic (loss) earnings per share is computed by dividing net loss by the weighted average number of common shares outstanding (“WASO”) during the period. Diluted loss per share includes the dilutive effect of common stock equivalents consisting of stock options and warrants using the treasury stock method and convertible notes and preferred stock using the if-converted method. Under the treasury stock method, the amount the holder must pay for exercising stock options or warrants and the amount of average compensation cost for future service that has not yet been recognized are collectively assumed to be used to repurchase shares.

 

For the year ended December 31, 2023, the Company’s basic and diluted net loss per share attributable to common stockholders are the same as the Company generated a net loss and common stock equivalents are excluded from diluted net loss per share as they have an anti-dilutive impact. Therefore, the Company did not have any dilutive securities and/or other contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. For the year ended December 31, 2022, potentially dilutive securities not included in the calculation of diluted net loss per share, because to do so would be anti-dilutive, are as follows: 214,400 of stock equivalent warrants, 69,654 of stock equivalent employee stock options and 146 of stock equivalent other options. For the year ended December 31, 2023, potentially dilutive securities not included in the calculation of diluted net loss per share, because to do so would be anti-dilutive, are as follows: 335,640 of Alphia Warrants (148,758 First Tranche Warrant and 186,882 Second Tranche Warrant); 214,400 of stock equivalent warrants; and 53,285 of stock equivalent employee stock options.

 

57

 

 

The following table sets forth basic and diluted net (loss) earnings per share attributable to common stockholders for the years ended December 31, 2023 and 2022 (in thousands, except share and per share amounts): 

 

   2023   2022 
   Year ended December 31, 
   2023   2022 
Numerator:          
Net loss  $(22,770)  $(39,316)
Less: Adjustment due to warrant modifications   —    — 
Adjusted net loss available to common stockholders  $(22,770)  $(39,316)
Denominator:          
Basic WASO   705,185    667,114 
Dilutive common stock equivalents   —    — 
Diluted WASO   705,185    667,114 
           
Net loss per share attributable to common stockholders, basic  $(32.29)  $(58.93)
Net loss per share attributable to common stockholders, diluted  $(32.29)  $(58.93)

 

Note 18 – Subsequent events

 

On February 9, 2024, the Company announced the acquisition of all the issued and outstanding common shares of Aimia Pet Healthco, Inc. for consideration consisting of 45,629 shares of common stock of the Company. The Company has not yet completed its evaluation of certain assets and liabilities acquired, or treatment of this transaction as either a business combination or asset acquisition in accordance with Topic 805.

 

In February 2024, the Company granted 42,088 shares of restricted common stock to members of its Board of Directors as part of their equity compensation pursuant to the Amended and Restated 2019 Incentive Award Plan. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of $0.4 million upon issuance.

 

On March 25, 2024, Better Choice Company, Inc. (“BTTR”) initiated a legal action to enforce a right of first refusal (“ROFR”) option exercised by Alphia, Inc. (“Alphia”), which is controlled by a Paris-based private equity firm, PAI Partners. The Company is unable to predict the outcome or impact on its business and financial results.

 

58

 

 

ITEM 9.CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None.

 

ITEM 9A.CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our chief executive officer (our principal executive officer) and our chief financial officer (our principal financial officer) evaluated the effectiveness of our disclosure controls and procedures as of the year ended December 31, 2023. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of December 31, 2023, our disclosure controls and procedures were not effective due to the material weaknesses discussed below. Notwithstanding the material weaknesses in our internal control over financial reporting, we have concluded that the condensed consolidated financial statements included in this Form 10-K fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented in conformity with accounting principles generally accepted in the United States of America.

 

Management’s Annual Report on Internal Control Over Financial Reporting

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projection of any evaluation of effectiveness to future periods is subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may deteriorate. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control – Integrated Framework (2013 Framework). Based on this assessment, management concluded that, as of December 31, 2023, the Company’s internal control over financial reporting was not effective due to the material weaknesses described below.

 

Material Weaknesses

 

In July 2023, Management became aware of a cybersecurity incident via email compromise. Management investigated the matter internally and engaged a third-party forensics expert to facilitate a full investigation to determine the exact nature, timing, and magnitude of the breach. The root cause of the incident was traced to lack of Multi-Factor Authentication (“MFA”) protection allowing a brute force attack on the user’s hosted Microsoft Exchange email account. Management determined that although there was a control that was designed and implemented, it did not prevent the cybersecurity breach. Management has thus determined that there is a material weakness related to the failure to maintain controls that should have been operating effectively as of December 31, 2023.

 

Additionally, our internal controls over financial reporting were not effective as of December 31, 2023, due to a material weakness in analyzing complex accounting transactions, including the proper classification of warrants as liabilities and the related financial statement disclosures, and the proper assessment of triggering events that occurred that would require an impairment analysis over intangible assets. In light of this material weakness, we performed additional analysis as deemed necessary to ensure that our consolidated financial statements were prepared in accordance with GAAP. Accordingly, management believes that the financial statements included in this report present fairly in all material respects our financial position, results of operations and cash flows for the periods presented.

 

Management has determined that we did not design and maintain effective controls to support proper revenue recognition. Specifically, management did not have effective controls (i) to ensure the accuracy of data input for price and quantity and (ii) to ensure that there was effective testing of period end sales cutoff, including a proper review and comparison of invoices.

 

Remediation Plan

 

To address the material weakness associated with failure to maintain controls over the operating effectiveness of IT general controls, we transitioned to a new outsourced managed IT service provider with an appropriate level of knowledge and technical experience to design and maintain IT general controls. We have also planned to (i) establish policies and procedures for the design and operation of IT general controls, (ii) implement an IT general controls framework, and (iii) where necessary, we have identified, implemented, and documented IT general controls. We continue to evaluate the appropriate controls to design and maintain effective controls supporting financial systems relevant to our financial reporting processes. We continue to evaluate staffing requirements and technology improvement opportunities to further address and achieve remediation.

 

To address the material weakness in internal controls related to the accounting for complex accounting transactions, we plan to engage outside advisors with specialist knowledge of GAAP and valuation as it relates to our complex financial instruments.

 

To address the material weakness in internal controls related to the revenue recognition, we continue to evaluate the appropriate controls to design and maintain effective controls supporting revenue recognition and are in the process of enhancing certain controls over revenue, including adding resources and training programs addressing the design, implementation, and documentary evidence requirement of control procedures over revenue recognition for appropriate personnel.

 

Although we implemented measures and plan to implement additional measures to remedy our internal control deficiencies, there can be no assurance that our efforts will be successful. In addition, until the remediation steps have been completed and operated for a sufficient period of time, and subsequent evaluation of their effectiveness is completed, the material weaknesses identified and described above will continue to exist.

 

Changes in Internal Control Over Financial Reporting

 

Other than the material weaknesses described above, there has not been any change in our internal controls over financial reporting identified in connection with the evaluation that occurred during the quarter ended December 31, 2023 that has materially affected, or is reasonably likely to materially affect, those controls.

 

Attestation Report of Independent Registered Public Accounting Firm

 

This Annual Report on Form 10-K does not include an attestation report of the Company’s registered public accounting firm, as non-accelerated filers are exempt from the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act.

 

ITEM 9B.OTHER INFORMATION

 

None.

 

59

 

 

PART III

 

ITEM 10.DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

The following table sets forth the names and positions of our executive officers and directors serving as of such date of filing of this annual report on Form 10-K. Directors will be elected at our annual meeting of stockholders and serve for one year or until their successors are elected and qualify. Officers are elected by the Board and their terms of office are, except to the extent governed by employment contract, at the discretion of the Board.

 

Name  Age  Position  Director Since
Kent Cunningham(1)  52  Chief Executive Officer  n/a
Carolina Martinez  34  Chief Financial Officer, Secretary and Treasurer  n/a
Lionel F. Conacher  60  Director  2021
Arlene Dickinson(1)  66  Director  2021
Gil Fronzaglia  61  Director  2021
John M. Word III  76  Director  2019
Michael Young  44  Chairman of the Board of Directors  2019

 

(1) Ms. Dickinson resigned effective April 1, 2024, and Mr. Cunningham was appointed as a member of the Board, effective April 1, 2024, to fill the vacancy resulting from Ms. Dickinson’s resignation.

 

Kent Cunningham. Mr. Cunningham was appointed as Chief Executive Officer of the Company effective as of May 22, 2023. Prior to joining the Company, Mr. Cunningham was a Principal with Catapult Consulting where he provided management and M&A advisory consulting services from February 2022 to May 2023. Prior to consulting, Mr. Cunningham served as the Chief Executive Officer of 1440 Foods, a sports and active nutrition company, between August 2021 and January 2022. Prior to 1440 Foods, he was a General Manager at The Bountiful Company, an American dietary supplements company, from May 2019 to August 2021. Prior to The Bountiful Company, Mr. Cunningham was Chief Marketing Officer for Whole Earth Brands, a global food company providing plant-based sweeteners and flavor enhancers, between April 2018 and May 2019. From 2013 to April 2018, Mr. Cunningham held various marketing positions at Glanbia Performance Nutrition, a global nutrition company. From 2006 to 2013, Mr. Cunningham held various Marketing positions at MARS Petcare, owner of several health and nutrition pet food brands. Mr. Cunningham is a passionate brand builder and business leader with over 25 years of CPG and Health & Wellness marketing and sales experience across a range of corporate environments and categories including accelerating growth within multinationals, brand turnarounds and high value exits in the private equity business for the likes of KKR & Co. Inc. Mr. Cunningham holds an MBA in Marketing from Vanderbilt University and a BA in Communications from the University of Michigan. Mr. Cunningham was appointed as a member of the Board, effective April 1, 2024.

 

Carolina Martinez. Mrs. Martinez was appointed as Chief Financial Officer, effective August 2, 2023. Mrs. Martinez was previously appointed and served as the Interim Chief Financial Officer, Secretary and Treasurer of the Company effective as of April 3, 2023, and will continue to serve as the Secretary and Treasurer of the Company. Prior to joining the Company, Mrs. Martinez was a Director of CFO Partnership Solutions at ONE10 Advisors, LLC, (“ONE10 Advisors”) a strategic finance and accounting advisory firm in Tampa, FL. Prior to joining ONE10 Advisors in January 2022, Mrs. Martinez spent nine years at PricewaterhouseCoopers, LLP where she served as a Manager in the National Quality Organization office from March through December 2021, and in various assurance roles from January 2013 through March 2021 where she primarily served publicly traded companies. Mrs. Martinez is a Certified Public Accountant in the State of Florida and holds a Master of Science in Accounting from The University of Tampa and a Bachelor of Science in Business Administration, Accounting from the University of Central Florida.

 

Lionel F. Conacher. Mr. Conacher has served as a director since September 2021. He has over thirty years of financial experience, spanning senior positions in public companies in both Canada and the US, investment banking, private equity and venture capital. Mr. Conacher currently serves as Chairman of DXL Group (NASDAQ: DXLG), where he has successfully guided the retail chain through the COVID-19 pandemic. In 2018, Mr. Conacher co-founded a San Francisco based venture capital fund, Next Ventures, after serving as a Senior Advisor and Operating Partner at Altamont Capital Partners, a Palo Alto based Private Equity Firm, for over seven years. Prior to his experience at Altamont Partners, he co-founded and served as the CEO of Westwind Partners Inc., a specialized Canadian institutional investment bank that was ultimately sold to Thomas Weisel Partners for $170 million in 2007 before being acquired by Steifel in 2010. Mr. Conacher holds an A.B. in Economics & Art History from Dartmouth College and is also actively involved in a variety of non-profits.

 

60

 

 

Arlene Dickinson. Ms. Dickinson has served as a director since September 2021. She is a well-known entrepreneur and General Partner of District Ventures Capital, a venture capital fund focused on helping market, fund and grow entrepreneurs and their companies in the food and health space. Dickinson is widely recognized for her role as a Dragon / Venture Capitalist for over 12 seasons on the multi-award-winning CBC television series, Dragons’ Den. Prior to joining the cast of Dragons’ Den, she served as the President and CEO of Venture Communications, a Calgary based agency that became one of Canada’s largest independent marketing firms. She is a three-time best-selling author, podcaster and accomplished public speaker and sits on several public and private boards. Ms. Dickinson has won numerous awards, including Calgary Business Owner of the year, PROFIT Magazine’s Top 100 Women Business Owners and Canada’s Most Powerful Women Top 100. Ms. Dickinson resigned from the Board effective April 1, 2024.

 

Gil Fronzaglia. Mr. Fronzaglia has served as a director since April 2021. He has had a successful career serving as both a board and management team member for large consumer products companies, natural food and beverage startups and most notably as a founding member and VP of Operations for Blue Buffalo. In addition to joining the board of Better Choice in 2021, Gil has served as a Board Member of Quinn Snacks since 2016, where he was the Interim COO from December 2018 through July 2019. Mr. Fronzaglia has also served as a member of the board of Grillo’s Pickles, the premium pet care brand I And Love And You and Spindrift Beverage Co. Mr. Fronzaglia is based in Boulder, Colorado and holds a Bachelor of Science from Northeastern University, and a Masters of Business Administration from Barry University.

 

John M. Word III. Mr. Word has served as a director since January 2020. Mr. Word founded the Word & Brown General Agency in 1984 to market and distribute health plans through California’s huge brokerage community by 1986, the company was recognized as the largest independent small group health distributor in the nation. That same year, the company launched the nation’s first COBRA administration operation, sensing that employers needed assistance and qualified support with federal COBRA laws. CaliforniaChoice®, a groundbreaking enterprise empowering small business employees to select from multiple health plans within one program, was launched in 1996. Mr. Word’s professional credentials include Chartered Life Underwriter (CLU), Registered Health Underwriter (RHU), and Registered Employee Benefits Consultant (REBC). He has served as President of the California Association of Health Underwriters (CAHU), President of the Orange County Association of Health Underwriters (OCAHU), and Chairman of the National Association of Health Underwriters (NAHU) Leading Producers Roundtable program. Mr. Word holds a Bachelor of Science in Marketing and Finance from William Jewell College in Liberty, MO. We believe Mr. Word’s qualifications to serve as a director of our Company include his background in running successful organizations, understanding of consumer needs and marketing to those needs. Mr. Word holds a Bachelor of Science in Marketing and Finance from William Jewel College in Liberty, MO.

 

Michael Young. Mr. Young has served as our Chairman since December 2019. Mr. Young is a founding partner of Cottingham Capital, an investment company focused on real estate and technology investment, where he has served as Managing Partner since its inception in January 2017. Prior to January 2017, Mr. Young served as the Managing Director and Co-Head of Trading of GMP Securities, L.P., a Canadian investment bank. Mr. Young currently serves on the boards of Aerues Inc., an anti-microbial copper coating technology company, and XIB I Capital Corp., a capital pool company, and was previously on the boards of Nuuvera Corp. and ICC Labs. Mr. Young holds a diploma in Finance from George Brown College. We believe Mr. Young’s qualifications to serve as a director of our Company include his extensive senior level executive management and trading experience in the Canadian and U.S. capital markets and his experience on other public company boards of directors.

 

Board of Directors

 

The number of members of our Board of Directors will be determined from time to time by resolution of the Board of Directors. Currently, our Board of Directors consists of five persons. Our Directors hold office until the earlier of their death, resignation, retirement, disqualification or removal or until their successors have been duly elected and qualified.

 

61

 

 

Committees of the Board

 

We have an Audit Committee, a Compensation Committee, a Nominating and Governance Committee, and a Strategic Advisory Committee. Each such committee of the Board of Directors has or will have the composition and responsibilities described below. Each committee is governed by a written charter. In 2022, each director attended all of the meetings of the Board and the committees on which such director serves. Each committee charter is posted on our website at https://ir.betterchoicecompany.com/corporate-governance. From time to time, our Board may also establish other, special committees when necessary to address specific issues.

 

Audit Committee

 

Our Audit Committee’s responsibilities include, among other matters: appointing, approving the compensation of, and assessing the independence of our registered public accounting firm; overseeing the work of our registered public accounting firm, including through the receipt and consideration of reports from such firm; reviewing and discussing with management and the registered public accounting firm our annual and quarterly financial statements and related disclosures; coordinating our Board of Directors’ oversight of our internal control over financial reporting, disclosure controls and procedures; discussing our risk management policies; meeting independently with our internal auditing staff, if any, registered public accounting firm and management; reviewing and approving or ratifying any related person transactions; and preparing the audit committee report required by the SEC.

 

The members of our Audit Committee are Ms. Dickinson and Messrs. Conacher, Fronzaglia and Young. Mr. Fronzaglia has been appointed as chairperson of this committee beginning in 2022. Our Board has determined that each of Ms. Dickinson and Messrs. Conacher, Fronzaglia and Young is independent under the applicable independence standards of Rule 10A-3 under the Exchange Act applicable to audit committee members. In addition, our Board has determined that Ms. Dickinson and Messrs. Conacher, Fronzaglia and Young each qualifies as an “audit committee financial expert” as defined by Item 407(d)(5)(ii) of Regulation S-K. Our Audit Committee met four times during 2023.

 

Compensation Committee

 

Our Compensation Committee’s responsibilities include, among other matters: reviewing and approving, or recommending for approval by the board of directors, the compensation of our Chief Executive Officer and our other executive officers; overseeing and administering our cash and equity incentive plans; reviewing and making recommendations to our board of directors with respect to director compensation; reviewing and discussing annually with management our “Compensation Discussion and Analysis,” to the extent required; reviewing and discussing the voting recommendations of our stockholders on matters involving executive compensation, to the extent required; and preparing the annual compensation committee report required by SEC rules, to the extent required. No compensation consultant was engaged to provide advice or recommendations on our executive or director compensation for 2022.

 

The members of our Compensation Committee are Ms. Dickinson and Messrs. Conacher, Fronzaglia and Young, and Mr. Young serves as chairman of this committee. Our Compensation Committee met once during 2023.

 

Nominating and Governance Committee

 

Our Nominating and Corporate Governance Committee’s responsibilities include, among other matters: identifying individuals qualified to become board of directors members; recommending to our board of directors the persons to be nominated for election as directors and to each board committee; developing and recommending to our board of directors corporate governance guidelines, and reviewing and recommending to our board of directors proposed changes to our corporate governance guidelines from time to time; and overseeing a periodic evaluation of our board of directors.

 

The members of our Nominating and Corporate Governance Committee are Ms. Dickinson and Messrs. Fronzaglia and Young. Ms. Dickinson was appointed as chairperson of this committee beginning in 2022. Our Nominating and Corporate Governance Committee did not meet during 2023. Mr. Conacher was appointed as the Chairperson of this committee effective April 1, 2024, to fill the vacancy resulting from Ms. Dickinson’s resignation.

 

62

 

 

Strategic Advisory Committee

 

Our Strategic Advisory Committee’s responsibilities include, among other matters: assessing the progress and performance of our development programs and projects, and identifying, assessing, implementing, and monitoring corporate opportunities that may offer meaningful strategic or commercial benefit to the Company. The members of our Strategic Advisory Committee are Messrs. Fronzaglia, Young and Word, and Messrs. Young and Word serve as co-chairs of this committee. Our Strategic Advisory Committee did not meet during 2023.

 

Code of Ethics and Code of Conduct

 

Our Board of Directors has adopted a Code of Ethics and Business Conduct that is applicable to all of our employees, executive officers, and directors of the Company (the “Code of Conduct”). The Code of Conduct is available on our website at https://ir.betterchoicecompany.com/corporate-governance/governance-documents. The Nominating and Governance Committee of our Board of Directors is responsible for overseeing the Code of Conduct and must approve any waivers of the Code of Conduct for employees, executive officers, and directors. We expect that any amendments to the Code of Conduct, or any waivers of its requirements, will be disclosed on our website.

 

Risk Oversight

 

The Audit Committee of our Board of Directors is responsible for overseeing our risk management process. Our Audit Committee focuses on our general risk management policies and strategy, the most significant risks facing us, and oversees the implementation of risk mitigation strategies by management. Our Board of Directors is also apprised of particular risk management matters in connection with its general oversight and approval of corporate matters and significant transactions.

 

Compensation Committee Interlocks and Insider Participation

 

None of our executive officers serve as a member of our Board of Directors or the Compensation Committee of our Board of Directors (or other committee performing equivalent functions) of any entity that has one or more executive officers serving on our Board of Directors or Compensation Committee.

 

Communications with Directors

 

Interested parties may communicate with our Board or with an individual director by writing to our Board or to the particular director and mailing the correspondence to: 12400 Race Track Road, Tampa, Florida 33626, Attention: Corporate Secretary. The Corporate Secretary will promptly relay to the addressee all communications that require prompt attention and will regularly provide our Board with a summary of all substantive communications.

 

Board Qualifications

 

Our Board has delegated to our Nominating and Governance Committee the responsibility for recommending to our Board the nominees for election as directors at the annual meeting of stockholders and for recommending persons to fill any vacancy on our Board. Our Nominating and Governance Committee selects individuals for nomination to our Board based on the following criteria. Nominees for director must:

 

  ● Possess unquestionable moral and ethical character and core values.
  ● Have a genuine interest in Better Choice and recognition that as a member of our Board, each director is accountable to all of our shareholders, not to any particular interest group.
  ● Have a background that demonstrates experience, expertise and education in areas such as consumer product marketing, corporate strategy, technology, cybersecurity, financial and regulatory affairs, international sales and distribution and general management.
  ● Have no conflict of interest or legal impediment that would interfere with the duty of loyalty owed to Better Choice and our stockholders.
  ● Have the ability and willingness to make the personal commitment to invest the time, schedule and workload to be an active, participatory member of our Board and the Board’s responsibilities and commitment to corporate best practices.
  ● Be compatible and able to work well with other directors, executives and other employees in a team effort with a view to a long-term relationship with Better Choice as a director.
  ● Have independent opinions and be willing to state them in a constructive manner.

 

Directors are selected on the basis of talent and experience. Diversity of background, including diversity of gender, race, ethnic or geographic origin and age, and education and experience in business, the consumer product market, the pet specialty sector, product marketing, product distribution and manufacturing and other areas relevant to our activities are factors in the selection process. As a majority of our Board must consist of individuals who are independent, a nominee’s ability to meet the independence criteria established by the NYSE American is also a factor in the nominee selection process. For a better understanding of the qualifications of each of our directors, we encourage you to read their biographies set forth in this report.

 

Director Nominations

 

The Nominating and Governance Committee will consider candidates for director recommended by stockholders so long as the recommendations comply with our Certificate of Incorporation and Bylaws and applicable laws, rules and regulations, including those promulgated by the SEC. The Nominating and Governance Committee will evaluate such recommendations in accordance with its charter, our Bylaws, our corporate governance guidelines, and the regular nominee criteria described above.

 

Attendance at Annual Meeting

 

Directors are expected to attend our annual meetings of stockholders. Our last annual meeting of shareholders was held on November 13, 2023.

 

63

 

 

ITEM 11.EXECUTIVE COMPENSATION

 

The following is a discussion and analysis of the compensation arrangements for our named executive officers, or NEOs. We are currently considered a “smaller reporting company” for purposes of the SEC’s executive compensation disclosure rules. In accordance with such rules, we are providing a Summary Compensation Table and an Outstanding Equity Awards at Fiscal Year-End Table as well as narrative disclosures regarding our executive compensation program. Our NEOs for 2023 consist of the following individuals:

 

  ● Kent Cunningham, Chief Executive Officer appointed May 2023
  ● Lionel F. Conacher, our former interim Chief Executive Officer, who resigned in May 2023;
  ● Carolina Martinez, Chief Financial Officer appointed August 2023
  ● Sharla A. Cook, our former Chief Financial Officer, who resigned in April 2023;
  ● Donald Young, our former Chief Sales Officer, who resigned in September 2023; and
  ● Robert Sauermann, our former Executive Vice President, Strategy, who resigned in March 2023.

 

Executive Compensation Components

 

Base Salaries

 

The NEOs receive a base salary to provide a fixed component of compensation reflecting the executive’s skill set, experience, role and responsibilities. Our Compensation Committee adjusts NEO base salaries based on the committee’s review of available market information. Our board of directors established an annual base salary for each of our NEOs as follows:

 

   Annual Base Salary 
Name  2021   2022   2023 
Kent Cunningham(1)   n/a    n/a    350,000 
Lionel F. Conacher   n/a    160,000    160,000 
Carolina Martinez(2)   n/a    n/a    240,000 
Sharla A. Cook   200,000    225,000    n/a 
Donald Young   250,000    275,000    275,000 
Robert Sauermann   225,000    240,000    240,000 

 

(1) Mr. Cunningham was appointed as Chief Executive Officer of the Company effective as of May 22, 2023.

(2) Mrs. Martinez was appointed as Chief Financial Officer of the Company effective as of August 2, 2023. Mrs. Martinez was previously appointed and served as the Interim Chief Financial Officer of the Company effective as of April 3, 2023.

 

Annual Incentive

 

The purpose of our annual incentive bonus program is to incent all individuals in the organization to meet or exceed both our annual budget goals as well as individual responsibilities. Our annual incentive program requires minimum performance thresholds for any payout to occur for specific performance measures and objectives. We believe the annual incentive effectively motivates our NEOs to drive operational performance without encouraging unreasonable risk. The Committee believes the achievement of year-over-year gross revenue, gross margin and Adjusted EBITDA growth goals will result in sustainable long-term stockholder value creation. Our 2023 annual incentive potential was based on achievement levels of these financial metrics, measured against our annual plan as approved by our Board. Overall, the NEOs’ annual incentive bonus was weighted as follows: 50% Gross Revenue and Adjusted EBITDA, and 50% individual performance and achievement of goals. The CEO was eligible for a payout of 50% of base salary while the other NEOs were eligible for a payout ranging from 25-40% of base salary based on these metrics.

 

64

 

 

Equity Compensation

 

The goals of our long-term, equity-based incentive awards are to align the interests of our NEOs and other employees, non-employee directors and consultants with the interests of our stockholders. Because vesting is based on continued employment, our equity-based incentives also encourage the retention of our NEOs through the vesting period of the awards.

 

To reward and retain our NEOs in a manner that best aligns employees’ interests with stockholders’ interests, we use stock options as the primary incentive vehicles for long-term compensation. We believe that stock options are an effective tool for meeting our compensation goal of increasing long-term stockholder value by tying the value of the stock options to our future performance. The exercise price of each stock option grant is the fair market value of our common stock on the grant date.

 

Repricing of Stock Options

 

Effective October 1, 2020, all outstanding stock option awards under the Amended and Restated 2019 Equity Incentive Plan held by current employees as of October 1, 2020 were repriced concurrent with the closing of the Company’s Series F Private Placement. In total, 1,012,956 stock options were repriced. The exercise price was set at a 20% premium to the Series F conversion price, or $3.60 per share. No other terms of the stock options were changed.

 

The board of directors effectuated the repricing to realign the value of the stock options with their intended purpose, which is to retain and motivate the holders of the stock options to continue to work in the best interests of the Company. Prior to the repricing, many of the stock options had exercise prices well above the then recent market prices of our common stock. The stock options were repriced unilaterally and the consent of holders was neither necessary nor obtained.

 

Other Elements of Compensation

 

Retirement Plans. We currently maintain a 401(k) retirement savings plan that allows eligible employees to contribute a portion of their compensation, within limits prescribed by the Internal Revenue Code, on a pre-tax basis through contributions to the plan. Our NEOs are eligible to participate in the 401(k) plan. We believe that providing a vehicle for tax-deferred retirement savings through our 401(k) plan adds to the overall desirability of our executive compensation package and further incentivizes our NEOs in accordance with our compensation policies. During 2020, the Company had a separate 401(k) plans for TruPet and Halo and provided an employer matching contribution under each plan. Beginning in 2021, the Company provided an employer matching contribution of 50% up to 5% of compensation under our 401(k) plan.

 

Employee Benefits and Perquisites. All of our full-time employees, including our NEOs, are eligible to participate in our employee benefit plans and programs, including medical, dental, and vision benefits, health spending accounts, short and long-term disability and life insurance, to the same extent as our other full-time employees, subject to the terms and eligibility requirements of those plans.

 

Termination and Change in Control Benefits. Our NEOs may become entitled to certain benefits or enhanced benefits in connection with certain qualifying terminations of employment and/or a change in control of our Company. Each of our NEOs’ employment agreements entitles them to severance in the event of their termination without cause or their resignation for good reason and upon termination by reason of death or disability.

 

65

 

 

Summary Compensation Table

 

The table below sets forth the compensation earned by our NEOs for the years ended December 31, 2023, 2022 and 2021.

 

Name and Principal Position  Year   Salary
($)		   Bonus
($)		   Stock Awards
($)		   Option Awards (1)
($)		   Non-Equity Incentive Plan Compensation
($)		   All Other Compensation (2) ($)   Total
($)		 
Kent Cunningham (3)   2023    350,000    53,459    362,727    —    —    8,785    774,971 
Chief Executive Officer   2022    —    —    —    —    —    —    — 
    2021    —    —    —    —    —    —    — 
Lionel F. Conacher (4)   2023    160,000    —    13,334    —    —    —    173,334 
Interim Chief Executive Officer   2022    160,000    —    153,336    18,573    —    —    331,909 
    2021    —    —    —    —    —    —    — 
Carolina Martinez (5)   2023    240,000    19,200    —    70,000    —    1,106    330,306 
Chief Financial Officer   2022    —    —    —    —    —    —    — 
    2021    —    —    —    —    —    —    — 
Sharla A. Cook (6)   2023    250,000    —    28,000    —    —    3,206    281,206 
Chief Financial Officer   2022    250,000    100,000    —    153,596    —    9,801    513,397 
    2021    200,000    34,375    —    317,701    —    9,942    562,018 
Donald Young (7)   2023    275,000    —    14,000    —    —    43,744    332,744 
Chief Sales Officer   2022    275,000    110,000    —    492,174    —    9,425    886,599 
    2021    250,000    42,969    —    991,704    —    8,694    1,293,367 
Robert Sauermann (8)   2023    240,000    —    28,000    —    —    1,811    269,811 
Executive Vice President, Strategy   2022    240,000    96,000    —    367,435    —    10,250    713,685 
    2021    225,000    38,672    —    590,701    —    6,794    861,167 

 

(1) The amounts reported reflect the grant date fair value of the stock options granted, as computed in accordance with ASC 718. The fair value of each option grant is estimated based on the fair market value on the date of grant using the Black-Scholes option pricing model. The assumptions that we used to calculate these amounts are discussed in Note 12 to our financial statements included in this Annual Report.

(2) The amounts reported reflect matching 401(k) payments and accrued PTO payout.

(3) Mr. Cunningham commenced employment with us and was appointed Chief Executive Officer effective as of May 22, 2023.

(4) Mr. Conacher was employed with us as interim Chief Financial Officer from September 14, 2022 until May 22, 2023.

(5) Mrs. Martinez was appointed as Chief Financial Officer effective as of August 2, 2023. Mrs. Martinez was previously appointed and served as the Interim Chief Financial Officer of the Company effective as of April 3, 2023.

(6) Ms. Cook commenced employment with us in April 2020 and was appointed as our Chief Financial Officer in October 2020. Ms. Cook resigned effective as of April 3, 2023.

(7) Mr. Young resigned effective as of September 8, 2023.

(8) Mr. Sauermann resigned effective as of March 17, 2023.

 

66

 

 

Outstanding Equity Awards at Fiscal Year-End

 

The table below sets forth the outstanding stock option awards held by the NEOs as of December 31, 2023. None of our NEOs hold stock awards.

 

   Option Awards
Name  Option Award Grant     Number of Securities Underlying Unexercised Options (#) Exercisable   Number of Securities Underlying Unexercised Options (#) Unexercisable   Option Exercise Price ($)   Option Expiration Date
Kent Cunningham  N/A      —    —   $—   N/A
Lionel F. Conacher  9/28/2021      256    358   $90.64   9/28/2031
Carolina Martinez  8/7/2023      —    4,545   $15.40    
Sharla A. Cook  2/1/2022  (1)   —    1,136   $62.00   2/1/2032
   8/19/2021  (1)   152    189   $73.92   8/19/2031
   7/8/2021  (1)   358    400   $100.32   7/8/2031
   3/3/2021  (2)   222    159   $240.24   3/3/2031
   3/3/2021  (2)   109    78   $240.24   3/3/2031
   1/8/2021  (1)   242    137   $211.20   1/8/2031
Donald Young  2/1/2022  (1)   —    1,705   $62.04   2/1/2032
   8/19/2021  (1)   152    189   $73.92   8/19/2031
   7/8/2021  (1)   358    400   $100.32   7/8/2031
   3/3/2021  (2)   401    286   $240.24   3/3/2031
   3/3/2021  (2)   814    582   $240.24   3/3/2031
   1/1/2021  (1)   1,894    —   $—   1/1/2031
Robert Sauermann  2/1/2022  (1)   —    1,136   $62.04   2/1/2032
   8/19/2021  (1)   152    189   $73.92   8/19/2031
   7/8/2021  (1)   358    400   $100.32   7/8/2031
   3/3/2021  (2)   328    234   $240.24   3/3/2031
   3/3/2021  (2)   666    476   $240.24   3/3/2031
   1/8/2021  (1)   242    137   $211.20   1/8/2031

 

(1) Options vest as follows: 1/3rd on the first annual anniversary of the grant date and 1/36th on each monthly anniversary thereafter.

(2) 67% of the options shall vest as to 1/3rd on the first annual anniversary of the grant date and 1/36th on each monthly anniversary thereafter, and 33% of the options shall vest as to 1/3rd on the 18 month anniversary of the grant date and 1/36th on each monthly anniversary thereafter.

 

67

 

 

Employment Agreements and Potential Payments Upon Termination

 

The Company entered into an Employment Agreement with Kent Cunningham, dated as of May 22, 2023 (the “Cunningham Employment Agreement”) in connection with Mr. Cunningham’s appointment as Chief Executive Officer of the Company as of May 22, 2023. Pursuant to the Cunningham Employment Agreement, Mr. Cunningham’s compensation will be an initial annual base salary of $350,000 and an annual discretionary performance bonus target of 50% of base salary, payable 50% in cash and 50% in shares of common stock of the Company. Pursuant to the Cunningham Employment Agreement, Mr. Cunningham will be entitled to six weeks’ paid vacation and will be eligible to participate in certain employee benefit plans offered by the Company. Further, Mr. Cunningham will receive an initial grant of 1,000,000 Restricted Stock Units of Common Stock (“RSUs”), subject to Board approval. The RSUs will vest over a period of three years subject to continued employment with the Company as follows: (a) 33.3% of the options will on the first anniversary of the date of the grant date provided the stock price is at least one dollar ($1.00); (b) an additional 33.3% of such RSUs shall vest on the second anniversary of the grant date provided the stock price is at least two dollars ($2.00); and (c) the remaining 33.4% of the RSUs shall vest on the third anniversary of the grant date provided that the stock price on such date is at least two dollars and fifty cents ($2.50). In the event Mr. Cunningham does not meet the time-based and performance-based vesting requirements, the applicable portion of the RSUs that were due to vest shall be forfeited. Should Mr. Cunningham’s employment be terminated, in any way or for any reason, prior to any of the aforementioned anniversary dates, the RSUs shall vest in proportion to the time remaining to the next anniversary date.

 

The Company entered into an Employment Agreement with Carolina Martinez, dated as of August 2, 2023 (the “Martinez Employment Agreement”) in connection with Mrs. Martinez’s appointment as Chief Financial Officer of the Company as of August 2, 2023. Pursuant to the Martinez Employment Agreement, Mrs. Martinez’s compensation will be an initial annual base salary of $240,000 and an annual discretionary performance bonus target of 40% of base salary, payable 50% in cash and 50% in shares of common stock of the Company. Pursuant to the Martinez Employment Agreement, Mrs. Martinez will be entitled to six weeks’ paid vacation and will be eligible to participate in certain employee benefit plans offered by the Company. Further, Mrs. Martinez will receive an initial grant to purchase 200,000 shares of Common Stock at an exercise price of $0.35 per share, subject to Board approval. The options will vest in equal installments over a period of three years.

 

Pursuant to the Cunningham Employment Agreement and the Martinez Employment Agreement (together, the NEO Employment Agreements”), each of Mr. Cunningham and Mrs. Martinez is employed on an at-will basis. Pursuant to the NEO Employment Agreements, in the event the executive’s employment is terminated for any reason, the Company shall pay the executive any amounts due to such executive under the Company’s benefit plans and any unreimbursed expenses properly incurred prior to the date of termination (the “Accrued Obligations”). In the event the executive’s employment is terminated for by the Company without Cause (as defined in the NEO Employment Agreements) or by the executive for Good Reason or for Good Reason Upon Change in Control (as such terms are defined in the NEO Employment Agreements), in addition to the Accrued Obligations, the executive shall also receive, subject to the execution of a release of claims in the form delivered by the Company, severance pay in an amount equal to the executive’s base salary then in effect for six (6) months, less applicable payroll deductions and tax withholdings, payable in accordance with normal payroll policies of the Company over a six (6) month period, with the first such payment being paid to the executive on the Company’s first regular pay date on or after the sixtieth (60th) day following the executive’s employment termination date.

 

The NEO Employment Agreements also contain standard confidentiality, intellectual property assignment, non-competition and non-solicitation covenants.

 

68

 

 

ITEM 12.SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

The following table sets forth information about the beneficial ownership of our capital stock by (i) each of our current directors, (ii) each of our named executive officers (iii) all our current directors and executive officers as a group, and (iv) each person or group known by us to own more than 5% of our common stock. The percentages reflect beneficial ownership, as determined in accordance with the SEC’s rules, as of April 11, 2024, and are based on 893,601 shares of common stock outstanding. Except as noted below, the address for all beneficial owners in the table below is 12400 Race Track Road, Tampa, FL 33626:

 

   Shares Beneficially Owned 
Name of Beneficial Owner  Number(1)   % 
Named Executive Officers and Directors:          
Kent Cunningham   7,576    * 
Carolina Martinez   —    * 
Sharla A. Cook   4,163    * 
Donald Young   20,476    2.49%
Robert Sauermann   9,702    1.18%
Lionel F. Conacher   32,845    3.99%
Arlene Dickinson   14,083    1.71%
Gil Fronzaglia   14,340    1.74%
John M. Word III   149,386    18.14%
Michael Young   52,865    6.42%
All executive officers and directors as a group (10 persons)   305,436    37.08%
           
5% Shareholders:          
HH-Halo LP (12)   54,719    7.51%
Edward J. Brown Jr TTEE   52,496    7.20%

 

(*) Represents beneficial ownership of less than 1% of class.

(1) In calculating the number of shares beneficially owned by an individual or entity and the percentage ownership of that individual or entity, shares underlying options, warrants or restricted stock units held by that individual or entity that are either currently exercisable or exercisable within 60 days from the date hereof are deemed outstanding. These shares, however, are not deemed outstanding for the purpose of computing the percentage ownership of any other individual or entity. Unless otherwise indicated and subject to community property laws where applicable, the individuals and entities named in the table above have sole voting and investment power with respect to all shares of our common stock shown as beneficially owned by them.

 

ITEM 13.CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

Related Party Transaction Policy

 

A “Related Party Transaction” is a transaction, arrangement or relationship in which we or any of our subsidiaries was, is or will be a participant, the amount of which involved exceeds $50,000 in any one fiscal year, and in which any related person had, has or will have a direct or indirect material interest. A “Related Person” means:

 

  ● any person who is, or at any time during the applicable period was, one of our executive officers, one of our directors, or a nominee to become one of our directors;
  ● any person who is known by us to be the beneficial owner of more than 5.0% of any class of our voting securities;
  ● any immediate family member of any of the foregoing persons, which means any child, stepchild, parent, stepparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law or sister-in-law of a director, executive officer or a beneficial owner of more than 5.0% of any class of our voting securities, and any person (other than a tenant or employee) sharing the household of such director, executive officer or beneficial owner of more than 5.0% of any class of our voting securities; and
  ● any firm, corporation or other entity in which any of the foregoing persons is employed or is a general partner or principal or in a similar position or in which such person has a 5.0% or greater beneficial ownership interest in any class of the Company’s voting securities.

 

69

 

 

Our Related Party Transaction policy subjects these transactions to review and either approval or disapproval of entry into the Related Party Transaction, subject to certain limited exceptions, by our Nominating and Governance Committee. In determining whether to approve or disapprove entry into a Related Party Transaction, our Nominating and Governance Committee shall take into account, among other factors, the following: (i) whether the Related Party Transaction is on terms no less favorable than terms generally available to an unaffiliated third-party under the same or similar circumstances and (ii) the extent of the Related Person’s interest in the transaction. Further, the policy requires that all Related Party Transactions required to be disclosed in our filings with the SEC be so disclosed in accordance with applicable laws, rules and regulations. Refer to Note 14 within this report.

 

Family Relationships

 

There are no family relationships amongst any of our executive officers or directors.

 

Director Independence

 

Each of our directors standing for election meets the definition of “independence” per Rule 803 of the NYSE American Company Guide.

 

ITEM 14.PRINCIPAL ACCOUNTING FEES AND SERVICES

 

The following table shows the fees paid or accrued for the audit and other services provided by BDO USA, P.C., our independent auditors for the fiscal years ended December 31, 2023 and 2022:

 

   Year ended December 31, 
   2023   2022 
Audit fees   562    483 
Tax fees   25    63 
Total   587    546 

 

(1) Audit fees consist of fees billed for services rendered for the audit of our financial statements included in our annual reports on Form 10-K and review of our financial statements included in our quarterly reports on Form 10–Q, and other fees, including fees related to our registration statements.

(2) Tax fees consist of fees billed for professional services related to the preparation of our U.S. federal and state income tax returns and tax advice.

 

70

 

 

PART IV

 

ITEM 15.EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

The following documents are filed as part of this report:

 

(1) Financial Statements - See Index to Consolidated Financial Statements appearing on page 35.
(2) Financial Statement Schedules - None.
(3) Exhibits - The exhibits listed on the accompanying index are filed as part of, or incorporated by reference into, this Annual Report on Form 10-K.

 

EXHIBIT INDEX

 

Exhibit   Exhibit Description   Form   File No.   Exhibit   Filing date
2.1   Agreement and Plan of Merger, dated February 28, 2019, by and among the Company, BBC Merger Sub, Inc. and Bona Vida, Inc.   8-K   333-161943   2.1   05/10/2019
2.2   First Amendment to Agreement and Plan of Merger, dated February 28, 2019, by and among the Company, BBC Merger Sub, Inc., and Bona Vida, Inc., dated May 3, 2019   8-K   333-161943   2.2   05/10/2019
2.3   Securities Exchange Agreement, dated February 2, 2019, by and among the Company, TruPet LLC and the members of TruPet LLC   8-K   333-161943   2.3   05/10/2019
2.4   First Amendment to Securities Exchange Agreement, dated February 2, 2019, by and among the Company, TruPet LLC and the members of TruPet LLC, dated May 6, 2019   8-K   333-161943   2.4   05/10/2019
2.5   Amended and Restated Stock Purchase Agreement, dated December 18, 2019, by and among the Company, Halo, Purely For Pets, Inc., Thriving Paws, LLC and HH-Halo LP   8-K   333-161943   2.1   12/26/2019
2.6   Agreement and Plan of Merger, dated July 28, 2022, by and among TruPet LLC and Halo, Purely for Pets, Inc.   10-Q   001-40477   2.6   08/11/2022
3.1   Certificate of Incorporation, dated January 1, 2019   10-Q   333-161943   3.1   04/15/2019
3.2   Certificate of Amendment to Certificate of Incorporation, dated February 1, 2019   10-Q   333-161943   3.2   04/15/2019
3.3   Certificate of Amendment to Certificate of Incorporation, dated March 13, 2019   8-K   333-161943   3.1   03/20/2019
3.4   Certificate of Amendment to Certificate of Incorporation, dated April 18, 2019   10-KT   333-161943   3.5   07/25/2019
3.5   Certificate of Amendment to Certificate of Incorporation, dated July 30, 2020   8-K   333-161943   99.1   07/30/2020
3.6   Certificate of Merger of Sport Endurance, Inc. with and into the Company   10-Q   333-161943   3.4   04/15/2019
3.7   Bylaws   10-Q   333-161943   3.5   04/15/2019
3.8   Certificate of Designation for Series F Convertible Preferred Stock   8-K   333-161943   3.1   10/02/2020
3.9   Certificate of Cancellation of Series F Preferred Stock of Better Choice   8-K   001-40477   3.10   07/29/2022
3.10   Certificate of Merger of TruPet LLC with and into Halo, Purely for Pets, Inc.   10-Q   001-40477   3.10   08/11/2022
4.1   Form of Warrant in connection with the November 2019 private placement   8-K   333-161943   4.2   11/15/2019
4.2   Form of Subscription Agreement, dated December 19, 2019, by and among the Company and the Halo Sellers   10-Q   333-161943   10.6   01/31/2020
4.3   Form of Warrant, dated December 19, 2019, by and among the Company and the Halo Sellers   10-Q   333-161943   4.8   01/31/2020
4.4   Form of Warrant, dated December 19, 2019, by and among the Company and the Shareholder Personal Guarantors   10-Q   333-161943   4.10   01/31/2020
4.5   Form of Subscription Agreement dated April 25, 2019 in connection with the May 2019 private placement   8-K   333-161943   10.1   04/30/2019
4.6   Form of Subscription Agreement in connection with the November 2019 private placement   8-K   333-161943   10.1   11/15/2019

 

71

 

 

Exhibit   Exhibit Description   Form   File No.   Exhibit   Filing date
4.7†   Better Choice Company Inc. Amended and Restated 2019 Incentive Award Plan   10-K   333-161943   10.19   05/04/2020
4.8†   Form of 2019 Incentive Award Plan Stock Option Agreement   S-1   333-234349   10.7   10/28/2019
4.9   Form of Common Stock Purchase Warrant in connection with the June 2020 private placement.   10-Q   333-161943   4.11   06/25/2020
4.10   Form of Subscription Agreement in connection with the June 2020 private placement.   10-Q   333-161943   4.13   06/25/2020
4.11   Form of July 2020 Warrants   8-K   333-161943   10.5   07/21/2020
4.12   Form of Warrant in connection with the October 2020 Series F Private Placement   8-K   333-161943   4.1   10/02/2020
4.13   Form of Securities Purchase Agreement in connection with the October 2020 Series F Private Placement   8-K   333-161943   10.1   10/02/2020
4.14   Form of warrant in connection with the January 2021 Private Placement   S-1/A   333-251241   4.22   02/16/2021
4.15   Form of Securities Purchase Agreement in connection with the January 2021 Private Placement   S-1/A   333-251241   4.23   02/16/2021
10.1†   Form of Indemnification Agreement by and among the Company and its officers and directors   S-1   333-234349   10.8   10/28/2019
10.2†   Employment Agreement, Dated December 28, 2020 by and between Scott Lerner and the Company   8-K/A   333-161943   10.2   01/05/2021
10.3†   Employment Agreement, dated October 8, 2020, by and between Sharla Cook and the Company   10-K   333-161943   10.12   03/30/2021
10.4†   Employment Agreement, dated September 27, 2020, by and between Robert Sauermann and the Company   10-K   333-161943   10.13   03/30/2021
10.5†   Employment Agreement, dated January 1, 2021, by and between Donald Young and the Company   10-K   333-161943   10.14   03/30/2021
10.6   Loan and Security Agreement, dated as of January 6, 2021, by and between Old Plank Trail Community Bank, N.A. (“Lender”) and Halo, Purely for Pets, Inc., a Delaware corporation (“Halo”)   8-K   333-161943   10.1   01/11/2021
10.7   Term Note A, dated as of January 6, 2021, issued by Halo in favor of Lender   8-K   333-161943   10.3   01/11/2021
10.8   Guaranty and Security Agreement, dated as of January 6, 2021, made by Better Choice Company Inc. , TruPet LLC, and Bona Vida, Inc., a Delaware corporation   8-K   333-161943   10.4   01/11/2021
10.9   Intellectual Property Security Agreement, dated as of January 6, 2021, executed and delivered by the Company, TruPet and Bona Vida   8-K   333-161943   10.5   01/11/2021
10.10   Stock Pledge Agreement, dated as of January 6, 2021, executed and delivered by the Company in favor of Lender   8-K   333-161943   10.6   01/11/2021
10.11   First Amendment to Loan and Security Agreement, dated as of August 13, 2021, by and between Old Plank Trail Community Bank, N.A. (“Lender”) and Halo, Purely for Pets, Inc.   8-K   001-40477   10.1   08/17/2021
10.12   Revolving Promissory Note, dated as of August 13, 2021, issued by Halo Purely for Pets, Inc.   8-K   001-40477   10.2   08/17/2021
10.13   Deposit Account Pledge Agreement, dated as of August 13, 2021, executed and delivered by Halo Purely for Pets Inc.   8-K   001-40477   10.3   08/17/2021
10.14   Second Amendment to Loan and Security Agreement, dated March 25, 2022, by and between Old Plank Trail Community Bank, N.A. and Halo, Purely for Pets, Inc.   10-K   001-40477   10.14   03/29/2022
10.15   Third Amendment to Loan and Security Agreement, dated October 24, 2022, by and between Old Plank Trail Community Bank, N.A. and Halo, Purely for Pets, Inc.   8-K   001-40477   10.1   10/25/2022
10.16   Revolving Promissory Note, dated as of October 24, 2022, issued by Halo in favor of Lender   8-K   001-40477   10.2   10/25/2022

 

72

 

 

Exhibit   Exhibit Description   Form   File No.   Exhibit   Filing date
10.17   First Amendment to Deposit Account Pledge Agreement, dated as of October 24, 2022, executed and delivered by Halo in favor of Lender.   8-K   001-40477   10.3   10/25/2022
10.18 †#   Separation Agreement, dated as of September 14, 2022, by and between the Company and Scott Lerner   10-Q   001-40477   10.18   11/10/2022
10.19 †#   Advisory Consulting Agreement, dated as of November 2, 2022, by and between the Company and Lionel F. Conacher   10-Q   001-40477   10.19   11/10/2022
10.20 †   Engagement Agreement, dated as of March 13, 2023, by and between ONE10 Advisors, LLC and Better Choice Company Inc.   8-K   001-40477   10.1   03/21/2023
10.21 †   Interim Officer Agreement, dated as of March 20, 2023, by and between Carolina Martinez and Better Choice Company, Inc.   8-K   001-40477   10.2   03/21/2023
10.22 †   Employment Agreement, dated as of May 22, 2023, by and between Kent Cunningham and Better Choice Company, Inc.   8-K   001-40477   10.2   05/16/2023
10.23 †   Term Loan Credit Agreement, dated as of June 21, 2023, by and between Better Choice Company Inc. and Alphia Inc.   8-K   001-40477   10.1   06/21/2023
10.24 †   Account Purchase Agreement, dated as of June 21, 2023, by and between Wintrust Receivables Finance, a division of Wintrust Bank N.A., and Halo, Purely for Pets, Inc.   8-K   001-40477   10.9   06/21/2023
10.25   Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing   8-K   001-40477   99.1   09/27/2023
10.26   Better Choice Acquires Aimia Pet Healthco to Enter the GLP1 Pet Market   8-K   001-40477   99.1   02/12/2024
10.27   Better Choice Company to Effectuate a 1 for 44 Reverse Stock Split   8-K   001-40477   99.1   03/14/2024
21.1 *   Subsidiaries of the Company   10-K   001-40477   21.1   03/28/2023
23.1 *   Consent of BDO USA, P.C.                
24.1 *   Power of Attorney (included on the signature page to this report)                
31.1 *   Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                
31.2 *   Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                
32.1 *   Certifications of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002                
101 *   The following materials from the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 formatted in Inline Extensible Business Reporting Language (“iXBRL”): (i) the Consolidated Statements of Operations, (ii) the Consolidated Balance Sheets, (iii) the Consolidated Statements of Stockholders’ Equity, (iv) the Consolidated Statements of Cash Flows and (v) related notes, tagged as blocks of text and including detailed tags.                
104 *   Cover page from the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, formatted in iXBRL (included as Exhibit 101).                

 

† Indicates a management contract or any compensatory plan, contract or arrangement.
   
* Filed or furnished herewith.
   
# Certain schedules and similar attachments to this agreement have been omitted in accordance with Item 601(b)(5) of Regulation S-K. The Company will furnish copies of any schedules or similar attachments to the SEC upon request.
   
*** Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.

 

ITEM 16.FORM 10-K SUMMARY

 

None.

 

73

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  BETTER CHOICE COMPANY INC.
   
Date: April 12, 2024 By: /S/ KENT CUNNINGHAM
    Kent Cunningham
    Chief Executive Officer
    (Principal Executive Officer)
     
Date: April 12, 2024 By: /S/ CAROLINA MARTINEZ
    Carolina Martinez
    Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

POWER OF ATTORNEY

 

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Sharla A. Cook his/her true and lawful attorney-in-fact, with full power of substitution and resubstitution for him/her and in his/her name, place and stead, in any and all capacities to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact or his/her substitute, each acting alone, may lawfully do or cause to be done by virtue thereof.

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

 

Signature   Title   Date
         
/S/ KENT CUNNINGHAM   Chief Executive Officer   April 12, 2024
Kent Cunningham   (Principal Executive Officer)    
         
/S/ CAROLINA MARTINEZ   Chief Financial Officer   April 12, 2024
Carolina Martinez   (Principal Financial and Accounting Officer)    
         
/S/ LIONEL F. CONACHER   Director   April 12, 2024
Lionel F. Conacher        
         
/s/ GIL FRONZAGLIA   Director   April 12, 2024
Gil Fronzaglia        
         
/s/ JOHN M. WORD III   Director   April 12, 2024
John M. Word III        
         
/s/ MICHAEL YOUNG   Director   April 12, 2024
Michael Young        

 

74

 

 EX-23.1 2 ex23-1.htm

 

Exhibit 23.1

 

 

 

 EX-31.1 3 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13a-14(a) /

RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Kent Cunningham, certify that:

 

1.I have reviewed this Annual Report on Form 10-K for the fiscal year ended December 31, 2023 of Better Choice Company Inc.;
   
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

  Date: April 12, 2024
   
/s/ KENT CUNNINGHAM  
Kent Cunningham  
Chief Executive Officer  
(Principal Executive Officer)  

 

 

 

 EX-31.2 4 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13a-14(a) /

RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Carolina Martinez, certify that:

 

1.I have reviewed this Annual Report on Form 10-K for the fiscal year ended December 31, 2023 of Better Choice Company Inc.;
   
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

  Dated: April 12, 2024
   
/s/ CAROLINA MARTINEZ  
Carolina Martinez  
Chief Financial Officer  
(Principal Financial and Accounting Officer)  

 

 

 

 EX-32.1 5 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with this Annual Report on Form 10-K of Better Choice Company Inc. (the “Company”) for the fiscal year ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned hereby certifies, pursuant to 18 U.S.C. (section) 1350, as adopted pursuant to (section) 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

 

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
   
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

  Dated: April 12, 2024
   
/s/ KENT CUNNINGHAM  
Kent Cunningham  
Chief Executive Officer  
(Principal Executive Officer)  
   
/s/ CAROLINA MARTINEZ  
Carolina Martinez  
Chief Financial Officer  
(Principal Financial Officer)  

 

 

 

 GRAPHIC 6 form10-k_001.jpg begin 644 form10-k_001.jpg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end GRAPHIC 7 ex23-1_001.jpg begin 644 ex23-1_001.jpg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end EX-101.SCH 8 bttr-20231231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Nature of business and summary of significant accounting policies link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Prepaid expenses and other current assets link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Fixed assets link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Goodwill and intangible assets link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Accrued and other liabilities link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Commitments and contingencies link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Share-based compensation link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Employee benefit plans link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Related party transactions link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Income taxes link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Concentrations link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Loss per share link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Subsequent events link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Nature of business and summary of significant accounting policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Prepaid expenses and other current assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Fixed assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Goodwill and intangible assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Accrued and other liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Share-based compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Income taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Loss per share (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Nature of business and summary of significant accounting policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Schedule of Information about Revenue Channels (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Schedule of Information about Revenue Channels (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Revenue (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Schedule of Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Schedule of Prepaid Expenses and Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Schedule of Prepaid Expenses and Other Current Assets (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Schedule of Fixed Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Fixed assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Schedule of goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Schedule of Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Goodwill and intangible assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Schedule of Accrued and Other Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Schedule of Components of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Schedule of Components of Debt (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Schedule of Future Debt Maturities (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Debt (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Schedule of Carrying Amount and Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Commitments and contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - Schedule of Outstanding Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - Schedule of Significant Inputs to Warrants Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - Schedule of Warrant Liability Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - Warrants (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - Schedule of Options Granted and Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - Schedule of Fair Value Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - Share-based compensation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - Employee benefit plans (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - Related party transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - Schedule of Effective Income Tax Rate Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - Schedule of Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - Schedule of Valuation Allowance (Details) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - Income taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - Concentrations (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) link:presentationLink link:calculationLink link:definitionLink 00000072 - Disclosure - Loss per share (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000073 - Disclosure - Subsequent events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 bttr-20231231_cal.xml XBRL CALCULATION FILE EX-101.DEF 10 bttr-20231231_def.xml XBRL DEFINITION FILE EX-101.LAB 11 bttr-20231231_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Sale of Stock [Axis] IPO [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Measurement Input Type [Axis] Measurement Input, EBITDA Multiple [Member] Cash and Cash Equivalents [Axis] Money Market Funds [Member] Product and Service [Axis] Shipping and Handling [Member] Contract with Customer, Sales Channel [Axis] E Commerce [Member] Concentration Risk Benchmark [Axis] Revenue from Contract with Customer Benchmark [Member] Concentration Risk Type [Axis] Sales Channel Concentration Risk [Member] Brick And Mortar [Member] Direct To Consumer [Member] International [Member] Customer Concentration Risk [Member] Customer [Axis] Two Customers [Member] Customer One [Member] Customer Two [Member] One Customer [Member] Counterparty Name [Axis] I Heart Media [Member] Long-Lived Tangible Asset [Axis] Equipment [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Furniture and Fixtures [Member] Computer Software, Intangible Asset [Member] Computer Equipment [Member] Finite-Lived Intangible Assets by Major Class [Axis] Customer Relationships [Member] Trade Names [Member] Credit Facility [Axis] Term Loan [Member] Line of Credit [Member] Variable Rate [Axis] Fed Funds Effective Rate Overnight Index Swap Rate [Member] Lender Name [Axis] Old Plank Trail Community Bank NA [Member] London Interbank Offered Rate [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Second Amendment [Member] Third Amendment [Member] Debt Instrument [Axis] Wintrust Credit Facility [Member] Wintrust Receivables Credit Facility [Member] Prime Rate [Member] Long-Term Debt, Type [Axis] Alphia Term Loan Facility [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 3 [Member] Measurement Basis [Axis] Reported Value Measurement [Member] Estimate of Fair Value Measurement [Member] Fair Value, Inputs, Level 2 [Member] Class of Warrant or Right [Axis] First Tranche Warrant [Member] Secured Debt [Member] Second Tranche Warrant [Member] Liability Class [Axis] Warrant [Member] Measurement Input, Exercise Price [Member] Measurement Input, Share Price [Member] Measurement Input, Price Volatility [Member] Measurement Input, Expected Term [Member] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Expected Dividend Rate [Member] Plan Name [Axis] 2019 Incentive Award Plan [Member] Award Type [Axis] Share-Based Payment Arrangement, Option [Member] Restricted Stock [Member] Title of Individual [Axis] Board of Directors [Member] Executives and Employees [Member] Two Member of Board of Directors [Member] Related Party, Type [Axis] Director [Member] Legal Entity [Axis] Believeco [Member] Income Tax Authority [Axis] Domestic Tax Authority [Member] Inventories [Member] Supplier Concentration Risk [Member] Two Vendors [Member] Accounts Receivable [Member] Three Customers [Member] Revenue Benchmark [Member] Antidilutive Securities [Axis] Employee Stock [Member] Other Option [Member] Warrant Liabilities [Member] Business Acquisition [Axis] Aimia Pet Healthco, Inc. [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Firm ID Auditor Name Auditor Location Income Statement [Abstract] Net sales Cost of goods sold Gross profit Operating expenses: Selling, general and administrative Impairment of goodwill Impairment of intangible assets Total operating expenses Loss from operations Other expense: Interest expense Change in fair value of warrant liabilities Total other expense Net loss before income taxes Income tax expense (benefit) Net loss available to common stockholders Weighted average number of shares outstanding, basic Weighted average number of shares outstanding, diluted Net loss per share available to common stockholders, basic Net loss per share available to common stockholders, diluted Statement of Financial Position [Abstract] Assets Cash and cash equivalents Restricted cash Accounts receivable, net Inventories, net Prepaid expenses and other current assets Total Current Assets Fixed assets, net Right-of-use assets, operating leases Intangible assets, net Other assets Total Assets Liabilities & Stockholders’ Equity Current Liabilities Accounts payable Accrued and other liabilities Line of credit Term loan, net Operating lease liability Total Current Liabilities Non-current Liabilities Line of credit, net Operating lease liability Total Non-current Liabilities Total Liabilities Stockholders’ Equity Common Stock, $0.001 par value, 200,000,000 shares authorized, 729,026 & 668,869 shares issued and outstanding as of December 31, 2023 and 2022, respectively Additional paid-in capital Accumulated deficit Total Stockholders’ Equity Total Liabilities and Stockholders’ Equity Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Statement [Table] Statement [Line Items] Balance Balance, shares Share-based compensation Share-based compensation, shares Net loss available to common stockholders Reclassification of Alphia Warrants Balance Balance, shares Statement of Cash Flows [Abstract] Cash Flow from Operating Activities: Net loss available to common stockholders Adjustments to reconcile net loss to net cash used in operating activities: Loss of disposal of assets Depreciation and amortization Amortization of debt issuance costs and discounts Goodwill impairment Intangible asset impairment Share-based compensation Change in fair value of warrant liabilities Amortization of prepaid assets Inventory reserve PIK interest expense on term loan Accreted interest expense on term loan Income tax provision Other Changes in operating assets and liabilities: Accounts receivable Inventories Prepaid expenses and other assets Accounts payable Accrued and other liabilities Cash Provided by (Used in) Operating Activities Cash Flow from Investing Activities: Capital expenditures Cash Used in Investing Activities Cash Flow from Financing Activities: Proceeds from short-term financing arrangement Payments on short-term financing arrangement Proceeds from revolving lines of credit Payments on revolving lines of credit Proceeds from line of credit Payments on line of credit Proceeds from term loan Payments on term loans Payment of loan issuance costs Cash (Used in) Provided by Financing Activities Net decrease in cash and cash equivalents and restricted cash Total cash and cash equivalents and restricted cash, beginning of period Total cash and cash equivalents and restricted cash, end of period Supplemental cash flow information Cash paid during the year for: Income taxes Interest Noncash items: Reclassification of warrants to equity Organization, Consolidation and Presentation of Financial Statements [Abstract] Nature of business and summary of significant accounting policies Revenue from Contract with Customer [Abstract] Revenue Inventory Disclosure [Abstract] Inventories Prepaid Expenses And Other Current Assets Prepaid expenses and other current assets Property, Plant and Equipment [Abstract] Fixed assets Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and intangible assets Payables and Accruals [Abstract] Accrued and other liabilities Debt Disclosure [Abstract] Debt Fair Value Disclosures [Abstract] Fair Value Measurements Commitments and Contingencies Disclosure [Abstract] Commitments and contingencies Warrants Warrants Share-Based Payment Arrangement [Abstract] Share-based compensation Retirement Benefits [Abstract] Employee benefit plans Related Party Transactions [Abstract] Related party transactions Income Tax Disclosure [Abstract] Income taxes Risks and Uncertainties [Abstract] Concentrations Earnings Per Share [Abstract] Loss per share Subsequent Events [Abstract] Subsequent events Initial public offering Reverse stock split Basis of presentation Consolidation Use of estimates Going concern considerations Cash and cash equivalents Restricted cash Accounts receivable and allowance for credit losses Inventories Fixed Assets Goodwill Intangible assets Share repurchases Common stock warrants Income taxes Revenue Cost of goods sold Advertising Freight Out Research and development Share-based compensation Operating leases Fair value of financial instruments Basic and diluted (loss) income per share Segment information New Accounting Standards Schedule of Information about Revenue Channels Schedule of Inventories Schedule of Prepaid Expenses and Other Current Assets Schedule of Fixed Assets Schedule of goodwill Schedule of Intangible Assets Schedule of Accrued and Other Liabilities Schedule of Components of Debt Schedule of Future Debt Maturities Schedule of Carrying Amount and Fair Value Schedule of Outstanding Warrants Schedule of Significant Inputs to Warrants Liabilities Schedule of Warrant Liability Activity Schedule of Options Granted and Outstanding Schedule of Fair Value Assumptions Schedule of Effective Income Tax Rate Reconciliation Schedule of Deferred Tax Assets and Liabilities Schedule of Valuation Allowance Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Sale of stock, number of shares issued in transaction Sale of stock, price per share Sale of stock, consideration received on transaction Payments of underwriting discounts and commissions Payments of stock issuance costs Conversion of convertible securities Convertible preferred stock, shares issued upon conversion Stockholders' Equity, Reverse Stock Split Minimum liquidity required Net income Maximum marketing spend ratio Cash Allowance for credit losses Stock repurchase program, authorized amount Stock repurchased, shares Advertising expense Amortization of other deferred charges Cost of revenue Research and development expense Number of operating segments Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Concentration risk, percentage Number of revenue channels Food, treats and supplements Inventory packaging and supplies Total Inventories Inventory reserve Inventories, net Schedule Of Prepaid Expenses And Other Current Assets Prepaid advertising contract with iHeart Prepaid marketing expenses Other prepaid expenses and other current assets Total Prepaid expenses and other current assets Shares issued to third-parties for services Stock issued during period, value, issued for services Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Total fixed assets Estimated useful life Accumulated depreciation Depreciation expense Beginning balance Impairment expense Impairment expense Ending balance Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Gross carrying amount Accumulated amortization Impairment Loss Net carrying amount Estimated useful life Number of reporting units Discount rate Impairment of goodwill Impairment charge Amortization expense Accrued taxes Accrued payroll and benefits Accrued trade promotions and advertising Accrued interest Accrued commissions Deferred revenue Short-term financing Other Total accrued and other liabilities Line of Credit Facility [Table] Line of Credit Facility [Line Items] Line of credit, net Maturity date Line of credit, net Less current portion Total long-term debt Basis spread on variable interest rate Floor interest rate Interest at fixed rate 2024 2025 2026 Total Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Maximum borrowing capacity Debt maturity date Maturity date, description Fixed charge coverage ratio Liquidity required (no less than) Covenant, minimum liquidity required Restricted cash Payments on revolving line of credit Long term debt Debt issuance costs Face amount advance (up to) Eligible customer invoices purchased, maximum Basis spread on variable interest rate Interest rate per annum Initial term of agreement Renewal term of agreement Accounts receivable, net Line of credit Original principal amount Line of credit Payable in kind interest Debt discounts Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Debt Purchase obligation Schedule Of Outstanding Warrants Warrants outstanding, Balance Weighted Average Exercise Price outstanding, Balance Warrants, Issued Weighted Average Exercise Price, Issued Warrants, Exercised Weighted Average Exercise Price, Exercised Warrants, Terminated/Expired Weighted Average Exercise Price, Terminated/Expired Warrants outstanding, Balance Weighted Average Exercise Price outstanding, Balance Class of Warrant or Right [Table] Class of Warrant or Right [Line Items] Warrant liabilities, measurement input Warrant liabilities, time to maturity Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Beginning balance Warrant liabilities issued Reclassification of warrants liabilities to equity Ending balance Warrants outstanding, intrinsic value Number of warrants converted Price per share Warrants expiration Term loan remains outstanding period Warrants liabilities Loss (gain) in change of fair value of warrant liabilities Options Outstanding, Balance Weighted Average Exercise Price, Balance Weighted Average Remaining Contractual Life (Years), Options outstanding Aggregate Intrinsic Value Options, Granted Weighted Average Exercise Price, Granted Options, Forfeited/Expired Weighted Average Exercise Price, Forfeited/Expired Options Outstanding, Balance Weighted Average Exercise Price, Balance Aggregate Intrinsic Value Options, Exercisable Weighted Average Exercise Price, Exercisable Weighted Average Remaining Contractual Life (Years), Options exercisable Aggregate Intrinsic Value, Exercisable Options, Fully vested Weighted Average Exercise Price, Fully vested Weighted Average Remaining Contractual Life (Years), Options Fully vested Aggregate Intrinsic Value, Fully vested Options, Option Vested Weighted Average Exercise Price, Option Expected Vested Weighted Average Remaining Contractual Life (Years), Options Expected vest Aggregate Intrinsic Value, Options Expected Vest Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Risk-free interest rate minimum Risk-free interest rate maximum Expected volatility Expected dividend yield Expected life Share-based compensation Authorized issuance shares of common stock Percent of common stock outstanding Authorized common stock issuance Award vesting period Expiration period Unrecognized share-based compensation related to options Period of recognition for unrecognized share-based compensation Awards granted Contribution expenses Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Director fees incurred Marketing expense Statutory U.S. Federal income tax Statutory U.S. Federal income tax percentage Statutory U.S. Federal income tax State income taxes, net percentage Meals and entertainment Meals and entertainment Statutory U.S. Federal income tax Change in valuation allowance percentage Statutory U.S. Federal income tax Goodwill impairment percentage Statutory U.S. Federal income tax Warrant valuation percentage Statutory U.S. Federal income tax Tax effect of non-deductible equity instruments percentage Statutory U.S. Federal income tax Return to provision adjustment percentage Statutory U.S. Federal income tax Other percentage Statutory U.S. Federal income tax Total provision percentage Net operating loss carryforwards ROU assets Share-based compensation Inventory Other assets Gross deferred tax assets Valuation allowance Net deferred tax assets Fixed assets Operating lease liabilities Intangibles Deferred tax liabilities, net of valuation allowance Valuation allowance, at beginning of year Increase in valuation allowance Valuation allowance, at end of year Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table] Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items] Income tax benefit (expense) Effective tax rate Federal statutory rate Net operating loss carryforwards Accrued interest and penalties Concentration Risk [Table] Concentration Risk [Line Items] Net loss Less: Adjustment due to warrant modifications Basic WASO Dilutive common stock equivalents Diluted WASO Net loss per share attributable to common stockholders, basic Net loss per share attributable to common stockholders, diluted Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Subsequent Event [Table] Subsequent Event [Line Items] Number of shares of common stock Restricted shares, granted Share based compensation expense Prepaid Expenses And Other Current Assets [Text Block] Class Of Warrant Or Right Disclosure [Text Block] Class of warrant or right warrants outstanding intrinsic value. First Tranche Warrant [Member] Alphia Term Loan Facility [Member] IHeart Media [Member] Second Tranche Warrant [Member] Debt instrument right of first refusal outstanding period. Class of warrant or right reclassification to equity. 2019 Incentive Award Plan [Member] Share based compensation arrangement by share based payment award maximum annual increase of equity award authorized percent of common stock outstanding. Accrued marketing costs and advertising current. Term Loan [Member] Debt instrument floor interest rate. Executives and Employees [Member] Believeco [Member] Old Plank Trail Community Bank NA [Member] Wintrust Credit Facility [Member] Debt instrument minimum liquidity required to be maintained. Line of credit facility eligible customer invoices purchased percent. Wintrust Receivables Credit Facility [Member] Line of credit facility eligible customer invoices purchased maximum. Line of credit facility renewal period. Accounts receivable aggregate face value. Reclassification of warrants to equity. Effective income tax rate reconciliation warrant valuation amount. Effective income tax rate reconciliation nondeductible expense equity instruments amount. Effective income tax rate reconciliation return to provision adjustment amount. Effective income tax rate reconciliation warrant valuation percent. Effective income tax rate reconciliation nondeductible expense equity instruments percent. Effective income tax rate reconciliation return to provision adjustment percent. Payments of underwriting discounts and commissions. Deferred tax assets leasing arrangements. Going concern considerations [Policy Text Block] Three Customers [Member] Two Customers [Member] Line of credit facility contract term. Initial Public Offering [Policy Text Block] Warrant modifications adjustment. Reverse Stock Split [Policy Text Block] Shares Repurchases [Policy Text Block] Class Of Warrant Or Right [Policy Text Block] Number of revenue channels. Aimia Pet Healthco, Inc. [Member] E Commerce [Member] Brick And Mortar [Member] Direct To Consumer [Member] International [Member] Sales Channel Concentration Risk [Member] One Customer [Member] Freight Out [Policy Text Block] Schedule of Significant Inputs to Warrants Liabilities [Table Text Block] Schedule of Warrants Liabilities Activity [Table Text Block] Weighted average exercise price, warrants outstanding. Weighted average exercise price, warrants issued. Weighted average exercise price, warrants exercised. Weighted average exercise price, warrants forfeiture/expired. Two Member of Board of Directors [Member] Board of Directors [Member] Effective income tax rate. Minimum liquidity required. Maximum marketing spend ratio. Two Vendors [Member] Customer One [Member] Customer Two [Member] Warrant Liabilities [Member] Other Options [Member] Second Amendment [Member] Third Amendment [Member] Fixed charge coverage ratio description. London Interbank Offered Rate [Member] Prepaid marketing expense current. Impairment of intangible assets. Impairment of goodwill. Goodwill impairments loss. Goodwill impairment losses. Share based compensation arrangement by share based payment award options fully vested eeighted average exercise price. Share based compensation arrangement by share based payment award options fully weighted average remaining contractual term 1. Share based compensation arrangement by share based payment award options fully vested intrinsic value 1. Share based compensation arrangement by sharebased payment award options expected vest intrinsic value 1. Sharebased compensation arrangement by sharebased payment award options expected vest weighted average remaining contractual term 1. Share based compensation arrangement by share based payment award options expected vest weighted average exercise price. Share based compensation arrangement by sharebased payment award options expected vest in period fair value 1. Other Option [Member] Payments on line of credit. Gross Profit Operating Expenses Operating Income (Loss) Interest Expense Other Nonoperating Expense Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Net Income (Loss) Available to Common Stockholders, Basic Assets, Current Assets [Default Label] Liabilities, Current Operating Lease, Liability, Noncurrent Liabilities, Noncurrent Liabilities Equity, Attributable to Parent Liabilities and Equity Shares, Outstanding Gain (Loss) on Disposition of Assets Share-Based Payment Arrangement, Noncash Expense Other Noncash Income (Expense) Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Other Short-Term Debt PaymentsOnLineOfCredit Repayments of Notes Payable Payments of Debt Issuance Costs Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents PrepaidExpensesAndOtherCurrentAssetsTextBlock Accounts Payable and Accrued Liabilities Disclosure [Text Block] ClassOfWarrantOrRightDisclosureTextBlock Share-Based Payment Arrangement [Text Block] Income Tax Disclosure [Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Inventory, Policy [Policy Text Block] Income Tax, Policy [Policy Text Block] Revenue from Contract with Customer [Policy Text Block] Cost of Goods and Service [Policy Text Block] Share-Based Payment Arrangement [Policy Text Block] Inventory, Gross Inventory Adjustments Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Goodwill [Default Label] GoodwillImpairmentsLoss Goodwill, Impairment Loss Finite-Lived Intangible Assets, Remaining Amortization Period Accrued Liabilities, Current Debt, Long-Term and Short-Term, Combined Amount Restricted Cash Debt Instrument, Basis Spread on Variable Rate AccountsReceivableAggregateFaceValue Long-Term Line of Credit Long-Term Debt, Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice Derivative Liability, Current Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFullyVestedWeightedAverageExercisePrice SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFullyVestedIntrinsicValue1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedVestWeightedAverageExercisePrice SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestIntrinsicValue1 Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount EffectiveIncomeTaxRateReconciliationWarrantValuationAmount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEquityInstrumentsAmount EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent Effective Income Tax Rate Reconciliation, Percent Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Deferred Tax Assets, Other Deferred Tax Assets, Gross Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance Deferred Tax Liabilities, Property, Plant and Equipment Deferred Tax Liabilities, Leasing Arrangements Deferred Tax Liabilities, Intangible Assets Deferred Tax Liabilities, Net Operating Loss Carryforwards EX-101.PRE 12 bttr-20231231_pre.xml XBRL PRESENTATION FILE XML 14 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2023
Apr. 11, 2024
Sep. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2023    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Current Fiscal Year End Date --12-31    
Entity File Number 001-40477    
Entity Registrant Name Better Choice Co Inc.    
Entity Central Index Key 0001471727    
Entity Tax Identification Number 83-4284557    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 12400 Race Track Road    
Entity Address, City or Town Tampa    
Entity Address, State or Province FL    
Entity Address, Postal Zip Code 33626    
City Area Code (212)    
Local Phone Number 896-1254    
Title of 12(b) Security Common Stock, $0.001 par value share    
Trading Symbol BTTR    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 3,615,969
Entity Common Stock, Shares Outstanding   893,601  
Documents Incorporated by Reference [Text Block] The information required by Items 10, 11, 12, 13, and 14 will be furnished (and are hereby incorporated) by an amendment hereto or pursuant to a definitive proxy statement pursuant to Regulation 14A that will contain such information.    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Auditor Firm ID 243    
Auditor Name BDO USA, P.C    
Auditor Location Tampa, Florida    

XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Net sales $ 38,592 $ 54,660
Cost of goods sold 26,795 39,399
Gross profit 11,797 15,261
Operating expenses:    
Selling, general and administrative 24,444 35,430
Impairment of goodwill 18,614
Impairment of intangible assets 8,532
Total operating expenses 32,976 54,044
Loss from operations (21,179) (38,783)
Other expense:    
Interest expense (1,353) (551)
Change in fair value of warrant liabilities (236)
Total other expense (1,589) (551)
Net loss before income taxes (22,768) (39,334)
Income tax expense (benefit) 2 (18)
Net loss available to common stockholders $ (22,770) $ (39,316)
Weighted average number of shares outstanding, basic 705,185 667,114
Weighted average number of shares outstanding, diluted 705,185 667,114
Net loss per share available to common stockholders, basic $ (32.29) $ (58.93)
Net loss per share available to common stockholders, diluted $ (32.29) $ (58.93)
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 4,455 $ 3,173
Restricted cash 6,300
Accounts receivable, net 4,354 6,744
Inventories, net 6,611 10,257
Prepaid expenses and other current assets 812 1,051
Total Current Assets 16,232 27,525
Fixed assets, net 230 375
Right-of-use assets, operating leases 120 173
Intangible assets, net 10,059
Other assets 155 544
Total Assets 16,737 38,676
Current Liabilities    
Accounts payable 6,928 2,932
Accrued and other liabilities 2,085 2,596
Line of credit 1,741
Term loan, net 2,881
Operating lease liability 57 52
Total Current Liabilities 13,692 5,580
Non-current Liabilities    
Line of credit, net 11,444
Operating lease liability 67 124
Total Non-current Liabilities 67 11,568
Total Liabilities 13,759 17,148
Stockholders’ Equity    
Common Stock, $0.001 par value, 200,000,000 shares authorized, 729,026 & 668,869 shares issued and outstanding as of December 31, 2023 and 2022, respectively 32 29
Additional paid-in capital 324,288 320,071
Accumulated deficit (321,342) (298,572)
Total Stockholders’ Equity 2,978 21,528
Total Liabilities and Stockholders’ Equity $ 16,737 $ 38,676
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 200,000,000 200,000,000
Common stock, shares issued 729,026 668,869
Common stock, shares outstanding 729,026 668,869
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2021 $ 29 $ 317,102 $ (259,256) $ 57,875
Balance, shares at Dec. 31, 2021 662,417      
Share-based compensation 2,969 2,969
Share-based compensation, shares 6,452      
Net loss available to common stockholders (39,316) (39,316)
Balance at Dec. 31, 2022 $ 29 320,071 (298,572) 21,528
Balance, shares at Dec. 31, 2022 668,869      
Share-based compensation $ 3 1,773 1,776
Share-based compensation, shares 60,157      
Net loss available to common stockholders (22,770) (22,770)
Reclassification of Alphia Warrants 2,444 2,444
Balance at Dec. 31, 2023 $ 32 $ 324,288 $ (321,342) $ 2,978
Balance, shares at Dec. 31, 2023 729,026      
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash Flow from Operating Activities:    
Net loss available to common stockholders $ (22,770) $ (39,316)
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss of disposal of assets 11
Depreciation and amortization 1,678 1,690
Amortization of debt issuance costs and discounts 193 56
Goodwill impairment 18,614
Intangible asset impairment 8,532
Share-based compensation 1,773 2,969
Change in fair value of warrant liabilities 236
Amortization of prepaid assets 2,095
Inventory reserve (474) 1,809
PIK interest expense on term loan 254
Accreted interest expense on term loan 291
Income tax provision (2)
Other 4 126
Changes in operating assets and liabilities:    
Accounts receivable 2,387 (66)
Inventories 4,120 (6,821)
Prepaid expenses and other assets 628 (1,047)
Accounts payable 3,996 (761)
Accrued and other liabilities (760) 99
Cash Provided by (Used in) Operating Activities 97 (20,553)
Cash Flow from Investing Activities:    
Capital expenditures (18) (198)
Cash Used in Investing Activities (18) (198)
Cash Flow from Financing Activities:    
Proceeds from short-term financing arrangement 413
Payments on short-term financing arrangement (248)
Proceeds from revolving lines of credit 1,906 12,317
Payments on revolving lines of credit (13,500) (5,640)
Proceeds from line of credit 7,841
Payments on line of credit (6,100)
Proceeds from term loan 5,000
Payments on term loans (5,450)
Payment of loan issuance costs (244) (110)
Cash (Used in) Provided by Financing Activities (5,097) 1,282
Net decrease in cash and cash equivalents and restricted cash (5,018) (19,469)
Total cash and cash equivalents and restricted cash, beginning of period 9,473 28,942
Total cash and cash equivalents and restricted cash, end of period 4,455 9,473
Cash paid during the year for:    
Income taxes 12
Interest 543 444
Noncash items:    
Reclassification of warrants to equity $ 2,444
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Nature of business and summary of significant accounting policies
 12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of business and summary of significant accounting policies

Note 1 – Nature of business and summary of significant accounting policies

 

Nature of the business

 

Better Choice Company Inc. (the “Company”) is a pet health and wellness company focused on providing pet products and services that help dogs and cats live healthier, happier and longer lives. The Company has a broad portfolio of pet health and wellness products for dogs and cats sold under its Halo brand across multiple forms, including foods, treats, toppers, dental products, chews and supplements. The products consist of kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products and supplements.

 

Initial public offering

 

The Company completed its initial public offering (the “IPO”) on July 1, 2021, in which it issued and sold 181,818 shares of its common stock at a price of $5.00 per share. The total net proceeds from the IPO were approximately $36.1 million, after deducting underwriting discounts and commissions of $2.8 million, and offering costs of approximately $1.1 million. These IPO costs were recorded as a reduction of stockholders’ equity, and presented net of cash proceeds received in the Consolidated Statement of Cash Flows.

 

Upon the commencement of the IPO, all of the Company’s outstanding convertible notes payable automatically converted into 107,555 shares of common stock and upon the consummation of the IPO, all outstanding shares of the Series F convertible preferred stock were converted into 131,012 shares of common stock. Additionally, since the anti-dilution provision of the Series F Warrants were no longer effective upon consummation of the Company’s IPO, these warrants met the requirements to be considered equity and the outstanding Series F Warrants were reclassified as such.

 

Reverse stock split

 

On March 8, 2024, the Company’s Board of Directors approved a reverse stock split of the Company’s issued and outstanding shares of common stock at a ratio of 1-for-44, effective March 20, 2024 (the “Reverse Split”). In addition, the conversion rates of the Company’s outstanding preferred stock and convertible notes and the exercise prices of the Company’s underlying common stock purchase warrants and stock options were proportionately adjusted at the applicable reverse stock split ratio in accordance with the terms of such instruments. Proportionate voting rights and other rights of common stockholders were not affected by the Reverse Stock Split, other than as a result of the rounding up of fractional shares. No fractional shares of common stock were issued in connection with the Reverse Stock Split.

 

Accordingly, all share and per share amounts related to the Company’s common stock for all periods presented in the accompanying consolidated financial statements and notes thereto have been retroactively adjusted, where applicable, to reflect the Reverse Stock Split. The number of authorized shares and the par values of the common stock and convertible preferred stock were not adjusted as a result of the Reverse Stock Split.

 

Basis of presentation

 

The Company’s consolidated financial statements are prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for annual financial reports and accounting principles generally accepted in the U.S. (“GAAP”).

 

Consolidation

 

The financial statements are presented on a consolidated basis and include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

 

Use of estimates

 

The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On an ongoing basis, the Company evaluates these assumptions, judgments and estimates. Actual results may differ from these estimates.

 

In the opinion of management, the consolidated financial statements contain all adjustments necessary for a fair statement of the results of operations for the years ended December 31, 2023 and 2022, the financial position as of December 31, 2023 and 2022 and the cash flows for the years ended December 31, 2023 and 2022.

 

 

Going concern considerations

 

The Company is subject to risks common in the pet wellness consumer market including, but not limited to, dependence on key personnel, competitive forces, successful marketing and sale of its products, the successful protection of its proprietary technologies, ability to grow into new markets, and compliance with government regulations. The Company has continually incurred losses and has an accumulated deficit. The Company’s term loan agreement with Alphia imposes certain financial covenants, including minimum liquidity of $3.0 million, minimum EBITDA of $(4.5) million, and maximum marketing spend ratio of 30%. The Company was not in compliance with certain covenants related to the Alphia Term Loan Facility as of December 31, 2023 and the debt is callable by the lender. Our continued operating losses along with our failure to meet the financial covenants create substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the date these consolidated financial statements are issued. The Company does not currently expect it will be able to generate sufficient cash flow from operations to maintain sufficient liquidity to meet the required financial covenants in certain periods prior to maturity giving the lender the right to call the debt. The Company will need to either raise additional capital or obtain additional financing, and/or secure future waivers or amendments from its lenders or accomplish some combination of these items to maintain sufficient liquidity. There can be no assurance that the Company will be successful in raising additional capital, securing future waivers and/or amendments from its lenders, renewing or refinancing its existing debt or securing new financing. If the Company is unsuccessful in doing so, it may need to reduce the scope of its operations, repay amounts owed to its lenders or sell certain assets.

 

During the third quarter, the Company received a notice of noncompliance from the NYSE American. If the Company fails to satisfy the continued listing requirements before the end of the cure period, the NYSE American may take steps to delist its common stock. Such a delisting or the announcement of such delisting will have a negative effect on the price of the Company’s common stock and would impair the ability for investors to sell or purchase the Company’s common stock. In the event of a delisting, the Company may attempt to take actions to restore its compliance with the NYSE American listing requirements, but can provide no assurance that any such action taken by the Company would allow its common stock to become listed again, stabilize the market price or improve the liquidity of its common stock, prevent its common stock from dropping below the NYSE American minimum listing requirements or prevent future non-compliance with the NYSE American listing requirements. If the Company does not maintain the listing of its common stock on NYSE American, it could make it harder for the Company to raise additional capital in the long-term. If the Company is unable to raise capital when needed in the future, it may have to cease or reduce operations. There can be no assurance that the Company will be able to satisfy the continued listing requirements in the future.

 

The Company is continuing to implement plans to achieve operating profitability, as well as implementing other strategic objectives to address liquidity. The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and payments of liabilities in the ordinary course of business. Accordingly, the consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount of and classification of liabilities that may result should the Company be unable to continue as a going concern.

 

Summary of significant accounting policies

 

Cash and cash equivalents

 

Cash and cash equivalents include demand deposits held with banks and highly liquid investments with original maturities of ninety days or less at acquisition date. Cash and cash equivalents are stated at cost, which approximates fair value because of the short-term nature of these instruments. The Company’s cash equivalents are held in government money market funds and at times may exceed federally insured limits. For purposes of reporting cash flows, the Company considers all cash accounts that are not subject to withdrawal restrictions or penalties to be cash and cash equivalents. At December 31, 2022, the Company had $8.0 million in money market funds all of which were held in cash. As of December 31, 2023, the Company had closed its money market funds.

 

Restricted cash

 

The Company was required to maintain a restricted cash balance of $6.3 million as of December 31, 2022, in connection with the Wintrust Credit Facility. As a result of the full repayment of the Wintrust Credit Facility, there are no restrictions on cash as of December 31, 2023. See “Note 8 - Debt” for additional information.

 

Accounts receivable and allowance for credit losses

 

Accounts receivable consist of unpaid buyer invoices from the Company’s customers and credit card payments receivable from third-party credit card processing companies. Accounts receivable is stated at the amount billed to customers, net of point of sale and cash discounts. The Company assesses the collectability of all receivables on an ongoing basis by considering its historical credit loss experience, current economic conditions, and other relevant factors. Based on this analysis, an allowance for credit losses is recorded, and the provision is included within SG&A expense. The Company recorded approximately $0.1 million allowance for credit losses for the years ended December 31, 2023 and 2022.

 

 

Inventories

 

Inventories, consisting of finished goods available for sale as well as packaging materials, are valued using the first-in first-out (“FIFO”) method and are recorded at the lower of cost or net realizable value. Cost is determined on a standard cost basis and includes the purchase price, as well as inbound freight costs and packaging costs.

 

The Company regularly reviews inventory quantities on hand. Excess or obsolete reserves are established when inventory is estimated to not be sellable before expiration dates based on forecasted usage, product demand and product life cycle. Additionally, inventory valuation reflects adjustments for anticipated physical inventory losses that have occurred since the last physical inventory.

 

Fixed Assets

 

Fixed assets are recorded at cost and depreciated using the straight-line method over the estimated useful lives of the assets, and depreciation expense is included within SG&A expense. Expenditures for normal repairs and maintenance are charged to operations as incurred. The cost of fixed assets that are retired or otherwise disposed of and the related accumulated depreciation are removed from the fixed asset accounts in the year of disposal and the resulting gain or loss is included in SG&A expense.

 

The Company assesses potential impairments of its fixed assets whenever events or changes in circumstances indicate that the asset’s carrying value may not be recoverable. An impairment charge would be recognized when the carrying amount of the identified asset grouping exceeds its fair value and is not recoverable, which would occur if the carrying amount exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the identified asset grouping.

 

Goodwill

 

Goodwill is evaluated for impairment either through a qualitative or quantitative approach at least annually, or more frequently if an event occurs or circumstances change that indicate the carrying value of a reporting unit may not be recoverable. If a quantitative assessment is performed that indicates the carrying amount of a reporting unit exceeds its fair market value, an impairment loss is recognized to reduce the carrying amount to its fair market value. The fair market value is determined based on a weighting of the present value of projected future cash flows (the “income approach”) and the use of comparative market approaches (“market approach”). Factors requiring significant judgment include, among others, the assumptions related to discount rates, forecasted operating results, long-term growth rates, the determination of comparable companies and market multiples. Fair value measurements used in the impairment review of goodwill are Level 3 measurements. See further information about the Company’s policy for fair value measurements within this section below. See “Note 6 - Goodwill and intangible assets” for additional information regarding the goodwill impairment test.

 

Intangible assets

 

Finite-lived Intangible assets acquired are carried at cost, less accumulated amortization. Amortization expense is included in selling, general and administrative expenses on the consolidated statements of operations. The Company assesses long lived assets, including finite-lived intangible assets, for impairment whenever events or changes in circumstances indicate the carrying amount of the asset group may not be recoverable. The Company operates as a single reporting unit and as such, is the asset group when assessing finite-lived intangible assets for impairment. If impairment indicators are present, the Company performs a recoverability test by comparing the sum of the estimated undiscounted future cash flows attributable to its long-lived asset group to its carrying value. If the carrying amount of an asset group is not recoverable, an impairment loss is recognized based on the excess of the carrying value of the impaired asset group over its fair value. An impairment loss for an asset group is allocated to the long-lived assets of the group on a pro rata basis using the relative carrying amounts of those assets, except that the loss allocated to an individual long-lived asset of the group shall not reduce the carrying amount of that asset below its fair value whenever that fair value is determinable without undue cost and effort.

 

Share repurchases

 

On May 10, 2022, the Company’s board of directors approved a share repurchase program that authorized the repurchase of up to $3.0 million of the Company’s outstanding common stock in the open market through December 31, 2022. Repurchased shares are immediately retired and returned to unissued status. During the years ended December 31, 2023 and 2022, no shares were repurchased.

 

Common stock warrants

 

Common stock warrants are recorded as either liabilities or as equity instruments, depending on the specific terms of the warrant agreement. Warrants classified as liabilities are revalued at each balance sheet date subsequent to the initial issuance and changes in the fair value are reflected in the Consolidated Statements of Operations as change in fair value of warrant liabilities. Upon exercise, the warrant is marked to fair value on the exercise date and the related fair value is reclassified to equity.

 

Income taxes

 

Income taxes are recorded in accordance with FASB ASC Topic 740, “Income Taxes (ASC 740)”, which provides for deferred taxes using an asset and liability approach. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the consolidated financial statements and tax bases of assets and liabilities and for loss and credit carryforwards using enacted tax rates anticipated to be in effect for the year in which the differences are expected to reverse. Valuation allowances are provided, if, based upon the weight of available evidence, it is more likely than not that some or all the deferred tax assets will not be realized.

 

 

The Company accounts for uncertain tax positions in accordance with the provisions of ASC 740. When uncertain tax positions exist, the Company recognizes the tax benefit of tax positions to the extent that some or all the benefit will more likely than not be realized. The determination as to whether the tax benefit will more likely than not be realized is based upon the technical merits of the tax position, as well as consideration of the available facts and circumstances. As of December 31, 2023 and 2022, the Company does not have any significant uncertain income tax positions. If incurred, the Company would classify interest and penalties on uncertain tax positions as income tax expense.

 

The Company was incorporated on May 6, 2019. Prior to this date, the Company operated as a flow through entity for state and U.S. federal tax purposes. The Company files a U.S. federal and state income tax return, including for its wholly owned subsidiaries.

 

Revenue

 

Generally, the Company’s customer contracts have a single performance obligation, and revenue is recognized when the product is shipped as this is when it has been determined that control has been transferred. Amounts billed and due from customers are classified as receivables and require payment on a short-term basis and therefore do not have any significant financing components.

 

Revenue is measured as the amount of consideration the Company expects in exchange for transferring goods, which varies with changes in trade incentives the Company offers to its customers. Trade incentives consist primarily of customer pricing allowances and merchandising funds, and point of sale discounts. Estimates of trade promotion expense and coupon redemption costs are based upon programs offered, timing of those offers, estimated redemption/usage rates from historical performance, management’s experience and current economic trends.

 

Cost of goods sold

 

Cost of goods sold consists primarily of the cost of product obtained from co-manufacturers, packaging materials, freight costs for shipping inventory to the warehouse, as well as third-party warehouse and order fulfillment costs.

 

Advertising

 

The Company charges advertising costs to expense as incurred and such charges are included in SG&A expense. The Company’s advertising expenses consist primarily of online advertising, search costs, email advertising and radio advertising. In addition, the Company reimburses its customers and third parties for in store activities and record these costs as advertising expenses. Advertising costs were $6.8 million and $12.2 million for the years ended December 31, 2023 and 2022, respectively, of which $2.1 million is related to the amortization of the prepaid advertising contract with iHeart for the year ended December 31, 2022. See “Note 4 - Prepaid expenses and other current assets” for additional information on the prepaid advertising contract with iHeart.

 

Freight Out

 

Costs incurred for shipping and handling, including moving finished product to customers are included in SG&A expense. Shipping costs associated with moving finished products to customers were $1.3 million and $1.6 million for the years ended December 31, 2023 and 2022, respectively.

 

Research and development

 

Research and development costs related to developing and testing new products are expensed as incurred and included in SG&A expense. Research and development costs were $0.1 million and $0.5 million for the years ended December 31, 2023 and 2022, respectively.

 

Share-based compensation

 

Share-based compensation awards are measured at their estimated fair value on each respective grant date. The Company recognizes share-based payment expenses over the requisite service period. The Company’s share-based compensation awards are subject only to service based vesting conditions. Pursuant to ASC 718-10-35-8, the Company recognizes compensation cost for stock awards with only service conditions that have a graded vesting schedule on a straight-line basis over the service period for each separately vesting portion of the award as if the award was, in-substance, multiple awards. Forfeitures are recognized as they occur.

 

Operating leases

 

The Company determines if a contract or arrangement meets the definition of a lease at inception. The Company has elected to make the accounting policy election for short-term leases. For leases with terms greater than 12 months, the Company records the related asset and obligation at the present value of lease payments over the term. Lease renewal options are only included in the measurement if the Company is reasonably certain to exercise the optional renewals. Any variable lease costs, other than those dependent upon an index or rate, are expensed as incurred. If a lease does not provide a readily available implicit rate, the Company estimates the incremental borrowing discount rate based on information available at lease commencement.

 

The Company’s only remaining operating lease as of December 31, 2023 relates to office space. There are no material residual value guarantees or material restrictive covenants.

 

 

Fair value of financial instruments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy uses a framework which requires categorizing assets and liabilities into one of three levels based on the inputs used in valuing the asset or liability.

 

Level 1 inputs are unadjusted, quoted market prices in active markets for identical assets or liabilities.

 

Level 2 inputs are observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.

 

Level 3 inputs include unobservable inputs that are supported by little, infrequent or no market activity and reflect management’s own assumptions about inputs used in pricing the asset or liability.

 

Level 1 provides the most reliable measure of fair value, while Level 3 generally requires significant management judgment. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s financial instruments recognized on the Consolidated Balance Sheets consist of cash and cash equivalents, restricted cash, accounts receivable, prepaid assets, accounts payable, term loan, line of credit, accrued liabilities and other liabilities.

 

The fair value of the Company’s money market funds is based on quoted market prices using Level 1 inputs. The fair value for the Company’s term loan and line of credit approximates carrying value as the instrument has a variable interest rate that approximates market rates. The inputs related to the Company’s term loan and line of credit are reflected as Level 3 inputs.

 

The Company values it’s warrant liabilities using Level 3 inputs.

 

Fair value measurements of non-financial assets and non-financial liabilities reflect Level 3 inputs and are primarily used to measure the estimated fair values of goodwill, other intangible assets and long-lived assets impairment analyses.

 

Basic and diluted (loss) income per share

 

Basic and diluted (loss) income per share has been determined by dividing the net (loss) income available to common stockholders for the applicable period by the basic and diluted weighted average number of shares outstanding, respectively. Common stock equivalents are excluded from the computation of diluted weighted average shares outstanding when their effect is anti-dilutive.

 

Segment information

 

Operating segments are defined as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision-maker (“CODM”) in making decisions regarding resource allocation and assessing performance. The Company has viewed its operations and manages its business as one segment. The Company’s CODM reviews operating results on an aggregated basis. All the assets and operations of the Company are in the U.S.

 

New Accounting Standards

 

Recently adopted

 

ASU 2016-13 “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”

 

In June 2016, the FASB issued ASU 2016-13, a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The standard was effective for the Company on January 1, 2023. The new standard did not have a material impact on the consolidated financial statements for the year ended December 31, 2023.

 
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue
 12 Months Ended
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]  
Revenue

Note 2 – Revenue

 

The Company records revenue net of discounts, which primarily consist of trade promotions, certain customer allowances and early pay discounts.

 

The Company excludes sales taxes collected from revenues. Retail-partner based customers are not subject to sales tax.

 

 

The Company’s direct-to-consumer (“DTC”) loyalty program enables customers to accumulate points based on their spending. A portion of revenue is deferred at the time of sale when points are earned and recognized when the loyalty points are redeemed.

 

Revenue channels

 

The Company groups its revenue channels into four categories: E-commerce, which includes the sale of product to online retailers such as Amazon and Chewy; Brick & Mortar, which primarily includes the sale of product to Pet Specialty retailers such as Petco, Pet Supplies Plus and neighborhood pet stores, as well as to select grocery chains; DTC, which includes the sale of product through the Company’s website; and International, which includes the sale of product to foreign distribution partners and to select international retailers (transacted in U.S. dollars).

 

Information about the Company’s net sales by revenue channel is as follows (in thousands):

 

   Twelve Months Ended December 31, 
   2023   2022 
E-commerce (1)  $13,405    35%  $14,565    27%
Brick & Mortar  $5,870    15%  $11,624    21%
DTC  $5,597    15%  $6,620    12%
International (2)  $13,720    35%  $21,851    40%
Net Sales  $38,592    100%  $54,660    100%

 

(1) The Company’s E-commerce channel includes two customers that amounted to greater than 10% of the Company’s total net sales. These customers had $5.9 million and $7.1 million of net sales for the year ended December 31, 2023, respectively and $7.5 million and $6.6 million of net sales for the year ended December 31, 2022, respectively.
   
(2) One of the Company’s International customers that distributes products in China amounted to greater than 10% of the Company’s total net sales during the years ended December 31, 2023 and December 31, 2022 and represented $11.0 million and $17.7 million of net sales, respectively.

 
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Inventories
 12 Months Ended
Dec. 31, 2023
Inventory Disclosure [Abstract]  
Inventories

Note 3 - Inventories

 

Inventories are summarized as follows (in thousands):

 

   December 31, 2023   December 31, 2022 
Food, treats and supplements  $6,296   $10,212 
Inventory packaging and supplies   1,166    1,699 
Total Inventories   7,462    11,911 
Inventory reserve   (851)   (1,654)
Inventories, net  $6,611   $10,257 

 
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Prepaid expenses and other current assets
 12 Months Ended
Dec. 31, 2023
Prepaid Expenses And Other Current Assets  
Prepaid expenses and other current assets

Note 4 – Prepaid expenses and other current assets

 

Prepaid expenses and other current assets are summarized as follows (in thousands):

 

   December 31, 2023   December 31, 2022 
Prepaid advertising contract with iHeart (1)  $—   $— 
Prepaid marketing expenses   451    — 
Other prepaid expenses and other current assets   361    1,051 
Total Prepaid expenses and other current assets  $812   $1,051 

 

(1) On August 28, 2019, the Company entered into a radio advertising agreement with iHeart Media + Entertainment, Inc. (“iHeart”) and issued 166,667 shares of common stock valued at $3.4 million for future advertising services. The Company issued an additional 20,834 shares valued at $0.1 million on March 5, 2020 pursuant to the agreement. The current portion of the remaining value, reflected above, is the remaining value of services that the Company expects to utilize within the twelve months following the reporting period date, unless the term is extended. The Company utilized the remaining advertising services during the year ended December 31, 2022.

 

 
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fixed assets
 12 Months Ended
Dec. 31, 2023
Property, Plant and Equipment [Abstract]  
Fixed assets

Note 5 - Fixed assets

 

Fixed assets consist of the following (in thousands):

 

   Estimated Useful Life  December 31, 2023   December 31, 2022 
Equipment  2 - 5 years  $18   $7 
Furniture and fixtures  2 - 5 years   221    221 
Computer software, including website development  2 - 3 years   187    187 
Computer equipment  1 - 2 years   108    129 
Total fixed assets      534    544 
Accumulated depreciation      (304)   (169)
Fixed assets, net     $230   $375 

 

Depreciation expense was $0.2 million for the years ended December 31, 2023 and 2022, respectively.

 
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Goodwill and intangible assets
 12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and intangible assets

Note 6 – Goodwill and intangible assets

 

Goodwill

 

The change in the carrying amount of goodwill for the years ended December 31, 2023 and 2022 is summarized as follows (in thousands):

 

   December 31, 2023   December 31, 2022 
Beginning balance  $—   $18,614 
Impairment expense   —    (18,614)
Ending balance  $—   $— 

 

Goodwill is evaluated for impairment if an event occurs or circumstances change that indicate the carrying value of a reporting unit may not be recoverable. During July 2022, the Company completed a legal merger of TruPet and Halo, Purely for Pets, Inc., a wholly owned subsidiary of Better Choice Company Inc. (“Halo”), with Halo as the surviving entity in connection with the execution of rebranding its former TruDog brand under the Halo brand umbrella. In conjunction with the legal merger and rebranding, the Company performed an analysis of its reporting units and concluded it has one reporting unit after the legal merger and rebrand, and as such, the Company performed a quantitative goodwill assessment as of July 1, 2022 in addition to its annual impairment test as of October 1, 2022.

 

Under the quantitative approach, the Company makes various estimates and assumptions to determine the estimated fair value of the reporting unit using a combination of a discounted cash flow model and a guideline comparable analysis. The fair value measurements used in the impairment review of goodwill are Level 3 measurements which include unobservable inputs that are supported by little, infrequent or no market activity and reflect management’s own assumptions. The key assumptions used in estimating the fair value of its reporting units as of July 1, 2022 and October 1, 2022 utilizing the income approach include the discount rate and revenue growth rates. The discount rate utilized in estimating the fair value of its reporting units as of July 1, 2022 and October 1 2022 was 20.0%, reflecting the assessment of a market participant’s view of the risks associated with the projected cash flows. Revenue growth rates varied for each year included in the valuation model based on management’s best estimate of forecasted operating results. The assumptions used in estimating the fair values are based on currently available data and management’s best estimates of revenues, EBITDA margins, and cash flows and, accordingly, a change in market conditions or other factors could have a material effect on the estimated values. There are inherent uncertainties related to the assumptions used and to management’s application of these assumptions. As a result of the annual impairment test, the Company recorded an intangible asset impairment charge of $18.6 million during the year ended December 31, 2022, resulting in full impairment to the goodwill carrying value.

 

Intangible assets

 

The Company’s intangible assets include the trade name and customer relationships. As of December 31, 2023, impairment indicators were present which required a recoverability test to be performed. As a result of the recoverability test, the carrying value of the asset group exceeded its fair value and the Company recorded an impairment charge of $8.5 million for the year ended December 31, 2023, which resulted in a full impairment to the carrying value of the trade name and customer relationships. This non-cash charge was recorded to intangible asset impairment expenses on the consolidated statements of operations. The Company did not record any impairment loss on long-lived assets for the year ended December 31, 2022.

 

The assumptions used in estimating the undiscounted future cash flows are based on currently available data and management’s best estimates of future income statement and working capital elements. A change in market conditions or other factors could have a material effect on the estimated values. Fair value was determined based on discounted cash flows requiring judgement. These factors include, among others, the assumptions related to discount rates, forecasted operating results, long-term growth rates, the determination of comparable companies and market multiples. The measurements used in the impairment review of finite-lived intangible assets are Level 3 measurements. There are inherent uncertainties related to the assumptions used and to management’s application of these assumptions.

 

The Company’s intangible assets (in thousands) and related useful lives (in years) are as follows:

 

       December 31, 2023 
  

Estimated

Useful

Life (in years)

  

Gross Carrying

Amount

  

Accumulated

Amortization

   Impairment Loss  

Net Carrying

Amount

 
Customer relationships  —   $7,190   $(4,142)  $(3,048)  $— 
Trade name  —    7,500    (2,016)   (5,484)   — 
Total intangible assets      $14,690   $(6,158)  $(8,532)  $— 

 

       December 31, 2022 
  

Estimated Useful

Life (in years)

  

Gross Carrying

Amount

  

Accumulated

Amortization

  

Net Carrying

Amount

 
Customer relationships  7   $7,190   $(3,115)  $4,075 
Trade name  15    7,500    (1,516)   5,984 
Total intangible assets      $14,690   $(4,631)  $10,059 

 

Amortization expense was $1.5 million for the years ended December 31, 2023 and 2022, respectively.

 

 

The Company assesses intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be fully recoverable. If impairment indicators are present, the Company performs a recoverability test by comparing the sum of the estimated undiscounted future cash flows attributable to these long-lived assets to their carrying value. The assumptions used in estimating the undiscounted future cash flows are based on currently available data and management’s best estimates of revenues, EBITDA margins, and working capital and, accordingly, a change in market conditions or other factors could have a material effect on the estimated values. There are inherent uncertainties related to the assumptions used and to management’s application of these assumptions. As a result of the recoverability test performed, the carrying value of the asset group exceeded its fair value, therefore a quantitative impairment test was performed to compare the fair value of the trade name and customer relationships assets with their carrying value. As a result, the Company recorded an impairment charge of $8.5 million during the year ended December 31, 2023, resulting in full impairment to the carrying value of the trade name and customer relationships intangible assets.

 
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accrued and other liabilities
 12 Months Ended
Dec. 31, 2023
Payables and Accruals [Abstract]  
Accrued and other liabilities

Note 7 – Accrued and other liabilities

 

Accrued and other liabilities consist of the following (in thousands):

 

   December 31, 2023   December 31, 2022 
Accrued taxes   105    110 
Accrued payroll and benefits   487    688 
Accrued trade promotions and advertising   90    567 
Accrued interest   254    84 
Accrued commissions   686    385 
Deferred revenue   7    336 
Short-term financing   162    165 
Other   294    261 
Total accrued and other liabilities  $2,085   $2,596 

 
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt
 12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
Debt

Note 8 – Debt

 

The components of the Company’s debt consist of the following (in thousands):

 

   December 31, 2023  December 31, 2022
   Amount   Rate  

Maturity
date

  Amount   Rate  

Maturity
date

Term loan, net  $2,881    (2)   6/21/2026  $—         
Line of credit, net   1,741    (3)   6/21/2025   11,444    (1)   10/31/2024
Total debt   4,622            11,444         
Less current portion   4,622            —         
Total long-term debt  $—           $11,444         

 

(1) Interest at a variable rate of the daily U.S. Federal Funds Rate plus 375 basis points with an interest rate floor of 3.75% per annum.
   
(2) Interest at a fixed rate of 10.00% per annum.
   
(3) Interest at a variable rate of the daily U.S. Federal Funds Rate plus 250 basis points with an interest rate floor of 5.50% per annum.

 

Wintrust term loan and lines of credit

 

On January 6, 2021, Halo entered into a credit facility with Old Plank Trail Community Bank, N.A., an affiliate of Wintrust Bank, N.A. (“Wintrust”) consisting of a $6.0 million term loan and a $6.0 million revolving line of credit, each scheduled to mature on January 6, 2024 and each bore interest at a variable rate of LIBOR plus 250 basis points, with an interest rate floor of 2.50% per annum (the “Wintrust Credit Facility”). The Second Wintrust Amendment described below updated the rate at which the Wintrust Credit Facility bore interest to the greater of the daily U.S. Federal Funds Rate plus 285 basis points, or the interest rate floor, which remained unchanged. The Third Wintrust Amendment described below updated the interest rate on the Wintrust Credit Facility to the U.S. Federal Funds Rate plus 375 basis points, with an interest rate floor of 3.75% and extends the maturity date of the Wintrust Credit Facility from January 6, 2024 to October 31, 2024. Accrued interest on the Wintrust Credit Facility is payable monthly which commenced on February 1, 2021. Principal payments were required to be made monthly on the term loan commencing February 2021 with a balloon payment upon the original maturity date. The proceeds from the Wintrust Credit Facility were used (i) to repay outstanding principal, interest and fees under the previous revolving line of credit with Citizens Business Bank (the “ABL Facility”) and (ii) for general corporate purposes.

 

 

The Wintrust Credit Facility subjected the Company to certain financial covenants, including the maintenance of a fixed charge coverage ratio of no less than 1.25 to 1.00, tested as of the last day of each fiscal quarter. The numerator in the fixed charge coverage ratio was the operating cash flow of Halo, defined as Halo EBITDA less cash paid for unfinanced Halo capital expenditures, income taxes and dividends. The denominator was fixed charges such as interest expense and principal payments paid or payable on other indebtedness attributable to Halo. As of December 31, 2021, the Company failed to satisfy the fixed charge coverage ratio and entered into a default waiver agreement with Wintrust in which Wintrust waived the existing default through the next testing date, March 31, 2022. As part of the Second Wintrust Amendment described below, the financial covenants were amended to subject the Company to a minimum liquidity covenant test in lieu of a fixed charge coverage ratio which required the Company to maintain liquidity, tested on the last day of each fiscal quarter beginning March 31, 2022, of no less than (i) $13.0 million as of the last day of each fiscal quarter ending March 31, 2022, through and including the last day of the fiscal quarter ending December 31, 2022 and (ii) $12.0 million as of the last day of the fiscal quarter ending March 31, 2023, and as of the last day of each fiscal quarter thereafter. Furthermore, as part of the Third Wintrust Amendment described below, the financial covenants were further amended to require the Company to maintain a minimum liquidity of $8.5 million tested on the last day of each fiscal quarter beginning September 30, 2022 and thereafter.

 

The Wintrust Credit Facility is secured by a general guaranty and security interest on the assets, including the intellectual property, of the Company and its subsidiaries. The Company has also pledged all of the capital stock of Halo held by the Company as additional collateral. Furthermore, the Wintrust Credit Facility was supported by a collateral pledge by a member of the Company’s board of directors; as a result of the First Wintrust Amendment described below, this collateral pledge was terminated and released.

 

On August 13, 2021, Halo entered into the first amendment to the Wintrust Credit Facility (the “First Wintrust Amendment”) to increase the revolving line of credit from $6.0 million to $7.5 million. The First Wintrust Amendment also required Halo to secure the credit facility with a pledge of a deposit account in the amount of $7.2 million, which was decreased to $6.9 million on January 1, 2022 and was to further decrease to $6.0 million on January 1, 2023. Additionally, on March 25, 2022, the Company entered into the second amendment to the Wintrust Credit Facility (the “Second Wintrust Amendment”) which provided for the release of the Company’s Bona Vida subsidiary as a guarantor, an update to the financial covenants as described above and an update to the rate at which the Wintrust Credit Facility bore interest, which is also described above. Furthermore, on October 24, 2022, the Company entered into the third amendment to the Wintrust Credit Facility (the “third Wintrust Amendment”) which provided for an increase to the revolving line of credit from $7.5 million to $13.5 million, set the amount of Halo’s obligation to pledge a deposit account with Wintrust to a fixed amount of $6.3 million throughout the remainder of the term and provided updates to the interest rate, maturity date and financial covenants as described above.

 

As part of the Third Wintrust Amendment described above, Halo used a portion of the increased revolving credit facility to repay and retire the outstanding term loan portion of the Wintrust Credit Facility.

 

On June 21, 2023, the Company paid off the entire balance in the sum of $13.5 million of the Wintrust Credit Facility removing any covenant requirements to be met at December 31, 2023.

 

As of December 31, 2023, there was no outstanding balance related to the Wintrust Credit Facility. As of December 31, 2022, the line of credit outstanding was $11.4 million, net of debt issuance costs of less than $0.2 million. Debt issuance costs are amortized using the effective interest method.

 

Wintrust Receivables Credit Facility

 

On June 21, 2023, the Company entered into an account purchase agreement with Wintrust Receivables Finance (AP Agreement), a division of Wintrust Bank N.A. (“Wintrust”) pursuant to which Wintrust will purchase, at its discretion, eligible customer invoices and advance up to 75% of the face amount of all purchased invoices. The maximum outstanding balance can be $4.8 million. Each advance under the Advance Purchase Agreement will bear a variable interest rate at the prime rate plus 2.5% percentage per annum. The interest rate at December 31, 2023 was 11.0% per annum. The AP Agreement has an initial term of two years and will automatically renew annually unless terminated by the Company on at least 60 days’ notice. The Wintrust Receivables Credit Facility is guaranteed and secured by a general security interest in the assets of the Company. The Company continues to service the receivables, the transfers are at full recourse and the eligible customer invoices are not legally isolated from the Company. As such, the Wintrust Receivables Credit Facility was accounted for as a secured borrowing under ASC 860.

 

The Wintrust Receivables Credit Facility limits or restrict the ability of the Company to incur additional indebtedness; incur additional liens; make dividends and other restricted payments; make investments; sell, assign, transfer or dispose of certain assets; make optional prepayments of other indebtedness; engage in transactions with affiliates; and enter into restrictive agreements. The Wintrust Receivables Credit Facility does not include any financial covenants and if an event of default occurs, Wintrust is entitled to accelerate the advances made thereunder and exercise rights against the collateral.

 

 

Borrowing under the Wintrust Receivables Credit Facility are classified as current debt as a result of a required lockbox arrangement and a subjective acceleration clause. During the year ended December 31, 2023, the Company sold receivables having an aggregate face value of $10.5 million, in exchange for cash proceeds of $7.8 million. As of December 31, 2023, the balance outstanding on the Wintrust Receivables Credit Facility amounted to $1.7 million.

 

Alphia Term Loan Facility

 

On June 21, 2023, the Company entered into a term loan credit agreement (the “Term Loan Agreement”) with Alphia Inc. (“Alphia”), a custom manufacturer of super-premium pet food in the U.S. Pursuant to the Term Loan Agreement, Alphia made a term loan to the Company in the original principal amount of $5.0 million (the “Term Loan”). In conjunction with the Term Loan Agreement, the Company issued warrants to Alphia (see Note 11 – Warrants for further discussion). The proceeds of the Term Loan, together with a portion of the Company’s cash on hand, were used to retire all of the outstanding obligations of Halo, Purely for Pets, Inc. (“Halo”), a wholly-owned subsidiary of the Company, under Halo’s long-term credit facility with Old Plank Trail Community Bank, N.A., an affiliate of Wintrust Bank, N.A described above.

 

The Term Loan bears an interest rate of 10% per annum, compounded quarterly, and will mature on June 21, 2026. Accrued interest on the Term Loan is payable quarterly in cash or, at the election of the Company, in-kind by capitalizing such interest and adding it to the then-outstanding principal amount of the Term Loan. The Term Loan Agreement provides for customary financial covenants and customary events of default, including, among others, those relating to failure to make payment, bankruptcy, breaches of representations and material adverse effects. The Company was not in compliance with these covenants as of December 31, 2023. The Company may prepay the principal of the Term Loan at any time upon written notice to Alphia and subject to a prepayment penalty if such prepayment occurs prior to June 21, 2025.

 

The Term Loan is secured by a general security interest on the assets, including the intellectual property of the Company and Halo pursuant to (i) that certain Term Loan Security Agreement, dated June 21, 2023, made by the Company and Halo in favor of Alphia (the “Security Agreement”) and (ii) that certain Intellectual Property Security Agreement, dated as of June 21, 2023, of the Company and Halo in favor of Alphia (the “Intellectual Property Security Agreement”). The Company has also pledged all of the capital stock of Halo held by the Company as additional collateral for the Term Loan.

 

The term Loan is guaranteed by Halo pursuant to that certain Term Loan Guaranty, dated as of June 21, 2023, by and between Halo and Alphia (the “Term Loan Guaranty”).

 

As of December 31, 2023, the Company’s indebtedness on the Alphia Term Loan Facility is $5.0 million and $0.3 million of payable-in-kind (“PIK”) interest. As discussed below, the total value of the consideration received in connection with the Term Loan Agreement was first allocated to the Warrants (as defined in Note 11) at fair value, with the remainder allocated to debt. Accordingly, the Company recorded a debt discount of $2.2 million on the Alphia Term Loan Agreement (see Note 11 for further discussion). Furthermore, the Company incurred debt issuance costs of $0.2 million. The discount and debt issuance costs associated with the Term Loan Agreement are amortized using the effective interest method.

 

Future Debt Maturities

 

Future debt maturities as of December 31, 2023 and for succeeding years are as follows (in thousands):

 

Year ending December 31:    
2024  $5,291 
2025  $— 
2026  $— 
Total  $5,291 

 
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value Measurements
 12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements

Note 9 - Fair Value Measurements

 

The carrying amounts of cash and cash equivalents, trade accounts receivable, prepaid expenses and other current assets, accounts payable and accrued expenses approximate fair value because of the short-term nature of these financial instruments. The carrying amounts of borrowings under credit facilities approximates fair value as variable interest rates on these instruments approximates current market rates.

 

 

The Company estimates the fair value of the term loan based on a discounted cash flow method. The carrying value of the term loan was based on an accounting entry where proceeds from the loan were first allocated to the warrants liabilities. The following table presents the carrying amount and fair value of the Company’s term note and line of credit by hierarchy level:

 

        December 31, 2023   December 31, 2022 
   Fair Value
Hierarchy		    Carrying
Amount		   Fair
Value		   Carrying
Amount		   Fair
Value		 
Term loan, net   Level 3(2)   $2,881   $3,314   $—   $— 
Line of credit   Level 2(1)   $1,741   $1,741   $11,444   $11,444 

 

(1) the fair value estimates are based upon observable market data
   
(2) the fair value estimates are based on unobservable inputs reflecting management’s assumptions about inputs used in pricing the asset or liability

 

 
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and contingencies
 12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and contingencies

Note 10 – Commitments and contingencies

 

The Company has manufacturing agreements with its vendors that provides for the company to make its commercial best efforts to purchase minimum quantities in the ordinary course of business. The Company had no material purchase obligations as of December 31, 2023 or 2022.

 

The Company may be involved in legal proceedings, claims, and regulatory, tax, or government inquiries and investigations that arise in the ordinary course of business resulting in loss contingencies. The Company accrues for loss contingencies when losses become probable and are reasonably estimable. If the reasonable estimate of the loss is a range and no amount within the range is a better estimate, the minimum amount of the range is recorded as a liability. Legal costs such as outside counsel fees and expenses are charged to expense in the period incurred and are recorded in SG&A expenses. The Company does not accrue for contingent losses that are considered to be reasonably possible, but not probable; however, the Company discloses the range of such reasonably possible losses. Loss contingencies considered remote are generally not disclosed.

 

Litigation is subject to numerous uncertainties and the outcome of individual claims and contingencies is not predictable. It is possible that some legal matters for which reserves have or have not been established could result in an unfavorable outcome for the Company and any such unfavorable outcome could be of a material nature or have a material adverse effect on the Company’s consolidated financial condition, results of operations and cash flows. Management is not aware of any claims or lawsuits that may have a material adverse effect on the consolidated financial position or results of operations of the Company.

 
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Warrants
 12 Months Ended
Dec. 31, 2023
Warrants  
Warrants

Note 11 – Warrants

 

The following summarizes the Company’s outstanding warrants to purchase shares of the Company’s common stock as of and for the years ended December 31, 2023 and 2022: 

 

   Warrants   Weighted Average
Exercise Price		 
Warrants outstanding as of December 31, 2021   214,400   $5.92 
Issued   —   $— 
Exercised   —   $— 
Terminated/Expired   —   $— 
Warrants outstanding as of December 31, 2022   214,400   $5.92 
Issued   335,639   $11.44 
Exercised   —   $— 
Terminated/Expired   —   $— 
Warrants outstanding as of December 31, 2023   550,039   $2.47 

 

The intrinsic value of outstanding warrants was $0.0 million as of December 31, 2023 and 2022, respectively. The following discussion provides details on the various types of outstanding warrants and the related relevant disclosures around each type.

 

The warrants shown in the table above outstanding as of December 31, 2022, are equity classified warrants issued between May 2019 and January 2021. There was no intrinsic value associated with these equity warrants as of December 31, 2022.

 

In conjunction with the Alphia Term Loan Facility mentioned in Note 8 - Debt, the Company issued to Alphia (i) a warrant (the “First Tranche Warrant”) to purchase 148,758 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”) at a price of $11.44 per share, and (ii) a warrant (the “Second Tranche Warrant” and together with the First Tranche Warrant, the “Warrants” or the “Alphia Warrants”) to purchase 186,882 shares of Common Stock at a price of $11.44 per share. Unless exercised, the Warrants expire on June 21, 2028. Alphia’s exercise of the Second Tranche Warrant was subject to the approval of the Company’s stockholders and was approved on November 15, 2023. The Warrants contained certain anti-dilution provisions in favor of Alphia in connection with any equity offering consummated by the Company prior to December 21, 2023 and equity issuances below the exercise price of the Warrants. The Warrants also contain a cashless exercise option at the election of Alphia.

 

 

Additionally, in conjunction with the Term Loan, the Company entered into a Side Letter Agreement with Alphia (the “Side Letter”) pursuant to which Alphia was granted a right of first refusal on any of the following relating to the Company or any of its subsidiaries and to the extent such transactions constitute a change of control: (i) any transfer, sale, lease or encumbrance of all or any portion of the capital stock or assets (other than the sale of inventory in the ordinary course of business), (ii) any merger, consolidation or other business combination, (iii) any recapitalization, reorganization or any other extraordinary business transaction, (iv) or any equity issuance or debt incurrence. Alphia’s right of first refusal is effective so long as the Term Loan remains outstanding and for a period of 12 months thereafter. The Side Letter also provides Alphia with certain Board observer rights.

 

The Company evaluated the Alphia Warrants under ASC 815-40, Derivatives and Hedging-Contracts in Entity’s Own Equity (“ASC 815-40”) and concluded they did not initially meet the criteria to be classified in shareholders’ equity. Specifically, there were contingent exercise provisions and settlement provisions that existed, including provisions where the number of shares available under the warrants may be adjusted based on a percentage of equity. Because the number of outstanding common shares was not a fair value input to a fixed-for-fixed model, this provision violated indexation guidance. Therefore, the warrants were not indexed to the Company’s stock. The Alphia warrant liabilities were remeasured at fair value each reporting period until provisions precluding equity classification lapsed and the Company reassessed the warrants classification on December 21, 2023. The total value of the consideration received in connection with the Alphia Term Loan Agreement was first allocated to warrants liabilities at fair value, with the remainder allocated to the Alphia Term Loan Agreement. Accordingly, the Company recorded a discount of $2.2 million on the Alphia Term Loan Agreement (see Note 8 – Debt for further discussion).

 

The Alphia warrant liabilities were determined using a risk-neutral Monte Carlo simulation based approach, a Level 3 valuation. The significant inputs to the warrant liabilities were as follows: 

 

   December 21, 2023 
   First Tranche
Warrant		   Second Tranche
Warrant		 
Exercise price  $11.44   $11.44 
Stock price  $12.00   $12.00 
Volatility   62.0%   62.0%
Time to maturity   5 years    5 years 
Risk-free rate   3.92%   3.92%
Dividend yield   —%   —%

 

The following table summarizes the Alphia warrant liability activity for twelve months ended December 31, 2023:

 

Balance as of December 31, 2022  $— 
Warrant liabilities issued   2,208 
Change in fair value of warrant liabilities   236 
Reclassification of warrants liabilities to equity   (2,444)
Balance as of December 31, 2023  $— 

 

The change in fair value related to the Alphia warrant liabilities was $0.2 million for the twelve months ended December 31, 2023. There were no transfers to/from levels 1, 2 and 3 during the twelve months ended December 31, 2023. The anti-dilution provisions which previously precluded equity treatment of the warrants, expired on December 21, 2023, and thus the warrants were reclassified and presented in equity as of December 31, 2023.

 
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-based compensation
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Share-based compensation

Note 12 – Share-based compensation

 

During the year ended December 31, 2023 and December 31, 2022, the Company recognized $1.8 million and $3.0 million, respectively, of share-based compensation expense.

 

On November 11, 2019, the Company received shareholder approval for the Amended and Restated 2019 Incentive Award Plan (the “Amended 2019 Plan”). The Amended 2019 Plan provides for the grant of stock options, stock appreciation rights, restricted stock awards, restricted stock units, other stock or cash-based awards or a dividend equivalent award. The Amended 2019 Plan authorized the issuance of 24,621 shares of common stock which was increased to 34,091 after the Halo acquisition; the Amended 2019 Plan also provides for an annual increase on the first day of each calendar year beginning on January 1, 2020 and ending on and including January 1, 2029, equal to the lesser of (A) 10% of the shares of common stock outstanding (on an as-converted basis) on the last day of the immediately preceding fiscal year and (B) such smaller number of shares of common stock as determined by the Board; provided, however, not more than 204,546 shares of common stock shall be authorized for issuance. The authorized shares for issuance was increased to 61,364 on January 1, 2021, increased to 127,606 on January 1, 2022 and again increased to 194,493 on January 1, 2023.

 

 

Stock options

 

The following table provides detail of the options granted and outstanding (dollars in thousands): 

 

   Options  

Weighted

Average

Exercise Price

   Weighted
Average
Remaining
Contractual
Life (Years)		   Aggregate
Intrinsic Value		 
Options outstanding as of December 31, 2021   61   $6.10    8.5   $— 
Granted   14   $2.24           
Forfeited/Expired   (5)  $5.26           
Options outstanding as of December 31, 2022   70   $5.39    7.2   $— 
                     
Options exercisable as of December 31, 2022   49   $5.84    6.5   $— 
Fully vested options as of December 31, 2022   49   $5.84    6.5   $— 
Options expected to vest as of December 31, 2022   21   $4.32    8.8   $— 

 

   Options  

Weighted
Average

Exercise Price

   Weighted
Average
Remaining
Contractual
Life (Years)		   Aggregate
Intrinsic Value		 
Options outstanding as of December 31, 2022   70   $5.39    7.2   $— 
Granted   5    0.35           
Forfeited/Expired   (21)   5.19           
Options outstanding as of December 31, 2023   54   $5.03    5.7   $— 
                     
Options exercisable as of December 31, 2023   46   $5.54    5.2   $— 
Fully vested options as of December 31, 2023   46   $5.54    5.2   $— 
Options expected to vest as of December 31, 2023   8   $1.74    8.9   $— 

 

Options granted under the Amended 2019 Plan vest over a period of two to three years. All vested options are exercisable and may be exercised through the ten-year anniversary of the grant date (or such earlier date described in the applicable award agreement).

 

During the years ended December 31, 2023 and 2022, $1.0 million and $2.4 million, respectively, of share-based compensation expense was recognized related to options issued. As of December 31, 2023, unrecognized share-based compensation related to options was $0.2 million, which is expected to be recognized over a weighted average period of 0.4 years.

 

The fair value of an option award is estimated on the date of grant using the Black–Scholes option valuation model, using the following assumptions primarily based on historical data:

 

    Years Ended December 31, 
    2023    2022 
Risk-free interest rate   0.33 - 4.02%   1.70 - 4.02%
Expected volatility (1)   0.0% - 72.5%   65.0% - 72.5%
Expected dividend yield   —%   —%
Expected life (years) (2)   0 - 7.6    6.0 - 6.5 

 

(1) Expected volatility was determined using a combination of historical volatility and implied volatility.
(2) For certain options, the simplified method is utilized to determine the expected life due to the lack of historical data.

 

 

Restricted Stock Awards

 

In February 2022, the Company granted 4,962 shares of restricted common stock to members of its board of directors under the Amended 2019 Plan as compensation for annual board service. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of $0.5 million upon issuance.

 

During the fourth quarter of 2022, the Company granted 1,489 shares of restricted common stock to a member of its board of directors for service as interim CEO. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of less than $0.1 million upon issuance.

 

In January 2023, the Company granted 20,292 shares of restricted common stock to members of its board of directors under the Amended 2019 Plan as compensation for annual board service. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of $0.5 million upon issuance.

 

In January 2023, the Company granted 4,545 shares of restricted common stock to certain executives and employees under the Amended 2019 Plan as performance bonus compensation totaling $0.1 million. These restricted stock awards were issued on the grant date with a one year cliff vesting condition and the Company will recognize the expense over the vesting period.

 

During the first quarter of 2023, the Company granted 409 shares of restricted common stock to a member of its board of directors for service as interim CEO. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of less than $0.1 million upon issuance.

 

During the second quarter of 2023, the Company granted 909 shares of restricted common stock to certain executives and employees under the Amended 2019 Plan as performance bonus compensation totaling less than $0.1 million. These restricted stock awards were issued on the grant date with a one year cliff vesting condition and the Company will recognize the expense over the vesting period.

 

During the third quarter of 2023, the Company granted 34,090 shares of restricted common stock to two members of its board of directors. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of less than $0.3 million upon issuance.

 
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Employee benefit plans
 12 Months Ended
Dec. 31, 2023
Retirement Benefits [Abstract]  
Employee benefit plans

Note 13 – Employee benefit plans

 

The Company has a qualified defined contribution 401(k) plan, which covers substantially all of its employees. Participants are entitled to make pre-tax and/or Roth post-tax contributions up to the annual maximums established by the IRS. The Company matches participant contributions pursuant to the terms of the plan, which contributions are limited to a percentage of the participant’s eligible compensation. The Company made contributions related to the plan and recognized expense of $0.1 million and $0.2 million during the years ended December 31, 2023 and 2022, respectively.

 
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related party transactions
 12 Months Ended
Dec. 31, 2023
Related Party Transactions [Abstract]  
Related party transactions

Note 14 – Related party transactions

 

Director Fees

 

The Company pays quarterly board of director fees. Board of director fees totaled $0.3 million during the years ended December 31, 2023 and 2022. As of December 31, 2023 and 2021, $0.1 million of these director fees were in accounts payable on the Consolidated Balance Sheets, respectively.

 

Marketing Support Services

 

On March 7, 2023, the Company entered into an agreement with Believeco to provide marketing support services for an interim period. A member of the Company’s board of directors is a partner at Believeco. As of December 31, 2023 marketing expense related to Believeco totaled $0.4 million of which $0.1 million is included within Accounts Payable.

 
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income taxes
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Income taxes

Note 15 – Income taxes

 

For the year ended December 31, 2023, the Company recorded income tax expense of less than $0.1 million. For the year ended December 31, 2022, the Company recorded income tax benefit of less than $0.1 million. For the years ended December 31, 2023 and 2022, the Company’s effective tax rate was 0%. The Company’s effective tax rate differs from the U.S. federal statutory rate of 21% primarily because the Company’s losses have been fully offset by a valuation allowance due to uncertainty of realizing the tax benefit of net operating losses (“NOLs”) for the years ended December 31, 2023 and 2022.

 

 

The following table is a reconciliation of the components that caused the Company’s provision for income taxes to differ from amounts computed by applying the U.S. federal statutory rate of 21% (in thousands):

 

   Years Ended December 31, 
   2023   2022 
Statutory U.S. Federal income tax  $(4,782)   21.0%  $(8,260)   21.0%
State income taxes, net   (309)   1.3%   (167)   0.4%
Meals and entertainment   5    —%   —    —%
Change in valuation allowance   5,031    (22.1)%   5,384    (13.7)%
Goodwill impairment   —    —%   3,802    (9.7)%
Warrant valuation   50    (0.2)%   —    —%
Tax effect of non-deductible equity instruments   —    —%   —    0.1%
Return to provision adjustment   5    —%   (5)   —%
Other   2    —%   (772)   2.0%
Total provision  $2    0.0%  $(18)   0.1%

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

 

Significant components of the Company’s deferred tax assets and liabilities are as follows (in thousands): 

 

   2023   2022 
   December 31, 
   2023   2022 
Deferred income tax assets:          
Net operating loss carryforwards  $21,662   $19,182 
ROU assets   28    42 
Share-based compensation   5,320    5,251 
Inventory   68    157 
Other assets   2,508    2,306 
Gross deferred tax assets   29,586    26,938 
Valuation allowance   (29,509)   (24,479)
Net deferred tax assets  $77   $2,459 
Deferred income tax liabilities:          
Fixed assets   (50)   (86)
Operating lease liabilities   (27)   (41)
Intangibles   —    (2,332)
Deferred tax liabilities, net of valuation allowance  $—   $— 

 

As of December 31, 2023, the Company had a deferred tax asset (before valuation allowance) recorded on gross federal and state net operating loss carryforwards of approximately $89.7 million and $59.3 million, respectively. The net operating losses will begin to expire in 2026.

 

The Internal Revenue Code, as amended (“IRC”), imposes restrictions on the utilization of NOLs and other tax attributes in the event of an “ownership change” of a corporation. Accordingly, a company’s ability to use pre-change NOLs may be limited as prescribed under IRC Section 382. Events which may cause limitation in the amount of the NOLs and credits that can be utilized annually include, but are not limited to, a cumulative ownership change of more than 50% over a three-year period.

 

Management assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to use the existing deferred tax assets in the future. A significant piece of objective negative evidence evaluated was the cumulative loss incurred through the years ended December 31, 2023 and 2022. Such objective evidence limits the ability to consider other subjective positive evidence such as current year taxable income and future income projections. On the basis of this evaluation, as of December 31, 2023, a valuation allowance of $(29.5) million was recorded since it is more likely than not that the deferred tax assets will not be realized.

 

 

Changes in valuation allowance are as follows (in thousands): 

 

   2023   2022 
   Years Ended December 31, 
   2023   2022 
Valuation allowance, at beginning of year  $24,479   $19,095 
Increase in valuation allowance   5,030    5,384 
Valuation allowance, at end of year  $29,509   $24,479 

 

As of December 31, 2023 and 2022, the Company does not have any significant uncertain tax positions and as of December 31, 2023 and 2022, the Company had no accrued interest and penalties related to uncertain income tax positions. The Company does not anticipate that the amount of unrecognized tax benefits will significantly increase or decrease within the next twelve months. If incurred, the Company would classify interest and penalties on uncertain tax positions as income tax expense.

 

The Company is subject to taxation in the U.S. federal and various state jurisdictions. The Company is not currently under audit by any taxing authorities. The Company remains open to examination by tax jurisdictions for tax years beginning with the 2020 tax year for federal and 2018 for states. Federal and state net operating losses are subject to review by taxing authorities in the year utilized and future years.

 
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Concentrations
 12 Months Ended
Dec. 31, 2023
Risks and Uncertainties [Abstract]  
Concentrations

Note 16 – Concentrations

 

Major suppliers

 

The Company sourced approximately 64% of its inventory purchases from two vendors for the year ended December 31, 2023. The Company sourced approximately 69% of its inventory purchases from three vendors for the year ended December 31, 2022.

 

Major customers

 

Accounts receivable from two customers represented 79% of accounts receivable as of December 31, 2023. Accounts receivable from three customers represented 88% of accounts receivable as of December 31, 2022. Three customers represented 62% of gross sales for the year ended December 31, 2023. Three customers represented 58% of gross sales for the year ended December 31, 2022.

 

Credit risk

 

As of December 31, 2023 and 2022, the Company’s cash and cash equivalents were deposited in accounts at several financial institutions and may maintain some balances in excess of federally insured limits. The Company maintains its cash and cash equivalents with high-quality, accredited financial institutions and, accordingly, such funds are subject to minimal credit risk. The Company has not experienced any losses historically in these accounts and believes it is not exposed to significant credit risk in its cash and cash equivalents.

 
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Loss per share
 12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Loss per share

Note 17 – Loss per share

 

The Company presents loss per share on a basic and diluted basis. Basic (loss) earnings per share is computed by dividing net loss by the weighted average number of common shares outstanding (“WASO”) during the period. Diluted loss per share includes the dilutive effect of common stock equivalents consisting of stock options and warrants using the treasury stock method and convertible notes and preferred stock using the if-converted method. Under the treasury stock method, the amount the holder must pay for exercising stock options or warrants and the amount of average compensation cost for future service that has not yet been recognized are collectively assumed to be used to repurchase shares.

 

For the year ended December 31, 2023, the Company’s basic and diluted net loss per share attributable to common stockholders are the same as the Company generated a net loss and common stock equivalents are excluded from diluted net loss per share as they have an anti-dilutive impact. Therefore, the Company did not have any dilutive securities and/or other contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. For the year ended December 31, 2022, potentially dilutive securities not included in the calculation of diluted net loss per share, because to do so would be anti-dilutive, are as follows: 214,400 of stock equivalent warrants, 69,654 of stock equivalent employee stock options and 146 of stock equivalent other options. For the year ended December 31, 2023, potentially dilutive securities not included in the calculation of diluted net loss per share, because to do so would be anti-dilutive, are as follows: 335,640 of Alphia Warrants (148,758 First Tranche Warrant and 186,882 Second Tranche Warrant); 214,400 of stock equivalent warrants; and 53,285 of stock equivalent employee stock options.

 

 

The following table sets forth basic and diluted net (loss) earnings per share attributable to common stockholders for the years ended December 31, 2023 and 2022 (in thousands, except share and per share amounts): 

 

   2023   2022 
   Year ended December 31, 
   2023   2022 
Numerator:          
Net loss  $(22,770)  $(39,316)
Less: Adjustment due to warrant modifications   —    — 
Adjusted net loss available to common stockholders  $(22,770)  $(39,316)
Denominator:          
Basic WASO   705,185    667,114 
Dilutive common stock equivalents   —    — 
Diluted WASO   705,185    667,114 
           
Net loss per share attributable to common stockholders, basic  $(32.29)  $(58.93)
Net loss per share attributable to common stockholders, diluted  $(32.29)  $(58.93)

 
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Subsequent events
 12 Months Ended
Dec. 31, 2023
Subsequent Events [Abstract]  
Subsequent events

Note 18 – Subsequent events

 

On February 9, 2024, the Company announced the acquisition of all the issued and outstanding common shares of Aimia Pet Healthco, Inc. for consideration consisting of 45,629 shares of common stock of the Company. The Company has not yet completed its evaluation of certain assets and liabilities acquired, or treatment of this transaction as either a business combination or asset acquisition in accordance with Topic 805.

 

In February 2024, the Company granted 42,088 shares of restricted common stock to members of its Board of Directors as part of their equity compensation pursuant to the Amended and Restated 2019 Incentive Award Plan. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of $0.4 million upon issuance.

 

On March 25, 2024, Better Choice Company, Inc. (“BTTR”) initiated a legal action to enforce a right of first refusal (“ROFR”) option exercised by Alphia, Inc. (“Alphia”), which is controlled by a Paris-based private equity firm, PAI Partners. The Company is unable to predict the outcome or impact on its business and financial results.
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Nature of business and summary of significant accounting policies (Policies)
 12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Initial public offering

Initial public offering

 

The Company completed its initial public offering (the “IPO”) on July 1, 2021, in which it issued and sold 181,818 shares of its common stock at a price of $5.00 per share. The total net proceeds from the IPO were approximately $36.1 million, after deducting underwriting discounts and commissions of $2.8 million, and offering costs of approximately $1.1 million. These IPO costs were recorded as a reduction of stockholders’ equity, and presented net of cash proceeds received in the Consolidated Statement of Cash Flows.

 

Upon the commencement of the IPO, all of the Company’s outstanding convertible notes payable automatically converted into 107,555 shares of common stock and upon the consummation of the IPO, all outstanding shares of the Series F convertible preferred stock were converted into 131,012 shares of common stock. Additionally, since the anti-dilution provision of the Series F Warrants were no longer effective upon consummation of the Company’s IPO, these warrants met the requirements to be considered equity and the outstanding Series F Warrants were reclassified as such.

 
Reverse stock split

Reverse stock split

 

On March 8, 2024, the Company’s Board of Directors approved a reverse stock split of the Company’s issued and outstanding shares of common stock at a ratio of 1-for-44, effective March 20, 2024 (the “Reverse Split”). In addition, the conversion rates of the Company’s outstanding preferred stock and convertible notes and the exercise prices of the Company’s underlying common stock purchase warrants and stock options were proportionately adjusted at the applicable reverse stock split ratio in accordance with the terms of such instruments. Proportionate voting rights and other rights of common stockholders were not affected by the Reverse Stock Split, other than as a result of the rounding up of fractional shares. No fractional shares of common stock were issued in connection with the Reverse Stock Split.

 

Accordingly, all share and per share amounts related to the Company’s common stock for all periods presented in the accompanying consolidated financial statements and notes thereto have been retroactively adjusted, where applicable, to reflect the Reverse Stock Split. The number of authorized shares and the par values of the common stock and convertible preferred stock were not adjusted as a result of the Reverse Stock Split.

 
Basis of presentation

Basis of presentation

 

The Company’s consolidated financial statements are prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for annual financial reports and accounting principles generally accepted in the U.S. (“GAAP”).

 
Consolidation

Consolidation

 

The financial statements are presented on a consolidated basis and include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

 
Use of estimates

Use of estimates

 

The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On an ongoing basis, the Company evaluates these assumptions, judgments and estimates. Actual results may differ from these estimates.

 

In the opinion of management, the consolidated financial statements contain all adjustments necessary for a fair statement of the results of operations for the years ended December 31, 2023 and 2022, the financial position as of December 31, 2023 and 2022 and the cash flows for the years ended December 31, 2023 and 2022.

 

 
Going concern considerations

Going concern considerations

 

The Company is subject to risks common in the pet wellness consumer market including, but not limited to, dependence on key personnel, competitive forces, successful marketing and sale of its products, the successful protection of its proprietary technologies, ability to grow into new markets, and compliance with government regulations. The Company has continually incurred losses and has an accumulated deficit. The Company’s term loan agreement with Alphia imposes certain financial covenants, including minimum liquidity of $3.0 million, minimum EBITDA of $(4.5) million, and maximum marketing spend ratio of 30%. The Company was not in compliance with certain covenants related to the Alphia Term Loan Facility as of December 31, 2023 and the debt is callable by the lender. Our continued operating losses along with our failure to meet the financial covenants create substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the date these consolidated financial statements are issued. The Company does not currently expect it will be able to generate sufficient cash flow from operations to maintain sufficient liquidity to meet the required financial covenants in certain periods prior to maturity giving the lender the right to call the debt. The Company will need to either raise additional capital or obtain additional financing, and/or secure future waivers or amendments from its lenders or accomplish some combination of these items to maintain sufficient liquidity. There can be no assurance that the Company will be successful in raising additional capital, securing future waivers and/or amendments from its lenders, renewing or refinancing its existing debt or securing new financing. If the Company is unsuccessful in doing so, it may need to reduce the scope of its operations, repay amounts owed to its lenders or sell certain assets.

 

During the third quarter, the Company received a notice of noncompliance from the NYSE American. If the Company fails to satisfy the continued listing requirements before the end of the cure period, the NYSE American may take steps to delist its common stock. Such a delisting or the announcement of such delisting will have a negative effect on the price of the Company’s common stock and would impair the ability for investors to sell or purchase the Company’s common stock. In the event of a delisting, the Company may attempt to take actions to restore its compliance with the NYSE American listing requirements, but can provide no assurance that any such action taken by the Company would allow its common stock to become listed again, stabilize the market price or improve the liquidity of its common stock, prevent its common stock from dropping below the NYSE American minimum listing requirements or prevent future non-compliance with the NYSE American listing requirements. If the Company does not maintain the listing of its common stock on NYSE American, it could make it harder for the Company to raise additional capital in the long-term. If the Company is unable to raise capital when needed in the future, it may have to cease or reduce operations. There can be no assurance that the Company will be able to satisfy the continued listing requirements in the future.

 

The Company is continuing to implement plans to achieve operating profitability, as well as implementing other strategic objectives to address liquidity. The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and payments of liabilities in the ordinary course of business. Accordingly, the consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount of and classification of liabilities that may result should the Company be unable to continue as a going concern.

 

Summary of significant accounting policies

 
Cash and cash equivalents

Cash and cash equivalents

 

Cash and cash equivalents include demand deposits held with banks and highly liquid investments with original maturities of ninety days or less at acquisition date. Cash and cash equivalents are stated at cost, which approximates fair value because of the short-term nature of these instruments. The Company’s cash equivalents are held in government money market funds and at times may exceed federally insured limits. For purposes of reporting cash flows, the Company considers all cash accounts that are not subject to withdrawal restrictions or penalties to be cash and cash equivalents. At December 31, 2022, the Company had $8.0 million in money market funds all of which were held in cash. As of December 31, 2023, the Company had closed its money market funds.

 
Restricted cash

Restricted cash

 

The Company was required to maintain a restricted cash balance of $6.3 million as of December 31, 2022, in connection with the Wintrust Credit Facility. As a result of the full repayment of the Wintrust Credit Facility, there are no restrictions on cash as of December 31, 2023. See “Note 8 - Debt” for additional information.

 
Accounts receivable and allowance for credit losses

Accounts receivable and allowance for credit losses

 

Accounts receivable consist of unpaid buyer invoices from the Company’s customers and credit card payments receivable from third-party credit card processing companies. Accounts receivable is stated at the amount billed to customers, net of point of sale and cash discounts. The Company assesses the collectability of all receivables on an ongoing basis by considering its historical credit loss experience, current economic conditions, and other relevant factors. Based on this analysis, an allowance for credit losses is recorded, and the provision is included within SG&A expense. The Company recorded approximately $0.1 million allowance for credit losses for the years ended December 31, 2023 and 2022.

 

 
Inventories

Inventories

 

Inventories, consisting of finished goods available for sale as well as packaging materials, are valued using the first-in first-out (“FIFO”) method and are recorded at the lower of cost or net realizable value. Cost is determined on a standard cost basis and includes the purchase price, as well as inbound freight costs and packaging costs.

 

The Company regularly reviews inventory quantities on hand. Excess or obsolete reserves are established when inventory is estimated to not be sellable before expiration dates based on forecasted usage, product demand and product life cycle. Additionally, inventory valuation reflects adjustments for anticipated physical inventory losses that have occurred since the last physical inventory.

 
Fixed Assets

Fixed Assets

 

Fixed assets are recorded at cost and depreciated using the straight-line method over the estimated useful lives of the assets, and depreciation expense is included within SG&A expense. Expenditures for normal repairs and maintenance are charged to operations as incurred. The cost of fixed assets that are retired or otherwise disposed of and the related accumulated depreciation are removed from the fixed asset accounts in the year of disposal and the resulting gain or loss is included in SG&A expense.

 

The Company assesses potential impairments of its fixed assets whenever events or changes in circumstances indicate that the asset’s carrying value may not be recoverable. An impairment charge would be recognized when the carrying amount of the identified asset grouping exceeds its fair value and is not recoverable, which would occur if the carrying amount exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the identified asset grouping.

 
Goodwill

Goodwill

 

Goodwill is evaluated for impairment either through a qualitative or quantitative approach at least annually, or more frequently if an event occurs or circumstances change that indicate the carrying value of a reporting unit may not be recoverable. If a quantitative assessment is performed that indicates the carrying amount of a reporting unit exceeds its fair market value, an impairment loss is recognized to reduce the carrying amount to its fair market value. The fair market value is determined based on a weighting of the present value of projected future cash flows (the “income approach”) and the use of comparative market approaches (“market approach”). Factors requiring significant judgment include, among others, the assumptions related to discount rates, forecasted operating results, long-term growth rates, the determination of comparable companies and market multiples. Fair value measurements used in the impairment review of goodwill are Level 3 measurements. See further information about the Company’s policy for fair value measurements within this section below. See “Note 6 - Goodwill and intangible assets” for additional information regarding the goodwill impairment test.

 
Intangible assets

Intangible assets

 

Finite-lived Intangible assets acquired are carried at cost, less accumulated amortization. Amortization expense is included in selling, general and administrative expenses on the consolidated statements of operations. The Company assesses long lived assets, including finite-lived intangible assets, for impairment whenever events or changes in circumstances indicate the carrying amount of the asset group may not be recoverable. The Company operates as a single reporting unit and as such, is the asset group when assessing finite-lived intangible assets for impairment. If impairment indicators are present, the Company performs a recoverability test by comparing the sum of the estimated undiscounted future cash flows attributable to its long-lived asset group to its carrying value. If the carrying amount of an asset group is not recoverable, an impairment loss is recognized based on the excess of the carrying value of the impaired asset group over its fair value. An impairment loss for an asset group is allocated to the long-lived assets of the group on a pro rata basis using the relative carrying amounts of those assets, except that the loss allocated to an individual long-lived asset of the group shall not reduce the carrying amount of that asset below its fair value whenever that fair value is determinable without undue cost and effort.

 
Share repurchases

Share repurchases

 

On May 10, 2022, the Company’s board of directors approved a share repurchase program that authorized the repurchase of up to $3.0 million of the Company’s outstanding common stock in the open market through December 31, 2022. Repurchased shares are immediately retired and returned to unissued status. During the years ended December 31, 2023 and 2022, no shares were repurchased.

 
Common stock warrants

Common stock warrants

 

Common stock warrants are recorded as either liabilities or as equity instruments, depending on the specific terms of the warrant agreement. Warrants classified as liabilities are revalued at each balance sheet date subsequent to the initial issuance and changes in the fair value are reflected in the Consolidated Statements of Operations as change in fair value of warrant liabilities. Upon exercise, the warrant is marked to fair value on the exercise date and the related fair value is reclassified to equity.

 
Income taxes

Income taxes

 

Income taxes are recorded in accordance with FASB ASC Topic 740, “Income Taxes (ASC 740)”, which provides for deferred taxes using an asset and liability approach. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the consolidated financial statements and tax bases of assets and liabilities and for loss and credit carryforwards using enacted tax rates anticipated to be in effect for the year in which the differences are expected to reverse. Valuation allowances are provided, if, based upon the weight of available evidence, it is more likely than not that some or all the deferred tax assets will not be realized.

 

 

The Company accounts for uncertain tax positions in accordance with the provisions of ASC 740. When uncertain tax positions exist, the Company recognizes the tax benefit of tax positions to the extent that some or all the benefit will more likely than not be realized. The determination as to whether the tax benefit will more likely than not be realized is based upon the technical merits of the tax position, as well as consideration of the available facts and circumstances. As of December 31, 2023 and 2022, the Company does not have any significant uncertain income tax positions. If incurred, the Company would classify interest and penalties on uncertain tax positions as income tax expense.

 

The Company was incorporated on May 6, 2019. Prior to this date, the Company operated as a flow through entity for state and U.S. federal tax purposes. The Company files a U.S. federal and state income tax return, including for its wholly owned subsidiaries.

 
Revenue

Revenue

 

Generally, the Company’s customer contracts have a single performance obligation, and revenue is recognized when the product is shipped as this is when it has been determined that control has been transferred. Amounts billed and due from customers are classified as receivables and require payment on a short-term basis and therefore do not have any significant financing components.

 

Revenue is measured as the amount of consideration the Company expects in exchange for transferring goods, which varies with changes in trade incentives the Company offers to its customers. Trade incentives consist primarily of customer pricing allowances and merchandising funds, and point of sale discounts. Estimates of trade promotion expense and coupon redemption costs are based upon programs offered, timing of those offers, estimated redemption/usage rates from historical performance, management’s experience and current economic trends.

 
Cost of goods sold

Cost of goods sold

 

Cost of goods sold consists primarily of the cost of product obtained from co-manufacturers, packaging materials, freight costs for shipping inventory to the warehouse, as well as third-party warehouse and order fulfillment costs.

 
Advertising

Advertising

 

The Company charges advertising costs to expense as incurred and such charges are included in SG&A expense. The Company’s advertising expenses consist primarily of online advertising, search costs, email advertising and radio advertising. In addition, the Company reimburses its customers and third parties for in store activities and record these costs as advertising expenses. Advertising costs were $6.8 million and $12.2 million for the years ended December 31, 2023 and 2022, respectively, of which $2.1 million is related to the amortization of the prepaid advertising contract with iHeart for the year ended December 31, 2022. See “Note 4 - Prepaid expenses and other current assets” for additional information on the prepaid advertising contract with iHeart.

 
Freight Out

Freight Out

 

Costs incurred for shipping and handling, including moving finished product to customers are included in SG&A expense. Shipping costs associated with moving finished products to customers were $1.3 million and $1.6 million for the years ended December 31, 2023 and 2022, respectively.

 
Research and development

Research and development

 

Research and development costs related to developing and testing new products are expensed as incurred and included in SG&A expense. Research and development costs were $0.1 million and $0.5 million for the years ended December 31, 2023 and 2022, respectively.

 
Share-based compensation

Share-based compensation

 

Share-based compensation awards are measured at their estimated fair value on each respective grant date. The Company recognizes share-based payment expenses over the requisite service period. The Company’s share-based compensation awards are subject only to service based vesting conditions. Pursuant to ASC 718-10-35-8, the Company recognizes compensation cost for stock awards with only service conditions that have a graded vesting schedule on a straight-line basis over the service period for each separately vesting portion of the award as if the award was, in-substance, multiple awards. Forfeitures are recognized as they occur.

 
Operating leases

Operating leases

 

The Company determines if a contract or arrangement meets the definition of a lease at inception. The Company has elected to make the accounting policy election for short-term leases. For leases with terms greater than 12 months, the Company records the related asset and obligation at the present value of lease payments over the term. Lease renewal options are only included in the measurement if the Company is reasonably certain to exercise the optional renewals. Any variable lease costs, other than those dependent upon an index or rate, are expensed as incurred. If a lease does not provide a readily available implicit rate, the Company estimates the incremental borrowing discount rate based on information available at lease commencement.

 

The Company’s only remaining operating lease as of December 31, 2023 relates to office space. There are no material residual value guarantees or material restrictive covenants.

 

 
Fair value of financial instruments

Fair value of financial instruments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy uses a framework which requires categorizing assets and liabilities into one of three levels based on the inputs used in valuing the asset or liability.

 

Level 1 inputs are unadjusted, quoted market prices in active markets for identical assets or liabilities.

 

Level 2 inputs are observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.

 

Level 3 inputs include unobservable inputs that are supported by little, infrequent or no market activity and reflect management’s own assumptions about inputs used in pricing the asset or liability.

 

Level 1 provides the most reliable measure of fair value, while Level 3 generally requires significant management judgment. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s financial instruments recognized on the Consolidated Balance Sheets consist of cash and cash equivalents, restricted cash, accounts receivable, prepaid assets, accounts payable, term loan, line of credit, accrued liabilities and other liabilities.

 

The fair value of the Company’s money market funds is based on quoted market prices using Level 1 inputs. The fair value for the Company’s term loan and line of credit approximates carrying value as the instrument has a variable interest rate that approximates market rates. The inputs related to the Company’s term loan and line of credit are reflected as Level 3 inputs.

 

The Company values it’s warrant liabilities using Level 3 inputs.

 

Fair value measurements of non-financial assets and non-financial liabilities reflect Level 3 inputs and are primarily used to measure the estimated fair values of goodwill, other intangible assets and long-lived assets impairment analyses.

 
Basic and diluted (loss) income per share

Basic and diluted (loss) income per share

 

Basic and diluted (loss) income per share has been determined by dividing the net (loss) income available to common stockholders for the applicable period by the basic and diluted weighted average number of shares outstanding, respectively. Common stock equivalents are excluded from the computation of diluted weighted average shares outstanding when their effect is anti-dilutive.

 
Segment information

Segment information

 

Operating segments are defined as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision-maker (“CODM”) in making decisions regarding resource allocation and assessing performance. The Company has viewed its operations and manages its business as one segment. The Company’s CODM reviews operating results on an aggregated basis. All the assets and operations of the Company are in the U.S.

 
New Accounting Standards

New Accounting Standards

 

Recently adopted

 

ASU 2016-13 “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”

 

In June 2016, the FASB issued ASU 2016-13, a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The standard was effective for the Company on January 1, 2023. The new standard did not have a material impact on the consolidated financial statements for the year ended December 31, 2023.
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue (Tables)
 12 Months Ended
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of Information about Revenue Channels

Information about the Company’s net sales by revenue channel is as follows (in thousands):

 

   Twelve Months Ended December 31, 
   2023   2022 
E-commerce (1)  $13,405    35%  $14,565    27%
Brick & Mortar  $5,870    15%  $11,624    21%
DTC  $5,597    15%  $6,620    12%
International (2)  $13,720    35%  $21,851    40%
Net Sales  $38,592    100%  $54,660    100%

 

(1) The Company’s E-commerce channel includes two customers that amounted to greater than 10% of the Company’s total net sales. These customers had $5.9 million and $7.1 million of net sales for the year ended December 31, 2023, respectively and $7.5 million and $6.6 million of net sales for the year ended December 31, 2022, respectively.
   
(2) One of the Company’s International customers that distributes products in China amounted to greater than 10% of the Company’s total net sales during the years ended December 31, 2023 and December 31, 2022 and represented $11.0 million and $17.7 million of net sales, respectively.
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Inventories (Tables)
 12 Months Ended
Dec. 31, 2023
Inventory Disclosure [Abstract]  
Schedule of Inventories

Inventories are summarized as follows (in thousands):

 

   December 31, 2023   December 31, 2022 
Food, treats and supplements  $6,296   $10,212 
Inventory packaging and supplies   1,166    1,699 
Total Inventories   7,462    11,911 
Inventory reserve   (851)   (1,654)
Inventories, net  $6,611   $10,257 
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Prepaid expenses and other current assets (Tables)
 12 Months Ended
Dec. 31, 2023
Prepaid Expenses And Other Current Assets  
Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets are summarized as follows (in thousands):

 

   December 31, 2023   December 31, 2022 
Prepaid advertising contract with iHeart (1)  $—   $— 
Prepaid marketing expenses   451    — 
Other prepaid expenses and other current assets   361    1,051 
Total Prepaid expenses and other current assets  $812   $1,051 

 

(1) On August 28, 2019, the Company entered into a radio advertising agreement with iHeart Media + Entertainment, Inc. (“iHeart”) and issued 166,667 shares of common stock valued at $3.4 million for future advertising services. The Company issued an additional 20,834 shares valued at $0.1 million on March 5, 2020 pursuant to the agreement. The current portion of the remaining value, reflected above, is the remaining value of services that the Company expects to utilize within the twelve months following the reporting period date, unless the term is extended. The Company utilized the remaining advertising services during the year ended December 31, 2022.
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fixed assets (Tables)
 12 Months Ended
Dec. 31, 2023
Property, Plant and Equipment [Abstract]  
Schedule of Fixed Assets

Fixed assets consist of the following (in thousands):

 

   Estimated Useful Life  December 31, 2023   December 31, 2022 
Equipment  2 - 5 years  $18   $7 
Furniture and fixtures  2 - 5 years   221    221 
Computer software, including website development  2 - 3 years   187    187 
Computer equipment  1 - 2 years   108    129 
Total fixed assets      534    544 
Accumulated depreciation      (304)   (169)
Fixed assets, net     $230   $375 
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Goodwill and intangible assets (Tables)
 12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of goodwill

The change in the carrying amount of goodwill for the years ended December 31, 2023 and 2022 is summarized as follows (in thousands):

 

   December 31, 2023   December 31, 2022 
Beginning balance  $—   $18,614 
Impairment expense   —    (18,614)
Ending balance  $—   $— 
Schedule of Intangible Assets

The Company’s intangible assets (in thousands) and related useful lives (in years) are as follows:

 

       December 31, 2023 
  

Estimated

Useful

Life (in years)

  

Gross Carrying

Amount

  

Accumulated

Amortization

   Impairment Loss  

Net Carrying

Amount

 
Customer relationships  —   $7,190   $(4,142)  $(3,048)  $— 
Trade name  —    7,500    (2,016)   (5,484)   — 
Total intangible assets      $14,690   $(6,158)  $(8,532)  $— 

 

       December 31, 2022 
  

Estimated Useful

Life (in years)

  

Gross Carrying

Amount

  

Accumulated

Amortization

  

Net Carrying

Amount

 
Customer relationships  7   $7,190   $(3,115)  $4,075 
Trade name  15    7,500    (1,516)   5,984 
Total intangible assets      $14,690   $(4,631)  $10,059 
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accrued and other liabilities (Tables)
 12 Months Ended
Dec. 31, 2023
Payables and Accruals [Abstract]  
Schedule of Accrued and Other Liabilities

Accrued and other liabilities consist of the following (in thousands):

 

   December 31, 2023   December 31, 2022 
Accrued taxes   105    110 
Accrued payroll and benefits   487    688 
Accrued trade promotions and advertising   90    567 
Accrued interest   254    84 
Accrued commissions   686    385 
Deferred revenue   7    336 
Short-term financing   162    165 
Other   294    261 
Total accrued and other liabilities  $2,085   $2,596 
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt (Tables)
 12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
Schedule of Components of Debt

The components of the Company’s debt consist of the following (in thousands):

 

   December 31, 2023  December 31, 2022
   Amount   Rate  

Maturity
date

  Amount   Rate  

Maturity
date

Term loan, net  $2,881    (2)   6/21/2026  $—         
Line of credit, net   1,741    (3)   6/21/2025   11,444    (1)   10/31/2024
Total debt   4,622            11,444         
Less current portion   4,622            —         
Total long-term debt  $—           $11,444         

 

(1) Interest at a variable rate of the daily U.S. Federal Funds Rate plus 375 basis points with an interest rate floor of 3.75% per annum.
   
(2) Interest at a fixed rate of 10.00% per annum.
   
(3) Interest at a variable rate of the daily U.S. Federal Funds Rate plus 250 basis points with an interest rate floor of 5.50% per annum.
Schedule of Future Debt Maturities

Future debt maturities as of December 31, 2023 and for succeeding years are as follows (in thousands):

 

Year ending December 31:    
2024  $5,291 
2025  $— 
2026  $— 
Total  $5,291 
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value Measurements (Tables)
 12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Carrying Amount and Fair Value

 

        December 31, 2023   December 31, 2022 
   Fair Value
Hierarchy		    Carrying
Amount		   Fair
Value		   Carrying
Amount		   Fair
Value		 
Term loan, net   Level 3(2)   $2,881   $3,314   $—   $— 
Line of credit   Level 2(1)   $1,741   $1,741   $11,444   $11,444 

 

(1) the fair value estimates are based upon observable market data
   
(2) the fair value estimates are based on unobservable inputs reflecting management’s assumptions about inputs used in pricing the asset or liability
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Warrants (Tables)
 12 Months Ended
Dec. 31, 2023
Warrants  
Schedule of Outstanding Warrants

The following summarizes the Company’s outstanding warrants to purchase shares of the Company’s common stock as of and for the years ended December 31, 2023 and 2022: 

 

   Warrants   Weighted Average
Exercise Price		 
Warrants outstanding as of December 31, 2021   214,400   $5.92 
Issued   —   $— 
Exercised   —   $— 
Terminated/Expired   —   $— 
Warrants outstanding as of December 31, 2022   214,400   $5.92 
Issued   335,639   $11.44 
Exercised   —   $— 
Terminated/Expired   —   $— 
Warrants outstanding as of December 31, 2023   550,039   $2.47 
Schedule of Significant Inputs to Warrants Liabilities

The Alphia warrant liabilities were determined using a risk-neutral Monte Carlo simulation based approach, a Level 3 valuation. The significant inputs to the warrant liabilities were as follows: 

 

   December 21, 2023 
   First Tranche
Warrant		   Second Tranche
Warrant		 
Exercise price  $11.44   $11.44 
Stock price  $12.00   $12.00 
Volatility   62.0%   62.0%
Time to maturity   5 years    5 years 
Risk-free rate   3.92%   3.92%
Dividend yield   —%   —%
Schedule of Warrant Liability Activity

The following table summarizes the Alphia warrant liability activity for twelve months ended December 31, 2023:

 

Balance as of December 31, 2022  $— 
Warrant liabilities issued   2,208 
Change in fair value of warrant liabilities   236 
Reclassification of warrants liabilities to equity   (2,444)
Balance as of December 31, 2023  $— 
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-based compensation (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Options Granted and Outstanding

The following table provides detail of the options granted and outstanding (dollars in thousands): 

 

   Options  

Weighted

Average

Exercise Price

   Weighted
Average
Remaining
Contractual
Life (Years)		   Aggregate
Intrinsic Value		 
Options outstanding as of December 31, 2021   61   $6.10    8.5   $— 
Granted   14   $2.24           
Forfeited/Expired   (5)  $5.26           
Options outstanding as of December 31, 2022   70   $5.39    7.2   $— 
                     
Options exercisable as of December 31, 2022   49   $5.84    6.5   $— 
Fully vested options as of December 31, 2022   49   $5.84    6.5   $— 
Options expected to vest as of December 31, 2022   21   $4.32    8.8   $— 

 

   Options  

Weighted
Average

Exercise Price

   Weighted
Average
Remaining
Contractual
Life (Years)		   Aggregate
Intrinsic Value		 
Options outstanding as of December 31, 2022   70   $5.39    7.2   $— 
Granted   5    0.35           
Forfeited/Expired   (21)   5.19           
Options outstanding as of December 31, 2023   54   $5.03    5.7   $— 
                     
Options exercisable as of December 31, 2023   46   $5.54    5.2   $— 
Fully vested options as of December 31, 2023   46   $5.54    5.2   $— 
Options expected to vest as of December 31, 2023   8   $1.74    8.9   $— 
Schedule of Fair Value Assumptions

The fair value of an option award is estimated on the date of grant using the Black–Scholes option valuation model, using the following assumptions primarily based on historical data:

 

    Years Ended December 31, 
    2023    2022 
Risk-free interest rate   0.33 - 4.02%   1.70 - 4.02%
Expected volatility (1)   0.0% - 72.5%   65.0% - 72.5%
Expected dividend yield   —%   —%
Expected life (years) (2)   0 - 7.6    6.0 - 6.5 

 

(1) Expected volatility was determined using a combination of historical volatility and implied volatility.
(2) For certain options, the simplified method is utilized to determine the expected life due to the lack of historical data.
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income taxes (Tables)
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Effective Income Tax Rate Reconciliation

The following table is a reconciliation of the components that caused the Company’s provision for income taxes to differ from amounts computed by applying the U.S. federal statutory rate of 21% (in thousands):

 

   Years Ended December 31, 
   2023   2022 
Statutory U.S. Federal income tax  $(4,782)   21.0%  $(8,260)   21.0%
State income taxes, net   (309)   1.3%   (167)   0.4%
Meals and entertainment   5    —%   —    —%
Change in valuation allowance   5,031    (22.1)%   5,384    (13.7)%
Goodwill impairment   —    —%   3,802    (9.7)%
Warrant valuation   50    (0.2)%   —    —%
Tax effect of non-deductible equity instruments   —    —%   —    0.1%
Return to provision adjustment   5    —%   (5)   —%
Other   2    —%   (772)   2.0%
Total provision  $2    0.0%  $(18)   0.1%
Schedule of Deferred Tax Assets and Liabilities

Significant components of the Company’s deferred tax assets and liabilities are as follows (in thousands): 

 

   2023   2022 
   December 31, 
   2023   2022 
Deferred income tax assets:          
Net operating loss carryforwards  $21,662   $19,182 
ROU assets   28    42 
Share-based compensation   5,320    5,251 
Inventory   68    157 
Other assets   2,508    2,306 
Gross deferred tax assets   29,586    26,938 
Valuation allowance   (29,509)   (24,479)
Net deferred tax assets  $77   $2,459 
Deferred income tax liabilities:          
Fixed assets   (50)   (86)
Operating lease liabilities   (27)   (41)
Intangibles   —    (2,332)
Deferred tax liabilities, net of valuation allowance  $—   $— 
Schedule of Valuation Allowance

Changes in valuation allowance are as follows (in thousands): 

 

   2023   2022 
   Years Ended December 31, 
   2023   2022 
Valuation allowance, at beginning of year  $24,479   $19,095 
Increase in valuation allowance   5,030    5,384 
Valuation allowance, at end of year  $29,509   $24,479 
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Loss per share (Tables)
 12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders

The following table sets forth basic and diluted net (loss) earnings per share attributable to common stockholders for the years ended December 31, 2023 and 2022 (in thousands, except share and per share amounts): 

 

   2023   2022 
   Year ended December 31, 
   2023   2022 
Numerator:          
Net loss  $(22,770)  $(39,316)
Less: Adjustment due to warrant modifications   —    — 
Adjusted net loss available to common stockholders  $(22,770)  $(39,316)
Denominator:          
Basic WASO   705,185    667,114 
Dilutive common stock equivalents   —    — 
Diluted WASO   705,185    667,114 
           
Net loss per share attributable to common stockholders, basic  $(32.29)  $(58.93)
Net loss per share attributable to common stockholders, diluted  $(32.29)  $(58.93)
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Nature of business and summary of significant accounting policies (Details Narrative)
$ / shares in Units, $ in Thousands
 12 Months Ended
Mar. 08, 2024
Jul. 01, 2021
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
Segment
shares
Dec. 31, 2022
USD ($)
shares
May 10, 2022
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Minimum liquidity required     $ 3,000    
Net income     $ (22,770) $ (39,316)  
Maximum marketing spend ratio     30.00%    
Restricted cash     6,300  
Allowance for credit losses     $ 100 $ 100  
Stock repurchase program, authorized amount         $ 3,000
Stock repurchased, shares | shares     0 0  
Advertising expense     $ 6,800 $ 12,200  
Amortization of other deferred charges     2,095  
Research and development expense     $ 100 500  
Number of operating segments | Segment     1    
Shipping and Handling [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Cost of revenue     $ 1,300 1,600  
Money Market Funds [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Cash       $ 8,000  
Measurement Input, EBITDA Multiple [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Net income     $ (4,500)    
Subsequent Event [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Stockholders' Equity, Reverse Stock Split 1-for-44        
IPO [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Sale of stock, number of shares issued in transaction | shares   181,818      
Sale of stock, price per share | $ / shares   $ 5.00      
Sale of stock, consideration received on transaction   $ 36,100      
Payments of underwriting discounts and commissions   2,800      
Payments of stock issuance costs   $ 1,100      
Conversion of convertible securities | shares   107,555      
Convertible preferred stock, shares issued upon conversion | shares   131,012      
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Information about Revenue Channels (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Line Items]    
Net sales $ 38,592 $ 54,660
Revenue from Contract with Customer Benchmark [Member] | Sales Channel Concentration Risk [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage 100.00% 100.00%
E Commerce [Member]    
Disaggregation of Revenue [Line Items]    
Net sales [1] $ 13,405 $ 14,565
E Commerce [Member] | Revenue from Contract with Customer Benchmark [Member] | Sales Channel Concentration Risk [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage [1] 35.00% 27.00%
Brick And Mortar [Member]    
Disaggregation of Revenue [Line Items]    
Net sales $ 5,870 $ 11,624
Brick And Mortar [Member] | Revenue from Contract with Customer Benchmark [Member] | Sales Channel Concentration Risk [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage 15.00% 21.00%
Direct To Consumer [Member]    
Disaggregation of Revenue [Line Items]    
Net sales $ 5,597 $ 6,620
Direct To Consumer [Member] | Revenue from Contract with Customer Benchmark [Member] | Sales Channel Concentration Risk [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage 15.00% 12.00%
International [Member]    
Disaggregation of Revenue [Line Items]    
Net sales [2] $ 13,720 $ 21,851
International [Member] | Revenue from Contract with Customer Benchmark [Member] | Sales Channel Concentration Risk [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage [2] 35.00% 40.00%
[1] The Company’s E-commerce channel includes two customers that amounted to greater than 10% of the Company’s total net sales. These customers had $5.9 million and $7.1 million of net sales for the year ended December 31, 2023, respectively and $7.5 million and $6.6 million of net sales for the year ended December 31, 2022, respectively.
[2] One of the Company’s International customers that distributes products in China amounted to greater than 10% of the Company’s total net sales during the years ended December 31, 2023 and December 31, 2022 and represented $11.0 million and $17.7 million of net sales, respectively.
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Information about Revenue Channels (Details) (Parenthetical) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Line Items]    
Net sales $ 38,592 $ 54,660
E Commerce [Member]    
Disaggregation of Revenue [Line Items]    
Net sales [1] 13,405 14,565
International [Member]    
Disaggregation of Revenue [Line Items]    
Net sales [2] $ 13,720 $ 21,851
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member] | E Commerce [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage 10.00% 10.00%
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | Customer One [Member] | E Commerce [Member]    
Disaggregation of Revenue [Line Items]    
Net sales $ 5,900 $ 7,500
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | Customer Two [Member] | E Commerce [Member]    
Disaggregation of Revenue [Line Items]    
Net sales $ 7,100 $ 6,600
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | One Customer [Member] | International [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage 10.00% 10.00%
Net sales $ 11,000 $ 17,700
[1] The Company’s E-commerce channel includes two customers that amounted to greater than 10% of the Company’s total net sales. These customers had $5.9 million and $7.1 million of net sales for the year ended December 31, 2023, respectively and $7.5 million and $6.6 million of net sales for the year ended December 31, 2022, respectively.
[2] One of the Company’s International customers that distributes products in China amounted to greater than 10% of the Company’s total net sales during the years ended December 31, 2023 and December 31, 2022 and represented $11.0 million and $17.7 million of net sales, respectively.
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue (Details Narrative)
 12 Months Ended
Dec. 31, 2023
Integer
Revenue from Contract with Customer [Abstract]  
Number of revenue channels 4
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Inventories (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Food, treats and supplements $ 6,296 $ 10,212
Inventory packaging and supplies 1,166 1,699
Total Inventories 7,462 11,911
Inventory reserve (851) (1,654)
Inventories, net $ 6,611 $ 10,257
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Prepaid Expenses And Other Current Assets    
Prepaid advertising contract with iHeart [1]
Prepaid marketing expenses 451
Other prepaid expenses and other current assets 361 1,051
Total Prepaid expenses and other current assets $ 812 $ 1,051
[1] On August 28, 2019, the Company entered into a radio advertising agreement with iHeart Media + Entertainment, Inc. (“iHeart”) and issued 166,667 shares of common stock valued at $3.4 million for future advertising services. The Company issued an additional 20,834 shares valued at $0.1 million on March 5, 2020 pursuant to the agreement. The current portion of the remaining value, reflected above, is the remaining value of services that the Company expects to utilize within the twelve months following the reporting period date, unless the term is extended. The Company utilized the remaining advertising services during the year ended December 31, 2022.
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Prepaid Expenses and Other Current Assets (Details) (Parenthetical) - Common Stock [Member] - I Heart Media [Member] - USD ($)
$ in Millions
Mar. 05, 2020
Aug. 28, 2019
Shares issued to third-parties for services 20,834 166,667
Stock issued during period, value, issued for services $ 0.1 $ 3.4
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Fixed Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Total fixed assets $ 534 $ 544
Accumulated depreciation (304) (169)
Fixed assets, net 230 375
Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Total fixed assets $ 18 7
Equipment [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life 2 years  
Equipment [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life 5 years  
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Total fixed assets $ 221 221
Furniture and Fixtures [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life 2 years  
Furniture and Fixtures [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life 5 years  
Computer Software, Intangible Asset [Member]    
Property, Plant and Equipment [Line Items]    
Total fixed assets $ 187 187
Computer Software, Intangible Asset [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life 2 years  
Computer Software, Intangible Asset [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life 3 years  
Computer Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Total fixed assets $ 108 $ 129
Computer Equipment [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life 1 year  
Computer Equipment [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life 2 years  
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fixed assets (Details Narrative) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Abstract]    
Depreciation expense $ 0.2 $ 0.2
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of goodwill (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
Beginning balance $ 18,614
Impairment expense  
Impairment expense (8,532) (18,614)
Ending balance
XML 61 R48.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Intangible Assets (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
Gross carrying amount $ 14,690 $ 14,690
Accumulated amortization (6,158) (4,631)
Impairment Loss (8,532) (18,614)
Net carrying amount 10,059
Customer Relationships [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross carrying amount 7,190 7,190
Accumulated amortization (4,142) (3,115)
Impairment Loss (3,048)  
Net carrying amount $ 4,075
Estimated useful life   7 years
Trade Names [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross carrying amount 7,500 $ 7,500
Accumulated amortization (2,016) (1,516)
Impairment Loss (5,484)  
Net carrying amount $ 5,984
Estimated useful life   15 years
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Goodwill and intangible assets (Details Narrative)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
USD ($)
Integer
Dec. 31, 2022
USD ($)
Oct. 01, 2022
Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]        
Number of reporting units | Integer 1      
Discount rate     20.00% 20.00%
Impairment of goodwill $ 8,532 $ 18,614    
Impairment charge 8,500 8,500    
Amortization expense $ 1,500 $ 1,500    
XML 63 R50.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Accrued and Other Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]    
Accrued taxes $ 105 $ 110
Accrued payroll and benefits 487 688
Accrued trade promotions and advertising 90 567
Accrued interest 254 84
Accrued commissions 686 385
Deferred revenue 7 336
Short-term financing 162 165
Other 294 261
Total accrued and other liabilities $ 2,085 $ 2,596
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Components of Debt (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Line of Credit Facility [Line Items]    
Line of credit, net $ 5,291 $ 11,444
Line of credit, net 4,622  
Less current portion 4,622
Total long-term debt 11,444
Term Loan [Member]    
Line of Credit Facility [Line Items]    
Line of credit, net $ 2,881 [1]
Maturity date [1] Jun. 21, 2026  
Line of Credit [Member]    
Line of Credit Facility [Line Items]    
Line of credit, net $ 1,741 [2] $ 11,444 [3]
Maturity date Jun. 21, 2025 [2] Oct. 31, 2024 [3]
[1] Interest at a fixed rate of 10.00% per annum.
[2] Interest at a variable rate of the daily U.S. Federal Funds Rate plus 250 basis points with an interest rate floor of 5.50% per annum.
[3] Interest at a variable rate of the daily U.S. Federal Funds Rate plus 375 basis points with an interest rate floor of 3.75% per annum.
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Components of Debt (Details) (Parenthetical)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Line of Credit [Member] | Fed Funds Effective Rate Overnight Index Swap Rate [Member]    
Line of Credit Facility [Line Items]    
Basis spread on variable interest rate 250 375
Floor interest rate 5.50% 3.75%
Term Loan [Member]    
Line of Credit Facility [Line Items]    
Interest at fixed rate 10.00%  
XML 66 R53.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Future Debt Maturities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Debt Disclosure [Abstract]    
2024 $ 5,291  
2025  
2026  
Total $ 5,291 $ 11,444
XML 67 R54.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt (Details Narrative) - USD ($)
 12 Months Ended
Jun. 21, 2023
Jan. 06, 2021
Dec. 31, 2023
Dec. 31, 2022
Mar. 31, 2023
Jan. 01, 2023
Oct. 24, 2022
Sep. 30, 2022
Mar. 31, 2022
Jan. 01, 2022
Aug. 13, 2021
Aug. 12, 2021
Debt Instrument [Line Items]                        
Covenant, minimum liquidity required     $ 3,000,000.0                  
Payments on revolving line of credit     13,500,000 $ 5,640,000                
Long term debt     5,291,000 11,444,000                
Line of credit     7,841,000                
Line of credit     1,741,000                
Payable in kind interest     $ 254,000                
Wintrust Receivables Credit Facility [Member]                        
Debt Instrument [Line Items]                        
Face amount advance (up to) 75.00%                      
Interest rate per annum     11.00%                  
Initial term of agreement 2 years                      
Renewal term of agreement 60 days                      
Accounts receivable, net     $ 10,500,000                  
Line of credit     7,800,000                  
Line of credit     1,700,000                  
Wintrust Receivables Credit Facility [Member] | Maximum [Member]                        
Debt Instrument [Line Items]                        
Eligible customer invoices purchased, maximum $ 4,800,000                      
Alphia Term Loan Facility [Member] | Line of Credit [Member]                        
Debt Instrument [Line Items]                        
Debt issuance costs     200,000                  
Interest rate per annum 10.00%                      
Original principal amount $ 5,000,000.0                      
Line of credit     5,000,000.0                  
Payable in kind interest     300,000                  
Debt discounts     $ 2,200,000                  
Prime Rate [Member] | Wintrust Receivables Credit Facility [Member]                        
Debt Instrument [Line Items]                        
Basis spread on variable interest rate 2.50%                      
Old Plank Trail Community Bank NA [Member] | Fed Funds Effective Rate Overnight Index Swap Rate [Member] | Second Amendment [Member]                        
Debt Instrument [Line Items]                        
Basis spread on variable interest rate   285                    
Old Plank Trail Community Bank NA [Member] | Fed Funds Effective Rate Overnight Index Swap Rate [Member] | Third Amendment [Member]                        
Debt Instrument [Line Items]                        
Basis spread on variable interest rate   375                    
Term Loan [Member]                        
Debt Instrument [Line Items]                        
Debt maturity date [1]     Jun. 21, 2026                  
Long term debt     $ 2,881,000 [1]                
Interest rate per annum     10.00%                  
Term Loan [Member] | Old Plank Trail Community Bank NA [Member]                        
Debt Instrument [Line Items]                        
Maximum borrowing capacity   $ 6,000,000.0                    
Debt maturity date   Jan. 06, 2024                    
Floor interest rate   2.50%                    
Term Loan [Member] | Old Plank Trail Community Bank NA [Member] | London Interbank Offered Rate [Member]                        
Debt Instrument [Line Items]                        
Basis spread on variable interest rate   250                    
Line of Credit [Member]                        
Debt Instrument [Line Items]                        
Debt maturity date     Jun. 21, 2025 [2] Oct. 31, 2024 [3]                
Long term debt     $ 1,741,000 [2] $ 11,444,000 [3]                
Line of Credit [Member] | Wintrust Credit Facility [Member]                        
Debt Instrument [Line Items]                        
Maximum borrowing capacity             $ 13,500,000       $ 7,500,000 $ 6,000,000.0
Floor interest rate   3.75%                    
Maturity date, description   January 6, 2024 to October 31, 2024                    
Fixed charge coverage ratio   1.25 to 1.00                    
Liquidity required (no less than)         $ 12,000,000.0       $ 13,000,000.0      
Covenant, minimum liquidity required               $ 8,500,000        
Restricted cash           $ 6,000,000.0 $ 6,300,000     $ 6,900,000 $ 7,200,000  
Payments on revolving line of credit $ 13,500,000                      
Long term debt     $ 0 11,400,000                
Debt issuance costs       $ 200,000                
Line of Credit [Member] | Fed Funds Effective Rate Overnight Index Swap Rate [Member]                        
Debt Instrument [Line Items]                        
Basis spread on variable interest rate     250 375                
Floor interest rate     5.50% 3.75%                
Line of Credit [Member] | Old Plank Trail Community Bank NA [Member]                        
Debt Instrument [Line Items]                        
Maximum borrowing capacity   $ 6,000,000.0                    
Debt maturity date   Jan. 06, 2024                    
Floor interest rate   2.50%                    
Line of Credit [Member] | Old Plank Trail Community Bank NA [Member] | London Interbank Offered Rate [Member]                        
Debt Instrument [Line Items]                        
Basis spread on variable interest rate   250                    
[1] Interest at a fixed rate of 10.00% per annum.
[2] Interest at a variable rate of the daily U.S. Federal Funds Rate plus 250 basis points with an interest rate floor of 5.50% per annum.
[3] Interest at a variable rate of the daily U.S. Federal Funds Rate plus 375 basis points with an interest rate floor of 3.75% per annum.
XML 68 R55.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Carrying Amount and Fair Value (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Term Loan [Member] | Fair Value, Inputs, Level 3 [Member] | Reported Value Measurement [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt [1] $ 2,881
Term Loan [Member] | Fair Value, Inputs, Level 3 [Member] | Estimate of Fair Value Measurement [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt [1] 3,314
Line of Credit [Member] | Fair Value, Inputs, Level 2 [Member] | Reported Value Measurement [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt [2] 1,741 11,444
Line of Credit [Member] | Fair Value, Inputs, Level 2 [Member] | Estimate of Fair Value Measurement [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt [2] $ 1,741 $ 11,444
[1] the fair value estimates are based on unobservable inputs reflecting management’s assumptions about inputs used in pricing the asset or liability
[2] the fair value estimates are based upon observable market data
XML 69 R56.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and contingencies (Details Narrative) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]    
Purchase obligation $ 0 $ 0
XML 70 R57.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Outstanding Warrants (Details) - $ / shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Warrants    
Warrants outstanding, Balance 214,400 214,400
Weighted Average Exercise Price outstanding, Balance $ 5.92 $ 5.92
Warrants, Issued 335,639
Weighted Average Exercise Price, Issued $ 11.44
Warrants, Exercised
Weighted Average Exercise Price, Exercised
Warrants, Terminated/Expired
Weighted Average Exercise Price, Terminated/Expired
Warrants outstanding, Balance 550,039 214,400
Weighted Average Exercise Price outstanding, Balance $ 2.47 $ 5.92
XML 71 R58.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Significant Inputs to Warrants Liabilities (Details)
Dec. 21, 2023
First Tranche Warrant [Member] | Measurement Input, Exercise Price [Member]  
Class of Warrant or Right [Line Items]  
Warrant liabilities, measurement input 11.44
First Tranche Warrant [Member] | Measurement Input, Share Price [Member]  
Class of Warrant or Right [Line Items]  
Warrant liabilities, measurement input 12.00
First Tranche Warrant [Member] | Measurement Input, Price Volatility [Member]  
Class of Warrant or Right [Line Items]  
Warrant liabilities, measurement input 62.0
First Tranche Warrant [Member] | Measurement Input, Expected Term [Member]  
Class of Warrant or Right [Line Items]  
Warrant liabilities, time to maturity 5 years
First Tranche Warrant [Member] | Measurement Input, Risk Free Interest Rate [Member]  
Class of Warrant or Right [Line Items]  
Warrant liabilities, measurement input 3.92
First Tranche Warrant [Member] | Measurement Input, Expected Dividend Rate [Member]  
Class of Warrant or Right [Line Items]  
Warrant liabilities, measurement input
Second Tranche Warrant [Member] | Measurement Input, Exercise Price [Member]  
Class of Warrant or Right [Line Items]  
Warrant liabilities, measurement input 11.44
Second Tranche Warrant [Member] | Measurement Input, Share Price [Member]  
Class of Warrant or Right [Line Items]  
Warrant liabilities, measurement input 12.00
Second Tranche Warrant [Member] | Measurement Input, Price Volatility [Member]  
Class of Warrant or Right [Line Items]  
Warrant liabilities, measurement input 62.0
Second Tranche Warrant [Member] | Measurement Input, Expected Term [Member]  
Class of Warrant or Right [Line Items]  
Warrant liabilities, time to maturity 5 years
Second Tranche Warrant [Member] | Measurement Input, Risk Free Interest Rate [Member]  
Class of Warrant or Right [Line Items]  
Warrant liabilities, measurement input 3.92
Second Tranche Warrant [Member] | Measurement Input, Expected Dividend Rate [Member]  
Class of Warrant or Right [Line Items]  
Warrant liabilities, measurement input
XML 72 R59.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Warrant Liability Activity (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Change in fair value of warrant liabilities $ 236
Warrant [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning balance  
Warrant liabilities issued 2,208  
Change in fair value of warrant liabilities 236  
Reclassification of warrants liabilities to equity (2,444)  
Ending balance
XML 73 R60.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Warrants (Details Narrative) - USD ($)
 12 Months Ended
Jun. 21, 2023
Dec. 31, 2023
Dec. 31, 2022
Class of Warrant or Right [Line Items]      
Warrants outstanding, intrinsic value     $ 0.0
Common stock, par value   $ 0.001 $ 0.001
Warrant [Member]      
Class of Warrant or Right [Line Items]      
Loss (gain) in change of fair value of warrant liabilities   $ 200,000  
Line of Credit [Member] | Fair Value, Inputs, Level 3 [Member] | Reported Value Measurement [Member]      
Class of Warrant or Right [Line Items]      
Warrants liabilities   $ 2,200,000  
Secured Debt [Member] | Line of Credit [Member] | Alphia Term Loan Facility [Member]      
Class of Warrant or Right [Line Items]      
Term loan remains outstanding period 12 months    
First Tranche Warrant [Member] | Secured Debt [Member] | Line of Credit [Member] | Alphia Term Loan Facility [Member]      
Class of Warrant or Right [Line Items]      
Number of warrants converted 148,758    
Common stock, par value $ 0.001    
Price per share $ 11.44    
Second Tranche Warrant [Member] | Secured Debt [Member] | Line of Credit [Member] | Alphia Term Loan Facility [Member]      
Class of Warrant or Right [Line Items]      
Number of warrants converted 186,882    
Price per share $ 11.44    
Warrants expiration Jun. 21, 2028    
XML 74 R61.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Options Granted and Outstanding (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]      
Options Outstanding, Balance 70 61  
Weighted Average Exercise Price, Balance $ 5.39 $ 6.10  
Weighted Average Remaining Contractual Life (Years), Options outstanding 5 years 8 months 12 days 7 years 2 months 12 days 8 years 6 months
Aggregate Intrinsic Value  
Options, Granted 5 14  
Weighted Average Exercise Price, Granted $ 0.35 $ 2.24  
Options, Forfeited/Expired (21) (5)  
Weighted Average Exercise Price, Forfeited/Expired $ 5.19 $ 5.26  
Options Outstanding, Balance 54 70 61
Weighted Average Exercise Price, Balance $ 5.03 $ 5.39 $ 6.10
Aggregate Intrinsic Value
Options, Exercisable 46 49  
Weighted Average Exercise Price, Exercisable $ 5.54 $ 5.84  
Weighted Average Remaining Contractual Life (Years), Options exercisable 5 years 2 months 12 days 6 years 6 months  
Aggregate Intrinsic Value, Exercisable  
Options, Fully vested   $ 49  
Weighted Average Exercise Price, Fully vested $ 5.54 $ 5.84  
Weighted Average Remaining Contractual Life (Years), Options Fully vested 5 years 2 months 12 days 6 years 6 months  
Aggregate Intrinsic Value, Fully vested  
Options, Option Vested $ 8 $ 21  
Weighted Average Exercise Price, Option Expected Vested $ 1.74 $ 4.32  
Weighted Average Remaining Contractual Life (Years), Options Expected vest 8 years 10 months 24 days 8 years 9 months 18 days  
Aggregate Intrinsic Value, Options Expected Vest  
XML 75 R62.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Fair Value Assumptions (Details)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Risk-free interest rate minimum 0.33% 1.70%
Risk-free interest rate maximum 4.02% 4.02%
Expected dividend yield
Minimum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expected volatility [1] 0.00% 65.00%
Expected life [2] 0 years 6 years
Maximum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expected volatility [1] 72.50% 72.50%
Expected life [2] 7 years 7 months 6 days 6 years 6 months
[1] Expected volatility was determined using a combination of historical volatility and implied volatility.
[2] For certain options, the simplified method is utilized to determine the expected life due to the lack of historical data.
XML 76 R63.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-based compensation (Details Narrative) - USD ($)
$ in Millions
 1 Months Ended 3 Months Ended 12 Months Ended
Nov. 11, 2019
Jan. 31, 2023
Feb. 28, 2022
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Jan. 01, 2023
Jan. 01, 2022
Jan. 01, 2021
Nov. 10, 2019
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Share-based compensation               $ 1.8 $ 3.0        
Share-Based Payment Arrangement, Option [Member] | Minimum [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Award vesting period               2 years          
Share-Based Payment Arrangement, Option [Member] | Maximum [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Award vesting period               3 years          
2019 Incentive Award Plan [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Authorized issuance shares of common stock 34,091                 194,493 127,606 61,364 24,621
Percent of common stock outstanding 10.00%                        
Authorized common stock issuance 204,546                        
2019 Incentive Award Plan [Member] | Share-Based Payment Arrangement, Option [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Share-based compensation               $ 1.0 $ 2.4        
Unrecognized share-based compensation related to options               $ 0.2          
Period of recognition for unrecognized share-based compensation               4 months 24 days          
2019 Incentive Award Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Maximum [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Expiration period               10 years          
2019 Incentive Award Plan [Member] | Restricted Stock [Member] | Board of Directors [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Share-based compensation   $ 0.5 $ 0.5     $ 0.1 $ 0.1            
Awards granted   20,292 4,962     409 1,489            
2019 Incentive Award Plan [Member] | Restricted Stock [Member] | Executives and Employees [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Share-based compensation   $ 0.1     $ 0.1                
Awards granted   4,545     909                
2019 Incentive Award Plan [Member] | Restricted Stock [Member] | Two Member of Board of Directors [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Share-based compensation       $ 0.3                  
Awards granted       34,090                  
XML 77 R64.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Employee benefit plans (Details Narrative) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Retirement Benefits [Abstract]    
Contribution expenses $ 0.1 $ 0.2
XML 78 R65.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related party transactions (Details Narrative) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Related Party Transaction [Line Items]    
Accounts payable $ 6,928 $ 2,932
Board of Directors [Member]    
Related Party Transaction [Line Items]    
Director fees incurred 300 300
Director [Member]    
Related Party Transaction [Line Items]    
Accounts payable 100 $ 100
Director [Member] | Believeco [Member]    
Related Party Transaction [Line Items]    
Accounts payable 100  
Marketing expense $ 400  
XML 79 R66.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Statutory U.S. Federal income tax $ (4,782) $ (8,260)
Statutory U.S. Federal income tax percentage 21.00% 21.00%
Statutory U.S. Federal income tax $ (309) $ (167)
State income taxes, net percentage 1.30% 0.40%
Meals and entertainment $ 5
Meals and entertainment
Statutory U.S. Federal income tax $ 5,031 $ 5,384
Change in valuation allowance percentage (22.10%) (13.70%)
Statutory U.S. Federal income tax $ 3,802
Goodwill impairment percentage (9.70%)
Statutory U.S. Federal income tax $ 50
Warrant valuation percentage (0.20%)
Statutory U.S. Federal income tax
Tax effect of non-deductible equity instruments percentage 0.10%
Statutory U.S. Federal income tax $ 5 $ (5)
Return to provision adjustment percentage
Statutory U.S. Federal income tax $ 2 $ (772)
Other percentage 2.00%
Statutory U.S. Federal income tax $ 2 $ (18)
Total provision percentage 0.00% 0.10%
XML 80 R67.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]      
Net operating loss carryforwards $ 21,662 $ 19,182  
ROU assets 28 42  
Share-based compensation 5,320 5,251  
Inventory 68 157  
Other assets 2,508 2,306  
Gross deferred tax assets 29,586 26,938  
Valuation allowance (29,509) (24,479) $ (19,095)
Net deferred tax assets 77 2,459  
Fixed assets (50) (86)  
Operating lease liabilities (27) (41)  
Intangibles (2,332)  
Deferred tax liabilities, net of valuation allowance  
XML 81 R68.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Valuation Allowance (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Valuation allowance, at beginning of year $ 24,479 $ 19,095
Increase in valuation allowance 5,030 5,384
Valuation allowance, at end of year $ 29,509 $ 24,479
XML 82 R69.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income taxes (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
Income tax benefit (expense) $ 2,000 $ (18,000)  
Effective tax rate 0.00%    
Federal statutory rate 21.00% 21.00%  
Valuation allowance $ (29,509,000) $ (24,479,000) $ (19,095,000)
Accrued interest and penalties 0 0  
Domestic Tax Authority [Member]      
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
Net operating loss carryforwards 89,700,000 59,300,000  
Maximum [Member]      
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
Income tax benefit (expense) $ 100,000 $ 100,000  
XML 83 R70.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Concentrations (Details Narrative)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Inventories [Member] | Supplier Concentration Risk [Member] | Two Vendors [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 64.00% 69.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customers [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 79.00%  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Three Customers [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage   88.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Three Customers [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 62.00% 58.00%
XML 84 R71.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Earnings Per Share [Abstract]    
Net loss $ (22,770) $ (39,316)
Less: Adjustment due to warrant modifications
Net loss available to common stockholders $ (22,770) $ (39,316)
Basic WASO 705,185 667,114
Dilutive common stock equivalents
Diluted WASO 705,185 667,114
Net loss per share attributable to common stockholders, basic $ (32.29) $ (58.93)
Net loss per share attributable to common stockholders, diluted $ (32.29) $ (58.93)
XML 85 R72.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Loss per share (Details Narrative) - shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   214,400
Employee Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 53,285 69,654
Other Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   146
Warrant Liabilities [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 335,640  
First Tranche Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 148,758  
Second Tranche Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 186,882  
XML 86 R73.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Subsequent events (Details Narrative) - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
Feb. 09, 2024
Feb. 29, 2024
Dec. 31, 2023
Dec. 31, 2022
Subsequent Event [Line Items]        
Share based compensation expense     $ 1.8 $ 3.0
Subsequent Event [Member] | Board of Directors [Member] | 2019 Incentive Award Plan [Member]        
Subsequent Event [Line Items]        
Restricted shares, granted   42,088    
Share based compensation expense   $ 0.4    
Aimia Pet Healthco, Inc. [Member] | Subsequent Event [Member]        
Subsequent Event [Line Items]        
Number of shares of common stock 45,629      
EXCEL 87 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( #EWC%@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " Y=XQ8THWH6N\ K @ $0 &1O8U!R;W!S+V-O&ULS9++ M:L,P$$5_I6AOCU]](!QM$KIJH=! 2W="FB0BU@-IBIV_K^TF#J7]@"XU#[5SB*JS8@2AP@*0.:&7*QX0;FSL?K:3Q&?<0I#K* M/4)5%'=@D:26)&$"9F$A,M%JQ55$23Z>\5HM^/ 9NQFF%6"'%ATE*/,2F)@F MAM/0M7 %3##":--W ?5"G*M_8N<.L'-R2&9)]7V?]_6<&W-S,N MD70*QU_)<#H%7+'+Y+=ZO=D^,E$559,53596V_*!W][SNOF87'_X786MUV9G M_K'Q15"T\.LNQ!=02P,$% @ .7>,6)E&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" Y=XQ8V\=NVD(( )- & 'AL+W=OIREF[_DSD1/S9/#+9Z>Y4P3DG&8YHA M1E9WG9']=>P5 <49?\;DE1]\1K(J2TJ?Y<8TO.M8LD0D(8&0$AC^O1"?)(E4 M@G+\O17M[*\I P\_[]0G1>6A,DO,B4^3O^)01'>=ZPX*R0KGB9C1U_^0;87Z M4B^@"2_^HM?RW+[;04'.!4VWP5""-,[*__AM"^(@X-IJ"'"V ZI =XVP"O(E%4I.(RQP,-;1E\1DV>#FOQ0P"RBH?IQ)K_WN6!P-(8X,?3I M"V&HBW[,Q^CS;U]N>P)$Y:%>L!6X+P6L"/2C-ODC. MKDCWCE9Q3()+Y-H7R+$<5U$@7Q\^VK!+9)?AGB)\K ^?DPU!?HR47#!KY_U2$2P5/K2![_E>^P0&YZT#7YH2]D,[PG_^P!]:_5'1, MBHT-B=7(>7MRGDY].*9!#G<8@1;O&Z+"I@^WK>[O*C[:J+9\#(G5^/3W?/K: M"HX 3E@ FB1XK0*DCU_AA*NX^MJPMH0,B=4(#?:$!J>UH%&6Y3A!,[*A3*A( MZ74$RY6@M%%M01D2JX&ZVH.Z.K&K,0R/].*)W Q+K]78K+1A;6D9$JO1NM[3 MNCZ-UA-A,0WE@P_!PU=YCSJBM'O4-3[KM/%MH1D2JT&[V4.[.0W:).8!],4M MNPGLYBIP>K7)3Q4L;4Q;6(;$:K!LJTK+K%:X?A+,FF$=$6MJ7/JPML!,J=6) M'22RMK:2?L[81V"ZGGE$KMNUG:YK*[%I(UMC,Z16Q^94V!QM/1\R$8MWH)80 M])BG2\*4L/0BEF5W/'G&J M;E]ZH7LB!!@#/Z)Q0)!/T30++I7XC";TIM3J^*J4WM8GY5M\/G14!IUT"I;Q M#?U.WI4 ]5(6-#KORKYRU(W.:)IO2JU.K4KT;7VFOJ6VP&]H&@*Z>!4'N$C2 M-#U6+WGM=CWGVNOWU?2,6@!3:G5ZE0FP]=G[EA[T+\H@I2W 7:"Y@.<"HM # M:0Z-$=HD#=7]^(C'>% "-&H-3*G5 5;FP-9G]%N HS $=7ZQ^X"^P7GH>Z:F MII>T'<^R/B'XF4&YI>T(GM&,XE )TZAS,*56AUEY!UN?\G^$ZKE%CC=8"4TH\[!E%H=6N4=;'VZ_Q':OO,^,?H29X&Z"1ZQ$-^4V(QZ"%-J M]7'4RD0X^KS_([8GR@4\=?\;;QKO=D<477?@#)1CLD:MA"FU.K?*2CA'K$1! MC1'Q (M%5\AV/B^_H#D)<@;M3(E,K^33-*59\?2< M"QH\7Z#?K$O(AM$&+.\+3G*">(29;O MZ9(F2I)Z@?O%8J:D9-0]F%*K4ZK<@Z-/]7OPY5R:[ M^K#6M,[A%IS*+3@GN86_2))TGS-(RJ"G8@ZWN!!-.<\;[G%ZS4>JQ&;4(YA2 MJV.K/()SDD?XDR;@IC K!Y28P)1:'5;E 9R3/,!NQ+*<:2EN M9)#7JD=XCRC^)*HH7Q_5FMHY3(!3F0#G)!,PS01AY7(1.;:+=QB5U/2*3=2, M>@!3:O75!Y4'<$_R $5W1#[8IC5ERJ3CB,XCS;HX" C(@$A8"BK7'QAU J;4 MZO0J)^#J$_DMO7F*DP3=YQP.IEF6&97 M!)TCY7>KE-\]:0+A*5\F<8 F"<7*&[]>I?62*J-V8*O6+]3DNLR7H3NP^S># MF]O>BPI.E>F[)\T3E/YPYPWGT@IR]#T77.!,^B4E,),YO+]5&QQ4\?K&'5CV MOH9;%.?(]=TJUW=/6Q_$#R8'X-&VE/-[*P))14#0KP5Y$^@^ 9;JM7OZ2RPB M\BG.RO6YY5+9O_.8E1>9"I)R9%L7Q7)%VX%?]P+!=X1L#[W&<#=8$K3*61;S M""(^RR/P7:((B@;A\4&9OT@]G"&\7Q,F3Q)4CI%N)Y$*&#FBGG+O5P M6G><0DH*;E=T?TFF_81KV.*;4ZM1\/OQ=_1C M/KI 3Y>^BI4^O/4*XG,8'*\R.)[>F.Q8R;%\V0.5O/02Q13DQ2?(Q5@<*ND<2G>0>'PF,LS4;Y&L=^[?\]E5+S=T:M.+U^2^0-+W\-1 M0E80:EU>07;#RO=.R@U!-\6;&$LJ!$V+CQ'!(6'R!#B^HE3L-N0%]F__#/\/ M4$L#!!0 ( #EWC%A8VO"<"04 ,X3 8 >&PO=V]R:W-H965T&ULK5AM;]LV$/XKA%8,+=#$(F6]98Z!Q-U+@'4-FG;],.P#;=$V M$4ET2=K._OV.DBW9$L6F1?(AMN2[X_,<[_B0G.R%?%1KQC1Z*O)277MKK3=7 MHY%:K%E!U:78L!)^60I94 V/%CQV8L MSTTDP/'U$-1KQC2.I]^/T7^KR .9.55L)O(O/-/K:R_Q4,:6=)OKCV+_!SL0 M"DV\AP(:79AH?M(1?.?CIZ4R42N0\HYIE MZ$'#!\R15D@LT8<-D]3D6J$+]/GA'7K]Z@UZA7B)/JW%5M$R4Y.1!@PFTFAQ M&.^V'H\,C(<)>B]*O5;HUS)CV7F $8!O&) C@UOBC/B.+2Y1@-\BXI/ FCV M?'?B@!,T"0VJ>,% O+MR(0K6IA+]OA*;>B"77O0 MI(K)'?.F/_^$(_\7&],7"G;&>]SP'KNB3_^")4?1G%EKHG8-*U>SL.RF01*F MD.[=*?R^53B.(K^Q.L,5-KA")ZZ94-I4\TJ(3"&H]0$V [5NT8B4PSQ&L<8AFL.QR MT\)&<&S\DW[QC.&O,T-]JR VT ZX]CS MBFSSD_8++8GPV$X#^ZT,^=]!A)>:EBL^SQFB2C%M%QJ_!R4)@^ZBXA[W6<3/ M*9TH*W92^B0TE)#H]9"5"^Y7!TGCJ$NF;Q:._?%0]DD+E3BA_FF6H*44Q1$N MB+X5)NF-?T',6UC,AN>@56GL%,5JZY6;#IXS.->9R:BVH)H^#20]MB2=Q%'2A6NQ@PU/ M,+3ZQ0[2C",[>M)J*G%KZI?J M# OG.KJ#11VZM-P6 M6^RB*,9#FP/2*BEQ*^EW$LEXOM7=L^6!2E] [53Z=DXJK=(2M](V%04Z6X/_ M9FVY9J8>+#XK'7))N@N/S2Y,+M,!/2:M'A.G /X8'=?\!,\D9+&S$1J=W(P4 M3*ZJ"R,%L+:EKJ\8FK?-I=1-=173>7^+KV;UU5(;IK[I>D_EBI<*Y6P)(?W+ M&!I9UI=']8,6F^K^92ZT%D7U=,6"3DYR/"!0 81D !@ !X;"]W;W)K3C93;M[.9R#>DPN*< M;4FMOEDS7F&I7OG=3&PYP47K5)4S% 3)K,*TGBP7[6?7?+E@C2QI3:XY$$U5 M8?[S/2G9_<4$3AX_^$+O-E)_,%LNMOB.W!#Y;7O-U=NLBU+0BM2"LAIPLKZ8 M7,*WJ[!U:"W^H>1>'#T#GZ5M6E= M88F7"\[N =?6*II^:/NF]5;9T%H/XXWDZENJ_.1RQ6K!2EI@20KP'I>XS@FX MT>$$. /?;J[ ;Z]_!Z\!K<'7#6L$K@NQF$G5LO:?Y8=6WN];08Y6KDA^#D(X M!2A H<5]]7QW-'2?J7R[I%&7-&KCA8YXET*H_&QI[/TBNY\NJ;=BBW-R,5$U M(PC?DR="&R# ML8^3',E/PB"PRX\[^;%7_F6>LT;UJ5K/9="(3K\B/]4Z-.^.4"*>XQ&PW@7 DSC2" 8I3N[JT4Y=ZU5USLL6T M .1!@4D0T$J]6/UIH:B#**1:M,&!C&TB\XZT9E7]%ZU1_HA#7K$&@X>8-X[DBEQQ_THF?YN:TO=UT=W ?M&CRP&,6N MM0KVV()^;NU+RUU2!_=A3:5A.A9GFH59DB8.>3VO8.3=.3S6_">*;VE))75, MTU^@EGL?\5+1ACGWD(//I-P6_]2(LR9L(=<<9>-1,:W0_&@]' KL 0?]A%," M>:-7NPX=Y1/#8Z(,!9DQP2U6\=PUA7K@03_Q/JEWP-8@YZ2@]O7#PJPT&N/8 MW\RS5IEA!CW]X!/X([P")<.U>P6T,"W+C R\S?Q"!CTHZ>;+3VLR M)@)C8[VQV#CF->HIB?R4'&XSGEARD 5ZH:K!D5"+61QGCGTPZN&(H'==_)O5 M9_DSA?X"'3UGK!>*-LS[Z"#I)^FPF)WUX(]RPHX 6<@,(Q=V48]=Y,?N206! M3+@FXX*PV$#DDMGC%_G/B_N*.&6R68Y]AE33!L(XR1QB>VXB/S?W8I\2:"(1 MJ@WV?*S18I;"R*6Q1R=*O'5[(UG^?1& M':3_(\44I&@^#5 "WN!J^PXD23;-DOFC(16BVY T4JB#0Z%K"PN]5ER1G%2W M:I?R>"'6VNFKK2E0SEO2WFR6]A$PMP;&>=)B@QQ'!M0S'_F9?UFH]8VR6LUH M?5X_HS7(\9:J&6Z5:?(_1)': HREVNR"('6.0'O-H2-E53MK>:!5G3 MW+[30B:VST($P\CH4XLAFF=QZH!\V$,^? [D3ZO#T(0XFJ?CSK59P1@YUHRP M9WWH/P@;ZUH[?T_, !JWB;9CG,7,=HR;'=U_ZW\^_(7Y':V%8ME:^07GJ0K M]_?Y^Q?)MNV5^"V3DE7MXX9@)5T;J._7C,G'%WW+WOU79?D_4$L#!!0 ( M #EWC%CJ([3JB@( "4' 8 >&PO=V]R:W-H965T&UL MK55=;],P%/TK5D (I-&D29MV(XVT=9K@ :E:!3P@'MSDMK'FV,%VVL&OY]K) MHG9+H97H0^./>\X]Q[FY3G92/>@"P)#'D@L]\PICJBO?UUD!)=4#68' G;54 M)34X51M?5PIH[D E]\,@B/V2,N&EB5M;J#21M>%,P$(179VW@7\)7!3N^- MB76RDO+!3C[E,R^P@H!#9BP#Q<<6YL"Y)4(9/UM.KTMI@?OC)_8[YQV]K*B& MN>3?6&Z*F3?U2 YK6G-S+W^ MP>R6P\_:3#=-IO!(IEO(!B0:7I P"*,>^/QT>'@(]]%S9SSLC(>.+SK"MS1H M&=RM$9*IL*)+0VA53L-^1]:AO">$\'-K;F]TSQ M*9$'JL>=ZO'YJIG6=;_B\0L=D_ R".-G,6+ZE !9'! N10 M !@ !X;"]W;W)K!P?&'\2&T(D^)ZEN9@8&RFWMZ8IX@W)L+AA6Y*K?U:,9UBJ(5^;8LL)3@JE M+#6197EFAFEN3,?%MP<^';.=3&E.'C@0NRS#_,<]2=EA8D#C^<,C76^D_F!. MQUN\)@LBOVP?N!J9%4I",Y(+RG+ R6IBW,';"#I:H9#XBY*#.'D'VI4E8T]Z M\&OC^C_UXXKYQ98D%F+/U* M$[F9&($!$K+"NU0^LL,?I'3(U7@Q2T7Q"PY'6=\V0+P3DF6ELII!1O/C$W\O MB3A10.B, BH54$/!]LXHV*6"W;3@GU%P2@6GH0#/^>"6"H7KYM'W@K@YEG@Z MYNP N)96:/JE8+_05GS17 ?*0G+U+U5Z4P EF!. MXAM@PP\ 60AV,7]$<@LDG2KV4Q2.S?TIJVT1&_K00G6Q>5MLA-P0N5Y=+FK+ MN7[@NY54S66[B<3\3SD0+_A?J]AG9UOQ1;'9&*H M]"L(WQ-C^O-/T+-^ZPJF(<&B@B"L1II;D6:^R;2GL.VBSRW':6.V]A[LUZS MU\;HD & UNKV*;J^7[D_J])0RH;+!'M,4+U,")-/$ZVHB3FI6%^^]T%<$ M[4 X-K=P6&Z$P M@T=F;+0>OEO&T-7BU*R%H(6M!MGFGZ M+5\;@H.B14.AU5D_Z7+@_UPR1J5P?'<1J98"AST25S M=19?VAOXJOZF687L3NKL=G9L'A@[91P4!$U>VG(C&T';:=;@#D$4^F=J,'SI M,F!_FW&A"G?[WSZZ^RBTD-?DX VM0D\2'!(M&@KM2+MY,6#SC.>P." DB< !@ !X;"]W;W)KEZJ:=-XCGGVF>8A"ST M2$(A(/G<7U\ H@B) &'+HQ=;HA;+_787^^V"O'[F[3>QIE2"[W75B)O)6LK- MU6PFBC6MB?C -[11OZQX6Q.IOK9/,[%I*2G-HKJ:H2A*9S5AS61Q;:[=MXMK MOI45:^A]"\2VKDG[\I%6_/EF B>'"U_8TUKJ"[/%]88\T0PQ:OGTY"I@3]PZ-C;YXS*$'KX%5RVOP^X:V1++F"=SJA&6247'E M<]M>*_9KU9OY2FQ(06\F:K<*VN[H9/'7O\ T^IL/\H64G3@ ]P[ (>V+WU3M MJ;@0@.P(J\AC18'DH.!UK7:MRN?BVYI7)6V]R;-7G1C5N@+M%E.$LBRZGNV. M\7G$XCR&:2]V8GG26YX$0W=;_E=MN'W^*Y-;6O"F8,K^Y@!)7=6?"QWCK5 [ M1FT&WD>8A".<7#+"%U)VXJ>T]U,:C/"_M"M4@2B9V'!!*OV9"$&E-Z1[7>E1 MK" 8#,#ZA M//)GYKRW=!ZT]/;(,.-Y^B@!$V)+FH*JO254QFH *B(%WS;^0,Q=P_)X8+PK MDXQLJKPW/0^:_@OGY3.K*L#J#6&MWET^XX)*WI0">P"Y"W*>0NS' "/+DE$0 MQ5TC2?/$=#$SF?X*FD[;L1GS)$8#9X?O>7[>PR/2AT$X#VO2TJEN?TI=F55/ M*$:3OE-UXM(L&R:.1PKE:3[B=V0-14%#EVOE=JK+[$JY&^Q(M:5Z SR3MB6- MJLJ,/++*U%RO[$<8;*L @T3L;&NE7V55&2BF885G[)-.T8EG MHCP9B9?E?A@F_[MFI[8$;U] =WLO".S<>XHS/ R+*P7GT5A&68Z'06IAWG?HJHQJ@KM2*Y(E_#R2NMQ+'X'=P5@;C5 RM)P,\_"08LJJ&+2OINJ8/N*HK'I;6?@. MNA[O92^E[71\M-R.PMRN=H_IF73#3]E.3RP^S,CE=!3/LT&\/%+3="1>R/(U M"O/UH:R.T!QRR1=#-!R:/%+3=([@B'&6HU&8H^\[UNIJSCZ#N,[Y )$AEYE3 M-&RE/4)3&.%LQ&++N^@5WCU$?$->1L/M$F2P2,US=(QEUH:16$:U05] MJ^JY]>0KC0[R4&J6.AG@2N4CA(HLH:(PH9H#CWM=G4ME\>,+^/'K?C+^R7OX MX;7>I=?'F>6>Z-@P';[!&3-/['(SAB/U([;<'(>Y^9Z\=$?FS?O@!=6? \_# M[PB/9'%LZ3U^C=Z/ ]C2':]V&I:6,\> :O90%<,+S>5OF$=##O5)H1B.L'Q\ M=! ?9OGCP)QGMH?489Q$0SKUR24I'CGKBRW[QV'V/_6X_O45>UU:S^9X.,6% M;WK^_!/;#B%^9>0^"L0;T'B(/H6N\R\\;<>V88C#T_9I>(+C=>R.URJ-'"@7 MGJ]C2_MQF/:/(],#\?)H6-$Y5&8N;8WB,/'XJ8WL)WRB>EYQ7R@?V[5)%V9W-(7]:%4RPI]1J5_]S[Z\TS. M2>3T:CXQF..QHV9L>1R'>?P/KAO@LV#\#![I$VL:'2M]?$M;QDLO-I>:<^R< MH7NDT#S'8Z&R#([##/XN9%2/GD%,+FUCG"1#3*[4"?)32);;\1N>LIM3AW+; M:O>K(1F\4-*"%6^]336^Z /V2VD[A7_TB/VU8_;#N:B_-(27GU&ML><0?BP? M;3^ P_W 77=*[;7<9?\$.QO%%<)XY!D?MKR.PPT?S/!%1_Y+ M:3N%:[D?A[G_"RTJ(@1;L:)_ -4]5C,O.N@*(5^\;LB#Z1WBUW+\>9M7LWU;[E;2JC@M0 MT952&7W(%+9V_P+8_HOD&_,.U2.7DM?FXYJ2DK9:0/V^XEP>ON@;]*_A+?X/ M4$L#!!0 ( #EWC%B=Z@3N"B &A< 8 >&PO=V]R:W-H965T&ULM5Q9D]M&DG['KT!H9B?L"#;5[)9DK0]%M&3+HXFQK7#;,[&Q ML0\@4"3+ @$81W?3OW[SR\RZ2%"MF8U]L-4D@:JLK#R^/*J^OF_[#\/.F#%_ MV-?-\,V3W3AV7SY].I0[LR^&9=N9AG[9M/V^&.ECOWTZ=+TI*GYI7S^]NKQ\ M\71?V.;)JZ_YN_?]JZ_;::QM8][W^3#M]T5_>&WJ]OZ;)ZLG[HN?[78WXHNG MK[[NBJVY->.OW?N>/CWUHU1V;YK!MDW>F\TW3VY67[Y^AN?Y@7]8FKC$0D?&[COG$3XD7X[_=Z&]Y[;26 M=3&8-VW]3UN-NV^>O'R25V933/7X8[QRK8>^/_YO3Y[^20OIV%L M]_HR4;"WC?Q;/"@?/N6%*WWABNF6B9C*;XNQ>/5UW][G/9ZFT? '+Y7?)N)L M@TVY'7OZU=)[XZL?BW'J3=YN\O4TT&_#D!=-Y?8(WP]VV]B-+8MF)!Z6[=2, MMMGF75O;TIKAZZV&7=#_EU3F2H=X"G1[Q=Q MY1;Q^NJC(WYKRF5^O5KD5Y=7UQ\9[]HSY9K'NSXSWD_]MFCL'P7D9I&_:9N! M%EL5(D;$G?>]&4PSRA?$HK>V*9K2%G5^2U\:DMEQR/_[9CV,/4G=_\RQ2 AX M-D\ -/'+H2M*\\V3#G/U=^;)J[_\:?7B\JN/+.^97]ZSCXW^_[/G'YUR?D$_ MMJ/)5OE?_O3R:K7Z*O\_DZ4C9/3DN#-AE-=F'$V?O=FUMC2TG?NN: [YNX:$ MYC,\" *N+K_2'_C3ZJO/ Q2QUETY*2FBHG0>CZ M]LY63!"]1)^JJ1QU#;1@FGL@NHHQVYFZRZMV*[^59%7SFDR3SF--O\AW1=?1 M'_Q W39;^A./#,O\EUU8PJX B>N^+2IB0C]NB!$M&'6.:D\46?,LI8!$O,HG M4L@^M_3QKT7=TLCXN2C[EM[=DYVS76WP[GY8Y+8IZXF7NVG;BKX8R2F,^+?M M.M/3'Q5TI/:3+G+R*/=N4SL:BA5EF6%)GK*2M,T.(U;QP:[7-)^0V#3$92+9 M4OZGMB<2RX+$)MVQB$ 2%3N2 M=F?=M"9)(](VIL?"B?#,[04$HC8C40'V67DC/WXCEK=W[W_RLD;B\[>I/N1B MPU;@;GZ_L^6.1B-!'"8C5/,NK5ZN%B]7+_/GR\O+_/K%/V1&23D,RU--2E%*HP'V3'(S9T$ZV1L$Y^7_1D T0G=!?;#@L9R*CTK+8P M//0%K8/DH:A^(\P"?H\\(>T9R3\+SMR>":=MP]:\K\B)TI26K!;>)9N]9\J' MJ=QEMB%O.JE"OH^GS>]:=@,] )BPH*7W>_?%T1[O2(6($*&?N)87O+5$\_K M\_I=9$)Y+QO-G#[(*[.1"? 1\NCM#/O&[ZO14*!$#VP\)AH")@)%(JA@IR$2 M=@6IU-H8(/R1'!GK6"1("S*#X$H0)#@8A / ]3%+LH0E\"G-M%_3\HG+9+1V M;6__@/8(ZYVB=$6?WQ7U%'0DM0='6G:LA4&(E-YL1CIF]^QU06X.4*6+P63D M4:(=>92MK(F&UB([,Z=-_53KLGNSG>I"E%@I_'5YN\QO33GU9*7DL>R[!S(! MA#P@(7L22I#WF1JZV^_>>-?%,M(T$Y$4B"-B2#]EOABID1,L 2*&?&L:T[,/ MH=]-%V1*B'$S?7]S\SY8TA2*@UD?XX>**D![RL0U>,^T"8@Q8JN$SF-C*<_1 MU_=D.8C<]AY(9)C6 X&]@G '(9@;TA%R@&1S]1T"_LT@ZBX3K8L:^S%$ F]J M2P%=,7IE#TM;YK\.C&/-,-H]NP@L5O;8AQT@D3/OB@XEFXCTC([170P_,JD:2=5[V%C9^[_E%SQO=[MH6:UNS M'!$$M$-9MX/B>B(*8H!IYU]P;@/;]+$5DI53_9TC!IZFF<3^F8?.- .-7$T, MP,([ M39KJ6H&D'^P#L>>$(,WQ$J)1M"N(<'I8VG_60ZZ,<[$H1V&M3QG' O M%J'[2SB/GQ!VTC3;%D2S]":H*3,P M887:5;(T$0&+_+>IV@;SZ]<$MS%.K*LP5A"* ^T7D"JYJG:O0T7/OQ-LV7:$ M;D4"@QQY8/.(J8((%#!1I#%B,^5[\GQ52H1DM;8$: M,;R!7P^F(+]ND%3(OZ7QV/J[M OGOZX6AQ)5=<.5B)[%I[S+WJ?41;#+M_4 M[?V0_6M3+_/OL8,9,:$TO>B\K?PZXG""[!.9F-]8Y\C=V>&#=\UJ)A'C1>%H M0SM.-'8M-TL]D'L2J*X ;2.(VGR!W8_T8B6#'4%-A"__IQ?+R_SSYXMGW^> M7U_^1_XM6S)6Q7%G*4KZ?2K(!/:)22 VE,9*M$2[C\0'#=60X 7..2W/?_RO MV^_R&Q(?I%9(SU/_1ZI8L[4:B*O#AD%RIHP$]\@N,OP6YR+JO#8D.>)635-Y M: 4_(#9W<3HQ&Z 1OHB 5,IE]WEB <<5(IK)C:\$\=."#P3*H,(Z- MB>*<[L+!D>AY)$ (1PNR6F9F*QL54CE+A%ZD?-/MH5\4A MTC>&:8#H;DEG%G #X.H?PC.U<+Q/&;B\Y[0 _Y;HS?'X"V!"YN7)S*P)%=FD MCATL2A5S\NFUDSF4)1*/K=7A-Q,G,DG9+OX]=I^H8-62#8$11YF%#0FVW\O^ MZ5HAS$B:Q!V==022$G,E_Y(^8KH6]Y[)CU98:3+>1/$H5Y1Q"?%:XH=X!X MCG .?-J-'=4X+ UX+KQKW^==Y+A(\H&H]DB;\@(P"I:I TA51XR+^7BW_[% M&#P$(#YD9+CHT''"/L(EZ-*0)KC.,&:\V%@U;+.N!B/8[D($KD1(U0<*P_E!"J&V%C9ECV*-L +(A+:9F%X5!S SJ[GZ@P70*(K/ ML=-+)C*?)1)1/^\^9Q_+=A@7FD/GS/&#AG(<67#*!]ZFF ;O[6D'^I'M6M[$ ME21Z(LD^S@'!66J8/23<$3HE"VT.SH=M*.+3>)M,E]T;"<+,0VF@O::2# ER MGQ,#54!X(N"MX B!EASPNH VA"8I&G21QL"!%S_ETQWBO36/%04=V*ZJ+^XE M1!S)C; -AL^EZ*&H18HYB"W/;0KI[7@2$%VEM.V*BC#N2\*X/^LTI- \4&QW M[XO!V>A*DA;J"0M/G='Y-=NL,101- PK:NDP%B/F\!&"4SE:AR>+,8S:/#$+R_ M(!M-FB$O9/)"WR*TTK0]S6*-6LCI:!B$D5XE&)^*A2(K5 L?/5D+^9,,2 MDBW1GD2)ET7&P1L12E:[:??D+.E? 2P:(VH1P-3F#K9P4W 9B3.ODA4D]F(S MBOK "96B^:@T6&8L^2 DI345D#$>V: DM(M<.!W$"!N%++=O$&#@,9T.*D761 M#'!&UA2A(C-(HV@2'ZM9WXI=V-I),'XFY1QY]XJM6;@D7[(M,(R))!)YVI#HE!P9N!-46=BH,-=M2 MTRPD7J6&:43RS+ODV.P#V?X;08SRP<''(_EBF5 L0M_;8DPD&! :FWZ!1I1< MY11>6")JSW3R_DA0<6^%@P$RXR(='2Q1-?XT5?\.?Q"3)^3;P;<&361<&2$ M(G+(/@Q9(.(+%DB2W&]%%*+T)HNR\% D5=0)VO\@X-W$7KPW(_M(""0LX#V" M,#+>0 N5@Z:"=R7!E2:[PGIUM#W7W+U;BR;-/(10 (\L*&:0V6BQ82I 7&P. M(GJ0QN8\9N0Y>YF=.)JN'1$N07(X[^)#"CB.A"=0-]3>)(7".BHU+2F1Q$EV M^J("4(_B2![$N>_,0WZ!CL!IP$OK*&Y@Q6HBJG1#->NACQ(Z_\.9 LDF)[&$ MDT*+[AG"\6XUR(9.2$]D @^E0A&!63:-DB6(*'(06$A@7. M$%2VQ?,[?"6I;VQ2J89+0Q@O) #57&P WU%C$(FP<>7J[ *1)6\K#C_='QDL MI=8X*LFM!28;RXY^W-'[6X*AL-($/R2Y1X^JT9;/[&P+Q 1D$$W!1D3RP6@% M(GC> WL1SJ21D2.&NK@,')C'\#>5'"V3LMQ$4A0Q6#:(,W@!JD^-ICWFQ.C= M1M81$<[BSPNV0T;6 >4]<#^>=C@G42<3GPB1AB1,*F.AB,-.62/QY4U'=B:; MFQ%ID;F!!0&=?'WD_;U[*\B7PXHKVI'T+)=U TMI.W]C.[H7E2J)[A;CK4-#1+Z% _59 IJ8&07<>)6N\0^!9S W>U*>R>7+N 52G4 D-P*@:(YLZS0:/N7OI$]U?IT,@?8# M)-QZUF7;2+LY>Z$U\.=<1,4I#4FU;\X0INZ9D?X@):B,T[LRGVXG&E'S%_E% M,#R",TG!M]SV(?Y$MUE04$B.QL02>"PX2\4$^U5'/*%]&)':=V,[@/,6+8/F MHN::S;OCJ241PKFZ7M3-QFD.29=$?ISDBI3]#VTFN(D^.>>:'3E?@$XN+&AC MAJ#Z"CEOSD=RI<05T[56DB0;H\1;4IY-HQ[OQ2&BC+LS=\3R,!X0[#6R2W Y->9!(5A[A' M_34/?P>'=N)8 R1HX[SH>XERUZ_1@ "5B/A!J!QX)[;7X5B<+ M70S+[)]N?E?&D-F3;BVF3--'Q $#8.VRKW*FC#NYT"PGD-H)N>N/1[.KA+]( M,P:;/2I,S#2VX8DX(1& QIO8^]PFWN>G)'I6@(Y\5I G>LHM.EK2DEOH??OT M(F8./"9#(E:.>"AG0+3GFM=\'&6GHDS[&;A*H\G6 1< I69C\<")O^A#(@4S M/9YO;VY?YS>W;_)?VHYV]XMG).?NH(% WU]XG,_P#/WZN:(9%R!J85_,5.6Z M7&5NMB^9MUUQT][!@^#3["9;V2$9[%S?GRM"^Z!2G0E> [:;DSQN7.PE%!$E-T \DIY5S!J8I)#C'"K6M,^3MI&I#G-+>E[B- M+1P]21>EV^YF7^#Y\U] ETASQ8J"I"/)N%NMNI4WY);,?K]7EK@\>1 MWI=S+Q*/U_8#,N/4>;!#"L2R2%/P-0L"^<"-'FE) M7E?K:1Y&MJ5S?'#O\MIGV7?,C#0B1 ,[BG\[HUF5E*1/&A8[=[39W.3'Z5XT MI 10$Z\OSMYG26^D3\V& D?A3FH=]/-+%F:)@WU@C36%H88KB=;^+F68/ MDMT0U*V9V718R;:IB3](:[C1A'6HG;;GY41ROF[*V7SHO3[34YA1:)\[ ,X+ M+'CUGS@D8Z'6K42_L#\ID1JU5!*U;*3G27)HR,QI$QO;*2:<^_*U*)TQN5J" M3BW_QO)!@^1Q:17ED:)EB>5-3Q+VC[3:\V$*=$%\[\X/++*/55NY;:)G8=&^ M/PW/-/Z10O&ZMEL][2LG)&2.-%KP&5M74$%.86>[CEF8,9?MH#6>D5M)V3-% MF2W66*:HK<,#?%A K!?'ZFR0M$++18A)Z\%1"1F!5H++HB)K)FO@A($K+FM) M+70XA'H:]%P*3=HP,ZL+ZKFTY-PVDK31W6!H)'D7)B:J-$O;?Z3*L0B*-V$+ M:]QQ$_9%CB-<,I#CI>*3[E@,Q C'>+$O*@,MA>3>J2GU@@X7-O@0TS&1Q!9O MY=%;KKK?]13@]K;F$K87)908.9J)G!S29 8P'Y$PBS!Z.N1\0EI(#_7S_+MP MKF CI$.F]FV=\^T([*H)^1EW3X2>D9C7WWC,"=&N2L)&(4-ZJ> M&??1!&ADR=QDX3/A:NCQ!6#GJ'[/77TAJ^(&S(W1W@Z7F%&4*.CG(-7BIP3=4ER 1,*.N^%48OK*]89K?7A*>)3FP,"4(U.A5AUD MJT%TT2@0%Z>I?8B, MDP4XN:8#)[C; U!)QI;"$%K4NNW[]A[*DE2<0Z8K*1''9L!&:A\'R?D#L1(OW+'NS!3DO9@J4HVTX%K+61 M7'G\E/0UHV+B#N1)F3OSXA=R=E%F/7Z&2Q,;1J,:^\@A,H[VXMX?.9#G#H/Y M?"H:JM%)#.2I@0]VVF=8/T,+RH/5,T^?^P.@@G%N7$%ZH4*G*T%T'$5V M/>;N9)R;*HQKI1>WYSM XB/K/G_ISEH!@6$JSE:.)WK$/C#SK1W"%5QD!!]^ M0'< 9Q@H1#&XHTU#.7\:'06G+2HG#"?FP,](U@PI#4\VW03 M(377C@!"7&7L=/U+:43(5OH:R]#4A)LG?I]:V*KXP)DF Z/V$,6EW,R$@,G5 M[/JTK"!37<53M6NX+E%5^3:R%CJWGS08,>F>6"WTL-UP]"B;;XK^ZJ*?IR4[ M70$W21T/\LB20(IMTH'<,J_=@MRYD:DY7:QO6,152W*&?XUC(^.(VBV9&>W" MXL;AUC?C".X_*.J76T!FXM+VOLGB5AKI(M&IG7RX@/XQ^?"U$19\:!I9(['V MJ@9L)[SL<[*B#HTNX:X++_-Q:B6ZC<%U""&/.:<'V5'B1TP!0&N#KL_QD.H# M.K"'452%.R2Q?FT92VG0J'>^CV86B&;S=C&"0NU,G>ZU5@=O=XQIHN,49\^0 M+(X/>"Q"VCYDO19R.X9U5?/H(;VZ:A%.:R]R1I*8E4LH_' OQP'3>DM[7&L5 MIY86$N<2D#,'?6QDK69MBY1N5,%56*.6.9GOZ+RFWX[H*#K+3+R^] 3446]# MX5" VT2]5\XC&I^^[GU_;#*>+H(32.(&5,\>N6KHXQ0G)5\BR"E3Q!8/I/4& M'QOT?Z:VF[ WC!,Y\J1U3([+7P0ICSQ3^D,\AS-)Z2S^B$3(K[ - B17 T(, MRN8B3R;$-9(Y0'G:$.0N"DP[1Z(6%#GG8N3\BRTELK;UA-D^0T7Q:#U=& M??J3<\GN-:X3T1L1L?TX_9&^'_ CGV\\O:/+@Q=_^U.F89Z>*T%T M8E],@.F6&JR5$NT%CT+TH$.1?4$60^X03P[&W>K2FQA_AO2\MDGA%J2>! _@ MFKV@P"\7'S/0[W%L)3;H849[?*[(^$,BM O"!\)ZFPC)5Z;DPN@%XLW>=\V^ M^>G;'\+MFD"7'^*GAZA[DMC53CV2RM*0Y&Y>]0UR<6(Z/9 &443;J9%;F^*# M%-S3"E\K?<_AFM&!H>6/YCZ["2=F;_7\T9#_;$IN!\^*JN6;JFYN?\VN+E??YG_$ %IVK#T25KV[,"N M%?5=D_UM(M)!C(1XW >B=\@1F;F2N> ;+^[#H2JNWW=UH:U:R64HL=V0LS.X MGN6@%Q2Y'#]?*<6Y@"*+GV('X8\/^8:!]#1=5*(:\I-:KUYJBN-[7!/B,Z[^ MGB1W/R>!1O5/7EHS%'GX8WIN,%QB!%'Q3$ --=SL>'P3 B[E+)H))](U"M5[ MY6(^5K:*BF8^M,S PG"KR.--($D+QIF+A);YW.V_3Z/;G_>FW_(=UV JR;%< M!.V_]==HW\CMT>%QN8/[AZ+?$@X@P+BA5R^77SQ_(K&PO=V]R:W-H965T&UL?5;;JQ*92^CPKGZ;#BT6<&5L -=LX)DI4TE')9F/;2U89$'HZH< MIG$\'59"JFA^$?9NS?Q"-ZZ4BF\-V::JA-E>Y1<5JRLU(H,KRZCJ^3L>NSU@\(?DC?VX)U\)$NM?_C%E_PR MBCTA+CES'D'@[X$77)8>"#3^[3"CO4MO>/B^0_\EQ(Y8EL+R0I=_RMP5E]%I M1#FO1%.Z.[WYE;MX)AXOTZ4-3]JTNN-91%ECG:XZ8S"HI&K_Q6.7AP.#T_@G M!FEGD ;>K:/ \D8X,;\P>D/&:P/-OX10@S7(2>6+&Z4\,DY2^:N4*2Y]5SOES@"%8[*FD.RK7Z5'$&\X&-$KZE,;I MZ C>:!_:*."-CH=&*Z,K6H"K00L@O:Z@14@L&_KK:FG#_M^O9:#%'[^.[X_+ MF:U%QI<1SH-E\\#1_/V;9!J?'V$_WK,?'T,_5IBCAJ_3^J8=]U)Z_^8T39)S MVJ7F>\&]A:YJH;8X89DVN<5_*U.8"'I%N;29;I2S?=H4,BNH-A+'5Y9;RC3. MI@U:R&'.$.E*^\,&Y8R-PTSH>ABI%B4&@% 96Q(J)Q8&$+78/GD8/./#CUG9 MY-"VHL33B4<\T>[^/'/>5K7C"LL[AK?R8RV,4]P>U'SO&QX- M(.LV?Y#^S) MZ2?89VY#AF;G%JR0$/?1Z8\^S,9'<.*%:7Q^\WT1WI+S#U3JK2C=UH>^-J(B M5F+I<9]L#2M-*-H2^JO2P014\L<1,$KR\3[/NK MK<%R^Q+-1RPLT'S/6#J1GKAN+"*R'\[H'E=3WI3<0P(.G%'K;-?M=&9C_HO:CJSZ"UUK[(,A]OE5WV-Q&'_9N@783E3^=R!GJN\;%#ZI>H."%)H-/ M-!LD^$UH.ICV//7?5"C,:S5_'N<+/Y@#SLAEXT #QREO,N>["G642AQED20# M/&:#&;TV>(<'MR.\K<,W@!\EP&LOROWN_C/CJKU=G]3;;Y2OPJRELE3R"J;Q M8#:)R+3W?KMPN@YW[5([A!9>"WPJL?$*D*\T!G&W\ [V'U_S_P%02P,$% M @ .7>,6.#0PW^@ @ W@4 !@ !X;"]W;W)K^W,VV2M^9#-'"0R&DF7N9M>4T"$R28<'-D2I1TLE: MZ8);,O4F,*5&GM:@0@11&,9!P7/I+6:U[UHO9JJR(I=XK<%41<'UXQ*%VLX] MYCTY;O)-9ITC6,Q*OL%;M-_+:TU6T+&D>8'2Y$J"QO7<.V73YSQ#(1P1R?C3"7NCME^PS6?L^!(E3/V%;1,[C#Q(*F-5T8))09'+ M9N4/[3OT "?A*X"H!42U[N:B6N4YMWPQTVH+VD43F]O4J=9H$I=+5Y1;J^DT M)YQ=7,I[E%;I',TLL$3HW$'2@I<-.'H%S"*X4M)F!C[+%-.7! $IZ>1$3W*6 MT5[&Y280RE4;X=;HR5M/_\'M7R@WA M:#>AZY&I*7F"3F%86^A&+!L]5HW3N^":7 MFV>02X#Y+([I&T\F@V_*+@415TC;MUWF[X77:].QS>#/YKKBF M% T(7!,T/#H>>Z";:=(85I5U!Z^4I7E0;S,:P*A= )VO%56Y-=P%W4A?_ -0 M2P,$% @ .7>,6/^_&ULI57;4MLP$'W/5^P8AH%I)K[$"6EN,TE*!QXH&>CE68DWL09; MN3$QF1]U]7+&%.F M6S)#05]64J7,T%2M79TI9%$!2A,W\+RNFS(NG/&P6)NK\5#F)N$"YPITGJ9, M/4TQD9N1XSO;A5N^CHU=<,?#C*WQ#LVW;*YHYM8L$4]1:"X%*%R-G(G?GX8V MO@CXSG&C=\9@G2RDO+>3JVCD>%80)K@TEH'1ZP%GF"26B&3\K#B=.J4%[HZW M[)\+[^1EP33.9/*#1R8>.3T'(ERQ/#&W# ,M=& MIA68%*1)"I6?F&'CH9(;4#::V.R@L%J@21P7 M]E#NC**OG'!F/%>8,1X!/M(Q:]3 1 32Q*@HNU(H##"MT>BA:RB=!;G+BGI: M4@=[J/T KJ4PL88+$6'TDL EG;788"MV&AQD_(3+%K3])@1>T#[ UZ[-MPN^ M]AOF+[;F)V3^IC _J\Q/]IHOJ MUL+#0^S_=VH'J5\7_D4:;(1P"QI:-10^H M#-=NP4F#V M[EUL=WWPFU[';WR5AB7_L/_'T*,R/*[05O:-:$SR-346"'K6MO^Q2;N+,)-I MQL03$!@5'0 71@(#Q2(N7VP(6RO$U.;8W9%KC#B##U3J!#=T&=B()EP)JMA3 MZSOP!F5H,?$'9PTKFFN=4S*_VVUVN^?0;H4DJ=EKA^"U?'BM4MR=7I>B6A<= M7=,QY<*4;:]>K2^-2=DKG\/+&^>:J347&A)<$=1KG7<<4&47+R=&9D7G7$A# M?;@8QG3QH;(!]'TEJ2ZJB4U07Z7CWU!+ P04 " Y=XQ8V(Y)$61 M'G=*_S(K1 OK6D@S"5?6-I=19(H5ULR1:32RTH-J$:5Q M?!K5C,MP.O:ZN9Z.56L%ESC78-JZ9OKQ"H7J)F$2/BD^\^7*.D4T'3=LB?=H MOS9S35(TL)2\1FFXDJ"QFH2SY/(J=_;>X!O'SNRLP66R4.J7$SZ4DS!V :' MPCH&1I\'O$8A'!&%\7O#&0XN'7!W_<1^ZW.G7!;,X+42WWEI5Y/P/(02*]8* M^UEU[W&3S\CQ%4H8_X:NM\W)8]$:J^H-F.2:R_[+UIMSV &4>ZMIEQ/.3F_Y&DM@QJ UX\@2H]-' MQ09]U:/3%]!)"G=*VI6!&UEB^3=!1*$,\:1/\5RE>QG?87$"67(,:9QF>_BR M(;_,\V4O\,TUW5]M'X]A+IBTP&0)-[];WM#%LO!CMC!6T\WX^5SN/7/^/+/K MEDO3L (G(;6#0?V X?3UJ^0T?KLG[GR(.]_'_M^Z[$4_']LG93$8P1O8Y>Z% M8",4BKK-6% 5V!5"I00U+9=+..22-*HU='[FZ!+N:3B4K4!GV=/-/$-P8RRG M7B'%5X-5*^ CKQ"HJE@O4 ^5_4>3!MNJI#"" TC.Z746W+9:@%'P>YI'X.D.7L :1;3.SL;T3EL@0&N:=8:A(X9VHY/4GCN)D4[W5ZC7OJ9 MYFK72MLW_J =QN:LGQ9;\W[FWC&]Y-* P(J@\L*KQLV.A+$TB MOUS1Z$?M#&B_4G2I-H)S,/Q,IG\ 4$L#!!0 ( #EWC%ACE9/4GP@ .$7 M 9 >&PO=V]R:W-H965T77[[GD/&79<3>+!8*8 MXN,^#N\]]W+.-DH_F%0(RS[G66'.!ZFUZ[>CD8E3D7,S5&M18&6I=,XM?NK5 MR*RUX(D[E&>CR7A\-,JY+ 879V[N3E^7HE,; M^$.N4DL3HXNS-5^)#\)^7-]I_!HU4A*9B\)(53 MEN>#R^CMU8SVNPU_2K$Q MG3$C3Q9*/="/V^1\,":#1"9B2Q(X_CR*:Y%E) AF?*ID#AJ5=+ [KJ7_Y'R' M+PMNQ+7*_BD3FYX/3@8L$4M>9O8/M?E%5/[,25ZL,N/^9QN_=SX=L+@T5N75 M85B0R\+_Y9\K'#H'3L;/')A4!R;.;J_(67G#+;\XTVK#-.V&-!HX5]UI&"<+ MNI0/5F-5XIR]^%FI9".SC/$B8;*PO%C)1288-T98%8E(^@)&,*ZQ<%);>#5Y4>*-B(=L&H5L,IY,7Y W;3R>.GG3 MUWA\VWI\Z3QF-]+$F3*E%NQ?EPMC->+FW_MP\%IF^[50+KTU:QZ+\P&2Q0C] M* 87/WP7'8U/7_!AUO@P>TGZ?W%K+\K;;^UORHK@B/WPWJ+"Q32[:J=X-6W)ZMX-HP03'#<.,B7PC=W+I3 MB<&$25/1A_R"C=S@? 9>,>S Z5*EP59S^)9] 'LE)"MZ=F0178B6+ M@JQ=\(P7L6#?>P@FIQA%)^%1- MN\S67&MQDF?@,?C2BV7/@M[## GPG)AZ M5(,6P"_QR+.26[A%F,A6@US"?RS36,5Q"9RP(98Z+G-C2;9A%> VY=@/O3$$ M];$GZ0X-#BY=*VUILBRD!9ML6:$L6XA BU@]"LUQKT-V4VK:\X\RVSIH0B?P M6L&R8LMB_,T$FZO$,]H5O[A6,#V$B:?FK+';4]%"B(ZVJ/K1KH9U: M0%L$O.#9UB ^8!L9U+\\XP1!79R5E#JXSA3>JT*PCV1E0'(_E9S\YU3_&%^O MM>)QVE>9\P=$T2/R"BG$A+$2!4]XZ4CP,E^3+X!5H>3A6E")?'S56Q&UB-!$WY0[)B@-H>)YJ)-36CQ2Q]!E(@[&?X\LR]BT)P(Q*N,4 M,AS$<$4MB""=#;)8E];XM*/SIER3RU"YV+),6IN),)#%4HM/I4M?C4P#V/J! MTH,:$@I+'PM+:E2P5J 7(L6.(XY/#25']PZ\OP]BV[N8VL_J/@AI6\$2-)>R M-WY<9+DDKRC0V?-[;!7Q8CV'_,CDEUHLP%!Y&TL-.+16WR;3Q$&0A3@ =\&" M%:H<[V.9_U@W^!'$/FI#;9-QL,QB'QXU*G^057%[MN<:/!_4NN" MKKMH$# J>"Y\*KJ6#<"!#%R(FU2NX>VE,^]) 0I[1.^)6X'@-P+1Y$HQYGT M4@Q)[?BVH6G@9;84SW-LCG#I&X"J(31UU=UU"?0'LD^'MV,IP[G%\1OF#:EAN6I:6NK*$( MXU*.6O($A ?DM88JW#]_Y#)S^9F@)78F/DVK8$&HM4P'TRH%57"CM%IWP@F@ MMP59%?,UF#1C>%8X=@#.K.UVJLP&'R?2.X:,5_!$ [/8W2R\R1*0-%$Q(]5: M\BP0RR5EORIV2-6!#"4_M8A3"#<Y9OO0^=.VT/V>^+D57P<]:&<.N M:W*Y].W_)7I87*,[B"F0^!?O?J>K?D\'?\-][QP.KO?R:Z>U/@ZC-V/\/9B% MT6S"#FDX#<>S$S>L]@7W+6O71X_#^7C,#B;A.#K"WH-Y.#M!&]\>493W3X'' MHV 6'GF=1V$T]XH.3L+Y=-+3^?2MT0 8_&\ _!N '7>AFH91-'>VSL+Q\;R+ M#N8K8*)P[H"9AV].9J]" X-IY,1&XW \?],S-J@?3L1GV.&+0AWH3AS]VZ-B MYWFT246!I-7^A>3?1HZ0C>OW>\^DSM,('=O^MRDZ[JKR05*W!+;O)%0*>K7T M7DNWRV=*.6\K^=XVWSQ3T!?;B@SK8@A*J"MS6R"^5B&MU7)16E<-/3D!#YCV M'Y3]#ZO6[B/N0ED X(:I #2:-F!]J92M?Y""YJO^Q7\ 4$L#!!0 ( #EW MC%@-!2I^Z ( )4& 9 >&PO=V]R:W-H965TFT\@JG]2*,(FB/&P9E\%R[FU7>CE7O15GUU,7;P/^,9Q8_;FX)2L ME/KE%N^K11 Y0BBPM Z!T7"#KU (!T0T?F\Q@[&D2]R?[]#?>NVD9<4,OE+B M.Z]LLPB* "JL62_L9[5YAUL]F<,KE3#^'S9#;)H&4/;&JG:;3 Q:+H>1W6[W M82^AB!Y(2+8)B><]%/(L7S/+EG.M-J!=-*&YB9?JLXD18+(C>)$<17R-Y0FD\7-(HB0]@I>.@E./ESZ =\7NV$J@\8J]>B8,_#A? M&:OIBOP\I'E G!Y&=,_FS'2LQ$5 [\*@OL%@^>11G$.7<+3DSCLY["T5O5=C0=5 /JB5H&?/Y1J>:B'C\%4JLN34P+6:0%\5]JF850J=5JUR_&"X(JVY06VZ<@M,(LGPVQG-I MD7;00I)-H9B.]E*U+3?&0^1%#FF1D80:M2:GQAN4/<(,TC2?7#=*VQ<$TT+- M)9.E*Q/G"?VRR; 1R>D4DCR>?%&6D8"C)_,8DN=1D?DQ.\WAT.T+]UI%BWKM M&Z([ME[:H6N,UK'GG@^MYCY\:-B73*\YB1184VIT,LL"T$,3'!96=;[QK)2E M-N:G#7TW4+L \M>*[MUVX0J,7Z+E'U!+ P04 " Y=XQ8M]^6VC@) 2 M& &0 'AL+W=OO(-RB MF %Z\8I68E'PVQ3EMP\W0NE-S>#=- N M?)3+E:.%\>UUS9?BDW"_U8\&;^..2R%+45FI*V;$XF9PE[ZZGQ&])_A=BHWM M/3.R9*[U%WIY6]P,)J204")WQ('CSUJ\%DH1(ZCQ9^0YZ$32QOYSR_W!VPY; MYMR*UUK](0NWNAE<#E@A%KQ1[J/>_"RB/6?$+]?*^E^V";39Q8#EC76ZC)NA M02FK\)=_C7[H;;B<'-B0Q0V9USL(\EJ^X8[?7AN]88:HP8T>O*E^-Y23%07E MDS/X*K'/W;X156UGVCZH0Q2Z#,53H],A: M/>ZSHQS?B'S$INF099-L>H3?M+-KZOE-C]C%WDB;*VT;(]B_[^;6&>3 ?UZR M-O":O>52')=UKH2E;-,+YA;"?8:*[QZ\I075Q9Y#-)#'#CNEVQQE+T^%L-F,GZ2E+)^.I7YTEG[7C M*GAC-CS/LDB6O!/6HAR-@:&LUL8C2J!H!8>M2E?+'QVI[)ET>N$ILB*);RN0 M".L2[AAG:VXDG\.=A@R/WB^X5$_LM]&G$7L0A3#@_=# _<$[M6HLFUZGH MXBPA7^RR7,BOHNCXI9/19)*0_7^/X.QLPLY&^/E#5LX I!+7!HDA11@EJ]T& M@7VHDE]XU0#TV;F//[+@9ZXT$UZ=@H&-ACZ1?,%SJ2@?-M*MV =5L$?%JR_L MLX%JE'!E4]'G>RP.V:^CN]&0D>3% MNB):UF/2)V0K'()E?M-_^:7ITF,?$I MU;&5(U;GHXG_MZOVS%N>D>79Y5GG_QY5XJE@S(?RU53D-:TBSJPHT^Y"%:$ M',A7W"R%WV;092G44B<@J#13E-5N!=^E(Y0$Y*5(%)9.87F:X>=R='9<<6F9 M%:@+")H_0>925#YCEO 'E'SRZ> I/'7,/J8KKS*W5CPWA*@4=>T&C&J#^<.X MIR%L2OK.(<82H /765E(9+*P(U*VHUAQR[BR&CDKBB4TY$JU29[S6E*YHK_F M7VC1I^-**&_'CAPP*6 S"MY[7RED&$P<)0^- :$IM1%#O^6@ES:<]*P)-UI' M;1E%]<)R&6#R $K/-3<%?2RD@7^TL5<)Z8?IR&(*:;<]2 ,E.FWN,$,5)0%7 M(6QNY)QTH&F,M$8 GZM"^E)%(^E(87*UP1R%X:<843'?-4MBG$X/%[-O(%X/ MWHF/RP?==$)?8XT>LJ&M63!+D#:&E/)]SJ[YVI"Q@!0TG0T8Q-XN&L,'[%#KJG)V&?Q M/J[B;F^@^3WWTT'=&& :HLZ71@@?$M\G.E?T13[( (@G=X_LKJ4_1;M ":VE M#9Y,=IK%\5Y!XFW#0S9O5C+O"=Y( $RK'F0X#U %AE *J\8 (Y1<2FJX8;*' M(V6UUC*'IHATPHNUU[:IB3L:RVQT2>V&_#IA;J/9D^#&LO,)NO23W87F8YY6 MLB15M"&D<$;F+N#O/'S>A1N2C<1M3!_X9$7SC"C0V.W5L\^)DCBG7:$'?1'> MLX6@B8$R6E."=&(13Z0Z!:&EA@/P+:[@M*:&U!;D$M["O%[9!<&A(2_6VH:Z MCCTQ=(_(1M=1D]H74]D.I$'\KO:B6E(GI#PG"=R?#VW(HFZ( !VI[[,PY&!K M TZ1V]R+/>>E*"3[42BTH"IQL=^!"YS]0F(7<*M M-J1&K]&Q>VV,/P@D8:\[8/"SM.- AEQ1.!>2X'$[0OOA>*]UT?.?C:2:5^C* M<_T5#!"@92ARTIBWDQ)BD'2F4A5##"!XQ-Y@THAS!-4*?(/SZ0':D70 MNS5DQ3U4$^HL$>DEN1. +3 QJT9$6)SX;G*)F>F"W:EZ)7DXJ[PCG/XFD.OA M?.P26XSK-\>MF [3.GSR61S4P;2?;Y$LK+5TPX1'$$+]5 V,PW$K3!Z85(3Y M$7542K2 &N>GA=9%VQ;\P>"Q!X*^63Y7:-@JX3.O;UK<$UV01+X:22@K/_&A M/&2-)QZ.@][;9P! @KNMI+F'0CQT4^7VN+-'>FA*_3L&TWWPI#3U$T';*!+8 M>R)/:I/OF7J1RF8W8SWTL/Y MM\VU>/@1(=UVDB$D_XN)\,]X9#KJTGEPXURXC1!5X$T+$7]>!HF6\]9AQZ:Y M9Z>.?O-L"R2&[06\@_VA6B>8J3.,@C0./C2$+HF_D(H7.Y*FL[#LFT&Y7>;Q M*FG_%HD,)?_;!L@O?%F&>8CZ##:%"RM[]+HJB&1[FB3_BKV">/8$OPKG>1@T MS'Y*$W]QM+UJVKMY"A= D9:]=#,X[MW38OA;^MMH.H !YL*5;;?:77C?A7O> M+7FX+7^/4SV:-8[P"VR=C"[.!J&-MR].U_[6=ZX=0-X_K@0@Q! !O@/37?M" M KK_!KC]'U!+ P04 " Y=XQ8C,=T;C,$ "\"0 &0 'AL+W=OQCV0$E'%A&*5$DJCO_]SJ%D16F=;'N1>#GGXW>NY')K[)VK$#T\U$J[ M55QYWYQ.IRZOL!;NR#2H::IG8S=8U%402E6DW3V>S]M!92Q^ME6+NQ MZZ5IO9(:;RRXMJZ%W5V@,MM5G,3[A<]R4WE>F*Z7C=C@+?H_FAM+L^F 4L@: MM9-&@\5R%9\GIQ<+E@\"7R5NW6@,;$EFS!U/?BM6\8P)H<+<,X*@WSU>HE(, M1#2^]9CQ<"0KCL=[](_!=K(E$PXOC?I3%KY:Q2^L.UDYXL8\M9Y4_?*Q*"6NON+A]X/(X63V3,*::^0!M[=08'EE?!BO;1F M"Y:E"8T'P=2@3>2DYJ#<>DN[DO3\^J.0%KX*U2)8] MT$4'E#X#E*1P;;2O''S0!19/ :;$:J"6[JE=I"\B7F%^!/-D NDLG;^ -Q], MG0>\^;^;>B5=K@Q;Z^"O\\QY2]GQ]R&C.\C%84BNF%/7B!Q7,96$0WN/\?KU MJ^3][.P%PHN!\.(E]/\3FQ>!#M/\W7B,?H&W\,PQ\*7"*!?6[J3>@*A-RXNF MA%RX"H0NN@%^:^6]4*PQ ?)C@51I>2=L,4?:S!1.@ YNA"P 'ZB?./([(QA? MH:4TMY;T03B'C#+H-V+'RA&+TJ)M<:S?--8\2"I,A))-N \F9)B+UB$3)7!P ME;'^K4=;@Q:>;.LW2**46NA<"@524P:TP>HC-AL.F!UEQE+\:-%!2QE.M"T6 MTM/9N532RZ>4W)B3<#2PDFVALX@,.@\V2%%CZMB,.#S%V7N'>N8=^BBH!9;1 MI:D;H7= :+TL6SPZM_=!L%X9H4/_*OA, 065 -N&?1Q+:L]0HZ],\9T/GL': MDE4!+V(\O8\::Q!=NX,MQ18I[B9'+,@?UM0!HM/FO5):QS7902;3"YM4.%-ZC.H5;NA>+5@6QR_V1YX]'/I931!T,ZXQ29=_% MX/N5-!I5WX 6UI[,HB][OT] TU7]B;G '-ZD/\-/D$Y.3A+ZSR?S9$'_8%QZ M]CB*/CVUJU-/X4W"ZLGD>)&,_\EDL5@,@XBEV,$C9SZFG* X=FG5-I0()N/V M$H+3)2P4="U%S/,_0!! JT<04C=MZ"-EN,7)&;70]%;@,ADB2&VCK1N^XVF< MT<-CK]8RI-24)3(/.4,$0H\!8X?O6NNA=U0<5/ZE*0Z.SI^%X/MW@K=Q)LFW,^9\73;AV%%SRNT+$#[ MI:'L["=\P/!@6_\#4$L#!!0 ( #EWC%@K>.9)^00 *<+ 9 >&PO M=V]R:W-H965TI5L<2KO;&?74/D MQ6/7:G>=-][W%XN%*QOJI)N;GC1V:F,[Z?%JMPO76Y)5=.K:Q7JY?+WHI-+Y MYBJN?;2;*Q-\JS1]M,*%KI/VZ99:L[_.5_FX\$EM&\\+B\U5+[?T0/Z/_J/% MVV)"J51'VBFCA:7Z.K]97=R>LWTT^%/1WAT\"\ZD,.8SO[ROKO,E$Z*62L\( M$G\[NJ.V92#0^)(P\RDD.QX^C^@_Q]R12R$=W9GV+U7YYCI_FXN*:AE:_\GL M?Z64SRO&*TWKXJ_8#[:OUKDH@_.F2\Y@T"D]_,O'I,.!P]OE=QS6R6$=>0^! M(LMWTLO-E35[8=D::/P04XW>(*DZY:&R=T+J2I1&>Z6W MI$M%[FKA$8(-%V6"NQW@UM^!6ZW%/1 :)W[2%57/ 1;@-A%KF5@OUV+M>K6Z%"=CBM\;RF#12_TD&NG0H#K4D"Y8V BYM42#ZU[Y1B@\[$A7QCKA M&^E%;\U.5<#!D,$* 7W \@90GREZ8*TC6RK9BH*<%U3#&NNPZ8,M$9;X@*@N M=-F7($'/,S6E(Z*QE=*8.H )%I:F%D5P4,*Y.=,77^E70IMG&77R"2&!M#/M MCBJ&;&D+'N!=$@%XZV:B;*7J\,_J6-J&5GICGV;"R\<9PHNMV9'5+ , O@1E MF1T; Q?YJ*WD,944D58Y2MRS$]P1R6'^L,K,RCCWO#+/;<_&^CB)/FY0V?23+6S&<0L+" M2@2,B4-FV9D 0;@M4J&&[6A9D/=D)ZA9%".5>/1,\).7!6^+R2,D([1*%JI5 M_FDN/L2*E<:A95PH&S; 1\JA[UA7C0^%J"F5A![QT6,9.&6TEMT"$8V6UK/$ MM2>K#!>P#-9R3+@.(B42L'OXY:7L^LN;"?-Y22J#*-KX5)M8FJDJ?JQ&Z@EF MJIFQC72RXED]>M@J:#]#=_B(.5;O4C1F3VB_*.'7V,.PB_BCA- SJG,$-Y&! ME-^T3G; RU*'V1'98I>L;('!;,9P%1#4V.^9XG(4_^(CS0+K@#-N@A-!EV0] M+A5^/";Q% &?\8M".<%W0E@A2\P1P]ME8XDUUYJY%'+G;'Q M3(SLQRDW'4MN&_RS\-DQAP&WB'E+IHB^ U-*AWZX MEQKWMV&RI6;><_F9+=)*Y>&9(_(HHB1)T,?9YJF0TI\ M+HY]?!<'ER$5V<"7ZX1TVKTRWT9KA\?34?KK#W&!0*85NJX;J,6!_(3G)J" X10 !D !X;"]W;W)K&UL MO5AK;]LX%OVN7T%X'D@ Q;9D.W6;!Y"D*::#=J=HNM//M$3;G%*BAJ3L>'[] MG$M*LIQQTMW]L$ 0Z\%[>>[KW$M=;K7Y9M="./98J-)>#=;.56]&(YNM1<'M M4%>BQ)NE-@5WN#6KD:V,X+D7*M0H'8_/1P67Y>#ZTC_[9*XO=>V4+,4GPVQ= M%-SL;H72VZM!,F@??):KM:,'H^O+BJ_$@W#_KCX9W(TZ+;DL1&FE+ID1RZO! M3?+F=DKK_8+?I=C:WC4C2Q9:?Z.;]_G58$R A!*9(PTI.EJNF[.1?PC*W%NQ.%Q4O=U[HU85E*%CK>)G3TFVK MP6E6U29;(^V977-LR?3RJ'BFBP)%AGS-OC'NET$9 VO0\F@GN+%,4*(PA%D4 M"V&Z4/N5N$C?L >03EXK0?*_]1"U-D6=<5]]O4'=S488T,?^3=^2@.3IC@E+ MDVD\'8_9CVPV?)U&[ZVMHHTF=032:S^'SR&D^39#B=_E\Q3=AL-H['?O=T.'WES9PN=/[+QE@MK2I^4&&:YK).ZN"KEZ%!AM1ZN-4.0J^A4;O/$[*&UK2G1N=(UU M@F?KB-0-O>V=#KO6VY+)L*WC"^0L7^B-^$\"'4.Y8.+/6KH=RQ2'34L)')UR M&2*_$&XK1,D^\AWDDM<>^*^\K-$^(\ICCPFJR-.E9N_+*-/E'W49.MY6NK6' M=Z.JM>2,DH-]T+QD[W@F%6V.]DI+L1D!HR33>?QJ-J<,&23D#@[ '9PSX(AX?L M9F6$($\$):V%)-W8U%O=60(S; W3(NC;KF76"5(P5F0T=N/,$$U1%BR]7S!S MU)8KRE="U;#I/L=]2M(%M/;A@T>;]9*2KUY8F4LDNVBR64>T6CPZ,L/60., MP7+O'*+GTCKI:@28,WB_7/FRQ6-GM'H3P@G]7F@I3,P 4L1,"0H4-A=E5A<+ M"JH71 A:2)4V/@#!E"CCE70P,'0"6F.M .03C;?4#'@H&=+OS2DW@*S-KJTE M;5 Z2'" @X?]FD5MT0BM/8T!M$%:"+,BG&295C+G 81A?I^H%:'&M"!&Q%LO MW8@;T0"5?S7OC,!HR\OFOG.X1PV_&MX!ZW3W7$RZ-Z>M5"CMB*HF>,R J!8. M)F:U,? EV"1D2]= G\D3B:ZY7 9&9%8SI0.M'&0Z5M/\_8300_N-.*L$2#$G MW9C9B,2ZFB#^]@S88XFN.X#]J#@>[M@\F9U-QS%XP<@-)R@AZWX1^0I;G=U1 M&L$/EF)X#T9Q^\'@-[#D?6"ZDZ::H#(**KMB(FV(9*;J/*#9@8MSPT]QOKR(7C(8J<"3?3>()])1%IX,:;XP@+R?F_)UF]#N,O:MP$$ M(@Q3$=^@>?G>$9Q-B[HF4(#U81W/_ZA)NS]\Y)XX**(9@/!0Q:UUM\CIVC[= MJI\3[9061CD0540>YFS)I6F:N2RKVC'/D4OY*/(SY-"9OV*%SH4B5D52=O:Q MC=2ABTJ8\!B*9U6C('V6^_X$%2(^-,Y['9M'7BJTEF-SI:<1KV9/KZ'G*,D7 MU,2( KTV% '8JB:21TQZ)E$+QUM/5!2:4 XU(JZB7IPP4;?1>]*:LV"5XA5% MH)T>VBK"61@49VU31IV)3Z3QUPT"34N;!,.<)L+L9BG/H@"$GF."*( )%)U/ M;[PIQ??Z>Z^C@2L"HR#G=1:*7>]!]KUXX+4XZM0'=J'\/-#Q\LX@N"SSE+E" MK3UQ&+WPW9$&+HQ9GOAHP@S\]+U(8^CS<]L= Y"W$BVF.1UTIX0' MWW^[=^G0GRO\;_0[56P8 ,_Q@/W4_$1?9$'I".IQM:'7,S:+/I-KEP@K0SH* M-L'1!!+A)WHK:0X'K)T4:G_8^*EW=7@,#:/RD\/H,P'?A8\V=.$/DENAT 6+ M\-7AFRY9TJ>=M_O;L)GJ_WR\/'O(S&PO=V]R:W-H965T<&[C/LT*?#%)CRL/12,38*/&\RRIDH!J?'=NU*G1[+RF2BX%<* M=)7G3#V<\4RN3P;^H%VX%JO4T,+H]+AD*W[#S9_EE<*W48>2B)P76L@"%%^> M#.;^X5E$\E;@J^!KW7L&\F0AY2V]?$Q.!AX1XAF/#2$P_'/'/_ L(R"D\;W! M''0F2;'_W*)?6M_1EP73_(/,OHG$I">#Z0 2OF159J[E^C?>^#,FO%AFVOZ& M=2T;A0.(*VUDWB@C@UP4]5]VW\2AIS#U=B@$C4)@>=>&+,MS9MCIL9)K4"2- M:/1@7;7:2$X4E)0;HW!7H)XYO4F9XN_)KP1BF6.N-:-P'8\,HI/,*&Z0SFJD M8 >2'\ G69A4PT61\.0QP AI==R"EMM9\"+B.8]="/TA!%X0OH 7=KZ&%B]\ MT=\#2,C!7BA4K;I__GB^T45@G_VSSOL:.MF/3V3G4)8OYR0 /A^;J MC@].W[WQ)][1"\RCCGGT$OJKLO0BTG:>GZ7A#N;OW9MIX/M'L,L.%/ *=. >>+Y@JLN5\"*YZO!$$CO ^*QX@$/="Q7A?B!^K^ [TXA=#WX M4CB?Y5VMYELU?_9,C>,Q3D 3QU1F"8JRLE3RCF6 32SJ>"KJ&;B%F3!*Q,2RD2)R>N@\VZ@*00H2 M#:G6@(*8Z;3)5ZU)BPP20= M":+A)/ AC(;>S ??0ZUH.(XF,/&'X20"/S@83KP)^+-H&,U"N"%N3N,\F7.6 M,L,1@/4#ABTRO@E&?=P=N\'D%38#./"L5CB# S?HV6PQ>.VAS< NC&AF,:81DN_S MOJRR[ 'NL":18)NGUX)LB)3<%K:1%G(G4$!1C-PPP"A.MP!U2?H_D[<[D&WR MQN"YX7A;YI#P/FKZLU?8"V$<67L>/KD'_REQ(>!Q) R$&C_B_(K$[09Y9>)" MF-K.?A!AWF8;G/9P.NT!KPKJX69K0[+X.!&HFY5<"9G8-K&6**]X/84T&%Z\ MM_/HR7S2+PZH>B8116QF;H3I#/ GJGL5$PJP8U:VG2"1.FAU]\2^",A+Y':L MR,)R3_"%9.ON7VG;YW#]+&/Q;3-8L47)#!M> T;X]1S(9<*S84^KZY4.PQZ< M-Y$O%=I4 E-9]WK43 4. 2QW''[(@&W:(/7L2_+BJ_5BOH%Q_K*AN7@6&L>& MAL+B7 M]^WY)$1:8(YI"H,A!+'DL$-<+X"VEUFN>G8NV)NYDABYEPCS GK^/ M\AX3B?,'8;'# M.&2NE75Z--;,3ABN\/9,U69CS.A>LQ!%'7X,52^./5TJ$Y&7F7CDF>N0=3SX M3LP5CJYB,^,I=]IJ+$DGYSBA;+U4I/JC/C0=&RO.'_F78*Z,M!M4.$^H48I= M>Z.I+P6.G;+U54;CW<:YY M5X]RBX6Q"A3[NGY:EK)1)X3OJ(C>R MNAO 'T;3&0+X9/!W5K3VPNWB@3<,9K7!GY*G6\78PO?Y"84E^)C>+GUO]E1; MXUT3,_E3ZK/GZB85ZB>U[?7(HV,"VZ[]H]Z'6L[5RGZ.:JS%JC#U-UNWVGWQ MSNL/O8UX_;G\B:F5P)Z0\26J>N[!>%!?)]L7(TO[V;>0!C\B[6.*7^U^IL7,M#]'^#T7U!+ P04 " Y=XQ8Z>;%+!,# #-!@ &0 'AL M+W=OR@#Z0W)F=.>?,7H;SG74/ MOD$D>-+*^$72$+57:>JK!K7P$]NBX9F-=5H0FVZ;^M:AJ&.25FF191]2+:1) MEO/HNW/+N>U(28-W#GRGM7#[%2J[6R1Y;ZWZ2];4+)++!&K M]P&OLLK'-^SZV"DS5ITGJX=DMK4T_5<\#>MPE'"9O9)0# E%U-T3196?!(GE MW-D=N!#-:&$02XW9+$Z:L"GWY'A6\-7MQ: MW0JSAT9X$/"M$TIN)-;AX#-3#15ONI-E%Z_8+,M_?/@I9K^#72.KAN M0)@ZM0[6EAIHK:?H/%;BH6N!LZA!#C:L.MP9J3O-C"RD5)*O3 WE/H9\6=]/ M0K5PJ)9O.W<_#^VSI(N7^&WG?,?N PNA8VPN*A@O%^ X+92EI);$Y)PIH$57 M<9W<_\;D9\ZX/Q^O6;.26UDJ9!&:V[$7 >U[R35^1^90B8'HH"HL'?LKNS7R M7Y["IP 7N7^ ;)+S4\"IXYL>M1B-;AL;J6?"SE#?;4;OV*MO^A;U'-XW^J_" M;27+4[CAU&SR\7T"KF^>O4&VC0VKM,3M+PX;_M^@"P$\O[%\?@&PO=V]R:W-H965TA37,L MA>WJ"A7O++0I!?'4+$-;&1293RJ+,(FBB[ 44@6C@5^;FM% KZB0"J<&[*HL MA=E.L-";81 'NX5'NPE7T3L)29.0>-YU(<_R3I 8#8S>@''1C.8&7JK/9G)2 MN98=J%7GP&293TCN#U6K4]C]?[A]JI5_NTIQ9^ MCN>6Y:?TZY#P&K9_&-9=G&M;B12' =\,BV:-P>CT)+Z(;HZ0[K>D^\?0__,5 M'<4ZS/2+)NS$?3@]N4KB^ ;>+PAWTO!UTJ9SCVCA**F1(>F/":-:%\FGWF.V)W^.%KVS#%MD'ZW?#Y/>5^.YU7/?ZOGN' MCEVXYQ(EFJ7W0@NI7BFJ#:-=;>UV7+O,6WCMU=S^I>3C4.""4Z/NY7D IO:_ M>D*Z\IXSU\0.YH7V@^<\W$%6@_0J/?4$L#!!0 ( #EWC%A0 MM,IW=P@ &04 9 >&PO=V]R:W-H965TV\54E4/87[_GWC*V MZ2:96:D[V*;N^]QS+[[:&/NG6RGEQ5.>%>ZZL_)^?3$8N/E*Y=+US5H5^&9A M;"X];NURX-96R92%\FR0Q/'I()>ZZ-Q<\;//]N;*E#[3A?ILA2OS7-KM:Y69 MS75GV-D]N-?+E:<'@YNKM5RJ!^6_KC];W UJ+:G.5>&T*815B^O.[?#B]9C. M\X'?M=JXUK6@2&;&_$DW=^EU)R:'5*;FGC1(?#RJ-RK+2!'<^*O2V:E-DF#[ M>J?]/<>.6&;2J3&BDYX-Y)?TZ2"?/2 \3\<$4?N7$ MNR)5Z;Z" 5RI_4EV_KQ.7M3X5LW[8C3LB21.1B_H&]7QC5C?Z.7XOL@G\5:[ M>69<:97X]^W,>0M$_.=0S$'C^+!&ZI(+MY9S==U!&SAE'U7GYN>?AJ?QY0O^ MCFM_QR]I_]MZO"A]V+>/QJMH.!$__S1-AL-+T38A .W(KY38*FF%HB(*E$#E M,V7K,O0$G7AC\K4LMNC$N;%T3M=ZA'H"23@ES$)DRCFF4(5G;5[,9>E@M.4)QW-V MZ<3:FD?-+ &2:KF%\+P1J5XL$,S"FES(W)30&)'RTD/=;"OD>IUMV26H_MI_ MZ(N%2I65F7!>^M(;BYBEY^"2X;'HZ@)'3>EDD;J3"_$ GDS+C+]_!U-,,Z*% MNWL2OM\+,OH7TETUS5Z^(\HW)3V)'FKK[-3[RJE6UH]$=]P[FR;B!([U8W%, M3Z:]Y#2NG[ 6M9>3GBC ]=U1?(Y3P_X(8MWAZ1ENXOX8$A^4S%"6(@4 MQ X2]J("4'()@=U5_21Z@XHOR9!XE%D9*BFIV+*8*S'IQ:.AZ"8)P'!RC-O1 M= RKHS[,'D>_&)-N=(;84%=MV=H/%L2H-XT3T3T/,G](:R7.-=8FL>C&_83T M_^@>U4%Q<:A,A2E>(?,E2D4H5'^5VF_A.SBAS!ER/YK?71&>CZ-[Y4M;$+P: M\,GT&_CZAUQU)TAMX\DGP,R*I'W@[(Q+R/7Z8CR*W"@]PM%X5]OAE*L$!P : M@-JJ--J#.R8:C3N&,E79UV$[[BN%GK*8O553*-3&B9GR&Z6*T'5(*S=#U2DD M)9U3/B "\)T!PUY#C'IMH0O45\LLL@J:/4FN2[LV3@4!TKE3Q?V[WZ'UX;YX MT,M"+_0<18U:O5^QP?DE^$@S=BWV[RR;WZVVC[K=&7:LS MGVG86DDKON#:1?01Q< B!1ZA%&$*N9!JI&,C;>JHSL/>Z6F"B^%Y;SA-HOM/ M7W>1)5,Q!B&L$-$K6D%29D9#*.[XA%Y(]8XG8KAY*S"VTY1 M;Q)/\7<4GT:_6/+B4"*3\]YD>BJ2T][Y:!K]?J"?NW2$":2;C'OC,UQQB(>T M'8FS,PJO-YZ<'\Q1JV87T7O]A&\KT>Z$F*P+7TZB3TWV%%*P5^EN0O35'8-< MD /)J*^;KJXBXA'Z+'&_'=V R<""(?(ZZC6TUS=NHAA\^*D7$E$81(=(QGQ=M.$4'X$1MNP:+/&DLKBK;PO4I,>?D'(1/ MD_B.N+V TGL%P)3D=*IZU"\R#VM EV)-XLN[^S=\-;P\Z1%#=#P+TE!B,;?7$[ITPA ]FVQ]_MX1R(BK MXKP=>]6IF ,'NMEH"G(@I(U 7Q0E<+ E2L]*J@92Q2Q6&+_S$]%PK&5>9I(W MC>_S149S0A\:('Z&B3]L4'6>"7%XVLB)!)_X+[CU)G MO*&AW)K-D/N%6@:;ZE&G-#PHMT "@TSH!7[:+4#AFFJZ*#UMVBA[V/1"O_.8 M1]!+51!Z.1ZN#EE53]HQH _12)78H!:U%ZX9&&*MT8D4N)E]JQ:P'WU5H=V@ M=B-#F*TL<@_!R3+875E3+E?U9NR>6XTY+<3^&& E,-'8K\URX:JT-HC$-N@T M82QTARMKP3KC.PV1(\UPF9U#M%S"[Q)+?E0IKYZ@^[\%[&*Z?@K9P_#0U4S% MIZKYAQO_,*')AJ6BAA-Q]HBF0'\BPN;GHF=6O_]C"C>3YG8GWAJO_V!E/C"J M$( 'X):Z*&AVP IG#_,HS"T>M_'Y!(2(YJ3!\L(*&X?-]5D[BMBNL1!F9&WJ MF9E10VA_>*0&O4B-OY+ M 1H5'@FI!+0VM>W]1"*=CQ)D4KIJ-'TKK7:IW@'O2\N4#@%5,,90"BPK2W B M_Q+#&5@C!I E0&)Y-N_KL(K>-#F:?KQ^JR>98PEE!VO-3Z[LDM]O@2EH^H270/73^A7:;7ASU!P/[]\^ M2+NDS&9J =&X?S;I"!O>:84;;];\'FEFO#,6'1UU/QI P =P< !D !X;"]W;W)K&ULC55-;]LX$+WK5PQ4H"=O9,N.XR:V <=ML3UD$:1?A\4> M:&EDL:%(A4/9\;_?(:6H#N 8O=A#DQGL+ MU%25L(=;5&:_B$?QR\:#W);.;R3+>2VV^!7=]_K>\BKI67)9H29I-%@L%O%J M='T[\?[!X8?$/1W9X"/9&//H%U_R13ST@E!AYCR#X+\=KE$I3\0RGCK.N+_2 M X_M%_;/(7:.92,(UT;]E+DK%_$LAAP+T2CW8/9_8Q?/I>?+C*+P"_O6=WP9 M0]:0,U4'9@65U.V_>.[R< 28#=\ I!T@#;K;BX+*C\*)Y=R:/5COS6S>"*$& M-(N3VA?EJ[-\*AGGEFNC,]3."I\CFB>..?U)DG7XVQ:?OH$?I7!GM"L)/ND< M\]<$"8OI%:4OBF[3LXP?,;N \6@ Z3 =G^$;]Q&. ]_X#;X'28\$0N?PG4.U MCAO5223X=[4ACCMS_YV*NN6OYNEH]$-O+X$[L0O8R-JZEI)M 3?2HS6IJJ% M/@"9QF:8@ZAK:YXE/P54!YA.8/JAP[6-ZG&K+#.-=A19S%#NQ$8A%-94X/8& M?KM9#,JT8]JK#S";P32%RQFL+>;2199K!BN*3 '<#EAMT/8M$4K)1CH 5R)T M(D-85S<$F: RN 0#GQH6H?@B@CU:Y =;&Y+^6NE'0BL6A /"'5JAH)!:Z$RR M)34YZ9J0G\@S5N( ?L[Y%N*D5,CS0+$S-Q-OX#,;!"RYP-Q3<8Z8HN&(0,E* M\NST67T1W#,QV)V5+5T))0^7OYX:H:0[#"+6'?+$S*?E>J9!",_F4F_58#"",WZJ<$T5M)S@<_]::2D(M'$<88U6H@Z]H ^1,D0< M>RFYJE9F7<2^*H1'N>6@-LA=M?-YZVQJ+N#4 M8TN.AB'WVC:,?&;Q:MJYV._V7Y55.TQ_N[>?I#MAM[Y "@N&#B^N>(C;=LRW M"V?J,%HWQG%C![/D+R-:[\#GA>%7URW\!?VW=OD_4$L#!!0 ( #EWC%A\ MP(MIOP4 #@. 9 >&PO=V]R:W-H965T%?JREQI3G@\&.DIYSG1?EKS 3B)5 MS@QNU6J@2\59[)SR;! .A]-!SD31N[IP:P_JZD)6)A,%?U"DJSQG:G/#,[F^ M[ 6]=N&36*7&+@RN+DJVXH_%M([;URWZ M>Y<[("<* M6Y1'H[ KX&>N/DBMJ>0H4\H4OQ@88-J=0=3XW]3^X0'_(*2/LC"IIG=%S.-= M@ '(=(S"EM%->!3QCD=]&@4^A<-P= 1OU&4X;]X"TT1 M0N&W@_B1@F5&#HN$!8-&"Q=CT$ M(_;$%48"%56^!(I,K'\.$@Y/$Z:+-B!B04YL6N%P\?7Z\0]W&2Q.*:Z4W0.H MI2%DW*>[AO.KS$01954,3&OK\L*4\'B28&QL!S8R^D;\>R6>6.9.*)*83-K8 M,#"K]V5I1XUV9[1F2C%K6.F6BL'8U)7:--8Y-ZF,G3' D+(1RPQ)HUP.PD,U M$JX42-<.+T@B>=NX8+/&Z=,7=* Z',AW6RR756'<92HSZY!CRE#)-H013_R9 MJTBX.#LI>=CK,K*,M["0?ELP6V9,;.8F;B0!;$&3RE0X:BM'$8%=R@RE3-M, M:0,-+#FW$SZ2JT+\9\NO+%+F)O<3SS;$-!X://:,A"V. 3:X5+RL5 0@WNBB M3YC4GF6V@0J)VXE$F"?)^QC!>UUL =73"?^O-Y2(_H*$R15R:GBRXD\%\K MKFORA8.:C/QP/MEKR/,RDQO.=^>$DY=7)^>&E6L5S8W-6)GT0)\=?G;\2,LE M6P+0KQ3@M6WO8EHIT(FKKJPT5K1OVXN7I@T'HZW@;L!I.J5'G&!<@0)D<-.E MT#Y3[I&">ZJ^O&-DV%O<8@!@=4IU[]ZW\?J$3 M*'LV&X(@KD=G_BB8TJGW@6L(ZSK^%Y,]M[6**\>AJ2WE,A:)B%C]L'(C,%RT M_U[MMRUS]L1$=JP AXC<\4+BI;6F71^;?4S3;#CQ ^AJ.IWY03#V[MI^/#@' M7Y-L3WXOW/U/36Z_T:9-(.R'9W4NDWG_;(14?A:S5?E>5-KWRCC8>IM'S5?N MF\6^;T"*]8M]M]I]%EW77P,OYO4WU4>F5@(ESG@"UV%_-NF1JK]3ZALC2_=M ML)0&7QKN,L6G'5?6 /N)Q-1L;FR [F/QZG]02P,$% @ .7>,6)]1SP12 M P @< !D !X;"]W;W)K&ULC55-;^,V$+W[ M5PRTP*(%7.O#3NHDM@$[N\'FL%TC2=M#T0,EC2UB*5(A1W'R[W=(V8K;S;J] M2.1PYNF]&P: MBZ(,0;6*LR0YCVLA=;28!=O:+F:F)24UKBVXMJZ%?5FA,KMYE$8'PYW<5N0- M\6+6B"W>(_W>K"WOXAZEE#5J)XT&BYMYM$PO5Q/O'QS^D+AS1VOP2G)COOK- M;3F/$D\(%1;D$02_GO :E?) 3.-QCQGUG_2!Q^L#^DW0SEIRX?#:J#]E2=4\ MFD90XD:TBN[,[A/N]9QYO,(H%YZPZWRSBPB*UI&I]\',H):Z>XOG?1Z. J;) M#P*R?4 6>'.->Y#C@C?];Y,<@$OY:YHXL7XF_W]+;H4W>1O-M \ MXCYP:)\P6KQ_EYXG5R>X3GJNDU/H_Z\@IR%^,X2#= KOWTVS-+V"[R#ABQ[< M8&Y;;D.X"&F>#($JA&M3-T*_@-#:M+K ,EA%\=A*)T,;F0T(I8)9.M>RA] E M<+L[XH746RA,7;.CJP1GQ_LO92T%K'G"?$*AJ"K,$&XUEYAGRJ PW. E6A'0 MP\Z1A^' R=GP/+M@WU>VWU/=6J&):4RR83*=0C*:L#SX+&Q1079V$+="(K1P M71E9]+%[&C_Y1&7)U>KAX2XLTZN?06K6*SRP (5;H<( 88ID #4S9Q@!UC<] M4QULI'7DIU3KV/6 >/?EYA71-"$>G]$6TC%P_@)+U512_(M'9SS$#6%72=8B MG<\.6:-4%\LI%5:Z7_Q0*J&Q\HGI#KC0DEZ ^=1#6"]OO1-IM&X$#T=98[16 MBURAU\/7N)0%A;1R);F _+8@V96MS%GRG1JNI&U&]M1_PRVZNO;IW?P>NYU9JQZ78<&@R^O4LZI)_ MV)!IPI3+#?',#,N*?U)HO0.?;PQWQ7[C/]#_]A;? %!+ P04 " Y=XQ8 M^[0L\D@A #2:0 &0 'AL+W=OO0&AF)^0(-M5D6[+&AR):LN75Q/@(MST3&QO[ !)%LBP0H'%TB_[U MFU]FUD6":(T>;'630%565AY?'E7]]4/3ON]VQO3YAWU5=]\\V?7]X_SRKOSFR34H M,I59]QBBH'_NS1M351B)Z/A#!WWBY\2+\<]N]+>\>%K,JNC,FZ;ZMRW[W3=/ M7C[)2[,IAJK_I7GX;Z,+>H[QUDW5\?_S!WWV^DF^'KJ^V>O+1,'>UO)O\4$9 M\3$O+/6%)=,M$S&5WQ9]\>KKMGG(6SQ-H^$'7BJ_3<39&KMRU[?TK:7W^E<_ M%OW0FKS9Y*NAH^^Z+B_JTFT2/N_LMK8;NR[JGGBX;H:ZM_4V/S2575O3Y4]_ MUI\^^_I93Q1AW&=KG?VUS+Z\,/MBF?_0U/VNR[^K2U.F SRCI?CU+-UZ7B\G M1_S6K.?YS6*6+Z^7-Q/CW7C^W/!X-Q?&^ZG=%K7]LX (S?(W3=W1:LM")(H8 M]7-K.E/W\@%QZZVMBWIMBRJ_HP\-R6_?Y?][N^KZE@3P_\98) 1\/DX M/++ M[E"LS3=/#IBKO3=/7OWM+XL7UU]-+.]SO[S/IT9_]:ZV/8@]#"O:1%K QK2T MNV-D3@XT3J:.GIV,GO^Z,]F;9G\HZF.^IG\KTYLRM\0I.TY/_K3?F?QO?WFY M7%Y_]>[GG_BGQ5>?Y<3T?PS5,9<-I__;.G_8V?6.1LMMUPTT+LMS4Y7YXN5B M]G+Q,G\^O[[.;U[,%_ER_C)?T+^_'9HZPQ1$#6W9FO<-VXG/:+Y97E25^UTI M!PV++[[JKRN1UTY-Z'(IC@=^*@529Q&1-(QW=XU*<7$SC[W._M\7>H;#^VJY.# MC.^JCIQ%(^<_U=D/14ML?\D;\?ELE%.OFZ(MP<9O;4M6N6G)V!P.;7./72(; M?T;Q)99'.QMQ/^MV!5&)E["/)!LR5-%C=*@HOEIR'A$7#)B*@EX2TM12FE! MYR*$3S&2^6#:M252#JU=7YY@(%/:5D<1QX@-AX'62 XL?RC:MH!=HH%U%YL# M%M+E#Z;%\,VA:?$!K8.$M2A_)T<$?O<\(>T9*2=+]=B>":=MS=ZB+9KNY05O+=&\.O*\?A>94-[+F8Q(>E\0K1U+8$?.W/&U)5?'2CT<\-$&!AS$ M5;G(V3S_L8D^O21]3)(*+#&%MK=61.*9,D+55@M61+QD0B(8C$G\T9C6*;DBR4N# AC][.L&_\OEHT=7GTP,9[ MMRYX-U D@@IV&B)A5Y!*K8P!;NO;1I!7)$@SLM'@2A"D&2@G90!8BUF2)2PA MOY'7PWY%RR*SM4NBNMV0Y5(39&&?C;_&Z>WYGUT)(1E<>R[SZ0A:JW+,![TAF0]U3M M\-UW;[S;9Q&NZX%("L01,60^9+X8J!* 6-L#*-F:VK3L?^E[PM<;%YJ*$TPZJSI2U:VL5Y=DN6A3 ->2I]AX!OW8F1 ME(E6104QZ2(S82I+L4W1>Q,9EC:Y 2_]!KR"1&/\Q6%BS?5%37,Q(E(SCOGAO MHIE8R,FI[-5QDQ-S3H]MN"@#?/;>[R0];U0_*ENL;,6*-\M+VZVKIM,XD(B" MWF#:\1<<#( 3:V0O);:XS%B@!SJ0?R9^7"@.)]&+@=&^^$=5F#Q4V+^G20B M$N]8%@-/B.$[2R:\!#@+1E?B4VR['O; *GG\G@4QSH%!*)##(D0>JC]AV MB$ !FTZZ+#Y0/B?@8KH.>0$VP/FFL&UXS^,F(16:T= 6J-7'&_CV: K":0;A M?D[!NF%O[@)V7CS]L)R=2-6AZ:S$W"P\EU_T&&!==+M\4S4/7?:?33UIV# 2R;/?> M T+U?@?3$^BI*D[_8"2"Y"W)3?N>OA"_0'/-\M70,RZ"M1:T2<;#',!1^'T: M\+TY0E\[@-QJQL&]Z2W@'W9A#6M#P!]2M!DJG0&0*DI!"F'=:\: M%+U"7_0*G\.CY.)-#[&DKW9U4S5;MFMBL8Y8]1;[AU [J\V#SHLG& GN";P% MX+*E<+2M6: CU)):'PJCU$X.#">(1P,#2#*CG5IG/%,P+AKV@Z#STFSLFG!B M]NL(1D=D1._CE6UK1*.8H-OJL+-%;O>D!#0V;3WDH\P^Q\8C:3/3PFP?<#SU@:C,X2 M$P<#!$$1B!;Z/697:T'XDIQ52 4A8(V>>K!D'!G!$%?,MN T@B04H BL5JWR MZM&0#-CWH1FJ$KL,H\H$J/C"?%F*5CI.F(!Y!LFH-@3TCXW/V0IFX+TN)EHO ML\\;"S"NZ,F@']A:, \=>.,0#508Q\9$<TB>4>I\(O4#YI]LJOBMND3PS1 =+>D,S,X*W#U3^&96CC> MIPQ8_+IM9,YE"42CZW5X3<# MI^=)V:X^C=UG*E@V9$-@Q%&R84."[?>R?[Y62',RSPRYU35SGT$I_4;A-U"1 M<[1N+@A,@825RY3!6!4'VQ>5VD _B"PRS@.4T0,2-NBM84E9EW+Q;_]AYB<$<#X3P*#68?B$?8Y/DFK; MQ@!IEDG.'H^0Y:D<2 ;NKK3XTU1=3O6SC2@B;1I8BO@#[GTEWU$Z6\"*"^N0P'R>CHY M J#.:\0/4!V*D\#5T7+BY%@7,B4T;C8V07[Y&[?1I=GC>P*Y"$!(X@WQE=D/1L^8NR,#:O9& UGQ8&]@8 M4TIZ#G6!@>$T @TBX*V@'0' G#QPR8$0YJ68U<5#'0>Q_)1/:@G&T!QO%!IA MN\JV>)!PNR=GQYX"R(!BG*(27>.$P/K2II!UZ<^"RV5*VZXH"8F_)"0^I4!1 M!7_Q2*5/:#5"S:C:3(YPJB@ZY^5*24XIEB@\YY0:E^V3Z./% M_(:8/KGL95CV$4&9:H[KJ'6,TCPY# M =X5>6FR.O)")B^T#8)K+1?2+-:HCSSE+A()WMQPA"(^BOQ0)7+@R9H1/.-U M'VZV1-?]-?\>KZ85+?0![.8[$-Y]:Y&0-(@R3^J1I_0Q1(-F4<_SS+5 M"PU(")#9;D=KVS8H5Q;WA:U$K(FM(E8! ],<[XLM)T"(!2W!.&P&V7IV@&4^ M= Z<;FS;]5><2,$/#46EK@#T]MU;WV*2[4V_:Z37 .,$3O<:P#Q(.1+^%^ - M@J^X%43RO.3%\2UM:VG@;FWMBC'<"@ UY-?/JC&B"2[0SSA233%_O4*9FE2< M^\]X&(>0'2?XLS3TD,Q66^&G>W2Z,6[!!AR1 ZI[Q2DU.:NZG.???8"-P/*: M%4%E6D2NVRB.WR"PKF2;.#H+P]F0HF<;04XW(P^*) 8S2/,[)-96JR8EPY:5 MTRQ\34:CY]TKMF;FLH,.G?%J]:/*;LAR'-<5\?S61YT ^H$BR(>V":#SM2Z36'K&X$U6(&$AP$-6M- ))XK36!0"2/O#N97EZ$OJW% M=./66_N!9KOE@&A4'S^A78O'S&3,7'YQ$=>)X+.P*C"FSVW1)ZJ%J!/2>(5I M@9%T!2X MC ?D+S&O.BO($99#9:;)@* M42$V!TDPD,;^+V;D)0>3G7GF0],CPP"1YE2EC\+A:1.>P Z@24*RCFP\I+HO MM<^X>D8?E(AMH]0+#^+P3N:C9(EC$#0 O*^B4)LUOHZHT@W51*$^2@'MG\Y& M29DH";^=%!)\H$5NK%L-"@@#,GJ9Q"I2>HPB*[;9DEB+*'+QF)# 1B*WF]&) MW;A2[]@[0M"")%#) 6JI:6&3UFI1->KW0H((CZN(X#N*AR(1-BY)7US@M'T* MW8>+Z?;#[\E7(^TS:IL^H>G0C9>['S+X%:VHEI(C#SMO+,.U?D>+VE*@!I]& M(%*2]/2HNCCYG2%3@:B9W(&9_?P3AM$.S0R:CW089=)QXYR@)B* MLW:QL#!'HAWMND@-9^)#,#O4FKXB^VNH^3LHXR?MC8/%1%[L*V2;#_KH+'R.C5'8BE^/87./+<$PJ=4(ZVUCIO-3QGD2=+9X+3)*<+A%)ED.$*H M*)6S^S/)UD&:+N@0UHNNA)W/O'0GU(!_M,'WM@3J/=NXF"QTZY,5EBW@TO#% M:*#01D@MYI\ ?Z_*_&#T101@6)S@=^"V2 0'XR-HG$$AK9LV_Z'/>#'=:'RW MDZC1)8S&S?\G=!OSP%DTL)SX.>:+ZY$*AW?'*W?@IQP[\-.=4 LIV;;%7GD> MVOM%4/QC2)>S DH[TR,%A= CO)AN$GZ3G-K0,S*C#/R$5F$9/$L'S\<_3;,M MG8MFXHHO-+/CNE-_C&MUKA^/X;&8B8X"1:#-^*S3)[ MTOG+E&DJE?;((&QR%1XY1VE,F;& M8^;)+XEXCIS\>'M[]SJ_O7N3_]H<2.R^^)Q,A#NZ*83^RN,\Q3/T[6<*HEVR M1/O"Q/^4[FB.S,V.(_-.*>Y,/_K8Z[PTPNZS2P:[U-SN>IA\@D51 EX!?&2Q M)L?+C?^"WD(:F'MA8I!Z!CI'NTLP)0W?&IH)^//;CZ 3NQ "Y"Q!!M(@SCVY M*],_&/.QA+ ,TYS277_QR #_OG%YQ%"!E#0=?4$*5#HO;^I"$E58H9Y=",EU M*:<3I[1U,N[5#H=YTT5IR2')@/%AK'G^+Y_:]]4W!RE9J$J"LIN9XJCAH/R2 ME *OUQ>7#!Y';5!.$DL:J++O45;C$X. #KSS'41:S]1)-!UVSP5+'/)Y5([B MD$LG^SC#97/! ?2=2IY?7/LJ^4V:DB0B*1H66)YDX"^:1\YZ3;ENI>A^VTY MW?WVBQR#&O/:TV]>/IN/QK[OW4G'63;5/L*=@"T+L+:R:RY @VWIW%E5=JL7 M8,A93IDC#4U]1<558I%>V]G#@;SX=P=XR2O*R%6&*FBH\P.<' MQ:)R8HB-I+:<<)%PT :7J"<&47T"8J.ND4S6P-DIURVCM?C0#A<*\; ]4J'6 M'M!1_51OJCTT32WY2]T-QI&2@F1BHM89.6\7F9=8+<3#L=4W[F L^T?'$2[I MH2G"0:=[%DUQ##&X;HO2P') F^[5O'OE@UOM?#[#,9%4"6_ET5NN7>G06H+% MMN*>'"]*Z$W@T#ERO,@8&T1M2+NP6J$!4 X&IIU!H2$H_RXA18C(?BTRZBG7\M'3$GH UQ.]P&^T<*TM,G@QI-1J_() MK8 8.4M&SD<^4O'H4OD0X"F4.=/0K.!H7%U[W5P1ZP;X4=(0[,-H$T_:X<(. M >8%&QD:,Q26$/XTNV;HTEZ9N /./R'=77)\8:C(9512.Y:>F:F-"9V*RTO,*&DA7N"5LD*V&(7I6WB3T>N8 DAG]VO MT/??98E-4X-NN4VR]>&>Y:1/*P>=[D.$(T&N-D2K:4E9ZY:*7J-3AO,M$FAY M?9DOEO-EOISNQ%N&3KSE="?>6U6$GX;1&WVFW[[0^2-#9C0D:W:7>0&)%4W/ M-=:E%%ZBPX84?V@5A%O G*+'+:$?(5EW;A['[*Z1WJ*,/=J%6;IT&N7[8GY# M_[V89'GHMEI.=UO]8E1$I2OIWE3- 69BE/^?T'GEQL].QL\O?B$FL>(429CF[3Z_GS2::'%I+E= L)YYROQ)'S M0>*ZNWB!QO10$SEM&3^+Q\\O?E%(7@-L#'B.BQ&VCM"KIK:< M@I2S'1?R5%VTRO<=14SD/.VZANPO;6XOKIY?O7R[ RQ6UTR.T,#B>[X M(*P0(P=G0(4C(4S*84*FXJWDKE0W_0R.JSR<+O% 3#(EXA1NP5$&J7A*Z*C[%LC#8ENBRJAD\2 M%AREHV@:=X1F@.5T,\!/O@L$;4WCJ>'I(<85QX^;R;@) O'Q7,>=4C["Y,P0 MTNIZI2-\DY\NX.J"GXH38G%N84/#CAH!841 9FLKG_O@,:K\ST0FU3-M M_-V?XL1\="=DR[$B78+DTKA"LFT-4*?DDQ9+G&#J=]VY.+>E.Z2H+0P^)1TB MYDQKE6<]2K+(<(K1B24?AE1; M>;*6ZIX%R\M$2<,8/![ 00&IZ!9+I:TM/T?/YP>IE 9_YFU/D$ MBJW!34/NV*.[4L)-%<:UF6J93Q5LX*XB6F13R/KIG/[28/1E7;%Q4QOJ>A.'F5W M8_=D1]IQ6K+S%7!7\ND@CRP)I-@Z'<@M\\8MR!UE'NKSQ?IC"]UPT"NZ5CC) MW/=H1R*SJ&W/?*ZI\=VO$B8?-4B62QM'LE_-0YW%O:O2MJE3._EP:I"=I)?% M%" "J''VHS^F^H #8ETOJL+G)+!^[=%.:=#DU7CCZBBJS\;M8H0KFY'6B=?: ML'&W8PP6G4*]>*QY=GJN=Q8*EB&W/I/+[ZQK!(L>TFN09^&:HUG.L!RS=9GOY*(3OQW1 M'4XL,_'ZTD/Y)^UZA4,M;A/E^JB P'SAKO6G9)+Q=!&^.N%JS;H_TB[3<+>,$[DR)->;;EGZBI(>>29TB_B.9Q)2F?Q M)SA#.I)M$$((-2#$H&PLC.]<6ATU9P> SWM3R5PQG&NGK-5*K,^9)%P@V#@VYV_BJ87>U<[BZ M>Q:E=*KC/$^:!T^OQ3 ?%#J@WN'NF2>9]!T%%TDXG]@76N%PI&?&2DO-%8]" M]$R+5^@J6TYWE=T9=S+%1T>C@O0)S64Z=!8'7B&KT!EW%69K8E0?2JO:3XU+ M;5M29X18C"T$U+H4#H=[+S^D(3OI(^+BNGM"% 5 MG)XQ<@EO?$B5C^8 P+UY<+6Y<$V'X$QOO(LS#7F?Q5?Y& M7-<_Y83V4^E!O%F^^.S+_(5=G_QB(E2!&$@_/VRJ/>,NOJQ7PO,&>HBBQ^ MBF& /\/N&^+2JR:B=H#"+LV-Z&7O,1]+6T8-&#[AD8&% MX=+%QYL+;N7/](3' MY:\=_5"T6P)[%!5LZ-7K^1?/G\A?-G"_],V!_VC/JNG[9L\_[@SV"0_0]YN& ML*O^@@G\GW%Z]?]02P,$% @ .7>,6"3_H897 P -0< !D !X;"]W M;W)K&ULC55+<]LX#+[K5V#4-I/,>*V']7 3VS.Q MTYW-H=M,DFT/.SW0$FQI(I$J2<7-OU^0DE6GXWI[L$P0P(ZXFKN%EHWEYZGL@)KIL:B04Z:C9 UTR3*K:<:B2RW3G7EA;Z?>#4KN;N8 MV;T[N9B)5E!Y?+R-A;@\\E[M3!&DPF:R&>C'";SUW?$,(*,VT0&/T] MXPJKR@ 1C6\]ICN$-(Z'ZSWZGS9WRF7-%*Y$]:7,=3%WIR[DN&%MI>_%[B_L M\XD-7B8J9;^PZVRCU(6L55K4O3,QJ$O>_;/O_3D<.$S]7SB$O4-H>7>!+,L; MIMEB)L4.I+$F-+.PJ5IO(E=RQ,D_M4)]M' /CJ%OGB@/LS;"D%LX)9W;6CK>4T]!OO<5@7C M'"MUC/UI_ -,I\/4!>&)NF'\Y>S-- S2*P63',(GAG9&B49S$$*;PSEG*,GN",U8W5P0M-9-D M$(^FJ0]!;QV,DC"","#KF\>55:$J'>B'Q(H22J8!E:+EOCEH 5L:4P35:/@% 7B\7M(QP']8DC&B6.H?^+V M8H[=^>L\?XJ3E]0OY;K51*.1(F\SK8@8W6/)V4D603"F3SI.CS6'=S#**-C6 M#FP%F8'KIMJP.[P)U]TH_&'>/2@?F=R67$&%&W+UQVGL@NR&="=HT=C!N!:: M,K/+@MXUE,: ]!LA]%XP 8:7&PO=V]R:W-H965T'EPF:Z4>G7&=+KS0"4*! MB74,G)8G_(1"."*2\:OE]+HK';"_W[-?U;E3+FMN\),2W_/49@OOW(,4-[P2 M]D[MOF";S\3Q)4J8^@N[)G84>9!4QJJB!9."(I?-RI_;_] #G(=O *(6$-6Z MFXMJE9?<\N5ZMIM.<<'9Y+9]06J5S-'#RP-<" MS7 >6&)VYT'2LJP:EN@-%A;!C9(V,_!9IIC^31"0I$Y7M->UBHXR7F)R"B/F M0Q1&HR-\HR[/4+W"9FT0H4VF$'Q=K8S4]C)^'4FX(QX<)7;/,3,D3 M7'C4#0;U$WK+#^]8''X\(G?4_.EE4!0&^B5Z)#,HT2'9?88!YS^ M0].1^6],@1O8*$&M2L\AEV S51DN4S.%"6B[X@.//'<02,^5/&>EQM^G!R/F$PA!."3\8P'/2@/DB:@TY/S%BK9W(& MAPH:]'JN0+VM)XN!1%72-NW7>;OA=='T[&MX,_ENN*84#0C<$#0\/9MXH)MI MTAA6E74'KY6E>5!O,QK J%T G6^4LGO#7="-].4?4$L#!!0 ( #EWC%B8 M_E J!P, !P' 9 >&PO=V]R:W-H965TOJ58PITVV9H: O:ZE29FBK-J[. M%+*H *6)&WA>STT9%\YD5-@6:C*2N4FXP(4"G:92@,+UV)GZ@UEH_0N'[QRW>F\--I.EE/=V MCW@')/$$I&,GQ6G4X>TP/WUCOUKD3OELF0:YS+YP2,3 MCYV^ Q&N69Z8&[F]P"J?KN5;R4073]B6OMW0@56NC4PK,"E(N2C?[+&JPQZ@ M[[T!""I 4.@N Q4JOS##)B,EMZ"L-['919%J@29Q7-A#N36*OG+"F %G0-\G;H*G8*O\TX5SG=5 MF%(5KHLJS*LJ3(LJO)9\21V^3FV;:J SML*Q0UVC43V@,SDY\GO>\(#PL!8> M'F*?W%*31GF"(-?P5Q+L'Y(X'*:B;KQ_2YC"JL'Y+XS("FN94.?3_>$"3"QS M35C=',!_26_0R6.Z)/ON].%/2]#8L;'H 97AFHL-K.@"*AH!U%XF!GZ!3!DX M]9MP#"='_< /AL^KFH"RN$=CX77B8=>OW4J!V8<[J-/SP6]Y7;]Q)PU+X..] M=PQ]:J+C"FUE7XO&--_0?("@;]/V/[>HN@ASF69,/ &!4=$!<&$D,% LXO)% M0=A&(:8VQGY%KC#B##Y1HQ+7&R*R8?TMI:)H6RYA^7ZBL WU?2VEV&QN@ M_B%.?@-02P,$% @ .7>,6%H/=?'E @ . 8 !D !X;"]W;W)K&UL?57?;]LX#'[/7T%XPZ$%BOIGVJZ7!$B[%ANP <': MWCT<[D&QZ428+'D2W73__2@Y<3,LS8-ED28_?A1%>K(Q]KM;(Q*\-$J[:;0F M:J_CV)5K;(0[-RUJ_E(;VPABT:YBUUH457!J5)PER47<"*FCV23H%G8V,1TI MJ7%AP75-(^S/&U1F,XW2:*?X)E=K\HIX-FG%"A^0GMJ%92D>4"K9H';2:+!8 M3Z-Y>GU3>/M@\(_$C=O;@\]D:&O4O[*B]32ZBJ#"6G2*OIG-)]SF,_9XI5$NK+#I M;0N.6':.3+-U9KF1NG^+E^TY[#E<)6\X9%N'+/#N P66'P6)V<2:#5AOS6A^ M$U(-WDQ.:E^4![+\5;(?S>[E"U8@G$-REALC=@ MT@R^&DUK!W>ZPNIW@)@Y#<2R';&;["CB1RS/(4_/($NR_ A>/B2:![S\#;R% MY8MLZ><9+)30!$)7CDRW?,(+_YDM'EJ_(_X=R[Y&+P\B^;:Y=*TJ<1MP7 M#NTS1K._WJ47R=]'>!<#[^(8^NR!V[#J%(*IH2_6/!3K$,^C2(=Y!LC1MOZE MX69SY$/1&J$VBGM6ZA6<2,T:TSD^-7=Z#6^1&MTYDMPJK'AR6'<*OL@:@6N) MS1+M4,\_--GHM189C.$]I%>\7([N.ZLE=19#P6KYXOP+@H1O.R[)I.A60KY!,MI0B#YB1/"CB%D_3B YR.]AOL##2/V?>0 MY0FO^>48#EV0>*^;&[2K,+-\<3I-?6,/VF$LSOMI\&K>S]2OPJZD=J"P9M?D M_'(<@>WG5"^0:<-L6!KB21.V:Q[M:+T!?Z^-H9W@ PP_B]DO4$L#!!0 ( M #EWC%BA D>WK@, ' ) 9 >&PO=V]R:W-H965TD9$6I'2,#]D4Z4G?//??"HZ8[J;[I$L"0QXH+/?-*8[:70:#S$BJJS^46 M!'Y92U51@TNU"?16 2V<4<6#. Q'0469\.93MW>GYE-9&\X$W"FBZZJBZFD) M7.YF7N3M-[ZP36GL1C"?;ND&[L%\W=XI7 4=2L$J$)I)012L9]XBNEQF5M\I M_,%@IWLRL9&LI/QF%[?%S LM(>"0&XM \?4=KH%S"X0T_FDQOS+>_1? M7>P8RXIJN);\3U:8\ M)?3;Y] 73>@W3.=TJ)&TG)--FT\QSB>1#G.\:&$05YB4@#[@I@2 M2$Z5>F)B0V@E:V'Z/@F.!Z?S!%1I K;D! L&U0I45S27:11BPG0[!M@/5*0: M[3G.!VPXYTO6&E7UV24Y%N#@$/CGG7BPA T3PK)=44Y%#N07\O[=)([B*Y2B MB3^*TL%MM:5,X8PQ!!YQSFGH=(:-"CD;8/^^!K.73E0RZRJ9O;F2!\UXK*0G MX5XOZ;7$F,638SZ^TL?._(L2N)HIX-1@H6H-ZYH3CH.TT7/E1AT%O2*^K-I! M,(?E&WS0AE7.P]?&PR>VAKZ#CTIJ3:[W#;AH&G"1YW55-]1P2QGV@[I9WZOK M)VOX.]YN/QD/KMUP118N.+32)=OJ7G''?G01XGN8^E$:DS,K)GZ83IS8Z@T> M%"V "%H]M\[8S\*0#&,_C$:H.\S\=(*-]&PB#>5'$H]MF?JCQN?(C[+&T7#B M9TG\PN=AMW<)'/P_"?P/"1OW4Y7X490YKJD?CK-^=G"_34SD9RXQF7\Q2=^4 M#122R,%&H1]F%TP&!Q,3$>/F ^. FE\;" ML8/MK-N_Y^RT64%=Q8?6]OGN\?/X?)?96NE?ID&T<-\*:>9!8VUW%H:F;+!E MYEAU*&FG5KIEEI9Z%9I.(ZM\4"O")(KRL&5^:JPSA(M9QU9XB_9K=Z-I%8XH%6]1&JXD:*SGP7E\=I$Z M?^_PC>/:[,S!*5DJ],01,GT -YT5#[U M>-,G\&[8@Q?GI?MK8,+ C_.EL9K>RL]]F@?$=#^BJY\ST[$2YP$5B$%]A\'B MQ;,XC]XJ%PBJAMVL??)9^_B8M7W$#T+O)[XY8[+_992* MZM)81X;VH%:"RIO+%;SDDBRJ-Q1GCL[@OVE/*,'8+LFX33+\:TDF6P3+[HE$ M'&40Q]%H[=B#)B(>?XD2:VX-I,4)Y$7Q&*I9A=!IU2K7%X;\L^H.M>7&*3B- M(,M/1G\N+=*E6$BR%(ITM)>J;;DQ'B(ODTG]PV M2MO7!--"S263I3LFSA/Z99/A(I+3%)(\GGQ1EI& @U7Y'))749'Y,3O-8=_C M"G=:0HMZY1N?2ULO[= =1NO86\^'EO+H/C3F:Z97G$0*K"DT.C[) M!#LQL6 M5G6^P2R5I7;EIPU]'U [!]JOE;+;A3M@_.(L_@!02P,$% @ .7>,6'W MBTR& P > @ !D !X;"]W;W)K&ULK59-;^,V M$+WK5PRTQ2(!7$NB+,=U; /Y:- %-D"09%L410^T-+:%I4B7I.+XWW=(R8H3 M>(4>>K%):M[C&_*-1K.=TM_-!M'":R6DF8<;:[?3*#+Y!BMNAFJ+DIZLE*ZX MI:E>1V:KD1<>5(F(Q?$XJG@IP\7,KSWHQ4S55I02'S28NJJXWE^C4+MYF(2' MA<=RO;%N(5K,MGR-3VB_;1\TS:*.I2@KE*94$C2NYN%5,KW.7+P/^+W$G3D: M@\MDJ=1W-_E2S,/8"4*!N74,G/Y>\ :%<$0DXY^6,^RV=,#C\8']SN=.N2RY MP1LE_B@+NYF'DQ *7/%:V$>U^PW;?+S 7 GC?V'7Q*99"'EMK*I:,"FH2MG\ M\]?V'(X D_@' -8"F-?=;.15WG++%S.M=J!=-+&Y@4_5HTE<*=VE/%E-3TO" MV<4M+BV(2$LGB!T$ M7;->QEO,AY F V Q2WOXTB[!U/.E?0G>EB87RM0:X:^KI;&:S/#WJ6P;KM%I M+E<@4[/E.=/R3B^[%$ZZI2.^M@73U1P12T0U IN5+55$J4U M;N9R.*6VG^]Y@T'^CL=NT#-SN?_\:<*2BTM##J;SR155F;&'F)425*RE7,-9 M*6E%U8;+PIQ/H5]C0)>'U1)U=X'P<84%5Y6JI85';A'NN:UU:?=P:C%X1EV! M4%P.0-+KZ2=@@\DD@3-V#N.()?3B86-:]:FPR^ KY>^4Y!J+TC:89' Q(D3Z MAL@@20:CT0C.DG-(XBCUJZ/@65DNFM,8#<:,M6'!5S2&"E%K2A2V2OMW21-Q MV+B!"B77/ULGV9-TNFC44KD=OT@*06,#;H'#"]>E*SW0+O'V] M>BCU\&SX- MX0X+U,1]5]/Q-Z>S%;6!]"*#='B1!>XLWE.NRE_TEFE.6[^4\7: ->>!OI>K(@;>V_>A88[D)*J"/7)- %)(H*8X3&]IG,XG^)-X *7G/-IX&C@'DD^R ?LE";Q) MWVS]P>6-V=I8.'4/T5$WJ%"O?<\C#[L*:QI#M]JUU:NFF[R%-SWYGNMU*0T( M7!$T)L>%H)L^UTRLVOK>LE26.I4?;NC3 +4+H.QAXC;H/C86_P)02P,$ M% @ .7>,6%/X$^7K @ H 8 !D !X;"]W;W)K&ULC55=3]LP%'WOK[@*$P*I(LT'4$$;J<#0)H&$@+&':0].3)6NF*6IGH6FULA*#ZI$& \&)V'%N RRD5^[T]E(-59PB7<:3%-53+]> MH%#+<1 %ZX5[/IM;MQ!FHYK-\ 'MC_I.TRSL6$I>H31<2= X'0>3Z.PB=?D^ MX8GCTFS$X"K)E7IVD^_E.!@X02BPL(Z!T;# 2Q3"$9&,/RO.H-O2 3?C-?NU MKYUJR9G!2R5^\M+.Q\$P@!*GK!'V7BV_X:J>8\=7*&'\$Y9M;IH$4#3&JFH% M)@45E^W(7E;GL $8#CX Q"M ['6W&WF55\RR;*35$K3+)C87^%(]FL1QZ2[E MP6IZRPEGLVO&-3PQT2#<(C.-1CIQ:^#@D>4"S>$HM+2+RPV+%>-%RQA_P!C% M<*NDG1OX*DLLWQ.$)*_3&*\U7L0[&:^P.((DZD,\B),=?$E7<^+YDO_7?,5- M(90KV\"O26ZLIL_D][:B6\IT.Z5KG3-3LP+' ?6&0;W (-O?BTX&YSL$IYW@ M=!=[]D"M6#8"04WADFG]RN4,)I5JI 4F2W@K:)ORG=S;EPT'DX%'_-(TVQZB?IFD7]%R6G6-OZF0MO%0T MEE/?TZ?!-/K>+Z&IR4I4[L[)-0BUHGXFJ27U7L_I_ 0%$31R@X++NJ&.(S?R M5D6'43%)AN@:T9=V>DYP0[99.R.C."=W7<,:1\DEU)H7#NL$4#)I4AH$9SD7 MW+YN^PC##=>H4,^\-QHHW"6W!M*M=O8[:5WG+;WU[ENF9YR4"9P2='!T>AR M;OVPG5A5>P_*E25'\^&&PO=V]R:W-H965T.CF[M1X*"LC>(%W"G25YTRM+U'(U[[(C)T(QL.2+7""YGMYI^@K:%%F/,="H1 6B&C\;##]=DOKN#O>H']QL5,L M4Z;Q2HI'/C/9R#_U889S5@ES+U=_81-/8O%2*;3[A55MFR0^I)4V,F^PD0 M$)^65+0A=1D=1;S&M MQKP-1&,5'\.(VR-CAQ:\$N2^VVK._W].FQ)DN68HC MGS2O42W1'W]XUQN$YT=X]5M>_6/HXPFEV*P2"'(.?U=&&U;,>+& 8WR/(N[G M^Y"A-Y>"\L^"U^G'_T$-)D.XDGG)BO6'=Z=1[^1<@]SAL=J(PT@H*Y5F)'_0 M&2-D2WF?>RKSG)*-=)L^ 7-F! 94/:RYMT:F-*#5"= M8SY%U=ZTLZ1!= :O MG8S7ZO;1Y1W!72Q141G9KNQ&4C/Y=<<>1+U^IQ^&\ 2J[U&_X%5=(!5'">=0?R99GN];K__OW** M(4G"3NAVC[K]$SBB_J15?_)F]4_XHN!SGA(=N"W*JM9<2_ K9U,NN.&X-R>. M[V/E?R'*C+.-H$%L\6"%"JF.&W=B=$Z5=L< BNNG/PNLC&+"%3@2.U-"@N9Y M)9A[4^Q[, -6EDJR-.N0UU="6'[V?E;++"23>O3W:N4($11*%F$1.'O6? M=\V7?$85 M8C(]H;M-H;O%E[S=&U)[>&"]LJT&"?UH[BOJ7^&OO. M_EJ%#^AS77.!ZO0;X7BA49Y792B M3A2>>E<9*Q8(O( YX\J)W^V^3]Q1//#N,15,:R=CETA;6_W"F)2#/RM+^V/4 MZ9,8/[U".][2WENC@IU6*4>U< VA?;:JPM1=4SO;]IP7=:NU-:\;UF],+7A! M?'%.KF'WA,J0JIO ^L/(TC5>4VFHC7/#C/IF5-: UN=2FLV'W:#MQ,?_ E!+ M P04 " Y=XQ8.LZGIID$ =# &0 'AL+W=O(AIXS42N1_[2F-5- MNZUG2\R8#N0*,Y_YXZ/8>U7@H"R-X MCH\*=)%E3&WO4,C-R(_\:N.)+Y;&;K3'PQ5;X#.:WU:/BK[:-4K*,\PUESDH MG(_\271SU[7R3N ;QXUNK,%Z,I7RQ7[\FH[\T!)"@3-C$1C]K/$C"F&!B,:/ M':9?F[2*S76%_N!\)U^F3.-'*;[SU"Q'_L"'%.>L$.9);G[!G3^.X$P*[?[" MII1-$A]FA38RVRD3@XSGY2][W=U#0V$0'E&(=PJQXUT:VZ \&T6GG/3,^'G)%'ZP?J4PDQG%6C-W79=?V52@;@W;ALQ8 MX?9L!WE70L9'(*,8/LO<+#7]+[.0PMBVB&[UB M,QSY5"4:U1K]\?MW42^\/<$\J9DGI]#'SU24:2$0Y!R^K&R@-/Q,Q UYPO(4 MOA1&&UKP?'&(^DGPP]2_+M&;2T'%2YA@;%+ 2LDU3U%3^AO&A25CEL1I1VC1 M("3WA. R)1RF-/"%9]A MXWRQ4+A@!FO5)B6FK5'*+\RFJ*H(HOO4J6E%" MFW$0)Q[UACERVFO?OZZXHK/++K3HM!O$O3-LQM /G5;G&OI!W+!986#IH8O M,8SDVF$,$B+?Y/U0"+&%-6I+OHK3N2![(BOJJ01DI(,\"A3;6TR"3DRW.#@ M5 ?I_PS>\8NL@M>%,.AT#T6."+=(,[H^PUX'NHFS%](JZ/^GP'4@Z3D,@NJ^ MX7Q&X(Z#G!FX#MA@14$_H;A=[W'@1 /KU@VL^Z\;V /C"KXQ42!,-$T%)LTIFM1%FOML B9Y;N[ K9A*@5.OFO#Z1&WMYB[;I72AY5UW0H*[=H;[=\) M-GMQ'D>WQ%;2(UB!6?SR=MU[OQ5-N.S\UY2U'D=:9 M<;%?[64%GR-<;BWY%M46@5-!]JBIA+:Q>-9<)>LU:&R8>UA0T;A#*.4=,SN= M3'E>7C]=5>,>&[KVN>#92O WG@6>M4[U[LU0T8M598>^&PO=V]R:W-H965T6B-SUS:Y_5]$Q6IN""?5:@J[*D:G/)"KD^[T6]W<(M7RR-71A,SU9T MP>Z8^;+ZK' V:%!R7C*AN12@V/R\=Q&=7H[L?K?A*V=KW1J#]60FY7<[^9"? M]T)+B!4L,Q:!XM\#NV)%88&0QH\M9J\Q:0^VQSOT&^<[^C*CFEW)XAO/S?*\ ME_8@9W-:%>96KG]C6W\2BY?)0KM?6-=[D[@'6:6-++>'D4')1?U/'[=Q:!U( MPV<.D.T!XGC7AAS+:VKH]$S)-2B[&]'LP+GJ3B,Y+FQ2[HS"IQS/F>D'D 7)JB)$= ML4MR$/&:97V(HP!(2.(#>''C:.SPXL..WM-'N.8Z*Z2N%(._+F;:*"R-O[M\ MKA&'W8A6+J=Z13-VWD,]:*8>6&_Z^E4T"M\>X#ML^ X/H4_O4'YY53"0VQKM\.&SE?LF\N2Q0FEPLL HP_< U4-1;&]B2 M,$L&:'PE!1-&XY0:R&BE6>X>7>$C*C:O7Z4D&K_5L%+R@3OI8N< WBXS(R'G MZ)*"N9(ET%)6B.A9\,H@W&P#=+4J-HX20G_IW_5ASG*F: ':4%,9J3:@; "0 M&(F.P><"M\I*4Y'KDU/X/]'S_F14;0L8L/Q8.4.*6(*>+4%;A\2[:ZP[4C=; M4GOWX C\83!."9P@L7X(QW8E#<@H;%8<"OLI)@$(;,!^'$YP5]2/\9@?C<8X M"?M#//&1T0+3(G+ X#-EL-MB9S20@ LX>8L'=J-FQ;M:4K&PAN"!%E6=26J3 M347&( G". *?D'X$)\R]EON8%^H9YYV(!XB -"?B3 M^LPWJA3%?7MK20A^V"<6_RD]FP?FDF/3)*1X@Y&O,%6V"MF/BIL-%U#LK51#W5KT07F^ MP,V6 )_190/24F)-[=3[ Y6%EQAL%[:A8./7V+>4VF!?6E.5:YO.*!B-" ZB M21"EQ+O]]&7G&4EAB+I?HD=O[.L_=TT0;R7; @]B$N(O22+O@WC N-GF,$HA M2L;;LMH!!4F8XF\V0K6^WN#[ADV$P'./( MN=B%=@3CL74O&":3SABUV8?G(Y<3[M(\>PQ#\E&F?V"[E M#[&'8 ,-APKW[U8??0X1BGMS?]BMVY]6 A=/>JHP=F/#LALU,AL]&*9[6-\ ML3/;):N#@-VRJMNO]I[IO_]!(QT<6\7_@O=61R$%@"_P&5MP(6QFTJT$N-Q3O'HV%_C"U2U;?U>F+DRMV09]+@?=L- ME_B!PY3=@,_G4IK=Q!IH/IFF_P)02P,$% @ .7>,6)"ZKW=0 P P@ M !D !X;"]W;W)K&ULM559;QLW$'[7KQALBL & M!.VARU8D 9*=H@5R&%'2H"CZ0.V.M*RYY(;D6LZ_[Y![6#%DH2W0E^6Q,]]\ MY(@6'@LAS2+(K2UG86C2' MF!JI$27]V2A?,TE'O0U-J9)E7*D28 M1-$D+!B7P7+N[^[TK4=.W@O\QO%@CO;@/-DJ=>\.OV:+('*$ M4&!J'0*CY0%O4 @'1#2^-9A!9](I'N];])^][^3+EAF\4>(KSVR^"*X"R'#' M*F$_J<,OV/@S=GBI$L9_X=#(1@&DE;&J:)2)0<%EO;+')@[_1"%I%!+/NS;D M6=XRRY9SK0Z@G32AN8UWU6L3.2Y=4C96TU].>G;Y3AD#)5*:8CJ 8=R' M)$J&9_"&G:M#CS=\ >\MTY++O8$[YZ6 MH]3[G9@_(^[*^$CB0U6@9E;I6<]9<_&"G^ B2?K3:40$:3^\[@_C"5SVWJ$Q M,UAE?]$LH&%H(:L\AP/3FM&Q4!G?\92Y&6?@]:NK)$[>M&NOUFL2X^VP!\;% MN02\1.06I:(!5-.NP_9UM?D(TVC<\JPP!VI1H/I. !=/SGUP:K2C_FM MLO1H^&U.KS1J)T#_=TK9]N ,=._^\F]02P,$% @ .7>,6$_=(+Q9" MPT$ !D !X;"]W;W)K&ULQ9S=;N,V&H9OA7"+ MM@MD8OW8CCU- B21A&:QG@:3SO:@Z $CT38QDJ@AJ612[,4O22F6:4GKYIU>DSY\8_RPVA$CTML(J7Z9L5X M@:7:Y>NQJ#C!F0DJ\G'@>;-Q@6DYNCPWQ^[XY3FK94Y+1J(L"\^=KDK.G MBY$_>CGPD:XW4A\87YY7>$WNB?Q4W7&U-]Y2,EJ04E!6(DY6%Z,K_WT23G6 M.>._E#R)G6VD+^6!L<]ZYS:[&'DZ1R0GJ=0(K/X]DAN2YYJD\O&EA8ZV:>K MW>T7>F(N7EW, Q;DAN6_TTQN+D;S$Y_,B>?B'M!9D,IBP7YA,]M>=Z M(Y360K*B#58Y*&C9_,=?VQNQ$^!/#@0$;4"P%S YE$+8!H1[ >'9@8!)&S#9 M"P@6!P*F;<[9$^+Z;$73&T8N$ZUN,"UU MR;J77'U+59R\_(!ES0EB*_10"_6=$ B7V4M!T\<%79=T15-<2E4.4E:7DI9K M5+&)$'53;OVU8+50* MXGPL5?9U)L9IF]6HR6IP(*M^@):LE!N!XC(CF0T8J^O>7GSP?,3%'C!9"!#-^[P?]>Y"O=-N(\^W4?HI^^M:V_^#5VI&QR1]!2%#3C<@N_) M6E5I>9@:_WUJL*4>I"6OW;MGY'LVS"%)N"V/H<&&!["JAAI[GG8\?=U6#3#$!@EFJ3;>J M39VJ?5"C(EJFK"!#*CECCU4)$A9->RJ]"X*SLWV=!DX+%Z$_LT]+@+)F*3#; M*C!SUQO\U=0;U9%_)J;/%FH\FB'=3+(A49RX8T6!A$4-;+%SM[W3<$\1R 03 M()BEV]E6MS.G;A^)D)RFDF0HQ6(SI)03<*Q2D+#H'\#04._5<&8[BL_"_<8R M 2I9_5L*"J>;I1SYFHXFS-<7&"<"TWC-._5&7" MA7YV&1+'"3]6'$A8! F+(6')PCV:L63TO>YIU#M*R.SDY5GJ?X>?5*[=T&,% M!*5%+6VW)=NO7:^?DD#ER99EQR3PW8U=]DBXI$(/(LA7-8H0@Z,Z-^5H'2!I M44O;+;"S>:^A&SC+#X)>6P>5-5N.H),C<,M1,*7&7]AX9:;]R?0NSP>_P"E12UM]\[[^^* >@]0-%O%SGWPW?;# M_896E99.5Z]?U$>N=_Y8$BWNH"WH!AZM'J@I 4J+06D)%,T6NC,Y_-E;&\8^ MJ#$"2HM :3$H+8&BV26CLU%\MX]RPX34S3A7G6M9#W>HH$8**"UJ:5:'VK- M8K]OE"A@KTO]%DZ)WUDEOMLK6;*2/*.E\2%14I>9<+?$H&8)*"T"I<6@M 2* M9JO<>3#^XLU;8E"G!I06@=)B4%H"1;/?LG>N3N!V=6X.V-CNL&/E!*5%H+2X MI>TVYO/>R[\$*DU;IL[E"=PNSY)@4?.FBMZ652U/4'Q]^UMTA99U+FF5$V>S M[:8?K2:H^P-*BT%I"13-5KTSDX+@K9OM -1U J5%H+08E)9 T>R2T5E4@=NB M-'_>EL MJT&M*E!:!$J+06D)%,W6N'.U@NF;M]6@-A@H+0*EQ:"T!(IFEXS.!@OULD!I$2@M!J4E4#1;ULX:"^9OWJ*#VFF@ MM B4%H/2$BB:73(Z.RUX94X3SLVZ#*';[A-4;E]+OBRL$*(FF5Y3(54A$;A9 MJ>.:)N-.\.B"L.@[SW/]9P^R(]!48U!: D6SESITOECXRFPG6^**TY2@2JEL M-%1:=FM)AO1TTX]>R="WJ/:F3$2@"<:@M 2*9DO9>6>AVSO;DS)EI:"9F3Y@ M5N"E1+74&6)691W4%-1$"_O3F<)9;UI&!)IH#$I+H&BVKIT[%KJG6MWAYV;F MA]*V+I6B3YR:*2$9%68M7+->+F5%H1ID)>IP304UP,*!^4V]J6P1:)HQ*"V! MHMFB[JPQ=V MA6ZWZX:5^M&VG0"9FCU)'U0C+$A:ZSKZRIQA-_]H/0>F5WEGTVFO!P7UMD!I M"13-5K3SMD+WC*V;'0U5 NU\=:5D3[L2X-09U,]J:9;.H>_YP;[. MH$X5*"V!HC4ZCW?6GA>$K\VO! AD^L9F)?;VZ/:7"*[,^ON]XY'_/FY^3Z## M-#]OL,1\34N!M3U#?KQB3 M+SLZ@>WO-ES^'U!+ P04 " Y=XQ8=)Z1K7$% !F(0 &0 'AL+W=O M^(1(0+\2).,3SJ1$.N+7H\'$4DQ[](UR>2=)64I%O*2K7I\S0@.3#NSL!F[C52340&\Z7N,5 MN2/BV_J&R:M>A1+&*)-(F[I]G=2)N0IO( F/'\%V]+6Z8!@PP5-2V<901IGQ3O^41*Q MYP#=%@=4.J!#![_%P2T=W$.'?HM#OW3HY\P4J>0\++# TS&C6\"4M413'W(R M;\33-Z-I9^8WLE""C<) 70)KK*BCO+Y>)1% F[),\DV!,PCG&4D MX>#]@@@<)_P#^ 2^W2W ^[T*&I#''JQ4CJX):R?2.UX<_I"FX$B3EWYN(*W#[S;BJ)5SP-0[(I"/7/"?L MF72F[]Y W_GA:N7NZH^]3QUA]Y(,O^\ M'_Y+*Z_O^TYEI<7E57%YQKAV$[%D- 5S685,-B*Y!$4$YOGB(PS,2!9$LBD^ M@8=KDCX2]AW\"^Y4,KMUH3P#HISS";Z->6W;E+ QIE.GU1*81I]?T>>?J;)] MFQ18 M,H&%04#(P5I$\]DU/_$:P)4V/R>[,I]0)OM%?(\*#4319:D,,JR*$Q MR$M9H6FJHC+6I1'DU$FQ!*;E.ZKR'9VI+D&H9RU;\.CW<'.JIE6(+32<6U<2B M,ZV7$M@6#9;0=!IJG0:-&NCT7CX[ MBVC-P7#=[INB]649,5&K0LHEJ)0;,4 MF[$X> )?LE"J;B8P,U>Y$>ODZ;6$IF=>:SWHG:O*K2HV6V@Z#;5F@T8]9-;B MI:\FLX<#Y[ T7UI!Z*-^2VW66@J:Q51K;;Y>FS<&?/+,6T+3Z:U5(!R>:P%8 ME8:VT'0::G$(C<+K%R1[":BW8OBB83=9H1;ICFH=A\Q:;!$S(BO]GJK:Y1M5 MYZ:*-:.=.E6VT/3<:\6'X)DJ%EG59[;0=!IJ?8:,PL?^G/LFZ%:KJ'^N5: 5>UF"TVGH=9NR+Q1 M=WK/+@&/].QF*]2R+&J-A3GB^X":^1DV[+P,T*$P;S!#<.BU:9!:,B&S9&JNY]?K M\%:WZ6RAZ8=#M;YSG7,=#UF5>K;0=!IJJ>>:-_=.WWPY MBRDDJO(YLOC58M M_]^Z2L?I(WM'@T=WB.XC\MN8K>*,@X0L91A.=R!['"L.]8L+0=?Y,?&PO=V]R:W-H965T[JNW>/53[X"8#B9K8G&W*KG1__#D_2 @$MU3A'DJ)/?-E MYO-,_,6,UEP\R1! H1])S.38"I5:GMNV]$-(J.SP)3 ],^J80I MC_^. A6.K8&% IC35:QN^?HW*!+* O1Y++-/M"YL'0OY*ZEX4CCK")*(Y?_I MCX*(+0?! "@>RZ^ =<.@6#MU=A]X!AU[AT,N8R5/)>)A112(9K,F'=]ASOC0EW1)8C8)>24'/A#[Y0S_1)(VAL3QR M5S=S39];SY/NP!UJYI^WP]^WYY16M;C<,B[7&-'KM;B&Y!%$ MXSH808Y=AY; :OEZ9;[>B4K1:Y."EL!J%/1+"OIO+L4+L^L#;J0F=_*V*A-W M>XZ[4[\-5CW7J(2' M;5+0$EB- NQ4N[CS]B)^P?>!-+)3>+FU,NX39Z>,&\P('KBXN8[QEB[!QJ@V MBS@7/-$/9::$EHA:'*D033-9! )= /-#+5>?RDI'_U:SVLF'U"^KB]M(ULSN MU[PTE=L3K]P"S.$?6SUMH=7))A79Y$0]5 "W14-+:'4:*EV&C9IG4J\8H2OF M$UJFE<"4?@=J3#\''&Y5O]/!NRUB-JH'6RDH;)90IVZ0TNQ/!F_I#V/T1Q=& M2VAUKBM5B-U3]4>K4K$MM#H-E5C$1B%F5NV%;TV0#YV][6+?JN\Z!U0[KC0< M-BNQ_ZT9TFWC#JM94O;SP[L!P?TO$EU^]C>;CY\?T**( M^?$J (F4WJ?\\O5&A50AFO"5[M *8YTN5+=K.D$0]A!;F>(^AVL_USD=;QT M"..._NAW^DW586^=..L[++*3>XG\] [Y*6 Y6OXZ<)&=B>^,3_'Y##>,?R6] M\RGI-B8[Q[>K6^<_4UQ3L8B81#',=1A.IZ]Y%?G)?WZA^#(["W_D2E.3 M?0V!!B!2 ST_YUQM+M(;E+^_3/X#4$L#!!0 ( #EWC%A?CP_#*@( *H$ M 9 >&PO=V]R:W-H965T,8S9\Z9S"0] M2O6D&P"#GELN=(8;8[H%(;IHH*5Z(CL0]J:2JJ7&FJHFNE- 2Y_4\.9@*U"NF];JEY6P.4QPU-\P7SKMLI: M9$0I60M",RF0@BK#R^EBE;AX'_"=P5&?G9%3LI?RR1EW988C1P@X%,8A4/LZ MP!HX=T"6QN\!$X\E7>+Y^83^Q6NW6O94PUKR'ZPT388_8E1"17MN=O+X%08] M-PZOD%S[)SJ&V.06HZ+71K9#LF70,A'>]'GHPUE"'+^2$ \)L><="GF6&VIH MGBIY1,I%6S1W\%)]MB7'A/LHCT;96V;S3+Z# X@>T+L-&,JX1@]4*>HZ]3XE MQA9P8:08P%8!+'X%;!JC>RE,H]%G44+Y+P"QS$9Z\8G>*KZ*N(%B@F;3#RB. MXAFZ$P9J4%=P9Z/LF<>=_4=VI62+UI:SLN-A6V\:M/9-!X5^+O?:^W]=ZD3 M3R[CNU5:Z(X6D&&[*QK4 7#^]LUT'GVZPCX9V2?7T/.'OMU;@K*R:Q%T% T5 M KB^Q#1@S3V6V]%#GJ3D<%Z>G,V/55[[+=&HD+TP891&[[B(RS!_?\/#%M]3 M53.A$8?*ID:3VQN,5-B,8!C9^6G<2V/;[(^-_9F <@'VOI+2G Q78/P]Y7\ M4$L#!!0 ( #EWC%B-5S*4L ( )8' 9 >&PO=V]R:W-H965T)B$*&P/TQ[R &X4Y6\$+CW M'NZBZ\:ZUUCW2K[!!WP[NZ]DQG4LI"X4D-_7"VT4%M>?+G\5X;";T!ZX*YVS M&"8.GB@-:@-.]/4+#?K?NMS^)[)WW@>-]\%G[-&ME$F/&#SW1A/<33S%>2X MCZ?IW-B*S2_9[,6PB0)O'(3NIFWH,(CV/>HU4>^4#ANEPT^5ONT2+L8S6_%L M]288*[5+;<48M(708%]M1U P'G>+]1NQ_J=B'Z5AHGV.NM3Y!XE'P\#;4W<8 M1.F8TFYY02,O.'(MZXKJDA<<9#Z_].F>O(X@&OC#;GFC1M[H*'FX;CV2@>E2 M-SHLQ(#NJSL,PD+T1WOJW-:M:5^L'TQA=6DB8(FX_L4("53U"E0=(_/R(EU( M@]=RV5SCPPG*!N#\4DJSZ]B[N7F*HW]02P,$% @ .7>,6+R^EN!+ P MF D !D !X;"]W;W)K&ULK59=;]LV%'WOK[A0 MBR)!/>O3LN;8!A*[0_M0-&C:[6'8 R-=6T0D4B,I._WW(RE%E1W9RSY>+'[< M98$CGF%3(]L^&B)$IWQ=:5E4"2 M65!9N('GQ6Y)*'.6?\P70^ M9@O',PEA@:DR#$1_=KC"HC!$.HT_6TZG6]( ^^TG]E^L=JWEGDA<\>(WFJE\ MX20.9+@A=:&^\/T';/5,#%_*"VE_8=_&>@ZDM52\;,$Z@Y*RYDL>6Q]Z #\\ M 0A:0' ,B$X PA80OA00M8#(.M-(L3ZLB2++N>![$"9:LYF&-=.BM7S*S-]^ MIX2>I1JGEG=Z'V5U@< W<"NP(C2#]X]Z4TF40%@&GU6. E:U$,@47$N)2L+% M&A6AA;R$G^#;W1HNWES"&Z ,ON:\EAHFYZ[2V9DUW+3-9-5D$IS(9(WI&$)_ M!($7A /P]> [^BSJ_H17[I$OJ RKB%[?X9$MMP MQ9;+U.?=,IKXIQEWI\-O6O7)&B*V;_*O5F@4DOK<0/CE)_'G,Z]:ES-)!T M6I*_.R6?V:OK>JMO @@24]W\GT>@9<"*EQ5AWT$K08&9KKZ* P%!,LH/SBO9 M"L32".X=6/B$&27P#MX;N"[FS$2,X"/39?3B[>LD"+RK)M1V_*O+5\9!*F6M M%_/C>!3'4PC'D4YIE(01>&-_:-^YO;NI1+&U=[S41:1FJJE#W6CWC+BQU^WQ M^'2VF@Z-)[.5?7:X/^B;-\LG(K:422APHY?RQE/]9XGF'=!T%*_LS7C/E;YG M;3/73R<4)D#/;SA73QVS0/<86_X%4$L#!!0 ( #EWC%CP0MPW;@( $,% M 9 >&PO=V]R:W-H965TB!EL86$5)42)&B,M.@M+:^#D.3ERB9&:D:*XJLE9;,DJDWH:DULL*#I B3*+H( M)>-5D*7>M]!9JAHK>(4+#::1DNG?MRC4;AK$P=[QR#>E=8XP2VNVP27:IWJA MR0I[EH)+K Q7%6A<3X.;^'HV=OD^X1O'G1FLP2E9*?7LC(=B&D2N(!286\? MZ+/%&0KAB*B,7QUGT/_2 8?K/?L7KYVTK)C!F1+?>6'+:7 50(%KU@C[J';W MV.DY=WRY$L:_8=?E1@'DC;%*=F"J0/*J_;*7K@\#0#QY!Y!T@.1_ >,.X#L7 MMI5Y67?,LBS5:@?:91.;6_C>>#2IX97;Q:75%.6$L]F2CD71" 2UAH7&FO$" M/K_0&3%H@%4%?+4E:I@U6F-EX<88M :.[] R+LP)'"^8"Y1H><[$"9S!3$E) M^[.T*G^&'W.4*]0_R?\ ]\BTA3D6G T#3\L[.#XZ@2/@%4D_[QB9]8Q// M-WFOL24UQ@ WIL$"K );[H/_4M'^ M)XX&!4:C^(V( TGCT>2-A'!PQ-WU0KN]X94!@6M"1:/+\P!T.[*M857M3_U* M69HAORSIED/M$BB^5LKN#3=(_;V9_0%02P,$% @ .7>,6&FZM^1-!0 MWB@ !D !X;"]W;W)K&ULM9IM;]LV$,>_"J$5 M0PNDD47Z*9EM('46+, "&$V[O1CV@K'I6*@DNB05)\ ^_"A9$45'/DL!]2:1 M;-Z?=\>C_,-1DQT7/^2&,86>XRB14V^CU/;2]^5RPV(JS_F6)?J;-1;^C'-$R\V23_;"%F$YZJ*$S80B"9QC$5+U]8Q'=3+_!> M/_@:/FY4]H$_FVSI([MGZOMV(?2=7ZJLPI@E,N0)$FP]]:Z"RWD_-\A'_!6R MG:QWJZG7RSQB$5NJ3(+J?T]LSJ(H4])^_"Q$O7+.S+!Z_:I^ MDP>O@WF@DLUY]'>X4INI-_;0BJUI&JFO?/<'*P(:9'I+'LG\+]KMQP[['EJF M4O&X,-8>Q&&R_T^?BT14#()C!K@PP$T-2&% \D#WGN5A75-%9Q/!=TADH[5: M=I'G)K?6T81)MHSW2NAO0VVG9O>Z+E9IQ!!?HYOPF:W0E91,2?3QFBD:1O(3 M^HR^WU^CCQ\^H0\H3-"W#4\E359RXBOM0";C+XO)ONPGPT,R=ISKD2-Z"Z%W@U O9V@1T40A'13Z_6<:;G69*O3/ MGWHXNE4LEO_6A;K7[M=K9[OO4F[IDDT]O;TD$T_,F_WZ2S#L_587N",Q*PVD M3 .!U&??N*(16N>+3_/%KPMWKS'(-;)GP]-L0/H3_ZD:1N# MSETMEVF<1E1IYU9,1[\,:;;_ZUS<*PTKTW\FO4,?:P8%PXMZ)P>EDP/0R9M* M[LY0PE2==X,W$V/2.W#N[1@R&M3[-BQ]&X*^50KZCL4/3-06,ZC1MI@=B5GA MCLIP1QWNZ9'+-#@2L](P+M,P=K"GQV_V:S ^J,CQFXHG91B@A\!7 Y2A7'^=$\E M6Z<1BL(UJXT:UL'HA5%15^5SV/*]$1K(", ?[R,%3Y]/%CRLVWJ=NT",P#!& M0+HL>9!@6J?"D9J="D,T 8PTS4L>UAD )0]:OC="@T/!"1Y*11*J5+!\F34= M9=<2+G90L?4*.U*SXS?(%0R[+':G,.9*S4Z%P;$ Q)R&(%*(5$D$X^ 18I! MPR.#; <-* 4P*9VHU89P D_2>LT" V 81B<&M1_ U:!)VG=#>F"V'"E+=1I7\AM8Z@+;,,&VS#< M&VI>_[ .P"JPY7LC-#2&88J:\WB;*B;0/5^K'17L#-TFBB:/X4/$]LU0N/(= MH5:1C"[ #1MPPX,N*]\IP[E2LU-A& [#?;-FX%*(V"V4T0&X%(.&1P;9#AJR MPC!9M2GBF"XX MC1A.(S!?M=T,#9 &GK%M!;A2L_-C*(\$'6X&XI3N7*G9J3!T1T[TXYINAA,Z MY/AF@"W?&V'E/ ^&K7(S-#O[@=5:KVX7.$<,SI%^EX7N%.9 M4-PD<.38E!+ (C%E"G#8$%GJ#U>G71*B,&Z$B71Y?$*;NY M4K-38=B-P$VYYL]H6"?(G]&U 79!9,00&8%)ZD3I-\$3IVTV5VKV.QX&W_I= M'HCVG9*:*S4[%8;4^HX.1$_H *P.6[:-T*^\?):]^7='Q6.82!2QM9;OG8_T MKX;8OTRWOU%\F[^/]L"5XG%^N6%TQ40V0'^_YER]WF2ON)6O-,[^!U!+ P04 M " Y=XQ8R%&UQV," "P!0 &0 'AL+W=OR!J0*Q/4Q[<)/3QL*Q@^U> M^/8[=M*LH);M82^)[9S_[USB[XHK3L(LT'-%OB ]K&>:MJ%':7@%4K#E02-\V%P%5^.^\[>&WSG MN#8[:W"9S)1Z.P.BUPC$*X4 4QG/+##J73KB[WM)O?.Z4 MRXP9'"OQ@Q>V' :? RAPSI;"WJOU+;;YG#E>KH3Q3U@WMF<7 >1+8U75BBF" MBLOFS39M'78$\?D!0=(*DK>"_@%!V@I2GV@3F4]KPBS+!EJM03MKHKF%KXU7 M4S9>1HVGY("G.($[)6UIX%H66+P&A!1V%WNRC7V4O$N< M8-Z#-#Z%)$K2/0&-_UV>O!-.VI4R];ST &^JJ;>T?3F%J6#2 I,%7#\O>4V7 MWL+/JYFQFF[MKWVE:\C]_637R9>F9CD. VI5@WJ%0?;Q0WP>?=F7]G^"O2I" MORM"_STZ%96@.6>^1W%#P\;@OH0;2AQYC!LUJRSJT5]8[2;R%Z,FP'#G\E>H M%WXF&,C54MKF+G6GW=BY\MWVYGQ$XZB9'G\PS2R[8WK!I0&!T,Z/M<*;O=. ?=D,Y^ U!+ P04 " Y=XQ8 M:T%CB;H" !)" &0 'AL+W=OU!LQA8J2YXD)]W?CY(3+RT< M=]WZ$NO"<\A#263&&ZGN=0Y@R$/!A9YXN3'EA>_K)(>"ZC-9@L"=E50%-3A5 MF:]+!31UH(+[8:\W] O*A!>/W=J-BL>R,IP)N%%$5T5!U:\9<+F9>(&W6[AE M66[L@A^/2YK! LQ=>:-PYC-/@XG)D[9W!5P8;O3?8:MG8/D2R;7[)9O:=C#T2%)I(XLM&",HF*B_]&&; MASU < @0;@'A4T#_ "#: B(GM([,R9I30^.QDANBK#6RV8'+C4.C&B;L*2Z, MPEV&.!,O\%JD%0&+4$=/GW\+ CG*C)9.3XH@-\GW;9P_R0*V&HR-@2$SO5&HPF(%_M*6Q]M)O]V(?]84N:0(3#U^M!K4&+W[[)ACVWK>EX)7('B6D MWR2DW\4>SR!C0C"1X3OC5"30IK:3HCU TB:TYADX'ENYUG%P/@SZ8W_=HF#0 M*!AT*K@J2LH4UBQ#X 'KIFZ5T,GQ @G_P//L60T;I<-74%IS#/>2?'H^B,(F MR;6.%JN.LQ@U$8XZ(\2J\F;K+75.$;TX3#"BE[9R.\0ZIN7/7$R-+5_J4TV$G< M,,=>#\H:X/Y*2K.;6 ?-OX?X-U!+ P04 " Y=XQ8W/O'L2L$ !5$P M&0 'AL+W=O].M+7:*+33-VZ[S$HC1S>&9( MGIEPO&'\NU@!2/0C33(QL592KB]L6T0K2(DX9VO(U)<%XRF1:LB7MEAS(''I ME":VZSBAG1*:6=-Q^>Z>3\!3,G F8L^8/& M!%+1/D7;2K;,+!0E O)TMI9,4AI5OV2'W4B M.@XXW./@U@[NMH._Q\&K';PRT(I9&=8UD60ZYFR#>&&MT(J',C>EMXJ&9L4R M/DJNOE+E)Z>/:E_$>0*(+=!-)DFVI',UNA0"I$#OKT$2FH@/Z Q]>[Q&[]]] M0.\0S=#7%AI"L\/=70,=KTFI5^)Y>_ ^T8Q*.+M5VS/6Y/3/ M6V6/;B2DXB]=]BIP7P]>G.H+L2813"QU; 7P)["F/_^$0^=77>0G NOEP6_R MX)O0IY\Y$P)%A/-GFBT125F>25W$%4Q0PA2R\S3%?CARQO93-Y37K'H<@X9C M8.1X&45YFB=$JJ52!+FD_Y!"7G0T*Z2P0^ LQ,%PBZ;&R@\]K*<9-C1#(\V; M=$TH5^HIT:U*JHY=N#OO,/#<+78:*SP,L:^G-VCH#8STOJAR<\ Z&T'TFQ'I M-O5@)PCL.,%('\.PB6%HC&%6:BUP] !)N07$BJ[5:;V#= Y<>U*-@,>>U!.! M]6(?-;&/WE*Q1J?,PXG >GG 3EL-G=-H5HW3W80#O*-9KUGU679J-CZ9:M50 M?4'"_K8PZ,P\C(,]5-V6JOM_E:M&Z$_M^-O":I[HO^Z,MJAC8ZT\5./,*$>( M7 W4K7>^,]BW'FU-QN:B_%%(FI8;)Q>PR!.4T 5H S'B''NJ7V$U0,] N# M M5%O1L;FD?^4D!O2%I&!6;S/,T0&>"*T?=-L?X/ M%1P;VX^CPN=\X2L.'NPKI.CC<9JHQPT''K$^U M[0ZPL>@>I.&CW:D#?^AO,WR+ZNZVU=TU5_<#-=R,JQE^6]C3JCQ0I4_^%T1_B29@(EL%"0SOE 99U7=SC50+)U>0TR9U(U^N7C"E2I MX(6!^KY@3+X,B@F:F[3IOU!+ P04 " Y=XQ8H]SV858# (#0 &0 M 'AL+W=O M]PS KP#^ <#M/P/H5X#^L8!!!2A2M\O<"^%"K' P%GR#A+'6;.:F4+] :[T( M,WURJX1^2C1.!>\YCS>$4H19C A3F*W)D@+"4H*2Z%4("A,JT2.OD_"V2J?IUJ?IM[,&G M/%V"0'RE3^*,"T78&N6,Z"K]:^GJ64DZ+$C-_\-]X([M^UVY6]V>*G>79(N. MR/;D'M1R#UKE-JW/\C,VA(5YU@Y M.-6[]3@_+:;8@_V9>SDOI_)'FO(;X5JW)F$245AI2J=WH<42Y=Q=+A3/BL%R MR94>4XO;1'^J@# &^OF*<[5=& ?UQT_P'U!+ P04 " Y=XQ813QW&3,# M @"@ &0 'AL+W=OL@5J]*1BOL%13OG9%PP'G M1E11-_"\V*TPJ9UT:IXM>#IE&TE)#0N.Q*:J,'^Z!? M\IGC:2*@D$GM JN_+=P!I=J3XOBS=^IT:VKAX?C9^P<3O IFA07<,?J3Y+*< M.8F#3J+5$Z MF2Y57>0;"H@5Z";+^ 9RA.L,I[^KS[$C^"=2M;>63D^G38 MIKX73=WM80 6&]_K;%YPC3JNT5E<#7[BC%*S-RNHH2#2BMEZBP\01LFXASFT MB9/$CAEUF-%YZ>,X!]1P5C%]3K6UA/,M<$D$J=.. M.#Z+F-025#E)&UD\6#:(1CVTH4TRLI.-.[+Q6609JRHB=,>P[O38LHMQ#VYH M$R:1G2[IZ)*3=',H@'.%QV$+]09L:,E@V7X)#BW",+:#33JPR4FP9XYT$-$W%VB6\89U-^G5F,XK](TP' M_<\_R?2=2:P.E8/6QTSKH_]:GY78'YQT@9?TCT.;533I;[-[T+[UW>D+YFNB M3@X*A9)Y5V.EY^UUI)U(UIB.OF)2W0_,L%17..#:0+TO&)//$WU)Z"Z%Z5]0 M2P,$% @ .7>,6(QSWH0,! W1$ !D !X;"]W;W)K&ULM5C;;MLX$'W?KR"TQ:(%6DO4S8[7-M#X@DW1H$'3[CX$?:"M ML2U4(EV2CM._7U)29"NA::=07VSQ,F?F')&C(0<[QK^+-8!$#WE&Q=!92[GI MNZY8K"$GHL,V0-7(DO&<2-7D*U=L.)"D,,HSU_>\V,U)2IW1H.B[X:,!V\HL MI7##D=CF.>$_+R%CNZ&#G<>.S^EJ+76'.QILR IN07[=W'#5QA#EFDD M%<>/"M2I?6K#P^=']%E!7I&9$P%CEOV7)G(]='H.2F!)MIG\S';_0$4HTG@+ MEHGB%^W*N7'LH,562)97QBJ"/*7E/WFHA#@PP,$1 [\R\)\:'/,05 ;!N1[" MRB!\:A =,8@J@^A<#W%E$!?:EV(52D^()*,!9SO$]6R%IA^*UU58*X%3JE?6 MK>1J-%5VOWJ# M7J&4HB]KMA6$)F+@2A6&!G,7E3;"5J:$;5*:8O-F0!0T?E$ '\'IS17W_BV/O;1+DEL(8 82U M:$.O!5@4 KQ%%*2);PD2%2 Z ]Z/(O\"#]S[0Q[/)V$$M@#;H7-=V+WY+A+MH4H"6PA@#8VW\WO3922(5RF+_\ M7N])DIN<\'6'36I.[58OW['XH&C UH"NB=QR_<(3(L$0VN4)>S.A\0FK#UO: M0;[Z3NL/=6Q4Q KPJVO"W\OBG[4FJFUA2P5VI)=NA;;0FKSW]0[^/04/;K7B M:0NM*<*^YL&M%#W84-!TPV<)P>[KSCN5AK^-YR(\\%'743]"-4-#I1J9@W(,38PY\59SM M52G)ME26Y6?=6]\?7!:GYB?]8WVO8.KW^Q/3_*G?GYGZW^.X/\6Q<:2K1HJK M"W9=0-B3;%&??.9/J)%T\KH$DP/4$-;YD M3#XVM(/Z1F?T/U!+ P04 " Y=XQ8Q*@/'@L# !O"@ &0 'AL+W=O M$BQ4J;8N7*3 ".K5-*7=_S.FZ*"7/"@9V; MBW# -XH2!G.!Y"9-L7@> >6[H=-T#A,/9+569L(-!QE>P0+4MVPNM.66*#%) M@4G"&1*0#)W;YLVX;_;;#=\)[.31&)E,EIP_&6,6#QW/$ (*D3((6+^V, 9* M#9"F\:O =,J0QO%X?$"?VMQU+DLL8N"[SU#DTS9X M$:?2/M&NV.LY*-I(Q=/"63-("%_H<.30[)QQ\ L'_Z5#ZXQ#4#@$-M&< MF4UK@A4.!X+OD#"[-9H96&VLM\Z&,/,5%TKH5:+]5+C091%O*"">H#%/,\Z M*6FL"2P5NIJ PH3*:W0UQT(OK4&1"-/K@:MT=(/A1D6D41[)/Q.IZ:-[K@$D M^L1BB$\!7$V[Y.X?N(_\6L0)1 T4-#\@W_.#"D+CU[O[-72"4LK XK7.X-UI MV\HH("8*/=Y#N@3Q$_U&4XC1=,-BG7J2@"U<]( 5H"];$,P4&III3?9HL<-9 MOG+PKM*YEH8Y]C;7DOG5;$.O MX;4U@^TQX^IMENFV@F2W)-FM)?D51(KN.&:UYZP6XZUE=B&PDW1[9;J]_W+. M>I<4X$)@)P+T2P'ZM=][=BA'K%!"]OHZ/E>7.4[_I-Z:+XJR-M9;,W&/_MTI MB)5M:22*^(:I_%=8SI9=TZUM%E[,CW0WE3<_?V'R5NP>BQ5A$E%(-*37Z.I[ M0.3M36XHGMD.8\SP#U!+ P04 " Y M=XQ8_C_=7F0" !M!P &0 'AL+W=OBO8"O?<_Q.1=S'6T8?Q$%@$2O):U$;!52UA/;%FD!)18C5D.E5G+&2RQ5 MR%>VJ#G@S(!*:GN.$]HE)I651&9NSI.(-9*2"N8)2,E5(*P"G'(8^O&G4Q#G6\2OA'8B)TQTDZ6 MC+WHX&L66XX6!!12J1FP>JUA"I1J(B7C5\=I]5MJX.YXRWYGO"LO2RQ@RNAW MDLDBMCY9*(,<-U0^LLT]='[&FB]E5)@GVK2YUXZ%TD9(5G9@I: D5?O&KUT= M=@!NL ?@=0#O5(#? 7QCM%5F;,VPQ$G$V09QG:W8],#4QJ"5&U+IK[B07*T2 MA9/)0AV+K*& 6([N&MEP0#-82O2 U9A( @)=SD!B0L45^HB>%S-T>7&%+A"I MT%/!&H&K3$2V5%(TH9UVV]ZVVWI[MIU!.D*^^P%YCNGP[VW<%L5H*^" MUU?!,WS^7CYE>49$2IG0)?AQLQ22JR/V<\A:RQ4,<^G?;B)JG$)LJ?]* %^# ME;Q_YX;.ER&C_XGLC6V_M^T?8D]4]8(A@RUJ;%"Z#:R3L??9C>SUKO"#U&<* M#WKAP3'AXR'A!U'#FM#01SF#YZBW<>]M?,Q;..3M(.H?O)W!<]1;V'L+#WI[ M8A+3(7/A*2?N[R37#8*@SVHEV3O-4%]$#YBO2"40A5SAG-&U(N!M,R:W@6ZY_0V;_ %02P,$% @ .7>,6,#)@;CR M$P ?#L! !D !X;"]W;W)K&ULO=U;;]M(GH?A M^_D4!>]BT0UD;9$Z.=G$0&+3#,]$TK-S$;##RG)ILLJ ME<3DW9V+CBVKGBI)\R_Q\&/Q[;>B_+.Z2]-:?%\N\NK=R5U=W[\Y.ZMF=^DR MJ4Z+^S1O_G)3E,ND;GXM;\^J^S)-YNM&R\69.1A,SI9)EI])[?IY[3^^WU<-K^= M/2GS;)GF55;DHDQOWIV\-][$Y^L&ZV?\;Y9^JY[]+-J7\K4H_FQ_<>;O3@;M MB-)%.JM;(FG^>4@OT\6BE9IQ_+5%3Y[Z;!L^__E1OUZ_^.;%?$VJ]+)8_".; MUW?O3LY/Q#R]25:+^E/Q[6.Z?4'CUIL5BVK]7_%M^]S!B9BMJKI8;ALW(UAF M^>;?Y/OVC7C6P!CN:6!N&Y@O&XSV-!AN&PQ?-!A.]C08;1N,7O:PK\%XVV!\ M[&N8;!M,7C88[VDPW3:8'MO#^;;!^;$]O-XV>'WLVVH,'C^YP=%-GC[LG4][ M;Y/'C]O8^;SWO1+C\0,W7G[B^WMY_,B-G<]\;Y/'#]W8^=3W-GG\V(WUYWZV M*9)UA5TE=7+QMBR^B;)]?N.U/ZS+=-V^*:PL;V>4SW79_#5KVM475^G76OQV ME=9)MJA$F)1ETI;X[^*_Q=\_7XG?_O/WMV=UTT_[[+/9UK0VIKG'-$P1%'E] M5PDKGZ=S&3AK!O@T2O-QE)>F5G17^:DPC5?"')A#Q8"N#C1/FN:#R;JYH7H] M^N97Z>Q4#/?W;A_?W%0T=_3-@Z34]NX>\]KW-_?TS:-9W;SSH[V#]_7-/Z?W MS> '>YL'Q[]V5?/P^->N:A[IF[]?W9X*8[CW_S;Q,T-= MJ3IY59>KYBN]%E_\Y@G"J=-E]4_%Z"XWVDBMM5LJ;ZK[9):^.VDV1:JT?$A/ M+O[K/XS)X']4!49B%HG9).:0F$MB'HGY)!:06$AB$8G%$":5_NBI]$*R M>$CS)*]?M1L!V7*U%(OLKU4VS^H?S69]\U/Y\FMV,P5HU;Y3 (E9&VR\QMJ] MGH>+X6#]O[=G#\^KF^S4(3&7Q#P2\TDL(+&0Q"(2BR%,JN[Q4W6/M=4=)S_: M+_1*K'?2'XK%0Y;?BO99HK@1LZ:VLUI5W5JU;W63F+7!)L^JVQB.5>4]WID& MQI/1[O,<;-QKFJ M1K7M^]8HB5F3G1H=FZ^-W1+=?9YAC$:CW1HE1^>2F$=B/HD%)!:26$1B,81) M-3I]JM&IOD8/?H]JV_>M41*SICNU-ST?*6KT)SH5J@UD)?$/!+S22P@ ML9#$(A*+(4PJX==/)?SZT#YN\G61BBP7?V;YO/FWV6Q.*V4Q:Z6^Q4QBUNN= MW55SO+LE;/]$G\I:)L?NDIA'8CZ)!206DEA$8C&$2;5L#+J3Q@-M-?^C*=]R M5=7B4SI+LX>VLBMQN?YV%M?)+%NT!Z:_!.GR:UHJSTWI_;XUCFH6JMFHYJ": MBVH>JOFH%J!:B&H1JL64)L\,S^(D!GJ2>LM1$P&I6:AFHYJ#:BZJ>:CFHUJ M:B&J1:@64YH\$9C=1&!J-Q&:S8!4),MBU4P"R?PAR9M??UO=B[I0)1YQS!>[-"C?3JHYJ*:AVH^J@6H M%J):A&HQI;,=G$CDMLR3=O->65UZRU3_$B3LE)6 M,IG@L5#-1C4'U5Q4\U#-1[4 U4)4BU MIC2YXKL$FJ&/H'U*\_3;T16OMR8# M,4]^J"L>39FAFHUJ#JJYJ.:AFH]J :J%J!:A6DQI:HN>#3%AFK65GM^3LX8*+.F:+\.JKFHYJ&:CVH!JH6H%J%:3&ER M@7>Q-^-7:CFHUJ :B&J1:@64YIZ%W5:!C.4*7AE%5-=NN@FHMJ'JKYJ!:@6HAJ$:K%E"97=1>.,_3I MN%YY&O$O$23?UU>!:B,V:(P.U2Q4LU'-0347U3Q4\U$M0+40U2)4BRE-7@JE M"]^9 S1B8Z)9.U2S4,U&-0?57%3S4,U'M0#50E2+4"VF-'DBZ+)VIC;"B:[7)R)IO10S4(U&]4<5'-1S4,U']4"5 M1+4*UF-+DB:!+\YG:[-!F M(LBJ:K7.X,^*JE9EU -5"5(M0+:8TN<"[>)[YJ_$\/=![@QR-YYF[\3SEC&.C MW3JHYJ*:AVH^J@6H%J):A&HQINM#:?.LVEPZHRQJ-'6':I:I M6+Y.?1@-#=2AFHMJ'JKYJ!:@6HAJ$:K%E";?5JD+U WUJ]G%9;9,Q:?V&-JS M<^B_O,:=OM>^4P&J6:AFHYJ#:BZJ>:CFHUJ :B&J1:@64YH\7W2YNR&[QMT0 M7>,.U2Q4LU'-0347U3Q4\U$M0+40U2)4BRE-G@BZ+-Y0G\7[D%19)3:WJOFH%J!: MB&H1JL64)A?[L[NOZA>\BQ9S$2^2_$_Q1YED"W%9+)>KO-T)^- ^&+Y_OO-P MG<[%]2J?5\*ZN4G7=TW?[&!$#VF9MWY]7]D:O[)U>V5N]LO=Z96_VRM[ME;W=*WN_5_:&K^P=7_\O M"+J8WU ? M\_N%W0ST%K$'AFF>CY6EC\8 4;+I4X MG++['&A&$=4L5+-1S4$U%]4\5/-1+4"U$-4B5(LI39X(NB#C4!]D_(5]#C36 M>&"8PZEZGX,<@XUJ#JJYJ.:AFH]J :J%J!:A6DQIA/N38+2VBW05 M@XZH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:3&E2^8^Z-.2(75YPA,8<4"95*ORO9XXUR]N?_A /+% M4$\::"02U:P#K\A=Y:?"-%X)80[,B7*>0%.0J.:BFH=J/JH%J!:B6H1J,:7) M\X39S1/Z%*1?Y+>;&X?-FQE#6>WH&H.H9FTUZ:*H\W-CYZ*HZP/O@GJBLW]F ML$(Y#:#Y2%3S4,U'M0#50E2+4"VF-'D:Z/*1(^R&P'JI]WR 1A9'RAL"O[A M$NW20347U3Q4\U$M0+40U2)4BRE-+NTNB3C2!IP41P3%O\3QT03E%$ &M*Y0 MS4(U&]4<5'-1S4,U']4"5 M1+4*UF-+DN:(+*X[&[.%#-**(:A:JV:CFH)J+ M:AZJ^:@6H%J(:A&JQ90F3P1=='&DCRX^WJ/L:U$V;;/\5LR2IKMF T$Y#:") MPM'N@H@3U?)D%MJMC6H.JKFHYJ&:CVH!JH6H%J%:3&ERA7=AP9%^"<.C3A!< MZI'>E:T?DIODIT(,)INC\R/EESH:"T0U!]5<5/-0S4>U -5"5(M0+:8TN>2[ M6.!(G[>[7A1%>3@#J%=ZU_Q&.[18@H7V:J.:@VHNJGFHYJ-:@&HAJD6H%E.: M7-E=ZF_4-_77ZQA?>].Q(I\7N5B?!_C:_CFZN6FFB;E\I9%RND"SA*AFH9J- M:@ZJN:CFH9J/:@&JA:@6H5I,:=*D,NZRA&,V2SA&LX2H9J&:C6H.JKFHYJ&: MCVH!JH6H%J%:3&GR1-!E"ZEWK:$X0U6Q4 +ALX9N]%/$8#@JAFH9J-:@ZJN:CFH9J/:@&JA:@6H5I, M:?)$T"4)Q]KTT9&G#/5([_(G->O "Y2N#E*M37!] /AB*J\C.- JFM6G8FCL M/^WY\5"W0U6W#OK>N:CFH9J/:@&JA:@6H5I,:?*$TL4-Q_I%!P]??*0'>D\F M:,!PJSW/*1G3D>+BHP/OPKY)0\$;H]%HQ_]XR-\S.Z 91%3S4,U'M0#50E2+ M4"VF-'EVZ#*(8WT&<<^QA^=W=^IS1R=];[VG$G390U2S4)[HDXYA=]G",9AI1S4(U&]4<5'-1S4,U']4"5 M1+4*UF-+D MB:#+-X[U^<9^%RWHL=[3 'H'9U2S4ZY7>%;G17@:/UXN.2LECM%L;U1Q4 MJOFH M%J!:B&H1JL64)D\'751PHL_@76??T[F8W27E;2IFQ4-:)LT/S1=^5BCG S0? M>&!LQJDY;BD]"M-\(U6)*DZNXB_I-],L 7C;?V'F2UZ_$,LO7Q](6 M.W6M+&0T\H=J%JK9J.:@FHMJ'JKY6^UY>9ZKCD(%:+5'?*LB;#1E>H9J&:C6H.JKE;[>!Z2)[JB4/5P6]T? &J MA:H7\5KQ(B+%$Z>FZK@V-3ZYSKJ0VT0?OXJ3'^UIZ:J]>_%7&-OGS)Y/BL9(\6LY*!#J5M.P#K=;)VMT21T?NHIJ':CZJ M!:@6HEJ$:C&ER27>9=:F!S)KQZ73]4KO>D;O>KO57F;=QR^B[O:>Y^UDXAUT M>"ZJ>:CFHUJ :B&J1:@64YI;/I3"]/]\JWM]-WVKG(TDH9J-JHYJ.:B MFH=J/JH%J!:B6H1J,:7)$T87;9NRJ]A-T4@;JEFH9J.:@VHNJGFHYJ-:@&HA MJD6H%E.:/!%TN;>I-N_3\RIQ/=9[&C@RRF6AW=JHYJ":BVH>JOFH%J!:B&H1 MJL64)E=XE[B;ZA-WQZU3J4=Z5[9^2$?V@[MU48U!]5<5/-0S4>U -5"5(M0+:8T MN;*[E-Y4G](C#O3]TOWM]./K/6>@^3]4LU'-0347U3Q4\U$M0+40U2)4BRE- MGEFZE.#TG#TBB(;]4,U"-1O5'%1S4%65ZTPS->//!/#G;>=PR MWGPT5(^;;ZY5S[?--Q]5C[\_'[R)FO=&]1>C^-?,I&G9/J'Y^TU1U(^_ MM!U\*\H_UV_-Q;\!4$L#!!0 ( #EWC%A3JO\Q&00 +D2 9 >&PO M=V]R:W-H965T7REL9.4:F51"SA_-S54\<7HF M(D@@4H:"Z)\US"!)#)..X^^"U"G'-,#J]8[]DTU>)Q,2"3.>_$ECM9HX(P?% ML"!YHN[XYG]U(<5Y H@OT(P(\433);I@/$\5(FF,/A$JT%>2Y(#>ST$1FL@/Z%?T MY7Z.WK_]@-XBFJ+/*YY+W5F.7:5#,L1N5 P_VP[O'1A^#M$I\O$)\GJ>WP"? M'P_WZG!7"U&JX95J>)8O.,#W&01#UYRDZ.$&6 CB+_1/18(3=)5FN9(GZ!K6 MD""_VNT.,BX4Q(5:-T!D+D!;1)6]FO1I#] MCTUJ=416T\XOM?,MNW] NZI,%U*"DK: KBD):4(5!;G3)$;:\'<0Y4*8:C.] M_N"I*!LNB:02/5SK ="5 B8;A?.[%*XCLIIP02EBZ5A3'^N3[ZGU-6 M>W@OK8NNV.IB[M?5V'M5GL*=+JN[8JN+MU]8X];EYV%7M<,.NLM^48C;5X5ZBE4K^ 7IOX6IDK5U"13FT74BP.[L;6'D*0^-P"34 M6U9JO6=.'^PI@BX.1E*RM-9Z]V;DX>%'#9G,]PT/BDKY_84P]W/\3V4.>&B"75LB2PT,/U3H?Z M18GM.&PO=V]R:W-H965T'.V15[)5 MZM$;=U6&(Y\0<"BM9Z!NV4,!G'LBE\:?D1-/(3WP>']@_Q*T.RU;:J!0_">K M;)/A3QA5L*,=M_>J_PJCGFO/5RINPA?U@^\BPJCLC%5B!+L,!)/#2I_&.AP! MYE?/ .(1$+\6D(R 4#DR9!9DK:BE>:I5C[3W=FQ^$VH3T$X-D_XO;JQVM\SA M;%XH(9AUO\4:1&6%2B4MDS7(DH%!%RNPE'&#OE.MJ2_X)?J 'C8K=/'V,B76 M)>!I2#D&NQV"Q<\$6T$Y0\G\/8JC.#D#+UX/CT_AQ,F>M,>3]CCP):_47IQH M7S%3C7S=98[5[<[W.:AR!7YX/X+ER:EI:08==F!O0>*NL:XFP;=S0 NT=W/U.*7LP M?%],8S#_!U!+ P04 " Y=XQ8#\Q;GS@# !/#0 &0 'AL+W=OK@A]8Q$ 1^LTR=A(BSC/ M;W2=!1&DF/5(#IEX,R,TQ5PTZ5QG.04<*J,TT2W#\/04QYGF#U7?E/I#LN!) MG,&4(K9(4TS_C2$AJY%F:IN.IW@><=FA^\,"7F3C8=PI!DR(D@@X%("B[\E3"!)I)*( MXV\IJE4^I6']>:/^7<$+F%?,8$*2ESCDT4B[UE (,[Q(^!-9_8 2R)5Z 4F8 M^D6K8JSK:2A8,$[2TEA$D,99\8_792)J!N8A ZLTL'8-G ,&=FF@,J<7D2FL M.\RQ/Z1DA:@<+=3D@\J-LA8T<2:G\9E3\386=MQ_%M]%N$@ D1GZN>",XRR, MLSEZP93BC#/T^0XXCA/V!7U%'Y&.6(0IL*'.A7,IH0>EHW'AR#K@R+30(\EX MQ-!]%D+8%-!%U%7HUB;TL=6I> =!#]GF%;(,RVX):'*\N=41CEUETE9Z]@&] M3<;:4E-8.NV6L!P',-+$4F1 EZ#YGSZ8GO&M#>M"8@U(IX)TNM0K2$2V MW\H5&N,$9P&TD1=RGI*36\K2MTS',8RAOJPSO3NL$:U;1>MV1ZL6,83H=@E4 M;$KH?@TTB!F@*8T#.!JB\-*O1>?V!M8.PCN#&@!>!> =E>XK],#88G?5%,%Y M>ZFS;=>S!SOA=3IJ_VI0QP?3KPCZYTQ!%UA_+Z&FV7.<':Y.]Z=S75=C<>0D_P(J#E\L M4J'?K_.8M@-WRYU ? &A)G*M'##/F_$C,]'IY91,G"_4S(2US81UV:.NU*OO MQ*YK&'L[<ZE9PJVKAG?ZQO"VHDG D5P7P*^&BG%:/D;CQ )4#Q/L9(7S3D ZJ.Y3_'U!+ P04 " Y=XQ8 M4DM*O4D$ !4'0 &0 'AL+W=O%+N@I6.;B"1Z)&TG0'_\2-D6 M-0K_3H4*.MD*]J":#16Y&7:APMM5[=Q+%*EU PU1$K*,V9 MN9 %TV97+F*UDL"RJE&1QR1)^G'!>!E-1M6Q9SD9B;7.>0G/$JEU43#Y?@NY MV(XC'!T.O/#%4ML#\62T8@N8@OYK]2S-7EQ'R7@!I>*B1!+FX^AW?'-+![9! M=<4G#EO5V$8VE9D0KW;G,1M'B54$.:3:AF#F;P-WD.Q_1/V"?5LO%3DJOI%V_VU2832 MM=*BV#[O[9VWX@&@UP]T0#LF] *MV[CBJ5]TRSR4B*+9+V:A/-;E2I M5JV-.%[:69EJ:Q-BILK#C=]WB[ZY&T@XB^ J1A-#_-H^- M^#H#4F= JGC=$_$>N%0:?30:32H'M>C+$Q0SD'^CK^@)F%I+,%;:IW6%_G@# MF7(%Z%GR%.J+CR7C[=S>,S=JQ5(81^:F4" W$$U^_@GWD]\\J=$Z-5I%IR=2 MN\N94G9F#ED)B:K[!GWY8"Y%CQH*=50U#:"Z6ZON>B?D(#9W?KE"16,2N)V$ M8ZIWK:?WPPTR73)YCCN\/;<+MO.=#7=7+7@>QQ M'4 U3AR0DD &V0=N.J1_PB&XP4<< "\K\](!&?H(LO :Q-]YV[%VZ,0DD$=P M""YB!T;L)=AQDVCSNFC?6,R[VEJ:6_.H;G_<'GH')I5/H\,@]G.PC7->N'I% M#Q+,T)<:S,AI],*TGT%^&6VGPM$5]T)Y* 0]L<,G]G+ND@=-__\O*K1S?>I9 MX]"(_6R\Z%ESSS<\@S([PS!>%6W'W4$7#T,9)@1/L0,J]I+O$L.T0"KRU4:. MIL1/TRFDPG@B7'GD[;[EE!!'9X(#>8F$("]I%*W^JK6]E_:!SZV2B&,J\;.O ME57.+93\?;<=;L=BT@WEDQ!T)8ZNQ%^\7N"3WMGU$G',)'YFMO+(=Y5,?@%M MQ]LAF Q"&24$58FC*O'7LA<897AVV40<*XF?E2VY E=;RD_FJV==WTC;C?KINH0R/UH[&5==H43GX=;>>BL;@;;'4W!$RI@RD- MMUVM%A5G\UF0FM15)M+8!E(>X$Y M/Q="'W;LE[CZ0^KD7U!+ P04 " Y=XQ8ZRUF-6 # #+# &0 'AL M+W=OV#FTP;"\,W..9YQ)9\;%DTP M%'I)*9-=)U%J>T#YK.OXSGSAAHP391;Y%GKF MEB@Q28%)PAD2,.HZ9_YIW[<&=L<]@9E<&"-#9+(5X&<#6/DDPP)],+:A$'$!VBAK^/ B]H M5 34_[QY4!-.H]2V8?$::_#.,1'H'M,,]DM-"4AT!5AF F*DT_@&HDP(PL:H MAR61^^B.\:$$,<5#?2@7;)(ILX>S2%MCF_F/E]H/NE"0RC]5JN=!-:N#,M?" MJ9S@"+J.KGOC"9SP^S>_[?VH4FQ+8$OZ-4O]FG7H83_!; PFRT9&R:E1TN3I MK,A3^J9IE0XY>,N"F]ML&@:-=L>=+M*K#:":'JIAUBJ9M6J9S2OM\0K2(8C* M8ZQ%^.HQ;@ELB6R[)-O^'\N@O4W]M@2VI-]1J=]1;;+T8$P8,]H,,<4L@BJV MM1"?2N2?ZHJ%NH:$2FSU7=#SCC':B^6=^ =K]1WK<,-Z9R4 M=$[^Y?5U\I[?N^NK-H -Z?G>6^O@U1+4!4FQE&1$HKPDW\C)I4-4',%SION( MRB;!>T?T(&@VFRM4ZV/9E.M"F^37, M6(BKWPH.!0 62 !D !X;"]W;W)K&ULS9IO M3^LV%,:_BI5-$TBL2=S2]K)2"9JA,<$5@OOGQ=5>N,EI:Y'$F>VV7&D??G82 MDJ8W-41RI_$"DM3G9_N)?>RG9K)E_%FL "1Z2>)47#HK*;,+UQ7A"A(B>BR# M5'VR8#PA4MWRI2LR#B3*@Y+8Q9XW=!-"4V0'[.'KBZX@N%K=BY1KHK<\:>]O])N\\ZHSR&*1_T;;LJSG MH' M)$O*8-6"A*;%7_)2"K$3H#CM ;@,P/L!PP,!_3*@OQ\P.! P* -RJ=VB M*[D. 9%D.N%LB[@NK6CZ(A.<,.2.RNX^ #7Q^B>I7(ET.]I!%$3X*I& M5BW%KRV]QD;BG^NTA[!_AK"'^VT-,H<'$/90_W!X\/YP;.A-O]*]G_/Z!WBS MF B!V *5+P QCO))A[[=J:+H5D(B_FIIYW7!';1S=9JX$!D)X=)1>4 WX S M_>4G?^C]UJ:935A@"=;0N[(+2< MB/IN6ZH=4S*G,9441)O&QKJZ:CS^(=&H7:/ZV9N@ENILJ/>A4N^#63T]Y)0\ M,PX1K:Q_ANY@ S'J[Q9[A(QQ"5%1%-T#$6L.:@-K MS@W&5G75V28LL 1KO W?JW>-WI&R0PFV)*E56F"+UA1U9RONOV\/\\;D-V,Z M2^C_./U;Y[^M:IOJX%H=;%3G"4(U8R,4P+R1 ZGAJLX6U&"/@%/T!TCJ
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end XML 88 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 89 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 91 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 193 367 1 true 79 0 false 6 false false R1.htm 00000001 - Document - Cover Sheet http://betterchoicecompany.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Statements of Operations Sheet http://betterchoicecompany.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets Sheet http://betterchoicecompany.com/role/BalanceSheets Consolidated Balance Sheets Statements 3 false false R4.htm 00000004 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://betterchoicecompany.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://betterchoicecompany.com/role/StatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://betterchoicecompany.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - Nature of business and summary of significant accounting policies Sheet http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPolicies Nature of business and summary of significant accounting policies Notes 7 false false R8.htm 00000008 - Disclosure - Revenue Sheet http://betterchoicecompany.com/role/Revenue Revenue Notes 8 false false R9.htm 00000009 - Disclosure - Inventories Sheet http://betterchoicecompany.com/role/Inventories Inventories Notes 9 false false R10.htm 00000010 - Disclosure - Prepaid expenses and other current assets Sheet http://betterchoicecompany.com/role/PrepaidExpensesAndOtherCurrentAssets Prepaid expenses and other current assets Notes 10 false false R11.htm 00000011 - Disclosure - Fixed assets Sheet http://betterchoicecompany.com/role/FixedAssets Fixed assets Notes 11 false false R12.htm 00000012 - Disclosure - Goodwill and intangible assets Sheet http://betterchoicecompany.com/role/GoodwillAndIntangibleAssets Goodwill and intangible assets Notes 12 false false R13.htm 00000013 - Disclosure - Accrued and other liabilities Sheet http://betterchoicecompany.com/role/AccruedAndOtherLiabilities Accrued and other liabilities Notes 13 false false R14.htm 00000014 - Disclosure - Debt Sheet http://betterchoicecompany.com/role/Debt Debt Notes 14 false false R15.htm 00000015 - Disclosure - Fair Value Measurements Sheet http://betterchoicecompany.com/role/FairValueMeasurements Fair Value Measurements Notes 15 false false R16.htm 00000016 - Disclosure - Commitments and contingencies Sheet http://betterchoicecompany.com/role/CommitmentsAndContingencies Commitments and contingencies Notes 16 false false R17.htm 00000017 - Disclosure - Warrants Sheet http://betterchoicecompany.com/role/Warrants Warrants Notes 17 false false R18.htm 00000018 - Disclosure - Share-based compensation Sheet http://betterchoicecompany.com/role/Share-basedCompensation Share-based compensation Notes 18 false false R19.htm 00000019 - Disclosure - Employee benefit plans Sheet http://betterchoicecompany.com/role/EmployeeBenefitPlans Employee benefit plans Notes 19 false false R20.htm 00000020 - Disclosure - Related party transactions Sheet http://betterchoicecompany.com/role/RelatedPartyTransactions Related party transactions Notes 20 false false R21.htm 00000021 - Disclosure - Income taxes Sheet http://betterchoicecompany.com/role/IncomeTaxes Income taxes Notes 21 false false R22.htm 00000022 - Disclosure - Concentrations Sheet http://betterchoicecompany.com/role/Concentrations Concentrations Notes 22 false false R23.htm 00000023 - Disclosure - Loss per share Sheet http://betterchoicecompany.com/role/LossPerShare Loss per share Notes 23 false false R24.htm 00000024 - Disclosure - Subsequent events Sheet http://betterchoicecompany.com/role/SubsequentEvents Subsequent events Notes 24 false false R25.htm 00000025 - Disclosure - Nature of business and summary of significant accounting policies (Policies) Sheet http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies Nature of business and summary of significant accounting policies (Policies) Policies 25 false false R26.htm 00000026 - Disclosure - Revenue (Tables) Sheet http://betterchoicecompany.com/role/RevenueTables Revenue (Tables) Tables http://betterchoicecompany.com/role/Revenue 26 false false R27.htm 00000027 - Disclosure - Inventories (Tables) Sheet http://betterchoicecompany.com/role/InventoriesTables Inventories (Tables) Tables http://betterchoicecompany.com/role/Inventories 27 false false R28.htm 00000028 - Disclosure - Prepaid expenses and other current assets (Tables) Sheet http://betterchoicecompany.com/role/PrepaidExpensesAndOtherCurrentAssetsTables Prepaid expenses and other current assets (Tables) Tables http://betterchoicecompany.com/role/PrepaidExpensesAndOtherCurrentAssets 28 false false R29.htm 00000029 - Disclosure - Fixed assets (Tables) Sheet http://betterchoicecompany.com/role/FixedAssetsTables Fixed assets (Tables) Tables http://betterchoicecompany.com/role/FixedAssets 29 false false R30.htm 00000030 - Disclosure - Goodwill and intangible assets (Tables) Sheet http://betterchoicecompany.com/role/GoodwillAndIntangibleAssetsTables Goodwill and intangible assets (Tables) Tables http://betterchoicecompany.com/role/GoodwillAndIntangibleAssets 30 false false R31.htm 00000031 - Disclosure - Accrued and other liabilities (Tables) Sheet http://betterchoicecompany.com/role/AccruedAndOtherLiabilitiesTables Accrued and other liabilities (Tables) Tables http://betterchoicecompany.com/role/AccruedAndOtherLiabilities 31 false false R32.htm 00000032 - Disclosure - Debt (Tables) Sheet http://betterchoicecompany.com/role/DebtTables Debt (Tables) Tables http://betterchoicecompany.com/role/Debt 32 false false R33.htm 00000033 - Disclosure - Fair Value Measurements (Tables) Sheet http://betterchoicecompany.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://betterchoicecompany.com/role/FairValueMeasurements 33 false false R34.htm 00000034 - Disclosure - Warrants (Tables) Sheet http://betterchoicecompany.com/role/WarrantsTables Warrants (Tables) Tables http://betterchoicecompany.com/role/Warrants 34 false false R35.htm 00000035 - Disclosure - Share-based compensation (Tables) Sheet http://betterchoicecompany.com/role/Share-basedCompensationTables Share-based compensation (Tables) Tables http://betterchoicecompany.com/role/Share-basedCompensation 35 false false R36.htm 00000036 - Disclosure - Income taxes (Tables) Sheet http://betterchoicecompany.com/role/IncomeTaxesTables Income taxes (Tables) Tables http://betterchoicecompany.com/role/IncomeTaxes 36 false false R37.htm 00000037 - Disclosure - Loss per share (Tables) Sheet http://betterchoicecompany.com/role/LossPerShareTables Loss per share (Tables) Tables http://betterchoicecompany.com/role/LossPerShare 37 false false R38.htm 00000038 - Disclosure - Nature of business and summary of significant accounting policies (Details Narrative) Sheet http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative Nature of business and summary of significant accounting policies (Details Narrative) Details http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies 38 false false R39.htm 00000039 - Disclosure - Schedule of Information about Revenue Channels (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails Schedule of Information about Revenue Channels (Details) Details 39 false false R40.htm 00000040 - Disclosure - Schedule of Information about Revenue Channels (Details) (Parenthetical) Sheet http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical Schedule of Information about Revenue Channels (Details) (Parenthetical) Details 40 false false R41.htm 00000041 - Disclosure - Revenue (Details Narrative) Sheet http://betterchoicecompany.com/role/RevenueDetailsNarrative Revenue (Details Narrative) Details http://betterchoicecompany.com/role/RevenueTables 41 false false R42.htm 00000042 - Disclosure - Schedule of Inventories (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfInventoriesDetails Schedule of Inventories (Details) Details 42 false false R43.htm 00000043 - Disclosure - Schedule of Prepaid Expenses and Other Current Assets (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails Schedule of Prepaid Expenses and Other Current Assets (Details) Details 43 false false R44.htm 00000044 - Disclosure - Schedule of Prepaid Expenses and Other Current Assets (Details) (Parenthetical) Sheet http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetailsParenthetical Schedule of Prepaid Expenses and Other Current Assets (Details) (Parenthetical) Details 44 false false R45.htm 00000045 - Disclosure - Schedule of Fixed Assets (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails Schedule of Fixed Assets (Details) Details 45 false false R46.htm 00000046 - Disclosure - Fixed assets (Details Narrative) Sheet http://betterchoicecompany.com/role/FixedAssetsDetailsNarrative Fixed assets (Details Narrative) Details http://betterchoicecompany.com/role/FixedAssetsTables 46 false false R47.htm 00000047 - Disclosure - Schedule of goodwill (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfGoodwillDetails Schedule of goodwill (Details) Details 47 false false R48.htm 00000048 - Disclosure - Schedule of Intangible Assets (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfIntangibleAssetsDetails Schedule of Intangible Assets (Details) Details 48 false false R49.htm 00000049 - Disclosure - Goodwill and intangible assets (Details Narrative) Sheet http://betterchoicecompany.com/role/GoodwillAndIntangibleAssetsDetailsNarrative Goodwill and intangible assets (Details Narrative) Details http://betterchoicecompany.com/role/GoodwillAndIntangibleAssetsTables 49 false false R50.htm 00000050 - Disclosure - Schedule of Accrued and Other Liabilities (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails Schedule of Accrued and Other Liabilities (Details) Details 50 false false R51.htm 00000051 - Disclosure - Schedule of Components of Debt (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetails Schedule of Components of Debt (Details) Details 51 false false R52.htm 00000052 - Disclosure - Schedule of Components of Debt (Details) (Parenthetical) Sheet http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetailsParenthetical Schedule of Components of Debt (Details) (Parenthetical) Details 52 false false R53.htm 00000053 - Disclosure - Schedule of Future Debt Maturities (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfFutureDebtMaturitiesDetails Schedule of Future Debt Maturities (Details) Details 53 false false R54.htm 00000054 - Disclosure - Debt (Details Narrative) Sheet http://betterchoicecompany.com/role/DebtDetailsNarrative Debt (Details Narrative) Details http://betterchoicecompany.com/role/DebtTables 54 false false R55.htm 00000055 - Disclosure - Schedule of Carrying Amount and Fair Value (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfCarryingAmountAndFairValueDetails Schedule of Carrying Amount and Fair Value (Details) Details 55 false false R56.htm 00000056 - Disclosure - Commitments and contingencies (Details Narrative) Sheet http://betterchoicecompany.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and contingencies (Details Narrative) Details http://betterchoicecompany.com/role/CommitmentsAndContingencies 56 false false R57.htm 00000057 - Disclosure - Schedule of Outstanding Warrants (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfOutstandingWarrantsDetails Schedule of Outstanding Warrants (Details) Details 57 false false R58.htm 00000058 - Disclosure - Schedule of Significant Inputs to Warrants Liabilities (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails Schedule of Significant Inputs to Warrants Liabilities (Details) Details 58 false false R59.htm 00000059 - Disclosure - Schedule of Warrant Liability Activity (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfWarrantLiabilityActivityDetails Schedule of Warrant Liability Activity (Details) Details 59 false false R60.htm 00000060 - Disclosure - Warrants (Details Narrative) Sheet http://betterchoicecompany.com/role/WarrantsDetailsNarrative Warrants (Details Narrative) Details http://betterchoicecompany.com/role/WarrantsTables 60 false false R61.htm 00000061 - Disclosure - Schedule of Options Granted and Outstanding (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails Schedule of Options Granted and Outstanding (Details) Details 61 false false R62.htm 00000062 - Disclosure - Schedule of Fair Value Assumptions (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfFairValueAssumptionsDetails Schedule of Fair Value Assumptions (Details) Details 62 false false R63.htm 00000063 - Disclosure - Share-based compensation (Details Narrative) Sheet http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative Share-based compensation (Details Narrative) Details http://betterchoicecompany.com/role/Share-basedCompensationTables 63 false false R64.htm 00000064 - Disclosure - Employee benefit plans (Details Narrative) Sheet http://betterchoicecompany.com/role/EmployeeBenefitPlansDetailsNarrative Employee benefit plans (Details Narrative) Details http://betterchoicecompany.com/role/EmployeeBenefitPlans 64 false false R65.htm 00000065 - Disclosure - Related party transactions (Details Narrative) Sheet http://betterchoicecompany.com/role/RelatedPartyTransactionsDetailsNarrative Related party transactions (Details Narrative) Details http://betterchoicecompany.com/role/RelatedPartyTransactions 65 false false R66.htm 00000066 - Disclosure - Schedule of Effective Income Tax Rate Reconciliation (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails Schedule of Effective Income Tax Rate Reconciliation (Details) Details 66 false false R67.htm 00000067 - Disclosure - Schedule of Deferred Tax Assets and Liabilities (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails Schedule of Deferred Tax Assets and Liabilities (Details) Details 67 false false R68.htm 00000068 - Disclosure - Schedule of Valuation Allowance (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfValuationAllowanceDetails Schedule of Valuation Allowance (Details) Details 68 false false R69.htm 00000069 - Disclosure - Income taxes (Details Narrative) Sheet http://betterchoicecompany.com/role/IncomeTaxesDetailsNarrative Income taxes (Details Narrative) Details http://betterchoicecompany.com/role/IncomeTaxesTables 69 false false R70.htm 00000070 - Disclosure - Concentrations (Details Narrative) Sheet http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative Concentrations (Details Narrative) Details http://betterchoicecompany.com/role/Concentrations 70 false false R71.htm 00000071 - Disclosure - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) Sheet http://betterchoicecompany.com/role/ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) Details 71 false false R72.htm 00000072 - Disclosure - Loss per share (Details Narrative) Sheet http://betterchoicecompany.com/role/LossPerShareDetailsNarrative Loss per share (Details Narrative) Details http://betterchoicecompany.com/role/LossPerShareTables 72 false false R73.htm 00000073 - Disclosure - Subsequent events (Details Narrative) Sheet http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative Subsequent events (Details Narrative) Details http://betterchoicecompany.com/role/SubsequentEvents 73 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod - form10-k.htm 27, 103, 104 bttr-20231231.xsd bttr-20231231_cal.xml bttr-20231231_def.xml bttr-20231231_lab.xml bttr-20231231_pre.xml form10-k.htm form10-k_001.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 94 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-k.htm": { "nsprefix": "BTTR", "nsuri": "http://betterchoicecompany.com/20231231", "dts": { "schema": { "local": [ "bttr-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "bttr-20231231_cal.xml" ] }, "definitionLink": { "local": [ "bttr-20231231_def.xml" ] }, "labelLink": { "local": [ "bttr-20231231_lab.xml" ] }, "presentationLink": { "local": [ "bttr-20231231_pre.xml" ] }, "inline": { "local": [ "form10-k.htm" ] } }, "keyStandard": 313, "keyCustom": 54, "axisStandard": 32, "axisCustom": 0, "memberStandard": 42, "memberCustom": 30, "hidden": { "total": 103, "http://betterchoicecompany.com/20231231": 25, "http://fasb.org/us-gaap/2023": 74, "http://xbrl.sec.gov/dei/2023": 4 }, "contextCount": 193, "entityCount": 1, "segmentCount": 79, "elementCount": 598, "unitCount": 6, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 687, "http://xbrl.sec.gov/dei/2023": 38 }, "report": { "R1": { "role": "http://betterchoicecompany.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R2": { "role": "http://betterchoicecompany.com/role/StatementsOfOperations", "longName": "00000002 - Statement - Consolidated Statements of Operations", "shortName": "Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R3": { "role": "http://betterchoicecompany.com/role/BalanceSheets", "longName": "00000003 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R4": { "role": "http://betterchoicecompany.com/role/BalanceSheetsParenthetical", "longName": "00000004 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R5": { "role": "http://betterchoicecompany.com/role/StatementsOfStockholdersEquity", "longName": "00000005 - Statement - Consolidated Statements of Stockholders' Equity", "shortName": "Consolidated Statements of Stockholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R6": { "role": "http://betterchoicecompany.com/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:GainLossOnDispositionOfAssets1", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R7": { "role": "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPolicies", "longName": "00000007 - Disclosure - Nature of business and summary of significant accounting policies", "shortName": "Nature of business and summary of significant accounting policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R8": { "role": "http://betterchoicecompany.com/role/Revenue", "longName": "00000008 - Disclosure - Revenue", "shortName": "Revenue", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R9": { "role": "http://betterchoicecompany.com/role/Inventories", "longName": "00000009 - Disclosure - Inventories", "shortName": "Inventories", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R10": { "role": "http://betterchoicecompany.com/role/PrepaidExpensesAndOtherCurrentAssets", "longName": "00000010 - Disclosure - Prepaid expenses and other current assets", "shortName": "Prepaid expenses and other current assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "BTTR:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "BTTR:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R11": { "role": "http://betterchoicecompany.com/role/FixedAssets", "longName": "00000011 - Disclosure - Fixed assets", "shortName": "Fixed assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R12": { "role": "http://betterchoicecompany.com/role/GoodwillAndIntangibleAssets", "longName": "00000012 - Disclosure - Goodwill and intangible assets", "shortName": "Goodwill and intangible assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R13": { "role": "http://betterchoicecompany.com/role/AccruedAndOtherLiabilities", "longName": "00000013 - Disclosure - Accrued and other liabilities", "shortName": "Accrued and other liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R14": { "role": "http://betterchoicecompany.com/role/Debt", "longName": "00000014 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R15": { "role": "http://betterchoicecompany.com/role/FairValueMeasurements", "longName": "00000015 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R16": { "role": "http://betterchoicecompany.com/role/CommitmentsAndContingencies", "longName": "00000016 - Disclosure - Commitments and contingencies", "shortName": "Commitments and contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R17": { "role": "http://betterchoicecompany.com/role/Warrants", "longName": "00000017 - Disclosure - Warrants", "shortName": "Warrants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "BTTR:ClassOfWarrantOrRightDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "BTTR:ClassOfWarrantOrRightDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R18": { "role": "http://betterchoicecompany.com/role/Share-basedCompensation", "longName": "00000018 - Disclosure - Share-based compensation", "shortName": "Share-based compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R19": { "role": "http://betterchoicecompany.com/role/EmployeeBenefitPlans", "longName": "00000019 - Disclosure - Employee benefit plans", "shortName": "Employee benefit plans", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R20": { "role": "http://betterchoicecompany.com/role/RelatedPartyTransactions", "longName": "00000020 - Disclosure - Related party transactions", "shortName": "Related party transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R21": { "role": "http://betterchoicecompany.com/role/IncomeTaxes", "longName": "00000021 - Disclosure - Income taxes", "shortName": "Income taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R22": { "role": "http://betterchoicecompany.com/role/Concentrations", "longName": "00000022 - Disclosure - Concentrations", "shortName": "Concentrations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R23": { "role": "http://betterchoicecompany.com/role/LossPerShare", "longName": "00000023 - Disclosure - Loss per share", "shortName": "Loss per share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R24": { "role": "http://betterchoicecompany.com/role/SubsequentEvents", "longName": "00000024 - Disclosure - Subsequent events", "shortName": "Subsequent events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R25": { "role": "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies", "longName": "00000025 - Disclosure - Nature of business and summary of significant accounting policies (Policies)", "shortName": "Nature of business and summary of significant accounting policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "25", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "BTTR:InitialPublicOfferingPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "BTTR:InitialPublicOfferingPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R26": { "role": "http://betterchoicecompany.com/role/RevenueTables", "longName": "00000026 - Disclosure - Revenue (Tables)", "shortName": "Revenue (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R27": { "role": "http://betterchoicecompany.com/role/InventoriesTables", "longName": "00000027 - Disclosure - Inventories (Tables)", "shortName": "Inventories (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R28": { "role": "http://betterchoicecompany.com/role/PrepaidExpensesAndOtherCurrentAssetsTables", "longName": "00000028 - Disclosure - Prepaid expenses and other current assets (Tables)", "shortName": "Prepaid expenses and other current assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "BTTR:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "BTTR:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R29": { "role": "http://betterchoicecompany.com/role/FixedAssetsTables", "longName": "00000029 - Disclosure - Fixed assets (Tables)", "shortName": "Fixed assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R30": { "role": "http://betterchoicecompany.com/role/GoodwillAndIntangibleAssetsTables", "longName": "00000030 - Disclosure - Goodwill and intangible assets (Tables)", "shortName": "Goodwill and intangible assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R31": { "role": "http://betterchoicecompany.com/role/AccruedAndOtherLiabilitiesTables", "longName": "00000031 - Disclosure - Accrued and other liabilities (Tables)", "shortName": "Accrued and other liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R32": { "role": "http://betterchoicecompany.com/role/DebtTables", "longName": "00000032 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R33": { "role": "http://betterchoicecompany.com/role/FairValueMeasurementsTables", "longName": "00000033 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R34": { "role": "http://betterchoicecompany.com/role/WarrantsTables", "longName": "00000034 - Disclosure - Warrants (Tables)", "shortName": "Warrants (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "BTTR:ClassOfWarrantOrRightDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "BTTR:ClassOfWarrantOrRightDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R35": { "role": "http://betterchoicecompany.com/role/Share-basedCompensationTables", "longName": "00000035 - Disclosure - Share-based compensation (Tables)", "shortName": "Share-based compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R36": { "role": "http://betterchoicecompany.com/role/IncomeTaxesTables", "longName": "00000036 - Disclosure - Income taxes (Tables)", "shortName": "Income taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R37": { "role": "http://betterchoicecompany.com/role/LossPerShareTables", "longName": "00000037 - Disclosure - Loss per share (Tables)", "shortName": "Loss per share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R38": { "role": "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "00000038 - Disclosure - Nature of business and summary of significant accounting policies (Details Narrative)", "shortName": "Nature of business and summary of significant accounting policies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "BTTR:MinimumLiquidityRequired", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "BTTR:GoingConcernConsiderationsPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "BTTR:MaximumMarketingSpendRatio", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "BTTR:GoingConcernConsiderationsPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R39": { "role": "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails", "longName": "00000039 - Disclosure - Schedule of Information about Revenue Channels (Details)", "shortName": "Schedule of Information about Revenue Channels (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_custom_SalesChannelConcentrationRiskMember", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R40": { "role": "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical", "longName": "00000040 - Disclosure - Schedule of Information about Revenue Channels (Details) (Parenthetical)", "shortName": "Schedule of Information about Revenue Channels (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember_custom_ECommerceMember", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "link:footnote", "span", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R41": { "role": "http://betterchoicecompany.com/role/RevenueDetailsNarrative", "longName": "00000041 - Disclosure - Revenue (Details Narrative)", "shortName": "Revenue (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "BTTR:NumberOfRevenueChannels", "unitRef": "Integer", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "BTTR:NumberOfRevenueChannels", "unitRef": "Integer", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R42": { "role": "http://betterchoicecompany.com/role/ScheduleOfInventoriesDetails", "longName": "00000042 - Disclosure - Schedule of Inventories (Details)", "shortName": "Schedule of Inventories (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:InventoryFinishedGoodsAndWorkInProcess", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:InventoryFinishedGoodsAndWorkInProcess", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R43": { "role": "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails", "longName": "00000043 - Disclosure - Schedule of Prepaid Expenses and Other Current Assets (Details)", "shortName": "Schedule of Prepaid Expenses and Other Current Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "BTTR:PrepaidMarketingExpenseCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "BTTR:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "BTTR:PrepaidMarketingExpenseCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "BTTR:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R44": { "role": "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetailsParenthetical", "longName": "00000044 - Disclosure - Schedule of Prepaid Expenses and Other Current Assets (Details) (Parenthetical)", "shortName": "Schedule of Prepaid Expenses and Other Current Assets (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "From2020-03-052020-03-05_us-gaap_CommonStockMember_custom_IHeartMediaMember", "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "BTTR:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2020-03-052020-03-05_us-gaap_CommonStockMember_custom_IHeartMediaMember", "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "BTTR:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R45": { "role": "http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails", "longName": "00000045 - Disclosure - Schedule of Fixed Assets (Details)", "shortName": "Schedule of Fixed Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R46": { "role": "http://betterchoicecompany.com/role/FixedAssetsDetailsNarrative", "longName": "00000046 - Disclosure - Fixed assets (Details Narrative)", "shortName": "Fixed assets (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R47": { "role": "http://betterchoicecompany.com/role/ScheduleOfGoodwillDetails", "longName": "00000047 - Disclosure - Schedule of goodwill (Details)", "shortName": "Schedule of goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "AsOf2021-12-31", "name": "us-gaap:Goodwill", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31", "name": "us-gaap:Goodwill", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R48": { "role": "http://betterchoicecompany.com/role/ScheduleOfIntangibleAssetsDetails", "longName": "00000048 - Disclosure - Schedule of Intangible Assets (Details)", "shortName": "Schedule of Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R49": { "role": "http://betterchoicecompany.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "longName": "00000049 - Disclosure - Goodwill and intangible assets (Details Narrative)", "shortName": "Goodwill and intangible assets (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NumberOfReportingUnits", "unitRef": "Integer", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NumberOfReportingUnits", "unitRef": "Integer", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R50": { "role": "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails", "longName": "00000050 - Disclosure - Schedule of Accrued and Other Liabilities (Details)", "shortName": "Schedule of Accrued and Other Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:TaxesPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:TaxesPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R51": { "role": "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetails", "longName": "00000051 - Disclosure - Schedule of Components of Debt (Details)", "shortName": "Schedule of Components of Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:LongTermDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DebtLongtermAndShorttermCombinedAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R52": { "role": "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetailsParenthetical", "longName": "00000052 - Disclosure - Schedule of Components of Debt (Details) (Parenthetical)", "shortName": "Schedule of Components of Debt (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_LineOfCreditMember_us-gaap_FederalFundsEffectiveSwapRateMember", "name": "us-gaap:DebtInstrumentDescriptionOfVariableRateBasis", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R53": { "role": "http://betterchoicecompany.com/role/ScheduleOfFutureDebtMaturitiesDetails", "longName": "00000053 - Disclosure - Schedule of Future Debt Maturities (Details)", "shortName": "Schedule of Future Debt Maturities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R54": { "role": "http://betterchoicecompany.com/role/DebtDetailsNarrative", "longName": "00000054 - Disclosure - Debt (Details Narrative)", "shortName": "Debt (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "BTTR:MinimumLiquidityRequired", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "BTTR:GoingConcernConsiderationsPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-06-212023-06-21_custom_WintrustReceivablesCreditFacilityMember", "name": "BTTR:LineOfCreditFacilityEligibleCustomerInvoicesPurchasedPercent", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R55": { "role": "http://betterchoicecompany.com/role/ScheduleOfCarryingAmountAndFairValueDetails", "longName": "00000055 - Disclosure - Schedule of Carrying Amount and Fair Value (Details)", "shortName": "Schedule of Carrying Amount and Fair Value (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_TermLoanMember_us-gaap_FairValueInputsLevel3Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember", "name": "us-gaap:LongTermDebtFairValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_TermLoanMember_us-gaap_FairValueInputsLevel3Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember", "name": "us-gaap:LongTermDebtFairValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R56": { "role": "http://betterchoicecompany.com/role/CommitmentsAndContingenciesDetailsNarrative", "longName": "00000056 - Disclosure - Commitments and contingencies (Details Narrative)", "shortName": "Commitments and contingencies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PurchaseObligation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PurchaseObligation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R57": { "role": "http://betterchoicecompany.com/role/ScheduleOfOutstandingWarrantsDetails", "longName": "00000057 - Disclosure - Schedule of Outstanding Warrants (Details)", "shortName": "Schedule of Outstanding Warrants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "BTTR:ClassOfWarrantOrRightDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "BTTR:ClassOfWarrantOrRightDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R58": { "role": "http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails", "longName": "00000058 - Disclosure - Schedule of Significant Inputs to Warrants Liabilities (Details)", "shortName": "Schedule of Significant Inputs to Warrants Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "AsOf2023-12-21_custom_FirstTrancheWarrantMember_us-gaap_MeasurementInputExercisePriceMember", "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "BTTR:ScheduleOfWarrantLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "BTTR:ClassOfWarrantOrRightDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-21_custom_FirstTrancheWarrantMember_us-gaap_MeasurementInputExercisePriceMember", "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "BTTR:ScheduleOfWarrantLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "BTTR:ClassOfWarrantOrRightDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R59": { "role": "http://betterchoicecompany.com/role/ScheduleOfWarrantLiabilityActivityDetails", "longName": "00000059 - Disclosure - Schedule of Warrant Liability Activity (Details)", "shortName": "Schedule of Warrant Liability Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FairValueAdjustmentOfWarrants", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_WarrantMember", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "BTTR:ScheduleOfWarrantLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "BTTR:ClassOfWarrantOrRightDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R60": { "role": "http://betterchoicecompany.com/role/WarrantsDetailsNarrative", "longName": "00000060 - Disclosure - Warrants (Details Narrative)", "shortName": "Warrants (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "BTTR:ClassOfWarrantOrRightWarrantsOutstandingIntrinsicValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "BTTR:ClassOfWarrantOrRightDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "BTTR:ClassOfWarrantOrRightWarrantsOutstandingIntrinsicValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "BTTR:ClassOfWarrantOrRightDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R61": { "role": "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails", "longName": "00000061 - Disclosure - Schedule of Options Granted and Outstanding (Details)", "shortName": "Schedule of Options Granted and Outstanding (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R62": { "role": "http://betterchoicecompany.com/role/ScheduleOfFairValueAssumptionsDetails", "longName": "00000062 - Disclosure - Schedule of Fair Value Assumptions (Details)", "shortName": "Schedule of Fair Value Assumptions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R63": { "role": "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative", "longName": "00000063 - Disclosure - Share-based compensation (Details Narrative)", "shortName": "Share-based compensation (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember_srt_MaximumMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R64": { "role": "http://betterchoicecompany.com/role/EmployeeBenefitPlansDetailsNarrative", "longName": "00000064 - Disclosure - Employee benefit plans (Details Narrative)", "shortName": "Employee benefit plans (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DefinedContributionPlanCostRecognized", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DefinedContributionPlanCostRecognized", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R65": { "role": "http://betterchoicecompany.com/role/RelatedPartyTransactionsDetailsNarrative", "longName": "00000065 - Disclosure - Related party transactions (Details Narrative)", "shortName": "Related party transactions (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_BoardOfDirectorsMember", "name": "us-gaap:OperatingCostsAndExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R66": { "role": "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails", "longName": "00000066 - Disclosure - Schedule of Effective Income Tax Rate Reconciliation (Details)", "shortName": "Schedule of Effective Income Tax Rate Reconciliation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R67": { "role": "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails", "longName": "00000067 - Disclosure - Schedule of Deferred Tax Assets and Liabilities (Details)", "shortName": "Schedule of Deferred Tax Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R68": { "role": "http://betterchoicecompany.com/role/ScheduleOfValuationAllowanceDetails", "longName": "00000068 - Disclosure - Schedule of Valuation Allowance (Details)", "shortName": "Schedule of Valuation Allowance (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:SummaryOfValuationAllowanceTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R69": { "role": "http://betterchoicecompany.com/role/IncomeTaxesDetailsNarrative", "longName": "00000069 - Disclosure - Income taxes (Details Narrative)", "shortName": "Income taxes (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "BTTR:EffectiveIncomeTaxRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R70": { "role": "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative", "longName": "00000070 - Disclosure - Concentrations (Details Narrative)", "shortName": "Concentrations (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_InventoriesMember_us-gaap_SupplierConcentrationRiskMember_custom_TwoVendorsMember", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_InventoriesMember_us-gaap_SupplierConcentrationRiskMember_custom_TwoVendorsMember", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R71": { "role": "http://betterchoicecompany.com/role/ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails", "longName": "00000071 - Disclosure - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details)", "shortName": "Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R72": { "role": "http://betterchoicecompany.com/role/LossPerShareDetailsNarrative", "longName": "00000072 - Disclosure - Loss per share (Details Narrative)", "shortName": "Loss per share (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_us-gaap_WarrantMember", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_us-gaap_WarrantMember", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R73": { "role": "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative", "longName": "00000073 - Disclosure - Subsequent events (Details Narrative)", "shortName": "Subsequent events (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-02-012024-02-29_us-gaap_SubsequentEventMember_custom_BoardOfDirectorsMember_custom_TwoThousandNineteenIncentiveAwardPlanMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } } }, "tag": { "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "presentation": [ "http://betterchoicecompany.com/role/AccruedAndOtherLiabilities" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued and other liabilities", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period." } } }, "auth_ref": [ "r24" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets", "http://betterchoicecompany.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r23", "r690" ] }, "BTTR_AccountsReceivableAggregateFaceValue": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "AccountsReceivableAggregateFaceValue", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts receivable, net", "documentation": "Accounts receivable aggregate face value.", "label": "AccountsReceivableAggregateFaceValue" } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableMember", "presentation": [ "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r643" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts receivable, net", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r261", "r262" ] }, "us-gaap_AccretionExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccretionExpense", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accreted interest expense on term loan", "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations." } } }, "auth_ref": [ "r667", "r761" ] }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesAndOtherLiabilities", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued and other liabilities", "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other." } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total accrued and other liabilities", "label": "Accrued Liabilities, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r28" ] }, "BTTR_AccruedMarketingCostsAndAdvertisingCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "AccruedMarketingCostsAndAdvertisingCurrent", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued trade promotions and advertising", "documentation": "Accrued marketing costs and advertising current." } } }, "auth_ref": [] }, "us-gaap_AccruedSalesCommissionCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedSalesCommissionCurrent", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued commissions", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r28", "r653" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r61", "r179", "r546" ] }, "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental cash flow information" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r105", "r690", "r828" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r427", "r428", "r429", "r574", "r739", "r740", "r741", "r804", "r830" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Reclassification of Alphia Warrants", "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC)." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingCostsPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Advertising", "documentation": "Disclosure of accounting policy for advertising cost." } } }, "auth_ref": [ "r159" ] }, "us-gaap_AdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingExpense", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Advertising expense", "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line." } } }, "auth_ref": [ "r435" ] }, "BTTR_AimiaPetHealthcoIncMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "AimiaPetHealthcoIncMember", "presentation": [ "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aimia Pet Healthco, Inc. [Member]", "documentation": "Aimia Pet Healthco, Inc. [Member]" } } }, "auth_ref": [] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative", "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based compensation", "label": "Share based compensation expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r422", "r434" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Allowance for credit losses", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r186", "r263", "r270", "r273", "r274", "r823" ] }, "BTTR_AlphiaTermLoanFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "AlphiaTermLoanFacilityMember", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Alphia Term Loan Facility [Member]", "documentation": "Alphia Term Loan Facility [Member]" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCostsAndDiscounts", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of debt issuance costs and discounts", "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r337", "r496", "r671", "r672", "r733" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amortization expense", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r4", "r55", "r58" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r717" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://betterchoicecompany.com/role/LossPerShareDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r234" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://betterchoicecompany.com/role/LossPerShareDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r44" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://betterchoicecompany.com/role/LossPerShareDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://betterchoicecompany.com/role/LossPerShareDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r44" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r464" ] }, "us-gaap_AssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetImpairmentCharges", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Impairment charge", "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill." } } }, "auth_ref": [ "r4", "r59" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Assets", "label": "Assets [Default Label]", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r149", "r183", "r206", "r239", "r252", "r256", "r264", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r465", "r467", "r487", "r540", "r599", "r690", "r702", "r765", "r766", "r810" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r174", "r189", "r206", "r264", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r465", "r467", "r487", "r690", "r765", "r766", "r810" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r717" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r714", "r716", "r717" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r714", "r716", "r717" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r714", "r716", "r717" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r393", "r394", "r395", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r417", "r418", "r419", "r420", "r421" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "BTTR_BelievecoMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "BelievecoMember", "presentation": [ "http://betterchoicecompany.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Believeco [Member]", "documentation": "Believeco [Member]" } } }, "auth_ref": [] }, "BTTR_BoardOfDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "BoardOfDirectorsMember", "presentation": [ "http://betterchoicecompany.com/role/RelatedPartyTransactionsDetailsNarrative", "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative", "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Board of Directors [Member]", "documentation": "Board of Directors [Member]" } } }, "auth_ref": [] }, "BTTR_BrickAndMortarMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "BrickAndMortarMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails" ], "lang": { "en-us": { "role": { "label": "Brick And Mortar [Member]", "documentation": "Brick And Mortar [Member]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r463", "r684", "r685" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r75", "r76", "r463", "r684", "r685" ] }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CarryingReportedAmountFairValueDisclosureMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfCarryingAmountAndFairValueDetails", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Reported Value Measurement [Member]", "documentation": "Measured as reported on the statement of financial position (balance sheet)." } } }, "auth_ref": [ "r83", "r84" ] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Cash", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r157", "r541", "r575", "r594", "r690", "r702", "r728" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r39", "r177", "r650" ] }, "us-gaap_CashAndCashEquivalentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAxis", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Axis]", "documentation": "Information by type of cash and cash equivalent balance." } } }, "auth_ref": [ "r177" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r40" ] }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Restricted cash", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits." } } }, "auth_ref": [ "r40", "r148" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Total cash and cash equivalents and restricted cash, beginning of period", "periodEndLabel": "Total cash and cash equivalents and restricted cash, end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r39", "r122", "r204" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net decrease in cash and cash equivalents and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r2", "r122" ] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Noncash items:" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r67" ] }, "BTTR_ClassOfWarrantOrRightDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ClassOfWarrantOrRightDisclosureTextBlock", "presentation": [ "http://betterchoicecompany.com/role/Warrants" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrants", "documentation": "Class Of Warrant Or Right Disclosure [Text Block]", "label": "ClassOfWarrantOrRightDisclosureTextBlock" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightLineItems", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of warrants converted", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r345" ] }, "BTTR_ClassOfWarrantOrRightPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ClassOfWarrantOrRightPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Common stock warrants", "documentation": "Class Of Warrant Or Right [Policy Text Block]" } } }, "auth_ref": [] }, "BTTR_ClassOfWarrantOrRightReclassificationToEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ClassOfWarrantOrRightReclassificationToEquity", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfWarrantLiabilityActivityDetails" ], "lang": { "en-us": { "role": { "label": "Reclassification of warrants liabilities to equity", "documentation": "Class of warrant or right reclassification to equity." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightTable", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Table]", "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r67" ] }, "BTTR_ClassOfWarrantOrRightWarrantsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ClassOfWarrantOrRightWarrantsOutstandingIntrinsicValue", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants outstanding, intrinsic value", "documentation": "Class of warrant or right warrants outstanding intrinsic value." } } }, "auth_ref": [] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r464" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://betterchoicecompany.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r132", "r300", "r301", "r644", "r762" ] }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Authorized common stock issuance", "documentation": "Aggregate number of common shares reserved for future issuance." } } }, "auth_ref": [ "r33" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetailsParenthetical", "http://betterchoicecompany.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r693", "r694", "r695", "r697", "r698", "r699", "r700", "r739", "r740", "r804", "r826", "r830" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://betterchoicecompany.com/role/BalanceSheetsParenthetical", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r104" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://betterchoicecompany.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r104", "r586" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://betterchoicecompany.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r104" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://betterchoicecompany.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r9", "r104", "r586", "r605", "r830", "r831" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common Stock, $0.001 par value, 200,000,000 shares authorized, 729,026 & 668,869 shares issued and outstanding as of December 31, 2023 and 2022, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r104", "r542", "r690" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComputerEquipmentMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Computer Equipment [Member]", "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems." } } }, "auth_ref": [] }, "us-gaap_ComputerSoftwareIntangibleAssetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComputerSoftwareIntangibleAssetMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Computer Software, Intangible Asset [Member]", "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks." } } }, "auth_ref": [ "r649", "r758", "r759" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r47", "r49", "r85", "r86", "r260", "r643" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r47", "r49", "r85", "r86", "r260", "r564", "r643" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r47", "r49", "r85", "r86", "r260", "r643", "r725" ] }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskDisclosureTextBlock", "presentation": [ "http://betterchoicecompany.com/role/Concentrations" ], "lang": { "en-us": { "role": { "label": "Concentrations", "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date." } } }, "auth_ref": [ "r126" ] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r643" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Concentration risk, percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r47", "r49", "r85", "r86", "r260" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r46", "r47", "r49", "r50", "r85", "r147", "r643" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r47", "r49", "r85", "r86", "r260", "r643" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r79", "r657" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred revenue", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r347", "r348", "r367" ] }, "us-gaap_ContractWithCustomerSalesChannelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerSalesChannelAxis", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Contract with Customer, Sales Channel [Axis]", "documentation": "Information by sales channel for delivery of good or service in contract with customer." } } }, "auth_ref": [ "r680", "r769" ] }, "us-gaap_ContractWithCustomerSalesChannelDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerSalesChannelDomain", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary." } } }, "auth_ref": [ "r680", "r769" ] }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible preferred stock, shares issued upon conversion", "documentation": "Number of shares issued for each share of convertible preferred stock that is converted." } } }, "auth_ref": [ "r21", "r65", "r103", "r135", "r344" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of goods sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r117", "r521" ] }, "us-gaap_CostOfSalesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Cost of goods sold", "label": "Cost of Goods and Service [Policy Text Block]", "documentation": "Disclosure of accounting policy for cost of product sold and service rendered." } } }, "auth_ref": [ "r727" ] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cost of revenue", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r115" ] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "auth_ref": [ "r208", "r209", "r319", "r343", "r507", "r654", "r656" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetails", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetailsParenthetical", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetails", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetailsParenthetical", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CreditLossFinancialInstrumentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditLossFinancialInstrumentPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounts receivable and allowance for credit losses", "documentation": "Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status." } } }, "auth_ref": [ "r168", "r267", "r268", "r269", "r271", "r272", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r48", "r260" ] }, "BTTR_CustomerOneMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "CustomerOneMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Customer One [Member]", "documentation": "Customer One [Member]" } } }, "auth_ref": [] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerRelationshipsMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r78" ] }, "BTTR_CustomerTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "CustomerTwoMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Customer Two [Member]", "documentation": "Customer Two [Member]" } } }, "auth_ref": [] }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionConvertedInstrumentSharesIssued1", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Conversion of convertible securities", "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period." } } }, "auth_ref": [ "r42", "r43" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://betterchoicecompany.com/role/Debt" ], "lang": { "en-us": { "role": { "label": "Debt", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r133", "r205", "r315", "r321", "r322", "r323", "r324", "r325", "r326", "r331", "r338", "r339", "r341" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfCarryingAmountAndFairValueDetails", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r20", "r100", "r101", "r150", "r151", "r210", "r316", "r317", "r318", "r319", "r320", "r322", "r327", "r328", "r329", "r330", "r332", "r333", "r334", "r335", "r336", "r337", "r497", "r668", "r669", "r670", "r671", "r672", "r735" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Basis spread on variable interest rate", "label": "Debt Instrument, Basis Spread on Variable Rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentDescriptionOfVariableRateBasis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentDescriptionOfVariableRateBasis", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Basis spread on variable interest rate", "documentation": "Description of reference rate used for variable rate of debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Original principal amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r88", "r90", "r316", "r497", "r669", "r670" ] }, "BTTR_DebtInstrumentFloorInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "DebtInstrumentFloorInterestRate", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Floor interest rate", "documentation": "Debt instrument floor interest rate." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Interest at fixed rate", "verboseLabel": "Interest rate per annum", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r30", "r317" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r210", "r316", "r317", "r318", "r319", "r320", "r322", "r327", "r328", "r329", "r330", "r332", "r333", "r334", "r335", "r336", "r337", "r340", "r497", "r668", "r669", "r670", "r671", "r672", "r735" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetails" ], "lang": { "en-us": { "role": { "label": "Maturity date", "verboseLabel": "Debt maturity date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r170", "r668", "r806" ] }, "us-gaap_DebtInstrumentMaturityDateDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDateDescription", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maturity date, description", "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities." } } }, "auth_ref": [ "r31" ] }, "BTTR_DebtInstrumentMinimumLiquidityRequiredToBeMaintained": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "DebtInstrumentMinimumLiquidityRequiredToBeMaintained", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Liquidity required (no less than)", "documentation": "Debt instrument minimum liquidity required to be maintained." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfCarryingAmountAndFairValueDetails", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r32", "r210", "r316", "r317", "r318", "r319", "r320", "r322", "r327", "r328", "r329", "r330", "r332", "r333", "r334", "r335", "r336", "r337", "r497", "r668", "r669", "r670", "r671", "r672", "r735" ] }, "BTTR_DebtInstrumentRightOfFirstRefusalOutstandingPeriod": { "xbrltype": "durationItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "DebtInstrumentRightOfFirstRefusalOutstandingPeriod", "presentation": [ "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Term loan remains outstanding period", "documentation": "Debt instrument right of first refusal outstanding period." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r32", "r65", "r66", "r87", "r88", "r90", "r93", "r134", "r136", "r210", "r316", "r317", "r318", "r319", "r320", "r322", "r327", "r328", "r329", "r330", "r332", "r333", "r334", "r335", "r336", "r337", "r340", "r497", "r668", "r669", "r670", "r671", "r672", "r735" ] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt discounts", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r87", "r90", "r768" ] }, "us-gaap_DebtLongtermAndShorttermCombinedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtLongtermAndShorttermCombinedAmount", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Line of credit, net", "label": "Debt, Long-Term and Short-Term, Combined Amount", "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt." } } }, "auth_ref": [] }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "presentation": [ "http://betterchoicecompany.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Prepaid Expenses and Other Current Assets", "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs." } } }, "auth_ref": [] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt issuance costs", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r89", "r768" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income tax provision", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r4", "r144", "r167", "r457", "r458", "r737" ] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Gross deferred tax assets", "label": "Deferred Tax Assets, Gross", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r448" ] }, "us-gaap_DeferredTaxAssetsInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsInventory", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Inventory", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory." } } }, "auth_ref": [ "r74", "r801" ] }, "BTTR_DeferredTaxAssetsLeasingArrangements": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "DeferredTaxAssetsLeasingArrangements", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "ROU assets", "documentation": "Deferred tax assets leasing arrangements." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net deferred tax assets", "label": "Deferred Tax Assets, Net of Valuation Allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r800" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Net operating loss carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r74", "r801" ] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other assets", "label": "Deferred Tax Assets, Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r74", "r801" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based compensation", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation." } } }, "auth_ref": [ "r74", "r801" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/IncomeTaxesDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails", "http://betterchoicecompany.com/role/ScheduleOfValuationAllowanceDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Valuation allowance", "periodStartLabel": "Valuation allowance, at beginning of year", "periodEndLabel": "Valuation allowance, at end of year", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r449" ] }, "us-gaap_DeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred tax liabilities, net of valuation allowance", "label": "Deferred Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting." } } }, "auth_ref": [ "r71", "r800" ] }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Intangibles", "label": "Deferred Tax Liabilities, Intangible Assets", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill." } } }, "auth_ref": [ "r74", "r801" ] }, "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesLeasingArrangements", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Operating lease liabilities", "label": "Deferred Tax Liabilities, Leasing Arrangements", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements." } } }, "auth_ref": [ "r74", "r801" ] }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Fixed assets", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment." } } }, "auth_ref": [ "r74", "r801" ] }, "us-gaap_DefinedContributionPlanCostRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanCostRecognized", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/EmployeeBenefitPlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Contribution expenses", "documentation": "Amount of cost for defined contribution plan." } } }, "auth_ref": [ "r387" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/FixedAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciation expense", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r4", "r60" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r4", "r60" ] }, "us-gaap_DerivativeLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfWarrantLiabilityActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Derivative Liability, Current", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r190" ] }, "BTTR_DirectToConsumerMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "DirectToConsumerMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails" ], "lang": { "en-us": { "role": { "label": "Direct To Consumer [Member]", "documentation": "Direct To Consumer [Member]" } } }, "auth_ref": [] }, "srt_DirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "DirectorMember", "presentation": [ "http://betterchoicecompany.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "auth_ref": [ "r744", "r827" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r366", "r674", "r675", "r676", "r677", "r678", "r679", "r680" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r366", "r674", "r675", "r676", "r677", "r678", "r679", "r680" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://betterchoicecompany.com/role/RevenueTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Information about Revenue Channels", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r769" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensation" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r389", "r392", "r423", "r424", "r426", "r687" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "BTTR_DisclosurePrepaidExpensesAndOtherCurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "DisclosurePrepaidExpensesAndOtherCurrentAssetsAbstract", "lang": { "en-us": { "role": { "label": "Prepaid Expenses And Other Current Assets", "verboseLabel": "Schedule Of Prepaid Expenses And Other Current Assets" } } }, "auth_ref": [] }, "BTTR_DisclosureWarrantsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "DisclosureWarrantsAbstract", "lang": { "en-us": { "role": { "label": "Warrants", "verboseLabel": "Schedule Of Outstanding Warrants" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r716" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r714", "r716", "r717" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r714", "r716", "r717", "r719" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r715" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r703" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r716" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r716" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r718" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r706" ] }, "us-gaap_DomesticCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DomesticCountryMember", "presentation": [ "http://betterchoicecompany.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Domestic Tax Authority [Member]", "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile." } } }, "auth_ref": [] }, "BTTR_ECommerceMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ECommerceMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "E Commerce [Member]", "documentation": "E Commerce [Member]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails", "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net loss per share available to common stockholders, basic", "verboseLabel": "Net loss per share attributable to common stockholders, basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r198", "r216", "r217", "r218", "r219", "r220", "r225", "r228", "r231", "r232", "r233", "r237", "r476", "r477", "r537", "r550", "r660" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails", "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net loss per share available to common stockholders, diluted", "verboseLabel": "Net loss per share attributable to common stockholders, diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r198", "r216", "r217", "r218", "r219", "r220", "r228", "r231", "r232", "r233", "r237", "r476", "r477", "r537", "r550", "r660" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basic and diluted (loss) income per share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r44", "r45" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://betterchoicecompany.com/role/LossPerShare" ], "lang": { "en-us": { "role": { "label": "Loss per share", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r224", "r234", "r235", "r236" ] }, "BTTR_EffectiveIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "EffectiveIncomeTaxRate", "presentation": [ "http://betterchoicecompany.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Effective tax rate", "documentation": "Effective income tax rate." } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total provision percentage", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r442" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/IncomeTaxesDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Statutory U.S. Federal income tax percentage", "verboseLabel": "Federal statutory rate", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r207", "r442", "r459" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Change in valuation allowance percentage", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r799", "r802" ] }, "BTTR_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEquityInstrumentsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEquityInstrumentsAmount", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Statutory U.S. Federal income tax", "documentation": "Effective income tax rate reconciliation nondeductible expense equity instruments amount.", "label": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEquityInstrumentsAmount" } } }, "auth_ref": [] }, "BTTR_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEquityInstrumentsPercent": { "xbrltype": "percentItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEquityInstrumentsPercent", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Tax effect of non-deductible equity instruments percentage", "documentation": "Effective income tax rate reconciliation nondeductible expense equity instruments percent." } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill impairment percentage", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss." } } }, "auth_ref": [ "r799", "r802" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Meals and entertainment", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense." } } }, "auth_ref": [ "r799", "r802" ] }, "BTTR_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Statutory U.S. Federal income tax", "documentation": "Effective income tax rate reconciliation return to provision adjustment amount.", "label": "EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" } } }, "auth_ref": [] }, "BTTR_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentPercent": { "xbrltype": "percentItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentPercent", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Return to provision adjustment percentage", "documentation": "Effective income tax rate reconciliation return to provision adjustment percent." } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "State income taxes, net percentage", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)." } } }, "auth_ref": [ "r799", "r802" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsOther", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Other percentage", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other tax credits." } } }, "auth_ref": [ "r799", "r802" ] }, "BTTR_EffectiveIncomeTaxRateReconciliationWarrantValuationAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationWarrantValuationAmount", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Statutory U.S. Federal income tax", "documentation": "Effective income tax rate reconciliation warrant valuation amount.", "label": "EffectiveIncomeTaxRateReconciliationWarrantValuationAmount" } } }, "auth_ref": [] }, "BTTR_EffectiveIncomeTaxRateReconciliationWarrantValuationPercent": { "xbrltype": "percentItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationWarrantValuationPercent", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Warrant valuation percentage", "documentation": "Effective income tax rate reconciliation warrant valuation percent." } } }, "auth_ref": [] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued payroll and benefits", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r28" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Period of recognition for unrecognized share-based compensation", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r425" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized share-based compensation related to options", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r798" ] }, "us-gaap_EmployeeStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockMember", "presentation": [ "http://betterchoicecompany.com/role/LossPerShareDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Employee Stock [Member]", "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r709" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r705" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://betterchoicecompany.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r705" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r723" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r705" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r720" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r717" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r705" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r705" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r705" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r705" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r721" ] }, "us-gaap_EquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquipmentMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Equipment [Member]", "documentation": "Tangible personal property used to produce goods and services." } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetailsParenthetical", "http://betterchoicecompany.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r9", "r172", "r194", "r195", "r196", "r211", "r212", "r213", "r215", "r221", "r223", "r238", "r265", "r266", "r346", "r427", "r428", "r429", "r453", "r454", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r488", "r489", "r490", "r491", "r492", "r493", "r501", "r559", "r560", "r561", "r574", "r630" ] }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EstimateOfFairValueFairValueDisclosureMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfCarryingAmountAndFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Estimate of Fair Value Measurement [Member]", "documentation": "Measured as an estimate of fair value." } } }, "auth_ref": [ "r329", "r486", "r669", "r670" ] }, "BTTR_ExecutivesAndEmployeesMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ExecutivesAndEmployeesMember", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Executives and Employees [Member]", "documentation": "Executives and Employees [Member]" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_FairValueAdjustmentOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAdjustmentOfWarrants", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OtherNonoperatingExpense", "weight": 1.0, "order": 2.0 }, "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfWarrantLiabilityActivityDetails", "http://betterchoicecompany.com/role/StatementsOfCashFlows", "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value of warrant liabilities", "label": "Change in fair value of warrant liabilities", "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability." } } }, "auth_ref": [ "r1", "r4" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfCarryingAmountAndFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r479", "r480", "r484" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfCarryingAmountAndFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r479", "r480", "r484" ] }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByBalanceSheetGroupingTextBlock", "presentation": [ "http://betterchoicecompany.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Carrying Amount and Fair Value", "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r80", "r83" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfCarryingAmountAndFairValueDetails", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r329", "r372", "r373", "r374", "r375", "r376", "r377", "r480", "r512", "r513", "r514", "r669", "r670", "r681", "r682", "r683" ] }, "us-gaap_FairValueByLiabilityClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByLiabilityClassAxis", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfWarrantLiabilityActivityDetails", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Liability Class [Axis]", "documentation": "Information by class of liability." } } }, "auth_ref": [ "r82", "r146" ] }, "us-gaap_FairValueByMeasurementBasisAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementBasisAxis", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfCarryingAmountAndFairValueDetails", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Measurement Basis [Axis]", "documentation": "Information by measurement basis." } } }, "auth_ref": [ "r18", "r80", "r329", "r669", "r670" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://betterchoicecompany.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r478" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfCarryingAmountAndFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r329", "r372", "r377", "r480", "r513", "r669", "r670", "r681", "r682", "r683" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfCarryingAmountAndFairValueDetails", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r329", "r372", "r373", "r374", "r375", "r376", "r377", "r480", "r514", "r669", "r670", "r681", "r682", "r683" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfWarrantLiabilityActivityDetails", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value." } } }, "auth_ref": [ "r10" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfWarrantLiabilityActivityDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfWarrantLiabilityActivityDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3." } } }, "auth_ref": [ "r10", "r82" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loss (gain) in change of fair value of warrant liabilities", "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r483" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfWarrantLiabilityActivityDetails" ], "lang": { "en-us": { "role": { "label": "Warrant liabilities issued", "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r81" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfCarryingAmountAndFairValueDetails", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r329", "r372", "r373", "r374", "r375", "r376", "r377", "r512", "r513", "r514", "r669", "r670", "r681", "r682", "r683" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair value of financial instruments", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r7", "r19" ] }, "us-gaap_FederalFundsEffectiveSwapRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FederalFundsEffectiveSwapRateMember", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]", "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg." } } }, "auth_ref": [ "r803" ] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r181", "r298" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r296", "r297", "r298", "r299", "r522", "r523" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Gross carrying amount", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r129", "r523" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r522" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r56", "r57" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Net carrying amount", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r129", "r522" ] }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Estimated useful life", "label": "Finite-Lived Intangible Assets, Remaining Amortization Period", "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r522" ] }, "BTTR_FirstTrancheWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "FirstTrancheWarrantMember", "presentation": [ "http://betterchoicecompany.com/role/LossPerShareDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "First Tranche Warrant [Member]", "documentation": "First Tranche Warrant [Member]" } } }, "auth_ref": [] }, "BTTR_FixedChargeCoverageRatioDescription": { "xbrltype": "stringItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "FixedChargeCoverageRatioDescription", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fixed charge coverage ratio", "documentation": "Fixed charge coverage ratio description." } } }, "auth_ref": [] }, "BTTR_FreightOutPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "FreightOutPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Freight Out", "documentation": "Freight Out [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "us-gaap_GainLossOnDispositionOfAssets1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnDispositionOfAssets1", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss of disposal of assets", "label": "Gain (Loss) on Disposition of Assets", "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee." } } }, "auth_ref": [ "r733" ] }, "BTTR_GoingConcernConsiderationsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "GoingConcernConsiderationsPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Going concern considerations", "documentation": "Going concern considerations [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfGoodwillDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Goodwill [Default Label]", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r180", "r292", "r536", "r666", "r690", "r748", "r755" ] }, "us-gaap_GoodwillAndIntangibleAssetImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetImpairment", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Intangible asset impairment", "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill." } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://betterchoicecompany.com/role/GoodwillAndIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Goodwill and intangible assets", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r128" ] }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Goodwill", "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined." } } }, "auth_ref": [ "r291", "r295", "r666" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfGoodwillDetails", "http://betterchoicecompany.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Impairment expense", "negatedTerseLabel": "Impairment Loss", "verboseLabel": "Impairment of goodwill", "label": "Goodwill, Impairment Loss", "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r4", "r293", "r294", "r295", "r666" ] }, "BTTR_GoodwillImpairmentLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "GoodwillImpairmentLosses", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Goodwill impairment", "documentation": "Goodwill impairment losses." } } }, "auth_ref": [] }, "BTTR_GoodwillImpairmentsLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "GoodwillImpairmentsLoss", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfGoodwillDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Impairment expense", "documentation": "Goodwill impairments loss.", "label": "GoodwillImpairmentsLoss" } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r116", "r206", "r239", "r251", "r255", "r257", "r264", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r487", "r662", "r765" ] }, "BTTR_IHeartMediaMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "IHeartMediaMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "I Heart Media [Member]", "documentation": "IHeart Media [Member]" } } }, "auth_ref": [] }, "us-gaap_IPOMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IPOMember", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "IPO [Member]", "documentation": "First sale of stock by a private company to the public." } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r714", "r716", "r717" ] }, "BTTR_ImpairmentOfGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ImpairmentOfGoodwill", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Impairment of goodwill", "documentation": "Impairment of goodwill." } } }, "auth_ref": [] }, "BTTR_ImpairmentOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ImpairmentOfIntangibleAssets", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Impairment of intangible assets", "documentation": "Impairment of intangible assets." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r113", "r153", "r239", "r251", "r255", "r257", "r538", "r548", "r662" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://betterchoicecompany.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://betterchoicecompany.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://betterchoicecompany.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "verboseLabel": "Income taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r207", "r438", "r443", "r445", "r451", "r455", "r460", "r461", "r462", "r570" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 2.0 }, "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://betterchoicecompany.com/role/IncomeTaxesDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails", "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income tax expense (benefit)", "totalLabel": "Statutory U.S. Federal income tax", "verboseLabel": "Income tax benefit (expense)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r156", "r169", "r222", "r223", "r243", "r441", "r456", "r551" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Income taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r193", "r439", "r440", "r445", "r446", "r450", "r452", "r566" ] }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Statutory U.S. Federal income tax", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r799" ] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Statutory U.S. Federal income tax", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r442" ] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Statutory U.S. Federal income tax", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible impairment loss." } } }, "auth_ref": [ "r799" ] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Meals and entertainment", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible meals and entertainment expense." } } }, "auth_ref": [ "r799" ] }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationOtherAdjustments", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Statutory U.S. Federal income tax", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments." } } }, "auth_ref": [ "r799" ] }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Statutory U.S. Federal income tax", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)." } } }, "auth_ref": [ "r799" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income taxes", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r41" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedLiabilities", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued and other liabilities", "label": "Increase (Decrease) in Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r3" ] }, "BTTR_InitialPublicOfferingPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "InitialPublicOfferingPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Initial public offering", "documentation": "Initial Public Offering [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsFiniteLivedPolicy", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Intangible assets", "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets." } } }, "auth_ref": [ "r57", "r518", "r519", "r520", "r522", "r658" ] }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetIncludingGoodwill", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible assets, net", "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance." } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OtherNonoperatingExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r89", "r155", "r197", "r242", "r495", "r615", "r701", "r829" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r200", "r202", "r203" ] }, "us-gaap_InterestPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPayableCurrent", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued interest", "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r28" ] }, "BTTR_InternationalMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "InternationalMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "International [Member]", "documentation": "International [Member]" } } }, "auth_ref": [] }, "us-gaap_InventoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoriesMember", "presentation": [ "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Inventories [Member]", "documentation": "Tangible personal property held for sale in the ordinary course of business, or in process of, or to be consumed in, production for sale." } } }, "auth_ref": [] }, "us-gaap_InventoryAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryAdjustments", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory reserve", "label": "Inventory Adjustments", "documentation": "Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods." } } }, "auth_ref": [ "r54", "r730" ] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://betterchoicecompany.com/role/Inventories" ], "lang": { "en-us": { "role": { "label": "Inventories", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r287" ] }, "us-gaap_InventoryFinishedGoodsAndWorkInProcess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsAndWorkInProcess", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfInventoriesDetails": { "parentTag": "us-gaap_InventoryGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Food, treats and supplements", "documentation": "Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale." } } }, "auth_ref": [ "r730" ] }, "us-gaap_InventoryGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryGross", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total Inventories", "label": "Inventory, Gross", "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r730" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 }, "http://betterchoicecompany.com/role/ScheduleOfInventoriesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets", "http://betterchoicecompany.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Inventories, net", "totalLabel": "Inventories, net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r188", "r651", "r690" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventories", "label": "Inventory, Policy [Policy Text Block]", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r158", "r176", "r187", "r287", "r288", "r290", "r517", "r659" ] }, "us-gaap_InventoryWriteDown": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWriteDown", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Inventory reserve", "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels." } } }, "auth_ref": [ "r289" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://betterchoicecompany.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Operating leases", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r500" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r27", "r206", "r264", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r466", "r467", "r468", "r487", "r585", "r661", "r702", "r765", "r810", "r811" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities and Stockholders\u2019 Equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r109", "r152", "r544", "r690", "r736", "r745", "r807" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities & Stockholders\u2019 Equity" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r29", "r175", "r206", "r264", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r466", "r467", "r468", "r487", "r690", "r765", "r810", "r811" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Non-current Liabilities", "label": "Liabilities, Noncurrent", "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r20", "r96", "r97", "r98", "r102", "r206", "r264", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r466", "r467", "r468", "r487", "r765", "r810", "r811" ] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Non-current Liabilities" } } }, "auth_ref": [] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Line of credit", "label": "Long-Term Line of Credit", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r20", "r151", "r821" ] }, "us-gaap_LineOfCreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityAxis", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lender Name [Axis]", "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit." } } }, "auth_ref": [ "r25", "r735" ] }, "BTTR_LineOfCreditFacilityContractTerm": { "xbrltype": "durationItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "LineOfCreditFacilityContractTerm", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Initial term of agreement", "documentation": "Line of credit facility contract term." } } }, "auth_ref": [] }, "BTTR_LineOfCreditFacilityEligibleCustomerInvoicesPurchasedMaximum": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "LineOfCreditFacilityEligibleCustomerInvoicesPurchasedMaximum", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Eligible customer invoices purchased, maximum", "documentation": "Line of credit facility eligible customer invoices purchased maximum." } } }, "auth_ref": [] }, "BTTR_LineOfCreditFacilityEligibleCustomerInvoicesPurchasedPercent": { "xbrltype": "percentItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "LineOfCreditFacilityEligibleCustomerInvoicesPurchasedPercent", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Face amount advance (up to)", "documentation": "Line of credit facility eligible customer invoices purchased percent." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityLenderDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityLenderDomain", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility." } } }, "auth_ref": [ "r25", "r735" ] }, "us-gaap_LineOfCreditFacilityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityLineItems", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetails", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r735" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maximum borrowing capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r25" ] }, "BTTR_LineOfCreditFacilityRenewalPeriod": { "xbrltype": "durationItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "LineOfCreditFacilityRenewalPeriod", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Renewal term of agreement", "documentation": "Line of credit facility renewal period." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityTable", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetails", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility [Table]", "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line." } } }, "auth_ref": [ "r25", "r735" ] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditMember", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfCarryingAmountAndFairValueDetails", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetails", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetailsParenthetical", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "us-gaap_LinesOfCreditCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LinesOfCreditCurrent", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets", "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Line of credit", "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r100", "r150" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "BTTR_LondonInterbankOfferedRateMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "LondonInterbankOfferedRateMember", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "London Interbank Offered Rate [Member]", "documentation": "London Interbank Offered Rate [Member]" } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfFutureDebtMaturitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetails", "http://betterchoicecompany.com/role/ScheduleOfFutureDebtMaturitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Line of credit, net", "totalLabel": "Total", "label": "Long term debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r20", "r151", "r328", "r342", "r669", "r670", "r821" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrent", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetails" ], "lang": { "en-us": { "role": { "label": "Less current portion", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r184" ] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfCarryingAmountAndFairValueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Debt", "label": "Long-Term Debt, Fair Value", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfFutureDebtMaturitiesDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFutureDebtMaturitiesDetails" ], "lang": { "en-us": { "role": { "label": "2024", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r210", "r333" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfFutureDebtMaturitiesDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFutureDebtMaturitiesDetails" ], "lang": { "en-us": { "role": { "label": "2026", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r210", "r333" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfFutureDebtMaturitiesDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFutureDebtMaturitiesDetails" ], "lang": { "en-us": { "role": { "label": "2025", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r210", "r333" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetails" ], "lang": { "en-us": { "role": { "label": "Total long-term debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r185" ] }, "us-gaap_LongTermLineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermLineOfCredit", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Line of credit, net", "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r32", "r62", "r63" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r32" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r32", "r64" ] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r260", "r676", "r769", "r824", "r825" ] }, "us-gaap_MarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketingExpense", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Marketing expense", "documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs." } } }, "auth_ref": [ "r119" ] }, "BTTR_MaximumMarketingSpendRatio": { "xbrltype": "percentItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "MaximumMarketingSpendRatio", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maximum marketing spend ratio", "documentation": "Maximum marketing spend ratio." } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/IncomeTaxesDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfFairValueAssumptionsDetails", "http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails", "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r302", "r303", "r304", "r305", "r388", "r516", "r558", "r577", "r578", "r636", "r637", "r638", "r639", "r640", "r645", "r646", "r664", "r673", "r686", "r692", "r767", "r812", "r813", "r814", "r815", "r816", "r817" ] }, "us-gaap_MeasurementInputEbitdaMultipleMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputEbitdaMultipleMember", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Measurement Input, EBITDA Multiple [Member]", "documentation": "Measurement input using earnings before interest, tax, depreciation and amortization (EBITDA) multiple." } } }, "auth_ref": [ "r805" ] }, "us-gaap_MeasurementInputExercisePriceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExercisePriceMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Exercise Price [Member]", "documentation": "Measurement input using agreed upon price for exchange of underlying asset." } } }, "auth_ref": [ "r805" ] }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExpectedDividendRateMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Expected Dividend Rate [Member]", "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year." } } }, "auth_ref": [ "r805" ] }, "us-gaap_MeasurementInputExpectedTermMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExpectedTermMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Expected Term [Member]", "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date." } } }, "auth_ref": [ "r805" ] }, "us-gaap_MeasurementInputPriceVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputPriceVolatilityMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Price Volatility [Member]", "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns." } } }, "auth_ref": [ "r805" ] }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputRiskFreeInterestRateMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Risk Free Interest Rate [Member]", "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss." } } }, "auth_ref": [ "r805" ] }, "us-gaap_MeasurementInputSharePriceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputSharePriceMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Share Price [Member]", "documentation": "Measurement input using share price of saleable stock." } } }, "auth_ref": [ "r805" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r481" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [] }, "BTTR_MinimumLiquidityRequired": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "MinimumLiquidityRequired", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Minimum liquidity required", "verboseLabel": "Covenant, minimum liquidity required", "documentation": "Minimum liquidity required." } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFairValueAssumptionsDetails", "http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails", "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r302", "r303", "r304", "r305", "r388", "r516", "r558", "r577", "r578", "r636", "r637", "r638", "r639", "r640", "r645", "r646", "r664", "r673", "r686", "r692", "r767", "r812", "r813", "r814", "r815", "r816", "r817" ] }, "us-gaap_MoneyMarketFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MoneyMarketFundsMember", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Money Market Funds [Member]", "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities." } } }, "auth_ref": [ "r771" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "auth_ref": [ "r260", "r676", "r769", "r824", "r825" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Cash (Used in) Provided by Financing Activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r201" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Flow from Financing Activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Cash Used in Investing Activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r201" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Flow from Investing Activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Cash Provided by (Used in) Operating Activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r122", "r123", "r124" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Flow from Operating Activities:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails", "http://betterchoicecompany.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Net loss available to common stockholders", "verboseLabel": "Net income", "terseLabel": "Net loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r114", "r124", "r154", "r173", "r191", "r192", "r196", "r206", "r214", "r216", "r217", "r218", "r219", "r222", "r223", "r229", "r239", "r251", "r255", "r257", "r264", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r477", "r487", "r549", "r607", "r628", "r629", "r662", "r701", "r765" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://betterchoicecompany.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://betterchoicecompany.com/role/ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails", "http://betterchoicecompany.com/role/StatementsOfCashFlows", "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss available to common stockholders", "verboseLabel": "Net loss available to common stockholders", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r199", "r216", "r217", "r218", "r219", "r225", "r226", "r230", "r233", "r239", "r251", "r255", "r257", "r662" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "New Accounting Standards", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other expense:" } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of operating segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r743" ] }, "us-gaap_NumberOfReportingUnits": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportingUnits", "presentation": [ "http://betterchoicecompany.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of reporting units", "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment." } } }, "auth_ref": [] }, "BTTR_NumberOfRevenueChannels": { "xbrltype": "integerItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "NumberOfRevenueChannels", "presentation": [ "http://betterchoicecompany.com/role/RevenueDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of revenue channels", "documentation": "Number of revenue channels." } } }, "auth_ref": [] }, "BTTR_OldPlankTrailCommunityBankNAMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "OldPlankTrailCommunityBankNAMember", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Old Plank Trail Community Bank NA [Member]", "documentation": "Old Plank Trail Community Bank NA [Member]" } } }, "auth_ref": [] }, "BTTR_OneCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "OneCustomerMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "One Customer [Member]", "documentation": "One Customer [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingCostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingCostsAndExpenses", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Director fees incurred", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r239", "r251", "r255", "r257", "r662" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Operating lease liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r499" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating lease liability", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r499" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets, operating leases", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r498" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Net operating loss carryforwards", "label": "Operating Loss Carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r73" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Nature of business and summary of significant accounting policies", "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements." } } }, "auth_ref": [ "r95", "r125", "r126", "r145" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r28" ] }, "us-gaap_OtherAmortizationOfDeferredCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAmortizationOfDeferredCharges", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of prepaid assets", "verboseLabel": "Amortization of other deferred charges", "documentation": "Amount of amortization of other deferred costs recognized in the income statement." } } }, "auth_ref": [ "r4", "r118" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other assets", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r182" ] }, "us-gaap_OtherInventorySupplies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherInventorySupplies", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfInventoriesDetails": { "parentTag": "us-gaap_InventoryGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Inventory packaging and supplies", "documentation": "Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r729" ] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "label": "Other Noncash Income (Expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r124" ] }, "us-gaap_OtherNonoperatingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingExpense", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total other expense", "label": "Other Nonoperating Expense", "documentation": "Amount of expense related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r120" ] }, "BTTR_OtherOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "OtherOptionMember", "presentation": [ "http://betterchoicecompany.com/role/LossPerShareDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Other Option [Member]", "documentation": "Other Option [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherPrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherPrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Other prepaid expenses and other current assets", "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r731", "r746" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r716" ] }, "us-gaap_PaidInKindInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaidInKindInterest", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "PIK interest expense on term loan", "verboseLabel": "Payable in kind interest", "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r4" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDebtIssuanceCosts", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of loan issuance costs", "label": "Payments of Debt Issuance Costs", "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt." } } }, "auth_ref": [ "r38" ] }, "us-gaap_PaymentsOfStockIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfStockIssuanceCosts", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments of stock issuance costs", "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security." } } }, "auth_ref": [ "r36" ] }, "BTTR_PaymentsOfUnderwritingDiscountsAndCommissions": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "PaymentsOfUnderwritingDiscountsAndCommissions", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments of underwriting discounts and commissions", "documentation": "Payments of underwriting discounts and commissions." } } }, "auth_ref": [] }, "BTTR_PaymentsOnLineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "PaymentsOnLineOfCredit", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on line of credit", "documentation": "Payments on line of credit.", "label": "PaymentsOnLineOfCredit" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Capital expenditures", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r121" ] }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "presentation": [ "http://betterchoicecompany.com/role/EmployeeBenefitPlans" ], "lang": { "en-us": { "role": { "label": "Employee benefit plans", "documentation": "The entire disclosure for retirement benefits." } } }, "auth_ref": [ "r369", "r370", "r371", "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r683" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative", "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r795", "r796", "r797" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative", "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r795", "r796", "r797" ] }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PortionAtFairValueFairValueDisclosureMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfCarryingAmountAndFairValueDetails", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes." } } }, "auth_ref": [ "r485" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r710" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r711" ] }, "us-gaap_PrepaidAdvertising": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidAdvertising", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid advertising contract with iHeart", "documentation": "Amount of consideration paid in advance for advertising that provides economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r652", "r665", "r746" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 }, "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets", "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses and other current assets", "totalLabel": "Total Prepaid expenses and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r732" ] }, "BTTR_PrepaidExpensesAndOtherCurrentAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "PrepaidExpensesAndOtherCurrentAssetsTextBlock", "presentation": [ "http://betterchoicecompany.com/role/PrepaidExpensesAndOtherCurrentAssets" ], "lang": { "en-us": { "role": { "verboseLabel": "Prepaid expenses and other current assets", "documentation": "Prepaid Expenses And Other Current Assets [Text Block]", "label": "PrepaidExpensesAndOtherCurrentAssetsTextBlock" } } }, "auth_ref": [] }, "BTTR_PrepaidMarketingExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "PrepaidMarketingExpenseCurrent", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid marketing expenses", "documentation": "Prepaid marketing expense current." } } }, "auth_ref": [] }, "us-gaap_PrimeRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrimeRateMember", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Prime Rate [Member]", "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLinesOfCredit", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from line of credit", "verboseLabel": "Line of credit", "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r35", "r735" ] }, "us-gaap_ProceedsFromLongTermLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLongTermLinesOfCredit", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from revolving lines of credit", "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer." } } }, "auth_ref": [ "r35" ] }, "us-gaap_ProceedsFromNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromNotesPayable", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from term loan", "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r35" ] }, "us-gaap_ProceedsFromOtherShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromOtherShortTermDebt", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from short-term financing arrangement", "documentation": "Amount of cash inflow from short-term debt classified as other." } } }, "auth_ref": [ "r35" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r258", "r521", "r552", "r553", "r554", "r555", "r556", "r557", "r648", "r674", "r691", "r726", "r763", "r764", "r769", "r824" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r258", "r521", "r552", "r553", "r554", "r555", "r556", "r557", "r648", "r674", "r691", "r726", "r763", "r764", "r769", "r824" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r5" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://betterchoicecompany.com/role/FixedAssets" ], "lang": { "en-us": { "role": { "label": "Fixed assets", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r130", "r162", "r165", "r166" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Total fixed assets", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r131", "r178", "r547" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets", "http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Fixed assets, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r5", "r539", "r547", "r690" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fixed Assets", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r5", "r162", "r165", "r545" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://betterchoicecompany.com/role/FixedAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Fixed Assets", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r5" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r131" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Estimated useful life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_PurchaseObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PurchaseObligation", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Purchase obligation", "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier." } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/IncomeTaxesDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfFairValueAssumptionsDetails", "http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails", "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r302", "r303", "r304", "r305", "r370", "r388", "r418", "r419", "r420", "r515", "r516", "r558", "r577", "r578", "r636", "r637", "r638", "r639", "r640", "r645", "r646", "r664", "r673", "r686", "r692", "r695", "r760", "r767", "r813", "r814", "r815", "r816", "r817" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/IncomeTaxesDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfFairValueAssumptionsDetails", "http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails", "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "auth_ref": [ "r302", "r303", "r304", "r305", "r370", "r388", "r418", "r419", "r420", "r515", "r516", "r558", "r577", "r578", "r636", "r637", "r638", "r639", "r640", "r645", "r646", "r664", "r673", "r686", "r692", "r695", "r760", "r767", "r813", "r814", "r815", "r816", "r817" ] }, "BTTR_ReclassificationOfWarrantsToEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ReclassificationOfWarrantsToEquity", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Reclassification of warrants to equity", "documentation": "Reclassification of warrants to equity." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://betterchoicecompany.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r379", "r505", "r506", "r580", "r581", "r582", "r583", "r584", "r604", "r606", "r635" ] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://betterchoicecompany.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r610", "r611", "r614" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://betterchoicecompany.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r379", "r505", "r506", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r580", "r581", "r582", "r583", "r584", "r604", "r606", "r635", "r809" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://betterchoicecompany.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "Related party transactions", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r502", "r503", "r504", "r506", "r508", "r571", "r572", "r573", "r612", "r613", "r614", "r633", "r634" ] }, "us-gaap_RepaymentsOfLongTermLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermLinesOfCredit", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on revolving lines of credit", "label": "Payments on revolving line of credit", "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer." } } }, "auth_ref": [ "r37" ] }, "us-gaap_RepaymentsOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfNotesPayable", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on term loans", "label": "Repayments of Notes Payable", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r37" ] }, "us-gaap_RepaymentsOfOtherShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfOtherShortTermDebt", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on short-term financing arrangement", "label": "Repayments of Other Short-Term Debt", "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing within one year or the operating cycle, if longer." } } }, "auth_ref": [ "r37" ] }, "us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount", "presentation": [ "http://betterchoicecompany.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Discount rate", "documentation": "Percentage of fair value of reporting unit in excess of carrying amount." } } }, "auth_ref": [] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetailsParenthetical" ], "auth_ref": [ "r208", "r209", "r319", "r343", "r507", "r655", "r656" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Research and development expense", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r94", "r437", "r818" ] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Research and development", "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process." } } }, "auth_ref": [ "r436" ] }, "us-gaap_RestrictedCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCash", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Restricted cash", "label": "Restricted Cash", "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r728", "r734", "r819", "r822" ] }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r177" ] }, "us-gaap_RestrictedCashCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashCurrent", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets", "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted cash", "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r728", "r734" ] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockMember", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock [Member]", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r44" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r106", "r137", "r543", "r562", "r563", "r569", "r587", "r690" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r172", "r211", "r212", "r213", "r215", "r221", "r223", "r265", "r266", "r427", "r428", "r429", "r453", "r454", "r469", "r471", "r472", "r474", "r475", "r559", "r561", "r574", "r830" ] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerAbstract", "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical", "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net sales", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r240", "r241", "r250", "r253", "r254", "r258", "r259", "r260", "r365", "r366", "r521" ] }, "us-gaap_RevenueFromContractWithCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer Benchmark [Member]", "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r260", "r724" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Revenue", "label": "Revenue from Contract with Customer [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r171", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r647" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://betterchoicecompany.com/role/Revenue" ], "lang": { "en-us": { "role": { "label": "Revenue", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r171", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r368" ] }, "BTTR_ReverseStockSplitPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ReverseStockSplitPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Reverse stock split", "documentation": "Reverse Stock Split [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_RisksAndUncertaintiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RisksAndUncertaintiesAbstract", "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockConsiderationReceivedOnTransaction", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of stock, consideration received on transaction", "documentation": "Cash received on stock transaction after deduction of issuance costs." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of stock, number of shares issued in transaction", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockPricePerShare", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of stock, price per share", "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction." } } }, "auth_ref": [] }, "BTTR_SalesChannelConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "SalesChannelConcentrationRiskMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetails" ], "lang": { "en-us": { "role": { "label": "Sales Channel Concentration Risk [Member]", "documentation": "Sales Channel Concentration Risk [Member]" } } }, "auth_ref": [] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r260", "r724" ] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://betterchoicecompany.com/role/AccruedAndOtherLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Accrued and Other Liabilities", "documentation": "Tabular disclosure of the components of accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://betterchoicecompany.com/role/LossPerShareDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities." } } }, "auth_ref": [ "r44" ] }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r464" ] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://betterchoicecompany.com/role/DebtTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Components of Debt", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r32", "r65", "r66", "r87", "r88", "r90", "r93", "r134", "r136", "r669", "r671", "r738" ] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://betterchoicecompany.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Deferred Tax Assets and Liabilities", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r142" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://betterchoicecompany.com/role/LossPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r742" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://betterchoicecompany.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Effective Income Tax Rate Reconciliation", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r141" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r56", "r57", "r522" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://betterchoicecompany.com/role/GoodwillAndIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Intangible Assets", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r56", "r57" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://betterchoicecompany.com/role/GoodwillAndIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of goodwill", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r666", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://betterchoicecompany.com/role/InventoriesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Inventories", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r22", "r110", "r111", "r112" ] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://betterchoicecompany.com/role/DebtTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Future Debt Maturities", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r6" ] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r5" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://betterchoicecompany.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Related Party Transactions, by Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r91", "r92", "r610", "r611", "r614" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFairValueAssumptionsDetails", "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r390", "r391", "r393", "r394", "r395", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r417", "r418", "r419", "r420", "r421" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Options Granted and Outstanding", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r16", "r17", "r69" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value Assumptions", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r140" ] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://betterchoicecompany.com/role/WarrantsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Outstanding Warrants", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r67" ] }, "BTTR_ScheduleOfWarrantLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ScheduleOfWarrantLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "presentation": [ "http://betterchoicecompany.com/role/WarrantsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Significant Inputs to Warrants Liabilities", "documentation": "Schedule of Warrants Liabilities Activity [Table Text Block]" } } }, "auth_ref": [] }, "BTTR_ScheduleOfWarrantLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ScheduleOfWarrantLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://betterchoicecompany.com/role/WarrantsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Warrant Liability Activity", "documentation": "Schedule of Significant Inputs to Warrants Liabilities [Table Text Block]" } } }, "auth_ref": [] }, "BTTR_SecondAmendmentMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "SecondAmendmentMember", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Second Amendment [Member]", "documentation": "Second Amendment [Member]" } } }, "auth_ref": [] }, "BTTR_SecondTrancheWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "SecondTrancheWarrantMember", "presentation": [ "http://betterchoicecompany.com/role/LossPerShareDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Second Tranche Warrant [Member]", "documentation": "Second Tranche Warrant [Member]" } } }, "auth_ref": [] }, "us-gaap_SecuredDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredDebtCurrent", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Term loan, net", "documentation": "Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower." } } }, "auth_ref": [ "r100", "r150" ] }, "us-gaap_SecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredDebtMember", "presentation": [ "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Secured Debt [Member]", "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r704" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r708" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r707" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r712" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Segment information", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r244", "r245", "r246", "r247", "r248", "r249", "r259", "r663" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Selling, general and administrative", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r119" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r3" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Award vesting period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r687" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative", "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Awards granted", "verboseLabel": "Restricted shares, granted", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r408" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFairValueAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Expected dividend yield", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r419" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFairValueAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Expected volatility", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r418" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFairValueAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Risk-free interest rate maximum", "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFairValueAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Risk-free interest rate minimum", "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFairValueAssumptionsDetails", "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r390", "r391", "r393", "r394", "r395", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r417", "r418", "r419", "r420", "r421" ] }, "BTTR_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAnnualIncreaseOfEquityAwardAuthorizedPercentOfCommonStockOutstanding": { "xbrltype": "percentItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAnnualIncreaseOfEquityAwardAuthorizedPercentOfCommonStockOutstanding", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percent of common stock outstanding", "documentation": "Share based compensation arrangement by share based payment award maximum annual increase of equity award authorized percent of common stock outstanding." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOutstandingWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants, Exercised", "documentation": "Number of non-option equity instruments exercised by participants." } } }, "auth_ref": [ "r14" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOutstandingWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants, Terminated/Expired", "documentation": "Number of shares under non-option equity instrument agreements that were either cancelled or expired." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOutstandingWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants, Issued", "documentation": "Net number of non-option equity instruments granted to participants." } } }, "auth_ref": [ "r13" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOutstandingWarrantsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants outstanding, Balance", "periodEndLabel": "Warrants outstanding, Balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments." } } }, "auth_ref": [ "r11", "r12" ] }, "BTTR_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOutstandingWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Terminated/Expired", "documentation": "Weighted average exercise price, warrants forfeiture/expired." } } }, "auth_ref": [] }, "BTTR_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOutstandingWarrantsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Exercise Price outstanding, Balance", "periodEndLabel": "Weighted Average Exercise Price outstanding, Balance", "documentation": "Weighted average exercise price, warrants outstanding.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Authorized issuance shares of common stock", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r689" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Options, Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r399" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted Average Exercise Price, Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r399" ] }, "BTTR_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedVestWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedVestWeightedAverageExercisePrice", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted Average Exercise Price, Option Expected Vested", "documentation": "Share based compensation arrangement by share based payment award options expected vest weighted average exercise price.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedVestWeightedAverageExercisePrice" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Options, Forfeited/Expired", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired." } } }, "auth_ref": [ "r778" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Forfeited/Expired", "documentation": "Weighted average price of options that were either forfeited or expired." } } }, "auth_ref": [ "r778" ] }, "BTTR_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFullyVestedWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFullyVestedWeightedAverageExercisePrice", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted Average Exercise Price, Fully vested", "documentation": "Share based compensation arrangement by share based payment award options fully vested eeighted average exercise price.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFullyVestedWeightedAverageExercisePrice" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Options, Granted", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r401" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregate Intrinsic Value", "periodEndLabel": "Aggregate Intrinsic Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r68" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Options Outstanding, Balance", "periodEndLabel": "Options Outstanding, Balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r397", "r398" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Exercise Price, Balance", "label": "Weighted Average Exercise Price, Balance", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r397", "r398" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r393", "r394", "r395", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r417", "r418", "r419", "r420", "r421" ] }, "BTTR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOutstandingWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Exercised", "documentation": "Weighted average exercise price, warrants exercised." } } }, "auth_ref": [] }, "BTTR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOutstandingWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Issued", "documentation": "Weighted average exercise price, warrants issued." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Granted", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r401" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based compensation", "label": "Share-Based Payment Arrangement [Policy Text Block]", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r389", "r396", "r415", "r416", "r417", "r418", "r421", "r430", "r431", "r432", "r433" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expiration period", "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r688" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfFairValueAssumptionsDetails" ], "lang": { "en-us": { "role": { "label": "Expected life", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r417" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Aggregate Intrinsic Value, Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r68" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Life (Years), Options exercisable", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r68" ] }, "BTTR_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestInPeriodFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestInPeriodFairValue1", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Options, Option Vested", "documentation": "Share based compensation arrangement by sharebased payment award options expected vest in period fair value 1." } } }, "auth_ref": [] }, "BTTR_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestIntrinsicValue1", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Aggregate Intrinsic Value, Options Expected Vest", "documentation": "Share based compensation arrangement by sharebased payment award options expected vest intrinsic value 1.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestIntrinsicValue1" } } }, "auth_ref": [] }, "BTTR_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestWeightedAverageRemainingContractualTerm1", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Life (Years), Options Expected vest", "documentation": "Sharebased compensation arrangement by sharebased payment award options expected vest weighted average remaining contractual term 1." } } }, "auth_ref": [] }, "BTTR_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFullyVestedIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFullyVestedIntrinsicValue1", "crdr": "debit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Aggregate Intrinsic Value, Fully vested", "documentation": "Share based compensation arrangement by share based payment award options fully vested intrinsic value 1.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFullyVestedIntrinsicValue1" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Life (Years), Options outstanding", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r139" ] }, "BTTR_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedFullyWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedFullyWeightedAverageRemainingContractualTerm1", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Life (Years), Options Fully vested", "documentation": "Share based compensation arrangement by share based payment award options fully weighted average remaining contractual term 1." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfOptionsGrantedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Options, Fully vested", "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock." } } }, "auth_ref": [ "r412" ] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Price per share", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "periodEndLabel": "Balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "BTTR_SharesRepurchasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "SharesRepurchasesPolicyTextBlock", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Share repurchases", "documentation": "Shares Repurchases [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_ShippingAndHandlingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShippingAndHandlingMember", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shipping and Handling [Member]", "documentation": "Packing and transport of product." } } }, "auth_ref": [ "r770" ] }, "us-gaap_ShortTermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermBorrowings", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Short-term financing", "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r99", "r150", "r690", "r820" ] }, "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems", "presentation": [ "http://betterchoicecompany.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable", "presentation": [ "http://betterchoicecompany.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]", "documentation": "A summary of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return for which the resultant tax benefit has not been recognized in the financial statements because it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination." } } }, "auth_ref": [ "r143" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r713" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetailsParenthetical", "http://betterchoicecompany.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r9", "r34", "r172", "r194", "r195", "r196", "r211", "r212", "r213", "r215", "r221", "r223", "r238", "r265", "r266", "r346", "r427", "r428", "r429", "r453", "r454", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r488", "r489", "r490", "r491", "r492", "r493", "r501", "r559", "r560", "r561", "r574", "r630" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetailsParenthetical", "http://betterchoicecompany.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r211", "r212", "r213", "r238", "r521", "r565", "r576", "r579", "r580", "r581", "r582", "r583", "r584", "r586", "r589", "r590", "r591", "r592", "r593", "r595", "r596", "r597", "r598", "r600", "r601", "r602", "r603", "r604", "r606", "r608", "r609", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r630", "r696" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetailsParenthetical", "http://betterchoicecompany.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r211", "r212", "r213", "r238", "r521", "r565", "r576", "r579", "r580", "r581", "r582", "r583", "r584", "r586", "r589", "r590", "r591", "r592", "r593", "r595", "r596", "r597", "r598", "r600", "r601", "r602", "r603", "r604", "r606", "r608", "r609", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r630", "r696" ] }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Shares issued to third-parties for services", "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares of common stock", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r9", "r103", "r104", "r137", "r567", "r630", "r641" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Share-based compensation, shares", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r9", "r103", "r104", "r137" ] }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Stock issued during period, value, issued for services", "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Share-based compensation", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r70", "r103", "r104", "r137" ] }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchaseProgramAuthorizedAmount1", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock repurchase program, authorized amount", "documentation": "Amount of stock repurchase plan authorized." } } }, "auth_ref": [] }, "us-gaap_StockRepurchasedDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedDuringPeriodShares", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock repurchased, shares", "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r9", "r103", "r104", "r137", "r568", "r630", "r642" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets", "http://betterchoicecompany.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total Stockholders\u2019 Equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r104", "r107", "r108", "r127", "r588", "r605", "r631", "r632", "r690", "r702", "r736", "r745", "r807", "r830" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://betterchoicecompany.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityReverseStockSplit": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityReverseStockSplit", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Reverse Stock Split", "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements." } } }, "auth_ref": [ "r138" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r494", "r510" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r494", "r510" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r494", "r510" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r494", "r510" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r494", "r510" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://betterchoicecompany.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r509", "r511" ] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_SummaryOfValuationAllowanceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfValuationAllowanceTextBlock", "presentation": [ "http://betterchoicecompany.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Valuation Allowance", "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance." } } }, "auth_ref": [ "r72" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://betterchoicecompany.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid during the year for:" } } }, "auth_ref": [] }, "us-gaap_SupplierConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierConcentrationRiskMember", "presentation": [ "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Supplier Concentration Risk [Member]", "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services." } } }, "auth_ref": [ "r48" ] }, "us-gaap_TaxesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxesPayableCurrent", "crdr": "credit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfAccruedAndOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued taxes", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r26" ] }, "BTTR_TermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "TermLoanMember", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfCarryingAmountAndFairValueDetails", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetails", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Term Loan [Member]", "documentation": "Term Loan [Member]" } } }, "auth_ref": [] }, "BTTR_ThirdAmendmentMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ThirdAmendmentMember", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Third Amendment [Member]", "documentation": "Third Amendment [Member]" } } }, "auth_ref": [] }, "BTTR_ThreeCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "ThreeCustomersMember", "presentation": [ "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Three Customers [Member]", "documentation": "Three Customers [Member]" } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative", "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "auth_ref": [ "r744", "r808" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative", "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative" ], "auth_ref": [] }, "us-gaap_TradeNamesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeNamesMember", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Trade Names [Member]", "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof." } } }, "auth_ref": [ "r77" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "BTTR_TwoCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "TwoCustomersMember", "presentation": [ "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfInformationAboutRevenueChannelsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Two Customers [Member]", "documentation": "Two Customers [Member]" } } }, "auth_ref": [] }, "BTTR_TwoMemberOfBoardOfDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "TwoMemberOfBoardOfDirectorsMember", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Two Member of Board of Directors [Member]", "documentation": "Two Member of Board of Directors [Member]" } } }, "auth_ref": [] }, "BTTR_TwoThousandNineteenIncentiveAwardPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "TwoThousandNineteenIncentiveAwardPlanMember", "presentation": [ "http://betterchoicecompany.com/role/Share-basedCompensationDetailsNarrative", "http://betterchoicecompany.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2019 Incentive Award Plan [Member]", "documentation": "2019 Incentive Award Plan [Member]" } } }, "auth_ref": [] }, "BTTR_TwoVendorsMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "TwoVendorsMember", "presentation": [ "http://betterchoicecompany.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Two Vendors [Member]", "documentation": "Two Vendors [Member]" } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r464" ] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accrued interest and penalties", "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return." } } }, "auth_ref": [ "r444" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://betterchoicecompany.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r51", "r52", "r53", "r160", "r161", "r163", "r164" ] }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfValuationAllowanceDetails" ], "lang": { "en-us": { "role": { "label": "Increase in valuation allowance", "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset." } } }, "auth_ref": [ "r447" ] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfComponentsOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "BTTR_WarrantLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "WarrantLiabilitiesMember", "presentation": [ "http://betterchoicecompany.com/role/LossPerShareDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant Liabilities [Member]", "documentation": "Warrant Liabilities [Member]" } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://betterchoicecompany.com/role/LossPerShareDetailsNarrative", "http://betterchoicecompany.com/role/ScheduleOfWarrantLiabilityActivityDetails", "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r693", "r694", "r697", "r698", "r699", "r700" ] }, "BTTR_WarrantModificationsAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "WarrantModificationsAdjustment", "crdr": "debit", "calculation": { "http://betterchoicecompany.com/role/ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails" ], "lang": { "en-us": { "role": { "label": "Less: Adjustment due to warrant modifications", "documentation": "Warrant modifications adjustment." } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstanding", "crdr": "credit", "presentation": [ "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants liabilities", "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price." } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingMaturityDate", "presentation": [ "http://betterchoicecompany.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants expiration", "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format." } } }, "auth_ref": [ "r806" ] }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingMeasurementInput", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Warrant liabilities, measurement input", "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur." } } }, "auth_ref": [ "r482" ] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfSignificantInputsToWarrantsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Warrant liabilities, time to maturity", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r806" ] }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails" ], "lang": { "en-us": { "role": { "label": "Dilutive common stock equivalents", "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation." } } }, "auth_ref": [ "r742" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails", "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding, diluted", "verboseLabel": "Diluted WASO", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r227", "r233" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://betterchoicecompany.com/role/ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails", "http://betterchoicecompany.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding, basic", "verboseLabel": "Basic WASO", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r225", "r233" ] }, "BTTR_WintrustCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "WintrustCreditFacilityMember", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Wintrust Credit Facility [Member]", "documentation": "Wintrust Credit Facility [Member]" } } }, "auth_ref": [] }, "BTTR_WintrustReceivablesCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://betterchoicecompany.com/20231231", "localname": "WintrustReceivablesCreditFacilityMember", "presentation": [ "http://betterchoicecompany.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Wintrust Receivables Credit Facility [Member]", "documentation": "Wintrust Receivables Credit Facility [Member]" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://betterchoicecompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r722" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "13", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(1)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(2)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(3)-(4)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "330", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-13" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-14" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB Topic 4.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.M.Q4)", "SubTopic": "20", "Topic": "326", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483530/326-20-S99-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479391/326-20-30-4A" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479391/326-20-30-5A" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "8A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479366/326-20-35-8A" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-5" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-17" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-21" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-3C" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-3D" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479175/326-30-30-1B" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "13A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479148/326-30-35-13A" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "7A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479148/326-30-35-7A" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-3A" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-3C" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-3D" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-20/tableOfContent" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715/tableOfContent" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r647": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r648": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r649": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(b)", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r650": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r653": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8" }, "r654": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16" }, "r655": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21" }, "r656": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r657": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r658": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r659": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r660": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r661": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r662": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r663": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r664": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r665": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r666": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r667": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481639/420-10-35-4" }, "r668": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r669": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r670": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r671": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r672": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r673": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r674": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r675": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r676": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r677": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r678": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r679": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r680": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r681": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r682": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r683": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r684": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r685": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r686": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r687": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r688": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r689": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r690": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r691": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r692": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r693": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r695": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r699": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r700": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r701": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r702": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r703": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r704": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r705": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r706": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r707": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r708": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r709": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r710": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r711": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r712": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r713": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r714": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r715": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r716": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r717": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r718": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r720": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r721": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r722": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r723": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r724": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r725": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r726": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r727": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "705", "Publisher": "FASB", "URI": "https://asc.fasb.org//705/tableOfContent" }, "r728": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r729": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r730": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r731": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r732": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r733": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r734": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r735": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r736": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r737": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r738": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r739": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r740": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r741": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r742": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r743": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r744": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r745": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r746": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r747": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r748": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r749": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r750": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r751": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r752": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r753": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r754": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r755": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r756": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r757": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r758": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r759": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r760": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r761": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r762": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r763": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r764": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r765": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r766": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r767": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r768": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r769": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r770": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r771": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r772": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r773": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r774": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r775": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r776": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r777": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r778": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r779": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r780": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r781": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r782": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r783": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r784": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r785": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r786": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r787": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r788": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r789": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r790": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r791": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r792": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r793": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r794": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r795": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r796": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r797": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r798": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r799": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r800": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r801": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r802": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r803": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A" }, "r804": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r805": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r806": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r807": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r808": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r809": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r810": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r811": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r812": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r813": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r814": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r815": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r816": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r817": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r818": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r819": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r820": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r821": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r822": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r823": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r824": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r825": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r826": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r827": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r828": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r829": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r830": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r831": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 95 0001493152-24-014436-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-014436-xbrl.zip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�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form10-k_htm.xml IDEA: XBRL DOCUMENT 0001471727 2023-01-01 2023-12-31 0001471727 2023-09-30 0001471727 2024-04-11 0001471727 2022-01-01 2022-12-31 0001471727 2023-12-31 0001471727 2022-12-31 0001471727 us-gaap:CommonStockMember 2021-12-31 0001471727 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001471727 us-gaap:RetainedEarningsMember 2021-12-31 0001471727 2021-12-31 0001471727 us-gaap:CommonStockMember 2022-12-31 0001471727 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001471727 us-gaap:RetainedEarningsMember 2022-12-31 0001471727 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001471727 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001471727 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001471727 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001471727 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001471727 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001471727 us-gaap:CommonStockMember 2023-12-31 0001471727 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001471727 us-gaap:RetainedEarningsMember 2023-12-31 0001471727 us-gaap:IPOMember 2021-07-01 2021-07-01 0001471727 us-gaap:IPOMember 2021-07-01 0001471727 us-gaap:SubsequentEventMember 2024-03-08 2024-03-08 0001471727 us-gaap:MeasurementInputEbitdaMultipleMember 2023-01-01 2023-12-31 0001471727 us-gaap:MoneyMarketFundsMember 2022-12-31 0001471727 2022-05-10 0001471727 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-12-31 0001471727 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-12-31 0001471727 BTTR:ECommerceMember 2023-01-01 2023-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember BTTR:ECommerceMember 2023-01-01 2023-12-31 0001471727 BTTR:ECommerceMember 2022-01-01 2022-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember BTTR:ECommerceMember 2022-01-01 2022-12-31 0001471727 BTTR:BrickAndMortarMember 2023-01-01 2023-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember BTTR:BrickAndMortarMember 2023-01-01 2023-12-31 0001471727 BTTR:BrickAndMortarMember 2022-01-01 2022-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember BTTR:BrickAndMortarMember 2022-01-01 2022-12-31 0001471727 BTTR:DirectToConsumerMember 2023-01-01 2023-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember BTTR:DirectToConsumerMember 2023-01-01 2023-12-31 0001471727 BTTR:DirectToConsumerMember 2022-01-01 2022-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember BTTR:DirectToConsumerMember 2022-01-01 2022-12-31 0001471727 BTTR:InternationalMember 2023-01-01 2023-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember BTTR:InternationalMember 2023-01-01 2023-12-31 0001471727 BTTR:InternationalMember 2022-01-01 2022-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember BTTR:InternationalMember 2022-01-01 2022-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember 2023-01-01 2023-12-31 0001471727 us-gaap:RevenueFromContractWithCustomerMember BTTR:SalesChannelConcentrationRiskMember 2022-01-01 2022-12-31 0001471727 BTTR:TwoCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember BTTR:ECommerceMember 2023-01-01 2023-12-31 0001471727 BTTR:TwoCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember BTTR:ECommerceMember 2022-01-01 2022-12-31 0001471727 BTTR:CustomerOneMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember BTTR:ECommerceMember 2023-01-01 2023-12-31 0001471727 BTTR:CustomerTwoMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember BTTR:ECommerceMember 2023-01-01 2023-12-31 0001471727 BTTR:CustomerOneMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember BTTR:ECommerceMember 2022-01-01 2022-12-31 0001471727 BTTR:CustomerTwoMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember BTTR:ECommerceMember 2022-01-01 2022-12-31 0001471727 BTTR:OneCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember BTTR:InternationalMember 2023-01-01 2023-12-31 0001471727 BTTR:OneCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember BTTR:InternationalMember 2022-01-01 2022-12-31 0001471727 BTTR:IHeartMediaMember us-gaap:CommonStockMember 2019-08-28 2019-08-28 0001471727 BTTR:IHeartMediaMember us-gaap:CommonStockMember 2020-03-05 2020-03-05 0001471727 us-gaap:EquipmentMember 2023-12-31 0001471727 us-gaap:EquipmentMember 2022-12-31 0001471727 srt:MinimumMember us-gaap:EquipmentMember 2023-12-31 0001471727 srt:MaximumMember us-gaap:EquipmentMember 2023-12-31 0001471727 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001471727 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001471727 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2023-12-31 0001471727 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2023-12-31 0001471727 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-12-31 0001471727 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-12-31 0001471727 srt:MinimumMember us-gaap:ComputerSoftwareIntangibleAssetMember 2023-12-31 0001471727 srt:MaximumMember us-gaap:ComputerSoftwareIntangibleAssetMember 2023-12-31 0001471727 us-gaap:ComputerEquipmentMember 2023-12-31 0001471727 us-gaap:ComputerEquipmentMember 2022-12-31 0001471727 srt:MinimumMember us-gaap:ComputerEquipmentMember 2023-12-31 0001471727 srt:MaximumMember us-gaap:ComputerEquipmentMember 2023-12-31 0001471727 2022-07-31 0001471727 2022-10-01 0001471727 us-gaap:CustomerRelationshipsMember 2023-12-31 0001471727 us-gaap:CustomerRelationshipsMember 2023-01-01 2023-12-31 0001471727 us-gaap:TradeNamesMember 2023-12-31 0001471727 us-gaap:TradeNamesMember 2023-01-01 2023-12-31 0001471727 us-gaap:CustomerRelationshipsMember 2022-12-31 0001471727 us-gaap:TradeNamesMember 2022-12-31 0001471727 BTTR:TermLoanMember 2023-12-31 0001471727 BTTR:TermLoanMember 2023-01-01 2023-12-31 0001471727 BTTR:TermLoanMember 2022-12-31 0001471727 us-gaap:LineOfCreditMember 2023-12-31 0001471727 us-gaap:LineOfCreditMember 2023-01-01 2023-12-31 0001471727 us-gaap:LineOfCreditMember 2022-12-31 0001471727 us-gaap:LineOfCreditMember 2022-01-01 2022-12-31 0001471727 us-gaap:LineOfCreditMember us-gaap:FederalFundsEffectiveSwapRateMember 2022-01-01 2022-12-31 0001471727 us-gaap:LineOfCreditMember us-gaap:FederalFundsEffectiveSwapRateMember 2023-01-01 2023-12-31 0001471727 BTTR:TermLoanMember BTTR:OldPlankTrailCommunityBankNAMember 2021-01-06 0001471727 us-gaap:LineOfCreditMember BTTR:OldPlankTrailCommunityBankNAMember 2021-01-06 0001471727 BTTR:TermLoanMember BTTR:OldPlankTrailCommunityBankNAMember 2021-01-06 2021-01-06 0001471727 us-gaap:LineOfCreditMember BTTR:OldPlankTrailCommunityBankNAMember 2021-01-06 2021-01-06 0001471727 BTTR:TermLoanMember BTTR:OldPlankTrailCommunityBankNAMember BTTR:LondonInterbankOfferedRateMember 2021-01-06 2021-01-06 0001471727 us-gaap:LineOfCreditMember BTTR:OldPlankTrailCommunityBankNAMember BTTR:LondonInterbankOfferedRateMember 2021-01-06 2021-01-06 0001471727 BTTR:OldPlankTrailCommunityBankNAMember BTTR:SecondAmendmentMember us-gaap:FederalFundsEffectiveSwapRateMember 2021-01-06 2021-01-06 0001471727 BTTR:OldPlankTrailCommunityBankNAMember BTTR:ThirdAmendmentMember us-gaap:FederalFundsEffectiveSwapRateMember 2021-01-06 2021-01-06 0001471727 us-gaap:LineOfCreditMember BTTR:WintrustCreditFacilityMember 2021-01-06 2021-01-06 0001471727 us-gaap:LineOfCreditMember BTTR:WintrustCreditFacilityMember 2022-03-31 0001471727 us-gaap:LineOfCreditMember BTTR:WintrustCreditFacilityMember 2023-03-31 0001471727 us-gaap:LineOfCreditMember BTTR:WintrustCreditFacilityMember 2022-09-30 0001471727 us-gaap:LineOfCreditMember BTTR:WintrustCreditFacilityMember 2021-08-12 0001471727 us-gaap:LineOfCreditMember BTTR:WintrustCreditFacilityMember 2021-08-13 0001471727 us-gaap:LineOfCreditMember BTTR:WintrustCreditFacilityMember 2022-01-01 0001471727 us-gaap:LineOfCreditMember BTTR:WintrustCreditFacilityMember 2023-01-01 0001471727 us-gaap:LineOfCreditMember BTTR:WintrustCreditFacilityMember 2022-10-24 0001471727 us-gaap:LineOfCreditMember BTTR:WintrustCreditFacilityMember 2023-06-21 2023-06-21 0001471727 us-gaap:LineOfCreditMember BTTR:WintrustCreditFacilityMember 2023-12-31 0001471727 us-gaap:LineOfCreditMember BTTR:WintrustCreditFacilityMember 2022-12-31 0001471727 BTTR:WintrustReceivablesCreditFacilityMember 2023-06-21 2023-06-21 0001471727 srt:MaximumMember BTTR:WintrustReceivablesCreditFacilityMember 2023-06-21 0001471727 BTTR:WintrustReceivablesCreditFacilityMember us-gaap:PrimeRateMember 2023-06-21 2023-06-21 0001471727 BTTR:WintrustReceivablesCreditFacilityMember 2023-12-31 0001471727 BTTR:WintrustReceivablesCreditFacilityMember 2023-01-01 2023-12-31 0001471727 BTTR:AlphiaTermLoanFacilityMember us-gaap:LineOfCreditMember 2023-06-21 0001471727 BTTR:AlphiaTermLoanFacilityMember us-gaap:LineOfCreditMember 2023-12-31 0001471727 BTTR:AlphiaTermLoanFacilityMember us-gaap:LineOfCreditMember 2023-01-01 2023-12-31 0001471727 BTTR:TermLoanMember us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-12-31 0001471727 BTTR:TermLoanMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-12-31 0001471727 BTTR:TermLoanMember us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-12-31 0001471727 BTTR:TermLoanMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0001471727 us-gaap:LineOfCreditMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-12-31 0001471727 us-gaap:LineOfCreditMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-12-31 0001471727 us-gaap:LineOfCreditMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-12-31 0001471727 us-gaap:LineOfCreditMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0001471727 BTTR:FirstTrancheWarrantMember us-gaap:SecuredDebtMember BTTR:AlphiaTermLoanFacilityMember us-gaap:LineOfCreditMember 2023-06-21 0001471727 BTTR:SecondTrancheWarrantMember us-gaap:SecuredDebtMember BTTR:AlphiaTermLoanFacilityMember us-gaap:LineOfCreditMember 2023-06-21 0001471727 us-gaap:SecuredDebtMember BTTR:AlphiaTermLoanFacilityMember us-gaap:LineOfCreditMember 2023-06-21 2023-06-21 0001471727 us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:LineOfCreditMember 2023-12-31 0001471727 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001471727 BTTR:FirstTrancheWarrantMember us-gaap:MeasurementInputExercisePriceMember 2023-12-21 0001471727 BTTR:SecondTrancheWarrantMember us-gaap:MeasurementInputExercisePriceMember 2023-12-21 0001471727 BTTR:FirstTrancheWarrantMember us-gaap:MeasurementInputSharePriceMember 2023-12-21 0001471727 BTTR:SecondTrancheWarrantMember us-gaap:MeasurementInputSharePriceMember 2023-12-21 0001471727 BTTR:FirstTrancheWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-21 0001471727 BTTR:SecondTrancheWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-21 0001471727 BTTR:FirstTrancheWarrantMember us-gaap:MeasurementInputExpectedTermMember 2023-12-21 0001471727 BTTR:SecondTrancheWarrantMember us-gaap:MeasurementInputExpectedTermMember 2023-12-21 0001471727 BTTR:FirstTrancheWarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-21 0001471727 BTTR:SecondTrancheWarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-21 0001471727 BTTR:FirstTrancheWarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-12-21 0001471727 BTTR:SecondTrancheWarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-12-21 0001471727 us-gaap:WarrantMember 2022-12-31 0001471727 us-gaap:WarrantMember 2023-12-31 0001471727 BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2019-11-10 0001471727 BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2019-11-11 0001471727 BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2019-11-11 2019-11-11 0001471727 BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2021-01-01 0001471727 BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2022-01-01 0001471727 BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2023-01-01 0001471727 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001471727 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001471727 srt:MaximumMember us-gaap:EmployeeStockOptionMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2023-01-01 2023-12-31 0001471727 us-gaap:EmployeeStockOptionMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2023-01-01 2023-12-31 0001471727 us-gaap:EmployeeStockOptionMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2022-01-01 2022-12-31 0001471727 us-gaap:EmployeeStockOptionMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2023-12-31 0001471727 BTTR:BoardOfDirectorsMember us-gaap:RestrictedStockMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2022-02-01 2022-02-28 0001471727 BTTR:BoardOfDirectorsMember us-gaap:RestrictedStockMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2022-10-01 2022-12-31 0001471727 BTTR:BoardOfDirectorsMember us-gaap:RestrictedStockMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2023-01-01 2023-01-31 0001471727 BTTR:ExecutivesAndEmployeesMember us-gaap:RestrictedStockMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2023-01-01 2023-01-31 0001471727 BTTR:BoardOfDirectorsMember us-gaap:RestrictedStockMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2023-01-01 2023-03-31 0001471727 BTTR:ExecutivesAndEmployeesMember us-gaap:RestrictedStockMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2023-04-01 2023-06-30 0001471727 BTTR:TwoMemberOfBoardOfDirectorsMember us-gaap:RestrictedStockMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember 2023-07-01 2023-09-30 0001471727 2021-01-01 2021-12-31 0001471727 srt:MinimumMember 2023-01-01 2023-12-31 0001471727 srt:MaximumMember 2023-01-01 2023-12-31 0001471727 srt:MinimumMember 2022-01-01 2022-12-31 0001471727 srt:MaximumMember 2022-01-01 2022-12-31 0001471727 BTTR:BoardOfDirectorsMember 2023-01-01 2023-12-31 0001471727 BTTR:BoardOfDirectorsMember 2022-01-01 2022-12-31 0001471727 srt:DirectorMember 2023-12-31 0001471727 srt:DirectorMember 2022-12-31 0001471727 srt:DirectorMember BTTR:BelievecoMember 2023-01-01 2023-12-31 0001471727 srt:DirectorMember BTTR:BelievecoMember 2023-12-31 0001471727 us-gaap:DomesticCountryMember 2023-12-31 0001471727 us-gaap:DomesticCountryMember 2022-12-31 0001471727 BTTR:TwoVendorsMember us-gaap:InventoriesMember us-gaap:SupplierConcentrationRiskMember 2023-01-01 2023-12-31 0001471727 BTTR:TwoVendorsMember us-gaap:InventoriesMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001471727 BTTR:TwoCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001471727 BTTR:ThreeCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001471727 BTTR:ThreeCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001471727 BTTR:ThreeCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001471727 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001471727 us-gaap:EmployeeStockMember 2022-01-01 2022-12-31 0001471727 BTTR:OtherOptionMember 2022-01-01 2022-12-31 0001471727 BTTR:WarrantLiabilitiesMember 2023-01-01 2023-12-31 0001471727 BTTR:FirstTrancheWarrantMember 2023-01-01 2023-12-31 0001471727 BTTR:SecondTrancheWarrantMember 2023-01-01 2023-12-31 0001471727 us-gaap:EmployeeStockMember 2023-01-01 2023-12-31 0001471727 BTTR:AimiaPetHealthcoIncMember us-gaap:SubsequentEventMember 2024-02-09 2024-02-09 0001471727 BTTR:BoardOfDirectorsMember BTTR:TwoThousandNineteenIncentiveAwardPlanMember us-gaap:SubsequentEventMember 2024-02-01 2024-02-29 iso4217:USD shares iso4217:USD shares BTTR:Integer pure BTTR:Segment false FY 0001471727 Better Choice Co Inc. P2Y P10Y 10-K true 2023-12-31 --12-31 2023 false 001-40477 DE 83-4284557 12400 Race Track Road Tampa FL 33626 (212) 896-1254 Common Stock, $0.001 par value share BTTR NYSE No No Yes Yes Non-accelerated Filer true false false false false 3615969 893601 The information required by Items 10, 11, 12, 13, and 14 will be furnished (and are hereby incorporated) by an amendment hereto or pursuant to a definitive proxy statement pursuant to Regulation 14A that will contain such information. 243 BDO USA, P.C Tampa, Florida 38592000 54660000 26795000 39399000 11797000 15261000 24444000 35430000 18614000 8532000 32976000 54044000 -21179000 -38783000 1353000 551000 236000 1589000 551000 -22768000 -39334000 2000 -18000 -22770000 -39316000 705185 667114 705185 667114 -32.29 -58.93 -32.29 -58.93 4455000 3173000 6300000 4354000 6744000 6611000 10257000 812000 1051000 16232000 27525000 230000 375000 120000 173000 10059000 155000 544000 16737000 38676000 6928000 2932000 2085000 2596000 1741000 2881000 57000 52000 13692000 5580000 11444000 67000 124000 67000 11568000 13759000 17148000 0.001 0.001 200000000 200000000 729026 729026 668869 668869 32000 29000 324288000 320071000 -321342000 -298572000 2978000 21528000 16737000 38676000 662417 29000 317102000 -259256000 57875000 6452 2969000 2969000 -39316000 -39316000 668869 29000 320071000 -298572000 21528000 668869 29000 320071000 -298572000 21528000 60157 3000 1773000 1776000 2444000 2444000 -22770000 -22770000 729026 32000 324288000 -321342000 2978000 729026 32000 324288000 -321342000 2978000 -22770000 -39316000 -11000 1678000 1690000 193000 56000 18614000 8532000 1773000 2969000 236000 2095000 -474000 1809000 254000 291000 -2000 -4000 -126000 -2387000 66000 -4120000 6821000 -628000 1047000 3996000 -761000 -760000 99000 97000 -20553000 18000 198000 -18000 -198000 413000 248000 1906000 12317000 13500000 5640000 7841000 6100000 5000000 5450000 244000 110000 -5097000 1282000 -5018000 -19469000 9473000 28942000 4455000 9473000 12000 543000 444000 2444000 <p id="xdx_805_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_zeCNoHJoCHLe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – <span id="xdx_82F_z0xRytDNn8R4">Nature of business and summary of significant accounting policies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature of the business</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Better Choice Company Inc. (the “Company”) is a pet health and wellness company focused on providing pet products and services that help dogs and cats live healthier, happier and longer lives. The Company has a broad portfolio of pet health and wellness products for dogs and cats sold under its Halo brand across multiple forms, including foods, treats, toppers, dental products, chews and supplements. The products consist of kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products and supplements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--InitialPublicOfferingPolicyTextBlock_zqYgOGclMnZb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zPxDAsgvUbn8">Initial public offering</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company completed its initial public offering (the “IPO”) on July 1, 2021, in which it issued and sold <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20210701__20210701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zvYkMYocOCl3" title="Sale of stock, number of shares issued in transaction">181,818</span> shares of its common stock at a price of $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20210701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zrHzE5qSkyr" title="Sale of stock, price per share">5.00</span> per share. The total net proceeds from the IPO were approximately $<span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn5n6_c20210701__20210701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zFshiFFfHIyd" title="Sale of stock, consideration received on transaction">36.1</span> million, after deducting underwriting discounts and commissions of $<span id="xdx_90D_ecustom--PaymentsOfUnderwritingDiscountsAndCommissions_pn5n6_c20210701__20210701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zx5aZKL3yX2e" title="Payments of underwriting discounts and commissions">2.8</span> million, and offering costs of approximately $<span id="xdx_903_eus-gaap--PaymentsOfStockIssuanceCosts_pn5n6_c20210701__20210701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zAbHuulM0uU4" title="Payments of stock issuance costs">1.1</span> million. These IPO costs were recorded as a reduction of stockholders’ equity, and presented net of cash proceeds received in the Consolidated Statement of Cash Flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon the commencement of the IPO, all of the Company’s outstanding convertible notes payable automatically converted into <span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20210701__20210701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zbt2leHBb7R9" title="Conversion of convertible securities">107,555</span> shares of common stock and upon the consummation of the IPO, all outstanding shares of the Series F convertible preferred stock were converted into <span id="xdx_90B_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_pid_c20210701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zP9cjG4GYOI1" title="Convertible preferred stock, shares issued upon conversion">131,012</span> shares of common stock. Additionally, since the anti-dilution provision of the Series F Warrants were no longer effective upon consummation of the Company’s IPO, these warrants met the requirements to be considered equity and the outstanding Series F Warrants were reclassified as such.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--ReverseStockSplitPolicyTextBlock_zhDLf4xmNDQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_z4iVItTZztI6">Reverse stock split</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 8, 2024, the Company’s Board of Directors approved a reverse stock split of the Company’s issued and outstanding shares of common stock at a ratio of <span id="xdx_900_eus-gaap--StockholdersEquityReverseStockSplit_c20240308__20240308__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zvmIkzHWuWUf">1-for-44</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, effective March 20, 2024 (the “Reverse Split”). In addition, the conversion rates of the Company’s outstanding preferred stock and convertible notes and the exercise prices of the Company’s underlying common stock purchase warrants and stock options were proportionately adjusted at the applicable reverse stock split ratio in accordance with the terms of such instruments. Proportionate voting rights and other rights of common stockholders were not affected by the Reverse Stock Split, other than as a result of the rounding up of fractional shares. No </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fractional shares of common stock were issued in connection with the Reverse Stock Split.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly, all share and per share amounts related to the Company’s common stock for all periods presented in the accompanying consolidated financial statements and notes thereto have been retroactively adjusted, where applicable, to reflect the Reverse Stock Split. The number of authorized shares and the par values of the common stock and convertible preferred stock were not adjusted as a result of the Reverse Stock Split.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zK5hrSMBv7zf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zhchvhojYIK4">Basis of presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s consolidated financial statements are prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for annual financial reports and accounting principles generally accepted in the U.S. (“GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_841_eus-gaap--ConsolidationPolicyTextBlock_zL4TFK7hqgEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zBqWdYxNZbjl">Consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements are presented on a consolidated basis and include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--UseOfEstimates_zBmh4gJPNBWh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zyob7kzQLmFa">Use of estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On an ongoing basis, the Company evaluates these assumptions, judgments and estimates. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the opinion of management, the consolidated financial statements contain all adjustments necessary for a fair statement of the results of operations for the years ended December 31, 2023 and 2022, the financial position as of December 31, 2023 and 2022 and the cash flows for the years ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_849_ecustom--GoingConcernConsiderationsPolicyTextBlock_zZKJcjobvuTb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zxClJVDaoFVk">Going concern considerations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is subject to risks common in the pet wellness consumer market including, but not limited to, dependence on key personnel, competitive forces, successful marketing and sale of its products, the successful protection of its proprietary technologies, ability to grow into new markets, and compliance with government regulations. The Company has continually incurred losses and has an accumulated deficit. The Company’s term loan agreement with Alphia imposes certain financial covenants, including minimum liquidity of $<span id="xdx_90E_ecustom--MinimumLiquidityRequired_iI_pn5n6_c20231231_zDc4UUkaaKli" title="Minimum liquidity required">3.0</span> million, minimum EBITDA of $<span id="xdx_900_eus-gaap--NetIncomeLoss_pn5n6_c20230101__20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputEbitdaMultipleMember_zQfaDKorR4jf" title="Net income">(4.5)</span> million, and maximum marketing spend ratio of <span id="xdx_902_ecustom--MaximumMarketingSpendRatio_pid_dp_uPure_c20230101__20231231_z5mn2PSyRo9l" title="Maximum marketing spend ratio">30%</span>. The Company was not in compliance with certain covenants related to the Alphia Term Loan Facility as of December 31, 2023 and the debt is callable by the lender. Our continued operating losses along with our failure to meet the financial covenants create substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the date these consolidated financial statements are issued. The Company does not currently expect it will be able to generate sufficient cash flow from operations to maintain sufficient liquidity to meet the required financial covenants in certain periods prior to maturity giving the lender the right to call the debt. The Company will need to either raise additional capital or obtain additional financing, and/or secure future waivers or amendments from its lenders or accomplish some combination of these items to maintain sufficient liquidity. There can be no assurance that the Company will be successful in raising additional capital, securing future waivers and/or amendments from its lenders, renewing or refinancing its existing debt or securing new financing. If the Company is unsuccessful in doing so, it may need to reduce the scope of its operations, repay amounts owed to its lenders or sell certain assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the third quarter, the Company received a notice of noncompliance from the NYSE American. If the Company fails to satisfy the continued listing requirements before the end of the cure period, the NYSE American may take steps to delist its common stock. Such a delisting or the announcement of such delisting will have a negative effect on the price of the Company’s common stock and would impair the ability for investors to sell or purchase the Company’s common stock. In the event of a delisting, the Company may attempt to take actions to restore its compliance with the NYSE American listing requirements, but can provide no assurance that any such action taken by the Company would allow its common stock to become listed again, stabilize the market price or improve the liquidity of its common stock, prevent its common stock from dropping below the NYSE American minimum listing requirements or prevent future non-compliance with the NYSE American listing requirements. If the Company does not maintain the listing of its common stock on NYSE American, it could make it harder for the Company to raise additional capital in the long-term. If the Company is unable to raise capital when needed in the future, it may have to cease or reduce operations. There can be no assurance that the Company will be able to satisfy the continued listing requirements in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is continuing to implement plans to achieve operating profitability, as well as implementing other strategic objectives to address liquidity. The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and payments of liabilities in the ordinary course of business. Accordingly, the consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount of and classification of liabilities that may result should the Company be unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary of significant accounting policies</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z1KkM6MlQPA" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zCEmBwoZ6hTb">Cash and cash equivalents</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents include demand deposits held with banks and highly liquid investments with original maturities of ninety days or less at acquisition date. Cash and cash equivalents are stated at cost, which approximates fair value because of the short-term nature of these instruments. The Company’s cash equivalents are held in government money market funds and at times may exceed federally insured limits. For purposes of reporting cash flows, the Company considers all cash accounts that are not subject to withdrawal restrictions or penalties to be cash and cash equivalents. At December 31, 2022, the Company had $<span id="xdx_909_eus-gaap--Cash_iI_pn5n6_c20221231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember_zRVi0zZZ9w7d" title="Cash">8.0</span> million in money market funds all of which were held in cash. As of December 31, 2023, the Company had closed its money market funds.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zHae5wuF7YQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zen9wJDeBIha">Restricted cash</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company was required to maintain a restricted cash balance of $<span id="xdx_907_eus-gaap--RestrictedCashCurrent_iI_pn5n6_c20221231_zvYwTsg7zM58" title="Restricted cash">6.3</span> million as of December 31, 2022, in connection with the Wintrust Credit Facility. As a result of the full repayment of the Wintrust Credit Facility, there are <span id="xdx_902_eus-gaap--RestrictedCashCurrent_iI_doxL_c20231231_zPXdPVuNH5vl" title="Restricted cash::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0464">no</span></span> restrictions on cash as of December 31, 2023. See “Note 8 - Debt” for additional information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--CreditLossFinancialInstrumentPolicyTextBlock_zUXIh9Ge1Kb2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zuC6oIaIXEa8">Accounts receivable and allowance for credit losses</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable consist of unpaid buyer invoices from the Company’s customers and credit card payments receivable from third-party credit card processing companies. Accounts receivable is stated at the amount billed to customers, net of point of sale and cash discounts. The Company assesses the collectability of all receivables on an ongoing basis by considering its historical credit loss experience, current economic conditions, and other relevant factors. Based on this analysis, an allowance for credit losses is recorded, and the provision is included within SG&amp;A expense. The Company recorded approximately $<span id="xdx_905_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn5n6_c20231231_zAOuGZRB6GF3" title="Allowance for credit losses"><span id="xdx_900_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn5n6_c20221231_zQQn3l8NnCh1" title="Allowance for credit losses">0.1</span></span> million allowance for credit losses for the years ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zoQMJa7OEUB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_z5j3TB1fiQk9">Inventories</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories, consisting of finished goods available for sale as well as packaging materials, are valued using the first-in first-out (“FIFO”) method and are recorded at the lower of cost or net realizable value. Cost is determined on a standard cost basis and includes the purchase price, as well as inbound freight costs and packaging costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company regularly reviews inventory quantities on hand. Excess or obsolete reserves are established when inventory is estimated to not be sellable before expiration dates based on forecasted usage, product demand and product life cycle. Additionally, inventory valuation reflects adjustments for anticipated physical inventory losses that have occurred since the last physical inventory.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zXtvH9clDTIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zNot9V7ctZI6">Fixed Assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets are recorded at cost and depreciated using the straight-line method over the estimated useful lives of the assets, and depreciation expense is included within SG&amp;A expense. Expenditures for normal repairs and maintenance are charged to operations as incurred. The cost of fixed assets that are retired or otherwise disposed of and the related accumulated depreciation are removed from the fixed asset accounts in the year of disposal and the resulting gain or loss is included in SG&amp;A expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assesses potential impairments of its fixed assets whenever events or changes in circumstances indicate that the asset’s carrying value may not be recoverable. An impairment charge would be recognized when the carrying amount of the identified asset grouping exceeds its fair value and is not recoverable, which would occur if the carrying amount exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the identified asset grouping.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zK59bkX4gfRe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zNv9fGOyUotb">Goodwill</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill is evaluated for impairment either through a qualitative or quantitative approach at least annually, or more frequently if an event occurs or circumstances change that indicate the carrying value of a reporting unit may not be recoverable. If a quantitative assessment is performed that indicates the carrying amount of a reporting unit exceeds its fair market value, an impairment loss is recognized to reduce the carrying amount to its fair market value. The fair market value is determined based on a weighting of the present value of projected future cash flows (the “income approach”) and the use of comparative market approaches (“market approach”). Factors requiring significant judgment include, among others, the assumptions related to discount rates, forecasted operating results, long-term growth rates, the determination of comparable companies and market multiples. Fair value measurements used in the impairment review of goodwill are Level 3 measurements. See further information about the Company’s policy for fair value measurements within this section below. See “Note 6 - Goodwill and intangible assets” for additional information regarding the goodwill impairment test.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zr0O2EkPZyUd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zWV1Q86wWTY4">Intangible assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finite-lived Intangible assets acquired are carried at cost, less accumulated amortization. Amortization expense is included in selling, general and administrative expenses on the consolidated statements of operations. The Company assesses long lived assets, including finite-lived intangible assets, for impairment whenever events or changes in circumstances indicate the carrying amount of the asset group may not be recoverable. The Company operates as a single reporting unit and as such, is the asset group when assessing finite-lived intangible assets for impairment. If impairment indicators are present, the Company performs a recoverability test by comparing the sum of the estimated undiscounted future cash flows attributable to its long-lived asset group to its carrying value. If the carrying amount of an asset group is not recoverable, an impairment loss is recognized based on the excess of the carrying value of the impaired asset group over its fair value. An impairment loss for an asset group is allocated to the long-lived assets of the group on a pro rata basis using the relative carrying amounts of those assets, except that the loss allocated to an individual long-lived asset of the group shall not reduce the carrying amount of that asset below its fair value whenever that fair value is determinable without undue cost and effort.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_ecustom--SharesRepurchasesPolicyTextBlock_ziseKANBV7C7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Share repurchases</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 10, 2022, the Company’s board of directors approved a share repurchase program that authorized the repurchase of up to $<span id="xdx_904_eus-gaap--StockRepurchaseProgramAuthorizedAmount1_iI_pn5n6_c20220510_zJ1WWRCDC5e8" title="Stock repurchase program, authorized amount">3.0</span> million of the Company’s outstanding common stock in the open market through December 31, 2022. Repurchased shares are immediately retired and returned to unissued status. During the years ended December 31, 2023 and 2022, <span id="xdx_907_eus-gaap--StockRepurchasedDuringPeriodShares_pid_do_c20230101__20231231_zDiqo4066bj9" title="Stock repurchased, shares"><span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodShares_pid_do_c20220101__20221231_zmrVaTVNbYpf" title="Stock repurchased, shares">no</span></span> shares were repurchased.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--ClassOfWarrantOrRightPolicyTextBlock_zRhTvkn9Llb7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zPoZiQsSfeB1">Common stock warrants</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock warrants are recorded as either liabilities or as equity instruments, depending on the specific terms of the warrant agreement. Warrants classified as liabilities are revalued at each balance sheet date subsequent to the initial issuance and changes in the fair value are reflected in the Consolidated Statements of Operations as change in fair value of warrant liabilities. Upon exercise, the warrant is marked to fair value on the exercise date and the related fair value is reclassified to equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zvz1pDfCgAwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_z3f0q2Dwhtoj">Income taxes</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes are recorded in accordance with FASB ASC Topic 740, “Income Taxes (ASC 740)”, which provides for deferred taxes using an asset and liability approach. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the consolidated financial statements and tax bases of assets and liabilities and for loss and credit carryforwards using enacted tax rates anticipated to be in effect for the year in which the differences are expected to reverse. Valuation allowances are provided, if, based upon the weight of available evidence, it is more likely than not that some or all the deferred tax assets will not be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for uncertain tax positions in accordance with the provisions of ASC 740. When uncertain tax positions exist, the Company recognizes the tax benefit of tax positions to the extent that some or all the benefit will more likely than not be realized. The determination as to whether the tax benefit will more likely than not be realized is based upon the technical merits of the tax position, as well as consideration of the available facts and circumstances. As of December 31, 2023 and 2022, the Company does not have any significant uncertain income tax positions. If incurred, the Company would classify interest and penalties on uncertain tax positions as income tax expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company was incorporated on May 6, 2019. Prior to this date, the Company operated as a flow through entity for state and U.S. federal tax purposes. The Company files a U.S. federal and state income tax return, including for its wholly owned subsidiaries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z3wz7q3rBgdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zdmCMXFsqhnf">Revenue</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, the Company’s customer contracts have a single performance obligation, and revenue is recognized when the product is shipped as this is when it has been determined that control has been transferred. Amounts billed and due from customers are classified as receivables and require payment on a short-term basis and therefore do not have any significant financing components.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue is measured as the amount of consideration the Company expects in exchange for transferring goods, which varies with changes in trade incentives the Company offers to its customers. Trade incentives consist primarily of customer pricing allowances and merchandising funds, and point of sale discounts. Estimates of trade promotion expense and coupon redemption costs are based upon programs offered, timing of those offers, estimated redemption/usage rates from historical performance, management’s experience and current economic trends.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--CostOfSalesPolicyTextBlock_zmjnUpyCuwO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zj9qrObFsmBg">Cost of goods sold</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of goods sold consists primarily of the cost of product obtained from co-manufacturers, packaging materials, freight costs for shipping inventory to the warehouse, as well as third-party warehouse and order fulfillment costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--AdvertisingCostsPolicyTextBlock_zbTPh5fWWEDd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zqoQGkXJo6o9">Advertising</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company charges advertising costs to expense as incurred and such charges are included in SG&amp;A expense. The Company’s advertising expenses consist primarily of online advertising, search costs, email advertising and radio advertising. In addition, the Company reimburses its customers and third parties for in store activities and record these costs as advertising expenses. Advertising costs were $<span id="xdx_909_eus-gaap--AdvertisingExpense_pn5n6_c20230101__20231231_zr5eswNgya09" title="Advertising expense">6.8</span> million and $<span id="xdx_90A_eus-gaap--AdvertisingExpense_pn5n6_c20220101__20221231_zxViznwMI94k" title="Advertising expense">12.2</span> million for the years ended December 31, 2023 and 2022, respectively, of which $<span id="xdx_902_eus-gaap--OtherAmortizationOfDeferredCharges_pn5n6_c20220101__20221231_zNfWtQ3ze5a6" title="Amortization of other deferred charges">2.1</span> million is related to the amortization of the prepaid advertising contract with iHeart for the year ended December 31, 2022. See “Note 4 - Prepaid expenses and other current assets” for additional information on the prepaid advertising contract with iHeart.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--FreightOutPolicyTextBlock_za9xYelQ2LL7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zLMapLwmTYzc">Freight Out</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs incurred for shipping and handling, including moving finished product to customers are included in SG&amp;A expense. Shipping costs associated with moving finished products to customers were $<span id="xdx_906_eus-gaap--CostsAndExpenses_pn5n6_c20230101__20231231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zEnXz2jkzb61" title="Cost of revenue">1.3</span> million and $<span id="xdx_907_eus-gaap--CostsAndExpenses_pn5n6_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zg5fs0x0M7l5" title="Cost of revenue">1.6</span> million for the years ended December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_844_eus-gaap--ResearchAndDevelopmentExpensePolicy_zhxvEwoTqrxe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zQCKZyRlwC37">Research and development</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development costs related to developing and testing new products are expensed as incurred and included in SG&amp;A expense. Research and development costs were $<span id="xdx_902_eus-gaap--ResearchAndDevelopmentExpense_pn5n6_c20230101__20231231_zSRbcuyRQb33" title="Research and development expense">0.1</span> million and $<span id="xdx_90A_eus-gaap--ResearchAndDevelopmentExpense_pn5n6_c20220101__20221231_zPenlYWcV6Gf" title="Research and development expense">0.5</span> million for the years ended December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_845_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z1CRw8TDCWAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zWKPdDlXebe9">Share-based compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based compensation awards are measured at their estimated fair value on each respective grant date. The Company recognizes share-based payment expenses over the requisite service period. The Company’s share-based compensation awards are subject only to service based vesting conditions. Pursuant to ASC 718-10-35-8, the Company recognizes compensation cost for stock awards with only service conditions that have a graded vesting schedule on a straight-line basis over the service period for each separately vesting portion of the award as if the award was, in-substance, multiple awards. Forfeitures are recognized as they occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--LesseeLeasesPolicyTextBlock_zkNyza4B7Y58" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z5XWLD8RR5M9">Operating leases</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines if a contract or arrangement meets the definition of a lease at inception. The Company has elected to make the accounting policy election for short-term leases. For leases with terms greater than 12 months, the Company records the related asset and obligation at the present value of lease payments over the term. Lease renewal options are only included in the measurement if the Company is reasonably certain to exercise the optional renewals. Any variable lease costs, other than those dependent upon an index or rate, are expensed as incurred. If a lease does not provide a readily available implicit rate, the Company estimates the incremental borrowing discount rate based on information available at lease commencement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s only remaining operating lease as of December 31, 2023 relates to office space. There are no material residual value guarantees or material restrictive covenants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_846_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z4mhaqyMfXn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zhgbcy45g3zh">Fair value of financial instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy uses a framework which requires categorizing assets and liabilities into one of three levels based on the inputs used in valuing the asset or liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 inputs are unadjusted, quoted market prices in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 inputs are observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 inputs include unobservable inputs that are supported by little, infrequent or no market activity and reflect management’s own assumptions about inputs used in pricing the asset or liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 provides the most reliable measure of fair value, while Level 3 generally requires significant management judgment. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s financial instruments recognized on the Consolidated Balance Sheets consist of cash and cash equivalents, restricted cash, accounts receivable, prepaid assets, accounts payable, term loan, line of credit, accrued liabilities and other liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Company’s money market funds is based on quoted market prices using Level 1 inputs. The fair value for the Company’s term loan and line of credit approximates carrying value as the instrument has a variable interest rate that approximates market rates. The inputs related to the Company’s term loan and line of credit are reflected as Level 3 inputs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company values it’s warrant liabilities using Level 3 inputs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value measurements of non-financial assets and non-financial liabilities reflect Level 3 inputs and are primarily used to measure the estimated fair values of goodwill, other intangible assets and long-lived assets impairment analyses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zIFvfR7enXea" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_z8vs600glHJ">Basic and diluted (loss) income per share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted (loss) income per share has been determined by dividing the net (loss) income available to common stockholders for the applicable period by the basic and diluted weighted average number of shares outstanding, respectively. Common stock equivalents are excluded from the computation of diluted weighted average shares outstanding when their effect is anti-dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--SegmentReportingPolicyPolicyTextBlock_znvTRtKYuFb4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zPDgdIJ8G0ii">Segment information</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating segments are defined as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision-maker (“CODM”) in making decisions regarding resource allocation and assessing performance. The Company has viewed its operations and manages its business as <span id="xdx_90D_eus-gaap--NumberOfOperatingSegments_pid_dc_uSegment_c20230101__20231231_zGVn1eMFWKdg" title="Number of operating segments">one</span> segment. The Company’s CODM reviews operating results on an aggregated basis. All the assets and operations of the Company are in the U.S.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zA8Tep0hT0ze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zy5znIf1cU09">New Accounting Standards</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recently adopted</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ASU 2016-13 “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB issued ASU 2016-13, a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The standard was effective for the Company on January 1, 2023. The new standard did not have a material impact on the consolidated financial statements for the year ended December 31, 2023.</span></p> <p id="xdx_857_z3KdW2qS69M6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--InitialPublicOfferingPolicyTextBlock_zqYgOGclMnZb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zPxDAsgvUbn8">Initial public offering</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company completed its initial public offering (the “IPO”) on July 1, 2021, in which it issued and sold <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20210701__20210701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zvYkMYocOCl3" title="Sale of stock, number of shares issued in transaction">181,818</span> shares of its common stock at a price of $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20210701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zrHzE5qSkyr" title="Sale of stock, price per share">5.00</span> per share. The total net proceeds from the IPO were approximately $<span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn5n6_c20210701__20210701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zFshiFFfHIyd" title="Sale of stock, consideration received on transaction">36.1</span> million, after deducting underwriting discounts and commissions of $<span id="xdx_90D_ecustom--PaymentsOfUnderwritingDiscountsAndCommissions_pn5n6_c20210701__20210701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zx5aZKL3yX2e" title="Payments of underwriting discounts and commissions">2.8</span> million, and offering costs of approximately $<span id="xdx_903_eus-gaap--PaymentsOfStockIssuanceCosts_pn5n6_c20210701__20210701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zAbHuulM0uU4" title="Payments of stock issuance costs">1.1</span> million. These IPO costs were recorded as a reduction of stockholders’ equity, and presented net of cash proceeds received in the Consolidated Statement of Cash Flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon the commencement of the IPO, all of the Company’s outstanding convertible notes payable automatically converted into <span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20210701__20210701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zbt2leHBb7R9" title="Conversion of convertible securities">107,555</span> shares of common stock and upon the consummation of the IPO, all outstanding shares of the Series F convertible preferred stock were converted into <span id="xdx_90B_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_pid_c20210701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zP9cjG4GYOI1" title="Convertible preferred stock, shares issued upon conversion">131,012</span> shares of common stock. Additionally, since the anti-dilution provision of the Series F Warrants were no longer effective upon consummation of the Company’s IPO, these warrants met the requirements to be considered equity and the outstanding Series F Warrants were reclassified as such.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 181818 5.00 36100000 2800000 1100000 107555 131012 <p id="xdx_844_ecustom--ReverseStockSplitPolicyTextBlock_zhDLf4xmNDQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_z4iVItTZztI6">Reverse stock split</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 8, 2024, the Company’s Board of Directors approved a reverse stock split of the Company’s issued and outstanding shares of common stock at a ratio of <span id="xdx_900_eus-gaap--StockholdersEquityReverseStockSplit_c20240308__20240308__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zvmIkzHWuWUf">1-for-44</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, effective March 20, 2024 (the “Reverse Split”). In addition, the conversion rates of the Company’s outstanding preferred stock and convertible notes and the exercise prices of the Company’s underlying common stock purchase warrants and stock options were proportionately adjusted at the applicable reverse stock split ratio in accordance with the terms of such instruments. Proportionate voting rights and other rights of common stockholders were not affected by the Reverse Stock Split, other than as a result of the rounding up of fractional shares. No </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fractional shares of common stock were issued in connection with the Reverse Stock Split.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly, all share and per share amounts related to the Company’s common stock for all periods presented in the accompanying consolidated financial statements and notes thereto have been retroactively adjusted, where applicable, to reflect the Reverse Stock Split. The number of authorized shares and the par values of the common stock and convertible preferred stock were not adjusted as a result of the Reverse Stock Split.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1-for-44 <p id="xdx_844_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zK5hrSMBv7zf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zhchvhojYIK4">Basis of presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s consolidated financial statements are prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for annual financial reports and accounting principles generally accepted in the U.S. (“GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_841_eus-gaap--ConsolidationPolicyTextBlock_zL4TFK7hqgEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zBqWdYxNZbjl">Consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements are presented on a consolidated basis and include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--UseOfEstimates_zBmh4gJPNBWh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zyob7kzQLmFa">Use of estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On an ongoing basis, the Company evaluates these assumptions, judgments and estimates. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the opinion of management, the consolidated financial statements contain all adjustments necessary for a fair statement of the results of operations for the years ended December 31, 2023 and 2022, the financial position as of December 31, 2023 and 2022 and the cash flows for the years ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_849_ecustom--GoingConcernConsiderationsPolicyTextBlock_zZKJcjobvuTb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zxClJVDaoFVk">Going concern considerations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is subject to risks common in the pet wellness consumer market including, but not limited to, dependence on key personnel, competitive forces, successful marketing and sale of its products, the successful protection of its proprietary technologies, ability to grow into new markets, and compliance with government regulations. The Company has continually incurred losses and has an accumulated deficit. The Company’s term loan agreement with Alphia imposes certain financial covenants, including minimum liquidity of $<span id="xdx_90E_ecustom--MinimumLiquidityRequired_iI_pn5n6_c20231231_zDc4UUkaaKli" title="Minimum liquidity required">3.0</span> million, minimum EBITDA of $<span id="xdx_900_eus-gaap--NetIncomeLoss_pn5n6_c20230101__20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputEbitdaMultipleMember_zQfaDKorR4jf" title="Net income">(4.5)</span> million, and maximum marketing spend ratio of <span id="xdx_902_ecustom--MaximumMarketingSpendRatio_pid_dp_uPure_c20230101__20231231_z5mn2PSyRo9l" title="Maximum marketing spend ratio">30%</span>. The Company was not in compliance with certain covenants related to the Alphia Term Loan Facility as of December 31, 2023 and the debt is callable by the lender. Our continued operating losses along with our failure to meet the financial covenants create substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the date these consolidated financial statements are issued. The Company does not currently expect it will be able to generate sufficient cash flow from operations to maintain sufficient liquidity to meet the required financial covenants in certain periods prior to maturity giving the lender the right to call the debt. The Company will need to either raise additional capital or obtain additional financing, and/or secure future waivers or amendments from its lenders or accomplish some combination of these items to maintain sufficient liquidity. There can be no assurance that the Company will be successful in raising additional capital, securing future waivers and/or amendments from its lenders, renewing or refinancing its existing debt or securing new financing. If the Company is unsuccessful in doing so, it may need to reduce the scope of its operations, repay amounts owed to its lenders or sell certain assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the third quarter, the Company received a notice of noncompliance from the NYSE American. If the Company fails to satisfy the continued listing requirements before the end of the cure period, the NYSE American may take steps to delist its common stock. Such a delisting or the announcement of such delisting will have a negative effect on the price of the Company’s common stock and would impair the ability for investors to sell or purchase the Company’s common stock. In the event of a delisting, the Company may attempt to take actions to restore its compliance with the NYSE American listing requirements, but can provide no assurance that any such action taken by the Company would allow its common stock to become listed again, stabilize the market price or improve the liquidity of its common stock, prevent its common stock from dropping below the NYSE American minimum listing requirements or prevent future non-compliance with the NYSE American listing requirements. If the Company does not maintain the listing of its common stock on NYSE American, it could make it harder for the Company to raise additional capital in the long-term. If the Company is unable to raise capital when needed in the future, it may have to cease or reduce operations. There can be no assurance that the Company will be able to satisfy the continued listing requirements in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is continuing to implement plans to achieve operating profitability, as well as implementing other strategic objectives to address liquidity. The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and payments of liabilities in the ordinary course of business. Accordingly, the consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount of and classification of liabilities that may result should the Company be unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary of significant accounting policies</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3000000.0 -4500000 0.30 <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z1KkM6MlQPA" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zCEmBwoZ6hTb">Cash and cash equivalents</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents include demand deposits held with banks and highly liquid investments with original maturities of ninety days or less at acquisition date. Cash and cash equivalents are stated at cost, which approximates fair value because of the short-term nature of these instruments. The Company’s cash equivalents are held in government money market funds and at times may exceed federally insured limits. For purposes of reporting cash flows, the Company considers all cash accounts that are not subject to withdrawal restrictions or penalties to be cash and cash equivalents. At December 31, 2022, the Company had $<span id="xdx_909_eus-gaap--Cash_iI_pn5n6_c20221231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember_zRVi0zZZ9w7d" title="Cash">8.0</span> million in money market funds all of which were held in cash. As of December 31, 2023, the Company had closed its money market funds.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 8000000.0 <p id="xdx_845_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zHae5wuF7YQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zen9wJDeBIha">Restricted cash</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company was required to maintain a restricted cash balance of $<span id="xdx_907_eus-gaap--RestrictedCashCurrent_iI_pn5n6_c20221231_zvYwTsg7zM58" title="Restricted cash">6.3</span> million as of December 31, 2022, in connection with the Wintrust Credit Facility. As a result of the full repayment of the Wintrust Credit Facility, there are <span id="xdx_902_eus-gaap--RestrictedCashCurrent_iI_doxL_c20231231_zPXdPVuNH5vl" title="Restricted cash::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0464">no</span></span> restrictions on cash as of December 31, 2023. See “Note 8 - Debt” for additional information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 6300000 <p id="xdx_846_eus-gaap--CreditLossFinancialInstrumentPolicyTextBlock_zUXIh9Ge1Kb2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zuC6oIaIXEa8">Accounts receivable and allowance for credit losses</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable consist of unpaid buyer invoices from the Company’s customers and credit card payments receivable from third-party credit card processing companies. Accounts receivable is stated at the amount billed to customers, net of point of sale and cash discounts. The Company assesses the collectability of all receivables on an ongoing basis by considering its historical credit loss experience, current economic conditions, and other relevant factors. Based on this analysis, an allowance for credit losses is recorded, and the provision is included within SG&amp;A expense. The Company recorded approximately $<span id="xdx_905_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn5n6_c20231231_zAOuGZRB6GF3" title="Allowance for credit losses"><span id="xdx_900_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn5n6_c20221231_zQQn3l8NnCh1" title="Allowance for credit losses">0.1</span></span> million allowance for credit losses for the years ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> 100000 100000 <p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zoQMJa7OEUB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_z5j3TB1fiQk9">Inventories</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories, consisting of finished goods available for sale as well as packaging materials, are valued using the first-in first-out (“FIFO”) method and are recorded at the lower of cost or net realizable value. Cost is determined on a standard cost basis and includes the purchase price, as well as inbound freight costs and packaging costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company regularly reviews inventory quantities on hand. Excess or obsolete reserves are established when inventory is estimated to not be sellable before expiration dates based on forecasted usage, product demand and product life cycle. Additionally, inventory valuation reflects adjustments for anticipated physical inventory losses that have occurred since the last physical inventory.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zXtvH9clDTIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zNot9V7ctZI6">Fixed Assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets are recorded at cost and depreciated using the straight-line method over the estimated useful lives of the assets, and depreciation expense is included within SG&amp;A expense. Expenditures for normal repairs and maintenance are charged to operations as incurred. The cost of fixed assets that are retired or otherwise disposed of and the related accumulated depreciation are removed from the fixed asset accounts in the year of disposal and the resulting gain or loss is included in SG&amp;A expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assesses potential impairments of its fixed assets whenever events or changes in circumstances indicate that the asset’s carrying value may not be recoverable. An impairment charge would be recognized when the carrying amount of the identified asset grouping exceeds its fair value and is not recoverable, which would occur if the carrying amount exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the identified asset grouping.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zK59bkX4gfRe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zNv9fGOyUotb">Goodwill</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill is evaluated for impairment either through a qualitative or quantitative approach at least annually, or more frequently if an event occurs or circumstances change that indicate the carrying value of a reporting unit may not be recoverable. If a quantitative assessment is performed that indicates the carrying amount of a reporting unit exceeds its fair market value, an impairment loss is recognized to reduce the carrying amount to its fair market value. The fair market value is determined based on a weighting of the present value of projected future cash flows (the “income approach”) and the use of comparative market approaches (“market approach”). Factors requiring significant judgment include, among others, the assumptions related to discount rates, forecasted operating results, long-term growth rates, the determination of comparable companies and market multiples. Fair value measurements used in the impairment review of goodwill are Level 3 measurements. See further information about the Company’s policy for fair value measurements within this section below. See “Note 6 - Goodwill and intangible assets” for additional information regarding the goodwill impairment test.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zr0O2EkPZyUd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zWV1Q86wWTY4">Intangible assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finite-lived Intangible assets acquired are carried at cost, less accumulated amortization. Amortization expense is included in selling, general and administrative expenses on the consolidated statements of operations. The Company assesses long lived assets, including finite-lived intangible assets, for impairment whenever events or changes in circumstances indicate the carrying amount of the asset group may not be recoverable. The Company operates as a single reporting unit and as such, is the asset group when assessing finite-lived intangible assets for impairment. If impairment indicators are present, the Company performs a recoverability test by comparing the sum of the estimated undiscounted future cash flows attributable to its long-lived asset group to its carrying value. If the carrying amount of an asset group is not recoverable, an impairment loss is recognized based on the excess of the carrying value of the impaired asset group over its fair value. An impairment loss for an asset group is allocated to the long-lived assets of the group on a pro rata basis using the relative carrying amounts of those assets, except that the loss allocated to an individual long-lived asset of the group shall not reduce the carrying amount of that asset below its fair value whenever that fair value is determinable without undue cost and effort.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_ecustom--SharesRepurchasesPolicyTextBlock_ziseKANBV7C7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Share repurchases</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 10, 2022, the Company’s board of directors approved a share repurchase program that authorized the repurchase of up to $<span id="xdx_904_eus-gaap--StockRepurchaseProgramAuthorizedAmount1_iI_pn5n6_c20220510_zJ1WWRCDC5e8" title="Stock repurchase program, authorized amount">3.0</span> million of the Company’s outstanding common stock in the open market through December 31, 2022. Repurchased shares are immediately retired and returned to unissued status. During the years ended December 31, 2023 and 2022, <span id="xdx_907_eus-gaap--StockRepurchasedDuringPeriodShares_pid_do_c20230101__20231231_zDiqo4066bj9" title="Stock repurchased, shares"><span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodShares_pid_do_c20220101__20221231_zmrVaTVNbYpf" title="Stock repurchased, shares">no</span></span> shares were repurchased.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3000000.0 0 0 <p id="xdx_842_ecustom--ClassOfWarrantOrRightPolicyTextBlock_zRhTvkn9Llb7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zPoZiQsSfeB1">Common stock warrants</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock warrants are recorded as either liabilities or as equity instruments, depending on the specific terms of the warrant agreement. Warrants classified as liabilities are revalued at each balance sheet date subsequent to the initial issuance and changes in the fair value are reflected in the Consolidated Statements of Operations as change in fair value of warrant liabilities. Upon exercise, the warrant is marked to fair value on the exercise date and the related fair value is reclassified to equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zvz1pDfCgAwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_z3f0q2Dwhtoj">Income taxes</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes are recorded in accordance with FASB ASC Topic 740, “Income Taxes (ASC 740)”, which provides for deferred taxes using an asset and liability approach. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the consolidated financial statements and tax bases of assets and liabilities and for loss and credit carryforwards using enacted tax rates anticipated to be in effect for the year in which the differences are expected to reverse. Valuation allowances are provided, if, based upon the weight of available evidence, it is more likely than not that some or all the deferred tax assets will not be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for uncertain tax positions in accordance with the provisions of ASC 740. When uncertain tax positions exist, the Company recognizes the tax benefit of tax positions to the extent that some or all the benefit will more likely than not be realized. The determination as to whether the tax benefit will more likely than not be realized is based upon the technical merits of the tax position, as well as consideration of the available facts and circumstances. As of December 31, 2023 and 2022, the Company does not have any significant uncertain income tax positions. If incurred, the Company would classify interest and penalties on uncertain tax positions as income tax expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company was incorporated on May 6, 2019. Prior to this date, the Company operated as a flow through entity for state and U.S. federal tax purposes. The Company files a U.S. federal and state income tax return, including for its wholly owned subsidiaries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z3wz7q3rBgdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zdmCMXFsqhnf">Revenue</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, the Company’s customer contracts have a single performance obligation, and revenue is recognized when the product is shipped as this is when it has been determined that control has been transferred. Amounts billed and due from customers are classified as receivables and require payment on a short-term basis and therefore do not have any significant financing components.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue is measured as the amount of consideration the Company expects in exchange for transferring goods, which varies with changes in trade incentives the Company offers to its customers. Trade incentives consist primarily of customer pricing allowances and merchandising funds, and point of sale discounts. Estimates of trade promotion expense and coupon redemption costs are based upon programs offered, timing of those offers, estimated redemption/usage rates from historical performance, management’s experience and current economic trends.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--CostOfSalesPolicyTextBlock_zmjnUpyCuwO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zj9qrObFsmBg">Cost of goods sold</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of goods sold consists primarily of the cost of product obtained from co-manufacturers, packaging materials, freight costs for shipping inventory to the warehouse, as well as third-party warehouse and order fulfillment costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--AdvertisingCostsPolicyTextBlock_zbTPh5fWWEDd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zqoQGkXJo6o9">Advertising</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company charges advertising costs to expense as incurred and such charges are included in SG&amp;A expense. The Company’s advertising expenses consist primarily of online advertising, search costs, email advertising and radio advertising. In addition, the Company reimburses its customers and third parties for in store activities and record these costs as advertising expenses. Advertising costs were $<span id="xdx_909_eus-gaap--AdvertisingExpense_pn5n6_c20230101__20231231_zr5eswNgya09" title="Advertising expense">6.8</span> million and $<span id="xdx_90A_eus-gaap--AdvertisingExpense_pn5n6_c20220101__20221231_zxViznwMI94k" title="Advertising expense">12.2</span> million for the years ended December 31, 2023 and 2022, respectively, of which $<span id="xdx_902_eus-gaap--OtherAmortizationOfDeferredCharges_pn5n6_c20220101__20221231_zNfWtQ3ze5a6" title="Amortization of other deferred charges">2.1</span> million is related to the amortization of the prepaid advertising contract with iHeart for the year ended December 31, 2022. See “Note 4 - Prepaid expenses and other current assets” for additional information on the prepaid advertising contract with iHeart.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 6800000 12200000 2100000 <p id="xdx_840_ecustom--FreightOutPolicyTextBlock_za9xYelQ2LL7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zLMapLwmTYzc">Freight Out</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs incurred for shipping and handling, including moving finished product to customers are included in SG&amp;A expense. Shipping costs associated with moving finished products to customers were $<span id="xdx_906_eus-gaap--CostsAndExpenses_pn5n6_c20230101__20231231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zEnXz2jkzb61" title="Cost of revenue">1.3</span> million and $<span id="xdx_907_eus-gaap--CostsAndExpenses_pn5n6_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zg5fs0x0M7l5" title="Cost of revenue">1.6</span> million for the years ended December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> 1300000 1600000 <p id="xdx_844_eus-gaap--ResearchAndDevelopmentExpensePolicy_zhxvEwoTqrxe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zQCKZyRlwC37">Research and development</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development costs related to developing and testing new products are expensed as incurred and included in SG&amp;A expense. Research and development costs were $<span id="xdx_902_eus-gaap--ResearchAndDevelopmentExpense_pn5n6_c20230101__20231231_zSRbcuyRQb33" title="Research and development expense">0.1</span> million and $<span id="xdx_90A_eus-gaap--ResearchAndDevelopmentExpense_pn5n6_c20220101__20221231_zPenlYWcV6Gf" title="Research and development expense">0.5</span> million for the years ended December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> 100000 500000 <p id="xdx_845_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z1CRw8TDCWAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zWKPdDlXebe9">Share-based compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based compensation awards are measured at their estimated fair value on each respective grant date. The Company recognizes share-based payment expenses over the requisite service period. The Company’s share-based compensation awards are subject only to service based vesting conditions. Pursuant to ASC 718-10-35-8, the Company recognizes compensation cost for stock awards with only service conditions that have a graded vesting schedule on a straight-line basis over the service period for each separately vesting portion of the award as if the award was, in-substance, multiple awards. Forfeitures are recognized as they occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--LesseeLeasesPolicyTextBlock_zkNyza4B7Y58" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z5XWLD8RR5M9">Operating leases</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines if a contract or arrangement meets the definition of a lease at inception. The Company has elected to make the accounting policy election for short-term leases. For leases with terms greater than 12 months, the Company records the related asset and obligation at the present value of lease payments over the term. Lease renewal options are only included in the measurement if the Company is reasonably certain to exercise the optional renewals. Any variable lease costs, other than those dependent upon an index or rate, are expensed as incurred. If a lease does not provide a readily available implicit rate, the Company estimates the incremental borrowing discount rate based on information available at lease commencement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s only remaining operating lease as of December 31, 2023 relates to office space. There are no material residual value guarantees or material restrictive covenants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_846_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z4mhaqyMfXn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zhgbcy45g3zh">Fair value of financial instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy uses a framework which requires categorizing assets and liabilities into one of three levels based on the inputs used in valuing the asset or liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 inputs are unadjusted, quoted market prices in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 inputs are observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 inputs include unobservable inputs that are supported by little, infrequent or no market activity and reflect management’s own assumptions about inputs used in pricing the asset or liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 provides the most reliable measure of fair value, while Level 3 generally requires significant management judgment. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s financial instruments recognized on the Consolidated Balance Sheets consist of cash and cash equivalents, restricted cash, accounts receivable, prepaid assets, accounts payable, term loan, line of credit, accrued liabilities and other liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Company’s money market funds is based on quoted market prices using Level 1 inputs. The fair value for the Company’s term loan and line of credit approximates carrying value as the instrument has a variable interest rate that approximates market rates. The inputs related to the Company’s term loan and line of credit are reflected as Level 3 inputs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company values it’s warrant liabilities using Level 3 inputs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value measurements of non-financial assets and non-financial liabilities reflect Level 3 inputs and are primarily used to measure the estimated fair values of goodwill, other intangible assets and long-lived assets impairment analyses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zIFvfR7enXea" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_z8vs600glHJ">Basic and diluted (loss) income per share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted (loss) income per share has been determined by dividing the net (loss) income available to common stockholders for the applicable period by the basic and diluted weighted average number of shares outstanding, respectively. Common stock equivalents are excluded from the computation of diluted weighted average shares outstanding when their effect is anti-dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--SegmentReportingPolicyPolicyTextBlock_znvTRtKYuFb4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zPDgdIJ8G0ii">Segment information</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating segments are defined as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision-maker (“CODM”) in making decisions regarding resource allocation and assessing performance. The Company has viewed its operations and manages its business as <span id="xdx_90D_eus-gaap--NumberOfOperatingSegments_pid_dc_uSegment_c20230101__20231231_zGVn1eMFWKdg" title="Number of operating segments">one</span> segment. The Company’s CODM reviews operating results on an aggregated basis. All the assets and operations of the Company are in the U.S.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 <p id="xdx_84D_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zA8Tep0hT0ze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zy5znIf1cU09">New Accounting Standards</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recently adopted</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ASU 2016-13 “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB issued ASU 2016-13, a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The standard was effective for the Company on January 1, 2023. The new standard did not have a material impact on the consolidated financial statements for the year ended December 31, 2023.</span></p> <p id="xdx_807_eus-gaap--RevenueFromContractWithCustomerTextBlock_zvsJUXLOYN36" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 – <span id="xdx_82E_zRimeZrJNLk1">Revenue</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records revenue net of discounts, which primarily consist of trade promotions, certain customer allowances and early pay discounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company excludes sales taxes collected from revenues. Retail-partner based customers are not subject to sales tax.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s direct-to-consumer (“DTC”) loyalty program enables customers to accumulate points based on their spending. A portion of revenue is deferred at the time of sale when points are earned and recognized when the loyalty points are redeemed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue channels</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company groups its revenue channels into <span id="xdx_90F_ecustom--NumberOfRevenueChannels_dc_uInteger_c20230101__20231231_z9hKq7iQ8Yre" title="Number of revenue channels">four</span> categories: E-commerce, which includes the sale of product to online retailers such as Amazon and Chewy; Brick &amp; Mortar, which primarily includes the sale of product to Pet Specialty retailers such as Petco, Pet Supplies Plus and neighborhood pet stores, as well as to select grocery chains; DTC, which includes the sale of product through the Company’s website; and International, which includes the sale of product to foreign distribution partners and to select international retailers (transacted in U.S. dollars).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--DisaggregationOfRevenueTableTextBlock_zNvQUYcikID4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information about the Company’s net sales by revenue channel is as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zM9S2gCTdykg" style="display: none">Schedule of Information about Revenue Channels</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Twelve Months Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-commerce <sup>(1)</sup></span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20231231__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_fKDEp_z3CIxaLuffLe" style="width: 12%; text-align: right" title="Net sales">13,405</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_fKDEp_ze6Nvq4F1Gbi" style="width: 12%; text-align: right" title="Concentration risk, percentage">35</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20221231__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_fKDEp_zceOA3bFpaqf" style="width: 12%; text-align: right" title="Net sales">14,565</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_fKDEp_z0Xxhud5iqR9" style="width: 12%; text-align: right" title="Concentration risk, percentage">27</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Brick &amp; Mortar</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20231231__us-gaap--ContractWithCustomerSalesChannelAxis__custom--BrickAndMortarMember_zio5hivAWbY7" style="text-align: right" title="Net sales">5,870</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--BrickAndMortarMember_zub2ItuObsmd" style="text-align: right" title="Concentration risk, percentage">15</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20221231__us-gaap--ContractWithCustomerSalesChannelAxis__custom--BrickAndMortarMember_z8shcop350M5" style="text-align: right" title="Net sales">11,624</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--BrickAndMortarMember_zV5y56wInZph" style="text-align: right" title="Concentration risk, percentage">21</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>DTC</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20231231__us-gaap--ContractWithCustomerSalesChannelAxis__custom--DirectToConsumerMember_zLaZfVMPPUih" style="text-align: right" title="Net sales">5,597</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--DirectToConsumerMember_zSlAhkefItg5" style="text-align: right" title="Concentration risk, percentage">15</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20221231__us-gaap--ContractWithCustomerSalesChannelAxis__custom--DirectToConsumerMember_zb4CoYHZWHT3" style="text-align: right" title="Net sales">6,620</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--DirectToConsumerMember_zKNOkL7Br4S1" style="text-align: right" title="Concentration risk, percentage">12</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">International <sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20231231__us-gaap--ContractWithCustomerSalesChannelAxis__custom--InternationalMember_fKDIp_zycyIy48BXY7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net sales">13,720</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--InternationalMember_fKDIp_zq5LB05v4A25" style="border-bottom: Black 1.5pt solid; text-align: right" title="Concentration risk, percentage">35</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20221231__us-gaap--ContractWithCustomerSalesChannelAxis__custom--InternationalMember_fKDIp_zt6buk27jIna" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net sales">21,851</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--InternationalMember_fKDIp_zYjXE1FKxiBj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Concentration risk, percentage">40</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net Sales</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20231231_zssB4YvB0NX2" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales">38,592</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember_zrX2ANwJsrX4" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20221231_zmnvIX0Mlmth" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales">54,660</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember_zX7dqTuKya3" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F07_ze00r9zRpzFi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F16_zTJyDq6y8xhb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s E-commerce channel includes two customers that amounted to greater than <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_zZxS3WGcOuV4" title="Concentration risk, percentage"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_zjOXMhtUVvE2" title="Concentration risk, percentage">10</span></span>% of the Company’s total net sales. These customers had $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_zT18GJYd3if2" title="Net sales">5.9</span> million and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_zKcKCMv7XuM6" title="Net sales">7.1</span> million of net sales for the year ended December 31, 2023, respectively and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_zDcAfJuDid2i" title="Net sales">7.5</span> million and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_zdOrqVvC8Leh" title="Net sales">6.6</span> million of net sales for the year ended December 31, 2022, respectively.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F03_zJUW6Lf7B3Mg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_zCmEX3gNbDGe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One of the Company’s International customers that distributes products in China amounted to greater than <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--InternationalMember_zgOof11uFlNd" title="Concentration risk, percentage"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--InternationalMember_z3sAYnn0OWg" title="Concentration risk, percentage">10</span></span>% of the Company’s total net sales during the years ended December 31, 2023 and December 31, 2022 and represented $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--InternationalMember_zuNaZ0odwQ4a" title="Net sales">11.0</span> million and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--InternationalMember_zh5VvtPWuy43" title="Net sales">17.7</span> million of net sales, respectively.</span></td></tr> </table> <p id="xdx_8AE_zyJ85GjkcYF8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 4 <p id="xdx_892_eus-gaap--DisaggregationOfRevenueTableTextBlock_zNvQUYcikID4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information about the Company’s net sales by revenue channel is as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zM9S2gCTdykg" style="display: none">Schedule of Information about Revenue Channels</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Twelve Months Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-commerce <sup>(1)</sup></span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20231231__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_fKDEp_z3CIxaLuffLe" style="width: 12%; text-align: right" title="Net sales">13,405</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_fKDEp_ze6Nvq4F1Gbi" style="width: 12%; text-align: right" title="Concentration risk, percentage">35</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20221231__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_fKDEp_zceOA3bFpaqf" style="width: 12%; text-align: right" title="Net sales">14,565</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_fKDEp_z0Xxhud5iqR9" style="width: 12%; text-align: right" title="Concentration risk, percentage">27</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Brick &amp; Mortar</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20231231__us-gaap--ContractWithCustomerSalesChannelAxis__custom--BrickAndMortarMember_zio5hivAWbY7" style="text-align: right" title="Net sales">5,870</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--BrickAndMortarMember_zub2ItuObsmd" style="text-align: right" title="Concentration risk, percentage">15</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20221231__us-gaap--ContractWithCustomerSalesChannelAxis__custom--BrickAndMortarMember_z8shcop350M5" style="text-align: right" title="Net sales">11,624</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--BrickAndMortarMember_zV5y56wInZph" style="text-align: right" title="Concentration risk, percentage">21</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>DTC</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20231231__us-gaap--ContractWithCustomerSalesChannelAxis__custom--DirectToConsumerMember_zLaZfVMPPUih" style="text-align: right" title="Net sales">5,597</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--DirectToConsumerMember_zSlAhkefItg5" style="text-align: right" title="Concentration risk, percentage">15</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20221231__us-gaap--ContractWithCustomerSalesChannelAxis__custom--DirectToConsumerMember_zb4CoYHZWHT3" style="text-align: right" title="Net sales">6,620</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--DirectToConsumerMember_zKNOkL7Br4S1" style="text-align: right" title="Concentration risk, percentage">12</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">International <sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20231231__us-gaap--ContractWithCustomerSalesChannelAxis__custom--InternationalMember_fKDIp_zycyIy48BXY7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net sales">13,720</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--InternationalMember_fKDIp_zq5LB05v4A25" style="border-bottom: Black 1.5pt solid; text-align: right" title="Concentration risk, percentage">35</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20221231__us-gaap--ContractWithCustomerSalesChannelAxis__custom--InternationalMember_fKDIp_zt6buk27jIna" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net sales">21,851</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--InternationalMember_fKDIp_zYjXE1FKxiBj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Concentration risk, percentage">40</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net Sales</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20231231_zssB4YvB0NX2" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales">38,592</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember_zrX2ANwJsrX4" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20221231_zmnvIX0Mlmth" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales">54,660</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__custom--SalesChannelConcentrationRiskMember_zX7dqTuKya3" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F07_ze00r9zRpzFi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F16_zTJyDq6y8xhb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s E-commerce channel includes two customers that amounted to greater than <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_zZxS3WGcOuV4" title="Concentration risk, percentage"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_zjOXMhtUVvE2" title="Concentration risk, percentage">10</span></span>% of the Company’s total net sales. These customers had $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_zT18GJYd3if2" title="Net sales">5.9</span> million and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_zKcKCMv7XuM6" title="Net sales">7.1</span> million of net sales for the year ended December 31, 2023, respectively and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_zDcAfJuDid2i" title="Net sales">7.5</span> million and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--ECommerceMember_zdOrqVvC8Leh" title="Net sales">6.6</span> million of net sales for the year ended December 31, 2022, respectively.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F03_zJUW6Lf7B3Mg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_zCmEX3gNbDGe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One of the Company’s International customers that distributes products in China amounted to greater than <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--InternationalMember_zgOof11uFlNd" title="Concentration risk, percentage"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--InternationalMember_z3sAYnn0OWg" title="Concentration risk, percentage">10</span></span>% of the Company’s total net sales during the years ended December 31, 2023 and December 31, 2022 and represented $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--InternationalMember_zuNaZ0odwQ4a" title="Net sales">11.0</span> million and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluZm9ybWF0aW9uIGFib3V0IFJldmVudWUgQ2hhbm5lbHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ContractWithCustomerSalesChannelAxis__custom--InternationalMember_zh5VvtPWuy43" title="Net sales">17.7</span> million of net sales, respectively.</span></td></tr> </table> 13405000 0.35 14565000 0.27 5870000 0.15 11624000 0.21 5597000 0.15 6620000 0.12 13720000 0.35 21851000 0.40 38592000 1 54660000 1 0.10 0.10 5900000 7100000 7500000 6600000 0.10 0.10 11000000.0 17700000 <p id="xdx_80A_eus-gaap--InventoryDisclosureTextBlock_zYRhZxA5U7hk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 3 - <span id="xdx_82A_z53JSiDxFcw5">Inventories</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_895_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zVyAspbLCyAf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories are summarized as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_znWwqS8wz9t6" style="display: none">Schedule of Inventories</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20231231_zGbokuIsJ3uj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20221231_z5KPaBl2Qzv1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iI_pn3n3_maIGzuHY_zQIfPqqCWcF2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Food, treats and supplements</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,296</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">10,212</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OtherInventorySupplies_iI_pn3n3_maIGzuHY_zbAeVc8mzdOh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Inventory packaging and supplies</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,166</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,699</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryGross_iTI_pn3n3_mtIGzuHY_maINzNG5_zXcOlY5WPPA2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total Inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,462</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,911</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryAdjustments_iNI_pn3n3_di_msINzNG5_z83PuftbDwzk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Inventory reserve</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(851</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,654</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--InventoryNet_iTI_pn3n3_mtINzNG5_zWexJXSOH3Zc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Inventories, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,611</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,257</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zXghiMzXIwyc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zVyAspbLCyAf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories are summarized as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_znWwqS8wz9t6" style="display: none">Schedule of Inventories</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20231231_zGbokuIsJ3uj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20221231_z5KPaBl2Qzv1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iI_pn3n3_maIGzuHY_zQIfPqqCWcF2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Food, treats and supplements</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,296</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">10,212</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OtherInventorySupplies_iI_pn3n3_maIGzuHY_zbAeVc8mzdOh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Inventory packaging and supplies</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,166</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,699</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryGross_iTI_pn3n3_mtIGzuHY_maINzNG5_zXcOlY5WPPA2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total Inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,462</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,911</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryAdjustments_iNI_pn3n3_di_msINzNG5_z83PuftbDwzk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Inventory reserve</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(851</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,654</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--InventoryNet_iTI_pn3n3_mtINzNG5_zWexJXSOH3Zc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Inventories, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,611</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,257</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 6296000 10212000 1166000 1699000 7462000 11911000 851000 1654000 6611000 10257000 <p id="xdx_80F_ecustom--PrepaidExpensesAndOtherCurrentAssetsTextBlock_zjcCU8OgRfJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 4 – <span id="xdx_827_z3HMMEYtSZu2">Prepaid expenses and other current assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_891_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_z33fzvud9m66" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses and other current assets are summarized as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_z3f6hpqECa13" style="display: none">Schedule of Prepaid Expenses and Other Current Assets</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20231231_zMy7r4G0fvvh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20221231_zBxn7qZK4W8i" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--PrepaidAdvertising_iI_pn3n3_maPEAOAzjiW_zUYqU87LFc1a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid advertising contract with iHeart <sup id="xdx_F40_zVoh9QsdnQn1">(1)</sup></span></td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0621">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0622">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--PrepaidMarketingExpenseCurrent_iI_pn3n3_maPEAOAzjiW_zBvKNHBVA4s3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">451</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0625">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OtherPrepaidExpenseCurrent_iI_pn3n3_maPEAOAzjiW_ziWiLW8izl05" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt">Other prepaid expenses and other current assets</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">361</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">1,051</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pn3n3_mtPEAOAzjiW_zD9oB0BbQYob" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total Prepaid expenses and other current assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">812</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,051</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_zSobJScuZCf6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F17_z1tkgcVKWTh5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 28, 2019, the Company entered into a radio advertising agreement with iHeart Media + Entertainment, Inc. (“iHeart”) and issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFByZXBhaWQgRXhwZW5zZXMgYW5kIE90aGVyIEN1cnJlbnQgQXNzZXRzIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20190828__20190828__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--CounterpartyNameAxis__custom--IHeartMediaMember_zdtoKa9XN9xb" title="Shares issued to third-parties for services">166,667</span> shares of common stock valued at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFByZXBhaWQgRXhwZW5zZXMgYW5kIE90aGVyIEN1cnJlbnQgQXNzZXRzIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn5n6_c20190828__20190828__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--CounterpartyNameAxis__custom--IHeartMediaMember_zPjTXZU25jX8" title="Stock issued during period, value, issued for services">3.4</span> million for future advertising services. The Company issued an additional <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFByZXBhaWQgRXhwZW5zZXMgYW5kIE90aGVyIEN1cnJlbnQgQXNzZXRzIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20200305__20200305__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--CounterpartyNameAxis__custom--IHeartMediaMember_z37xk3ZOBI3g" title="Shares issued to third-parties for services">20,834</span> shares valued at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFByZXBhaWQgRXhwZW5zZXMgYW5kIE90aGVyIEN1cnJlbnQgQXNzZXRzIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn5n6_c20200305__20200305__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--CounterpartyNameAxis__custom--IHeartMediaMember_zJw8mvD4Hpn1" title="Stock issued during period, value, issued for services">0.1</span> million on March 5, 2020 pursuant to the agreement. The current portion of the remaining value, reflected above, is the remaining value of services that the Company expects to utilize within the twelve months following the reporting period date, unless the term is extended. The Company utilized the remaining advertising services during the year ended December 31, 2022.</span></td></tr> </table> <p id="xdx_8A9_zxAHNwnc9gci" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_z33fzvud9m66" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses and other current assets are summarized as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_z3f6hpqECa13" style="display: none">Schedule of Prepaid Expenses and Other Current Assets</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20231231_zMy7r4G0fvvh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20221231_zBxn7qZK4W8i" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--PrepaidAdvertising_iI_pn3n3_maPEAOAzjiW_zUYqU87LFc1a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid advertising contract with iHeart <sup id="xdx_F40_zVoh9QsdnQn1">(1)</sup></span></td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0621">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0622">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--PrepaidMarketingExpenseCurrent_iI_pn3n3_maPEAOAzjiW_zBvKNHBVA4s3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">451</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0625">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OtherPrepaidExpenseCurrent_iI_pn3n3_maPEAOAzjiW_ziWiLW8izl05" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt">Other prepaid expenses and other current assets</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">361</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">1,051</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pn3n3_mtPEAOAzjiW_zD9oB0BbQYob" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total Prepaid expenses and other current assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">812</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,051</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_zSobJScuZCf6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F17_z1tkgcVKWTh5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 28, 2019, the Company entered into a radio advertising agreement with iHeart Media + Entertainment, Inc. (“iHeart”) and issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFByZXBhaWQgRXhwZW5zZXMgYW5kIE90aGVyIEN1cnJlbnQgQXNzZXRzIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20190828__20190828__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--CounterpartyNameAxis__custom--IHeartMediaMember_zdtoKa9XN9xb" title="Shares issued to third-parties for services">166,667</span> shares of common stock valued at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFByZXBhaWQgRXhwZW5zZXMgYW5kIE90aGVyIEN1cnJlbnQgQXNzZXRzIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn5n6_c20190828__20190828__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--CounterpartyNameAxis__custom--IHeartMediaMember_zPjTXZU25jX8" title="Stock issued during period, value, issued for services">3.4</span> million for future advertising services. The Company issued an additional <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFByZXBhaWQgRXhwZW5zZXMgYW5kIE90aGVyIEN1cnJlbnQgQXNzZXRzIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20200305__20200305__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--CounterpartyNameAxis__custom--IHeartMediaMember_z37xk3ZOBI3g" title="Shares issued to third-parties for services">20,834</span> shares valued at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFByZXBhaWQgRXhwZW5zZXMgYW5kIE90aGVyIEN1cnJlbnQgQXNzZXRzIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn5n6_c20200305__20200305__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--CounterpartyNameAxis__custom--IHeartMediaMember_zJw8mvD4Hpn1" title="Stock issued during period, value, issued for services">0.1</span> million on March 5, 2020 pursuant to the agreement. The current portion of the remaining value, reflected above, is the remaining value of services that the Company expects to utilize within the twelve months following the reporting period date, unless the term is extended. The Company utilized the remaining advertising services during the year ended December 31, 2022.</span></td></tr> </table> 451000 361000 1051000 812000 1051000 166667 3400000 20834 100000 <p id="xdx_801_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zMjECrV2d8T1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 5 - <span id="xdx_821_zXq1q4VXtz62">Fixed assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_891_eus-gaap--PropertyPlantAndEquipmentTextBlock_zqU6JADYSlmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets consist of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zVo4Qbi37C52" style="display: none">Schedule of Fixed Assets</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Estimated Useful Life</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20231231_zxjn0hQsq28" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20221231_zl5mJC0clrJ5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zWJuzp1T9pq8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%">Equipment</td><td style="width: 2%"> </td> <td style="width: 12%; text-align: center"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember__srt--RangeAxis__srt--MinimumMember_zNybOsIDnEvi" title="Estimated useful life">2</span> - <span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember__srt--RangeAxis__srt--MaximumMember_zsBNVZQNVXN" title="Estimated useful life">5</span> years</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">18</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">7</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z4xSg7224Jwc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and fixtures</td><td> </td> <td style="text-align: center"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zD8KeLtzjIE4" title="Estimated useful life">2</span> - <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zqVLSTZDSJp1" title="Estimated useful life">5</span> years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">221</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">221</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zVghQpGGZFh5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Computer software, including website development</td><td> </td> <td style="text-align: center"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerSoftwareIntangibleAssetMember__srt--RangeAxis__srt--MinimumMember_zHmiqgeDqKD7" title="Estimated useful life">2</span> - <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerSoftwareIntangibleAssetMember__srt--RangeAxis__srt--MaximumMember_z8hYfYWnoJHi" title="Estimated useful life">3</span> years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zRVEqDSXFTTc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Computer equipment</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zpwKrI8GfxRl" title="Estimated useful life">1</span> - <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_z0sfJC1Fwl8f" title="Estimated useful life">2</span> years</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">108</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">129</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_zwWq8jejlTQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total fixed assets</td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">534</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">544</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_zJyNW70s2He6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(304</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(169</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_zeAcBM07cced" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Fixed assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">230</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">375</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zC9QIYc6CN0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense was $<span id="xdx_903_eus-gaap--Depreciation_pn5n6_c20230101__20231231_zX17IxdqZrJ3" title="Depreciation expense"><span id="xdx_903_eus-gaap--Depreciation_pn5n6_c20220101__20221231_zhllrlL2MYEf" title="Depreciation expense">0.2</span></span> million for the years ended December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--PropertyPlantAndEquipmentTextBlock_zqU6JADYSlmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets consist of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zVo4Qbi37C52" style="display: none">Schedule of Fixed Assets</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Estimated Useful Life</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20231231_zxjn0hQsq28" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20221231_zl5mJC0clrJ5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zWJuzp1T9pq8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%">Equipment</td><td style="width: 2%"> </td> <td style="width: 12%; text-align: center"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember__srt--RangeAxis__srt--MinimumMember_zNybOsIDnEvi" title="Estimated useful life">2</span> - <span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember__srt--RangeAxis__srt--MaximumMember_zsBNVZQNVXN" title="Estimated useful life">5</span> years</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">18</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">7</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z4xSg7224Jwc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and fixtures</td><td> </td> <td style="text-align: center"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zD8KeLtzjIE4" title="Estimated useful life">2</span> - <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zqVLSTZDSJp1" title="Estimated useful life">5</span> years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">221</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">221</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zVghQpGGZFh5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Computer software, including website development</td><td> </td> <td style="text-align: center"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerSoftwareIntangibleAssetMember__srt--RangeAxis__srt--MinimumMember_zHmiqgeDqKD7" title="Estimated useful life">2</span> - <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerSoftwareIntangibleAssetMember__srt--RangeAxis__srt--MaximumMember_z8hYfYWnoJHi" title="Estimated useful life">3</span> years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zRVEqDSXFTTc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Computer equipment</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zpwKrI8GfxRl" title="Estimated useful life">1</span> - <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_z0sfJC1Fwl8f" title="Estimated useful life">2</span> years</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">108</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">129</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_zwWq8jejlTQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total fixed assets</td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">534</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">544</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_zJyNW70s2He6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(304</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(169</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_zeAcBM07cced" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Fixed assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">230</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">375</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> P2Y P5Y 18000 7000 P2Y P5Y 221000 221000 P2Y P3Y 187000 187000 P1Y P2Y 108000 129000 534000 544000 304000 169000 230000 375000 200000 200000 <p id="xdx_806_eus-gaap--GoodwillAndIntangibleAssetsDisclosureTextBlock_zg6mBPLrmSJ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 6 – <span id="xdx_82B_zY2AS1SbZBJb">Goodwill and intangible assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Goodwill</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89B_eus-gaap--ScheduleOfGoodwillTextBlock_zGKhq6MED0bf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The change in the carrying amount of goodwill for the years ended December 31, 2023 and 2022 is summarized as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zGvRWna2B6K7" style="display: none">Schedule of goodwill</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-weight: bold; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Goodwill_iS_pn3n3_c20230101__20231231_zCEJaBYm3ls9" style="width: 16%; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl0691">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Goodwill_iS_pn3n3_c20220101__20221231_zVo7ujmduBh" style="width: 16%; text-align: right" title="Beginning balance">18,614</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Impairment expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_ecustom--GoodwillImpairmentsLoss_iN_pn3n3_di_c20230101__20231231_zgcdAQmiHRwl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairment expense"><span style="-sec-ix-hidden: xdx2ixbrl0695">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--GoodwillImpairmentLoss_iN_pn3n3_di_c20220101__20221231_zEmKjleBazg9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairment expense">(18,614</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iE_pn3n3_c20230101__20231231_zOVRPLUlgK4f" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0699">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Goodwill_iE_pn3n3_c20220101__20221231_z3IS4T2kymD4" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0701">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_ziebszsjdmja" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill is evaluated for impairment if an event occurs or circumstances change that indicate the carrying value of a reporting unit may not be recoverable. During July 2022, the Company completed a legal merger of TruPet and Halo, Purely for Pets, Inc., a wholly owned subsidiary of Better Choice Company Inc. (“Halo”), with Halo as the surviving entity in connection with the execution of rebranding its former TruDog brand under the Halo brand umbrella. In conjunction with the legal merger and rebranding, the Company performed an analysis of its reporting units and concluded it has <span id="xdx_907_eus-gaap--NumberOfReportingUnits_dc_uInteger_c20230101__20231231_zbyGT7EEa7M2" title="Number of reporting units">one</span> reporting unit after the legal merger and rebrand, and as such, the Company performed a quantitative goodwill assessment as of July 1, 2022 in addition to its annual impairment test as of October 1, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the quantitative approach, the Company makes various estimates and assumptions to determine the estimated fair value of the reporting unit using a combination of a discounted cash flow model and a guideline comparable analysis. The fair value measurements used in the impairment review of goodwill are Level 3 measurements which include unobservable inputs that are supported by little, infrequent or no market activity and reflect management’s own assumptions. The key assumptions used in estimating the fair value of its reporting units as of July 1, 2022 and October 1, 2022 utilizing the income approach include the discount rate and revenue growth rates. The discount rate utilized in estimating the fair value of its reporting units as of July 1, 2022 and October 1 2022 was <span id="xdx_904_eus-gaap--ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_iI_pid_dp_uPure_c20220731_zSMcjWmeOE11" title="Discount rate"><span id="xdx_90D_eus-gaap--ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_iI_pid_dp_uPure_c20221001_znPl4tWWvyS5" title="Discount rate">20.0</span></span>%, reflecting the assessment of a market participant’s view of the risks associated with the projected cash flows. Revenue growth rates varied for each year included in the valuation model based on management’s best estimate of forecasted operating results. The assumptions used in estimating the fair values are based on currently available data and management’s best estimates of revenues, EBITDA margins, and cash flows and, accordingly, a change in market conditions or other factors could have a material effect on the estimated values. There are inherent uncertainties related to the assumptions used and to management’s application of these assumptions. As a result of the annual impairment test, the Company recorded an intangible asset impairment charge of $<span id="xdx_902_eus-gaap--GoodwillImpairmentLoss_pn5n6_c20220101__20221231_zmCFQGKD8AIj" title="Impairment of goodwill">18.6</span> million during the year ended December 31, 2022, resulting in full impairment to the goodwill carrying value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The Company’s intangible assets include the trade name and customer relationships. As of December 31, 2023, impairment indicators were present which required a recoverability test to be performed. As a result of the recoverability test, the carrying value of the asset group exceeded its fair value and the Company recorded an impairment charge of $<span id="xdx_901_eus-gaap--AssetImpairmentCharges_pn5n6_c20220101__20221231_zTpuR2Gc9qR7" title="Impairment charge">8.5</span> million for the year ended December 31, 2023, which resulted in a full impairment to the carrying value of the trade name and customer relationships. This non-cash charge was recorded to intangible asset impairment expenses on the consolidated statements of operations. The Company did not record any impairment loss on long-lived assets for the year ended December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The assumptions used in estimating the undiscounted future cash flows are based on currently available data and management’s best estimates of future income statement and working capital elements. A change in market conditions or other factors could have a material effect on the estimated values. Fair value was determined based on discounted cash flows requiring judgement. These factors include, among others, the assumptions related to discount rates, forecasted operating results, long-term growth rates, the determination of comparable companies and market multiples. The measurements used in the impairment review of finite-lived intangible assets are Level 3 measurements. There are inherent uncertainties related to the assumptions used and to management’s application of these assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> </p> <p id="xdx_89A_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zpk5NIwv777d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s intangible assets (in thousands) and related useful lives (in years) are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zvpts3Nn5M5h" style="display: none">Schedule of Intangible Assets</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td> <td style="vertical-align: bottom; text-align: center"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31, 2023</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Estimated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> Useful</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Life (in years)</b></span></p></td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amortization</b></span></p></td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Impairment Loss</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 31%; text-align: left">Customer relationships</td><td style="width: 2%"> </td> <td style="width: 10%; text-align: center">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zumWOL2drG4i" style="width: 10%; text-align: right" title="Gross carrying amount">7,190</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zFRih6XSgLkk" style="width: 10%; text-align: right" title="Accumulated amortization">(4,142</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--GoodwillImpairmentLoss_iN_pn3n3_di_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zfzwrV7Bjn7e" style="width: 10%; text-align: right" title="Impairment Loss">(3,048</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zsvAXH2l3WA7" style="width: 10%; text-align: right" title="Net carrying amount"><span style="-sec-ix-hidden: xdx2ixbrl0721">—</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Trade name</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center">—</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zflpXmap09H6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross carrying amount">7,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_z4W30Kq8eiEh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(2,016</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--GoodwillImpairmentLoss_iN_pn3n3_di_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zhxT6nEvwTV4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairment Loss">(5,484</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zpKQhoZZGCLl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net carrying amount"><span style="-sec-ix-hidden: xdx2ixbrl0729">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: center"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231_z3cMSMrzdRG7" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount">14,690</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231_zlqjVp4gcn4j" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization">(6,158</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--GoodwillImpairmentLoss_iN_pn3n3_di_c20230101__20231231_zyiDuxTgFo66" style="border-bottom: Black 2.5pt double; text-align: right" title="Impairment Loss">(8,532</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231_ziZS0DZ0CNjh" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount"><span style="-sec-ix-hidden: xdx2ixbrl0737">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31, 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Estimated Useful</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Life (in years)</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amortization</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 41%; text-align: left">Customer relationships</td><td style="width: 2%"> </td> <td style="width: 11%; text-align: center"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zkakgDUmHyG5" title="Estimated useful life">7</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zsnCmJGUsABi" style="width: 11%; text-align: right" title="Gross carrying amount">7,190</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zr1rySXXue39" style="width: 11%; text-align: right" title="Accumulated amortization">(3,115</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zIrjHMikBmMb" style="width: 11%; text-align: right" title="Net carrying amount">4,075</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Trade name</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zy9IUNEO7m9" title="Estimated useful life">15</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zMjQM5WCiM8i" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross carrying amount">7,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zMX9OHufqc37" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(1,516</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zuH5Pesqb0d9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net carrying amount">5,984</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: center"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231_zXD01EzI4ega" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount">14,690</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231_zm6tTgpbJl1j" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization">(4,631</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231_zfHpxE6WN3s8" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount">10,059</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_z9CsUtOk6kWc" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization expense was $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pn5n6_c20230101__20231231_z2CinzfeOH69" title="Amortization expense"><span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_pn5n6_c20220101__20221231_zXCsG8AxwKhi" title="Amortization expense">1.5</span></span> million for the years ended December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assesses intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be fully recoverable. If impairment indicators are present, the Company performs a recoverability test by comparing the sum of the estimated undiscounted future cash flows attributable to these long-lived assets to their carrying value. The assumptions used in estimating the undiscounted future cash flows are based on currently available data and management’s best estimates of revenues, EBITDA margins, and working capital and, accordingly, a change in market conditions or other factors could have a material effect on the estimated values. There are inherent uncertainties related to the assumptions used and to management’s application of these assumptions. As a result of the recoverability test performed, the carrying value of the asset group exceeded its fair value, therefore a quantitative impairment test was performed to compare the fair value of the trade name and customer relationships assets with their carrying value. As a result, the Company recorded an impairment charge of $<span id="xdx_900_eus-gaap--AssetImpairmentCharges_pn5n6_c20230101__20231231_zZKXAag9eewb" title="Impairment charge">8.5</span> million during the year ended December 31, 2023, resulting in full impairment to the carrying value of the trade name and customer relationships intangible assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89B_eus-gaap--ScheduleOfGoodwillTextBlock_zGKhq6MED0bf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The change in the carrying amount of goodwill for the years ended December 31, 2023 and 2022 is summarized as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zGvRWna2B6K7" style="display: none">Schedule of goodwill</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-weight: bold; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Goodwill_iS_pn3n3_c20230101__20231231_zCEJaBYm3ls9" style="width: 16%; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl0691">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Goodwill_iS_pn3n3_c20220101__20221231_zVo7ujmduBh" style="width: 16%; text-align: right" title="Beginning balance">18,614</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Impairment expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_ecustom--GoodwillImpairmentsLoss_iN_pn3n3_di_c20230101__20231231_zgcdAQmiHRwl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairment expense"><span style="-sec-ix-hidden: xdx2ixbrl0695">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--GoodwillImpairmentLoss_iN_pn3n3_di_c20220101__20221231_zEmKjleBazg9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairment expense">(18,614</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iE_pn3n3_c20230101__20231231_zOVRPLUlgK4f" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0699">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Goodwill_iE_pn3n3_c20220101__20221231_z3IS4T2kymD4" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0701">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 18614000 18614000 1 0.200 0.200 18600000 8500000 <p id="xdx_89A_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zpk5NIwv777d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s intangible assets (in thousands) and related useful lives (in years) are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zvpts3Nn5M5h" style="display: none">Schedule of Intangible Assets</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td> <td style="vertical-align: bottom; text-align: center"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31, 2023</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Estimated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> Useful</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Life (in years)</b></span></p></td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amortization</b></span></p></td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Impairment Loss</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 31%; text-align: left">Customer relationships</td><td style="width: 2%"> </td> <td style="width: 10%; text-align: center">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zumWOL2drG4i" style="width: 10%; text-align: right" title="Gross carrying amount">7,190</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zFRih6XSgLkk" style="width: 10%; text-align: right" title="Accumulated amortization">(4,142</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--GoodwillImpairmentLoss_iN_pn3n3_di_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zfzwrV7Bjn7e" style="width: 10%; text-align: right" title="Impairment Loss">(3,048</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zsvAXH2l3WA7" style="width: 10%; text-align: right" title="Net carrying amount"><span style="-sec-ix-hidden: xdx2ixbrl0721">—</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Trade name</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center">—</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zflpXmap09H6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross carrying amount">7,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_z4W30Kq8eiEh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(2,016</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--GoodwillImpairmentLoss_iN_pn3n3_di_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zhxT6nEvwTV4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairment Loss">(5,484</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zpKQhoZZGCLl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net carrying amount"><span style="-sec-ix-hidden: xdx2ixbrl0729">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: center"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231_z3cMSMrzdRG7" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount">14,690</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231_zlqjVp4gcn4j" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization">(6,158</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--GoodwillImpairmentLoss_iN_pn3n3_di_c20230101__20231231_zyiDuxTgFo66" style="border-bottom: Black 2.5pt double; text-align: right" title="Impairment Loss">(8,532</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231_ziZS0DZ0CNjh" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount"><span style="-sec-ix-hidden: xdx2ixbrl0737">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31, 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Estimated Useful</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Life (in years)</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amortization</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 41%; text-align: left">Customer relationships</td><td style="width: 2%"> </td> <td style="width: 11%; text-align: center"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zkakgDUmHyG5" title="Estimated useful life">7</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zsnCmJGUsABi" style="width: 11%; text-align: right" title="Gross carrying amount">7,190</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zr1rySXXue39" style="width: 11%; text-align: right" title="Accumulated amortization">(3,115</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zIrjHMikBmMb" style="width: 11%; text-align: right" title="Net carrying amount">4,075</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Trade name</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zy9IUNEO7m9" title="Estimated useful life">15</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zMjQM5WCiM8i" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross carrying amount">7,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zMX9OHufqc37" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(1,516</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zuH5Pesqb0d9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net carrying amount">5,984</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: center"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231_zXD01EzI4ega" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount">14,690</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231_zm6tTgpbJl1j" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization">(4,631</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231_zfHpxE6WN3s8" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount">10,059</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 7190000 -4142000 3048000 7500000 -2016000 5484000 14690000 -6158000 8532000 P7Y 7190000 -3115000 4075000 P15Y 7500000 -1516000 5984000 14690000 -4631000 10059000 1500000 1500000 8500000 <p id="xdx_800_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zLIf0w4DBjBj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7 – <span id="xdx_829_zWoehGQy4TIa">Accrued and other liabilities</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89C_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z217CCFRHBee" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued and other liabilities consist of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zEber3c7hVrj" style="display: none">Schedule of Accrued and Other Liabilities</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20231231_zeA048labiec" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20221231_zZ9lKzDDPxi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--TaxesPayableCurrent_iI_pn3n3_maALCz1hd_zfD1aTp6Z7n8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accrued taxes</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">105</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">110</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pn3n3_maALCz1hd_zidOYtk9LpPf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued payroll and benefits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">487</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">688</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--AccruedMarketingCostsAndAdvertisingCurrent_iI_pn3n3_maALCz1hd_zGIzYDtQM60h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued trade promotions and advertising</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">90</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">567</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InterestPayableCurrent_iI_pn3n3_maALCz1hd_z6udvx2EwgYd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">254</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">84</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AccruedSalesCommissionCurrent_iI_pn3n3_maALCz1hd_zSkKvgXJVlfg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued commissions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">686</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">385</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_maALCz1hd_zSaIm9z9htGi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">336</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ShortTermBorrowings_iI_pn3n3_maALCz1hd_z6sf8FRqJ2N7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Short-term financing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">162</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">165</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maALCz1hd_zj3x9zcGJBlf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">294</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">261</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iTI_pn3n3_mtALCz1hd_z2GuXv0UBE8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total accrued and other liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,085</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,596</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zOiwNQ08IWr5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z217CCFRHBee" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued and other liabilities consist of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zEber3c7hVrj" style="display: none">Schedule of Accrued and Other Liabilities</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20231231_zeA048labiec" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20221231_zZ9lKzDDPxi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--TaxesPayableCurrent_iI_pn3n3_maALCz1hd_zfD1aTp6Z7n8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accrued taxes</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">105</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">110</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pn3n3_maALCz1hd_zidOYtk9LpPf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued payroll and benefits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">487</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">688</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--AccruedMarketingCostsAndAdvertisingCurrent_iI_pn3n3_maALCz1hd_zGIzYDtQM60h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued trade promotions and advertising</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">90</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">567</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InterestPayableCurrent_iI_pn3n3_maALCz1hd_z6udvx2EwgYd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">254</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">84</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AccruedSalesCommissionCurrent_iI_pn3n3_maALCz1hd_zSkKvgXJVlfg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued commissions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">686</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">385</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_maALCz1hd_zSaIm9z9htGi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">336</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ShortTermBorrowings_iI_pn3n3_maALCz1hd_z6sf8FRqJ2N7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Short-term financing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">162</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">165</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maALCz1hd_zj3x9zcGJBlf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">294</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">261</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iTI_pn3n3_mtALCz1hd_z2GuXv0UBE8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total accrued and other liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,085</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,596</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 105000 110000 487000 688000 90000 567000 254000 84000 686000 385000 7000 336000 162000 165000 294000 261000 2085000 2596000 <p id="xdx_801_eus-gaap--DebtDisclosureTextBlock_z4mLAn0OZiH8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 8 – <span id="xdx_827_zUfc334KnFbb">Debt</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_894_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zQsFfCFj2VA5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The components of the Company’s debt consist of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_z2qnP6SaYBDc" style="display: none">Schedule of Components of Debt</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Aptos; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Rate</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Maturity<br/> date</b></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Rate</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Maturity<br/> date</b></p></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 26%; text-align: left">Term loan, net</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--CreditFacilityAxis__custom--TermLoanMember_fKDIp_zPzN0zM4ODI" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Term loan, net">2,881</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: center">(2)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--CreditFacilityAxis__custom--TermLoanMember_fKDIp_zrijsbaoVpQl" title="Maturity date">6/21/2026</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--CreditFacilityAxis__custom--TermLoanMember_zWB3b6AMmLT" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Term loan, net"><span style="-sec-ix-hidden: xdx2ixbrl0806">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 7%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 10%; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Line of credit, net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_fKDMp_zRnkx6ePl6d2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Line of credit, net">1,741</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">(3)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_fKDMp_zNoCOzikIoA" title="Maturity date">6/21/2025</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_fKDEp_zdRdH5X3huyk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Line of credit, net">11,444</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">(1)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_c20220101__20221231__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_fKDEp_zBS5jS2VDnjl" title="Maturity date">10/31/2024</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total debt</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--DebtLongtermAndShorttermCombinedAmount_iI_pn3n3_c20231231_z8k873wfVqo3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Line of credit, net">4,622</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--LongTermDebt_iI_pn3n3_c20221231_znualX3h92e3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Line of credit, net">11,444</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Less current portion</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--LongTermDebtCurrent_iI_pn3n3_c20231231_znIj3i0MyQF4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less current portion">4,622</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pn3n3_c20221231_zgu8tovlaVr5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less current portion"><span style="-sec-ix-hidden: xdx2ixbrl0822">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total long-term debt</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--LongTermDebtNoncurrent_iI_pn3n3_c20231231_zLSI66iuLX69" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total long-term debt"><span style="-sec-ix-hidden: xdx2ixbrl0824">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--LongTermDebtNoncurrent_iI_pn3n3_c20221231_zgVJXezOZSzg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total long-term debt">11,444</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0B_zuc3kXauAVpj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zn4bB4kFk709" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest at a variable rate of the daily U.S. Federal Funds Rate plus <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbXBvbmVudHMgb2YgRGVidCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_902_eus-gaap--DebtInstrumentDescriptionOfVariableRateBasis_c20220101__20221231__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember__us-gaap--VariableRateAxis__us-gaap--FederalFundsEffectiveSwapRateMember_z3DMTxfPayFl" title="Basis spread on variable interest rate">375</span> basis points with an interest rate floor of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbXBvbmVudHMgb2YgRGVidCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_ecustom--DebtInstrumentFloorInterestRate_pid_dp_uPure_c20220101__20221231__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember__us-gaap--VariableRateAxis__us-gaap--FederalFundsEffectiveSwapRateMember_zfCnxJO4pQY9" title="Floor interest rate">3.75</span>% per annum.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0C_zZkDcLhRD8Ol" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zcExwYV2BBp1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest at a fixed rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbXBvbmVudHMgb2YgRGVidCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20231231__us-gaap--CreditFacilityAxis__custom--TermLoanMember_zyU3PEiz8RN2" title="Interest at fixed rate">10.00</span>% per annum.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F06_zBsNME9Sp5p8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zdOLRLwutDnd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest at a variable rate of the daily U.S. Federal Funds Rate plus <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbXBvbmVudHMgb2YgRGVidCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_900_eus-gaap--DebtInstrumentDescriptionOfVariableRateBasis_c20230101__20231231__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember__us-gaap--VariableRateAxis__us-gaap--FederalFundsEffectiveSwapRateMember_zQAdglNohpW8" title="Basis spread on variable interest rate">250</span> basis points with an interest rate floor of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbXBvbmVudHMgb2YgRGVidCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_ecustom--DebtInstrumentFloorInterestRate_pid_dp_uPure_c20230101__20231231__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember__us-gaap--VariableRateAxis__us-gaap--FederalFundsEffectiveSwapRateMember_zoRGZYjGtvQb" title="Floor interest rate">5.50</span>% per annum.</span></td></tr> </table> <p id="xdx_8A4_zQnmA0AQVZi2" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Wintrust term loan and lines of credit</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 6, 2021, Halo entered into a credit facility with Old Plank Trail Community Bank, N.A., an affiliate of Wintrust Bank, N.A. (“Wintrust”) consisting of a $<span id="xdx_90E_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn5n6_c20210106__us-gaap--CreditFacilityAxis__custom--TermLoanMember__us-gaap--LineOfCreditFacilityAxis__custom--OldPlankTrailCommunityBankNAMember_zsvEe2bG35a1" title="Maximum borrowing capacity">6.0</span> million term loan and a $<span id="xdx_90D_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn5n6_c20210106__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember__us-gaap--LineOfCreditFacilityAxis__custom--OldPlankTrailCommunityBankNAMember_zP3jjdT93poe" title="Maximum borrowing capacity">6.0</span> million revolving line of credit, each scheduled to mature on <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20210106__20210106__us-gaap--CreditFacilityAxis__custom--TermLoanMember__us-gaap--LineOfCreditFacilityAxis__custom--OldPlankTrailCommunityBankNAMember_ziYD3S8Xv2i6" title="Debt maturity date"><span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_dd_c20210106__20210106__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember__us-gaap--LineOfCreditFacilityAxis__custom--OldPlankTrailCommunityBankNAMember_zcAhYfnqOJx9" title="Debt maturity date">January 6, 2024</span></span> and each bore interest at a variable rate of LIBOR plus <span id="xdx_900_eus-gaap--DebtInstrumentDescriptionOfVariableRateBasis_c20210106__20210106__us-gaap--CreditFacilityAxis__custom--TermLoanMember__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__us-gaap--LineOfCreditFacilityAxis__custom--OldPlankTrailCommunityBankNAMember_zhir6blcZ6A6" title="Basis spread on variable interest rate"><span id="xdx_906_eus-gaap--DebtInstrumentDescriptionOfVariableRateBasis_c20210106__20210106__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__us-gaap--LineOfCreditFacilityAxis__custom--OldPlankTrailCommunityBankNAMember_zrdyjebUwrj1" title="Basis spread on variable interest rate">250</span></span> basis points, with an interest rate floor of <span id="xdx_902_ecustom--DebtInstrumentFloorInterestRate_pid_dp_uPure_c20210106__20210106__us-gaap--CreditFacilityAxis__custom--TermLoanMember__us-gaap--LineOfCreditFacilityAxis__custom--OldPlankTrailCommunityBankNAMember_zUbwMHwVzMFh" title="Floor interest rate"><span id="xdx_902_ecustom--DebtInstrumentFloorInterestRate_pid_dp_uPure_c20210106__20210106__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember__us-gaap--LineOfCreditFacilityAxis__custom--OldPlankTrailCommunityBankNAMember_zNpFZ7UPYokg" title="Floor interest rate">2.50</span></span>% per annum (the “Wintrust Credit Facility”). The Second Wintrust Amendment described below updated the rate at which the Wintrust Credit Facility bore interest to the greater of the daily U.S. Federal Funds Rate plus <span id="xdx_904_eus-gaap--DebtInstrumentDescriptionOfVariableRateBasis_c20210106__20210106__us-gaap--VariableRateAxis__us-gaap--FederalFundsEffectiveSwapRateMember__us-gaap--LineOfCreditFacilityAxis__custom--OldPlankTrailCommunityBankNAMember__us-gaap--TypeOfArrangementAxis__custom--SecondAmendmentMember_zKgYyI9fzwPl" title="Basis spread on variable interest rate">285</span> basis points, or the interest rate floor, which remained unchanged. The Third Wintrust Amendment described below updated the interest rate on the Wintrust Credit Facility to the U.S. Federal Funds Rate plus <span id="xdx_90C_eus-gaap--DebtInstrumentDescriptionOfVariableRateBasis_c20210106__20210106__us-gaap--VariableRateAxis__us-gaap--FederalFundsEffectiveSwapRateMember__us-gaap--LineOfCreditFacilityAxis__custom--OldPlankTrailCommunityBankNAMember__us-gaap--TypeOfArrangementAxis__custom--ThirdAmendmentMember_zCw9GByGRqB1" title="Basis spread on variable interest rate">375</span> basis points, with an interest rate floor of <span id="xdx_905_ecustom--DebtInstrumentFloorInterestRate_pid_dp_uPure_c20210106__20210106__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember_zVVeXWonjMge" title="Floor interest rate">3.75</span>% and extends the maturity date of the Wintrust Credit Facility from <span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDateDescription_c20210106__20210106__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember_zAyUeU3ARCG3" title="Maturity date, description">January 6, 2024 to October 31, 2024</span>. Accrued interest on the Wintrust Credit Facility is payable monthly which commenced on February 1, 2021. Principal payments were required to be made monthly on the term loan commencing February 2021 with a balloon payment upon the original maturity date. The proceeds from the Wintrust Credit Facility were used (i) to repay outstanding principal, interest and fees under the previous revolving line of credit with Citizens Business Bank (the “ABL Facility”) and (ii) for general corporate purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Wintrust Credit Facility subjected the Company to certain financial covenants, including the maintenance of a fixed charge coverage ratio of no less than <span id="xdx_90D_ecustom--FixedChargeCoverageRatioDescription_c20210106__20210106__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_zM8IPWTjCMbi" title="Fixed charge coverage ratio">1.25 to 1.00</span>, tested as of the last day of each fiscal quarter. The numerator in the fixed charge coverage ratio was the operating cash flow of Halo, defined as Halo EBITDA less cash paid for unfinanced Halo capital expenditures, income taxes and dividends. The denominator was fixed charges such as interest expense and principal payments paid or payable on other indebtedness attributable to Halo. As of December 31, 2021, the Company failed to satisfy the fixed charge coverage ratio and entered into a default waiver agreement with Wintrust in which Wintrust waived the existing default through the next testing date, March 31, 2022. As part of the Second Wintrust Amendment described below, the financial covenants were amended to subject the Company to a minimum liquidity covenant test in lieu of a fixed charge coverage ratio which required the Company to maintain liquidity, tested on the last day of each fiscal quarter beginning March 31, 2022, of no less than (i) $<span id="xdx_902_ecustom--DebtInstrumentMinimumLiquidityRequiredToBeMaintained_iI_pn5n6_c20220331__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_zLlerVl3KTOg" title="Liquidity required (no less than)">13.0</span> million as of the last day of each fiscal quarter ending March 31, 2022, through and including the last day of the fiscal quarter ending December 31, 2022 and (ii) $<span id="xdx_90E_ecustom--DebtInstrumentMinimumLiquidityRequiredToBeMaintained_iI_pn5n6_c20230331__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_zmN7YqNiKyu8" title="Liquidity required (no less than)">12.0</span> million as of the last day of the fiscal quarter ending March 31, 2023, and as of the last day of each fiscal quarter thereafter. Furthermore, as part of the Third Wintrust Amendment described below, the financial covenants were further amended to require the Company to maintain a minimum liquidity of $<span id="xdx_90A_ecustom--MinimumLiquidityRequired_iI_pn5n6_c20220930__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_zR94KGBb4cpa" title="Covenant, minimum liquidity required">8.5</span> million tested on the last day of each fiscal quarter beginning September 30, 2022 and thereafter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Wintrust Credit Facility is secured by a general guaranty and security interest on the assets, including the intellectual property, of the Company and its subsidiaries. The Company has also pledged all of the capital stock of Halo held by the Company as additional collateral. Furthermore, the Wintrust Credit Facility was supported by a collateral pledge by a member of the Company’s board of directors; as a result of the First Wintrust Amendment described below, this collateral pledge was terminated and released.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 13, 2021, Halo entered into the first amendment to the Wintrust Credit Facility (the “First Wintrust Amendment”) to increase the revolving line of credit from $<span id="xdx_90E_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn5n6_c20210812__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_zAukxcRLhiRa" title="Maximum borrowing capacity">6.0</span> million to $<span id="xdx_90E_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn5n6_c20210813__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_ziHrPsKzxDHd" title="Maximum borrowing capacity">7.5</span> million. The First Wintrust Amendment also required Halo to secure the credit facility with a pledge of a deposit account in the amount of $<span id="xdx_903_eus-gaap--RestrictedCash_iI_pn5n6_c20210813__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_zWt5rkDNt4t9" title="Restricted cash">7.2</span> million, which was decreased to $<span id="xdx_904_eus-gaap--RestrictedCash_iI_pn5n6_c20220101__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_zpMltSzAKYG1" title="Restricted cash">6.9</span> million on January 1, 2022 and was to further decrease to $<span id="xdx_909_eus-gaap--RestrictedCash_iI_pn5n6_c20230101__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_zSZkGy23HrZb" title="Restricted cash">6.0</span> million on January 1, 2023. Additionally, on March 25, 2022, the Company entered into the second amendment to the Wintrust Credit Facility (the “Second Wintrust Amendment”) which provided for the release of the Company’s Bona Vida subsidiary as a guarantor, an update to the financial covenants as described above and an update to the rate at which the Wintrust Credit Facility bore interest, which is also described above. Furthermore, on October 24, 2022, the Company entered into the third amendment to the Wintrust Credit Facility (the “third Wintrust Amendment”) which provided for an increase to the revolving line of credit from $<span id="xdx_90F_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn5n6_c20210813__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_zoEBXoGQp4kg" title="Maximum borrowing capacity">7.5</span> million to $<span id="xdx_90A_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn5n6_c20221024__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_zETJvWKzAEu7" title="Maximum borrowing capacity">13.5</span> million, set the amount of Halo’s obligation to pledge a deposit account with Wintrust to a fixed amount of $<span id="xdx_901_eus-gaap--RestrictedCash_iI_pn5n6_c20221024__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_zDuC1CrzKLsh" title="Restricted cash">6.3</span> million throughout the remainder of the term and provided updates to the interest rate, maturity date and financial covenants as described above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the Third Wintrust Amendment described above, Halo used a portion of the increased revolving credit facility to repay and retire the outstanding term loan portion of the Wintrust Credit Facility.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 21, 2023, the Company paid off the entire balance in the sum of $<span id="xdx_90D_eus-gaap--RepaymentsOfLongTermLinesOfCredit_pn5n6_c20230621__20230621__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_zN8VVqVCMa0e" title="Payments on revolving line of credit">13.5</span> million of the Wintrust Credit Facility removing any covenant requirements to be met at December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, there was <span id="xdx_901_eus-gaap--LongTermDebt_iI_pp0p0_do_c20231231__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_zqJ5M7sYoad3" title="Long term debt">no</span> outstanding balance related to the Wintrust Credit Facility. As of December 31, 2022, the line of credit outstanding was $<span id="xdx_90D_eus-gaap--LongTermDebt_iI_pn5n6_c20221231__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_zokkx4ARak28" title="Long term debt">11.4</span> million, net of debt issuance costs of less than $<span id="xdx_900_eus-gaap--DeferredFinanceCostsNet_iI_pn5n6_c20221231__us-gaap--DebtInstrumentAxis__custom--WintrustCreditFacilityMember__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_zH89z8m56WN" title="Debt issuance costs">0.2</span> million. Debt issuance costs are amortized using the effective interest method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Wintrust Receivables Credit Facility</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 21, 2023, the Company entered into an account purchase agreement with Wintrust Receivables Finance (AP Agreement), a division of Wintrust Bank N.A. (“Wintrust”) pursuant to which Wintrust will purchase, at its discretion, eligible customer invoices and advance up to <span id="xdx_90C_ecustom--LineOfCreditFacilityEligibleCustomerInvoicesPurchasedPercent_pid_dp_c20230621__20230621__us-gaap--DebtInstrumentAxis__custom--WintrustReceivablesCreditFacilityMember_zUfNzDaVxLlk" title="Face amount advance (up to)">75</span>% of the face amount of all purchased invoices. The maximum outstanding balance can be $<span id="xdx_90F_ecustom--LineOfCreditFacilityEligibleCustomerInvoicesPurchasedMaximum_iI_pn5n6_c20230621__us-gaap--DebtInstrumentAxis__custom--WintrustReceivablesCreditFacilityMember__srt--RangeAxis__srt--MaximumMember_zx7GEjqhMLQg" title="Eligible customer invoices purchased, maximum">4.8</span> million. Each advance under the Advance Purchase Agreement will bear a variable interest rate at the prime rate plus <span id="xdx_90C_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_c20230621__20230621__us-gaap--DebtInstrumentAxis__custom--WintrustReceivablesCreditFacilityMember__us-gaap--VariableRateAxis__us-gaap--PrimeRateMember_z435bMrQX3zl" title="Basis spread on variable interest rate">2.5</span>% percentage per annum. The interest rate at December 31, 2023 was <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20231231__us-gaap--DebtInstrumentAxis__custom--WintrustReceivablesCreditFacilityMember_zebmyVg26b5l" title="Interest rate per annum">11.0</span>% per annum. The AP Agreement has an initial term of <span id="xdx_90B_ecustom--LineOfCreditFacilityContractTerm_dc_c20230621__20230621__us-gaap--DebtInstrumentAxis__custom--WintrustReceivablesCreditFacilityMember_zGWzvSAgM355" title="Initial term of agreement">two years</span> and will automatically renew annually unless terminated by the Company on at least <span id="xdx_903_ecustom--LineOfCreditFacilityRenewalPeriod_dc_c20230621__20230621__us-gaap--DebtInstrumentAxis__custom--WintrustReceivablesCreditFacilityMember_zrxRVavq2xAj" title="Renewal term of agreement">60 days</span>’ notice. The Wintrust Receivables Credit Facility is guaranteed and secured by a general security interest in the assets of the Company. The Company continues to service the receivables, the transfers are at full recourse and the eligible customer invoices are not legally isolated from the Company. As such, the Wintrust Receivables Credit Facility was accounted for as a secured borrowing under ASC 860.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Wintrust Receivables Credit Facility limits or restrict the ability of the Company to incur additional indebtedness; incur additional liens; make dividends and other restricted payments; make investments; sell, assign, transfer or dispose of certain assets; make optional prepayments of other indebtedness; engage in transactions with affiliates; and enter into restrictive agreements. The Wintrust Receivables Credit Facility does not include any financial covenants and if an event of default occurs, Wintrust is entitled to accelerate the advances made thereunder and exercise rights against the collateral.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing under the Wintrust Receivables Credit Facility are classified as current debt as a result of a required lockbox arrangement and a subjective acceleration clause. During the year ended December 31, 2023, the Company sold receivables having an aggregate face value of $<span id="xdx_901_ecustom--AccountsReceivableAggregateFaceValue_pn5n6_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--WintrustReceivablesCreditFacilityMember_zwiQ86Vdffsk" title="Accounts receivable, net">10.5</span> million, in exchange for cash proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromLinesOfCredit_pn5n6_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--WintrustReceivablesCreditFacilityMember_zEYT4FknMjL8" title="Line of credit">7.8</span> million. As of December 31, 2023, the balance outstanding on the Wintrust Receivables Credit Facility amounted to $<span id="xdx_90A_eus-gaap--LinesOfCreditCurrent_iI_pn5n6_c20231231__us-gaap--DebtInstrumentAxis__custom--WintrustReceivablesCreditFacilityMember_zI1xtagLO8e6" title="Line of credit">1.7</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Alphia Term Loan Facility</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 21, 2023, the Company entered into a term loan credit agreement (the “Term Loan Agreement”) with Alphia Inc. (“Alphia”), a custom manufacturer of super-premium pet food in the U.S. Pursuant to the Term Loan Agreement, Alphia made a term loan to the Company in the original principal amount of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20230621__us-gaap--LongtermDebtTypeAxis__us-gaap--LineOfCreditMember__us-gaap--DebtInstrumentAxis__custom--AlphiaTermLoanFacilityMember_zi1jRb0QyTB2" title="Original principal amount">5.0</span> million (the “Term Loan”). In conjunction with the Term Loan Agreement, the Company issued warrants to Alphia (see Note 11 – Warrants for further discussion). The proceeds of the Term Loan, together with a portion of the Company’s cash on hand, were used to retire all of the outstanding obligations of Halo, Purely for Pets, Inc. (“Halo”), a wholly-owned subsidiary of the Company, under Halo’s long-term credit facility with Old Plank Trail Community Bank, N.A., an affiliate of Wintrust Bank, N.A described above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Term Loan bears an interest rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20230621__us-gaap--LongtermDebtTypeAxis__us-gaap--LineOfCreditMember__us-gaap--DebtInstrumentAxis__custom--AlphiaTermLoanFacilityMember_z8KajPDRn655" title="Interest rate per annum">10</span>% per annum, compounded quarterly, and will mature on June 21, 2026. Accrued interest on the Term Loan is payable quarterly in cash or, at the election of the Company, in-kind by capitalizing such interest and adding it to the then-outstanding principal amount of the Term Loan. The Term Loan Agreement provides for customary financial covenants and customary events of default, including, among others, those relating to failure to make payment, bankruptcy, breaches of representations and material adverse effects. The Company was not in compliance with these covenants as of December 31, 2023. The Company may prepay the principal of the Term Loan at any time upon written notice to Alphia and subject to a prepayment penalty if such prepayment occurs prior to June 21, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Term Loan is secured by a general security interest on the assets, including the intellectual property of the Company and Halo pursuant to (i) that certain Term Loan Security Agreement, dated June 21, 2023, made by the Company and Halo in favor of Alphia (the “Security Agreement”) and (ii) that certain Intellectual Property Security Agreement, dated as of June 21, 2023, of the Company and Halo in favor of Alphia (the “Intellectual Property Security Agreement”). The Company has also pledged all of the capital stock of Halo held by the Company as additional collateral for the Term Loan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The term Loan is guaranteed by Halo pursuant to that certain Term Loan Guaranty, dated as of June 21, 2023, by and between Halo and Alphia (the “Term Loan Guaranty”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, the Company’s indebtedness on the Alphia Term Loan Facility is $<span id="xdx_90A_eus-gaap--LineOfCredit_iI_pn5n6_c20231231__us-gaap--LongtermDebtTypeAxis__us-gaap--LineOfCreditMember__us-gaap--DebtInstrumentAxis__custom--AlphiaTermLoanFacilityMember_zIyrU61u60K5" title="Line of credit">5.0</span> million and $<span id="xdx_90B_eus-gaap--PaidInKindInterest_pn5n6_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__us-gaap--LineOfCreditMember__us-gaap--DebtInstrumentAxis__custom--AlphiaTermLoanFacilityMember_z9zgdn4IgjS8" title="Payable in kind interest">0.3</span> million of payable-in-kind (“PIK”) interest. As discussed below, the total value of the consideration received in connection with the Term Loan Agreement was first allocated to the Warrants (as defined in Note 11) at fair value, with the remainder allocated to debt. Accordingly, the Company recorded a debt discount of $<span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn5n6_c20231231__us-gaap--LongtermDebtTypeAxis__us-gaap--LineOfCreditMember__us-gaap--DebtInstrumentAxis__custom--AlphiaTermLoanFacilityMember_zlXdJyRlnSB6" title="Debt discounts">2.2</span> million on the Alphia Term Loan Agreement (see Note 11 for further discussion). Furthermore, the Company incurred debt issuance costs of $<span id="xdx_908_eus-gaap--DeferredFinanceCostsNet_iI_pn5n6_c20231231__us-gaap--LongtermDebtTypeAxis__us-gaap--LineOfCreditMember__us-gaap--DebtInstrumentAxis__custom--AlphiaTermLoanFacilityMember_zJ2oU9E2Beze" title="Debt issuance costs">0.2</span> million. The discount and debt issuance costs associated with the Term Loan Agreement are amortized using the effective interest method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Future Debt Maturities </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89C_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zqO1voVH1bV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future debt maturities as of December 31, 2023 and for succeeding years are as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_z7MzAfNFe5lb" style="display: none">Schedule of Future Debt Maturities</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Year ending December 31:</td><td> </td> <td colspan="2" id="xdx_493_20231231_zvLLSuCqy955"> </td><td> </td></tr> <tr id="xdx_40F_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pn3n3_maLTDzVj1_zmum8yLlVgGk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 80%; text-align: left">2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5,291</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pn3n3_maLTDzVj1_zRWK7mdfAT6h" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">2025</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0931">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_pn3n3_maLTDzVj1_z5Sd9XOQ2AU6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">2026</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0933">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LongTermDebt_iTI_pn3n3_mtLTDzVj1_zYd6KGB7r5t" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,291</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_ztHpvaPQ8Pjj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zQsFfCFj2VA5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The components of the Company’s debt consist of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_z2qnP6SaYBDc" style="display: none">Schedule of Components of Debt</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Aptos; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Rate</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Maturity<br/> date</b></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Rate</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Maturity<br/> date</b></p></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 26%; text-align: left">Term loan, net</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--CreditFacilityAxis__custom--TermLoanMember_fKDIp_zPzN0zM4ODI" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Term loan, net">2,881</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: center">(2)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--CreditFacilityAxis__custom--TermLoanMember_fKDIp_zrijsbaoVpQl" title="Maturity date">6/21/2026</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--CreditFacilityAxis__custom--TermLoanMember_zWB3b6AMmLT" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Term loan, net"><span style="-sec-ix-hidden: xdx2ixbrl0806">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 7%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 10%; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Line of credit, net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_fKDMp_zRnkx6ePl6d2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Line of credit, net">1,741</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">(3)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_fKDMp_zNoCOzikIoA" title="Maturity date">6/21/2025</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_fKDEp_zdRdH5X3huyk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Line of credit, net">11,444</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">(1)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_c20220101__20221231__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember_fKDEp_zBS5jS2VDnjl" title="Maturity date">10/31/2024</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total debt</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--DebtLongtermAndShorttermCombinedAmount_iI_pn3n3_c20231231_z8k873wfVqo3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Line of credit, net">4,622</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--LongTermDebt_iI_pn3n3_c20221231_znualX3h92e3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Line of credit, net">11,444</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Less current portion</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--LongTermDebtCurrent_iI_pn3n3_c20231231_znIj3i0MyQF4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less current portion">4,622</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pn3n3_c20221231_zgu8tovlaVr5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less current portion"><span style="-sec-ix-hidden: xdx2ixbrl0822">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total long-term debt</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--LongTermDebtNoncurrent_iI_pn3n3_c20231231_zLSI66iuLX69" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total long-term debt"><span style="-sec-ix-hidden: xdx2ixbrl0824">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--LongTermDebtNoncurrent_iI_pn3n3_c20221231_zgVJXezOZSzg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total long-term debt">11,444</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0B_zuc3kXauAVpj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zn4bB4kFk709" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest at a variable rate of the daily U.S. Federal Funds Rate plus <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbXBvbmVudHMgb2YgRGVidCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_902_eus-gaap--DebtInstrumentDescriptionOfVariableRateBasis_c20220101__20221231__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember__us-gaap--VariableRateAxis__us-gaap--FederalFundsEffectiveSwapRateMember_z3DMTxfPayFl" title="Basis spread on variable interest rate">375</span> basis points with an interest rate floor of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbXBvbmVudHMgb2YgRGVidCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_ecustom--DebtInstrumentFloorInterestRate_pid_dp_uPure_c20220101__20221231__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember__us-gaap--VariableRateAxis__us-gaap--FederalFundsEffectiveSwapRateMember_zfCnxJO4pQY9" title="Floor interest rate">3.75</span>% per annum.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0C_zZkDcLhRD8Ol" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zcExwYV2BBp1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest at a fixed rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbXBvbmVudHMgb2YgRGVidCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20231231__us-gaap--CreditFacilityAxis__custom--TermLoanMember_zyU3PEiz8RN2" title="Interest at fixed rate">10.00</span>% per annum.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F06_zBsNME9Sp5p8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zdOLRLwutDnd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest at a variable rate of the daily U.S. Federal Funds Rate plus <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbXBvbmVudHMgb2YgRGVidCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_900_eus-gaap--DebtInstrumentDescriptionOfVariableRateBasis_c20230101__20231231__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember__us-gaap--VariableRateAxis__us-gaap--FederalFundsEffectiveSwapRateMember_zQAdglNohpW8" title="Basis spread on variable interest rate">250</span> basis points with an interest rate floor of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbXBvbmVudHMgb2YgRGVidCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_ecustom--DebtInstrumentFloorInterestRate_pid_dp_uPure_c20230101__20231231__us-gaap--CreditFacilityAxis__us-gaap--LineOfCreditMember__us-gaap--VariableRateAxis__us-gaap--FederalFundsEffectiveSwapRateMember_zoRGZYjGtvQb" title="Floor interest rate">5.50</span>% per annum.</span></td></tr> </table> 2881000 2026-06-21 1741000 2025-06-21 11444000 2024-10-31 4622000 11444000 4622000 11444000 375 0.0375 0.1000 250 0.0550 6000000.0 6000000.0 2024-01-06 2024-01-06 250 250 0.0250 0.0250 285 375 0.0375 January 6, 2024 to October 31, 2024 1.25 to 1.00 13000000.0 12000000.0 8500000 6000000.0 7500000 7200000 6900000 6000000.0 7500000 13500000 6300000 13500000 0 11400000 200000 0.75 4800000 0.025 0.110 P2Y P60D 10500000 7800000 1700000 5000000.0 0.10 5000000.0 300000 2200000 200000 <p id="xdx_89C_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zqO1voVH1bV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future debt maturities as of December 31, 2023 and for succeeding years are as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_z7MzAfNFe5lb" style="display: none">Schedule of Future Debt Maturities</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Year ending December 31:</td><td> </td> <td colspan="2" id="xdx_493_20231231_zvLLSuCqy955"> </td><td> </td></tr> <tr id="xdx_40F_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pn3n3_maLTDzVj1_zmum8yLlVgGk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 80%; text-align: left">2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5,291</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pn3n3_maLTDzVj1_zRWK7mdfAT6h" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">2025</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0931">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_pn3n3_maLTDzVj1_z5Sd9XOQ2AU6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">2026</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0933">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LongTermDebt_iTI_pn3n3_mtLTDzVj1_zYd6KGB7r5t" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,291</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 5291000 5291000 <p id="xdx_80D_eus-gaap--FairValueDisclosuresTextBlock_zTvOhRWwn3Ya" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 9 - <span id="xdx_82F_zpEdmwrJ0sii">Fair Value Measurements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of cash and cash equivalents, trade accounts receivable, prepaid expenses and other current assets, accounts payable and accrued expenses approximate fair value because of the short-term nature of these financial instruments. The carrying amounts of borrowings under credit facilities approximates fair value as variable interest rates on these instruments approximates current market rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company estimates the fair value of the term loan based on a discounted cash flow method. The carrying value of the term loan was based on an accounting entry where proceeds from the loan were first allocated to the warrants liabilities. The following table presents the carrying amount and fair value of the Company’s term note and line of credit by hierarchy level:</span></p> <p id="xdx_894_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_z3OK1j0r1YBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zRoP0SKUGnTl" style="display: none">Schedule of Carrying Amount and Fair Value</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value<br/> Hierarchy</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carrying<br/> Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair <br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carrying<br/> Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair <br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 34%; text-align: left">Term loan, net</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">Level 3</td><td style="width: 1%; text-align: left">(2)</td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--TermLoanMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--CarryingReportedAmountFairValueDisclosureMember_fKDIp_zGn0klgkaeDe" style="width: 9%; text-align: right" title="Debt">2,881</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--TermLoanMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--EstimateOfFairValueFairValueDisclosureMember_fKDIp_zHtwHiUx8ml" style="width: 9%; text-align: right" title="Debt">3,314</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TermLoanMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--CarryingReportedAmountFairValueDisclosureMember_fKDIp_zEUAVOvse9r2" style="width: 9%; text-align: right" title="Debt"><span style="-sec-ix-hidden: xdx2ixbrl0945">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TermLoanMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--EstimateOfFairValueFairValueDisclosureMember_fKDIp_zZpXcG18Vck8" style="width: 9%; text-align: right" title="Debt"><span style="-sec-ix-hidden: xdx2ixbrl0947">—</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Line of credit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">Level 2</td><td style="text-align: left">(1)</td> <td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--CarryingReportedAmountFairValueDisclosureMember_fKDEp_z2Ps3K0Li5L3" style="text-align: right" title="Debt">1,741</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--EstimateOfFairValueFairValueDisclosureMember_fKDEp_zR4NHYgWx8dl" style="text-align: right" title="Debt">1,741</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--CarryingReportedAmountFairValueDisclosureMember_fKDEp_zRKK8zu3j6Pa" style="text-align: right" title="Debt">11,444</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--EstimateOfFairValueFairValueDisclosureMember_fKDEp_zSAsqQ16cVX2" style="text-align: right" title="Debt">11,444</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0E_zbLmfOvQtKR4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F15_z4vE6HHe50Bg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the fair value estimates are based upon observable market data</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F06_z72a0MU6qRxa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F15_zPIG3TmVNHi4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the fair value estimates are based on unobservable inputs reflecting management’s assumptions about inputs used in pricing the asset or liability</span></td></tr> </table> <p id="xdx_8A8_zKrTm1XWx1Kg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_z3OK1j0r1YBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zRoP0SKUGnTl" style="display: none">Schedule of Carrying Amount and Fair Value</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value<br/> Hierarchy</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carrying<br/> Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair <br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carrying<br/> Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair <br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 34%; text-align: left">Term loan, net</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">Level 3</td><td style="width: 1%; text-align: left">(2)</td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--TermLoanMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--CarryingReportedAmountFairValueDisclosureMember_fKDIp_zGn0klgkaeDe" style="width: 9%; text-align: right" title="Debt">2,881</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--TermLoanMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--EstimateOfFairValueFairValueDisclosureMember_fKDIp_zHtwHiUx8ml" style="width: 9%; text-align: right" title="Debt">3,314</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TermLoanMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--CarryingReportedAmountFairValueDisclosureMember_fKDIp_zEUAVOvse9r2" style="width: 9%; text-align: right" title="Debt"><span style="-sec-ix-hidden: xdx2ixbrl0945">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TermLoanMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--EstimateOfFairValueFairValueDisclosureMember_fKDIp_zZpXcG18Vck8" style="width: 9%; text-align: right" title="Debt"><span style="-sec-ix-hidden: xdx2ixbrl0947">—</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Line of credit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">Level 2</td><td style="text-align: left">(1)</td> <td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--CarryingReportedAmountFairValueDisclosureMember_fKDEp_z2Ps3K0Li5L3" style="text-align: right" title="Debt">1,741</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--EstimateOfFairValueFairValueDisclosureMember_fKDEp_zR4NHYgWx8dl" style="text-align: right" title="Debt">1,741</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--CarryingReportedAmountFairValueDisclosureMember_fKDEp_zRKK8zu3j6Pa" style="text-align: right" title="Debt">11,444</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--EstimateOfFairValueFairValueDisclosureMember_fKDEp_zSAsqQ16cVX2" style="text-align: right" title="Debt">11,444</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0E_zbLmfOvQtKR4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F15_z4vE6HHe50Bg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the fair value estimates are based upon observable market data</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F06_z72a0MU6qRxa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F15_zPIG3TmVNHi4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the fair value estimates are based on unobservable inputs reflecting management’s assumptions about inputs used in pricing the asset or liability</span></td></tr> </table> 2881000 3314000 1741000 1741000 11444000 11444000 <p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zYOZffoREKMk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 10 – <span id="xdx_82A_zIpala1jTSN1">Commitments and contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has manufacturing agreements with its vendors that provides for the company to make its commercial best efforts to purchase minimum quantities in the ordinary course of business. The Company had <span id="xdx_901_eus-gaap--PurchaseObligation_iI_pdp0_do_c20231231_zIkucOHmFhw8" title="Purchase obligation"><span id="xdx_90D_eus-gaap--PurchaseObligation_iI_pdp0_do_c20221231_zf5vvNbF7Jed" title="Purchase obligation">no</span></span> material purchase obligations as of December 31, 2023 or 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may be involved in legal proceedings, claims, and regulatory, tax, or government inquiries and investigations that arise in the ordinary course of business resulting in loss contingencies. The Company accrues for loss contingencies when losses become probable and are reasonably estimable. If the reasonable estimate of the loss is a range and no amount within the range is a better estimate, the minimum amount of the range is recorded as a liability. Legal costs such as outside counsel fees and expenses are charged to expense in the period incurred and are recorded in SG&amp;A expenses. The Company does not accrue for contingent losses that are considered to be reasonably possible, but not probable; however, the Company discloses the range of such reasonably possible losses. Loss contingencies considered remote are generally not disclosed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Litigation is subject to numerous uncertainties and the outcome of individual claims and contingencies is not predictable. It is possible that some legal matters for which reserves have or have not been established could result in an unfavorable outcome for the Company and any such unfavorable outcome could be of a material nature or have a material adverse effect on the Company’s consolidated financial condition, results of operations and cash flows. Management is not aware of any claims or lawsuits that may have a material adverse effect on the consolidated financial position or results of operations of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_803_ecustom--ClassOfWarrantOrRightDisclosureTextBlock_zQg6QAD061Ue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 11 – <span id="xdx_82C_zSIWBFDlmiQ">Warrants</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_892_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zYnXIMByRbL1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following summarizes the Company’s outstanding warrants to purchase shares of the Company’s common stock as of and for the years ended December 31, 2023 and 2022: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B2_zwkzZLY8Clua" style="display: none">Schedule of Outstanding Warrants</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average<br/> Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Warrants outstanding as of December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20220101__20221231_zfseDelzCvfb" style="width: 16%; text-align: right" title="Warrants outstanding, Balance">214,400</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zUeu4hNSRTI8" style="width: 16%; text-align: right" title="Weighted Average Exercise Price outstanding, Balance">5.92</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20220101__20221231_zpUu1mFNtby5" style="text-align: right" title="Warrants, Issued"><span style="-sec-ix-hidden: xdx2ixbrl0973">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_ztzFI31DG5u8" style="text-align: right" title="Weighted Average Exercise Price, Issued"><span style="-sec-ix-hidden: xdx2ixbrl0975">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20220101__20221231_zE2tLKd4JNjb" style="text-align: right" title="Warrants, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0977">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zYCbiOLPYBef" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0979">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Terminated/Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_pid_c20220101__20221231_znC4HGkr0ic1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants, Terminated/Expired"><span style="-sec-ix-hidden: xdx2ixbrl0981">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_z3DURolJtUIk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Terminated/Expired"><span style="-sec-ix-hidden: xdx2ixbrl0983">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Warrants outstanding as of December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20231231_z3psUoJed27" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, Balance">214,400</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231_zqBKTOLGdex5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price outstanding, Balance">5.92</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20230101__20231231_zBZzpfmlZq41" style="text-align: right" title="Warrants, Issued">335,639</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zEwsf4v3LRe" style="text-align: right" title="Weighted Average Exercise Price, Issued">11.44</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20230101__20231231_zfukYG2t1r98" style="text-align: right" title="Warrants, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0993">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zSFV5N4izg18" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0995">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Terminated/Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_pid_c20230101__20231231_zqtNLpOKRYh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants, Terminated/Expired"><span style="-sec-ix-hidden: xdx2ixbrl0997">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zriiTwR5elia" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Terminated/Expired"><span style="-sec-ix-hidden: xdx2ixbrl0999">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Warrants outstanding as of December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20231231_z0i9tMGpa1P1" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, Balance">550,039</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231_zysF2aP758Ua" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price outstanding, Balance">2.47</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zJmpwLKREnri" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The intrinsic value of outstanding warrants was $<span id="xdx_90E_ecustom--ClassOfWarrantOrRightWarrantsOutstandingIntrinsicValue_iI_do_c20221231_zl0SoRZFnjQl">0.0 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million as of December 31, 2023 and 2022, respectively. The following discussion provides details on the various types of outstanding warrants and the related relevant disclosures around each type.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants shown in the table above outstanding as of December 31, 2022, are equity classified warrants issued between May 2019 and January 2021. There was <span id="xdx_903_ecustom--ClassOfWarrantOrRightWarrantsOutstandingIntrinsicValue_iI_do_c20221231_zWQkpbRQmank" title="Warrants outstanding, intrinsic value">no</span> intrinsic value associated with these equity warrants as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In conjunction with the Alphia Term Loan Facility mentioned in Note 8 - Debt, the Company issued to Alphia (i) a warrant (the “First Tranche Warrant”) to purchase <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20230621__us-gaap--ClassOfWarrantOrRightAxis__custom--FirstTrancheWarrantMember__us-gaap--CreditFacilityAxis__us-gaap--SecuredDebtMember__us-gaap--LongtermDebtTypeAxis__us-gaap--LineOfCreditMember__us-gaap--DebtInstrumentAxis__custom--AlphiaTermLoanFacilityMember_zreVUAVBKZU4" title="Number of warrants converted">148,758</span> shares of the Company’s common stock, par value $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230621__us-gaap--ClassOfWarrantOrRightAxis__custom--FirstTrancheWarrantMember__us-gaap--CreditFacilityAxis__us-gaap--SecuredDebtMember__us-gaap--LongtermDebtTypeAxis__us-gaap--LineOfCreditMember__us-gaap--DebtInstrumentAxis__custom--AlphiaTermLoanFacilityMember_zD7Arjgg5DTc" title="Common stock, par value">0.001</span> per share (“Common Stock”) at a price of $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230621__us-gaap--ClassOfWarrantOrRightAxis__custom--FirstTrancheWarrantMember__us-gaap--CreditFacilityAxis__us-gaap--SecuredDebtMember__us-gaap--LongtermDebtTypeAxis__us-gaap--LineOfCreditMember__us-gaap--DebtInstrumentAxis__custom--AlphiaTermLoanFacilityMember_zV0PYQp797Pj" title="Price per share">11.44</span> per share, and (ii) a warrant (the “Second Tranche Warrant” and together with the First Tranche Warrant, the “Warrants” or the “Alphia Warrants”) to purchase <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20230621__us-gaap--ClassOfWarrantOrRightAxis__custom--SecondTrancheWarrantMember__us-gaap--CreditFacilityAxis__us-gaap--SecuredDebtMember__us-gaap--LongtermDebtTypeAxis__us-gaap--LineOfCreditMember__us-gaap--DebtInstrumentAxis__custom--AlphiaTermLoanFacilityMember_zng3lkslKYMe" title="Number of warrants converted">186,882</span> shares of Common Stock at a price of $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230621__us-gaap--ClassOfWarrantOrRightAxis__custom--SecondTrancheWarrantMember__us-gaap--CreditFacilityAxis__us-gaap--SecuredDebtMember__us-gaap--LongtermDebtTypeAxis__us-gaap--LineOfCreditMember__us-gaap--DebtInstrumentAxis__custom--AlphiaTermLoanFacilityMember_zDtXDsaeExTk" title="Price per share">11.44</span> per share. Unless exercised, the Warrants expire on <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_pid_c20230621__us-gaap--ClassOfWarrantOrRightAxis__custom--SecondTrancheWarrantMember__us-gaap--CreditFacilityAxis__us-gaap--SecuredDebtMember__us-gaap--LongtermDebtTypeAxis__us-gaap--LineOfCreditMember__us-gaap--DebtInstrumentAxis__custom--AlphiaTermLoanFacilityMember_zOXvWXejVP7a" title="Warrants expiration">June 21, 2028</span>. Alphia’s exercise of the Second Tranche Warrant was subject to the approval of the Company’s stockholders and was approved on November 15, 2023. The Warrants contained certain anti-dilution provisions in favor of Alphia in connection with any equity offering consummated by the Company prior to December 21, 2023 and equity issuances below the exercise price of the Warrants. The Warrants also contain a cashless exercise option at the election of Alphia.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally, in conjunction with the Term Loan, the Company entered into a Side Letter Agreement with Alphia (the “Side Letter”) pursuant to which Alphia was granted a right of first refusal on any of the following relating to the Company or any of its subsidiaries and to the extent such transactions constitute a change of control: (i) any transfer, sale, lease or encumbrance of all or any portion of the capital stock or assets (other than the sale of inventory in the ordinary course of business), (ii) any merger, consolidation or other business combination, (iii) any recapitalization, reorganization or any other extraordinary business transaction, (iv) or any equity issuance or debt incurrence. Alphia’s right of first refusal is effective so long as the Term Loan remains outstanding and for a period of <span id="xdx_90C_ecustom--DebtInstrumentRightOfFirstRefusalOutstandingPeriod_dtM_c20230621__20230621__us-gaap--CreditFacilityAxis__us-gaap--SecuredDebtMember__us-gaap--DebtInstrumentAxis__custom--AlphiaTermLoanFacilityMember__us-gaap--LongtermDebtTypeAxis__us-gaap--LineOfCreditMember_z31AJ3Dqfrrg" title="Term loan remains outstanding period">12</span> months thereafter. The Side Letter also provides Alphia with certain Board observer rights.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluated the Alphia Warrants under ASC 815-40, Derivatives and Hedging-Contracts in Entity’s Own Equity (“ASC 815-40”) and concluded they did not initially meet the criteria to be classified in shareholders’ equity. Specifically, there were contingent exercise provisions and settlement provisions that existed, including provisions where the number of shares available under the warrants may be adjusted based on a percentage of equity. Because the number of outstanding common shares was not a fair value input to a fixed-for-fixed model, this provision violated indexation guidance. Therefore, the warrants were not indexed to the Company’s stock. The Alphia warrant liabilities were remeasured at fair value each reporting period until provisions precluding equity classification lapsed and the Company reassessed the warrants classification on December 21, 2023. The total value of the consideration received in connection with the Alphia Term Loan Agreement was first allocated to warrants liabilities at fair value, with the remainder allocated to the Alphia Term Loan Agreement. Accordingly, the Company recorded a discount of $<span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20231231__us-gaap--LongtermDebtTypeAxis__us-gaap--LineOfCreditMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--CarryingReportedAmountFairValueDisclosureMember_zHXrDG5Ku5q9" title="Warrants liabilities">2.2</span> million on the Alphia Term Loan Agreement (see Note 8 – Debt for further discussion).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_ecustom--ScheduleOfWarrantLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zr3ZdgxXzaB4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Alphia warrant liabilities were determined using a risk-neutral Monte Carlo simulation based approach, a Level 3 valuation. The significant inputs to the warrant liabilities were as follows: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B9_z3f4kCPUYL56" style="display: none">Schedule of Significant Inputs to Warrants Liabilities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 21, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">First Tranche<br/> Warrant</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Second Tranche<br/> Warrant</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Exercise price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--FirstTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zSo1VTySGuM1" title="Warrant liabilities, measurement input">11.44</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--SecondTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zNRYgpQNcx66" title="Warrant liabilities, measurement input">11.44</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Stock price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--FirstTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zszii7Vj2k84" title="Warrant liabilities, measurement input">12.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--SecondTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_ztI3snS0x1ng" title="Warrant liabilities, measurement input">12.00</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--FirstTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zFtQTpcZjBFa" title="Warrant liabilities, measurement input">62.0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--SecondTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zml3F6j8FjVe" title="Warrant liabilities, measurement input">62.0</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Time to maturity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--FirstTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zf14ZkkO8vVg" title="Warrant liabilities, time to maturity">5</span> years</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--SecondTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zllQZ6lnxvpi" title="Warrant liabilities, time to maturity">5</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--FirstTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zRcGSratzMX" title="Warrant liabilities, measurement input">3.92</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--SecondTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zIJvjgK6bJ6b" title="Warrant liabilities, measurement input">3.92</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--FirstTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zqvZ1IUTB889" title="Warrant liabilities, measurement input"><span style="-sec-ix-hidden: xdx2ixbrl1046">—</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--SecondTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zoZbwbcFyTzl" title="Warrant liabilities, measurement input"><span style="-sec-ix-hidden: xdx2ixbrl1048">—</span></span></td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8AB_zfqhahccRuhb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_ecustom--ScheduleOfWarrantLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zKWUZY8vtL69" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the Alphia warrant liability activity for twelve months ended December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zT2FlYqYG9pa" style="display: none">Schedule of Warrant Liability Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Balance as of December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeLiabilitiesCurrent_iS_pn3n3_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--WarrantMember_zGdo19eHG24j" style="text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1052">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: left">Warrant liabilities issued</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_pn3n3_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--WarrantMember_zjm1GgrtG5c9" style="width: 16%; text-align: right" title="Warrant liabilities issued">2,208</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in fair value of warrant liabilities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--WarrantMember_zqVAr3JbTx5k" style="text-align: right" title="Change in fair value of warrant liabilities">236</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Reclassification of warrants liabilities to equity</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_ecustom--ClassOfWarrantOrRightReclassificationToEquity_pn3n3_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--WarrantMember_z0OvDejnfwE4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Reclassification of warrants liabilities to equity">(2,444</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Balance as of December 31, 2023</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DerivativeLiabilitiesCurrent_iE_pn3n3_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--WarrantMember_zXgdYJh0zBag" style="text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1060">—</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A2_zJrneKG7vCrl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The change in fair value related to the Alphia warrant liabilities was $<span id="xdx_90D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn5n6_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--WarrantMember_zMdPSerb5qR5" title="Loss (gain) in change of fair value of warrant liabilities">0.2</span> million for the twelve months ended December 31, 2023. There were no transfers to/from levels 1, 2 and 3 during the twelve months ended December 31, 2023. The anti-dilution provisions which previously precluded equity treatment of the warrants, expired on December 21, 2023, and thus the warrants were reclassified and presented in equity as of December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_892_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zYnXIMByRbL1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following summarizes the Company’s outstanding warrants to purchase shares of the Company’s common stock as of and for the years ended December 31, 2023 and 2022: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B2_zwkzZLY8Clua" style="display: none">Schedule of Outstanding Warrants</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average<br/> Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Warrants outstanding as of December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20220101__20221231_zfseDelzCvfb" style="width: 16%; text-align: right" title="Warrants outstanding, Balance">214,400</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zUeu4hNSRTI8" style="width: 16%; text-align: right" title="Weighted Average Exercise Price outstanding, Balance">5.92</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20220101__20221231_zpUu1mFNtby5" style="text-align: right" title="Warrants, Issued"><span style="-sec-ix-hidden: xdx2ixbrl0973">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_ztzFI31DG5u8" style="text-align: right" title="Weighted Average Exercise Price, Issued"><span style="-sec-ix-hidden: xdx2ixbrl0975">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20220101__20221231_zE2tLKd4JNjb" style="text-align: right" title="Warrants, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0977">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zYCbiOLPYBef" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0979">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Terminated/Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_pid_c20220101__20221231_znC4HGkr0ic1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants, Terminated/Expired"><span style="-sec-ix-hidden: xdx2ixbrl0981">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_z3DURolJtUIk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Terminated/Expired"><span style="-sec-ix-hidden: xdx2ixbrl0983">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Warrants outstanding as of December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20231231_z3psUoJed27" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, Balance">214,400</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231_zqBKTOLGdex5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price outstanding, Balance">5.92</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20230101__20231231_zBZzpfmlZq41" style="text-align: right" title="Warrants, Issued">335,639</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zEwsf4v3LRe" style="text-align: right" title="Weighted Average Exercise Price, Issued">11.44</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20230101__20231231_zfukYG2t1r98" style="text-align: right" title="Warrants, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0993">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zSFV5N4izg18" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0995">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Terminated/Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_pid_c20230101__20231231_zqtNLpOKRYh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants, Terminated/Expired"><span style="-sec-ix-hidden: xdx2ixbrl0997">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zriiTwR5elia" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Terminated/Expired"><span style="-sec-ix-hidden: xdx2ixbrl0999">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Warrants outstanding as of December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20231231_z0i9tMGpa1P1" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, Balance">550,039</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231_zysF2aP758Ua" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price outstanding, Balance">2.47</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 214400 5.92 214400 5.92 335639 11.44 550039 2.47 0.0 0 148758 0.001 11.44 186882 11.44 2028-06-21 P12M 2200000 <p id="xdx_897_ecustom--ScheduleOfWarrantLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zr3ZdgxXzaB4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Alphia warrant liabilities were determined using a risk-neutral Monte Carlo simulation based approach, a Level 3 valuation. The significant inputs to the warrant liabilities were as follows: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B9_z3f4kCPUYL56" style="display: none">Schedule of Significant Inputs to Warrants Liabilities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 21, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">First Tranche<br/> Warrant</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Second Tranche<br/> Warrant</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Exercise price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--FirstTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zSo1VTySGuM1" title="Warrant liabilities, measurement input">11.44</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--SecondTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zNRYgpQNcx66" title="Warrant liabilities, measurement input">11.44</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Stock price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--FirstTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zszii7Vj2k84" title="Warrant liabilities, measurement input">12.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--SecondTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_ztI3snS0x1ng" title="Warrant liabilities, measurement input">12.00</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--FirstTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zFtQTpcZjBFa" title="Warrant liabilities, measurement input">62.0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--SecondTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zml3F6j8FjVe" title="Warrant liabilities, measurement input">62.0</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Time to maturity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--FirstTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zf14ZkkO8vVg" title="Warrant liabilities, time to maturity">5</span> years</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--SecondTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zllQZ6lnxvpi" title="Warrant liabilities, time to maturity">5</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--FirstTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zRcGSratzMX" title="Warrant liabilities, measurement input">3.92</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--SecondTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zIJvjgK6bJ6b" title="Warrant liabilities, measurement input">3.92</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--FirstTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zqvZ1IUTB889" title="Warrant liabilities, measurement input"><span style="-sec-ix-hidden: xdx2ixbrl1046">—</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231221__us-gaap--ClassOfWarrantOrRightAxis__custom--SecondTrancheWarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zoZbwbcFyTzl" title="Warrant liabilities, measurement input"><span style="-sec-ix-hidden: xdx2ixbrl1048">—</span></span></td><td style="text-align: left">%</td></tr> </table> 11.44 11.44 12.00 12.00 62.0 62.0 P5Y P5Y 3.92 3.92 <p id="xdx_89E_ecustom--ScheduleOfWarrantLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zKWUZY8vtL69" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the Alphia warrant liability activity for twelve months ended December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zT2FlYqYG9pa" style="display: none">Schedule of Warrant Liability Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Balance as of December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeLiabilitiesCurrent_iS_pn3n3_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--WarrantMember_zGdo19eHG24j" style="text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1052">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: left">Warrant liabilities issued</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_pn3n3_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--WarrantMember_zjm1GgrtG5c9" style="width: 16%; text-align: right" title="Warrant liabilities issued">2,208</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in fair value of warrant liabilities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--WarrantMember_zqVAr3JbTx5k" style="text-align: right" title="Change in fair value of warrant liabilities">236</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Reclassification of warrants liabilities to equity</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_ecustom--ClassOfWarrantOrRightReclassificationToEquity_pn3n3_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--WarrantMember_z0OvDejnfwE4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Reclassification of warrants liabilities to equity">(2,444</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Balance as of December 31, 2023</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DerivativeLiabilitiesCurrent_iE_pn3n3_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--WarrantMember_zXgdYJh0zBag" style="text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1060">—</span></td><td style="text-align: left"> </td></tr> </table> 2208000 236000 -2444000 200000 <p id="xdx_802_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zrzvBGPTKr41" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 12 – <span id="xdx_822_zLWUOre42xUb">Share-based compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023 and December 31, 2022, the Company recognized $<span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20231231_zP03627vhXve" title="Share-based compensation">1.8</span> million and $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20220101__20221231_zSEP47mctipd" title="Share-based compensation">3.0</span> million, respectively, of share-based compensation expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 11, 2019, the Company received shareholder approval for the Amended and Restated 2019 Incentive Award Plan (the “Amended 2019 Plan”). The Amended 2019 Plan provides for the grant of stock options, stock appreciation rights, restricted stock awards, restricted stock units, other stock or cash-based awards or a dividend equivalent award. The Amended 2019 Plan authorized the issuance of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20191110__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_z5FBo0asTSU1" title="Authorized issuance shares of common stock">24,621</span> shares of common stock which was increased to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20191111__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zPve9PLx7cr8" title="Authorized issuance shares of common stock">34,091</span> after the Halo acquisition; the Amended 2019 Plan also provides for an annual increase on the first day of each calendar year beginning on January 1, 2020 and ending on and including January 1, 2029, equal to the lesser of (A) <span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAnnualIncreaseOfEquityAwardAuthorizedPercentOfCommonStockOutstanding_pid_dp_uPure_c20191111__20191111__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zy4EUI3028k5" title="Percent of common stock outstanding">10</span>% of the shares of common stock outstanding (on an as-converted basis) on the last day of the immediately preceding fiscal year and (B) such smaller number of shares of common stock as determined by the Board; provided, however, not more than <span id="xdx_90C_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_uShares_c20191111__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zCs6dMcaYls" title="Authorized common stock issuance">204,546</span> shares of common stock shall be authorized for issuance. The authorized shares for issuance was increased to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20210101__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zMtWf1xfhxF" title="Authorized issuance shares of common stock">61,364</span> on January 1, 2021, increased to <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20220101__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zEoXj7pufP8d" title="Authorized issuance shares of common stock">127,606</span> on January 1, 2022 and again increased to <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20230101__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zlXwry2Dmgo6" title="Authorized issuance shares of common stock">194,493</span> on January 1, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock options</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zCEyevm6dGxk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides detail of the options granted and outstanding (dollars in thousands): </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B3_zvmTH4ZtDrgj" style="display: none">Schedule of Options Granted and Outstanding</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Remaining<br/> Contractual <br/> Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate<br/> Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Options outstanding as of December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20220101__20221231_zc8FG9uDUjdi" style="width: 11%; text-align: right" title="Options Outstanding, Balance">61</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zunmg3o24Hlb" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Balance">6.10</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zCxaXfN3Bdya" title="Weighted Average Remaining Contractual Life (Years), Options outstanding">8.5</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pn3n3_c20220101__20221231_zTrvaBqrURsj" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Options outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1092">—</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231_zGDvLhacaSOi" style="text-align: right" title="Options, Granted">14</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_z9RPDzNroJ9k" style="text-align: right" title="Weighted Average Exercise Price, Granted">2.24</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Forfeited/Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20221231_zb7EYDcBOhnb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Options, Forfeited/Expired">(5</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zKqa5wdad1Fe" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Forfeited/Expired">5.26</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Options outstanding as of December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231_zwfw1BZ1y0Bk" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, Balance">70</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pp2d_c20221231_ztZMYi80Kow7" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance">5.39</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zgKg2yN69yD6" title="Weighted Average Remaining Contractual Life (Years), Options outstanding">7.2</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pn3n3_c20220101__20221231_zkUixcSiO2jl" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Options outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1108">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Options exercisable as of December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231_zLMBzecCM1Ki" style="text-align: right" title="Options, Exercisable">49</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zs3xeXJbqo3i" style="text-align: right" title="Weighted Average Exercise Price, Exercisable">5.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zZK3YSkcHZf8" title="Weighted Average Remaining Contractual Life (Years), Options exercisable">6.5</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pn3n3_c20220101__20221231_z3J56VXtLWjk" style="text-align: right" title="Aggregate Intrinsic Value, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl1116">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Fully vested options as of December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pid_c20220101__20221231_zsNxYQCrTqJ3" style="text-align: right" title="Options, Fully vested">49</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFullyVestedWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zMT7TmJNoZz1" style="text-align: right" title="Weighted Average Exercise Price, Fully vested">5.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedFullyWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zIUDwOI1DlQc" title="Weighted Average Remaining Contractual Life (Years), Options Fully vested">6.5</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFullyVestedIntrinsicValue1_iE_pn3n3_c20220101__20221231_zVMy3CrWA2Oi" style="text-align: right" title="Aggregate Intrinsic Value, Fully vested"><span style="-sec-ix-hidden: xdx2ixbrl1124">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Options expected to vest as of December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestInPeriodFairValue1_pid_c20220101__20221231_zouamnIguOy1" style="text-align: right" title="Options, Option Vested">21</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedVestWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zAAUGsDi72m7" style="text-align: right" title="Weighted Average Exercise Price, Option Expected Vested">4.32</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zq0gn5gRu8u3" title="Weighted Average Remaining Contractual Life (Years), Options Expected vest">8.8</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestIntrinsicValue1_iE_pn3n3_c20220101__20221231_zkqVBP0SLMd1" style="text-align: right" title="Aggregate Intrinsic Value, Options Expected Vest"><span style="-sec-ix-hidden: xdx2ixbrl1132">—</span></td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Remaining<br/> Contractual <br/> Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate<br/> Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Options outstanding as of December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230101__20231231_zSEL1WCVj4S2" style="width: 11%; text-align: right" title="Options Outstanding, Balance">70</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231_zxLC1Xz5UPae" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Balance">5.39</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zso4oOtaMft1" title="Weighted Average Remaining Contractual Life (Years), Options outstanding">7.2</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pn3n3_c20230101__20231231_zB4ZuIAm1Uo4" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value"><span style="-sec-ix-hidden: xdx2ixbrl1140">—</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231_znEzUZUcqeQa" style="text-align: right" title="Options, Granted">5</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zWIJcCkWRP42" style="text-align: right" title="Weighted Average Exercise Price, Granted">0.35</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Forfeited/Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20231231_zu8tIJ5fZkVa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Options, Forfeited/Expired">(21</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20230101__20231231_zYVeldO7HGgf" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Forfeited/Expired">5.19</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Options outstanding as of December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20231231_zWVynBGtB6x6" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, Balance">54</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pp2d_c20231231_zLc1otlOJYRi" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance">5.03</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zeQrLjOOrFA5" title="Weighted Average Remaining Contractual Life (Years), Options outstanding">5.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pn3n3_c20230101__20231231_zE3E3RlFFU96" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value"><span style="-sec-ix-hidden: xdx2ixbrl1156">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Options exercisable as of December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20231231_zpgFzXA8bmB8" style="text-align: right" title="Options, Exercisable">46</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231_zKYMMYYkYg3d" style="text-align: right" title="Weighted Average Exercise Price, Exercisable">5.54</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_z9yO6GymO83k" title="Weighted Average Remaining Contractual Life (Years), Options exercisable">5.2</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pn3n3_c20230101__20231231_zQS9oXptLJRd" style="text-align: right" title="Aggregate Intrinsic Value, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl1164">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Fully vested options as of December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20231231_zqgKsepEOpsk" style="text-align: right" title="Options, Exercisable">46</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFullyVestedWeightedAverageExercisePrice_iE_pid_c20230101__20231231_z2nrkAe3KZ3d" style="text-align: right" title="Weighted Average Exercise Price, Fully vested">5.54</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedFullyWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zWa3WKwW9nE1" title="Weighted Average Remaining Contractual Life (Years), Options Fully vested">5.2</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFullyVestedIntrinsicValue1_iE_pn3n3_c20230101__20231231_zJXqTHEfNw3l" style="text-align: right" title="Aggregate Intrinsic Value, Fully vested"><span style="-sec-ix-hidden: xdx2ixbrl1172">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Options expected to vest as of December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestInPeriodFairValue1_pid_c20230101__20231231_zSkdf2I9sTJ8" style="text-align: right" title="Options, Option Vested">8</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedVestWeightedAverageExercisePrice_iE_pid_c20230101__20231231_zzJpVsTYFzY7" style="text-align: right" title="Weighted Average Exercise Price, Option Expected Vested">1.74</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_z7V1AsxlhgRj" title="Weighted Average Remaining Contractual Life (Years), Options Expected vest">8.9</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestIntrinsicValue1_iE_pn3n3_c20230101__20231231_zwcni4Agfska" style="text-align: right" title="Aggregate Intrinsic Value, Options Expected Vest"><span style="-sec-ix-hidden: xdx2ixbrl1180">—</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AE_zvN5JumgVtp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options granted under the Amended 2019 Plan vest over a period of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dxL_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_ztKIY36bmAte" title="Award vesting period::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1182">two</span></span> to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_zkfrMlvEQjwe" title="Award vesting period">three years</span>. All vested options are exercisable and may be exercised through the <span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dxL_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember__srt--RangeAxis__srt--MaximumMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zeRdQylDTkhd" title="Expiration period::XDX::P10Y"><span style="-sec-ix-hidden: xdx2ixbrl1186">ten-year</span></span> anniversary of the grant date (or such earlier date described in the applicable award agreement).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2023 and 2022, $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zn8T7gqLVrKj" title="Share-based compensation expense">1.0</span> million and $<span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zAyGAOeb6cni" title="Share-based compensation expense">2.4</span> million, respectively, of share-based compensation expense was recognized related to options issued. As of December 31, 2023, unrecognized share-based compensation related to options was $<span id="xdx_905_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn5n6_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zrRZn3c4j6x6" title="Unrecognized share-based compensation related to options">0.2</span> million, which is expected to be recognized over a weighted average period of <span id="xdx_90E_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zNqiRNNOi9qa" title="Period of recognition for unrecognized share-based compensation">0.4</span> years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_z6L67XbANkIk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of an option award is estimated on the date of grant using the Black–Scholes option valuation model, using the following assumptions primarily based on historical data:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zMvzF6jB7pjg" style="display: none">Schedule of Fair Value Assumptions</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years Ended December 31,</b></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Risk-free interest rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20231231_zl5gqmMDne39" title="Risk-free interest rate minimum">0.33</span> - <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20231231_zuOAfeAZIkvh" title="Risk-free interest rate maximum">4.02</span></span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220101__20221231_zGPFsQyZH5W3" title="Risk-free interest rate minimum">1.70</span> - <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220101__20221231_zGWo1ytcbgjf" title="Risk-free interest rate maximum">4.02</span></span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility <sup>(1)</sup></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_fKDEp_zcoglQqqyzH3" title="Expected volatility">0.0</span>% - <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_fKDEp_zJHzmuBy2Sj2" title="Expected volatility">72.5</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_fKDEp_zrw1HmjhwQs5" title="Expected volatility">65.0</span>% - <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_fKDEp_zPBepv0kgGCl" title="Expected volatility">72.5</span></span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230101__20231231_za4ZOvOIucJ" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl1214">—</span></span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20220101__20221231_zHToosFyNMhg" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl1216">—</span></span></span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected life (years) <sup>(2)</sup></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_fKDIp_zxtzNbMgIA68" title="Expected life">0</span> - <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_fKDIp_ziwIcVrGfjq3" title="Expected life">7.6</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_fKDIp_zYYXzLa41HG8" title="Expected life">6.0</span> - <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_fKDIp_zWsBIX4ECmFg" title="Expected life">6.5</span></span></td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0B_zLbvyNOFHFM1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F1A_zG7KDzWHi08j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility was determined using a combination of historical volatility and implied volatility.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0E_zCC97lIxeFE1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F1F_zV3MOyD7MOj4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For certain options, the simplified method is utilized to determine the expected life due to the lack of historical data.</span></td></tr> </table> <p id="xdx_8A2_znAll7gVnLOk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted Stock Awards</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2022, the Company granted <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220201__20220228__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zpTOwMpd1Up" title="Awards granted">4,962</span> shares of restricted common stock to members of its board of directors under the Amended 2019 Plan as compensation for annual board service. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20220201__20220228__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zRTiyq6VdFqb" title="Share-based compensation">0.5</span> million upon issuance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the fourth quarter of 2022, the Company granted <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20221001__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zkprKe6viUh5" title="Awards granted">1,489</span> shares of restricted common stock to a member of its board of directors for service as interim CEO. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of less than $<span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20221001__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zyVRmNG5BZFh" title="Share-based compensation">0.1</span> million upon issuance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2023, the Company granted <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230101__20230131__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zpUOSuFVfG9j" title="Awards granted">20,292</span> shares of restricted common stock to members of its board of directors under the Amended 2019 Plan as compensation for annual board service. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20230131__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zc1ZoDj8TTZb" title="Share-based compensation">0.5</span> million upon issuance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2023, the Company granted <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230101__20230131__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--ExecutivesAndEmployeesMember__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zE9RX9V72dve" title="Awards granted">4,545</span> shares of restricted common stock to certain executives and employees under the Amended 2019 Plan as performance bonus compensation totaling $<span id="xdx_90F_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20230131__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--ExecutivesAndEmployeesMember__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zBnwgwxeB748" title="Share-based compensation">0.1</span> million. These restricted stock awards were issued on the grant date with a one year cliff vesting condition and the Company will recognize the expense over the vesting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first quarter of 2023, the Company granted <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zuXPEPtuw3Zf" title="Awards granted">409</span> shares of restricted common stock to a member of its board of directors for service as interim CEO. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of less than $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zIbAB3ADmlbj" title="Share-based compensation">0.1</span> million upon issuance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the second quarter of 2023, the Company granted <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230401__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--ExecutivesAndEmployeesMember__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zUPJNjDbsayi" title="Awards granted">909</span> shares of restricted common stock to certain executives and employees under the Amended 2019 Plan as performance bonus compensation totaling less than $<span id="xdx_90F_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230401__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--ExecutivesAndEmployeesMember__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zTxOk3pcYHDf" title="Share-based compensation">0.1</span> million. These restricted stock awards were issued on the grant date with a one year cliff vesting condition and the Company will recognize the expense over the vesting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the third quarter of 2023, the Company granted <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230701__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--TwoMemberOfBoardOfDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zxjpyK1OMaNb" title="Awards granted">34,090</span> shares of restricted common stock to two members of its board of directors. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of less than $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230701__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--TwoMemberOfBoardOfDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zjqo5weh98J8" title="Share-based compensation">0.3</span> million upon issuance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1800000 3000000.0 24621 34091 0.10 204546 61364 127606 194493 <p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zCEyevm6dGxk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides detail of the options granted and outstanding (dollars in thousands): </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B3_zvmTH4ZtDrgj" style="display: none">Schedule of Options Granted and Outstanding</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Remaining<br/> Contractual <br/> Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate<br/> Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Options outstanding as of December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20220101__20221231_zc8FG9uDUjdi" style="width: 11%; text-align: right" title="Options Outstanding, Balance">61</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zunmg3o24Hlb" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Balance">6.10</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zCxaXfN3Bdya" title="Weighted Average Remaining Contractual Life (Years), Options outstanding">8.5</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pn3n3_c20220101__20221231_zTrvaBqrURsj" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Options outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1092">—</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231_zGDvLhacaSOi" style="text-align: right" title="Options, Granted">14</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_z9RPDzNroJ9k" style="text-align: right" title="Weighted Average Exercise Price, Granted">2.24</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Forfeited/Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20221231_zb7EYDcBOhnb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Options, Forfeited/Expired">(5</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zKqa5wdad1Fe" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Forfeited/Expired">5.26</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Options outstanding as of December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231_zwfw1BZ1y0Bk" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, Balance">70</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pp2d_c20221231_ztZMYi80Kow7" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance">5.39</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zgKg2yN69yD6" title="Weighted Average Remaining Contractual Life (Years), Options outstanding">7.2</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pn3n3_c20220101__20221231_zkUixcSiO2jl" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Options outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1108">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Options exercisable as of December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231_zLMBzecCM1Ki" style="text-align: right" title="Options, Exercisable">49</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zs3xeXJbqo3i" style="text-align: right" title="Weighted Average Exercise Price, Exercisable">5.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zZK3YSkcHZf8" title="Weighted Average Remaining Contractual Life (Years), Options exercisable">6.5</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pn3n3_c20220101__20221231_z3J56VXtLWjk" style="text-align: right" title="Aggregate Intrinsic Value, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl1116">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Fully vested options as of December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pid_c20220101__20221231_zsNxYQCrTqJ3" style="text-align: right" title="Options, Fully vested">49</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFullyVestedWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zMT7TmJNoZz1" style="text-align: right" title="Weighted Average Exercise Price, Fully vested">5.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedFullyWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zIUDwOI1DlQc" title="Weighted Average Remaining Contractual Life (Years), Options Fully vested">6.5</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFullyVestedIntrinsicValue1_iE_pn3n3_c20220101__20221231_zVMy3CrWA2Oi" style="text-align: right" title="Aggregate Intrinsic Value, Fully vested"><span style="-sec-ix-hidden: xdx2ixbrl1124">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Options expected to vest as of December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestInPeriodFairValue1_pid_c20220101__20221231_zouamnIguOy1" style="text-align: right" title="Options, Option Vested">21</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedVestWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zAAUGsDi72m7" style="text-align: right" title="Weighted Average Exercise Price, Option Expected Vested">4.32</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zq0gn5gRu8u3" title="Weighted Average Remaining Contractual Life (Years), Options Expected vest">8.8</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestIntrinsicValue1_iE_pn3n3_c20220101__20221231_zkqVBP0SLMd1" style="text-align: right" title="Aggregate Intrinsic Value, Options Expected Vest"><span style="-sec-ix-hidden: xdx2ixbrl1132">—</span></td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Remaining<br/> Contractual <br/> Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate<br/> Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Options outstanding as of December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230101__20231231_zSEL1WCVj4S2" style="width: 11%; text-align: right" title="Options Outstanding, Balance">70</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231_zxLC1Xz5UPae" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Balance">5.39</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zso4oOtaMft1" title="Weighted Average Remaining Contractual Life (Years), Options outstanding">7.2</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pn3n3_c20230101__20231231_zB4ZuIAm1Uo4" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value"><span style="-sec-ix-hidden: xdx2ixbrl1140">—</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231_znEzUZUcqeQa" style="text-align: right" title="Options, Granted">5</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zWIJcCkWRP42" style="text-align: right" title="Weighted Average Exercise Price, Granted">0.35</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Forfeited/Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20231231_zu8tIJ5fZkVa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Options, Forfeited/Expired">(21</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20230101__20231231_zYVeldO7HGgf" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Forfeited/Expired">5.19</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Options outstanding as of December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20231231_zWVynBGtB6x6" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, Balance">54</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pp2d_c20231231_zLc1otlOJYRi" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance">5.03</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zeQrLjOOrFA5" title="Weighted Average Remaining Contractual Life (Years), Options outstanding">5.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pn3n3_c20230101__20231231_zE3E3RlFFU96" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value"><span style="-sec-ix-hidden: xdx2ixbrl1156">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Options exercisable as of December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20231231_zpgFzXA8bmB8" style="text-align: right" title="Options, Exercisable">46</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231_zKYMMYYkYg3d" style="text-align: right" title="Weighted Average Exercise Price, Exercisable">5.54</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_z9yO6GymO83k" title="Weighted Average Remaining Contractual Life (Years), Options exercisable">5.2</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pn3n3_c20230101__20231231_zQS9oXptLJRd" style="text-align: right" title="Aggregate Intrinsic Value, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl1164">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Fully vested options as of December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20231231_zqgKsepEOpsk" style="text-align: right" title="Options, Exercisable">46</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFullyVestedWeightedAverageExercisePrice_iE_pid_c20230101__20231231_z2nrkAe3KZ3d" style="text-align: right" title="Weighted Average Exercise Price, Fully vested">5.54</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedFullyWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zWa3WKwW9nE1" title="Weighted Average Remaining Contractual Life (Years), Options Fully vested">5.2</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFullyVestedIntrinsicValue1_iE_pn3n3_c20230101__20231231_zJXqTHEfNw3l" style="text-align: right" title="Aggregate Intrinsic Value, Fully vested"><span style="-sec-ix-hidden: xdx2ixbrl1172">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Options expected to vest as of December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestInPeriodFairValue1_pid_c20230101__20231231_zSkdf2I9sTJ8" style="text-align: right" title="Options, Option Vested">8</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedVestWeightedAverageExercisePrice_iE_pid_c20230101__20231231_zzJpVsTYFzY7" style="text-align: right" title="Weighted Average Exercise Price, Option Expected Vested">1.74</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_z7V1AsxlhgRj" title="Weighted Average Remaining Contractual Life (Years), Options Expected vest">8.9</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpectedVestIntrinsicValue1_iE_pn3n3_c20230101__20231231_zwcni4Agfska" style="text-align: right" title="Aggregate Intrinsic Value, Options Expected Vest"><span style="-sec-ix-hidden: xdx2ixbrl1180">—</span></td><td style="text-align: left"> </td></tr> </table> 61 6.10 P8Y6M 14 2.24 5 5.26 70 5.39 P7Y2M12D 49 5.84 P6Y6M 49 5.84 P6Y6M 21 4.32 P8Y9M18D 70 5.39 P7Y2M12D 5 0.35 21 5.19 54 5.03 P5Y8M12D 46 5.54 P5Y2M12D 46 5.54 P5Y2M12D 8 1.74 P8Y10M24D P3Y 1000000.0 2400000 200000 P0Y4M24D <p id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_z6L67XbANkIk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of an option award is estimated on the date of grant using the Black–Scholes option valuation model, using the following assumptions primarily based on historical data:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zMvzF6jB7pjg" style="display: none">Schedule of Fair Value Assumptions</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years Ended December 31,</b></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Risk-free interest rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20231231_zl5gqmMDne39" title="Risk-free interest rate minimum">0.33</span> - <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20231231_zuOAfeAZIkvh" title="Risk-free interest rate maximum">4.02</span></span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220101__20221231_zGPFsQyZH5W3" title="Risk-free interest rate minimum">1.70</span> - <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220101__20221231_zGWo1ytcbgjf" title="Risk-free interest rate maximum">4.02</span></span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility <sup>(1)</sup></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_fKDEp_zcoglQqqyzH3" title="Expected volatility">0.0</span>% - <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_fKDEp_zJHzmuBy2Sj2" title="Expected volatility">72.5</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_fKDEp_zrw1HmjhwQs5" title="Expected volatility">65.0</span>% - <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_fKDEp_zPBepv0kgGCl" title="Expected volatility">72.5</span></span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230101__20231231_za4ZOvOIucJ" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl1214">—</span></span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20220101__20221231_zHToosFyNMhg" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl1216">—</span></span></span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected life (years) <sup>(2)</sup></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_fKDIp_zxtzNbMgIA68" title="Expected life">0</span> - <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_fKDIp_ziwIcVrGfjq3" title="Expected life">7.6</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_fKDIp_zYYXzLa41HG8" title="Expected life">6.0</span> - <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_fKDIp_zWsBIX4ECmFg" title="Expected life">6.5</span></span></td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0B_zLbvyNOFHFM1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F1A_zG7KDzWHi08j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility was determined using a combination of historical volatility and implied volatility.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0E_zCC97lIxeFE1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F1F_zV3MOyD7MOj4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For certain options, the simplified method is utilized to determine the expected life due to the lack of historical data.</span></td></tr> </table> 0.0033 0.0402 0.0170 0.0402 0.000 0.725 0.650 0.725 P0Y P7Y7M6D P6Y P6Y6M 4962 500000 1489 100000 20292 500000 4545 100000 409 100000 909 100000 34090 300000 <p id="xdx_800_eus-gaap--PensionAndOtherPostretirementBenefitsDisclosureTextBlock_zIwXiHfdGisg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 13 – <span id="xdx_825_zy1c8Ixn8d18">Employee benefit plans</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has a qualified defined contribution 401(k) plan, which covers substantially all of its employees. Participants are entitled to make pre-tax and/or Roth post-tax contributions up to the annual maximums established by the IRS. The Company matches participant contributions pursuant to the terms of the plan, which contributions are limited to a percentage of the participant’s eligible compensation. The Company made contributions related to the plan and recognized expense of $<span id="xdx_909_eus-gaap--DefinedContributionPlanCostRecognized_pn5n6_c20230101__20231231_zV9wgHFQDOki" title="Contribution expenses">0.1</span> million and $<span id="xdx_907_eus-gaap--DefinedContributionPlanCostRecognized_pn5n6_c20220101__20221231_zSumH5EEunP" title="Contribution expenses">0.2</span> million during the years ended December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 100000 200000 <p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zMfqgPPh1Jgd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 14 – <span id="xdx_828_z3vra9SrZCif">Related party transactions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director Fees</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company pays quarterly board of director fees. Board of director fees totaled $<span id="xdx_903_eus-gaap--OperatingCostsAndExpenses_pn5n6_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BoardOfDirectorsMember_zERrFOMqZSt" title="Director fees incurred"><span id="xdx_901_eus-gaap--OperatingCostsAndExpenses_pn5n6_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BoardOfDirectorsMember_zr9yHneeCKv3" title="Director fees incurred">0.3</span></span> million during the years ended December 31, 2023 and 2022. As of December 31, 2023 and 2021, $<span id="xdx_90C_eus-gaap--AccountsPayableCurrent_iI_pn5n6_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zqp8OyA154E4" title="Accounts payable"><span id="xdx_90E_eus-gaap--AccountsPayableCurrent_iI_pn5n6_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_z8A9qqhXPrNf" title="Accounts payable">0.1</span></span> million of these director fees were in accounts payable on the Consolidated Balance Sheets, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Marketing Support Services</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 7, 2023, the Company entered into an agreement with Believeco to provide marketing support services for an interim period. A member of the Company’s board of directors is a partner at Believeco. As of December 31, 2023 marketing expense related to Believeco totaled $<span id="xdx_90B_eus-gaap--MarketingExpense_pn5n6_c20230101__20231231__dei--LegalEntityAxis__custom--BelievecoMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zQuEuQ7BHfac" title="Marketing expense">0.4</span> million of which $<span id="xdx_900_eus-gaap--AccountsPayableCurrent_iI_pn5n6_c20231231__dei--LegalEntityAxis__custom--BelievecoMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zuUAM2Wgg5M3" title="Accounts payable">0.1</span> million is included within Accounts Payable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 300000 300000 100000 100000 400000 100000 <p id="xdx_80A_eus-gaap--IncomeTaxDisclosureTextBlock_zkm8FG7M9yUh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 15 – <span id="xdx_827_ztgiTkm8wFvl">Income taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2023, the Company recorded income tax expense of less than $<span id="xdx_90A_eus-gaap--IncomeTaxExpenseBenefit_pn5n6_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zi108flT4Q13" title="Income tax benefit (expense)">0.1</span> million. For the year ended December 31, 2022, the Company recorded income tax benefit of less than $<span id="xdx_90E_eus-gaap--IncomeTaxExpenseBenefit_pn5n6_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z9iwRmYmyy5b" title="Income tax benefit (expense)">0.1</span> million. For the years ended December 31, 2023 and 2022, the Company’s effective tax rate was <span id="xdx_901_ecustom--EffectiveIncomeTaxRate_pid_dp_c20230101__20231231_zDlOj8CTAYW3" title="Effective tax rate">0</span>%. The Company’s effective tax rate differs from the U.S. federal statutory rate of <span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_c20230101__20231231_zKa4dUdHwkA7" title="Federal statutory rate">21</span>% primarily because the Company’s losses have been fully offset by a valuation allowance due to uncertainty of realizing the tax benefit of net operating losses (“NOLs”) for the years ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_znZOt2tILEs5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table is a reconciliation of the components that caused the Company’s provision for income taxes to differ from amounts computed by applying the U.S. federal statutory rate of 21% (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B1_zRYZYX0jAM27" style="display: none">Schedule of Effective Income Tax Rate Reconciliation</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Statutory U.S. Federal income tax</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_iN_pn3n3_di_maLS_c20230101__20231231_zWAdEKcxtqfb" style="width: 11%; text-align: right" title="Statutory U.S. Federal income tax">(4,782</td><td style="width: 2%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maMP_c20230101__20231231_zYtwUddWHwod" title="Statutory U.S. Federal income tax percentage">21.0</span></td><td style="width: 2%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_iN_pn3n3_di_maLS_c20220101__20221231_zmpNHBFW0PE" style="width: 11%; text-align: right" title="Statutory U.S. Federal income tax">(8,260</td><td style="width: 2%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maMP_c20220101__20221231_zFeqikdHg8a2" title="Statutory U.S. Federal income tax percentage">21.0</span></td><td style="width: 2%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State income taxes, net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_iN_pn3n3_di_maLS_c20230101__20231231_zkyCyS68uJHj" style="text-align: right" title="Statutory U.S. Federal income tax">(309</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maMP_c20230101__20231231_zcFBngAUoZT5" title="State income taxes, net percentage">1.3</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_iN_pn3n3_di_maLS_c20220101__20221231_z0X0ZAnDaw5" style="text-align: right" title="Statutory U.S. Federal income tax">(167</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maMP_c20220101__20221231_zuTNe76fQjH9" title="State income taxes, net percentage">0.4</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Meals and entertainment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_pn3n3_maLS_c20230101__20231231_zNxOvFvpSom5" style="text-align: right" title="Meals and entertainment">5</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_pid_dp_uPure_maMP_c20230101__20231231_z891UryVxt17" title="Meals and entertainment"><span style="-sec-ix-hidden: xdx2ixbrl1306">—</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_pn3n3_maLS_c20220101__20221231_z0NsULVSusmf" style="text-align: right" title="Meals and entertainment"><span style="-sec-ix-hidden: xdx2ixbrl1308">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_pid_dp_uPure_maMP_c20220101__20221231_zWPFDe8nwA4j" title="Meals and entertainment"><span style="-sec-ix-hidden: xdx2ixbrl1310">—</span></span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pn3n3_di_maLS_c20230101__20231231_zQbKAHx5mFs9" style="text-align: right" title="Statutory U.S. Federal income tax">5,031</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maMP_c20230101__20231231_zqRXRHx8PJn" title="Change in valuation allowance percentage">(22.1</span></td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pn3n3_di_maLS_c20220101__20221231_zwAkO8YDYQT7" style="text-align: right" title="Statutory U.S. Federal income tax">5,384</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maMP_c20220101__20221231_z8CnoVJlFap8" title="Change in valuation allowance percentage">(13.7</span></td><td style="text-align: left">)%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Goodwill impairment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_pn3n3_maLS_c20230101__20231231_zdMGW2mfQpL" style="text-align: right" title="Statutory U.S. Federal income tax"><span style="-sec-ix-hidden: xdx2ixbrl1320">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_pid_dp_uPure_maMP_c20230101__20231231_zF4zNdRnu5bl" title="Goodwill impairment percentage"><span style="-sec-ix-hidden: xdx2ixbrl1322">—</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_pn3n3_maLS_c20220101__20221231_zfMIS5Uh8Ov1" style="text-align: right" title="Statutory U.S. Federal income tax">3,802</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_pid_dp_uPure_maMP_c20220101__20221231_zt6j3ipIuk5c" title="Goodwill impairment percentage">(9.7</span></td><td style="text-align: left">)%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrant valuation</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--EffectiveIncomeTaxRateReconciliationWarrantValuationAmount_iN_pn3n3_di_maLS_c20230101__20231231_zKQQBwZ33jU2" style="text-align: right" title="Statutory U.S. Federal income tax">50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--EffectiveIncomeTaxRateReconciliationWarrantValuationPercent_pid_dp_uPure_maMP_c20230101__20231231_z2vIwSCy9M8" title="Warrant valuation percentage">(0.2</span></td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--EffectiveIncomeTaxRateReconciliationWarrantValuationAmount_iN_pn3n3_di_maLS_c20220101__20221231_ziMJlpj2tSgh" style="text-align: right" title="Statutory U.S. Federal income tax"><span style="-sec-ix-hidden: xdx2ixbrl1332">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_ecustom--EffectiveIncomeTaxRateReconciliationWarrantValuationPercent_pid_dp_uPure_maMP_c20220101__20221231_zUtjof0SnQU8" title="Warrant valuation percentage"><span style="-sec-ix-hidden: xdx2ixbrl1334">—</span></span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Tax effect of non-deductible equity instruments</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEquityInstrumentsAmount_iN_pn3n3_di_maLS_c20230101__20231231_zxsbnUmA2Ooj" style="text-align: right" title="Statutory U.S. Federal income tax"><span style="-sec-ix-hidden: xdx2ixbrl1336">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEquityInstrumentsPercent_pid_dp_uPure_maMP_c20230101__20231231_zk83HSniTfO" title="Tax effect of non-deductible equity instruments percentage"><span style="-sec-ix-hidden: xdx2ixbrl1338">—</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEquityInstrumentsAmount_iN_pn3n3_di_maLS_c20220101__20221231_zvCQ8zA0z5Ga" style="text-align: right" title="Statutory U.S. Federal income tax"><span style="-sec-ix-hidden: xdx2ixbrl1340">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEquityInstrumentsPercent_pid_dp_uPure_maMP_c20220101__20221231_zqTEgFt2vani" title="Tax effect of non-deductible equity instruments percentage">0.1</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Return to provision adjustment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_iN_pn3n3_di_maLS_c20230101__20231231_zW62j3Je8l26" style="text-align: right" title="Statutory U.S. Federal income tax">5</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentPercent_pid_dp_uPure_maMP_c20230101__20231231_zMsPB3o0WGFb" title="Return to provision adjustment percentage"><span style="-sec-ix-hidden: xdx2ixbrl1346">—</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_iN_pn3n3_di_maLS_c20220101__20221231_zFZyIXRZWWl" style="text-align: right" title="Statutory U.S. Federal income tax">(5</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentPercent_pid_dp_uPure_maMP_c20220101__20221231_z3x3c525vLK7" title="Return to provision adjustment percentage"><span style="-sec-ix-hidden: xdx2ixbrl1350">—</span></span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeTaxReconciliationOtherAdjustments_iN_pn3n3_di_maLS_c20230101__20231231_zkoTUG65pGM7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Statutory U.S. Federal income tax">2</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxCreditsOther_iN_pid_dpi_uPure_msMP_c20230101__20231231_zLrFasWjamw8" title="Other percentage"><span style="-sec-ix-hidden: xdx2ixbrl1354">—</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationOtherAdjustments_iN_pn3n3_di_maLS_c20220101__20221231_zqDjWS9Qa8j2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Statutory U.S. Federal income tax">(772</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxCreditsOther_iN_pid_dpi_uPure_msMP_c20220101__20221231_zThYIlXI2Lwe" title="Other percentage">2.0</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total provision</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeTaxExpenseBenefit_iT_pn3n3_mtLS_c20230101__20231231_zSUzIQI81zdf" style="border-bottom: Black 2.5pt double; text-align: right" title="Statutory U.S. Federal income tax">2</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_pid_dp_uPure_mtMP_c20230101__20231231_ziFtEYtO1jQa" title="Total provision percentage">0.0</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeTaxExpenseBenefit_iT_pn3n3_mtLS_c20220101__20221231_zNSHioUenOm1" style="border-bottom: Black 2.5pt double; text-align: right" title="Statutory U.S. Federal income tax">(18</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_pid_dp_uPure_mtMP_c20220101__20221231_zUUijBjvMHTe" title="Total provision percentage">0.1</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8AA_zwLkXR6Prkrd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zGzbIfgjLLP4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant components of the Company’s deferred tax assets and liabilities are as follows (in thousands): </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8BB_zz6ZD9RUgzR8" style="display: none">Schedule of Deferred Tax Assets and Liabilities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20231231_zb43YUTMuLGk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20221231_zpRFVaGDcTW9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred income tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGz64Q_zJUTzZOL4mc7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left">Net operating loss carryforwards</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">21,662</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">19,182</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--DeferredTaxAssetsLeasingArrangements_iI_pn3n3_maDTAGz64Q_zTFra5IVMxre" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">ROU assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">42</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pn3n3_maDTAGz64Q_zpkD6HjuJta7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Share-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,320</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,251</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsInventory_iI_pn3n3_maDTAGz64Q_zV1rpufpErR9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Inventory</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">68</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">157</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOther_iI_pn3n3_maDTAGz64Q_zQSWA6Q7KHDb" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,508</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,306</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGz64Q_maDTANzCkR_zdE1TkAS1zQ2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29,586</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,938</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzCkR_zKPuBQ6QSndi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(29,509</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(24,479</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzCkR_msDTLzBZW_zc892POLMPfj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">77</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,459</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred income tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pn3n3_di_maDTLzBZW_zZJSsEysoAYk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Fixed assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(50</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(86</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxLiabilitiesLeasingArrangements_iNI_pn3n3_di_maDTLzBZW_zxzDslYq5XXc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Operating lease liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(27</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(41</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_iNI_pn3n3_di_maDTLzBZW_zUKlh7v0Pbd9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Intangibles</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1400">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,332</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxLiabilities_iTI_pn3n3_mtDTLzBZW_zuyqRHLud3e6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Deferred tax liabilities, net of valuation allowance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1403">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1404">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zCvIm8cAKUNl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, the Company had a deferred tax asset (before valuation allowance) recorded on gross federal and state net operating loss carryforwards of approximately $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zJgYA007fEG5" title="Net operating loss carryforwards">89.7</span> million and $<span id="xdx_903_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z9nCE2XAasH" title="Net operating loss carryforwards">59.3</span> million, respectively. The net operating losses will begin to expire in 2026.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Internal Revenue Code, as amended (“IRC”), imposes restrictions on the utilization of NOLs and other tax attributes in the event of an “ownership change” of a corporation. Accordingly, a company’s ability to use pre-change NOLs may be limited as prescribed under IRC Section 382. Events which may cause limitation in the amount of the NOLs and credits that can be utilized annually include, but are not limited to, a cumulative ownership change of more than 50% over a three-year period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to use the existing deferred tax assets in the future. A significant piece of objective negative evidence evaluated was the cumulative loss incurred through the years ended December 31, 2023 and 2022. Such objective evidence limits the ability to consider other subjective positive evidence such as current year taxable income and future income projections. On the basis of this evaluation, as of December 31, 2023, a valuation allowance of $<span id="xdx_909_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn5n6_di_c20231231_z6HRH4KL501c" title="Valuation allowance">(29.5</span>) million was recorded since it is more likely than not that the deferred tax assets will not be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--SummaryOfValuationAllowanceTextBlock_zbiWTxTeYtdc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in valuation allowance are as follows (in thousands): </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8BF_zWY6615r0Sw1" style="display: none">Schedule of Valuation Allowance</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230101__20231231_zTWBe1Z5sjAi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20220101__20221231_z8PoM6a15kTc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iS_pn3n3_zYuvXc1FuAd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Valuation allowance, at beginning of year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">24,479</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">19,095</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pn3n3_zpR4WDmsx5Te" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Increase in valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,030</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,384</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pn3n3_zGCvxTXZBx68" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Valuation allowance, at end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">29,509</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">24,479</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zmoVglBuZfmg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023 and 2022, the Company does not have any significant uncertain tax positions and as of December 31, 2023 and 2022, the Company had <span id="xdx_900_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_do_c20231231_zXkcrc3rasya" title="Accrued interest and penalties"><span id="xdx_900_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_do_c20221231_zswcOT84moHa" title="Accrued interest and penalties">no</span></span> accrued interest and penalties related to uncertain income tax positions. The Company does not anticipate that the amount of unrecognized tax benefits will significantly increase or decrease within the next twelve months. If incurred, the Company would classify interest and penalties on uncertain tax positions as income tax expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is subject to taxation in the U.S. federal and various state jurisdictions. The Company is not currently under audit by any taxing authorities. The Company remains open to examination by tax jurisdictions for tax years beginning with the 2020 tax year for federal and 2018 for states. Federal and state net operating losses are subject to review by taxing authorities in the year utilized and future years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 100000 100000 0 0.21 <p id="xdx_896_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_znZOt2tILEs5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table is a reconciliation of the components that caused the Company’s provision for income taxes to differ from amounts computed by applying the U.S. federal statutory rate of 21% (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B1_zRYZYX0jAM27" style="display: none">Schedule of Effective Income Tax Rate Reconciliation</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Statutory U.S. Federal income tax</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_iN_pn3n3_di_maLS_c20230101__20231231_zWAdEKcxtqfb" style="width: 11%; text-align: right" title="Statutory U.S. Federal income tax">(4,782</td><td style="width: 2%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maMP_c20230101__20231231_zYtwUddWHwod" title="Statutory U.S. Federal income tax percentage">21.0</span></td><td style="width: 2%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_iN_pn3n3_di_maLS_c20220101__20221231_zmpNHBFW0PE" style="width: 11%; text-align: right" title="Statutory U.S. Federal income tax">(8,260</td><td style="width: 2%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maMP_c20220101__20221231_zFeqikdHg8a2" title="Statutory U.S. Federal income tax percentage">21.0</span></td><td style="width: 2%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State income taxes, net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_iN_pn3n3_di_maLS_c20230101__20231231_zkyCyS68uJHj" style="text-align: right" title="Statutory U.S. Federal income tax">(309</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maMP_c20230101__20231231_zcFBngAUoZT5" title="State income taxes, net percentage">1.3</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_iN_pn3n3_di_maLS_c20220101__20221231_z0X0ZAnDaw5" style="text-align: right" title="Statutory U.S. Federal income tax">(167</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maMP_c20220101__20221231_zuTNe76fQjH9" title="State income taxes, net percentage">0.4</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Meals and entertainment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_pn3n3_maLS_c20230101__20231231_zNxOvFvpSom5" style="text-align: right" title="Meals and entertainment">5</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_pid_dp_uPure_maMP_c20230101__20231231_z891UryVxt17" title="Meals and entertainment"><span style="-sec-ix-hidden: xdx2ixbrl1306">—</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_pn3n3_maLS_c20220101__20221231_z0NsULVSusmf" style="text-align: right" title="Meals and entertainment"><span style="-sec-ix-hidden: xdx2ixbrl1308">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_pid_dp_uPure_maMP_c20220101__20221231_zWPFDe8nwA4j" title="Meals and entertainment"><span style="-sec-ix-hidden: xdx2ixbrl1310">—</span></span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pn3n3_di_maLS_c20230101__20231231_zQbKAHx5mFs9" style="text-align: right" title="Statutory U.S. Federal income tax">5,031</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maMP_c20230101__20231231_zqRXRHx8PJn" title="Change in valuation allowance percentage">(22.1</span></td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pn3n3_di_maLS_c20220101__20221231_zwAkO8YDYQT7" style="text-align: right" title="Statutory U.S. Federal income tax">5,384</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maMP_c20220101__20221231_z8CnoVJlFap8" title="Change in valuation allowance percentage">(13.7</span></td><td style="text-align: left">)%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Goodwill impairment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_pn3n3_maLS_c20230101__20231231_zdMGW2mfQpL" style="text-align: right" title="Statutory U.S. Federal income tax"><span style="-sec-ix-hidden: xdx2ixbrl1320">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_pid_dp_uPure_maMP_c20230101__20231231_zF4zNdRnu5bl" title="Goodwill impairment percentage"><span style="-sec-ix-hidden: xdx2ixbrl1322">—</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_pn3n3_maLS_c20220101__20221231_zfMIS5Uh8Ov1" style="text-align: right" title="Statutory U.S. Federal income tax">3,802</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_pid_dp_uPure_maMP_c20220101__20221231_zt6j3ipIuk5c" title="Goodwill impairment percentage">(9.7</span></td><td style="text-align: left">)%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrant valuation</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--EffectiveIncomeTaxRateReconciliationWarrantValuationAmount_iN_pn3n3_di_maLS_c20230101__20231231_zKQQBwZ33jU2" style="text-align: right" title="Statutory U.S. Federal income tax">50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--EffectiveIncomeTaxRateReconciliationWarrantValuationPercent_pid_dp_uPure_maMP_c20230101__20231231_z2vIwSCy9M8" title="Warrant valuation percentage">(0.2</span></td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--EffectiveIncomeTaxRateReconciliationWarrantValuationAmount_iN_pn3n3_di_maLS_c20220101__20221231_ziMJlpj2tSgh" style="text-align: right" title="Statutory U.S. Federal income tax"><span style="-sec-ix-hidden: xdx2ixbrl1332">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_ecustom--EffectiveIncomeTaxRateReconciliationWarrantValuationPercent_pid_dp_uPure_maMP_c20220101__20221231_zUtjof0SnQU8" title="Warrant valuation percentage"><span style="-sec-ix-hidden: xdx2ixbrl1334">—</span></span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Tax effect of non-deductible equity instruments</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEquityInstrumentsAmount_iN_pn3n3_di_maLS_c20230101__20231231_zxsbnUmA2Ooj" style="text-align: right" title="Statutory U.S. Federal income tax"><span style="-sec-ix-hidden: xdx2ixbrl1336">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEquityInstrumentsPercent_pid_dp_uPure_maMP_c20230101__20231231_zk83HSniTfO" title="Tax effect of non-deductible equity instruments percentage"><span style="-sec-ix-hidden: xdx2ixbrl1338">—</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEquityInstrumentsAmount_iN_pn3n3_di_maLS_c20220101__20221231_zvCQ8zA0z5Ga" style="text-align: right" title="Statutory U.S. Federal income tax"><span style="-sec-ix-hidden: xdx2ixbrl1340">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEquityInstrumentsPercent_pid_dp_uPure_maMP_c20220101__20221231_zqTEgFt2vani" title="Tax effect of non-deductible equity instruments percentage">0.1</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Return to provision adjustment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_iN_pn3n3_di_maLS_c20230101__20231231_zW62j3Je8l26" style="text-align: right" title="Statutory U.S. Federal income tax">5</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentPercent_pid_dp_uPure_maMP_c20230101__20231231_zMsPB3o0WGFb" title="Return to provision adjustment percentage"><span style="-sec-ix-hidden: xdx2ixbrl1346">—</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_iN_pn3n3_di_maLS_c20220101__20221231_zFZyIXRZWWl" style="text-align: right" title="Statutory U.S. Federal income tax">(5</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentPercent_pid_dp_uPure_maMP_c20220101__20221231_z3x3c525vLK7" title="Return to provision adjustment percentage"><span style="-sec-ix-hidden: xdx2ixbrl1350">—</span></span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeTaxReconciliationOtherAdjustments_iN_pn3n3_di_maLS_c20230101__20231231_zkoTUG65pGM7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Statutory U.S. Federal income tax">2</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxCreditsOther_iN_pid_dpi_uPure_msMP_c20230101__20231231_zLrFasWjamw8" title="Other percentage"><span style="-sec-ix-hidden: xdx2ixbrl1354">—</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationOtherAdjustments_iN_pn3n3_di_maLS_c20220101__20221231_zqDjWS9Qa8j2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Statutory U.S. Federal income tax">(772</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxCreditsOther_iN_pid_dpi_uPure_msMP_c20220101__20221231_zThYIlXI2Lwe" title="Other percentage">2.0</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total provision</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeTaxExpenseBenefit_iT_pn3n3_mtLS_c20230101__20231231_zSUzIQI81zdf" style="border-bottom: Black 2.5pt double; text-align: right" title="Statutory U.S. Federal income tax">2</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_pid_dp_uPure_mtMP_c20230101__20231231_ziFtEYtO1jQa" title="Total provision percentage">0.0</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeTaxExpenseBenefit_iT_pn3n3_mtLS_c20220101__20221231_zNSHioUenOm1" style="border-bottom: Black 2.5pt double; text-align: right" title="Statutory U.S. Federal income tax">(18</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_pid_dp_uPure_mtMP_c20220101__20221231_zUUijBjvMHTe" title="Total provision percentage">0.1</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> 4782000 0.210 8260000 0.210 309000 0.013 167000 0.004 5000 -5031000 -0.221 -5384000 -0.137 3802000 -0.097 -50000 -0.002 0.001 -5000 5000 -2000 772000 -0.020 2000 0.000 -18000 0.001 <p id="xdx_894_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zGzbIfgjLLP4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant components of the Company’s deferred tax assets and liabilities are as follows (in thousands): </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8BB_zz6ZD9RUgzR8" style="display: none">Schedule of Deferred Tax Assets and Liabilities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20231231_zb43YUTMuLGk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20221231_zpRFVaGDcTW9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred income tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGz64Q_zJUTzZOL4mc7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left">Net operating loss carryforwards</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">21,662</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">19,182</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--DeferredTaxAssetsLeasingArrangements_iI_pn3n3_maDTAGz64Q_zTFra5IVMxre" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">ROU assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">42</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pn3n3_maDTAGz64Q_zpkD6HjuJta7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Share-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,320</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,251</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsInventory_iI_pn3n3_maDTAGz64Q_zV1rpufpErR9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Inventory</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">68</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">157</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOther_iI_pn3n3_maDTAGz64Q_zQSWA6Q7KHDb" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,508</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,306</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGz64Q_maDTANzCkR_zdE1TkAS1zQ2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29,586</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,938</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzCkR_zKPuBQ6QSndi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(29,509</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(24,479</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzCkR_msDTLzBZW_zc892POLMPfj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">77</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,459</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred income tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pn3n3_di_maDTLzBZW_zZJSsEysoAYk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Fixed assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(50</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(86</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxLiabilitiesLeasingArrangements_iNI_pn3n3_di_maDTLzBZW_zxzDslYq5XXc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Operating lease liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(27</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(41</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_iNI_pn3n3_di_maDTLzBZW_zUKlh7v0Pbd9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Intangibles</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1400">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,332</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxLiabilities_iTI_pn3n3_mtDTLzBZW_zuyqRHLud3e6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Deferred tax liabilities, net of valuation allowance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1403">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1404">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 21662000 19182000 28000 42000 5320000 5251000 68000 157000 2508000 2306000 29586000 26938000 29509000 24479000 77000 2459000 50000 86000 27000 41000 2332000 89700000 59300000 29500000 <p id="xdx_899_eus-gaap--SummaryOfValuationAllowanceTextBlock_zbiWTxTeYtdc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in valuation allowance are as follows (in thousands): </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8BF_zWY6615r0Sw1" style="display: none">Schedule of Valuation Allowance</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230101__20231231_zTWBe1Z5sjAi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20220101__20221231_z8PoM6a15kTc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iS_pn3n3_zYuvXc1FuAd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Valuation allowance, at beginning of year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">24,479</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">19,095</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pn3n3_zpR4WDmsx5Te" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Increase in valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,030</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,384</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pn3n3_zGCvxTXZBx68" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Valuation allowance, at end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">29,509</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">24,479</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 24479000 19095000 5030000 5384000 29509000 24479000 0 0 <p id="xdx_808_eus-gaap--ConcentrationRiskDisclosureTextBlock_zBcV6HRvFFve" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 16 – <span id="xdx_82A_zT4XOw1rkX0l">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Major suppliers</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company sourced approximately <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--InventoriesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_znAfgayrxG8l" title="Concentration risk, percentage">64</span>% of its inventory purchases from two vendors for the year ended December 31, 2023. The Company sourced approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--InventoriesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_z9XRHrSt5Qgj" title="Concentration risk, percentage">69</span>% of its inventory purchases from three vendors for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Major customers</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable from two customers represented <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zWbLi11dlECc" title="Concentration risk, percentage">79</span>% of accounts receivable as of December 31, 2023. Accounts receivable from three customers represented <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_zzEFFQP7BN18" title="Concentration risk, percentage">88</span>% of accounts receivable as of December 31, 2022. Three customers represented <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_z5XIWTdQhvc1" title="Concentration risk, percentage">62</span>% of gross sales for the year ended December 31, 2023. Three customers represented <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_zeRwF0a3cXvd" title="Concentration risk, percentage">58</span>% of gross sales for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Credit risk</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023 and 2022, the Company’s cash and cash equivalents were deposited in accounts at several financial institutions and may maintain some balances in excess of federally insured limits. The Company maintains its cash and cash equivalents with high-quality, accredited financial institutions and, accordingly, such funds are subject to minimal credit risk. The Company has not experienced any losses historically in these accounts and believes it is not exposed to significant credit risk in its cash and cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> 0.64 0.69 0.79 0.88 0.62 0.58 <p id="xdx_80E_eus-gaap--EarningsPerShareTextBlock_zk8X4KqGTKV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 17 – <span id="xdx_82A_zh70T8SjHzYf">Loss per share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company presents loss per share on a basic and diluted basis. Basic (loss) earnings per share is computed by dividing net loss by the weighted average number of common shares outstanding (“WASO”) during the period. Diluted loss per share includes the dilutive effect of common stock equivalents consisting of stock options and warrants using the treasury stock method and convertible notes and preferred stock using the if-converted method. Under the treasury stock method, the amount the holder must pay for exercising stock options or warrants and the amount of average compensation cost for future service that has not yet been recognized are collectively assumed to be used to repurchase shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2023, the Company’s basic and diluted net loss per share attributable to common stockholders are the same as the Company generated a net loss and common stock equivalents are excluded from diluted net loss per share as they have an anti-dilutive impact. Therefore, the Company did not have any dilutive securities and/or other contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. For the year ended December 31, 2022, potentially dilutive securities not included in the calculation of diluted net loss per share, because to do so would be anti-dilutive, are as follows: <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zdUlBIvfBij2">214,400</span> of stock equivalent warrants, <span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockMember_zk2RAhVTPSk7">69,654</span> of stock equivalent employee stock options and <span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OtherOptionMember_zoCjJHt53Nc5">146</span> of stock equivalent other options. For the year ended December 31, 2023, potentially dilutive securities not included in the calculation of diluted net loss per share, because to do so would be anti-dilutive, are as follows: <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantLiabilitiesMember_zECxDd2CyIn8">335,640 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Alphia Warrants (<span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--FirstTrancheWarrantMember_zEmwpA6Wq7Sk">148,758 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First Tranche Warrant and <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SecondTrancheWarrantMember_zCxdnxK2eEC3">186,882 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Tranche Warrant); <span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zekKpCtvXzia">214,400 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of stock equivalent warrants; and <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockMember_z7eGMEqhuO5h">53,285</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of stock equivalent employee stock options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zk9g4HzEexG7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth basic and diluted net (loss) earnings per share attributable to common stockholders for the years ended December 31, 2023 and 2022 (in thousands, except share and per share amounts<i>)</i>: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B4_z5C6YQoh4m2f" style="display: none">Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230101__20231231_zIpi2zAclMd5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220101__20221231_zo1vSguWpEzd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--NetIncomeLoss_pn3n3_maNILATz1QY_zCOOHEPjxRZ7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left">Net loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(22,770</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(39,316</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_406_ecustom--WarrantModificationsAdjustment_pn3n3_msNILATz1QY_z3YqiVUlvd5k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Less: Adjustment due to warrant modifications</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1456">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1457">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_pn3n3_mtNILATz1QY_zcVE8WKlR6Za" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Adjusted net loss available to common stockholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(22,770</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(39,316</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_zVhWfAdNnTJd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Basic WASO</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">705,185</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">667,114</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_zjrzB3jQy8bd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Dilutive common stock equivalents</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1465">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1466">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_zvl12PT0dsT1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Diluted WASO</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">705,185</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">667,114</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--EarningsPerShareBasic_pid_zLbOcViROHsj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders, basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(32.29</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(58.93</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--EarningsPerShareDiluted_pid_z9TUR4n1tgpa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders, diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(32.29</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(58.93</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8AE_zHYAXnywK892" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 214400 69654 146 335640 148758 186882 214400 53285 <p id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zk9g4HzEexG7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth basic and diluted net (loss) earnings per share attributable to common stockholders for the years ended December 31, 2023 and 2022 (in thousands, except share and per share amounts<i>)</i>: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B4_z5C6YQoh4m2f" style="display: none">Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230101__20231231_zIpi2zAclMd5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220101__20221231_zo1vSguWpEzd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--NetIncomeLoss_pn3n3_maNILATz1QY_zCOOHEPjxRZ7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left">Net loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(22,770</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(39,316</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_406_ecustom--WarrantModificationsAdjustment_pn3n3_msNILATz1QY_z3YqiVUlvd5k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Less: Adjustment due to warrant modifications</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1456">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1457">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_pn3n3_mtNILATz1QY_zcVE8WKlR6Za" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Adjusted net loss available to common stockholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(22,770</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(39,316</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_zVhWfAdNnTJd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Basic WASO</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">705,185</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">667,114</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_zjrzB3jQy8bd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Dilutive common stock equivalents</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1465">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1466">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_zvl12PT0dsT1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Diluted WASO</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">705,185</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">667,114</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--EarningsPerShareBasic_pid_zLbOcViROHsj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders, basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(32.29</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(58.93</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--EarningsPerShareDiluted_pid_z9TUR4n1tgpa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders, diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(32.29</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(58.93</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> -22770000 -39316000 -22770000 -39316000 705185 667114 705185 667114 -32.29 -58.93 -32.29 -58.93 <p id="xdx_803_eus-gaap--SubsequentEventsTextBlock_zPuUSmGbvvu" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 18 – <span id="xdx_823_zH1j5LhR2eqj">Subsequent events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 9, 2024, the Company announced the acquisition of all the issued and outstanding common shares of Aimia Pet Healthco, Inc. for consideration consisting of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240209__20240209__us-gaap--BusinessAcquisitionAxis__custom--AimiaPetHealthcoIncMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpfjNvE5hJ1j" title="Number of shares of common stock">45,629</span> shares of common stock of the Company. The Company has not yet completed its evaluation of certain assets and liabilities acquired, or treatment of this transaction as either a business combination or asset acquisition in accordance with Topic 805.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2024, the Company granted <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20240201__20240229__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember_zNIbsKAgcyFh" title="Restricted shares, granted">42,088</span> shares of restricted common stock to members of its Board of Directors as part of their equity compensation pursuant to the Amended and Restated 2019 Incentive Award Plan. These restricted stock awards were immediately vested and, as such, the Company recorded share-based compensation expense of $<span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20240201__20240229__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--TwoThousandNineteenIncentiveAwardPlanMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zLEOpZ8IiHFh" title="Share based compensation expense">0.4</span> million upon issuance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 25, 2024, Better Choice Company, Inc. (“BTTR”) initiated a legal action to enforce a right of first refusal (“ROFR”) option exercised by Alphia, Inc. (“Alphia”), which is controlled by a Paris-based private equity firm, PAI Partners. The Company is unable to predict the outcome or impact on its business and financial results.</span></p> 45629 42088 400000 The Company’s E-commerce channel includes two customers that amounted to greater than 10% of the Company’s total net sales. These customers had $5.9 million and $7.1 million of net sales for the year ended December 31, 2023, respectively and $7.5 million and $6.6 million of net sales for the year ended December 31, 2022, respectively. One of the Company’s International customers that distributes products in China amounted to greater than 10% of the Company’s total net sales during the years ended December 31, 2023 and December 31, 2022 and represented $11.0 million and $17.7 million of net sales, respectively. On August 28, 2019, the Company entered into a radio advertising agreement with iHeart Media + Entertainment, Inc. (“iHeart”) and issued 166,667 shares of common stock valued at $3.4 million for future advertising services. The Company issued an additional 20,834 shares valued at $0.1 million on March 5, 2020 pursuant to the agreement. The current portion of the remaining value, reflected above, is the remaining value of services that the Company expects to utilize within the twelve months following the reporting period date, unless the term is extended. The Company utilized the remaining advertising services during the year ended December 31, 2022. Interest at a variable rate of the daily U.S. Federal Funds Rate plus 375 basis points with an interest rate floor of 3.75% per annum. Interest at a fixed rate of 10.00% per annum. Interest at a variable rate of the daily U.S. Federal Funds Rate plus 250 basis points with an interest rate floor of 5.50% per annum. the fair value estimates are based upon observable market data the fair value estimates are based on unobservable inputs reflecting management’s assumptions about inputs used in pricing the asset or liability Expected volatility was determined using a combination of historical volatility and implied volatility. For certain options, the simplified method is utilized to determine the expected life due to the lack of historical data.